LAB_LOINC,RAW_LAB_NAME,n
,"POCT URINALYSIS DIPSTICK, AUTO W/O MICRO",163586
,RAPID COVID-19 ABBOTT IDNOW,12553
,URINALYSIS WITH CULTURE IF INDICATED,169009
,COVID-19 RT-PCR,13847
,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,114978
,AUTO DIFF SYSMEX,144057
,POCT URINE CHEMISTRY UNSOLICITED RESULTS,18873
94500-6,COVID-19 RT-PCR,16249
5792-7,URINALYSIS WITH CULTURE IF INDICATED,37043
50551-1,URINALYSIS WITH CULTURE IF INDICATED,37097
5802-4,URINALYSIS WITH CULTURE IF INDICATED,37443
5797-6,URINALYSIS WITH CULTURE IF INDICATED,37043
50563-6,URINALYSIS WITH CULTURE IF INDICATED,37040
58413-6,CBC WITH AUTO DIFFERENTIAL,123953
771-6,CBC WITH AUTO DIFFERENTIAL,123948
,"POCT PREGNANCY, URINE",5186
,POCT RAPID STREP A,947
42254-3,ANA,296
94759-8,RAPID COVID-19 ABBOTT IDNOW,22032
,"PREGNANCY, URINE",191
94500-6,SARS-COV-2 RT-PCR,10237
,SARS-COV-2 RT-PCR,6087
69002-4,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,866
704-7,CBC WITH AUTO DIFFERENTIAL,125032
,CHLAMYDIA/GC DNA PCR,2284
69002-4,THINPREP PAP AND HPV MRNA E6/E7,103
,HM CERVICAL HRHPV,122
,HM CERVICAL CYTOLOGY,207
43304-5,"SURESWAB(R), ADVANCED VAGINITIS PLUS",829
72391-6,"SURESWAB(R), ADVANCED VAGINITIS PLUS",820
72495-5,"SURESWAB(R), ADVANCED VAGINITIS PLUS",822
69563-5,"SURESWAB(R), ADVANCED VAGINITIS PLUS",824
,POCT URINE HCG QUALITATIVE UNSOLICITED RESULTS,715
43305-2,"SURESWAB(R), ADVANCED VAGINITIS PLUS",820
74669-3,"SURESWAB(R), ADVANCED VAGINITIS PLUS",829
74667-7,"SURESWAB(R), ADVANCED VAGINITIS PLUS",820
74762-6,"SURESWAB(R), ADVANCED VAGINITIS PLUS",820
46154-1,"SURESWAB(R), ADVANCED VAGINITIS PLUS",829
62460-1,"SURESWAB(R), ADVANCED VAGINITIS PLUS",829
5804-0,URINALYSIS WITH CULTURE IF INDICATED,37090
27297-1,URINALYSIS WITH CULTURE IF INDICATED,37042
53290-3,URINALYSIS WITH CULTURE IF INDICATED,37070
53115-2,CBC WITH DIFFERENTIAL,3398
71695-1,CBC WITH DIFFERENTIAL,3406
69002-4,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",281
2106-3,"PREGNANCY, URINE",5889
43304-5,CHLAMYDIA/GC DNA PCR,4167
24111-7,CHLAMYDIA/GC DNA PCR,4167
6568-0,VAGINITIS PANEL,1670
6410-5,VAGINITIS PANEL,1670
47000-5,VAGINITIS PANEL,1670
59420-0,"IGP, APTIMA HPV, RFX 16/18,45",294
94500-6,SARS-COV-2/FLU/RSV,17190
92142-9,SARS-COV-2/FLU/RSV,17172
92141-1,SARS-COV-2/FLU/RSV,17173
92131-2,SARS-COV-2/FLU/RSV,17173
704-7,CBC WITH DIFFERENTIAL,16010
42931-6,CHLAMYDIA/N.GONORRHOEAE RNA TMA URINE,594
60256-5,CHLAMYDIA/N.GONORRHOEAE RNA TMA URINE,583
,"GROUP B STREPTOCOCCUS COLONIZATION DETECTION, NAA",793
,"RUBELLA ANTIBODY, IGG",1952
,HEPATITIS B SURFACE ANTIGEN,2652
,"HCG, SERUM, QUALITATIVE",682
5770-3,URINALYSIS WITH MICROSCOPIC LEGACY,360
2514-8,URINALYSIS WITH MICROSCOPIC LEGACY,359
5802-4,URINALYSIS WITH MICROSCOPIC LEGACY,363
25428-4,URINALYSIS WITH MICROSCOPIC LEGACY,265
5794-3,URINALYSIS WITH MICROSCOPIC LEGACY,359
20454-5,URINALYSIS WITH MICROSCOPIC LEGACY,359
,URINALYSIS WITH REFLEX MICROSCOPIC,35901
2118-8,"HCG, SERUM, QUALITATIVE",9785
53115-2,CBC WITH AUTO DIFFERENTIAL,120872
71695-1,CBC WITH AUTO DIFFERENTIAL,120868
711-2,CBC WITH AUTO DIFFERENTIAL,125031
5770-3,URINALYSIS WITH CULTURE IF INDICATED,397
2514-8,URINALYSIS WITH CULTURE IF INDICATED,397
5799-2,URINALYSIS WITH CULTURE IF INDICATED,399
5794-3,URINALYSIS WITH CULTURE IF INDICATED,397
20454-5,URINALYSIS WITH CULTURE IF INDICATED,397
53115-2,T-HELPER CELLS (CD4) COUNT,71
71695-1,T-HELPER CELLS (CD4) COUNT,71
,"COTININE, URINE",390
,HEPATITIS B SURFACE ANTIBODY,432
,HEPATITIS C ANTIBODY,1220
,RUBEOLA ANTIBODY IGG,176
,QUANTIFERON-TB GOLD PLUS,2525
,"VARICELLA ZOSTER ANTIBODY, IGG",711
,"MUMPS ANTIBODY, IGG",170
62461-9,NUSWAB VAGINITIS PLUS (VG+),297
45084-1,NUSWAB VAGINITIS PLUS (VG+),297
69562-7,NUSWAB VAGINITIS PLUS (VG+),297
69563-5,NUSWAB VAGINITIS PLUS (VG+),297
32705-6,NUSWAB VAGINITIS PLUS (VG+),297
,MANUAL DIFFERENTIAL,40034
,SARS-COV-2/FLU/RSV,11640
,TYPE AND SCREEN,63850
6437-8,RAPID INFLUENZA A/B ANTIGENS,1494
31971-5,RAPID STREP SCREEN,1430
704-7,T-HELPER CELLS (CD4) COUNT,71
,ECG 12-LEAD,699909
,CHLAMYDIA SCREEN,35
,RAPID HIV 1&2 SCREEN,670
43305-2,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",220
43304-5,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",220
16130-7,"SURESWAB(R), HSV TYPE 1/2 MRNA, TMA",62
16131-5,"SURESWAB(R), HSV TYPE 1/2 MRNA, TMA",61
5196-1,HEPATITIS B SURFACE ANTIGEN,14669
43304-5,"SURESWAB(R), C. TRACHOMATIS / N. GONORRHOEAE/ T.VAGINALIS",233
43305-2,"SURESWAB(R), C. TRACHOMATIS / N. GONORRHOEAE/ T.VAGINALIS",233
46154-1,"SURESWAB(R), C. TRACHOMATIS / N. GONORRHOEAE/ T.VAGINALIS",233
2106-3,POCT URINE HCG QUALITATIVE UNSOLICITED RESULTS,2503
5804-0,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
5792-7,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
5770-3,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
5797-6,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
5802-4,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7055
,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",371
5792-7,URINALYSIS WITH REFLEX MICROSCOPIC,7043
53290-3,URINALYSIS WITH REFLEX MICROSCOPIC,7048
50551-1,URINALYSIS WITH REFLEX MICROSCOPIC,7051
27297-1,URINALYSIS WITH REFLEX MICROSCOPIC,7043
5802-4,URINALYSIS WITH REFLEX MICROSCOPIC,9734
5797-6,URINALYSIS WITH REFLEX MICROSCOPIC,7043
50563-6,URINALYSIS WITH REFLEX MICROSCOPIC,7042
43304-5,"C TRACHOMATIS/N GONORRHOEAE RNA, TMA, UROGENITAL",77
43305-2,"C TRACHOMATIS/N GONORRHOEAE RNA, TMA, UROGENITAL",76
43305-2,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",275
43304-5,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",275
,CHLAMYDIA TRACHOMATIS DNA PCR,1246
,NEISSERIA GONORRHOEAE DNA PCR,772
22322-2,HEPATITIS B SURFACE ANTIBODY,7978
13955-0,HEPATITIS C ANTIBODY,15702
94500-6,"SARS-COV-2, NAA",208508
5770-3,URINALYSIS WITH REFLEX MICROSCOPIC,2690
2514-8,URINALYSIS WITH REFLEX MICROSCOPIC,2691
5799-2,URINALYSIS WITH REFLEX MICROSCOPIC,2689
25428-4,URINALYSIS WITH REFLEX MICROSCOPIC,2311
5794-3,URINALYSIS WITH REFLEX MICROSCOPIC,2690
20454-5,URINALYSIS WITH REFLEX MICROSCOPIC,2691
713-8,CBC WITH AUTO DIFFERENTIAL,125051
706-2,"Q DIFFERENTIAL, MANUAL",105
704-7,"Q DIFFERENTIAL, MANUAL",105
711-2,CBC WITH DIFFERENTIAL,16009
713-8,CBC WITH DIFFERENTIAL,16010
706-2,CBC WITH DIFFERENTIAL,16010
2349-9,URINALYSIS WITH REFLEX MICROSCOPIC,380
6864-3,SICKLE CELL SCREEN,3027
,ANTIBODY SCREEN,3917
,AFP4-GENZYME,300
,"PROTEIN ELECTROPHORESIS, SERUM",2674
5770-3,"UA/M W/RFLX CULTURE, COMP",707
2514-8,"UA/M W/RFLX CULTURE, COMP",707
5799-2,"UA/M W/RFLX CULTURE, COMP",707
5802-4,"UA/M W/RFLX CULTURE, COMP",707
25428-4,"UA/M W/RFLX CULTURE, COMP",627
5794-3,"UA/M W/RFLX CULTURE, COMP",706
20454-5,"UA/M W/RFLX CULTURE, COMP",707
32693-4,"COTININE, URINE",1615
5804-0,URINALYSIS WITH REFLEX MICROSCOPIC,7049
91847-4,GROUP B STREP PCR,283
,VIRAL ATYPICAL PNEUMONIA PCR PANEL,6351
,"POCT URINALYSIS DIPSTICK, NON-AUTO W/O MICRO",7459
,"HEPATITIS PANEL, ACUTE",2207
82675-0,THINPREP PAP AND HPV DNA,15
,MONONUCLEOSIS SCREEN,15
8061-4,ANACHOICE(R) SCREEN WITH REFLEX,100
8061-4,ANA,37
48683-7,"GROUP B STREPTOCOCCUS COLONIZATION DETECTION, NAA",397
43304-5,C. TRACHOMATIS / N. GONORRHOEAE BY NAA,2213
43305-2,C. TRACHOMATIS / N. GONORRHOEAE BY NAA,2199
13950-1,"HEPATITIS PANEL, ACUTE",3261
24113-3,"HEPATITIS PANEL, ACUTE",3261
5196-1,"HEPATITIS PANEL, ACUTE",3254
13955-0,"HEPATITIS PANEL, ACUTE",3140
,"NEISSERIA GONORRHEA DNA, QUANTITATIVE",473
69002-4,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",143
43304-5,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,19
43305-2,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,19
5799-2,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7069
706-2,CBC WITH AUTO DIFFERENTIAL,125053
,HM COLONOSCOPY,1004
5794-3,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
,"UA/M W/RFLX CULTURE, COMP",246
,ANA,330
43304-5,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",136
43305-2,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",136
69002-4,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",137
94563-4,"SARS-COV-2 SEROLOGY (COVID-19) ANTIBODIES (IGG, IGM), IMMUNOY",66
94564-2,"SARS-COV-2 SEROLOGY (COVID-19) ANTIBODIES (IGG, IGM), IMMUNOY",66
547-0,L - STREP GP B CULTURE - 188130 LEGACY,25
,GROUP B STREP PCR,50
69002-4,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",598
60489-2,STREP A PCR,1211
,STREP A PCR,210
31418-7,MONONUCLEOSIS SCREEN,260
,VAGINITIS PANEL,560
48159-8,HEPATITIS C ANTIBODY,2200
77400-0,HPV HIGH RISK PCR,294
77399-4,HPV HIGH RISK PCR,294
71431-1,HPV HIGH RISK PCR,294
77379-6,HPV HIGH RISK PCR,294
,POCT SARS-COV-2/FLU PCR CEPHEID,288
,POCT SARS-COV-2/FLU RAPID,1678
24111-7,NEISSERIA GONORRHOEAE DNA PCR,34
24385-7,"CARDIOLIPIN ANTIBODY, IGG",356
24386-5,"CARDIOLIPIN ANTIBODY, IGM",360
30470-9,"CARDIOLIPIN ANTIBODY, IGA",360
43304-5,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",135
43305-2,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",133
25428-4,URINALYSIS WITH CULTURE IF INDICATED,328
50388-8,"IGP, CTNG, RFX APTIMA HPV ASCU",101
50387-0,"IGP, CTNG, RFX APTIMA HPV ASCU",101
68961-2,RAPID HIV 1&2 SCREEN,170
81641-3,RAPID HIV 1&2 SCREEN,170
80203-3,RAPID HIV 1&2 SCREEN,170
25835-0,HIV RNA QL  083950,163
25514-1,"RUBELLA ANTIBODY, IGG",2032
22415-4,"MUMPS ANTIBODY, IGG",642
20479-2,RUBEOLA ANTIBODY IGG,651
20454-5,"UA/M W/RFLX CULTURE, ROUTINE",137
2349-9,"UA/M W/RFLX CULTURE, ROUTINE",108
5802-4,"UA/M W/RFLX CULTURE, ROUTINE",136
5770-3,"UA/M W/RFLX CULTURE, ROUTINE",136
5799-2,"UA/M W/RFLX CULTURE, ROUTINE",134
2514-8,"UA/M W/RFLX CULTURE, ROUTINE",137
5794-3,"UA/M W/RFLX CULTURE, ROUTINE",134
53115-2,CBC/DIFF AMBIGUOUS DEFAULT,718
71695-1,CBC/DIFF AMBIGUOUS DEFAULT,719
51916-5,"HSV 1 AND 2 SPECIFIC ANTIBODIES IGG, SERUM MAYO (HSVG)",235
6568-0,BV/VAGINITIS PANEL DNA PROBE,110
6410-5,BV/VAGINITIS PANEL DNA PROBE,107
47000-5,BV/VAGINITIS PANEL DNA PROBE,107
69002-4,"Q HPV MRNA E6/E7 REFLEX HPV 16, 18/45",152
94563-4,SARS-COV2 IGG N PROTEIN,5350
,CYTOPLASMIC NEUTROPHILIC ANTIBODY-MAYO,96
,ENTERIC BACTERIAL PATHOGEN PCR,340
,C.DIFFICILE SCREEN,216
,"HSV 1 AND 2 SPECIFIC ANTIBODIES IGG, SERUM MAYO (HSVG)",76
,POCT SARS-COV-2 IDNOW,342
,URINALYSIS WITH MICROSCOPIC LEGACY,1587
,CBC WITH AUTO DIFFERENTIAL,26479
,POCT OCCULT BLOOD STOOL,465
,HPV HIGH RISK PCR,209
75983-7,QNATAL(R) ADVANCED,56
77021-4,QNATAL(R) ADVANCED,56
75982-9,QNATAL(R) ADVANCED,56
75981-1,QNATAL(R) ADVANCED,56
13954-3,HEPATITIS B E ANTIGEN,60
,ANTIMITOCHONDRIAL ANTIBODY,29
,DAT POSITIVE LEGACY,87
74668-5,"SURESWAB(R), ADVANCED VAGINITIS PLUS",820
,"RUBELLA ANTIBODY, IGM",7
79177-2,C.DIFFICILE SCREEN,1414
13952-7,"HEPATITIS B CORE ANTIBODY, TOTAL",111
5799-2,URINALYSIS WITH MICROSCOPIC LEGACY,359
35492-8,MRSA PCR,8633
82205-6,PARASITE PCR PANEL,314
82207-2,PARASITE PCR PANEL,314
82208-0,PARASITE PCR PANEL,314
82196-7,ENTERIC BACTERIAL PATHOGEN PCR,816
82199-1,ENTERIC BACTERIAL PATHOGEN PCR,816
80350-2,ENTERIC BACTERIAL PATHOGEN PCR,816
82203-1,ENTERIC BACTERIAL PATHOGEN PCR,816
2335-8,"OCCULT BLOOD X 1, STOOL",2010
46154-1,"IGP,CTNGTV,RFX APTIMA HPV ASCU",31
50388-8,"IGP,CTNGTV,RFX APTIMA HPV ASCU",32
50387-0,"IGP,CTNGTV,RFX APTIMA HPV ASCU",30
94565-9,VIRAL ATYPICAL PNEUMONIA PCR PANEL,2457
82165-2,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3876
82160-3,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3875
87621-9,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82176-9,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82170-2,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82168-6,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3872
82169-4,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3873
82167-8,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3872
82174-4,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82172-8,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82173-6,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82171-0,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82163-7,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3875
82178-5,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82177-7,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82179-3,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3877
82161-1,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3876
82162-9,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3876
82164-5,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3876
82175-1,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3876
82166-0,VIRAL ATYPICAL PNEUMONIA PCR PANEL,3876
94563-4,"SARS-COV-2 ANTIBODY, IGG",42
46154-1,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",153
43305-2,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",153
43304-5,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",153
82675-0,"HPV DNA, HIGH RISK, CERVICAL",19
94563-4,SARS COV 2 AB SPIKE (IGG),48
2349-9,URINALYSIS WITH MICROSCOPIC LEGACY,94
,"CARDIOLIPIN ANTIBODY, IGG",66
,"CARDIOLIPIN ANTIBODY, IGM",64
,"CARDIOLIPIN ANTIBODY, IGA",60
94500-6,POCT SARS-COV-2/FLU/RSV,35
92142-9,POCT SARS-COV-2/FLU/RSV,35
92141-1,POCT SARS-COV-2/FLU/RSV,35
92131-2,POCT SARS-COV-2/FLU/RSV,35
,AMNISURE (RUPTURE OF MEMBRANE),138
10331-7,ABORH,697
890-4,ANTIBODY SCREEN,12373
,ANA IFA TITER,248
6320-6,"LYME DISEASE, WESTERN BLOT",27
6321-4,"LYME DISEASE, WESTERN BLOT",27
94500-6,POCT SARS-COV-2/FLU/RSV PCR,562
92142-9,POCT SARS-COV-2/FLU/RSV PCR,562
92141-1,POCT SARS-COV-2/FLU/RSV PCR,562
92131-2,POCT SARS-COV-2/FLU/RSV PCR,562
,LYME DISEASE PCR,20
50388-8,"IGP,CTNG,APTIMAHPV,RFX16/18,45",104
59420-0,"IGP,CTNG,APTIMAHPV,RFX16/18,45",104
50387-0,"IGP,CTNG,APTIMAHPV,RFX16/18,45",104
29891-9,H. PYLORI BREATH TEST,60
43304-5,"CT, NG, TRICH VAG BY NAA",41
43305-2,"CT, NG, TRICH VAG BY NAA",41
69937-1,"CT, NG, TRICH VAG BY NAA",41
34467-1,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
35363-1,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
3045-2,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
66499-5,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
43304-5,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
69002-4,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
43305-2,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
,"ENDOMYSIAL (EMA) ANTIBODY, IGA TITER",6
,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",817
,SARS-COV2 IGG N PROTEIN,499
,POCT INFLUENZA A/B,238
,BETA-2 GLYCOPROTEIN ANTIBODIES,66
49311-4,ANA,1174
,"HEPATITIS A ANTIBODY, IGM",37
94500-6,SARS-COV2-2 PCR MAYO,65
,PROTEIN URINE DIPSTICK,20
82675-0,THINPREP TIS PAP AND HR HPV DNA,113
60489-2,POCT STREP A PCR MANUAL RESULTS,123
4576-5,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,20
82201-5,STOOL PCR PANEL,355
80349-4,STOOL PCR PANEL,355
82196-7,STOOL PCR PANEL,355
82211-4,STOOL PCR PANEL,355
82210-6,STOOL PCR PANEL,355
82205-6,STOOL PCR PANEL,355
80350-2,STOOL PCR PANEL,355
82203-1,STOOL PCR PANEL,355
82209-8,STOOL PCR PANEL,355
82207-2,STOOL PCR PANEL,355
82208-0,STOOL PCR PANEL,355
82206-4,STOOL PCR PANEL,355
82198-3,STOOL PCR PANEL,355
82213-0,STOOL PCR PANEL,355
82212-2,STOOL PCR PANEL,355
82199-1,STOOL PCR PANEL,355
82202-3,STOOL PCR PANEL,355
82200-7,STOOL PCR PANEL,355
80348-6,STOOL PCR PANEL,355
80351-0,STOOL PCR PANEL,355
,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",121
,CYSTIC FIBROSIS MUTATION PANEL,147
,HM MAMMOGRAPHY,621
,"CHLAMYDIA/N. GONORRHOEAE DNA, SDA Q LEGACY",107
2615-3,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8312
,"CHLAMYDIA TRACHOMATIS, NAA, MISC SITES-MAYO",12
94500-6,"SARS COV-2 RNA, QUAL NAAT - QUEST",68
20454-5,"URINALYSIS, ROUTINE W/RFX",16
2349-9,"URINALYSIS, ROUTINE W/RFX",16
5802-4,"URINALYSIS, ROUTINE W/RFX",17
5770-3,"URINALYSIS, ROUTINE W/RFX",17
5799-2,"URINALYSIS, ROUTINE W/RFX",16
2514-8,"URINALYSIS, ROUTINE W/RFX",16
5794-3,"URINALYSIS, ROUTINE W/RFX",16
58413-6,"AUTO DIFFERENTIAL, ADD ON",619
704-7,"AUTO DIFFERENTIAL, ADD ON",552
711-2,"AUTO DIFFERENTIAL, ADD ON",552
771-6,"AUTO DIFFERENTIAL, ADD ON",618
69002-4,HPV MRNA E6/E7,139
24027-5,"STREP PNEUMONIAE AG, URINE",2018
77684-9,"LEGIONELLA ANTIGEN, URINE",2101
6864-3,HEMOGLOBIN ELECTROPHORESIS,335
4576-5,HEMOGLOBIN ELECTROPHORESIS,121
4625-0,HEMOGLOBIN ELECTROPHORESIS,8
4563-3,HEMOGLOBIN ELECTROPHORESIS,4
890-4,OB PANEL W/HIV,155
5196-1,OB PANEL W/HIV,155
53115-2,OB PANEL W/HIV,43
706-2,OB PANEL W/HIV,155
713-8,OB PANEL W/HIV,155
71695-1,OB PANEL W/HIV,43
711-2,OB PANEL W/HIV,155
704-7,OB PANEL W/HIV,155
10331-7,OB PANEL W/HIV,155
1968-7,HEPATIC FUNCTION PANEL,3192
,EBV HETEROPHILE ANTIBODY,6
,"HEPATITIS B CORE ANTIBODY, IGM",43
,"DRUG PANEL, URINE",8255
,VENOUS BLOOD GAS UNSOLICITED RESULTS,1975
42483-8,"PROTEIN ELECTROPHORESIS, URINE",15
13990-7,"PROTEIN ELECTROPHORESIS, URINE",15
20507-0,RPR,25240
,SARS-COV2-2 PCR MAYO,11
,"CYTOMEGALOVIRUS ANTIBODY, IGG",26
,"TOXOPLASMA GONDII ANTIBODY, IGG",20
,CMV IGM,13
,"DIFFERENTIAL, ADD ON",1279
72174-6,"ROTAVIRUS ANTIGEN, STOOL",45
,POCT SARS-COV-2/FLU/RSV PCR,1004
,"FECAL LACTOFERRIN, QUALITATIVE",365
46154-1,"SURESWAB(R), ADVANCED VAGINITIS",113
62460-1,"SURESWAB(R), ADVANCED VAGINITIS",113
72495-5,"SURESWAB(R), ADVANCED VAGINITIS",108
74667-7,"SURESWAB(R), ADVANCED VAGINITIS",108
74762-6,"SURESWAB(R), ADVANCED VAGINITIS",108
69563-5,"SURESWAB(R), ADVANCED VAGINITIS",108
72391-6,"SURESWAB(R), ADVANCED VAGINITIS",108
25156-1,EOSINOPHIL URINE,392
,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",31
94762-2,SARS COV-2 ABS,5
92861-4,HSV/VZV LESION PCR,350
82188-4,HSV/VZV LESION PCR,175
,ANTIBODY IDENTIFICATION,869
50388-8,"PAP IG, CT-NG",24
50387-0,"PAP IG, CT-NG",24
890-4,PRENATAL PROFILE I,106
5196-1,PRENATAL PROFILE I,106
53115-2,PRENATAL PROFILE I,105
704-7,PRENATAL PROFILE I,105
71695-1,PRENATAL PROFILE I,105
10331-7,PRENATAL PROFILE I,106
29893-5,Q HIV 1/2 AB DIFF (SUPPLEMENTAL USE ONLY),4
30361-0,Q HIV 1/2 AB DIFF (SUPPLEMENTAL USE ONLY),4
,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,7
10900-9,HEPATITIS B SURFACE ANTIBODY,174
,"ANTI-SMOOTH MUSCLE ANTIBODY, IGG",39
,"TOXOPLASMA GONDII ANTIBODY, IGM",12
,"HEPATITIS B CORE ANTIBODY, TOTAL",99
13950-1,"HEPATITIS A ANTIBODY, IGM",113
82675-0,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",15
43304-5,"CHLAMYDIA/GC NAA, CONFIRMATION",132
43305-2,"CHLAMYDIA/GC NAA, CONFIRMATION",132
48683-7,"STREPTOCOCCUS GROUP B DNA, PCR WITH BROTH ENRICH W/RFX SUSCEPTIBILITY",266
10900-9,"HEPATITIS PANEL, GENERAL",21
13952-7,"HEPATITIS PANEL, GENERAL",21
742-7,CBC WITH AUTO DIFFERENTIAL,125017
,"EPSTEIN-BARR VIRUS EARLY ANTIGEN ANTIBODY, IGG",8
,MDA BHCG QUAL LEGACY,10
6864-3,SICKLE CELL SCREEN W/REFL HEMOGLOBINOPATHY EVAL,53
,CRE CULTURE,104
5792-7,URINALYSIS CHEM ONLY,220
50551-1,URINALYSIS CHEM ONLY,220
5802-4,URINALYSIS CHEM ONLY,286
5797-6,URINALYSIS CHEM ONLY,220
50563-6,URINALYSIS CHEM ONLY,220
77399-4,"Q HPV GENOTYPES 16,18/45",11
75694-0,"Q HPV GENOTYPES 16,18/45",11
6320-6,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
6321-4,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
21759-6,"XSENSE(R), FRAGILE X WITH REFLEX",37
21654-9,CYSTIC FIBROSIS CARRIER SCREEN,50
,FECAL IMMUNOCHEMICAL,167
,HEMOGLOBIN ELECTROPHORESIS,995
43304-5,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",29
43305-2,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",29
82675-0,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",29
,"VARICELLA ZOSTER ANTIBODY, IGM",3
704-7,CBC/DIFF AMBIGUOUS DEFAULT,726
706-2,CBC/DIFF AMBIGUOUS DEFAULT,726
706-2,PRENATAL PROFILE I,105
71773-6,QUANTIFERON-TB GOLD PLUS,2296
,RAPID STREP SCREEN,81
,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",124
,"POCT URINALYSIS DIPSTICK, AUTO W/ MICRO",738
40466-5,"HSV 1/2 AB (IGM), IFA W/RFL TO TITER SERUM",45
45210-2,"HSV 1/2 AB (IGM), IFA W/RFL TO TITER SERUM",45
17780-8,"H. PYLORI ANTIGEN, STOOL",182
19162-7,"VARICELLA ZOSTER ANTIBODY, IGG",847
42678-3,URO RISK(R) DIAGNOSTIC PROFILE,28
,POCT INFECTIOUS MONONUCLEOSIS ANTIBODY,11
43305-2,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",32
69002-4,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",32
43304-5,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",32
,POCT SAR-COV-2 CEPHEID PCR,141
54067-4,C DIFF TOX B GENE DETECTION BY PCR,11
77400-0,"PAP IG, HPV, RFX 16/18 (SP)",56
71431-1,"PAP IG, HPV, RFX 16/18 (SP)",56
77399-4,"PAP IG, HPV, RFX 16/18 (SP)",56
,ANTI-SCLERODERMA ANTIBODY,14
,CENTROMERE B ANTIBODY,68
,ANTI-SMITH ANTIBODY,1
,SM/RNP ANTIBODY,132
,SJOGRENS SYNDROME-B EXTRACTABLE NUCLEAR ANTIBODY,20
,SJOGRENS SYNDROME-A EXTRACTABLE NUCLEAR ANTIBODY,22
,THINPREP TIS AND HPV MRNA E6/E7,287
70173-0,STRATIFY JCV(TM) AB (WITH INDEX) W/RFL INHIBITION,19
2349-9,"UA/M W/RFLX CULTURE, COMP",80
,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",612
5770-3,URINALYSIS CHEM ONLY,66
2514-8,URINALYSIS CHEM ONLY,66
5799-2,URINALYSIS CHEM ONLY,66
25428-4,URINALYSIS CHEM ONLY,55
5794-3,URINALYSIS CHEM ONLY,66
20454-5,URINALYSIS CHEM ONLY,66
94759-8,"COVID-19, FLU A+B NAA",14
76078-5,"COVID-19, FLU A+B NAA",14
76080-1,"COVID-19, FLU A+B NAA",14
,HEPARIN AB EIA,62
,CBC WITH DIFFERENTIAL,118826
,FETAL FIBRONECTIN,9
35707-9,"ALKALINE PHOSPHATASE, ISOENZYMES",14
15016-9,"ALKALINE PHOSPHATASE, ISOENZYMES",14
,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",52
48683-7,STREP GP B NAA+RFLX,16
,"INFLUENZA A,B PCR",9
46154-1,"TRICHOMONAS VAGINALIS, QL TMA, PAP VIAL",11
71695-1,T/B LYMPH PROFILE,36
704-7,T/B LYMPH PROFILE,37
706-2,T/B LYMPH PROFILE,37
713-8,T/B LYMPH PROFILE,37
711-2,T/B LYMPH PROFILE,37
53115-2,T/B LYMPH PROFILE,36
16130-7,"HERPES SIMPLEX VIRUS 1 AND 2, PCR",9
16131-5,"HERPES SIMPLEX VIRUS 1 AND 2, PCR",9
77399-4,"HPV GENOTYPES 16/18,45",56
75694-0,"HPV GENOTYPES 16/18,45",58
74669-3,"SURESWAB(R), ADVANCED VAGINITIS",113
43304-5,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",7
43305-2,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",7
,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,5056
43304-5,CHLAMYDIA TRACHOMATIS DNA PCR,55
32017-6,HEMOGLOBIN ELECTROPHORESIS,302
32683-5,HEMOGLOBIN ELECTROPHORESIS,302
32681-9,HEMOGLOBIN ELECTROPHORESIS,302
,T/B LYMPH PROFILE,440
,RPR,2495
94534-5,POCT RAPID COVID-19,11
43180-9,"HSV 1 AND 2 SPECIFIC ANTIBODIES IGG, SERUM MAYO (HSVG)",235
43304-5,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",34
43305-2,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",34
46154-1,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",34
711-2,T-HELPER CELLS (CD4) COUNT,72
59420-0,"IGP, APTIMA HPV",26
713-8,PRENATAL PROFILE I,105
711-2,PRENATAL PROFILE I,105
,NUSWAB VAGINITIS PLUS (VG+),68
,HEPATITIS B SCREEN,12
,EBV ANTIBODY PANEL,82
2111-3,POCT BETA HCG UNSOLICITED RESULTS,37
43305-2,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
69002-4,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
43304-5,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
,"PROTEIN / CREATININE RATIO, URINE",880
,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,8290
,SICKLE CELL SCREEN,151
32286-7,HEPATITIS C GENOTYPE,442
15924-4,RESPIRATORY ALLERGY PANEL REGION IV,26
15685-1,RESPIRATORY ALLERGY PANEL REGION IV,26
15530-9,RESPIRATORY ALLERGY PANEL REGION IV,26
15549-9,RESPIRATORY ALLERGY PANEL REGION IV,26
15609-1,RESPIRATORY ALLERGY PANEL REGION IV,26
15581-2,RESPIRATORY ALLERGY PANEL REGION IV,26
15682-8,RESPIRATORY ALLERGY PANEL REGION IV,26
15647-1,RESPIRATORY ALLERGY PANEL REGION IV,26
15680-2,RESPIRATORY ALLERGY PANEL REGION IV,26
15861-8,RESPIRATORY ALLERGY PANEL REGION IV,26
15642-2,RESPIRATORY ALLERGY PANEL REGION IV,26
16085-3,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
16011-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15846-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15650-5,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
16018-4,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15568-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15689-3,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
16006-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15766-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15527-5,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15607-5,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
16065-5,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
15917-8,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
16074-7,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
5877-6,RSV RAPID ANTIGEN,158
,REFERENCE DAT,469
20449-5,LYME DISEASE SEROLOGY-MAYO,25
94342-3,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
96486-6,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94347-2,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
93428-1,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94815-8,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
82976-2,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94285-4,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94287-0,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94346-4,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
96476-7,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94345-6,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94694-7,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,3
94350-6,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94348-0,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,3
94349-8,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,3
93503-1,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94352-2,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94351-4,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
93489-3,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94340-7,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94341-5,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94343-1,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
94344-9,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
33463-1,HEPATITIS B E ANTIBODY,30
43588-3,"VARICELLA ZOSTER ANTIBODY, IGM",15
12187-1,CREATINE KINASE ISOENZYME PANEL,4
,PARASITE PCR PANEL,104
,POCT FLU A & B PCR MANUAL  RESULTS,6
,"SURESWAB(R), HSV TYPE 1/2 MRNA, TMA",2
43305-2,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,3
43304-5,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,3
29771-3,FECAL IMMUNOCHEMICAL,25
15697-6,RESPIRATORY ALLERGY PANEL REGION IV,26
15585-3,RESPIRATORY ALLERGY PANEL REGION IV,26
15875-8,RESPIRATORY ALLERGY PANEL REGION IV,26
15615-8,RESPIRATORY ALLERGY PANEL REGION IV,26
15936-8,RESPIRATORY ALLERGY PANEL REGION IV,26
16054-9,RESPIRATORY ALLERGY PANEL REGION IV,26
15738-8,RESPIRATORY ALLERGY PANEL REGION IV,26
15975-6,RESPIRATORY ALLERGY PANEL REGION IV,26
15737-0,RESPIRATORY ALLERGY PANEL REGION IV,26
15872-5,RESPIRATORY ALLERGY PANEL REGION IV,26
16016-8,RESPIRATORY ALLERGY PANEL REGION IV,26
,DIRECT ANTIGLOBULIN TEST,314
42254-3,"ANA SCREEN,IFA,REFLEX TITER/PATTERN,REFLEX MPLX 11 AB CASCADE WITH IDENTRA",12
13951-9,HEPATITIS A AB TOTAL W/REFL IGM,15
,FETAL BLEED SCREEN,240
46154-1,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
50388-8,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
59420-0,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
50387-0,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
42254-3,"ANA SCREEN, IFA, W/REFLEX TO TITER AND PATTERN/RHEUMATOID ARTHRITIS PANEL 2",3
,OLIGOCLONAL BANDING,18
,"TOXOPLASMA GONDII, MOLECULAR DETECTION, PCR",12
,HIV RNA QUANT VIRAL LOAD,56
,"(1, 3) BETA-D-GLUCAN (FUNGITELL), S",76
,"ANTI-JO 1 ANTIBODY, IGG",4
75983-7,MATERNIT GENOME (9W+),3
92899-4,MATERNIT GENOME (9W+),3
92903-4,MATERNIT GENOME (9W+),3
79211-9,MATERNIT GENOME (9W+),9
75570-2,MATERNIT GENOME (9W+),3
,MATERNIT GENOME (9W+),24
75578-5,MATERNIT GENOME (9W+),3
75602-3,MATERNIT GENOME (9W+),3
92900-0,MATERNIT GENOME (9W+),3
92902-6,MATERNIT GENOME (9W+),3
75980-3,MATERNIT GENOME (9W+),3
75558-7,MATERNIT GENOME (9W+),3
73824-5,MATERNIT GENOME (9W+),3
,C DIFF TOX B GENE DETECTION BY PCR,57
69002-4,THINPREP TIS AND HPV MRNA E6/E7,27
,HCV RNA QUANT VIRAL LOAD,66
,"HISTOPLASMA ANTIGEN, URINE",22
20572-4,HEMOGLOBIN ELECTROPHORESIS,302
35279-9,CYTOPLASMIC NEUTROPHILIC ANTIBODY-MAYO,10
17357-5,CYTOPLASMIC NEUTROPHILIC ANTIBODY-MAYO,10
43304-5,"CHLAMYDIA TRACHOMATIS, NAA, MISC SITES-MAYO",12
69002-4,SUREPATH FPGS PAP AND HPV MRNA E6/E7,7
21759-6,"XSENSE(R), FRAGILE X WITH REFLEX AND CHROMOSOME ANALYSIS, BLOOD",6
19146-0,SMA CARRIER SCREEN,41
43304-5,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,11
43305-2,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,11
,POCT STREP A PCR MANUAL RESULTS,21
20507-0,OBSTETRIC PANEL WITHOUT HIV,326
82675-0,SUREPATH IMAGING PAP AND HPV DNA,2
50387-0,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
50388-8,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
77400-0,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
71431-1,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
77399-4,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
82187-6,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82189-2,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82182-7,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82188-4,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82192-6,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82193-4,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82191-8,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82181-9,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82183-5,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82184-3,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82185-0,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82186-8,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82194-2,MENINGITIS/ENCEPHALITIS PCR PANEL,114
82190-0,MENINGITIS/ENCEPHALITIS PCR PANEL,114
,"CRYPTOCOCCAL ANTIGEN, CSF",58
3879-4,"DRUG PANEL, URINE",7
3936-2,"DRUG PANEL, URINE",7
3349-8,"DRUG PANEL, URINE",9
5645-7,"DRUG PANEL, URINE",4
3377-9,"DRUG PANEL, URINE",7
3390-2,"DRUG PANEL, URINE",7655
3393-6,"DRUG PANEL, URINE",7
3773-9,"DRUG PANEL, URINE",7
19141-1,"DRUG PANEL, URINE",4
3426-4,"DRUG PANEL, URINE",7
48159-8,"HEPATITIS PANEL, GENERAL",21
8061-4,ANA MULTIPLEX W/REFLEX 11 AB CASCADE,35
,"WEST NILE VIRUS, CSF",10
69002-4,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",80
62461-9,NUSWAB VAGINITIS (VG),86
69562-7,NUSWAB VAGINITIS (VG),86
69563-5,NUSWAB VAGINITIS (VG),86
2640-1,MYOGLOBIN SCREEN URINE,20
711-2,CBC/DIFF AMBIGUOUS DEFAULT,725
,HEPARIN-INDUCED PLATELET ANTIBODY,34
8061-4,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
6457-6,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
45224-3,"MYCOPLASMA PNEUMONIAE AB, IGG, IGM- MAYO",64
,HEPATITIS B VIRAL DNA QUANT-MAYO,7
706-2,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
53115-2,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",12
704-7,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
71695-1,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",12
29771-3,FECAL GLOBIN BY IMMUNOCHEMISTRY,267
,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,2965
42595-9,HEPATITIS B VIRAL DNA QUANT-MAYO,95
,HEPATITIS A ANTIBODY IGG,39
24113-3,HEPATITIS B SCREEN,62
5196-1,HEPATITIS B SCREEN,62
,RHEUMATOID PANEL,220
,"LYME CNS INFECTION IGG, AB INDEX",6
,POCT VAGINAL PH BV,10
75694-0,"IGP, APTIMA HPV, RFX 16/18,45",17
59263-4,"IGP, APTIMA HPV, RFX 16/18,45",17
,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",38
,MYCOPLASMA PNEUMONIAE IGM AB IFA-MAYO,9
71695-1,LYMPHOCYTE ACTIVITY PROFILE LEGACY,4
53115-2,LYMPHOCYTE ACTIVITY PROFILE LEGACY,4
42254-3,"ANA SCR,IFA W/REFL TITER/ PATTERN/MPX AB CASCADE",27
,PENTA SCREEN,19
64084-7,LC QUANTIFERON-TB GOLD PLUS,3
88517-8,LC QUANTIFERON-TB GOLD PLUS,3
71776-9,LC QUANTIFERON-TB GOLD PLUS,3
53115-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
704-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
,"FRAGILE X SYNDROME, MOLECULAR ANALYSIS-MAYO",76
2110-5,"HCG, SERUM, QUALITATIVE",34
20404-0,FETAL FIBRONECTIN,87
890-4,AB SCR+ANTIBODY ID 114041,22
26465-5,"CELL COUNT WITH DIFFERENTIAL, CSF",406
,"EPSTEIN-BARR VIRUS VCA, IGM",7
93812-6,"(1, 3) BETA-D-GLUCAN (FUNGITELL), S",455
,ANTI ENA 2,24
,ANTI ENA 1,20
94357-1,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94358-9,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94364-7,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94363-9,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94354-8,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94355-5,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94356-3,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94706-9,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
94362-1,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
92813-5,"LYME CNS INFECTION IGG, AB INDEX",13
,MTB PCR,7
48159-8,"HEPATITIS C ANTIBODY AND HIV-1/2, SCREEN AND DIAGNOSTIC PANEL WITH REFLEXES",124
711-2,"Q DIFFERENTIAL, MANUAL",105
713-8,"Q DIFFERENTIAL, MANUAL",105
74668-5,"SURESWAB(R), ADVANCED VAGINITIS",108
,POCT BETA HCG UNSOLICITED RESULTS,23
23201-7,"LEPTOSPIRA ANTIBODY, IGM, S - MAYO",6
25835-0,"HIV 1 RNA, QL TMA",24
16130-7,HSV NAA,22
16131-5,HSV NAA,22
2030-5,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8312
,"SPINAL MUSCULAR ATROPHY CARRIER SCREENING, DELETION/DUPLICATION ANALYSIS, VARIES",74
46154-1,"SURESWAB(R) TRICHOMONAS VAGINALIS RNA, QL, TMA",31
2335-8,FECAL IMMUNOCHEMICAL,205
13955-0,"HEPATITIS C ANTIBODY AND HIV-1/2, SCREEN AND DIAGNOSTIC PANEL WITH REFLEXES",124
,"EPSTEIN-BARR VIRUS VCA, IGG",6
,"ADENOVIRUS, MOLECULAR DETECTION,PCR-MAYO",1
50388-8,"PAP IG, CT-NG, RFX HPV ALL",13
50387-0,"PAP IG, CT-NG, RFX HPV ALL",13
47000-5,"VAGINITIS/VAGINOSIS, DNA PROBE",45
6410-5,"VAGINITIS/VAGINOSIS, DNA PROBE",45
6568-0,"VAGINITIS/VAGINOSIS, DNA PROBE",45
43305-2,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,15
43304-5,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,15
,TB SKIN TEST,47
43304-5,"MISC CHLAMYDIA TRACHOMATIS/N GONORRHOEAE, NAA-MAYO",33
43305-2,"MISC CHLAMYDIA TRACHOMATIS/N GONORRHOEAE, NAA-MAYO",33
64084-7,QUANTIFERON-TB GOLD PLUS,219
88517-8,QUANTIFERON-TB GOLD PLUS,219
43305-2,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
82675-0,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
43304-5,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
,"VAGINITIS/VAGINOSIS, DNA PROBE",18
706-2,"AUTO DIFFERENTIAL, ADD ON",554
713-8,"AUTO DIFFERENTIAL, ADD ON",554
69937-1,TRICHOMONAS VAGINALIS DNA PCR,67
43304-5,CHLAMYDIA/GC DNA PCR SCH BSP,227
24111-7,CHLAMYDIA/GC DNA PCR SCH BSP,227
,"CELL PROFILE, BAL",288
43304-5,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,16
43305-2,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,16
3390-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
3426-4,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
9835-0,"DRUG MONITOR, PANEL 1, W/CONF, URINE",4
3508-9,"DRUG MONITOR, PANEL 1, W/CONF, URINE",4
3681-4,"DRUG MONITOR, PANEL 1, W/CONF, URINE",4
3936-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
61422-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",4
10998-3,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
3831-5,"DRUG MONITOR, PANEL 1, W/CONF, URINE",4
58714-7,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
3349-8,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
3377-9,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
3393-6,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
3773-9,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
43304-5,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",16
43305-2,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",16
94500-6,COVID-19,11728
5792-7,"Glucose Qual, Urine",8375
94534-5,COVID-19 Abbott IDNOW,14866
704-7,Baso Absolute,117988
,Fecal Immunochemical Test (FIT),126
711-2,Eosin Absolute,27853
,NRBC %,27733
,NRBC Absolute,27723
713-8,Eosin %,27853
20405-7,"Urobilinogen, Urine",8371
5794-3,-- Blood,1014
5770-3,-- Bilirubin,1014
2514-8,"Ketones, Urine",8378
5797-6,-- Ketones,1014
25428-4,"Glucose Qual, Urine",8375
2118-8,HCG Qual - Serum,2249
5794-3,"Occult Blood, Urine",8368
33764-2,Shiga Toxin,380
70242-3,Shigella sp.,380
1975-2,"Bilirubin, Urine",60019
,Clostridium Difficile Screen Result,468
71429-5,Campylobacter sp.,380
27297-1,-- Leuk Esterase,1014
5802-4,"Nitrite, Urine",8369
5792-7,-- Glucose,1014
5802-4,-- Nitrite,1014
5804-0,"Protein, Urine",51299
49612-5,Salmonella sp.,380
20454-5,"Protein, Urine",51291
5799-2,"Leukocyte Esterase, Urine",8372
2106-3,HCG Qual - Urine,365
5804-0,-- Protein,1014
59646-0,Cotinine Screen,956
2030-5,Arterial CO-Hb,3695
60545-1,Cryptosporidium PCR,190
6396-6,Entamoeba histolytica PCR,190
25514-1,Rubella IgG (AB),1438
,C trachomatis DNA,908
706-2,Baso %,27863
5196-1,Hepatitis B Surface Antigen,1732
13955-0,Hepatitis C (AB),4109
24113-3,Hepatitis B Core (AB) IgM,479
13950-1,Hepatitis A (AB) IgM,512
742-7,Mono Absolute,117999
751-8,Neut Abs,141187
,--Extended Beta Lactam,866
,N gonorrhoeae DNA,660
6568-0,Trichomonas rRNA,121
6410-5,Gardnerella rRNA,121
47000-5,Candida rRNA,121
82197-5,C. difficile,35
,Para Protein in EX,111
48683-7,Group B Strep by PCR (RAPID),135
,POCT Urine HCG Qualitative,316
94500-6,SARS CoV-2 RNA,289
60544-4,Giardia lamblia PCR,190
,QFT-Plus Result,88
57761-9,Heparin (AB) EIA,115
2615-3,Arterial Met Hb,3695
8061-4,ANA Human,264
34487-9,Influenza A RNA,265
40982-1,Influenza B RNA,265
46274-7,Dir Antiglobulin Polyspecific Interp,249
38917-1,Human Metapneumovirus,1754
1925-7,Arterial BE,4019
3298-7,Tylenol/Acetaminophen Level,378
22244-8,Cytomegalovirus IgG,261
40991-2,Rhinovirus/Enterovirus,1754
22322-2,Hepatitis B Surface (AB),168
,Fetal Screen Interp,86
30325-5,Cytomegalovirus IgM,147
764-1,Bands,1979
14236-4,Anti Mitochondrial (AB),36
14252-1,Anti Smooth Muscle (AB),44
13951-9,Hepatitis A (AB) IgG,84
21522-8,Sm/RNP Ab,33
33569-5,SS-A (AB),39
45142-7,SS-B (AB),42
43182-5,Sm Ab,34
29910-7,Parainfluenza 3,1764
13955-0,"Hepatitis Core Antibody, Total",155
22580-5,"Toxoplasma, IgG Level",25
55776-9,Direct Antiglobulin IgG Interp,124
3181-5,Cardiolipin IgG,1177
,Dir Antiglobulin Complement Interp,123
24469-9,Hemoglobin Other,24
32681-9,Hemoglobin C,24
3182-3,Cardiolipin IgM,1177
32683-5,Hemoglobin S,24
6864-3,Sickle Cell Solubility,26
31418-7,Mononucleosis Screen,41
33037-3,Anion Gap,153485
5076-5,Cardiolipin IgA,1163
2890-2,Protein/Creatinine Ratio Total,568
19162-7,Varicella Zoster Virus (ABS) IgG,2
,SARS-COV2 IgG N Protein.,196
,POCT Venous Base Excess calc,451
,COVID-19 Result,77
51196-4,Hemoglobin A1,24
5159-9,EBV VCA IgM,172
5157-3,EBV VCA IgG,172
30083-0,EBV EBNA-1 IgG,25
24007-7,EBV EA-D IgG,25
31418-7,EBV Heterophile Ab,25
,Chromatin (AB),14
,Centromere B (AB),14
,Scl-70 (AB),21
,Jo-1 (AB),18
,Ribosomal P (AB),14
39528-5,Adenovirus.,1756
35729-3,Chlamydia DNA Amplified Probe,1
731-0,Lymph Absolute,117982
753-4,Neut Abs Man,1958
5905-5,Mono %,27865
736-9,Lymph %,27958
,POCT Arterial Base Excess calc,2075
62423-9,Coronavirus HKU1,283
31616-6,Rubella IgM (AB),7
25542-2,"Toxoplasma, IgM Level",14
24111-7,GC DNA Amplified Probe,1
,Direct Antiglobulin Interp TR,17
55465-9,FluA-H1-2009,1754
29908-1,Parainfluenza 1,1754
40982-1,FluB,1754
740-1,Metamyelocytes,23041
16960-7,Herpes simplex virus 2(HSV-2),34
,Rate mand,2101
,Amnisure,12
2640-1,"Myoglobin Screen, Urine",5
44449-7,Beta-2 Glycoprotein 1 IgM,19
44448-9,Beta-2 Glycoprotein 1 IgG,19
4447-1,Beta-2 Glycoprotein 1 IgA,19
48039-2,Fetal Fibronectin,2
41005-0,Coronavirus NL63,283
,Total Amylase AMP,1
116-4,--Cefoxitin,5
1968-7,"Bilirubin, Direct",4274
707-0,Basophils,430
13068-2,ANA Pattern,2399
5048-4,ANA Dilution,56
40988-8,Respiratory Syncytial Virus,1763
14658-9,Cold Agglutin Titer,5
94500-6,SARS-CoV2 RNA,775
,SARS-CoV-2 (COVID-19),353
,Imm Gran. %,8847
,Imm Gran. Absolute,8847
12179-8,Basophils (BF),19
749-2,Myelocytes,19831
769-0,Segmented Neutrophils,2133
13941-0,Lymphocytes (BF),297
54218-3,T4/T8 Ratio,880
,Vt exp spont,864
41003-5,Coronavirus 229E,283
41010-0,Parainfluenza 4,1754
,Plasma Cell,8
41003-5,CoV-229E (Not COVID-19),1471
62423-9,CoV-HKU1 (Not COVID-19),1471
4621-9,Sickle Cell Screen,38
41009-2,CoV-OC43 (Not COVID-19,1471
14241-4,Anti Parietal Cell (AB),1
714-6,Eosinophils,956
32700-7,"Malaria, Thick Drop Exam",1
8116-6,CD19,30
8117-4,CD19%,30
772-4,Nucleated Red Bl Cells,618
2032-1,Venous CO-Hb,112
,P low,17
12209-3,Eosinophils (BF),94
51625-2,Malignant Cells (BF),11
13516-0,"Neutrophils, CSF",54
,Atypical/Abnormal cell CSF,2
792-2,"Red Bl Cell Cnt, CSF",118
41009-2,Coronavirus OC43,283
2617-9,Venous Met Hgb,112
,Neutrophil Absolute,8707
,PS,743
737-7,Lymphocytes,2130
5196-1,Hepatitis B Surface,7154
24113-3,Hepatitis B Core (AB,2407
22322-2,Hepatitis B Surface,687
13955-0,Hepatitis Core Antib,577
25542-2,"Toxoplasma, IgM Leve",66
6864-3,Sickle Cell Solubili,392
22580-5,"Toxoplasma, IgG Leve",100
3094-0,Blood Urea Nitrogen,335785
3097-3,Blood Urea Nitrogen/,265338
21598-8,Varicella-zoster virus (VZV),34
49098-7,Cryptococcus neoformans/gattii,34
6690-2,WBC,2234692
75983-7,MATERNIT21 PLUS CORE+SCA,28
79211-9,MATERNIT21 PLUS CORE+SCA,84
75570-2,MATERNIT21 PLUS CORE+SCA,28
75980-3,MATERNIT21 PLUS CORE+SCA,28
75558-7,MATERNIT21 PLUS CORE+SCA,28
73824-5,MATERNIT21 PLUS CORE+SCA,28
2349-9,URINALYSIS WITH CULTURE IF INDICATED,69
,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,15063
53290-3,URINALYSIS CHEM ONLY,220
5804-0,URINALYSIS CHEM ONLY,220
27297-1,URINALYSIS CHEM ONLY,220
82675-0,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",13
,DIABETIC EYE EXAM,16
62460-1,"Q SURESWAB(R), CANDIDIASIS, PCR",32
69563-5,"Q SURESWAB(R), CANDIDIASIS, PCR",31
72391-6,"Q SURESWAB(R), CANDIDIASIS, PCR",31
72495-5,"Q SURESWAB(R), CANDIDIASIS, PCR",31
46154-1,"Q SURESWAB(R) TRICHOMONAS VAGINALIS RNA, QL, TMA",32
,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",281
94505-5,SARS COV 2 AB SPIKE (IGG),351
,POCT URINE HCG QUALITATIVE,1
890-4,Q PLATELET ESTIMATION,7
13955-0,"HEPATITIS C AB W/RFL RNA, PCR W/RFL GENOTYPE,LIPA",110
13951-9,"HEPATITIS PANEL, GENERAL",21
13955-0,"HEPATITIS PANEL, GENERAL",21
95608-6,VIRAL ATYPICAL PNEUMONIA PCR PANEL,1419
3390-2,URINE DRUG SCREEN PANEL 5,1
3426-4,URINE DRUG SCREEN PANEL 5,1
3879-4,URINE DRUG SCREEN PANEL 5,1
58714-7,URINE DRUG SCREEN PANEL 5,1
3349-8,URINE DRUG SCREEN PANEL 5,1
3377-9,URINE DRUG SCREEN PANEL 5,1
3393-6,URINE DRUG SCREEN PANEL 5,1
3773-9,URINE DRUG SCREEN PANEL 5,1
46154-1,"PAP IG, CT-NG TV HPV-HR",2
50388-8,"PAP IG, CT-NG TV HPV-HR",2
59420-0,"PAP IG, CT-NG TV HPV-HR",2
50387-0,"PAP IG, CT-NG TV HPV-HR",2
43180-9,"Q HSV 2 IGG INHIBITION, IA",9
,HM FIT-DNA (COLOGUARD),48
,ANA COMPREHENSIVE PANEL,24
,PAP SMEAR,1586
33910-1,RHEUMATOID FACTOR,46
,RAD ONC ARIA SESSION SUMMARY,276415
5804-0,PROTEIN URINE DIPSTICK,614
92141-1,SARS-COV-2/FLU/RSV RT-PCR BAYFRONT,598
94500-6,SARS-COV-2/FLU/RSV RT-PCR BAYFRONT,600
92142-9,SARS-COV-2/FLU/RSV RT-PCR BAYFRONT,599
92131-2,SARS-COV-2/FLU/RSV RT-PCR BAYFRONT,599
11555-0,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4009
2614-6,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,517
43730-1,"EPSTEIN-BARR VIRUS DNA, QUANTITATIVE",68
10839-9,POCT TROPONIN UNSOLICITED RESULTS,287
,POCT TROPONIN UNSOLICITED RESULTS,135
24113-3,"HEPATITIS B CORE ANTIBODY, IGM",182
731-0,CBC WITH AUTO DIFFERENTIAL,125048
5353-8,RHEUMATOID PANEL,104
5351-2,RHEUMATOID PANEL,104
68380-5,RHEUMATOID PANEL,104
31627-3,RHEUMATOID PANEL,104
5301-7,RHEUMATOID PANEL,104
31592-9,RHEUMATOID PANEL,104
5348-8,RHEUMATOID PANEL,104
5234-0,RHEUMATOID PANEL,104
53981-7,RHEUMATOID PANEL,104
11555-0,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8068
5257-1,"MYCOPLASMA PNEUMONIAE AB, IGG, IGM- MAYO",64
73819-5,HEPARIN-INDUCED PLATELET ANTIBODY,306
95209-3,SARS ANTIGEN FLUORESCENT IMMUNOASSAY (FIA),1019
53115-2,"AUTO DIFFERENTIAL, ADD ON",543
71695-1,"AUTO DIFFERENTIAL, ADD ON",545
742-7,"AUTO DIFFERENTIAL, ADD ON",552
24114-1,EBV ANTIBODY PANEL,63
50969-5,EBV ANTIBODY PANEL,63
24115-8,EBV ANTIBODY PANEL,63
69420-8,EBV ANTIBODY PANEL,63
22296-8,EBV ANTIBODY PANEL,63
,READ PPD,41
5048-4,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",18
94345-6,GLUTAMIC ACID DECARBOXYLASE,13
15642-2,"REGIONAL ALLERGY PROFILE, IGE",14
15875-8,"REGIONAL ALLERGY PROFILE, IGE",14
15585-3,"REGIONAL ALLERGY PROFILE, IGE",14
15697-6,"REGIONAL ALLERGY PROFILE, IGE",14
15579-6,"REGIONAL ALLERGY PROFILE, IGE",14
15615-8,"REGIONAL ALLERGY PROFILE, IGE",14
15737-0,"REGIONAL ALLERGY PROFILE, IGE",14
15774-3,"REGIONAL ALLERGY PROFILE, IGE",14
15738-8,"REGIONAL ALLERGY PROFILE, IGE",14
16054-9,"REGIONAL ALLERGY PROFILE, IGE",14
15549-9,"REGIONAL ALLERGY PROFILE, IGE",14
15530-9,"REGIONAL ALLERGY PROFILE, IGE",14
15861-8,"REGIONAL ALLERGY PROFILE, IGE",14
15936-8,"REGIONAL ALLERGY PROFILE, IGE",14
16016-8,"REGIONAL ALLERGY PROFILE, IGE",14
15872-5,"REGIONAL ALLERGY PROFILE, IGE",14
15924-4,"REGIONAL ALLERGY PROFILE, IGE",14
547-0,"CULTURE, GROUP B STREP",160
1968-7,"BILIRUBIN, DIRECT",1108
44449-7,BETA-2 GLYCOPROTEIN ANTIBODIES,150
44447-1,BETA-2 GLYCOPROTEIN ANTIBODIES,150
44448-9,BETA-2 GLYCOPROTEIN ANTIBODIES,150
31627-3,ANTI-SMITH ANTIBODY,52
1778-0,"ALKALINE PHOSPHATASE, ISOENZYMES",28
15014-4,"ALKALINE PHOSPHATASE, ISOENZYMES",51
53981-7,CENTROMERE B ANTIBODY,45
5301-7,SM/RNP ANTIBODY,78
26028-1,HLA B27-MAYO,44
5234-0,"ANTI-JO 1 ANTIBODY, IGG",44
5348-8,ANTI-SCLERODERMA ANTIBODY,91
5351-2,ANTI ENA 2,39
5353-8,ANTI ENA 2,39
8098-6,THYROGLOBULIN ANTIBODY,439
5393-4,FTA ANTIBODIES,40
,POCT GONADOTROPIN CHORIONIC (HCG) QUAL,18
,DAT C3,82
17284-1,MITOCHONDRIAL ANTIBODY W/REFL TITER,20
33253-6,ANA IFA TITER,360
49311-4,ANA IFA TITER,360
62458-5,COCCIDIOIDES ANTIBODIES,16
5096-3,COCCIDIOIDES ANTIBODIES,16
62459-3,COCCIDIOIDES ANTIBODIES,16
90232-0,HISTOPLASMA ANTIBODIES,18
20573-2,HISTOPLASMA ANTIBODIES,18
20574-0,HISTOPLASMA ANTIBODIES,18
44524-7,"HISTOPLASMA ANTIGEN, URINE",85
48952-6,"HISTOPLASMA ANTIGEN, URINE",85
,CRYPTOCOCCAL ANTIGEN,133
48159-8,"HEPATITIS PANEL, ACUTE",542
59263-4,"HPV GENOTYPES 16 AND 18, CERVICAL",4
59264-2,"HPV GENOTYPES 16 AND 18, CERVICAL",4
29566-7,"WEST NILE ANTIBODIES, IGG AND IGM",5
29567-5,"WEST NILE ANTIBODIES, IGG AND IGM",5
43638-6,NEUROMELITIS OPTICA (NMO) ANTIBODY IGG SERUM,4
1925-7,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,406
8117-4,LYMPHOCYTE SUBSET PANEL 1,16
13954-3,HEPATITIS BE ANTIGEN AND ANTIBODY-MAYO,9
33463-1,HEPATITIS BE ANTIGEN AND ANTIBODY-MAYO,9
94563-4,SARS COV-2 ABS,26
57768-4,"CAMPYLOBACTER ANTIGEN, EIA",50
21759-6,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
3773-9,URINE DRUG SCREEN SUPER PANEL 9,3
3936-2,URINE DRUG SCREEN SUPER PANEL 9,3
3390-2,URINE DRUG SCREEN SUPER PANEL 9,3
19261-7,URINE DRUG SCREEN SUPER PANEL 9,3
19270-8,URINE DRUG SCREEN SUPER PANEL 9,3
19429-0,URINE DRUG SCREEN SUPER PANEL 9,3
19295-5,URINE DRUG SCREEN SUPER PANEL 9,3
18282-4,URINE DRUG SCREEN SUPER PANEL 9,3
3393-6,URINE DRUG SCREEN SUPER PANEL 9,3
13951-9,HEPATITIS A ANTIBODY IGG,66
24113-3,"HEPATITIS B CORE ANTIBODY, TOTAL",274
4633-4,FETAL HEMOGLOBIN  STAIN,32
94563-4,"%SARS COV 2 SEROLOGY (COVID 19) AB (IGG), IA",4
94564-2,"SARS COV 2 SEROLOGY (COVID 19) AB (IGM),IA",4
,TRANSFUSION REACTION EVALUATION,131
,RHOGAM WORKUP,896
51940-5,SHIGA TOXINS 1 & 2,50
51939-7,SHIGA TOXINS 1 & 2,46
,ELUTION SCREEN,32
14252-1,"ANTI-SMOOTH MUSCLE ANTIBODY, IGG",196
17284-1,ANTIMITOCHONDRIAL ANTIBODY,156
94769-7,"SARS COV 2 AB, TOTAL SPIKE SEMI QN",4
74822-8,C DIFF TOX B GENE DETECTION BY PCR,80
82675-0,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
43305-2,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
43304-5,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
2890-2,"PROTEIN / CREATININE RATIO, URINE",6289
24388-1,"BRUCELLA ANTIBODY SCREEN IGM/IGG ELISA, S",11
24387-3,"BRUCELLA ANTIBODY SCREEN IGM/IGG ELISA, S",11
60463-7,INSULIN ANTIBODY,13
26028-1,HLA-B27 ANTIGEN,69
,SARS-COV-2/FLU/RSV RT-PCR BAYFRONT,230
24475-6,PROTHROMBIN (FACTOR II) 20210G>A MUTATION ANALYSIS,15
29901-6,HTLV I/II ANTIBODY-MAYO,16
21823-0,Q P190 BCR ABL1,3
21822-2,Q P210 BCR ABL1,3
8040-8,"TOXOPLASMA GONDII ANTIBODY, IGM",63
1925-7,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,118
92141-1,"SARS-COV-2, FLUA + FLUB, PCR",7
95406-5,"SARS-COV-2, FLUA + FLUB, PCR",7
92142-9,"SARS-COV-2, FLUA + FLUB, PCR",7
94769-7,SARS-COV-2 SEMI-QUANT TOTAL AB,27
94661-6,SARS-COV-2 SEMI-QUANT TOTAL AB,26
74822-8,C DIFF TOX B GENE DETECTION BY PCR SCH BSP,30
50387-0,"PAP IG, CT-NG, HPV-HR",8
59420-0,"PAP IG, CT-NG, HPV-HR",8
50388-8,"PAP IG, CT-NG, HPV-HR",8
,GENE TEST BETA-THALASSEMIA,37
,TAY-SACHS DISEASE PROFILE,28
13949-3,"CYTOMEGALOVIRUS ANTIBODY, IGG",118
24119-0,"CYTOMEGALOVIRUS ANTIBODY, IGM",92
,"MYASTHENIA GRAVIS (MG) EVALUATION,SERUM",17
,"ACETYLCHOLINE RECEPTOR, BINDING",18
49107-6,"RUBELLA ANTIBODY, IGM",28
29660-8,"PARVOVIRUS B19 ANTIBODY, IGG AND IGM",34
40658-7,"PARVOVIRUS B19 ANTIBODY, IGG AND IGM",34
8039-0,"TOXOPLASMA GONDII ANTIBODY, IGG",89
17351-8,ANCA SCREEN WITH REFLEX TO TITER,7
1925-7,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,244
,TRANSFUSION REACTION PRE-TWO TUBE,33
,TRANSFUSION REACTION POST-TWO TUBE,13
82166-0,"INFLUENZA A,B PCR",6
82170-2,"INFLUENZA A,B PCR",6
82166-0,RESPIRATORY PANEL BSP,4
82175-1,RESPIRATORY PANEL BSP,4
82161-1,RESPIRATORY PANEL BSP,4
82160-3,RESPIRATORY PANEL BSP,4
82163-7,RESPIRATORY PANEL BSP,4
82171-0,RESPIRATORY PANEL BSP,4
87621-9,RESPIRATORY PANEL BSP,4
82170-2,RESPIRATORY PANEL BSP,4
82177-7,RESPIRATORY PANEL BSP,4
82173-6,RESPIRATORY PANEL BSP,4
82178-5,RESPIRATORY PANEL BSP,4
82172-8,RESPIRATORY PANEL BSP,4
82176-9,RESPIRATORY PANEL BSP,4
82174-4,RESPIRATORY PANEL BSP,4
82179-3,RESPIRATORY PANEL BSP,4
82165-2,RESPIRATORY PANEL BSP,4
82164-5,RESPIRATORY PANEL BSP,4
94565-9,RESPIRATORY PANEL BSP,1
82162-9,RESPIRATORY PANEL BSP,4
5797-6,KETONES URINE DIPSTICK,84
35492-8,MRSA PCR BSP,30
26454-9,"CELL COUNT WITH DIFFERENTIAL, CSF",406
34468-9,C.DIFFICILE SCREEN,7
53115-2,CBC/DIFFERENTIAL (NO PLATELET),4
71695-1,CBC/DIFFERENTIAL (NO PLATELET),4
16014-3,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
5000-5,"CYTOMEGALOVIRUS (CMV), MOLECULAR DETECTION, PCR",16
706-2,PREECLAMPSIA MONITORING PROFILE,8
71695-1,PREECLAMPSIA MONITORING PROFILE,8
704-7,PREECLAMPSIA MONITORING PROFILE,8
53115-2,PREECLAMPSIA MONITORING PROFILE,8
2032-1,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,517
16016-8,"ALLERGY PANEL, REGION 3, WEEDS",5
16095-2,"ALLERGY PANEL, REGION 3, WEEDS",5
15872-5,"ALLERGY PANEL, REGION 3, WEEDS",5
15805-5,"ALLERGY PANEL, REGION 3, WEEDS",5
15952-5,"ALLERGY PANEL, REGION 3, WEEDS",5
20449-5,TICK-BORNE DISEASE ANTIBODIES PANEL- MAYO,9
42254-3,"Q ANA SCREEN, IFA",5
6457-6,"Q DNA AB (DS) CRITHIDIA,IFA",7
32284-2,BK VIRUS DNA DETECT/QUANT,64
706-2,T-HELPER CELLS (CD4) COUNT,71
1925-7,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,344
71695-1,CMP14+LP+CBC/D/PLT+TSH,4
704-7,CMP14+LP+CBC/D/PLT+TSH,4
53115-2,CMP14+LP+CBC/D/PLT+TSH,4
13951-9,HEPATITIS A SCREEN,33
13950-1,HEPATITIS A SCREEN,33
9571-1,"PARVOVIRUS B19 MOLECULAR DETECTION,PCR-M",6
5353-8,SJOGRENS SYNDROME-B EXTRACTABLE NUCLEAR ANTIBODY,122
5351-2,SJOGRENS SYNDROME-A EXTRACTABLE NUCLEAR ANTIBODY,135
80660-4,"STRONGYLOIDES ANTIBODY, IGG",103
32286-7,"Q HEPATITIS C VIRAL RNA GENOTYPE, LIPA(R)",6
26020-8,CK ISOENZYMES,2
12187-1,CK ISOENZYMES,2
15048-2,CK ISOENZYMES,2
46126-9,"ENDOMYSIAL (EMA) ANTIBODY, IGA TITER",14
94286-2,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94358-9,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94354-8,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94363-9,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94362-1,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94364-7,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
93491-9,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
82989-5,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94288-8,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94706-9,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
93502-3,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94359-7,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
96490-8,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
93426-5,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
96479-1,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94360-5,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94361-3,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94357-1,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94356-3,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
94355-5,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
15748-7,"ALLERGY PANEL, REGION 3, GRASSES",6
15746-1,"ALLERGY PANEL, REGION 3, GRASSES",6
15737-0,"ALLERGY PANEL, REGION 3, GRASSES",6
15744-6,"ALLERGY PANEL, REGION 3, GRASSES",6
16054-9,"ALLERGY PANEL, REGION 3, GRASSES",6
15947-5,"ALLERGY PANEL, REGION 3, TREES",5
15585-3,"ALLERGY PANEL, REGION 3, TREES",5
15841-0,"ALLERGY PANEL, REGION 3, TREES",5
15697-6,"ALLERGY PANEL, REGION 3, TREES",5
15615-8,"ALLERGY PANEL, REGION 3, TREES",5
59420-0,HPV APTIMA,694
713-8,CBC/DIFF AMBIGUOUS DEFAULT,725
5301-7,ANTI ENA 1,34
31627-3,ANTI ENA 1,34
,LAB COLOGUARD COLON CANCER SCREEN,30
,"HSV NON-SPECIFIC ANTIBODY, IGM",3
31444-3,INTRINSIC FACTOR BLOCKING ANTIBODY,33
50563-6,URINE FOR TRANSFUSION REACTION WK-UP,1
54218-3,T/B LYMPH PROFILE,150
50956-2,"HLA-B 5701 GENOTYPE, PGX",9
,CK TOTAL AND CKMB,1998
16952-4,"HERPES SIMPLEX VIRUS, MOLECULAR DETECTION, PCR, SPINAL FLUID, MAYO",63
16960-7,"HERPES SIMPLEX VIRUS, MOLECULAR DETECTION, PCR, SPINAL FLUID, MAYO",63
42626-2,"TOXOPLASMA GONDII, MOLECULAR DETECTION, PCR",25
77953-8,"WEST NILE VIRUS, CSF",27
29569-1,"WEST NILE VIRUS, CSF",27
46131-9,CLOSTRIDIUM DIFFICILE TOXIN B SCREEN,6
26499-4,MANUAL DIFF CELLAVISION,7885
9598-4,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9599-2,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9593-5,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
14273-7,LUPUS SCREEN/CONFIRM PANEL,21
42254-3,LUPUS SCREEN/CONFIRM PANEL,21
13931-1,LUPUS SCREEN/CONFIRM PANEL,21
17284-1,LUPUS SCREEN/CONFIRM PANEL,21
6457-6,LUPUS SCREEN/CONFIRM PANEL,21
42181-8,LUPUS SCREEN/CONFIRM PANEL,21
,"CYTOMEGALOVIRUS ANTIBODY, IGM",8
58413-6,CBC WITH DIFFERENTIAL,20
,DAT IGG,116
94815-8,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94344-9,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94340-7,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94816-6,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94351-4,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94350-6,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94352-2,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94343-1,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94342-3,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94341-5,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
3879-4,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
41858-2,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",8
3390-2,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
3349-8,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
3377-9,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
10998-3,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
3879-4,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
3936-2,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
21556-6,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
3393-6,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
10976-9,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
3414-0,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",4
69933-0,"UREAPLASMA SPECIES, MOLECULAR DETECTION, PCR, VARIES",9
51988-4,"UREAPLASMA SPECIES, MOLECULAR DETECTION, PCR, VARIES",9
,SEROTONIN RELEASE ASSAY SRA (FPORC) - MAYO,114
742-7,CBC WITH DIFFERENTIAL,16006
53115-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
71695-1,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
42254-3,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
72391-6,"SURESWAB(R), ADVANCED CANDIDA VAGINITIS",21
62460-1,"SURESWAB(R), ADVANCED CANDIDA VAGINITIS",21
69563-5,"SURESWAB(R), ADVANCED CANDIDA VAGINITIS",21
72495-5,"SURESWAB(R), ADVANCED CANDIDA VAGINITIS",21
79379-4,"HIV-1 DNA AND RNA QUALITATIVE DETECTION BY PCR, PLASMA",16
10362-2,CELIAC DISEASE COMPREHENSIVE PANEL,5
,HM DIABETES EYE EXAM,44
44871-2,"HIV 1 DNA,QUALITATIVE PCR",6
,ROM PLUS (RUPTURE OF MEMBRANE),28
1925-7,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
11555-0,VENOUS BLOOD GAS UNSOLICITED RESULTS,149
,CHLAMYDIA/GC DNA PCR SCH BSP,46
,TRICHOMONAS VAGINALIS DNA PCR,20
32682-7,HEMOGLOBINOPATHY EVALUATION,25
32683-5,HEMOGLOBINOPATHY EVALUATION,25
,LOWER RESPIRATORY CULTURE,814
73824-5,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",36
75558-7,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",36
75983-7,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",36
75980-3,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",36
,"LYME DISEASE, WESTERN BLOT",20
74762-6,"Q SURESWAB(R) BACTERIAL VAGINOSIS, DNA, QN, RT PCR",31
74669-3,"Q SURESWAB(R) BACTERIAL VAGINOSIS, DNA, QN, RT PCR",32
74667-7,"Q SURESWAB(R) BACTERIAL VAGINOSIS, DNA, QN, RT PCR",31
74668-5,"Q SURESWAB(R) BACTERIAL VAGINOSIS, DNA, QN, RT PCR",31
33469-8,DIPHTHERIA / TETANUS ANTIBODY PANEL,4
45166-6,DIPHTHERIA / TETANUS ANTIBODY PANEL,4
711-2,EOSINOPHIL COUNT,30
13994-9,"PROTEIN ELECTROPHORESIS, URINE",15
13995-6,"PROTEIN ELECTROPHORESIS, URINE",15
13993-1,"PROTEIN ELECTROPHORESIS, URINE",15
,ANTIBODY SCREEN TUBE,24
20447-9,"HIV 1 RNA, QUANTITATIVE REAL TIME PCR",149
29541-0,"HIV 1 RNA, QUANTITATIVE REAL TIME PCR",149
32623-1,CBC,110087
90894-7,"OPIATE CONFIRMATION REFLEX, URINE",3
17395-5,"OPIATE CONFIRMATION REFLEX, URINE",3
16252-9,"OPIATE CONFIRMATION REFLEX, URINE",3
16250-3,"OPIATE CONFIRMATION REFLEX, URINE",3
19448-0,"OPIATE CONFIRMATION REFLEX, URINE",3
77207-9,"OPIATE CONFIRMATION REFLEX, URINE",3
61425-5,"OPIATE CONFIRMATION REFLEX, URINE",3
16998-7,"OPIATE CONFIRMATION REFLEX, URINE",3
16249-5,"OPIATE CONFIRMATION REFLEX, URINE",3
61422-2,"OPIATE CONFIRMATION REFLEX, URINE",3
71695-1,CMP14+CBC/D/PLT,1
53115-2,CMP14+CBC/D/PLT,1
14241-4,PARIETAL CELL ANTIBODY IGG-MAYO,2
95608-6,RESPIRATORY PANEL BSP,3
,BLOOD CULTURE,2895
,MUSK ANTIBODY-MAYO,20
63212-5,GANGLIOSIDE ANTIBODY PANEL-MAYO,7
63243-0,GANGLIOSIDE ANTIBODY PANEL-MAYO,7
63247-1,GANGLIOSIDE ANTIBODY PANEL-MAYO,7
94868-7,GANGLIOSIDE ANTIBODY PANEL-MAYO,7
94870-3,GANGLIOSIDE ANTIBODY PANEL-MAYO,7
63384-2,GANGLIOSIDE ANTIBODY PANEL-MAYO,7
51716-9,MUSK ANTIBODY-MAYO,18
42588-4,BORDETELLA PERTUSSIS / PARAPERTUSSIS PCR,5
43913-3,BORDETELLA PERTUSSIS / PARAPERTUSSIS PCR,5
,QUAD SCREEN,25
68380-5,CHROMATIN ANTIBODY,4
50397-9,HEMOCHROMATOSIS MUTATION,19
,POCT FECAL BLOOD SCREEN IMMUNOASSAY,57
53115-2,CBC/D/PLT,6
704-7,CBC/D/PLT,6
706-2,CBC/D/PLT,6
751-8,CBC WITH AUTO DIFFERENTIAL,125040
8116-6,T/B LYMPH PROFILE,150
8117-4,T/B LYMPH PROFILE,150
711-2,T-HELPER CELLS CD4/CD8 %,2
704-7,T-HELPER CELLS CD4/CD8 %,2
53115-2,T-HELPER CELLS CD4/CD8 %,2
713-8,T-HELPER CELLS CD4/CD8 %,2
706-2,T-HELPER CELLS CD4/CD8 %,2
88517-8,QFT-TB GOLD PLUS 182880,37
64084-7,QFT-TB GOLD PLUS 182880,37
71776-9,QFT-TB GOLD PLUS 182880,37
,ADAMTS13 INHIBITOR-MAYO,8
34468-9,CLOSTRIDIUM DIFFICILE EIA,12
6690-2,CBC WITH AUTO DIFFERENTIAL,139253
,HLA SCREEN,9
15975-6,"REGIONAL ALLERGY PROFILE, IGE",14
15685-1,"REGIONAL ALLERGY PROFILE, IGE",14
15647-1,"REGIONAL ALLERGY PROFILE, IGE",14
15609-1,"REGIONAL ALLERGY PROFILE, IGE",14
26451-5,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,2
75506-6,LUPUS ANTICOAG CONFIRM CONSULT,4
3282-1,LUPUS ANTICOAG CONFIRM CONSULT,4
15642-2,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15917-8,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
16018-4,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15647-1,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
16074-7,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15861-8,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15846-9,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15689-3,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15530-9,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
16085-3,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15609-1,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15650-5,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15568-9,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
547-0,STREP GP B CULTURE,20
82306-2,CHLAMYDIA/N. GONORRHOEAE RNA TMA THROAT,2
60255-7,CHLAMYDIA/N. GONORRHOEAE RNA TMA THROAT,2
69002-4,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
43305-2,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
43304-5,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
46154-1,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
11011-4,"HCV RNA DETECT/QUANT, S (MAYO)",4
3936-2,DRUG PROFILE 764875 LEGACY,2
58430-0,DRUG PROFILE 764875 LEGACY,2
3377-9,DRUG PROFILE 764875 LEGACY,2
5645-7,DRUG PROFILE 764875 LEGACY,2
19261-7,DRUG PROFILE 764875 LEGACY,2
19141-1,DRUG PROFILE 764875 LEGACY,2
3773-9,DRUG PROFILE 764875 LEGACY,2
19710-3,DRUG PROFILE 764875 LEGACY,2
3746-5,DRUG PROFILE 764875 LEGACY,2
19295-5,DRUG PROFILE 764875 LEGACY,2
19289-8,DRUG PROFILE 764875 LEGACY,1
3393-6,DRUG PROFILE 764875 LEGACY,2
14316-4,DRUG PROFILE 764875 LEGACY,2
10362-2,Q ENDOMYSIAL ANTIBODY SCR (IGA) W/REFL TO TITER,1
44099-0,ASPERGILLUS GALACTOMANNAN ANTIGEN,6
,"FUNGITELL ASSAY FOR (1,3)-B-D-GLUCAN",11
,ANAEROBIC CULTURE,614
32700-7,MALARIA SMEAR,4
12782-9,OLIGOCLONAL BANDING,10
94694-7,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
94349-8,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
,SIX MINUTE WALK,5415
,HM FIT,10
21262-1,STOOL CULTURE,9
94500-6,POCT SARS-COV-2 RT-PCR,74
51786-2,HIV-2 ANTIBODIES,1
24113-3,ACUTE HEPATITIS,4
13950-1,ACUTE HEPATITIS,4
5196-1,ACUTE HEPATITIS,4
68547-9,"GENITAL MYCOPLASMA PROFILE NAA, SWAB",6
69935-5,"GENITAL MYCOPLASMA PROFILE NAA, SWAB",6
68546-1,"GENITAL MYCOPLASMA PROFILE NAA, SWAB",6
54905-5,"NOROVIRUS PCR, FECES-MAYO",7
54906-3,"NOROVIRUS PCR, FECES-MAYO",7
,HUMAN HERPESVIRUS 6 (HHV-6A AND HHV-6B) BY QUANTITATIVE PCR (MAYO),97
94251-6,LYME DISEASE PCR,17
94250-8,LYME DISEASE PCR,17
94252-4,LYME DISEASE PCR,17
26452-3,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",156
2334-1,GASTROCCULT,6
71695-1,CBC/D/PLT,6
11060-1,"REDUCING SUBSTANCES, STOOL",4
32623-1,CBC WITH AUTO DIFFERENTIAL,139261
48159-8,"HEPATITIS C AB W/RFL RNA, PCR W/RFL GENOTYPE,LIPA",110
1007-4,DIRECT ANTIGLOBULIN TEST,4
69933-0,"SURESWAB(R), MYCOPLASMA/UREAPLASMA PANEL, REAL-TIME PCR",1
68546-1,"SURESWAB(R), MYCOPLASMA/UREAPLASMA PANEL, REAL-TIME PCR",1
,"SURESWAB(R), MYCOPLASMA/UREAPLASMA PANEL, REAL-TIME PCR",1
51988-4,"SURESWAB(R), MYCOPLASMA/UREAPLASMA PANEL, REAL-TIME PCR",1
,POCT GLUCOSE,1590
736-9,CBC WITH AUTO DIFFERENTIAL,125050
5905-5,CBC WITH AUTO DIFFERENTIAL,125050
6412-1,"GIARDIA / CRYPTOSPORIDIUM ANTIGENS,EIA",4
31794-1,"GIARDIA / CRYPTOSPORIDIUM ANTIGENS,EIA",4
,CHLAMYDIA TRACHOMATIS DNA PCR BSP,5
,NEISSERIA GONORRHOEAE DNA PCR BSP,5
94564-2,"SARS-COV-2 ANTIBODY, IGM",6
43228-6,"CRYPTOCOCCAL AG, LATEX SCREEN W/REFL TITER",6
,URINALYSIS CHEM ONLY,37
11043-7,"CRYOGLOBULIN AND CRYOFIBRINOGEN PANEL, SERUM AND PLASMA",9
19146-0,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
74669-3,SURESWAB(R) ADVANCED BACTERIAL VAGINOSIS,28
,C DIFF TOX B GENE DETECTION BY PCR SCH BSP,18
,Q HEMOGLOBINOPATHY EVALUATION,35
,INTRINSIC FACTOR BLOCKING ANTIBODY,6
,"SARS COV-2 RNA, QUAL NAAT - QUEST",33
,SARS ANTIGEN FLUORESCENT IMMUNOASSAY (FIA),1198
,URINALYSIS ONLY MICROSCOPIC,1060
,RESPIRATORY PANEL BSP,68
,ANCA SCREEN WITH REFLEX TO TITER,1
,FETAL HEMOGLOBIN  STAIN,8
,"OCCULT BLOOD X 3, STOOL",72
,"C. TRACHOMATIS N. GONORRHOEAE, RNA, MISC SOURCE LEGACY",2
71776-9,QUANTIFERON-TB GOLD PLUS,219
53115-2,CBC/D/PLT W/ REFLEX FERRITIN,1
71695-1,CBC/D/PLT W/ REFLEX FERRITIN,1
11555-0,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,516
68546-1,"MYCOPLASMA HOMINIS, PCR-MAYO",9
90248-6,MYELIN OLIGODENDROCYTE GLYCOPROTEIN- MAYO,2
1975-2,COMPREHENSIVE METABOLIC PANEL,158211
,Q HEXAGONAL PHASE CONFIRM,2
,JAK2 EXON 12 MUTATION,14
,DRVVT CONFIRM,1
12201-0,"CRYOGLOBULIN AND CRYOFIBRINOGEN PANEL, SERUM AND PLASMA",9
,LYME DISEASE ANTIBODIES (IGGIGM) WESTERN BLOT LEGACY,15
,MRSA PCR BSP,1
1927-3,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,173
43399-5,JAK2 V617F MUTATION ANALYSIS,8
56485-6,"CYSTICERCOSIS ANTIBODY, IGG",3
69563-5,"NUSWAB BV AND CANDIDA, NAA",7
69562-7,"NUSWAB BV AND CANDIDA, NAA",7
706-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
704-7,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
94661-6,"SARS-COV-2 ANTIBODY, IGG",11
,ANACHOICE(R) PANEL 1 WITH REFLEXES,8
,"H. PYLORI ANTIGEN, STOOL",19
13951-9,"HEPATITIS A AB, TOTAL (REFL)",22
26455-6,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",666
,CF LOWER RESPIRATORY CULTURE,20
14625-8,"CELL PROFILE, BAL",5
742-7,CBC/DIFF AMBIGUOUS DEFAULT,726
5905-5,CBC/DIFF AMBIGUOUS DEFAULT,725
5905-5,CBC WITH DIFFERENTIAL,16011
21613-5,"CHLAMYDIA TRACHOMATIS, TMA (ALTERNATE TARGET)",1
,ORGANISM ID CULTURE,6
24111-7,NEISSERIA GONORRHOEAE DNA PCR BSP,5
43304-5,CHLAMYDIA TRACHOMATIS DNA PCR BSP,6
21668-9,FACTOR 5 LEIDEN,14
,"IGP, APTIMA HPV, RFX 16/18,45",336
33295-7,"JC VIRUS, MOLECULAR DETECTION, PCR, CSF-",3
38379-4,MTB PCR,7
17355-9,"INFLAMMATORY BOWEL DISEASE PANEL, S (MAYO-DHI)",5
26513-2,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",634
5218-3,"HISTOPLASMA ANTIBODY, IMMUNODIFFUSION",4
73561-3,INSULIN LIKE GROWTH FACTOR 1,77
53115-2,HRT FEMALE PRE PELLET,1
71695-1,HRT FEMALE PRE PELLET,1
706-2,HRT FEMALE PRE PELLET,1
704-7,HRT FEMALE PRE PELLET,1
68961-2,HIV 1/2 AB DIFF 083940,6
81641-3,HIV 1/2 AB DIFF 083940,6
94505-5,"SARS-COV-2 ANTIBODY, IGG",11
15642-2,"ALLERGY EVALUATION 2, SOUTHEAST",2
15936-8,"ALLERGY EVALUATION 2, SOUTHEAST",2
15530-9,"ALLERGY EVALUATION 2, SOUTHEAST",2
15744-6,"ALLERGY EVALUATION 2, SOUTHEAST",2
15975-6,"ALLERGY EVALUATION 2, SOUTHEAST",2
15875-8,"ALLERGY EVALUATION 2, SOUTHEAST",2
15680-2,"ALLERGY EVALUATION 2, SOUTHEAST",2
15685-1,"ALLERGY EVALUATION 2, SOUTHEAST",2
15609-1,"ALLERGY EVALUATION 2, SOUTHEAST",2
15738-8,"ALLERGY EVALUATION 2, SOUTHEAST",2
6320-6,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9597-6,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9593-5,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
50969-5,"EPSTEIN-BARR VIRUS EARLY ANTIGEN ANTIBODY, IGG",29
24114-1,"EPSTEIN-BARR VIRUS VCA, IGG",36
57838-5,Q DRVVT CONFIRM,5
33930-9,Q HEXAGONAL PHASE CONFIRM,10
15642-2,MITE AND MOLD GROUPING,6
15530-9,MITE AND MOLD GROUPING,6
15924-4,MITE AND MOLD GROUPING,6
15680-2,MITE AND MOLD GROUPING,6
6821-3,HYPERSENSITIVITY PNEUMONITIS PROFILE LEGACY,1
19726-9,HYPERSENSITIVITY PNEUMONITIS PROFILE LEGACY,1
6818-9,HYPERSENSITIVITY PNEUMONITIS PROFILE LEGACY,1
21561-6,HYPERSENSITIVITY PNEUMONITIS PROFILE LEGACY,1
6733-0,HYPERSENSITIVITY PNEUMONITIS PROFILE LEGACY,1
11584-0,HYPERSENSITIVITY PNEUMONITIS PROFILE LEGACY,1
13953-5,HEPATITIS B E ANTIBODY,16
,ANACHOICE(R) SCREEN WITH REFLEX,5
,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,519
69933-0,"SURESWAB(R), UREAPLASMA$SPECIES, PCR",1
51988-4,"SURESWAB(R), UREAPLASMA$SPECIES, PCR",1
5000-5,"CYTOMEGALOVIRUS DNA, QL REAL TIME PCR",1
,REPEAT TYPE AND SCREEN LAB ONLY,92
,COMPREHENSIVE METABOLIC PANEL,408045
3094-0,COMPREHENSIVE METABOLIC PANEL,158094
82168-6,RESPIRATORY PANEL BSP,1
82167-8,RESPIRATORY PANEL BSP,1
82169-4,RESPIRATORY PANEL BSP,1
,HISTORICAL PATHOLOGY CASE,118
24115-8,"EPSTEIN-BARR VIRUS VCA, IGM",42
35279-9,GRANULOCYTE ANTIBODIES,3
1747-5,"ALBUMIN, BODY FLUID",185
21055-9,"ADENOVIRUS, MOLECULAR DETECTION,PCR-MAYO",5
15729-7,ALLERGEN GLUTEN IGE,3
,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",1389
,POCT OCCULT BLOOD STOOL 1-3 TESTS,30
7947-5,"LEGIONELLA PNEUMOPHILA ANTIBODIES, TOTAL",4
26969-6,ANTI-PARIETAL ANTIBODY,12
33422-7,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
84927-3,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
43187-4,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
82976-2,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
94285-4,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
13931-1,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
33615-6,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
72523-4,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
93869-6,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
72504-4,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
82978-8,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
72524-2,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
93867-0,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
35458-9,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
93870-4,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
63439-4,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
93868-8,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
84926-5,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
84924-0,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
84925-7,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
43102-3,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
1927-3,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
22285-1,ENTAMOEBA HISTOLYTICA ANTIBODY-MAYO,5
17817-8,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
17815-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
17813-7,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
17811-1,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
73982-1,CARBA R PCR,26
85498-4,CARBA R PCR,26
49617-4,CARBA R PCR,26
85501-5,CARBA R PCR,26
85503-1,CARBA R PCR,26
59152-9,VAN A PCR,25
50397-9,CYSTIC FIBROSIS MUTATION PANEL (MAYO),6
706-2,CMP14+LP+CBC/D/PLT+TSH,4
20578-1,"VANCOMYCIN, RANDOM",1656
28544-5,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",310
35569-3,OLIGOCLONAL BANDING,10
49852-7,OLIGOCLONAL BANDING,22
50397-9,ALPHA-GLOBIN GENE ANALYSIS-MAYO,3
38476-8,"ANTI-MULLERIAN HORMONE (AMH), FEMALE",16
43304-5,"Q CHLAMYDIA/N. GONORRHOEAE RNA, TMA, UROGENITAL",23
43305-2,"Q CHLAMYDIA/N. GONORRHOEAE RNA, TMA, UROGENITAL",22
59646-0,"NICOTINE METABOLITE, URINE LEGACY",5
26019-0,CK ISOENZYMES,2
15642-2,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15936-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15530-9,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15743-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15975-6,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15875-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15680-2,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15685-1,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15609-1,"ALLERGY EVALUATION 3, SUBTROPICAL",1
15738-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
58413-6,WHITE BLOOD COUNT AND DIFFERENTIAL,8
771-6,WHITE BLOOD COUNT AND DIFFERENTIAL,8
704-7,WHITE BLOOD COUNT AND DIFFERENTIAL,10
77399-4,HPV GENOTYPES 1618/45 SUREPATH VIAL,8
75694-0,HPV GENOTYPES 1618/45 SUREPATH VIAL,8
42254-3,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
6457-6,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
94500-6,"SARS COV2 (COVID19) AND INFLUENZA A AND B, NAAT",2
92142-9,"SARS COV2 (COVID19) AND INFLUENZA A AND B, NAAT",2
92141-1,"SARS COV2 (COVID19) AND INFLUENZA A AND B, NAAT",2
59263-4,"HPV GENOTYPES 16/18,45",2
13951-9,"HEPATITIS A ANTIBODY, TOTAL",23
6690-2,CBC,113151
26971-2,SMOOTH MUSCLE AB W/REFL TITER,9
42254-3,"ANA, IFA RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL WITH REFLEX TITER/PATTERN",6
15682-8,"REGIONAL ALLERGY PROFILE, IGE",14
15680-2,"REGIONAL ALLERGY PROFILE, IGE",14
2349-9,URINALYSIS CHEM ONLY,11
10998-3,"DRUG PANEL, URINE",3
58714-7,"DRUG PANEL, URINE",3
10900-9,HEPATITIS B SURFACE AB QUAL/QUANT-MAYO,8
25428-4,"UA/M W/RFLX CULTURE, ROUTINE",29
22296-8,"EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN ANTIBODY, IGG",25
95269-7,PLATELET ANTIBODY-MAYO,3
87757-1,PLATELET ANTIBODY-MAYO,3
48505-2,PLATELET ANTIBODY-MAYO,6
24375-8,PLATELET ANTIBODY-MAYO,3
48506-0,PLATELET ANTIBODY-MAYO,3
47084-9,PLATELET ANTIBODY-MAYO,6
6873-4,BETA HYDROXYBUTYRATE,709
29495-9,"HUMAN HERPESVIRUS-6, MOLECULAR DETECTION, PCR, PLASMA",3
43180-9,HSV-2 IGG SUPPLEMENTAL 163006,7
77022-2,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
77024-8,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
40991-2,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
94500-6,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",4
76070-2,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",4
76084-3,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
77023-0,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
76086-8,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
76085-0,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
76080-1,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
77026-3,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
77027-1,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
76078-5,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
5265-4,ISLET CELL AB SCREEN W/RFX TITER,3
33509-1,"HEMOGLOBIN, BODY FLUID",12
705-4,CBC+PLATELET+HEM REVIEW,3
707-0,CBC+PLATELET+HEM REVIEW,3
15861-8,ALLERGEN MOUSE URINE IGE,6
1751-7,COMPREHENSIVE METABOLIC PANEL,158213
,ALPHA-GLOBIN GENE ANALYSIS-MAYO,14
5274-6,"PARVOVIRUS B19 ANTIBODY, IGG AND IGM",48
20522-9,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
49876-6,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16232-1,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
72768-5,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
72770-1,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
59615-5,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16348-5,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
20559-1,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16231-3,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16201-6,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
17479-7,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
,"BENZODIAZEPINE CONFIRMATION REFLEX, U",28
17088-6,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
59635-3,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
51777-1,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
20528-6,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16228-9,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
51776-3,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16227-1,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
16229-7,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
15892-3,RESPIRATORY ALLERGY PROFILE REGION XII,3
15642-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
15615-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15549-9,RESPIRATORY ALLERGY PROFILE REGION XII,3
15530-9,RESPIRATORY ALLERGY PROFILE REGION XII,3
15519-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
15875-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15975-6,RESPIRATORY ALLERGY PROFILE REGION XII,3
15697-6,RESPIRATORY ALLERGY PROFILE REGION XII,3
15659-6,RESPIRATORY ALLERGY PROFILE REGION XII,3
15682-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15738-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15924-4,RESPIRATORY ALLERGY PROFILE REGION XII,3
15749-5,RESPIRATORY ALLERGY PROFILE REGION XII,3
15743-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15861-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15863-4,RESPIRATORY ALLERGY PROFILE REGION XII,3
16052-3,RESPIRATORY ALLERGY PROFILE REGION XII,3
15936-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
15680-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
13931-1,MYASTHENIA GRAVIS PANEL 1,1
32682-7,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,4
32683-5,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,4
7905-3,HBSAG CONF 016105,1
73824-5,MATERNIT21 PLUS CORE+ESS,6
75558-7,MATERNIT21 PLUS CORE+ESS,6
75578-5,MATERNIT21 PLUS CORE+ESS,6
92900-0,MATERNIT21 PLUS CORE+ESS,6
,MATERNIT21 PLUS CORE+ESS,54
92899-4,MATERNIT21 PLUS CORE+ESS,6
92903-4,MATERNIT21 PLUS CORE+ESS,6
92902-6,MATERNIT21 PLUS CORE+ESS,6
75602-3,MATERNIT21 PLUS CORE+ESS,6
75983-7,MATERNIT21 PLUS CORE+ESS,6
75980-3,MATERNIT21 PLUS CORE+ESS,6
15549-9,ALLERGEN ASPERGILLUS FUMIGATUS,8
23858-4,EPSTEIN BARR VIRUS CSF BY RAPID PCR-MAYO,8
15697-6,TREE GROUPING TREA,6
15774-3,"ALLERGEN TREE: PECAN, HICKORY (CARYA PECAN) IGE LEGACY",5
15975-6,WEED GROUPING,6
15936-8,WEED GROUPING,6
16016-8,WEED GROUPING WED3,6
15872-5,WEED GROUPING WED3,6
15682-8,MITE AND MOLD GROUPING,6
15549-9,MITE AND MOLD GROUPING,6
15609-1,DANDER GROUPING,6
15685-1,DANDER GROUPING,6
15647-1,COCKROACH (I6) IGE,6
15585-3,TREE GROUPING TRE3,5
15615-8,TREE GROUPING TRE3,5
74822-8,"Q CLOSTRIDIUM DIFFICILE TOXINB,QL REAL TIME PCR",2
704-7,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
706-2,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,4
5792-7,GLUCOSE URINE DIPSTICK,1
10839-9,TROPONIN I,170292
,AEROBIC CULTURE,1502
16240-4,"BARBITURATES CONFIRMATION, U",1
16239-6,"BARBITURATES CONFIRMATION, U",1
16241-2,"BARBITURATES CONFIRMATION, U",1
16238-8,"BARBITURATES CONFIRMATION, U",1
,HM FLEX SIGMOIDOSCOPY,1
6632-4,"STRONGYLOIDES ANTIBODY, IGG",7
888-8,"ANTIBODY ID, TITER AND TYPING, RBC",30
,"EPSTEIN-BARR VIRUS DNA, QUANTITATIVE",3
46718-3,NMO-IGG CSF-MAYO,6
50941-4,MTB-RIF NAA WITH AFB CULTURE,1
,"CASPR2-IGG CBA, S",5
,"LGI1-IGG CBA, S",5
48558-1,Q HIV 1 GENOTYPE,4
48558-1,GENOSURE(R) MG,1
6864-3,Q SICKLE CELL SCREEN,1
74762-6,SURESWAB(R) ADVANCED BACTERIAL VAGINOSIS,27
74667-7,SURESWAB(R) ADVANCED BACTERIAL VAGINOSIS,27
26450-7,MANUAL DIFF CELLAVISION,3574
30180-4,MANUAL DIFF CELLAVISION,2407
16251-1,"OPIATE CONFIRMATION REFLEX, URINE",3
,REFERENCE ANTIBODY ID,403
42358-2,"HLA-B 5701 GENOTYPE, PGX",6
5274-6,PARVOVIRUS B-19 ANTIBODY (IGM),4
,POCT VAGINAL WET PREP,2971
,POCT VAGINAL PH ROM,266
,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",2
6412-1,GIARDIA ANTIGEN,13
49049-0,"%CORTISOL, LC/MS, SALIVA, SAMPLE 2",3
49049-0,"%CORTISOL, LC/MS, SALIVA, SAMPLE 3",3
49049-0,"%CORTISOL, LC/MS, SALIVA, SAMPLE 4",3
49049-0,"%CORTISOL, LC/MS, SALIVA, SAMPLE 1",3
,T-HELPER CELLS (CD4) COUNT,79
96396-7,"CYTOMEGALOVIRUS DNA, QN  RT PCR",10
34720-3,"CYTOMEGALOVIRUS DNA, QN  RT PCR",10
29495-9,"HERPES VIRUS 6 DNA,QL REAL TIME PCR",1
5048-4,L - ANA W/REFLEX 382965,4
81155-4,"ISLET ANTIGEN 2 (IA-2) ANTIBODY, SERUM",2
32576-1,"BARTONELLA SPECIES ANTIBODIES (IGG,IGM) W/REFLEX TO TITERS",1
32575-3,"BARTONELLA SPECIES ANTIBODIES (IGG,IGM) W/REFLEX TO TITERS",1
32577-9,"BARTONELLA SPECIES ANTIBODIES (IGG,IGM) W/REFLEX TO TITERS",1
32578-7,"BARTONELLA SPECIES ANTIBODIES (IGG,IGM) W/REFLEX TO TITERS",1
54218-3,T LYMPH PROFILE,460
26508-2,MANUAL DIFF CELLAVISION,5283
35276-5,RUBEOLA (MEASLES) AB IGG AND IGM-MAYO,2
35275-7,RUBEOLA (MEASLES) AB IGG AND IGM-MAYO,2
5048-4,"ANTINUCLEAR ANTIBODIES, IFA",9
,REFERENCE ABSC,218
15875-8,TREE GROUPING TREA,6
15738-8,GRASS GROUPING,6
15579-6,TREE GROUPING TRE3,5
9780-8,SEMEN ANALYSIS,15
6800-7,SEMEN ANALYSIS,15
72517-6,SEMEN ANALYSIS,15
10620-3,SEMEN ANALYSIS,15
81319-6,SEMEN ANALYSIS,15
10611-2,SEMEN ANALYSIS,15
71776-9,QFT-TB PLUS (CLIENT INCUBATED),2
82204-9,STOOL PCR PANEL,355
20447-9,HIV VIRAL LOAD W/REFLEX TO GENOSURE PRIME,6
29541-0,HIV VIRAL LOAD W/REFLEX TO GENOSURE PRIME,6
,HM FECAL OCCULT BLOOD,3
1927-3,VENOUS BLOOD GAS UNSOLICITED RESULTS,43
32578-7,"B. QUINTANA AB (IGM), SCREEN",2
32575-3,"B. HENSELAE AB (IGG), SCREEN",2
32577-9,"B. QUINTANA AB (IGG), SCREEN",2
32576-1,"B. HENSELAE AB (IGM), SCREEN",2
,HSV/VZV LESION PCR,148
,STRATIFY JCV(TM) AB (WITH INDEX) W/RFL INHIBITION,25
,HLA B27-MAYO,14
53115-2,"CBC WITH DIFF, PLATELET, NLR",2
,"PARVOVIRUS B19 ANTIBODY, IGG AND IGM",9
704-7,CBC/DIFFERENTIAL (NO PLATELET),4
,LYME DISEASE SEROLOGY-MAYO,5
18390-5,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",4
18392-1,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",4
34180-0,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",4
16369-1,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",3
70155-7,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",4
16195-0,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",4
19360-7,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",3
19416-7,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",3
6873-4,POCT BETA HYDROXYBUTYRATE UNSOLICITED RESULTS,41
94348-0,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",5
94817-4,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",5
8061-4,ANA MULTIPLEX WITH REFLEX TO DSDNA,6
92142-9,"Q SARS COV2 (COVID19) AND INFLUENZA A AND B, NAAT",3
92141-1,"Q SARS COV2 (COVID19) AND INFLUENZA A AND B, NAAT",3
94500-6,"Q SARS COV2 (COVID19) AND INFLUENZA A AND B, NAAT",3
711-2,OBSTETRIC PANEL WITHOUT HIV,321
704-7,OBSTETRIC PANEL WITHOUT HIV,321
713-8,OBSTETRIC PANEL WITHOUT HIV,322
706-2,OBSTETRIC PANEL WITHOUT HIV,322
43305-2,"NEISSERIA GONORRHOEAE RNA, TMA, UROGENITAL",4
,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",341
,"CT, NG, TRICH VAG BY NAA",3
,ALPHA THALASSEMIA LEGACY,12
,PULMONARY FUNCTION TESTING,33251
,COLD AGGLUTININ TITER,3
56974-9,OLIGOCLONAL BANDING,12
56764-4,OLIGOCLONAL BANDING,12
,"BARBITURATES CONFIRMATION, U",6
,POCT INFLUENZA B,1
,"CHLAMYDIA/GC NAA, CONFIRMATION",4
,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",118
,HISTOPLASMA ANTIBODIES,3
,"EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN ANTIBODY, IGG",3
,"LEGIONELLA ANTIGEN, URINE",189
,"STREP PNEUMONIAE AG, URINE",184
,"PARVOVIRUS B19 MOLECULAR DETECTION,PCR-M",6
,GLUTAMIC ACID DECARBOXYLASE,3
,"SURESWAB(R), C. TRACHOMATIS / N. GONORRHOEAE/ T.VAGINALIS",234
,BLADDER SCAN,26
,"HLA-B 5701 GENOTYPE, PGX",4
,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",22
,HEPATITIS B CORE AB TOTAL W/REFL IGM,1
26043-0,HLA B27-MAYO,9
11268-0,"STREP A CULTURE, THROAT",4
,BLASTOMYCES QUANTITATIVE ANTIGEN LEGACY,2
53115-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
71695-1,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
,CMV QUANT VIRAL LOAD,35
30522-7,HIGH SENSITIVITY CRP,25027
,FLU B RAPID LEGACY,23
,FLU A RAPID LEGACY,23
8061-4,ANTINUCLEAR ANTIBODIES DIRECT,8
6478-2,"MUMPS VIRUS AB, IGG AND IGM, S-MAYO",2
6476-6,"MUMPS VIRUS AB, IGG AND IGM, S-MAYO",2
,H. PYLORI BREATH TEST,2
,HEPATITIS A SCREEN,2
25841-8,HIV 2 DNA/RNA QUALITATIVE REAL TIME PCR,1
,MYCOPLASMA PNEUMONIAE PCR - MAYO,2
5393-4,Q FTA-ABS,11
50387-0,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
50388-8,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
16085-3,FOOD ALLERGY PROFILE WITH REFLEXES,9
15846-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
15650-5,FOOD ALLERGY PROFILE WITH REFLEXES,9
15568-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
15689-3,FOOD ALLERGY PROFILE WITH REFLEXES,9
16006-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
15766-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
15527-5,FOOD ALLERGY PROFILE WITH REFLEXES,9
15607-5,FOOD ALLERGY PROFILE WITH REFLEXES,9
16065-5,FOOD ALLERGY PROFILE WITH REFLEXES,9
15917-8,FOOD ALLERGY PROFILE WITH REFLEXES,9
,ANTI-PARIETAL ANTIBODY,1
,C. TRACHOMATIS / N. GONORRHOEAE BY NAA,1637
,"HSV PCR, B - MAYO",4
711-2,WHITE BLOOD COUNT AND DIFFERENTIAL,10
,PRENATAL PROFILE I,602
,"IGP,CTNG,APTIMAHPV,RFX16/18,45",118
3016-3,TSH,55026
10900-9,HEPATITIS PANEL (REFL) LEGACY,2
69002-4,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
890-4,OBSTETRIC PANEL WITHOUT HIV,325
,"HCV GENOTYPE RESOLUTION, S",1
,BONE MARROW REQUEST,25
,PANCREATIC ENZYME FLUID COLLECTION 1,50
,KETONES URINE DIPSTICK,6
14212-5,HEPATITIS E VIRUS AB IGM-MAYO,2
49693-5,HEPATITIS E VIRUS AB IGG-MAYO,1
69002-4,"HPV MRNA E6/E7 REFLEX TO HPV 16, 18/45",1
751-8,"AUTO DIFFERENTIAL, ADD ON",553
75694-0,"IGP,CTNG,APTIMAHPV,RFX16/18,45",8
59263-4,"IGP,CTNG,APTIMAHPV,RFX16/18,45",8
33548-9,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",1
,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,10
,"SARS-COV-2 ANTIBODY, IGG",2
80364-3,"CHLAMYDIA/N. GONORRHOEAE RNA, TMA, RECTAL",3
80366-8,"CHLAMYDIA/N. GONORRHOEAE RNA, TMA, RECTAL",3
888-8,ANTIBODY IDENTIFICATION,675
,ESTIMATED GLOMERULAR FILTRATION RATE LEGACY,53232
,"CYTOMEGALOVIRUS (CMV), MOLECULAR DETECTION, PCR",1
21654-9,CFVANTAGE CYSTIC FIBROSIS EXPANDED SCREEN,5
15642-2,ALLERGY MOLD PANEKM COMPLETE,1
16033-3,ALLERGY MOLD PANEKM COMPLETE,1
15924-4,ALLERGY MOLD PANEKM COMPLETE,1
15530-9,ALLERGY MOLD PANEKM COMPLETE,1
15549-9,ALLERGY MOLD PANEKM COMPLETE,1
15862-6,ALLERGY MOLD PANEKM COMPLETE,1
,CBC+PLATELET+HEM REVIEW,34
5213-4,MONONUCLEOSIS SCREEN,9
14709-0,"CELL PROFILE, BAL",88
15016-9,ISOENZYME PATTERN,1
35707-9,ISOENZYME PATTERN,1
40727-0,"HEPATITIS D VIRUS TOTAL ANTIBODIES, SERUM",1
32362-6,BK VIRUS DNA DETECT/QUANT,30
69420-8,EBV HETEROPHILE ANTIBODY,26
75983-7,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
75980-3,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
75558-7,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
73824-5,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
26512-4,"CELL COUNT WITH DIFFERENTIAL, CSF",134
17783-2,"HEMOSIDERIN, URINE",12
,POCT RSV,1
11034-6,"ACETYLCHOLINE RECEPTOR, BINDING",13
,POCT I-STAT G3+  LEGACY,1070
12187-1,CREATINE KINASE$ISOENZYMES W/O TOTAL,2
,"JC VIRUS, MOLECULAR DETECTION, PCR, CSF-",2
712-0,CBC+PLATELET+HEM REVIEW,3
714-6,CBC+PLATELET+HEM REVIEW,3
2514-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
53115-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2349-9,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5799-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5802-4,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5770-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
71695-1,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
19146-0,SMA DIAGNOSTIC TEST LEGACY,1
30106-9,Q ACETYLCHOLINESTERASE,2
8117-4,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
7919-4,HIV 2 DNA/RNA QUALITATIVE REAL TIME PCR,1
5095-5,"COCCIDIOIDES ANTIBODY, ID",6
30193-7,"CARNITINE, PLASMA",2
,STOOL CULTURE,75
,QUANTIFERON TB GOLD LEGACY,5
,HLA-B27 DNA TYPING LEGACY,4
,BASIC METABOLIC PANEL,400779
,ENDOMYSIAL AB SCREEN(IGA) REFLEX TO TITER LEGACY,1
,MITOCHONDRIAL ANTIBODY LEGACY,6
,TSH,7192
,"ALKALINE PHOSPHATASE, ISOENZYMES",16
,POCT BETA HYDROXYBUTYRATE UNSOLICITED RESULTS,30
,EPSTEIN BARR VIRUS ANTIBODY PANEL,6
,"ASPERGILLUS ANTIGEN, EIA, SERUM LEGACY",8
,"SARS-COV-2 RNA, QUALITATIVE REAL-TIME RT-PCR LEGACY",4
,ANA CASCADE LEGACY,1
,PROSTATE SPECIFIC ANTIGEN TOTAL,171
,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",10
,"CRYPTOCOCCAL AG, LATEX SCREEN W/REFL TITER",6
,GIARDIA ANTIGEN,2
,CRYPTOSPORIDIUM ANTIGEN LEGACY,2
,"CELL COUNT WITH DIFFERENTIAL, CSF",711
,HIV 1/2 EIA AG/AB SCREEN LEGACY,7
,ABORH,5259
5058-3,BLASTOMYCES ANTIBODIES,13
,IGG SYNTHESIS RATE CSF & SERUM LEGACY,12
,DIGOXIN LEVEL,103
43588-3,"VARICELLA ZOSTER ANTIBODY, IGM , IGG- MAYO",1
15410-4,"VARICELLA ZOSTER ANTIBODY, IGM , IGG- MAYO",1
4935-3,HLA TYPING FOR CELIAC DISEASE,1
41283-3,HLA TYPING FOR CELIAC DISEASE,1
94500-6,SARS-COV-2/FLU/RSV ORMC LEGACY,2
92142-9,SARS-COV-2/FLU/RSV ORMC LEGACY,2
92141-1,SARS-COV-2/FLU/RSV ORMC LEGACY,2
92131-2,SARS-COV-2/FLU/RSV ORMC LEGACY,2
75694-0,"IGP,CTNGTV,APT HPV,RFX16/18,45",4
59263-4,"IGP,CTNGTV,APT HPV,RFX16/18,45",4
,ANTIBODY SCREEN TUBE 3 CELL- SLK,5
34468-9,CDIFF A+B+GIARDIA+O+P+STOOL,1
21262-1,CDIFF A+B+GIARDIA+O+P+STOOL,1
6412-1,CDIFF A+B+GIARDIA+O+P+STOOL,1
80203-3,HIV 1/2 AB DIFF 083940,6
16011-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
16018-4,FOOD ALLERGY PROFILE WITH REFLEXES,9
16014-3,FOOD ALLERGY PROFILE WITH REFLEXES,9
16074-7,FOOD ALLERGY PROFILE WITH REFLEXES,9
6412-1,GIARDIA ANTIGEN W/REFL TO OVA AND PARASITES,1
1975-2,HEPATIC FUNCTION PANEL,3183
890-4,"ANTIBODY SCREEN, RBC W/REFL ID, TITER AND AG",166
11555-0,POCT CORD BLOOD GAS UNSOLICITED RESULTS,235
15581-2,ALLERGEN MITE: BLOMIA TROPICALIS (HOUSE DUST MITE) IGE,1
15585-3,TREE GROUPING TRE4,1
15615-8,TREE GROUPING TRE4,1
15737-0,GRASS GROUPING,6
16054-9,GRASS GROUPING,6
,"AMPHETAMINES CONFIRMATION, U",7
11153-4,"HEMATOCRIT, BODY FLUID",17
10976-9,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
3426-4,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
5644-0,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
58714-7,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
10998-3,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
3349-8,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
3390-2,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
3414-0,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
3393-6,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
14267-9,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
3879-4,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
48683-7,STREPTOCOCCUS GROUP B DNA PCR BROTH ENRICHMENT LEGACY,25
,"CK ISOENZYME ELECTROPHORESIS, S",21
,POCT BACTERIAL VAGINOSIS BLUE TEST,2
26485-3,MANUAL DIFF CELLAVISION,7621
74668-5,SURESWAB(R) ADVANCED BACTERIAL VAGINOSIS,27
35276-5,"MEASLES (RUBEOLA) ANTIBODY, IGM - MAYO",1
87558-3,"EHRLICHIA/ANAPLASMA, PCR, BLOOD-MAYO",1
87559-1,"EHRLICHIA/ANAPLASMA, PCR, BLOOD-MAYO",1
87560-9,"EHRLICHIA/ANAPLASMA, PCR, BLOOD-MAYO",1
87561-7,"EHRLICHIA/ANAPLASMA, PCR, BLOOD-MAYO",1
50956-2,HLA B*5701 TYPING,2
6369-3,"CRYPTOCOCCUS ANTIBODIES, QUANT LEGACY",1
94359-7,GAD65 ANTIBODY CSF REFLEX-MAYO,1
6478-2,"MUMPS ANTIBODY, IGM -MAYO",2
80692-7,"HIV-1 RESISTANCE,PROVIRAL DNA (RTI,PI INHIB)",1
42181-8,%ANTIMYOCARDIAL ANTIBODY SCREEN,4
13931-1,%STRIATED MUSCLE AB SCREEN,4
17284-1,%MITOCHONDRIAL AB SCREEN 1,4
14273-7,%RETICULIN IGA SCREEN,4
15924-4,RESPIRATORY ALLERGY PROFILE REGION X,1
15647-1,RESPIRATORY ALLERGY PROFILE REGION X,1
15530-9,RESPIRATORY ALLERGY PROFILE REGION X,1
15549-9,RESPIRATORY ALLERGY PROFILE REGION X,1
15685-1,RESPIRATORY ALLERGY PROFILE REGION X,1
15609-1,RESPIRATORY ALLERGY PROFILE REGION X,1
15682-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15546-5,RESPIRATORY ALLERGY PROFILE REGION X,1
15579-6,RESPIRATORY ALLERGY PROFILE REGION X,1
15585-3,RESPIRATORY ALLERGY PROFILE REGION X,1
15659-6,RESPIRATORY ALLERGY PROFILE REGION X,1
15615-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15738-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15697-6,RESPIRATORY ALLERGY PROFILE REGION X,1
15875-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15864-2,RESPIRATORY ALLERGY PROFILE REGION X,1
15774-3,RESPIRATORY ALLERGY PROFILE REGION X,1
15680-2,RESPIRATORY ALLERGY PROFILE REGION X,1
16016-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15975-6,RESPIRATORY ALLERGY PROFILE REGION X,1
16054-9,RESPIRATORY ALLERGY PROFILE REGION X,1
15693-5,RESPIRATORY ALLERGY PROFILE REGION X,1
15936-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15861-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15872-5,RESPIRATORY ALLERGY PROFILE REGION X,1
15642-2,RESPIRATORY ALLERGY PROFILE REGION X,1
18282-4,DRUG PROFILE 764875 LEGACY,1
,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",7
24110-9,SYPHILIS ANTIBODY CASCADING REFLEX,2
51968-6,"LEUKOVANTAGE(R), MYELOPROLIFERATIVE NEOPLASMS (MPN)",1
6864-3,HGB SOLUBILITY,209
8061-4,LUPUS PROFILE LEGACY,2
71695-1,HRT MALE PRE PELLET,1
704-7,HRT MALE PRE PELLET,1
53115-2,HRT MALE PRE PELLET,1
34487-9,POCT FLU A & B PCR MANUAL  RESULTS,4
40982-1,POCT FLU A & B PCR MANUAL  RESULTS,4
19295-5,"PREGNANCY DRUG PROFILE, UR, 10",1
58430-0,"PREGNANCY DRUG PROFILE, UR, 10",1
3349-8,"PREGNANCY DRUG PROFILE, UR, 10",1
12293-7,"PREGNANCY DRUG PROFILE, UR, 10",1
19270-8,"PREGNANCY DRUG PROFILE, UR, 10",1
14316-4,"PREGNANCY DRUG PROFILE, UR, 10",1
18282-4,"PREGNANCY DRUG PROFILE, UR, 10",1
19359-9,"PREGNANCY DRUG PROFILE, UR, 10",1
19659-2,"PREGNANCY DRUG PROFILE, UR, 10",1
45324-1,"PREGNANCY DRUG PROFILE, UR, 10",1
18309-5,MANUAL DIFFERENTIAL,657
706-2,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
704-7,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
70910-5,"CRYPTOCOCCUS ANTIGEN SCREEN WITH TITER, SERUM LEGACY",2
42254-3,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 1",2
742-7,"Q DIFFERENTIAL, MANUAL",105
5905-5,"Q DIFFERENTIAL, MANUAL",105
,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",5
48558-1,HIV 1 GENOTYPE LEGACY,1
16082-0,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
15783-4,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
15570-5,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
15782-6,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
16080-4,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
15537-4,ALLERGY INSECT VENOM PANEL,1
15782-6,ALLERGY INSECT VENOM PANEL,1
15570-5,ALLERGY INSECT VENOM PANEL,1
16080-4,ALLERGY INSECT VENOM PANEL,1
16082-0,ALLERGY INSECT VENOM PANEL,1
42484-6,"IFE AND PE, RANDOM URINE",2
13984-0,"IFE AND PE, RANDOM URINE",2
13987-3,"IFE AND PE, RANDOM URINE",2
13994-9,"IFE AND PE, RANDOM URINE",2
13989-9,"IFE AND PE, RANDOM URINE",2
55300-8,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
62947-7,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
43399-5,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
77174-1,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
92674-1,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
21759-6,Q FRAGILE X PCR,4
32645-4,Q FEVER IGM PHASE I SCR,15
46725-8,"TROPHERYMA WHIPPLEI DNA, QL, REAL TIME PCR",1
31314-8,Q FEVER IGG PHASE II SCR,15
32644-7,Q FEVER IGG PHASE I SCR,15
31315-5,Q FEVER IGM PHASE II SCR,15
10998-3,"DRUG TOX MONITORING 8 SCREEN, URINE",1
3349-8,"DRUG TOX MONITORING 8 SCREEN, URINE",1
3377-9,"DRUG TOX MONITORING 8 SCREEN, URINE",1
3393-6,"DRUG TOX MONITORING 8 SCREEN, URINE",1
41858-2,"DRUG TOX MONITORING 8 SCREEN, URINE",1
3879-4,"DRUG TOX MONITORING 8 SCREEN, URINE",1
14116-8,IGG INDEX CSF-MAYO,16
11545-1,ACID FAST SMEAR+CULTURE,3
50941-4,ACID FAST SMEAR+CULTURE,3
11545-1,ACID FAST SMEAR AND CULTURE WITH REFLEX ID,1
50941-4,ACID FAST SMEAR AND CULTURE WITH REFLEX ID,1
13952-7,HEPATITIS B CORE AB TOTAL W/REFL IGM,14
8117-4,LYMPHOCYTE SUBSET PANEL 2,5
,GESTATIONAL DIABETIC (3 HR) TOLERANCE,521
55300-8,JAK2 EXON 12 MUTATION,2
,MYELIN ASSOC GLYCOPROTEIN W/RELFEX MAG WESTERN BLOT LEGACY,2
,POCT TROPONIN,2
15530-9,ALLERGEN MICROORGANISM: ALTERNARIA ALTERNATA IGE,2
12210-1,EOSINOPHIL URINE,2
13317-3,MRSA CULTURE,8
43225-2,"TOXOCARA AB (IGG), SERUM",1
22264-6,"ECHINOCOCCUS AB (IGG), EIA WITH REFLEX TO WB LEGACY",1
43983-6,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",1
19359-9,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",1
19415-9,"DRUG ABUSE SURVEY WITH CONFIRMATION, URINE",1
,"OPIATE CONFIRMATION REFLEX, URINE",12
3773-9,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
3879-4,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
3349-8,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
58714-7,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
3377-9,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
3390-2,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
3393-6,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
3426-4,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
10998-3,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
5372-8,MYASTHENIA GRAVIS PROFILE,1
11555-0,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,585
13992-3,"PROTEIN ELECTROPHORESIS, URINE",15
17351-8,INFLAMMATORY BOWEL DISEASE DIFFERENTIATION PANEL,1
8061-4,L - ANA W/REFLEX 164902,1
706-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
704-7,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
53115-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
71695-1,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
26465-5,CSF ADDITIONAL CELL COUNT,36
42757-5,"TROPONIN, I-STAT",1
43304-5,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
43305-2,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
69002-4,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
8061-4,"ANACHOICE(R) SCREEN W/REFL TO TITER, IFA",2
3282-1,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,2
42254-3,ANA PROFILE 11 (RDL),1
50398-7,"BRCAVANTAGE(R), COMPREHENSIVE",2
5117-7,"CRYOGLOBULIN SCR W/REFL CRYOGLOBULIN PROFILE, S LEGACY",2
,HIV ANTIGEN/ANTIBODY,1621
17811-1,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
17813-7,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
17815-2,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
17817-8,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
770-8,CBC WITH AUTO DIFFERENTIAL,125046
,HEMATOCRIT,1602
90738-6,PI-LINKED ANTIGEN-MAYO,1
90737-8,PI-LINKED ANTIGEN-MAYO,1
90736-0,PI-LINKED ANTIGEN-MAYO,1
43304-5,"CHLAMYDIA TRACHOMATIS, DNA, AMP PROBE",3
70241-5,HIV-1 QUANT WITH REFLEX TO GENOTYPE-MAYO,27
,"TRICHOMONAS VAGINALIS, QL TMA, PAP VIAL",2
43304-5,C. TRACH NAA CONF 183620,1
11259-9,"HEPATITIS C VIRUS (HCV) RNA, QN, NAA",1
69937-1,TRICHOMONAS VAGINALIS DNA PROBE,6
27085-0,"DRUG PANEL, URINE",2
3779-6,"DRUG PANEL, URINE",2
61046-9,"DRUG PANEL, URINE",2
40481-4,"DRUG PANEL, URINE",2
,HIV-1 QUANT WITH REFLEX TO GENOTYPE-MAYO,2
2342-4,"GLUCOSE, CSF",355
19157-7,CSF ADDITIONAL CELL COUNT,36
19157-7,"CELL COUNT WITH DIFFERENTIAL, CSF",350
,STOOL PCR PANEL,22
,BONE MARROW EXAM,2536
,"BRUCELLA ANTIBODY SCREEN IGM/IGG ELISA, S",3
,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",21
4546-8,HEMOGLOBIN ELECTROPHORESIS,122
,WOUND CULTURE,393
42254-3,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
11034-6,"MYASTHENIA GRAVIS (MG) EVALUATION,SERUM",2
30192-9,"MYASTHENIA GRAVIS (MG) EVALUATION,SERUM",2
94817-4,"MYASTHENIA GRAVIS (MG) EVALUATION,SERUM",2
82197-5,STOOL PCR PANEL,1
,SERUM BANDS MAYO REFLEX,3
,CSF BANDS MAYO REFLEX,8
,AMB BESIDE COMMODE/SHOWER CHAIR,1
43305-2,NEISSERIA GONORRHEA DNA PROBE,2
,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,25
,"STRONGYLOIDES ANTIBODY, IGG",2
49135-7,FRACTIONAL EXCRETION OF SODIUM (URINE),97
,TRANSFUSION REACTION POST DAT POLY,1
,NUSWAB VAGINITIS (VG),6
,SUREPATH FPGS PAP AND HPV MRNA E6/E7,19
15898-0,Q EGG COMPONENT PANEL,2
4546-8,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
5196-1,HEPATITIS B SURFACE ANTIGEN W/REFL CONFIRM,689
,GAD65 ANTIBODY CSF REFLEX-MAYO,1
,T-HELPER CELLS CD4/CD8 %,29
,HTLV I/II ANTIBODY-MAYO,1
20507-0,Q RPR (MONITOR) W/REFL TITER,14
15218-1,"ALLERGEN PROFILE, BASIC FOOD",1
,DRUG ABUSE PANEL 10,1
94563-4,"SARS-COV-2 IGG, SPIKE S1/S2",1
,"MISC CHLAMYDIA TRACHOMATIS/N GONORRHOEAE, NAA-MAYO",7
82675-0,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
33921-8,SRP AUTOANTIBODIES,1
33771-7,PL 12 AUTOANTIBODIES,1
18484-6,KU AUTOANTIBODIES,1
33772-5,PL 7 AUTOANTIBODIES,1
18485-3,MI 2 AUTOANTIBODIES,1
45152-6,OJ AUTOANTIBODIES,1
45149-2,EJ AUTOANTIBODIES,1
35656-8,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
53115-2,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
71695-1,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
60255-7,"NEISSERIA GONORRHOEAE RNA, TMA, THROAT",1
80366-8,"NEISSERIA GONORRHOEAE RNA, TMA, RECTAL",1
,"CELL COUNT AND DIFF, SYNOVIAL FLUID",33
712-0,MANUAL DIFFERENTIAL,113
3773-9,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
3879-4,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
3349-8,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
58714-7,"DRUG MONITOR, PANEL 1, SCREEN, URINE",1
3377-9,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
3390-2,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
3393-6,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
3426-4,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
10998-3,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
3936-2,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
15606-7,Q MILK COMPONENT PANEL,1
15529-1,Q MILK COMPONENT PANEL,1
15577-0,Q MILK COMPONENT PANEL,1
713-8,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
711-2,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
,URINE CULTURE,2983
15609-1,RESPIRATORY ALLERGY PROFILE REGION XII,3
15647-1,RESPIRATORY ALLERGY PROFILE REGION XII,3
15685-1,RESPIRATORY ALLERGY PROFILE REGION XII,3
35642-8,"COTININE, URINE",1
3879-4,7 DRUG-UNBUND,1
3936-2,7 DRUG-UNBUND,1
40419-4,7 DRUG-UNBUND,1
19270-8,7 DRUG-UNBUND,1
3390-2,7 DRUG-UNBUND,1
18282-4,7 DRUG-UNBUND,1
3393-6,7 DRUG-UNBUND,1
,"HIV 1 DNA,QUALITATIVE PCR",1
29661-6,DENGUE ANTIBODIES IGG IGM,1
29663-2,DENGUE ANTIBODIES IGG IGM,1
77400-0,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
71431-1,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
77399-4,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
,MPN PROFILE,20
21739-8,MPN PROFILE,2
48726-4,MPN PROFILE,2
26479-6,"CELL COUNT WITH DIFFERENTIAL, CSF",192
71695-1,T-HELPER CELLS CD4/CD8 %,2
74762-6,"SURESWAB(R), RECURRENT VAGINITIS",1
74668-5,"SURESWAB(R), RECURRENT VAGINITIS",1
46154-1,"SURESWAB(R), RECURRENT VAGINITIS",1
62460-1,"SURESWAB(R), RECURRENT VAGINITIS",1
74669-3,"SURESWAB(R), RECURRENT VAGINITIS",1
74667-7,"SURESWAB(R), RECURRENT VAGINITIS",1
10362-2,CELIAC DISEASE COMPREHENSIVE,7
4092-3,"VANCOMYCIN, TROUGH",2053
26498-6,MANUAL DIFF CELLAVISION,2833
11259-9,HCV NAA QUALITATIVE (RFX GENO) LEGACY,1
53115-2,T-LYMPH MARKERS + NK,1
71695-1,T-LYMPH MARKERS + NK,1
50388-8,"PAP IG, CT-NG TV",1
46154-1,"PAP IG, CT-NG TV",1
50387-0,"PAP IG, CT-NG TV",1
20447-9,"HIV 1 RNA, QN PCR W/REFLEX TO GENOTYPE",36
29541-0,"HIV 1 RNA, QN PCR W/REFLEX TO GENOTYPE",36
,"HSV NON-SPECIFIC ANTIBODY, IGG",3
,PARASITE BLOOD EXAM,2
91545-4,MYELIN OLIGODENDROCYTE GLYCOPROTEIN- MAYO,1
,HEMOGLOBIN S SCREEN-MAYO,1
,HM CT COLONOGRAPHY,1
16233-9,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
59590-0,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
,POCT HPT/HR-ACT UNSOLICITED RESULTS,63
15897-2,Q EGG COMPONENT PANEL,2
,"MVISTA HISTOPLASMA AG QUANT, U REFLEX",2
5117-7,"CRYOGLOBULIN (%CRYOCRIT), SERUM",1
11259-9,HCV RNA NAA QUALITATIVE,49
50398-7,"BRCAVANTAGE PLUS(R) (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)",4
9589-3,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
71695-1,"CBC WITH DIFF, PLATELET, NLR",2
53115-2,DIFFERENTIAL/TOTAL WBC COUNT,1
704-7,DIFFERENTIAL/TOTAL WBC COUNT,1
711-2,DIFFERENTIAL/TOTAL WBC COUNT,1
8116-6,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
34147-9,"LC T PALLIDUM ANTIBODY, EIA",2
5196-1,HBV SCREENING AND DIAGNOSIS,1
13952-7,HBV SCREENING AND DIAGNOSIS,1
15738-8,ALLERGEN BERMUDA GRASS,1
15744-6,RYE GRASS (LOLIUM PERENNE),1
15975-6,"ALLERGEN RAGWEED, SHORT/COMMON IGE",1
15936-8,"ALLERGEN PIGWEED, ROUGH IGE",1
15875-8,"ALLERGEN OAK, WHITE IGE",1
15642-2,ALLERGEN CLADOSPORIUM,1
41499-5,"LEGIONELLA ANTIGEN, EIA, URINE",1
60677-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
28073-5,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
19328-4,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
59589-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
12602-9,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
3725-9,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
2160-0,COMPREHENSIVE METABOLIC PANEL,158094
53115-2,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
704-7,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
714-6,Eos Man,4237
707-0,Basophil Man,4237
712-0,Abs Eos Manual,4056
705-4,Abs Baso Manual,4056
,BP Ven,624
,PIP Ven,624
19048-8,NRBC %,6272
58413-6,NRBC,4126
26450-7,Eos Auto,6029
26449-9,Eos Absolute,6029
26444-0,Basos Absolute,6029
1927-3,BE Ven,629
,Measles IgG Interp,246
43978-6,Var Zos IgG Int,277
,BP Cap,1810
,RRIV Cap,1810
,PIP Cap,1810
5799-2,UA Leuk Est,223279
5802-4,UA Nitrite,223276
1978-6,UA Bili,2459
5794-3,UA Blood,223294
12258-0,UA Squam Epi,2305
1926-5,BE Cap,1825
8247-9,UA Mucous,2226
25145-4,UA Bacteria,2457
25428-4,UA Glucose,223278
2514-8,UA Ketones,223340
76087-6,Parainfluenza 4 PCR,387
82171-0,Parainfluenza 1 PCR,387
40982-1,Influenza B by PCR,368
82173-6,Parainfluenza 3 PCR,387
,Parainfluenza 2 PCR,387
29257-3,Mycoplasma pneumoniae PCR,387
87621-9,Bordetella Parapertussis PCR,368
40988-8,RSV by PCR,467
82178-5,Chlamydia pneumoniae PCR,387
23826-1,Bordetella pertussis PCR,387
7805-5,Adenovirus PCR,387
82165-2,Metapneumovirus PCR,387
62423-9,Coronavirus HKU1 PCR,7633
41003-5,Coronavirus 229E PCR,7633
82164-5,Coronavirus OC43 PCR,387
41005-0,Coronavirus NL63 PCR,7633
55465-9,Inf A 2009 H1N1,379
82166-0,Influenza A by PCR,387
82175-1,Rhino/Entero PCR,387
77027-1,Influenza A H3 PCR,379
82167-8,Influenza A H1 PCR,379
,Mumps IgG Intrp,248
,SC2 Gel,811
,SC1 Gel,811
,SC3 Gel,811
,Anti-B,1013
,A1,1012
,DCon,1012
,Number of mls*,963
,Anti-A,1013
2106-3,U beta hCG Ql,478
20454-5,UA Protein,2459
32727-0,UA Urobilinogen,2459
25841-8,HIV-2 DNA/RNA,5
5799-2,UA WBC,2457
,IBD-specific pANCA Pattern DNAse Sensiti,30
,IBD-specific pANCA IFA Perinuclear Patte,30
,Anti-Endomysial IgA,38
14212-5,Hep E Ab IgM,3
2106-3,HCG Ur POCT,1588
,Quantiferon Ag,412
20409-9,UA RBC,2457
,RRIV Art,987
,BP Art,986
5256-3,Mycoplasma IgM,41
46082-4,Influenza A POCT,217
46083-2,Influenza B POCT,217
,Influenza A,367
40982-1,Influenza B,277
26444-0,Basophil Auto,6029
32781-7,U Legion Ag,9
42757-5,Troponin iSTAT,184
,Mycopls DNA PCR,1
68966-1,RSV by EIA POCT,2
24111-7,N gonorrhoeae PCR,230
21613-5,C trachomatis PCR,230
24119-0,CMV IgM Interp,29
20475-0,CMV IgG Interp,31
,Toxo gond CSF PCR,1
5005-4,EBV QPCR (Plasma),120
49693-5,Hep E Ab IgG,2
1971-1,Bili Indirect,1172
56888-1,HIV Ag/Ab Combo,111
805-2,WBC CSF,175
792-2,RBC CSF,573
26517-3,Polymorph CSF,117
,Mononuclear CSF,121
31418-7,Mono Scr,124
,PIP Art,987
,POC Ur Dipstick Leuk Est,125
25428-4,POC Ur Dipstick Glucose,125
,POC Ur Dipstick Bili,125
,POC Ur Dipstick Blood,125
5802-4,POC Ur Dipstick Nitrite,125
,POC Ur Dipstick Protein,125
2514-8,POC Ur Dipstick Ketones,125
19642-8,U Oxy Scr,172
3545-1,U Propoxyphene,172
18282-4,U Cannab Scr,172
19261-7,U Amph Scr,172
19659-2,U PCP Scr,172
19359-9,U Cocaine Scr,172
19554-5,U Methamp Scr,172
19295-5,U Opiate Scr,172
14316-4,U Benzodia Scr,172
19550-3,U MTD Scr,172
19270-8,U Barb Scr,172
78012-2,Strep Group A POCT,275
19312-8,U TCA Scr,172
16131-5,HSV 2 PCR QL (Skin Swab),3
16130-7,HSV 1 PCR QL (Skin Swab),3
54067-4,C diff Stl PCR,108
,Smth Mus Ab Scr,15
,Bz U Alpha OH-Alpr,22
,Bz U 7-NH-Flunitr,22
,Bz U Interp,22
,Bz U Alpha OH-Triaz,22
15372-6,Bz U Nordiazepam,22
3887-7,Bz U Oxazepam,22
12382-8,Bz U Temazepam,22
3725-9,Bz U Lorazepam,22
,Bz U OH-Eth-Flura,22
35492-8,MRSA Nares,77
,S aureus Nares,77
,MRSA SST PCR,60
,S aureus SST,60
1968-7,Bili Direct,1302
21033-6,UA Budding Yeast,2127
,Pneumo Jiroveci qPCR (Bronch Wash),2
,"HCV C Ab Confirm, S (Mayo)",1
,Antidep Scr Ur,7
,CMV PCR Qual (Tissue),13
,Adenovirus PCR Ql (Tissue),4
,EBV PCR Qual (Tissue),8
2335-8,Occult Bld Stl,45
,Bz U 7-NH-Clonaz,22
,B,1012
,THC U Interp,54
26484-6,Mono Absolute,6029
743-5,Abs Mono Manual,4057
743-5,Monocyte Man,4237
,Pre TR Hemolysis,1
,Post TR Hemolysis,1
,Pre TR Icteric,1
,Post TR Icteric,1
,Anti-AB,1
,Anti-D,1013
,Poly,50
,Post TR Direct Coombs Interp,1
20447-9,HIV-1 RNA PCR Quant,28
30247-1,CMV Quant PCR,11
8248-7,UA Sperm,2126
,IS,498
1961-2,HCO3 Cap,1826
16551-4,CO2 Totl Cap,1826
2745-8,pH Cap,1826
32682-7,HGB F %.,35
32017-6,HGB Var %,35
,Mycopl IgG Intp,11
51006-5,Direct Coombs,48
890-4,Antibody Screen,42871
,C3 DAT,22
,HGBE Sickle Cell Prep,36
,SSB Ab Interp,60
14611-8,ANA Scr Interp,69
,SSA Ab Interp,60
12454-5,UA Amorph Crys,2163
,SARCOSINE (Quantitative),16
,alpha-AMINOADIPIC ACID (Quantitative),16
,3-METHYLHISTIDINE (Quantitative),15
,ANSERINE (Quantitative),16
,ARGININOSUCCINIC ACID (Quantitative),7
,CYSTATHIONINE (Quantitative),16
,+<83>-ALANINE (Quantitative),16
,HYDROXYLYSINE (Quantitative),16
2744-1,pH Art,988
2026-3,CO2 Totl Art,987
1960-4,HCO3 Art,988
2708-6,O2 Sat Art,988
1925-7,BE Art,988
20563-3,COHb (nonsmoke),109
2614-6,MetHb,109
53935-3,Tetanus Tox IgG Ab,11
,Number of Units*,964
,Op U Hydrocodod,5
,Op U Dihydrocodeine,5
,Op U Oxymorph,5
,Op U Norhydrocodone,5
10998-3,Op U Oxycodone,5
,Op U Noroxycodone,5
,Op U Noroxymorphone,5
,Op U Naloxone,5
,Op U Interp,5
32681-9,Hgb C %,35
4625-0,HGB S %.,35
13997-2,ANNA-1,10
,PCA-2,10
13998-0,ANNA-2,10
33924-2,ANNA-3,10
,AGNA-1,10
,PCA-1,10
,P/Q-Type Calcium Chan Ab,8
,PCA-Tr,10
,Amphiphysin Ab,8
,CRMP-5-IgG,10
,Striational Ab,2
,N-Type Calcium Chan Ab,8
11034-6,ACHr Binding Ab,5
42233-7,AChR Ganglionic Neuronal Ab,8
41871-5,Neuronal (V-G) K+ Channel Ab,6
26499-4,Neutro Absolute,6029
31950-9,RSV Antigen,1
,BP Art Pump,26
,RRIV Art Pump,26
,FiO2 Art Pump,26
,PIP Art Pump,26
,PEEP Art Pump,26
,PIP Ven Pump,14
,FiO2 Ven Pump,14
,PEEP Ven Pump,14
,RR/IVM Ven Pump,14
,BP Ven Pump,14
17656-0,Strep Group A,52
769-0,Segs Man,4237
,Aspergil Niger Ab,4
,Aspergil Flavus Ab,4
,Aspergil Fumigatus Ab,4
,Beta-2 Transf BF,2
22322-2,"HBs Antibody, S",34
,HOMOCYSTINE (Quantitative),16
,+<83>-AMINOISOBUTYRIC ACID (Quantitative),16
,gamma-AMINOBUTYRIC ACID (Quantitative),16
,1-METHYLHISTIDINE (Quantitative),16
,CARNOSINE (Quantitative),16
,Toxo IgM Interp,5
,ds-DNA Ab Intrp,136
,Parvovirus B19 qPCR (Serum),4
,Enterovirus qRT-PCR (Plasma),2
5005-4,EBV QPCR (Serum),27
29901-6,HTLV I/II Ab,1
,HSV 1 qPCR (Serum),7
,HSV 2 qPCR (Serum),7
,Bybry/Waxy/Class,1
48952-6,Histo Ag Ur,4
,Histo Ag Ur Interp,4
,Cryptococcal Ag,2
,JO 1 Ab Interp,57
,SCL70 Ab Interp,58
,SM Ab Interp,57
,RNP Ab Interp,56
,Toxo IgG Interp,7
7959-0,Leptospira IgM Ab,2
,TPOG Interp,65
13953-5,Hep Be Ab,193
,PHOSPHOETHANOLAMINE (Quantitative),16
,Gel IgG,230
29257-3,M. Pneumoniae PCR,29
,A. Terreus,2
,Pan-Aspergillus,2
,A. Fumigatus,2
16130-7,HSV I PCR,16
16131-5,HSV II PCR,16
,Anser ADA.,18
,A-Glob Result Summary,2
,GABA-B-R Ab CBA,8
,AMPA-R Ab CBA,8
,GAD65 Ab Assay,8
,NMDA-R Ab CBA,6
,"LGI1-IgG CBA, S",14
,"CASPR2-IgG CBA, S",14
17353-4,c-ANCA,11
17357-5,p-ANCA,11
,HGBE Sickle Cell Confirmation,19
737-7,Lymph Man,4237
4821-5,HLA B27,9
30247-1,CMV qPCR (Serum),19
15152-2,Bili Conjugated,18
1971-1,Bili Unconj,18
,Olig Bands Intp,2
,Olig Bands Ser,2
49852-7,Olig Bands CSF,2
734-4,Abs Lymph Manual,4058
26455-6,RBC BF,32
12209-3,Eos BF,13
12179-8,Basophil BF,4
,U Glu Fasting,3
26546-2,U Glu 1 Hr,3
,U Glu 30 Min,3
26547-0,U Glu 2 Hr,3
20572-4,Hgb A %,35
,Am U Interp,5
,Am U Phentermine,5
,Am U Pseudoeph/Ephedrine,5
3780-4,Am U Methamphet,5
,Am U MDA (Ecstacy metab),5
14267-9,Am U MDMA (Ecstacy),5
46126-9,Endomysial IgA,1
29661-6,Dengue Fev IgG,1
,Dengue Fev IgM,1
2270-7,Fecal Fat Ql,10
,Abs Lymph ALPS,4
,%DNT cells,4
79379-4,HIV-1 DNA/RNA Qual,12
764-1,Band Man,2147
16130-7,HSV 1 qPCR (Mouth Swab),1
16131-5,HSV 2 qPCR (Mouth Swab),1
5196-1,Hep Bs Ag,370
11483-5,VZV PCR,1
94534-5,SARS CoV 2 (ID Now),745
95608-6,SARS CoV 2 by PCR,325
40982-1,Influenza B PCR,18831
34487-9,Influenza A PCR,18814
94558-4,SARS CoV 2 Ag EIA (POCT),92
94500-6,SARS-CoV-2 RNA,191
,Adenovirus qPCR (Plasma),51
49392-4,HHV6 QPCR (Plasma),45
30247-1,CMV qPCR (Plasma),105
94500-6,SARS-CoV-2 (NCH),1192
11060-1,Reduc Subst Stl,13
94500-6,SARS-CoV-2 RT-PCR,240
94558-4,SARS-CoV-2 FIA,257
5334-8,Rubella IgG Int,246
5000-5,CMV PCR Qual (Fecal),4
80660-4,Strongyloides Ab IgG,1
,K kingae PCR,1
,Shistosoma Ab IgG,1
94563-4,SARS CoV 2 IgG,24
,Yeast Stl,8
,Eos Stl,8
,Charcot Cry Stl,8
,Adenovirus PCR (Fecal),2
,Toxo IgM Index,5
,Enterovirus qRT-PCR (CSF),1
,Parvovirus B19 qPCR (Plasma),3
29615-2,Hep B PCR Qnt,6
94500-6,SARS CoV 2 PCR Batch,112
,NMO/AQP4-IgG CBA,1
49392-4,HHV6 qPCR (Serum),3
38180-6,HCV qRT-PCR Log (10)IU/mL (Pl),2
11011-4,HCV qRT-PCR IU/mL (Pl),2
6320-6,IgG West Blot,2
6321-4,IgM West Blot,2
,Ct Value,36
,PHOSPHOSERINE (Quantitative),16
3436-3,THC U Carbox Acid,54
8117-4,%CD19+ (B-Cells),31
8116-6,Absolute CD19,31
49551-5,CKMB i STAT,34
29257-3,Mycoplasma DNA PCR,1
,Zolpidem Phenyl-4-Carboxylic acid Ur by,6
,Zolpidem Ur by LC-MS/MS,6
,Benzodiazepines Ur Interpretation,6
16227-1,Diazepam Ur by LC-MS/MS,6
,Chlordiazepoxide by Ur LC-MS/MS,6
,Alpha-Hydroxyalprazolam Ur by LC-MS/MS,6
20559-1,Temazepam Ur by LC-MS/MS,6
16233-9,Midazolam Ur by LC-MS/MS,6
16201-6,Oxazepam Ur by LC-MS/MS,6
,Alpha-Hydroxy Midazolam Ur by LC-MS/MS,6
59615-5,Alprazolam Ur by LC-MS/MS,6
,Flurazepam Ur by LC-MS/MS,6
,N-Desmethylclobazam Ur by LC-MS/MS,6
,Clobazam Ur by LC-MS/MS,6
,Flunitrazepam Ur by LC-MS/MS,6
,Alpha-Hydroxy Triazolam Ur by LC-MS/MS,6
,2-Hydroxy Ethyl Flurazepam Ur by LC-MS/M,6
,Triazolam Ur by LC-MS/MS,6
,Prazepam Ur by LC-MS/MS,6
45210-2,HSV 2 IgM screen,2
40466-5,HSV 1 IgM screen,2
,ANA Scr IFA (Specialty),6
,EBV QPCR (CSF),1
16229-7,Clonazepam by Ur LC-MS/MS,6
51776-3,7-aminoclonazepam Ur by LC-MS/MS,6
51777-1,7-aminoflunitrazepam Ur by LC-MS/MS,6
3507-1,Op U Codeine,5
7793-3,Howell Jolly Body,69
29662-4,Varicella-Zoster Ab IgM,12
5273-8,Parvo B19 IgG,3
40658-7,Parvo B19 IgM,3
45166-6,Dipht Tox IgG Ab,10
,CMV qPCR (Urine),3
,Adenovirus qPCR (Serum),6
,Immature Manual,70
753-4,Abs Neut Manual,4056
12248-1,UA Renal Epi,2132
5388-4,Toxo IgG Index,7
26485-3,Mono Auto,6029
16228-9,Nordiazepam Ur by LC-MS/MS,6
17088-6,Lorazepam Ur by LC-MS/MS,6
,Band CSF,8
30374-3,Basophil CSF,9
,Atyp Lymph CSF,11
38180-6,HCV qRT-PCR Log (10)IU/mL (Ser),4
11011-4,HCV qRT-PCR IU/mL (Ser),4
13954-3,Hep Be Ag,222
26511-6,Neutro Auto,6029
20570-8,HCT iSTAT,2198
38483-4,Creatinine iSTAT,268
20509-6,HGB iSTAT,2198
2069-3,CL iSTAT,250
6299-2,BUN iSTAT,267
2339-0,Glucose iSTAT,2745
26474-7,Lymph Absolute,6029
,Ur EDDP-by GC MS,1
,Ur Methadone-by GC MS,1
5206-8,HSV Type 1 IgG,6
5209-2,HSV Type 2 IgG,6
6690-2,Instr WBC,6375
3271-4,LMWH Anti Xa,77
13655-6,WBC Stl,8
79190-5,Zika Virus RT-PCR,1
26466-3,WBC BF,32
94558-4,SARS CoV 2 Antigen FIA (POCT),164
,HIT Interp,2
,Eos Abs BM,1
,Baso Abs BM,1
38392-7,Legionella Ab,2
9571-1,Parvo B19 PCR,3
2160-0,Dialysis-Creatinine Lvl,510
11064-3,Dialysis-BUN,512
3398-5,Co U Cocaine,1
,Co U Interp,1
26510-8,Band BF,4
,Count/Diff CSF,28
5244-9,Measles IgG ISR,246
34720-3,CMV qPCR (CSF),1
29896-8,Crypto Ag CSF,1
736-9,Lymph Auto,6029
,Op U Hydromorph,5
13518-6,Atyp Lymph BF,4
26451-5,Eos CSF,10
40729-6,HSV Ab Scr IgM EIA,1
,IgG DAT,22
29591-5,Enterov PCR Ql,1
25418-5,Mumps IgG ISR,248
5196-1,"HBs Antigen, S (Mayo)",2
49380-9,HCV RNA RT-PCR Quant,2
,"DPPX Receptor Ab, CBA IFA",4
,"GFAP IFA, S",11
,mGluR1 Ab IFA,4
29893-5,HIV-1 Ab Differentiation,1
30361-0,HIV-2 Ab Differentiation,1
70241-5,HIV-1 RNA Detect/Quant,2
14107-7,Segs CSF,25
5124-3,CMV IgG Index,31
5126-8,CMV IgM Index,29
890-4,Ref Antibody Screen,2
54410-6,Anti-C3,1
,Test Name,66
,Misc Esoteric,66
,SARS CoV 2 RT-PCR (CBS),15
,BE Art Pump,26
3830-7,Op U Morphine,5
32285-9,BK Virus DNA Ur,3
48065-7,D-Dimer,209
58413-6,TOP NRBC %,133
706-2,TOP Basophil Auto,133
704-7,TOP Basos Absolute,133
,TOP Left_Shift?,133
,TOP Fragments?,133
,PNH RBC-Complete Ag Loss,1
,PNH RBC-Partial Ag Loss,1
,PNH Granulocytes.,1
711-2,TOP Eos Absolute,133
30522-7,TOP CRP High Sensitive,133
,TOP PLT_Clumps?,133
,TOP Atypical_Lympho?,133
713-8,TOP Eos Auto,133
740-1,Meta Man,250
13046-8,Atypical Lymphs,1816
5334-8,Rubella Antibody IgG ISR,246
5403-1,Var Zos IgG ISR,277
,TOP A1C for A1C Grp,1
,TOP HGB for A1c Grp,1
,Immature CSF,2
6478-2,Mumps IgM,1
,Adenovirus qPCR (Urine),1
41479-7,BK Virus DNA Qt,4
,HSV 1 qPCR (Plasma),1
,HSV 2 qPCR (Plasma),1
24103-4,% PLASMA CELLS,4471
704-7,Basophils Absolute,20718
706-2,% BASOPHILS,467870
713-8,% EOSINOPHILS,479543
711-2,Eosinophils Absolute,63808
58413-6,NUCLEATED RBCS,4222
47534-3,2-HYDROXYPHENYLACETATE/CREATININE,8
3950-3,Phenobarbital,48
5196-1,HEPATITIS B SURF AG,25528
3879-4,OPIATES,3660
3426-4,Marijuana Metabolite,27
82166-0,INFLUENZA A PCR,16483
,"SARS-COV-2 (COVID-19) AB IGG, SPIKE, SEMI-QUAL, SERUM INTERPRETATION",794
43305-2,"Neisseria gonorrhoeae RNA, TMA",12593
50561-0,PROTEIN,67198
38917-1,HMPV PCR RESULTS,14524
43305-2,"Neisseria gonorrhoeae, NAA",3603
82170-2,INFLUENZA B PCR,16485
48159-8,Signal/Cutoff,6299
39528-5,ADV PCR RESULT,13772
10331-7,RH,36074
76080-1,"INFLUENZA B, NAA",69
,"SARS-COV-2 ANTIBODIES QUAL, SERUM",88
10331-7,RH GROUPING,2919
43305-2,"N. gonorrhoeae RNA,TMA, Urogenital",5
94661-6,SARS-CoV-2 Spike Ab Interp,13
17851-7,"HSV 2 IGG, AB, SERUM",387
82163-7,CORONAVIRUS 229E PCR,13562
6410-5,GARDNERELLA:,987
45210-2,HSV 2 IGM SCREEN SERUM,189
46182-2,Coccidioides IgG,45
43305-2,Gonococcus by NAA,90
15861-8,CLASS,216
70068-2,STREPTOCOCCUS G/C DNA NAAT,1286
19059-5,"Amphetamines, Urine",260
57458-2,"Neisseria gonorrhoeae, NAA",48
57289-1,"N. gonorrhoeae, NAA, Pharyn",97
76075-1,ASPERGILLUS AG BAL RESULT,192
6410-5,Gardnerella vaginalis,77
40982-1,"INFLUENZA B RNA, PCR",27
34487-9,"INFLUENZA A RNA, PCR",30
82182-7,E.COLI DNA CSF,372
6955-9,B HENSELAE IGM,79
21654-9,CF RESULT,119
76078-5,"INFLUENZA A, NAA",69
9571-1,"PARVOVIRUS B19, PCR",101
33772-5,PL 7 AUTOABS,32
48310-7,Influenza A,7
3377-9,Barbiturates,249
7993-9,Rhinovirus,34
32577-9,B. QUINTANA IGG SCREEN,3
40419-4,AMPHETAMINE,5266
15570-5,CLASS,8
15529-1,CLASS,6
15607-5,Class,295
40610-8,BETA 2 TRANSFERRIN,31
13952-7,HEPATITIS B CORE TOTAL,7119
10900-9,Hepatitis B Surface Ab Qual,1225
82183-5,H.INFLUENZA DNA CSF,372
,HLA-DQ2 (DQA1*05/DQB1*02),143
5255-5,MYCOPLAMSA PCR,54
16074-7,Class,87
21305-8,URINE GLUCOSE,66852
19270-8,Barbiturates,83
5005-4,"EBV DNA, QL PCR",10
16131-5,HSV-2 DNA,123
13951-9,HEPATITIS A AB TOTAL,1229
31104-3,0.85% NACL,2
8117-4,% CD19 (B CELLS),356
3508-9,Codeine,58
40979-7,Human Metapneumovirus,30
6874-2,"CALCIUM, 24 HOUR URINE",90
33516-6,IMMATURE RETIC FRACTION,10504
23826-1,B. PERTUSSIS DNA,11
81641-3,HIV 2 AB,19
30361-0,"HIV 2 ANTIBODY, EIA",10
12187-1,CK-MB,43
48309-9,"BK Virus DNA Qaunt PCR, SERUM/PLASMA",897
11545-1,Acid Fast Smear,5
6024-4,Aspergillus Flavus Antibodies,1
20574-0,Histoplasma Yeast CF Ab,1
14249-7,"YO AB SCREEN, IFA, SERUM",117
29893-5,HIV-1 Antibody,10
15577-0,CLASS,6
13984-0,"Alpha 1, Urine",232
19270-8,"Barbiturates Screen, Urine",34
82161-1,Coronavirus HKU1,1
92141-1,FLUBV RNA Resp Ql NAA+probe,31
15551-5,CLASS,1
15554-9,CLASS,2
15832-9,CLASS,2
15618-2,CLASS,1
41514-1,Logcopies/mL,292
31186-0,IGM,5
42606-4,HSV 2 IGM SCREEN CSF,4
,SARS-COV-2 (COVID-19) ORF GENE,68
13969-1,CK MB RELATIVE INDEX,11933
6818-9,"Micropolyspora faeni, IgG",2
6818-9,MICROPOLYSPORA FAENI,4
16130-7,HSV 1 DNA,31
6412-1,Giardia Antigen,302
42481-2,HPV DNA Low Risk,47
11071-8,Butalbital,46
25125-6,PHENYLLACTATE/CREATININE,8
3390-2,Benzodiazepines,50
3755-6,Meprobamate,54
,NTQR Ultrasonographer ID#,963
19261-7,Amphetamine Screen,3621
7555-6,Aspergillus flavus,1
75694-0,"HPV GENOTYPE 18, 45",43
76089-2,RSV PCR RESULT,7507
33771-7,PL 12 AUTOABS,31
20463-6,M. AVIUM DNA,3
43228-6,SCREEN,6
60256-5,"Neisseria gonorrhoeae, NAA",345
69563-5,"Candida glabrata, NAA",429
4576-5,Hgb F,543
15661-2,CLASS,1
15734-7,CLASS,1
15784-2,CLASS,1
15633-1,CLASS,1
29904-0,Toxoplasma gondii DNA,2
24113-3,HEPATITIS B CORE IGM,4317
69935-5,"SURESWAB(R), MYCOPLASMA GENITALIUM, PCR",15
15572-1,CLASS,1
75664-3,HPV 16,14
,NDM GENE,24
9588-5,LYME 18 KD IGG,79
3377-9,BARBITURATES,3431
,SARS-COV-2 (COVID-19) N2 GENE,75
13956-8,RIFAMPIN RESISTANCE RESULT,1
13956-8,M TUBERCULOSIS PCR,744
,"Amphiphysin Ab, CSF",12
15956-6,PORK ANTIBODY IGE RAST CLASS,1
45324-1,Ethyl Glucuronide (ETG),5
32576-1,B. HENSELAE IGM SCREEN,5
51723-5,Fungal Culture W/Rfx,3
33000-1,RMSF IGM,3
69668-2,HIV 1 ANTIBODY,440
69668-2,HIV 2 ANTIBODY,440
41268-4,VWF GENE P THR71MET,1
43180-9,"HSV2 IGG INHIBITION,ELISA",22
6318-0,"LYME AB IGG , CSF",12
14308-1,AMPHETAMINES$(1000 ng/mL SCREEN),1
11597-2,TREPONEMAL ABD TEST,7139
11483-5,"VARICELLA ZOSTER VIRUS$(VZV) DNA, QL RT PCR",5
3780-4,Methamphetamine,51
24446-7,"PORPHOBILIOGEN, QN",6
13954-3,HEPATITIS BE ANTIGEN,104
3637-6,Fentanyl,54
35393-8,HANTAVIRUS IGM,1
94500-6,"SARS-COV-2 (COVID-19), NUCLEIC ACID AMPLIFICATION PCR SWAB",95797
15869-1,CLASS,1
82196-7,CAMPYLOBACTER COLI+JEJUNI+upsaliensis DNA,9
50728-5,"UFH LOW DOSE, 0.1 IU/ML",1
15811-3,CLASS,1
15736-2,CLASS,1
79383-6,SALMONELLA SPECIES,9
5274-6,PARVO (B19) IGM,64
15978-0,CLASS,1
3349-8,Amphetamine,2
19328-4,Alphahydroxyalprazolam,51
46725-8,"T. WHIPPLEI DNA, QL PCR",2
35492-8,MRSA DNA RESULT,14535
11556-8,PO2,99926
15388-2,Mycoplasma hominis,1
47000-5,CANDIDA:,987
8116-6,ABSOLUTE CD19+ CELLS,245
59264-2,"HPV Genotype, 18",23
40419-4,Amphetamine,3
15746-1,CLASS,1
25126-4,PHENYLPYRUVATE/CREATININE,8
19695-6,Secobarbital,46
3393-6,Cocaine Metabolite,28
3926-3,Pentobarbital,46
25124-9,PHENYLACETATE/CREATININE,8
11230-0,Amobarbital,46
3773-9,Methadone,220
25088-6,4-HYDROXYPHENYLACETATE/CREATININE,8
19648-5,Oxymorphone,52
92900-0,4P16 DELETION WORLF HIRSCHHORN,284
714-6,% LYMPHOCYTES,70650
3415-7,Buprenorphine,26
3887-7,Oxazepam,51
92902-6,8Q24 DELETION (LANGER-GIEDION),284
3936-2,Phencyclidine,76
,TIME COLLECTED,72717
25113-2,MALATE/CREATININE,8
82177-7,Mycoplasma pneumoniae,1
744-3,% MONOCYTES,68994
75602-3,FETAL 1P36 DELETION RISK,284
3393-6,COCAINE,30
29507-1,ALPHA KETOGLUTARATE/CREATININE,8
3879-4,Opiates,103
82212-2,Rotavirus A RNA,5
15372-6,Nordiazepam,51
707-0,Basophils Manual,1379
19346-6,Amphetamine,53
733-6,% ATYPICAL LYMPHS,14477
12382-8,Temazepam,51
10998-3,Oxycodone,28
3394-4,COCAINE METABOLITE,27
3773-9,METHADONE,3465
20507-0,RPR SCREEN,12505
25116-5,METHYLMALONATE/CREATININE,136
3426-4,MARIJUANA,24
58714-7,Oxidant,29
82176-9,RESPIRATORY SYNCYTIAL VIRUS RNA,8467
51006-5,DIRECT COOMBS,662
82161-1,CORONAVIRUS HKU1 PCR,13562
13990-7,"Alpha-1-Globulin, U",94
31628-1,"SM/RNP, AB, SERUM",321
6568-0,Trichomonas vaginosis,77
40988-8,RSV RNA XXX Ql NAA+probe,18
64084-7,QUANTIFERON TB1 AG VALUE,529
6457-6,"DNA Ab (DS) Crithidia, IFA",407
8009-3,B QUINTANA IGG,79
38382-8,Influenza B,7
34487-9,Influenza A,34
70155-7,BARBITURATES,6940
,SARS-COV-2 (COVID-19) E GENE,43
7719-8,Staphylococcus aureus,31
82184-3,L.MONOCYTOGENES DNA CSF,372
41283-3,HLA-DQ8$(DQA1*03/DQB1*0302),143
3681-4,Hydrocodone,58
5863-6,Influenza A,6
29723-4,B. PARAPERTUSSIS DNA,13
,% CD 4 Pos. Lymph.,564
43201-3,BKV DNA Spec NAA+probe-Log,3
50941-4,Acid Fast Culture,5
22086-3,Aspergillus Niger Antibodies,1
6816-3,Histoplasma Mycelial ID Ab.,1
43187-4,"RI AB SCREEN, IFA, SERUM",122
7287-6,"Alpha 2, Urine",232
14316-4,"Benzodiazepines Screen, Urine",34
48558-1,HIV 1 GENOTYPE,8
82162-9,Coronavirus NL63,1
94500-6,,421
48505-2,GPIIB/IIIA (CELL 1),2
31185-2,IGA,5
6821-3,"Thermoactinomyces vulgaris, IgG",2
6733-0,PIGEON SERUM,4
14316-4,Benzodiazepines,3676
46216-8,MITOGEN-NIL,1676
53596-3,ALCA,5
16131-5,HSV 2 DNA,29
47696-0,MALONATE/CREATININE,8
11075-9,Norfentanyl,53
10894-4,Aspergillus niger,1
5025-2,M. INTRACELLULARE DNA,3
5372-8,Anti-striation Abs,6
1925-7,BASE EXCESS,50473
75695-7,HPV 18,14
85503-1,OXA-48 GENE,24
9589-3,LYME 23 KD IGG,79
3390-2,BENZODIAZEPINES,3627
90827-7,"Anti-Glial Nuclear Ab, Type 1",12
792-2,RED BLOOD CELL COUNT,11
60676-4,Ethyl Sulfate (ETS),5
30075-6,RSV A,10
53926-2,"Chlamydia trachomatis, NAA",345
8122-4,ABSOLUTE CD3,1223
41210-6,VWF GENE P ARG816TRP,1
21081-5,CANAVAN DISEASE,1
18485-3,MI 2 AUTOABS,17
13953-5,HEPATITIS BE ANTIBODY,103
21262-1,SHIGA TOXIN,141
82197-5,CLOSTRIDIOIDES DIFFICILE TOXIN A+B tcdA+tcdB GENES,5
46455-2,SHIGELLA SPECIES,9
58470-6,"WBC, CSF",2
11557-6,PCO2,100011
9318-7,MICROALB/CREAT RATIO,9600
62460-1,C PARAPSILOSIS/TROPICALIS,2
8147-1,Amphetamine,1
5048-4,ANA Screen IFA,1619
60677-2,Alphahydroxytriazolam,51
29515-4,3-HYDROXYPROPIONATE/CREATININE,8
5645-7,ETHANOL,2511
3349-8,Amphetamines,28
3831-5,Morphine,58
25114-0,2-METHYLCITRATE/CREATININE,8
9835-0,Hydromorphone,58
29519-6,4-HYDROXYPHENYLPYRUVATE/CREATININE,8
10976-9,6 Acetylmorphine,13
25089-4,4-HYDROXYPHENYLLACTATE/CREATININE,8
3936-2,PCP (PHENCYCLIDINE),18
50542-0,METHADONE METABOLITE,27
79178-0,4-HYDROXYCYCLOHEXYLACETATE/CREATININ,8
19141-1,PROPOXYPHENE,1226
82181-9,CRYPTOCOCCUS NEOFORMANS GATII DNA CSF,372
33037-3,ANION GAP,591076
5769-5,Bacteria,29503
75578-5,FETAL 22Q11.2 DELETION RISK (DIGEORGE),284
82179-3,BORDETELLA PERTUSSIS PCR,13563
26498-6,% MYELOCYTES,15449
14245-5,Antiphosphatidylserine IgG,29
43304-5,"Chlamydia trachomatis RNA, TMA",12733
9587-7,LYME 41 KD IGM,79
25082-9,2-METHYL-3-HYDROXYBUTYRATE/CREATININE,8
79211-9,FETAL CHROMOSOME X/Y ANEUPLOIDY RISK,840
13503-8,Lyme IgM Wb,22
751-8,Neutrophils Absolute,63814
82205-6,CRYPTOSPORIDIUM SP DNA,197
770-8,% NEUTROPHILS,433453
30376-8,% BLASTS,5450
68549-5,Anti-U2 RNP Ab (RDL),14
82173-6,PARAINFLUENZA 3,13563
54067-4,C difficile Toxin Gene NAA,33
21613-5,CHLAMYDIA DNA,10489
10362-2,Endomysial Ab IgA,402
70141-7,BENZODIAZEPINES,5109
18282-4,CANNABINOIDS,5956
14314-9,"Cocaine (Metab.) Screen, Urine",5473
19295-5,Opiates,5037
43304-5,"Chlamydia trachomatis, NAA",3604
74661-0,PHOSPHATIDYLETHANOL (PETH),509
21709-1,4 H FOLATE MUTATION,50
13876-8,"BETA 2 TRANSFERRIN, BODY FLUID",2
5645-7,Ethanol,4050
14310-7,PHENCYCLIDINE,3968
70149-0,METHADONE,3982
2118-8,PREGNANCY TEST,6904
47383-5,ANA SCREEN,2534
17780-8,"HELICOBACTER PYLORI ANTIGEN, STOOL",547
43304-5,"C. trachomatis RNA,TMA, Urogenital",5
46154-1,"SURESWAB(R) TRICHOMONAS VAGINALIS RNA, QL TMA",1382
16935-9,HEPATITIS B SURF AB,5605
5036-9,"STREPTOCOCCUS, GROUP A, DNA PROBE",343
13950-1,HEPATITIS A IGM AB,4109
94507-1,"SARS-COV-2 AB IGG, SERUM/PLASMA",4450
11470-2,CLOSTRIDIUM DIFFICILE ANTI TOXIN INTERPRETATION,2043
17850-9,"HSV 1 IGG, AB, SERUM",387
30339-6,EBV IGG,414
5130-0,ANTI-DNA(DS) ABDY,732
31418-7,HETEROPHILE,401
56888-1,HIV ANTIGEN ANTIBODY COMBO,23848
29903-2,"CRYPTOCOCCAL ANTIGEN, SERUM",180
34468-9,"C difficile Toxins A+B, EIA",124
6568-0,TRICHOMONAS:,1002
40466-5,HSV 1 IGM SCREEN SERUM,191
17780-8,H. pylori stool Ag,161
8034-1,STRONGYLOIDES IGG AB,702
45323-3,"QUANTIFERON(R)-TB GOLD PLUS, 1 TUBE",1581
13955-0,"INTERPRETATION, HCV AB",3479
46183-0,"COCCIDIOIDES AB,IGM",45
15410-4,VARICELLA IGG,541
54067-4,"CLOSTRIDIUM DIFFICILE$TOXINB,QL REAL TIME PCR",127
60489-2,STREPTOCOCCUS GROUP A DNA NAAT,1354
29891-9,H PYLORI RESULT:,362
24312-1,T pallidum Antibodies (TP-PA),141
2335-8,FECAL OCCULT BLOOD,1417
24027-5,"S. PNEUMONIAE ANTIGENS, URINE",732
41499-5,"LEGIONELLA PNEUMOPHILA ANTIGEN, URINE",695
24115-8,EBV IGM,303
17351-8,ANCA SCREEN,112
57287-5,"Chlamydia trachomatis, NAA",46
57288-3,"C. trachomatis, NAA, Pharyn",96
2112-1,PREGNANCY TEST,58
5117-7,"CRYOGLOBULIN, QL",271
47000-5,Candida Species,77
5213-4,"Mononucleosis Test, Qual",17
26043-0,HLA B27,217
17284-1,MITOCHONDRIAL ANTIBODY (AMA),672
87620-1,"CANDIDA AURIS PCR, FLUID/SWAB",62
41480-5,"BK VIRUS DNA, QN REAL TIME PCR, URINE",61
2110-5,"hCG,Beta Subunit,Qual,Serum",37
6864-3,SICKLE CELL PREP,868
5393-4,T pallidum Ab (FTA-Ab),237
21667-1,MUTATION ANALYSIS,63
24475-6,FACTOR 2 MUTATION,370
50191-6,GASTRIC OCCULT BLOOD,17
29896-8,"CRYPTOCOCCAL ANTIGEN, CSF",26
9537-2,INTRINSIC FACTOR AB,26
3251-6,FIBRIN SPLIT PRODUCTS (FDP),434
19080-1,"HCG, Total",94
6954-2,B HENSELAE IGG,79
4537-7,SEDIMENTATION RATE,19064
29770-5,CF Plus,259
44525-4,HISTOPLASMA GAL'MANNAN AG SERUM,6
33295-7,"JC POLYOMA VIRUS DNA, QL, CSF",46
46970-0,"BK VIRUS DNA, QUALITATIVE, CSF",36
13317-3,MRSA Culture Only,13
5213-4,"Heterophile, Mono Screen",50
55095-4,Adenovirus,9
43172-6,T3 (TRIIODOTHYRONINE)$ANTIBODY,1
26043-0,HLA-B27,221
39528-5,Adenovirus,44
49413-8,"JC POLYOMA VIRUS DNA, QN, SERUM/PLASMA",42
62460-1,"C. ALBICANS, DNA",1283
32575-3,B. HENSELAE IGG SCREEN,5
91545-4,MYELIN OLIGODENDROCYTE GLYCOPROTEIN AB,32
91543-9,"MYELIN OLIGODENDROCYTE GLYCOPROTEIN AB CBA, CSF RESULT",2
,"AQUAPORIN 4 AB, CBA, SERUM RESULT",19
90818-6,"AQUAPORIN 4 AB, CBA, CSF RESULT",3
62947-7,MPL EXON 10 MUTATION,12
77174-1,CALR MUTATION (EXON 9),11
49738-8,"HU AB SCREEN, IFA, SERUM",117
29771-3,FECAL OCCULT BLOOD,192
13931-1,STRIATED MUSCLE AB$W/REFL TO TITER,52
94564-2,"SARS-COV-2 AB QUAL, IGM, SERUM",326
94563-4,"SARS-COV-2 AB IGG, SERUM/PLASMA",665
10362-2,ENDOMYSIAL ANTIBODY SCR$(IGA) W/REFL TO TITER,41
1832-5,AFP Amniotic Fluid,5
30167-1,HPV DNA High Risk,593
80824-6,ZIKA VIRUS AB (IGM),6
94564-2,"SARS-COV-2 AB IGM, SERUM/PLASMA",53
49411-2,"JC VIRUS DNA, QUANT, URINE",11
10365-5,"COTININE, SERUM/PLASMA",14
5265-4,ISLET CELL ANTIBODY$SCREEN,10
13514-5,HGB ELECTROPH INTERPRETATION,589
29901-6,HTLV 1 AND 2,49
22759-5,ANTI-PLATELET AB,16
30073-1,VGCC Antibody,8
50398-7,CLINICAL INTERPRETATION,6
897-9,ELUTION,84
16130-7,HSV-1 DNA,121
547-0,Strep A Culture,129
5859-4,HSV Culture Without Typing,39
22330-5,"HEPATITIS D ANTIBODY, TOTAL",18
38476-8,"ANTI-MULLERIAN HORMONE (AMH),FEMALE",124
8116-6,ABSOLUTE CD19,203
4546-8,HGB A,1077
46131-9,"CYTOTOXIN ASSAY, STOOL",19
14232-3,ADRENAL AB,9
43180-9,HSV-2 IgG Supplemental Test,18
13927-9,Antipancreatic Islet Cells,1
5834-7,Adenovirus,6
47982-4,"Epstein-Barr DNA Quant, PCR",9
68961-2,HIV 1 AB,19
34701-3,HEPARIN INDUCED PLATELET$ANTIBODY,3
25835-0,HIV 1 RNA QUALITATIVE,9
13927-9,ISLET CELL ANTIBODY,23
6808-0,A.Fumigatus #1 Abs,3
20573-2,Histoplasma Mycelial CF Ab.,1
5117-7,"CRYOGLOBULIN SCR W/REFL$CRYOGLOBULIN PROFILE, S",43
5151-6,E. HISTOLYTICA AB,14
,"SARS-COV-2 (COVID-19) AB IGG, SPIKE, SEMI-QUAL, SERUM",908
23800-6,"MOLD MIX 1, IGE",1
19261-7,"Amphetamine Screen, Urine",34
,"SARS-COV-2 (COVID-19), NAA",45
92142-9,FLUAV RNA Resp Ql NAA+probe,40
41513-3,HIV1 Copies/mL,305
42587-6,"BKV DNA, Quant PCR, Plasma",12
24375-8,OVERALL RESULT,1
6927-8,IGG,5
,HSV 1 IGM SCREEN CSF,4
11246-6,OXYCODONE,460
28067-7,"FETAL HEMOGLOBIN,$AMNIOTIC FLUID",2
30106-9,ACETYLCHOLINESTERASE,2
23821-2,ASPERGILLUS FUMIGATUS,4
1007-4,DAT,18
13928-7,PTH ANTIBODY,4
30167-1,HPV DNA HIGH RISK,4
59646-0,Cotinine,10
22362-8,"HTLV-I/II Antibodies, Qual",3
739-3,% METAMYELOCYTES,19051
14246-3,Antiphosphatidylserine IgM,29
736-9,% LYMPHOCYTES,410169
5905-5,% MONOCYTES,426187
92903-4,FETAL CHROMOSOME REGION 15Q11 DELETION,284
82178-5,CHLAMYDOPHILA PNEUMONIAE,13563
3725-9,Lorazepam,51
3936-2,PHENCYCLIDINE,6217
742-7,Monocytes Absolute,63811
49963-2,Anti-U3 RNP (Fibrillarin)(RDL),16
82174-4,PARAINFLUENZA 4,13563
14314-9,COCAINE,3656
19295-5,OPIATES,3893
19073-6,CANNABINOIDS,3611
22327-1,HEPATITIS C ANTIBODY,10223
19550-3,"Methadone Screen, Urine",2721
45323-3,QUANTIFERON(R)-TB GOLD,146
7909-5,"HSV 1,2  IGG",39
,TRICHOMONAS KIT,478
,Mitochondrial Ab,119
23821-2,"Aspergillus fumigatus, IgG",1
7903-8,HELICOBACTER PYLORI ANTIBODY,12
25835-0,HIV-1 RNA Qualitative,12
59263-4,HPV GENOTYPE 16,43
8061-4,ANACHOICE(R) SCREEN,62
2514-8,Urine Ketones,6832
21347-0,LINE IMMUNOASSAY (LIA),4
5255-5,MYCOPLASMA IGG,24
30167-1,"HPV, high-risk",673
21759-6,FRAGILE X PCR,8
22238-0,Cysticercosis (Taenia solium),1
69562-7,"Candida albicans, NAA",429
12853-8,"YO AB, WESTERN BLOT, SERUM",25
33008-4,"RI AB, WESTERN BLOT",25
60026-2,LEUKOCYTES,66852
34586-8,"JC VIRUS DNA, QUAL, TISSUE",1
47251-4,"BK VIRUS DNA, QUAL, TISSUE",1
32286-7,HCV Genotype,501
3349-8,AMPHETAMINES,2395
94562-6,"SARS-COV-2 AB IGA, SERUM/PLASMA",13
35134-6,TSH ANTIBODY,3
24110-9,"T. PALLIDUM AB, EIA",1
33600-8,HU AB SCREEN,18
5880-0,Rotavirus Antigen,7
883-9,BLOOD TYPING ABO,2600
35492-8,MRSA by NAA,1
69048-7,"Paraneoplastic Interpretation, CSF",2
13951-9,"HEPATITIS A AB, TOTAL$W/REFL IGM",36
4644-1,URINE HEMOSIDERIN,4
2349-9,Glucose,19052
38356-2,T4 (THYROXINE) ANTIBODY,3
5825-5,"ADENOVIRUS AG, EIA",1
23811-3,AFP MATERNAL SCREEN,17
49117-5,"NOROVIRUS, EIA (STOOL)",1
32999-5,RMSF IGG,4
6457-6,"DNA AB (DS) CRITHIDIA,IFA",62
5052-6,ASPERGILLUS ANTIBODY$SCREEN,2
5005-4,Epstein-Barr Virus Real Time,3
19289-8,Cannabinoid,4
11483-5,VZV Real Time PCR,4
18484-6,KU AUTOABS,17
45149-2,EJ AUTOABS,31
45152-6,OJ AUTOABS,31
33921-8,SRP AUTOABS,31
29497-5,ANTI-IGG,6
777-3,PLATELET COUNT,727385
49434-4,Parvovirus B19 Quant PCR,72
21613-5,"CHLAMYDIA TRACHOMATIS,TMA$(ALTERNATE TARGET)",1
18481-2,RESULT:,3
32361-8,WNV PCR RESULT,4
13955-0,HEPATITIS C ANTIBODY$(REFL),51
1708-7,"ACHE, Amn",1
9522-4,ENTAMOEBA HISTOLYTICA IGG$ELISA,1
31023-5,"MAG AB (IGM),WESTERN BLOT",3
17781-6,21 HYDROXYLASE ANTIBODY,5
94563-4,"REFLEX RESULT SARS-COV-2 AB IGG, SERUM/PLASMA",168
18483-8,Vaginal Yeast Culture,2
10975-1,"6-Acetylmorphine, Urine",1
49580-4,HIV ANTIBODY SCREEN,2671
35392-0,HANTAVIRUS IGG,1
57768-4,"CAMPYLOBACTER SP. AG, EIA",20
42358-2,Result,1
18282-4,Cannabinoid,261
50733-5,UFH SRA RESULT,1
5218-3,"HISTOPLASMA ANTIBODY, ID",1
5058-3,"BLASTOMYCES ANTIBODY, ID",1
27391-2,Candida Antibodies IgM,1
3393-6,Cocaine (Metab.),281
22296-8,Mono Qual W/Rflx Qn,3
42254-3,ANTI-NUCLEAR AB BY IFA (RDL),2
14273-7,RETICULIN IGA SCREEN,2
42181-8,"MYOCARDIAL AB, IF",1
79382-8,CAMPYLOBACTER GROUP,9
32667-8,"LYME DISEASE (BORRELIA$SPP) DNA, QL, BLOOD",2
5646-5,ETHYLENE GLYCOL,25
9780-8,SPERM CONCENTRATION,3
7918-6,"HIV 1,2",2
11004-9,TRICYCLICS,3
94505-5,"SARS-CoV-2 IGG (VIRACOR), SERUM/PLASMA",26
57320-4,"TRYPANOSOMA CRUZI ANTIBODY, IGG",1
17781-6,21-HYDROXYLASE ANTIBODIES,1
17852-5,Ureaplasma urealyticum,1
43638-6,"AQUAPORIN 4 AB (IGG), CBA IFA",1
44938-9,"HEPATITIS D VIRUS (HDV)$IGM ANTIBODY, EIA",1
59263-4,"HPV Genotype, 16",23
94563-4,"REFLEX RESULT SARS-COV-2 AB IGG, SERUM/PLASMA (EUROIMMUN)",33
5043-5,Adrenal Total AutoAb,1
5876-8,"RSV Ag, EIA",1
82991-1,"PHOSPHOLIPASE A2 RECEPTOR (PLA2R) AB, IFA",1
5096-3,Coccidioides CF Antibody,1
5274-6,PARVOVIRUS B19 ANTIBODY (IGM),17
92899-4,FETAL CHROMOSOME REGION 11Q23 DELETION (JACOBSEN),284
10834-0,GLOBULIN,463440
82177-7,MYCOPLASMA PNEUMONIAE,13562
1759-0,ALB/GLOB RATIO,256396
19141-1,Propoxyphene,217
82208-0,GIARDIA LAMBLIA DNA,197
25136-3,SUCCINATE/CREATININE,8
11246-6,Oxycodone,52
25101-7,FUMARATE/CREATININE,8
82209-8,ADENOVIRUS 40+41 DNA,5
3774-7,Methadone,45
3937-0,Phencyclidine,47
50542-0,EDDP,69
5770-3,"Bilirubin, UA",19051
5802-4,Nitrite,7181
20454-5,Protein,19053
82190-0,HSV1 DNA CSF,371
50388-8,"Neisseria gonorrhoeae, NAA",229
50387-0,"Chlamydia, Nuc. Acid Amp",415
20407-3,Nitrite,11871
19429-0,Propoxyphene Urine,34
50387-0,"Chlamydia trachomatis, NAA",230
50388-8,"Gonococcus, Nuc. Acid Amp",144
46154-1,Trich vag by NAA,551
9596-8,LYME 66 KD IGG,79
53327-3,BILIRUBIN,67202
82171-0,PARAINFLUENZA 1,13563
35651-9,"SYNOVIOCYTES, %",30
82191-8,HSV2 DNA CSF,372
15783-4,CLASS,3
90843-4,Purkinje Cell Cytoplasmic Ab Type 2,12
29504-8,2-HYDROXYISOVALERATE/CREATININE,8
3282-1,Hex Phosph Neut Test,32
3786-1,Methaqualone,21
3786-1,METHAQUALONE,1252
9834-3,Hydromorphone,1
80348-6,ESCHERICHIA COLI ENTEROPATHOGENIC EAE GENE,5
15782-6,CLASS,8
34658-5,MUCOLIPIDOSIS TYPE IV,1
82168-6,Influenza A/H1-2009,1
2613-8,MET HEMOGLOBIN,27051
5799-2,"WBC Esterase, UA",11871
3746-5,"Meperidine Screen, Urine",22
75570-2,FETAL MONOSOMY X RISK (TURNER SYNDROME),280
82172-8,PARAINFLUENZA 2,13563
82192-6,HHV6 DNA CSF,372
3746-5,Meperidine,197
14267-9,MDMA,1
9597-6,LYME 93 KD IGG,79
25083-7,"2-OXO,3-METHYLVALERATE/CREATININE",8
13502-0,Lyme IgG Wb,22
16252-9,Hydrocodone GC/MS Conf,1
3821-6,MIDAZOLAM,3
80351-0,ESCHERICHIA COLI ENTEROTOXIGENIC ltA+st1a+st1b GENES,5
3415-7,"Buprenorphine, Urine",7
21680-4,GLYCOGEN STORAGE DISEASE,1
82169-4,Influenza A/H3,1
82193-4,PARECHOVIRUS RNA CSF,372
16130-7,HSV 1 NAA,2
82203-1,ESCHERICHIA COLI STX1+STX2 TOXIN STX1+STX2 GENES,5
33359-1,MSUD MUTATION (JEWISH),1
18484-6,Anti-Ku Ab (RDL),14
3394-4,Benzoylecgonine,48
19710-3,"Tramadol Screen, Urine",22
82188-4,VARICELLA ZOSTER DNA CSF,372
9598-4,LYME 23 KD IGM,79
25085-2,2-OXOISOVALERATE/CREATININE,8
16131-5,HSV 2 NAA,2
80350-2,SHIGELLA SPECIES+EIEC INVASION PLASMID ANTIGENH (ipaH) GENE,5
9599-2,LYME 39 KD IGM,79
29523-8,2-ETHYL-3-HYDROXYPROPIONATE/CREATININE,8
24435-0,2-METHYLBUTYRYLGLYCINE/CREATININE,8
75980-3,FETAL CHROMOSOME 13+18+21+X+Y ANEUPLOIDY,347
82162-9,CORONAVIRUS NL63 PCR,13562
13987-3,"Alpha-2-Globulin, U",100
64084-7,TB1-NIL,1539
88517-8,QUANTIFERON TB2 AG VALUE,529
8010-1,B QUINTANA IGM,79
55097-0,Parainfluenza 1,7
77026-3,INFLUENZA A SUBTYPE H1,24
32578-7,B. QUINTANA IGM SCREEN,3
43399-5,JAK2 V617F,12
82185-0,N.MENINGITIS DNA CSF,372
5867-7,Influenza B,6
18416-8,Aspergillus nidulans,1
17815-2,"Beta, Urine",229
18282-4,"Cannabinoid Screen, Urine",34
82163-7,Coronavirus 229E,1
11584-0,A. Pullulans Abs,2
21560-8,T. CANDIDUS,6
24440-0,ISOVALERYLGLYCINE/CREATININE,8
64084-7,TB-NIL,137
4625-0,HGB S,1810
85501-5,VIM GENE,24
9590-1,LYME 28 KD IGG,79
29509-7,BETA HYDROXYBUTYRATE/CREATININE,8
93777-1,HPV HIGH RISK,1
44768-0,"Anti-Neuronal Nuclear Ab, Type 1",12
13984-0,"Alpha-1-Globulin, U",6
806-0,WHITE BLOOD CELL COUNT,11
30076-4,RSV B,10
19370-6,BUTABARBITAL,3
41209-8,VWF GENE P ARG854GLN,1
21729-9,GAUCHER DISEASE,1
64091-2,Cells Karyotyped,16
792-2,"RBC, CSF",2
50727-7,"UFH HIGH DOSE, 100 IU/ML",1
79384-4,VIBRIO GROUP,9
3779-6,Methamphetamine,2
11558-4,PH,100053
16080-4,CLASS,8
29514-7,3-HYDROXYISOVALERATE/CREATININ,8
29516-2,3-HYDROXYVALERATE/CREATININE,8
38360-4,ISOBUTYRYLGLYCINE/CREATININE,8
24443-4,SUBERYLGLYCINE,8
24441-8,PHENYLPROPIONYLGLYCINE,8
82164-5,CORONAVIRUS OC43 PCR,13562
13989-9,"Gamma Globulin, U",100
82186-8,S.AGALACTIAE DNA CSF,372
55099-6,Parainfluenza 3,7
76080-1,"INFLUENZA B RNA, PCR",16
16082-0,CLASS,8
82187-6,S.PNEUMONIAE DNA CSF,372
5877-6,Respiratory Syncytial Virus,6
9592-7,LYME 39 KD IGG,79
,ASPERGILLUS TERREUS IGG,1
4575-7,Hgb E Quant,6
19295-5,"Opiate Screen, Urine",34
82165-2,Human Metapneumovirus,1
47084-9,GPIA/IIA (CELL 1),2
6733-0,Pigeon Serum Abs,2
15209-0,S. VIRIDIS,6
25097-7,DODECANEDIOIC ACID,8
3530-3,Marijuana Metabolite,49
29858-8,ALPHA HYDROXYBUTYRATE/CREATININE,8
1968-7,CONJUGATED BILIRUBIN,11159
13989-9,"Gamma Globulin, Urine",232
90836-8,"Anti-Neuronal Nuclear Ab, Type 3",12
13988-1,"Beta Globulin, U",100
29909-9,Parainfluenza 2,1764
3926-3,PENTOBARBITAL,59
21557-4,MARIJUANA METABOLITES$(100 ng/mL SCREEN),10
15537-4,CLASS,5
32640-5,BLOOM SYNDROME,1
29908-1,PARAINFLUENZA 1 RNA,2
29524-6,ACETOACETATE/CREATININE,8
82200-7,VIBRIO CHOLERAE+PARAHAEMOLYTICUS+VULNIFICUS DNA DNA,5
79386-9,SHIGA TOXIN 1,9
25093-6,DECADIENEOIC ACID,8
29521-2,5-HYDROXYHEXANOATE/CREATININE,8
29506-3,2-OxoADIPATE/CREATININE,8
29500-6,2-HYDROXYADIPATE/CREATININE,8
29518-8,3-METHYLGLUTARATE/CREATININE,8
75983-7,FETAL CHROMOSOME 21 TRISOMY (DOWN SYNDROME),347
82175-1,RHINO/ENTEROVIRUS PCR,13559
42483-8,"M-Spike, %",94
9593-5,LYME 41 KD IGG,79
18485-3,MI-2 Autoab,14
55100-2,Respiratory Syncytial Virus,7
11054-4,LDL/HDL RATIO,30894
21395-9,"MONOCYTE/MACROPHAGE, %",34
82189-2,CYTOMEGALOVIRUS DNA CSF,429
9558-8,ABSOLUTE CD 20,92
58430-0,"Oxycodone/Oxymorphone, Urine",232
82175-1,Human Rhinovirus/Enterovirus,1
48506-0,GPIB/IX,1
26583-5,"3-HYDROXY,3-METHYLGLUTARATE/CREATININE",8
25084-5,2-OXOISOCAPROATE/CREATININE,8
42482-0,"M-Spike, %",10
,"CRMP-5-IgG, CSF",12
3414-0,Buprenorphine,1
19695-6,SECOBARBITAL,59
19550-3,Methadone,38
29909-9,PARAINFLUENZA 2 RNA,2
3393-6,COCAINE METABOLITES,1
81743-7,ANTI-TH/TO AB (RDL),2
17088-6,LORAZEPAM,6
79387-7,SHIGA TOXIN 2,9
3831-5,MORPHINE,1079
47812-3,2-METHYLGLUTACONATE/CREATININE,8
25087-8,3-METHYLGLUTACONATE/CREATININE,8
25103-3,GLUTACONATE/CREATININE,8
48084-8,3-HYDROXYDODECANEDIOATE/CREATININE,8
75078-6,3-HYDROXYDODECANOATE/CREATININE,8
47537-6,3-HYDROXYSEBACATE/CREATININE,8
25104-1,GLUTARIC ACID,8
29859-6,ADIPATE/CREATININE,8
64084-7,TB2-NIL,1539
55098-8,Parainfluenza 2,7
53029-5,Atypical pANCA,4
13327-2,Parainfluenza,6
32998-7,t-Transglutaminase (tTG) IgG,111
13194-6,Aspergillus glaucus,1
82164-5,Coronavirus OC43,1
21561-6,Thermoact. Saccharii,2
6821-3,T. VULGARIS,4
40491-3,"NEUTROPHILS, %",34
25135-5,SUBERATE/CREATININE,8
4563-3,HGB C,66
85498-4,IMP GENE,24
9591-9,LYME 30 KD IGG,79
13982-4,% BETA,1558
93778-9,HPV LOW RISK,1
56959-0,"Anti-Neuronal Nuclear Ab, Type 2",12
5869-3,Parainfluenza 1,10
11230-0,AMOBARBITAL,64
12238-2,"Polys, Fluid",7
32639-7,FANCONI ANEMIA,1
41458-1,"SARS-COV-2 (COVID-19) RNA, PAN-SARS:",83
82199-1,SALMONELLA ENTERICA+BONGORI DNA,197
28643-5,Measured O2 SAT,98885
25134-8,SEBACATE/CREATININE,8
25120-7,OCTANOATE/CREATININE,8
24437-6,BUTYRYLGLYCINE/CREATININE,8
25099-3,ETHYLMALONATE/CREATININE,8
25117-3,METHYLSUCCINATE/CREATININE,8
14948-4,Vanillylmandelate/Creatinine,8
5794-3,Occult Blood,19051
75558-7,FETAL TRISOMY 18 RISK (EDWARDS SYNDROME),347
57391-5,"EOSINOPHILS, %",22
82194-2,ENTEROVIRUS DNA CSF,372
3284-7,Platelet Neutralization,36
9594-3,LYME 45 KD IGG,79
35026-4,csf MONOCYTES,871
3936-2,"Phencyclidine Screen, Urine",33
82166-0,INFLUENZA A VIRUS RNA,1
87757-1,GPIV,1
12209-3,"Eos, Fluid",7
29520-4,5-HYDROXYINDOLEACETATE/CREATININE,8
29503-0,2-HYDROXYISOCAPROATE/CREATININE,8
90845-9,Purkinje Cell Cytoplasmc Ab Type Tr,12
42484-6,"M-Spike, %",6
3950-3,PHENOBARBITAL,59
32653-8,Familial Dysautonomia,1
29910-7,PARAINFLUENZA 3 RNA,2
30313-1,HEMOGLOBIN,69976
82202-3,YERSINIA ENTEROCOLITICA DNA,197
16230-5,FLURAZEPAM METABOLITE,6
1959-6,HCO3,101638
15748-7,CLASS,1
2865-4,ALPHA 1,2227
3507-1,CODEINE,117
17869-9,OROTIC ACID,8
48157-2,THYMINE/CREATININE,8
29502-2,2-HYDROXYGLUTARATE/CREATININE,8
29510-5,3-HYDROXYGLUTARATE/CREATININE,8
76023-1,N-ACETYL-L-ASPARTATE/CREATININE,8
47650-7,Homogentisic Acid,8
73824-5,FETAL TRISOMY 13 RISK,347
57836-9,"BASOPHILS, %",21
19141-1,"Propoxyphene, Urine",18
9595-0,LYME 58 KD IGG,79
82167-8,INFLUENZA A H1 RNA,1
,HLA CLASS I,1
90841-8,Purkinje Cell Cytoplasmic Ab Type 1,12
42482-0,"M-Spike, mg/24 hr",6
38917-1,Metapneumovirus,10
29511-3,3-HYDROXYISOBUTYRATE/CREATININE,8
32623-1,MPV,2299648
80349-4,ESCHERICHIA COLI ENTEROAGGREGATIVE PAA PLASMID AGGR+AATA GENES,5
3313-4,ALPRAZOLAM,6
25105-8,GLYCERATE/CREATININE,8
47542-6,GAMMA HYDROXYBUTYRATE/CREATININE,8
48145-7,MEVALONOLACTONE/CREATININE,8
59377-2,2-METHYLACETOACETATE/CREATININE,8
22322-2,HEP B S AB,9351
704-7,BASOS ABS,676553
50551-1,BILIRUBIN URINE,139883
57747-8,"BLOOD URINE, POC",26071
13952-7,HEP B C TOTAL AB,947
16128-1,HEP C AB,29729
20409-9,BLOOD UA,59190
783-1,PROMYELOCYTES PCT,52070
706-2,BASOS,514643
7905-3,HEP B S AG,27767
5770-3,BILIRUBIN URINE,25820
5196-1,HEP B S AG,15716
749-2,MYELOCYTES PCT,73940
70199-5,BILIRUBIN URINE,66639
740-1,META,74554
20454-5,PROTEIN - URINE,25075
711-2,EOS ABS,678442
50551-1,BILIRUBIN -UR,26075
16935-9,HEPATITIS B SURFACE AB QUANT,4685
31204-1,HEP B C IGM,10152
713-8,EOS,673449
713-8,EOSINO PCT AUTO,69198
25514-1,RUBELLA IGG SCR,2458
6864-3,FREE HEMOGLOBIN PLAS,508
13955-0,HEP C AB,12025
5770-3,UROBILINOGEN URINE,138668
712-0,EOS ABS,68825
707-0,BASOS PCT MAN,67102
6864-3,HEMOGLOBIN (HGB) SOLUBILITY,650
48159-8,HEP C AB,12167
6864-3,HEMOGLOBIN SOLUBILITY,161
737-7,LYMPHS,454556
29541-0,HIV-1 RNA PCR (LOG),971
2162-6,CREATININE 24H UR,5033
51914-0,HEPATITIS B CORE AB TOTAL,3515
1968-7,BILIRUBIN DIRECT,236698
5195-3,HEP B S AG,490
24113-3,HEP B C IGM,3024
33910-1,RHEUMATOID FACT SCREEN REF TITER,1222
2888-6,PROTEIN URINE,11037
705-4,BASOS ABS,37732
1971-1,BILIRUBIN INDIRECT,47837
20447-9,HIV-1 RNA PCR (CPY/ML),969
22244-8,CMV IGG,2792
20507-0,RPR (MONITOR) W/REFL TITER,4849
48159-8,SIGNAL/CUTOFF,11978
707-0,BASOS ABS,1686
13952-7,HEPATITIS B CORE AB TOTAL,3643
11011-4,HCV QUANT REFLEX GENOTYPE,1245
53326-5,SPEC GRAV UA,94332
45210-2,HSV 2 IGM SCREEN,213
742-7,MONOS ABS,722828
49539-0,CMV IGM,129
13457-7,LDL CALC,131436
5390-0,TOXOPLASMA IGM,326
43180-9,"HSV2 IGG INHIBITION, ELISA",81
732-8,LYMPHS ABS MAN,50588
10331-7,RH TYPE,107520
10331-7,RH FACTOR,3379
744-3,MONO PCT MAN,71754
706-2,BASOPHILS,237491
23761-0,NEUTROS PCT MAN,71766
743-5,MONOS ABS,13170
753-4,NEUTROPHIL ABS MAN,50573
731-0,LYMPHS ABS,742381
737-7,LYMPHO PCT MAN,71939
23761-0,NEUTROS PCT,222870
707-0,BASOS,28842
48067-3,D DIMER,14945
743-5,MONOS ABS MAN,48403
30180-4,BASOS,7536
751-8,NEUTROS ABS,693159
49347-8,CMV QUANT DNA PCR (URINE),16
744-3,MONOCYTES,48491
712-0,EOS ABS MAN,35243
58450-8,ICTOTEST,30
5905-5,MONOCYTES,762444
10466-1,ANION GAP,945407
753-4,NEUTROS ABS,58017
2345-7,GLUCOSE,1853864
3016-3,"TSH, 3RD GENERATION",138195
33006-8,CMV DNA-PCR,827
29539-4,HIV 1 RNA VIRAL LOAD,914
40466-5,HSV 1 IGM SCREEN,209
737-7,LYMPHS PCT,169583
736-9,LYMPHS,125318
26449-9,EOS,7734
43180-9,HSV-2 IGG SUPPLEMENTAL,81
714-6,EOS,35299
70154-0,HEP B SURFACE AG CONFIRMATION,14
32286-7,HCV GENOTYPE,202
6864-3,HEMOGLOBIN S (QUANT),29
4548-4,HEMOGLOBIN A1C POC,19873
732-8,ABSOLUTE LYMPHOCYTES,1691
1975-2,BILIRUBIN FLUID,188
7905-3,HBSAG CONFIRMATION,175
22580-5,TOXOPLASMA IGG ANTIBODY,88
1975-2,BILIRUBIN TOTAL,1076507
2160-0,CREATININE,1802985
3053-6,T3 TOTAL,15702
26478-8,LYMPHS PCT,2606
2345-7,GLUCOSE RANDOM,48514
10900-9,HEP B S AB,223
33959-8,PROCALCITONIN,36133
30341-2,SED RATE,28918
6768-6,ALK PHOS,571694
2965-2,"SPECIFIC GRAVITY, URINE",1204
1920-8,AST,1237194
16934-2,POLYMERASE MUTATIONS,11
1742-6,ALT,1236253
2324-2,GGT,27805
2161-8,CREATININE UR,42945
11011-4,HEPATITIS C RNA-PCR - QUANT,875
26453-1,RBC,152
883-9,ABO GROUPING,110514
770-8,NEUTROS PCT,506844
48643-1,EGFR DUMMY,2
14957-5,MICROALBUMIN URINE,5865
26515-7,PLATELET COUNT,956819
12187-1,CK MB,12097
4544-3,HEMATOCRIT,1660613
23811-3,ADJ MULTIPLE OF MEDIAN,1325
23869-1,HEPATITIS B DNA QUANT,14
14957-5,MICROALBUMIN-RANDOM,4328
32693-4,LACTATE (POINT OF CARE),22826
5770-3,BILIRUBIN,432
883-9,MOTHER'S ABORH,478
1975-2,BILIRUBIN,243
33006-8,"CMV DNA, QN PCR",5798
26524-9,PROMYELOCYTES PCT,6056
43396-1,NON-HDL CHOLESTEROL,167701
5902-2,PROTHROMBIN TIME (POINT OF CARE),6109
5403-1,VARICELLA IGG,1797
72523-4,"GAD65 AB, WB",1
8047-3,VARICELLA-ZOSTER VIRUS IGG AB,15
30352-9,HEMOGLOBIN,2540
2888-6,PROTEIN UR,3273
3016-3,"TSH, ULTRASENSITIVE, HAMA",3
11572-5,RHEUMATOID FACTOR,9591
3016-3,"TSH, UNTREATED",3
24119-0,CMV IGM,23
4621-9,SICKLE CELL SCREEN,160
31147-2,RPR TITER,1155
2777-1,PHOSPHORUS,791603
2164-2,CREAT CLEAR,1484
30522-7,CRP HIGH SENSITIVITY,75107
24113-3,"HEP B CORE AB, IGM",2
2889-4,PROTEIN 24H UR,4287
30180-4,BASOS PCT,12
10834-0,CALC TOTAL GLOBULIN,450416
15179-5,D DIMER (HS),8504
,UF BKR QUEST OVERALL RESULTS,21
34714-6,PROTHROMBIN TIME INR (POC),7457
26485-3,EOSINO PCT AUTO,88
22496-4,RUBELLA IMMUNE STATUS,2661
4625-0,HB S,832
11259-9,"HCV RNA PCR, QUAL., PLASMA",6
711-2,ABSOLUTE EOSINOPHIL,6
3097-3,BUN/CREATININE RATIO,216801
2708-6,O2 CONTENT ART,101261
20447-9,COPIES/ML,2163
29541-0,LOGCOPIES/ML,2388
50561-0,PROTEIN-UA,164292
57735-3,PROTEIN URINE,67315
50561-0,PROTEIN - URINE,1946
5804-0,PROTEIN-UA,508
35663-4,PROTEIN UR,17607
3427-2,CANNABINOID SCRN UR,25900
14316-4,"BENZODIAZEPINES SCREEN, URINE",1820
3879-4,"OPIATE SCREEN, URINE",26465
19268-2,"AMPHETAMINE SCREEN, URINE",25886
3773-9,"METHADONE SCREEN, URINE",26033
3397-7,COCAINE METAB UR,26309
14308-1,AMPHETAMINES (1000 NG/ML SCREEN),1207
3377-9,"BARBITURATE SCREEN, URINE",26296
19550-3,"METHADONE SCREEN, URINE",1902
19642-8,"OXYCODONE SCREEN, URINE",25841
19261-7,"AMPHETAMINE SCREEN, URINE",1577
18282-4,"CANNABINOID SCREEN, URINE",1791
58430-0,"OXYCODONE/OXYMORPHONE, URINE",1851
14316-4,"BENZODIAZEPINE SCREEN, URINE",25895
19429-0,"PROPOXYPHENE SCREEN, URINE",1824
12308-3,HYDROCODONE,290
41858-2,METHADONE METABOLITE,36
3393-6,COCAINE METAB UR,1367
14314-9,"COCAINE (METAB.) SCREEN, URINE",1822
59673-4,"FENTANYL SCREEN, URINE",4945
3393-6,COCAINE METABOLITE,2403
10998-3,OXYCODONE,2468
72613-3,OXAZEPAM,2
9834-3,HYDROMORPHONE,322
19270-8,"BARBITURATES SCREEN, URINE",1820
3414-0,"BUPRENORPHINE, URINE",188
19295-5,"OPIATE SCREEN, URINE",1828
3725-9,LORAZEPAM,471
58430-0,OXYCODONE/OXYMORPH,412
9835-0,HYDROMORPHONE,1104
19328-4,ALPHAHYDROXYALPRAZOLAM,479
3681-4,HYDROCODONE,1104
12361-2,OXAZEPAM UR QT,114
14192-9,TRIAZOLAM UR,105
59705-4,METHADONE,9
16208-1,BUPRENORPHINE,71
19261-7,AMPHETAMINE SCRN UR,248
10998-3,OXYCODONE UR,36
58430-0,OXYCODONE/OXYMORPHONE,3
3426-4,MARIJUANA METABOLITE,2304
3508-9,CODEINE,1065
3936-2,"PHENCYCLIDINE SCREEN, URINE",1794
14312-3,MARIJUANA METABOLITES (50 NG/ML SCREEN),1169
10976-9,6 ACETYLMORPHINE,115
28073-5,AMINOCLONAZEPAM,472
18325-1,OXYMORPHONE,385
42491-1,"THC (MARIJUANA) MTB,IA",107
19643-6,OXYCODONES CONFIRMATION,366
42662-7,BENZODIAZEPINES,55
60677-2,ALPHAHYDROXYTRIAZOLAM,479
19416-7,CANNABINOIDS URINE INTERP,417
12602-9,HYDROXYETHYLFLURAZEPAM,472
40419-4,AMPHETAMINES,141
9351-8,ALPRAZOLAM UR,114
74677-6,6-MONOACETYLMORPHONE-FREE,3
19648-5,OXYMORPHONE,459
16206-5,TEMAZEPAM,108
12382-8,TEMAZEPAM,471
51691-4,"OPIATES, IA",55
19429-0,PROPOXYPHENE-U,66
58362-5,NORBUPRENORPHINE UR,26
3887-7,OXAZEPAM,472
3654-1,FLURAZEPAM GC/MS CONF,105
15372-6,NORDIAZEPAM,472
3376-1,BARBITURATES,64
19710-3,TRAMADOL UR,76
61422-2,NORHYDROCODONE,1076
3390-2,BENZODIAZEPINE GC/MS UR,105
3780-4,METHAMPHETAMINE,193
19586-7,MIDAZOLAM UR QT,114
3348-0,AMPHETAMINES,17
3936-2,PCP SCRN UR,170
18187-5,LORAZEPAM UR QT,114
3390-2,"BENZODIAZEPINE SCREEN, URINE",298
50542-0,EDDP UR,17
18282-4,CANNABINOID SCRN UR,172
74108-2,MEPERIDINE,3
3774-7,METHADONE UR,16
42662-7,"BENZODIAZEPINES, IA",51
11071-8,BUTALBITAL UR,15
3390-2,BENZODIAZEPINE SCRN UR,36
59589-2,ALPHAHYDROXYMIDAZOLAM,523
51690-6,AMPHETAMINES,55
73823-7,"COCAINE/METABOLITE, IA",51
27085-0,MDEA,2
71430-3,OXYCODONE/OXYMORPHONE,14
19289-8,CANNABINOID GC/MS UR,2
3528-7,MARIJUANA,20
40808-8,PHENCYCLIDINE,28
51690-6,"AMPHETAMINES, IA",51
17719-6,TRAMADOL,60
20559-1,TEMAZEPAM,6
19270-8,"BARBITURATE SCREEN, URINE",132
73823-7,"COCAINE/METABOLITE,IA",55
9835-0,HYDROMORPHONE UR,60
48934-4,HYDROXY-THC,14
21556-6,CANNABINOID SCRN UR,36
3746-5,MEPERIDINE-URINE,85
3926-3,PENTOBARBITAL UR,15
19245-0,CLONAZEPAM UR,105
72742-0,NOROXYCODONE,7
29520-4,5-HIAA,8
3377-9,BARBITURATE,10
3861-2,NORDIAZEPAM UR QT,105
61425-5,NOROXYCODONE,551
3377-9,"BARBITURATES SCREEN, URINE",39
51691-4,"OPIATES , IA",51
18282-4,CANNABINOID,4
19261-7,AMPHETAMINE GC/MS UR,147
74645-3,HYDROMORPHONE,3
19643-6,OXYCODONE,19
3780-4,METHAMPHETAMINE UR,25
16249-5,OXYCODONE UR,84
11230-0,AMOBARBITAL UR,16
58428-4,EDDP,4
74131-4,MORPHINE,37
3349-8,AMPHETAMINE,42
19289-8,CANNABINOIDS,185
72633-1,BENZODIAZEPINES,28
40419-4,AMPHETAMINE GC/MS UR,8
3376-1,"BARBITURATES, IA",51
38373-7,BUPRENORPHINE UR,30
72739-6,NORDIAZEPAM,2
12382-8,TEMAZEPAM UR,52
3414-0,BUPRENORPHINE,184
51692-2,"PHENCYCLIDINE, IA",51
3725-9,LORAZEPAM UR,52
40801-3,MARIJUANA,12
38373-7,"BUPRENORPHINE, URINE",5
19346-6,AMPHETAMINE UR,24
72400-5,METHADONE,54
10976-9,HEROIN METABOLITE URINE,36
58379-9,FENTANYL URINE,75
3950-3,PHENOBARBITAL UR,15
19270-8,BARBITURATES,8
14316-4,BENZODIAZEPINES,13
20413-1,CANNABINOID SCRN UR,6
40799-9,AMPHETAMINES,26
48962-5,OXAZEPAM,4
21557-4,MARIJUANA METABOLITES (100 NG/ML SCREEN),16
72627-3,BARBITURATES,28
3887-7,OXAZEPAM UR,52
19695-6,SECOBARBITAL UR,15
19710-3,TRAMADOL,12
74130-6,6-ACETYLMORPHINE,37
8217-2,OPIATES,1
3878-6,OPIATES,17
3414-0,BUPRENORPHINE UR,53
72626-5,METHADONE,28
3831-5,MORPHINE UR,60
18338-4,DESMETHYLTRAMADOL,55
17395-5,OXYMORPHONE UR,85
3830-7,MORPHINE,122
48943-5,CANNABINOID CONFIRMATION,14
72766-9,OXYMORPHONE,7
3508-9,CODEINE URINE,7
40839-3,FENTANYL,11
16249-5,OXYCODONE,380
72759-4,CODEINE,5
40802-1,COCAINE,14
3680-6,HYDROCODONE,20
3681-4,HYDROCODONE UR,60
72631-5,AMOBARBITAL,2
60677-2,ALPHAHYDROXYTRIAZOLAM UR,44
74644-6,HYDROCODONE,3
40806-2,OPIATES,26
49753-7,NORBUPRENORPHINE UR,46
15372-6,NORDIAZEPAM UR,52
3530-3,MARIJUANA METABOLITE UR,23
3393-6,COCAINE (METAB.),38
19346-6,AMPHETAMINE,193
19328-4,ALPHAHYDROXYALPRAZOLAM UR,46
8172-9,"THC (MARIJUANA) MTB,IA",9
47542-6,4OH-BUTYRIC ACID,8
3376-1,"BARBITURATES SCREEN, BLOOD",1
46976-7,"BENZODIAZEPINES, IA",9
73942-5,BUPRENORPHINE,12
19295-5,OPIATE URINE CONF INTERP,5
74675-0,CODEINE,3
51692-2,PHENCYCLIDINE,3
43200-5,NORFENTANYL,11
72617-4,PROPOXYPHENE,17
51691-4,"OPIATES SCREEN, BLOOD",1
3508-9,CODEINE UR,55
3415-7,BUPRENORPHINE UR,47
72629-9,SECOBARBITAL,2
8149-7,"AMPHETAMINES, IA",9
48966-6,TRIAZOLAM,4
14334-7,LITHIUM LVL,1168
43828-3,BENZODIAZEPINES,23
34177-6,OPIATE CONFIRMATION,23
48958-3,MIDAZOLAM,4
59734-4,PROPOXYPHENE,9
9834-3,HYDROMORPHONE UR,3
18338-4,"O-DESMETHYLTRAMADOL, UR",16
3393-6,COCAINE (METABOLITE),10
66129-8,FENTANYL/NORFENTANYL,20
72401-3,PROPOXYPHENE,2
3772-1,METHADONE,13
3389-4,BENZODIAZEPINES,9
17719-6,TRAMADOL UR,9
3935-4,PCP (PHENCYCLIDINE),17
74654-5,MORPHINE,3
16251-1,MORPHINE,2
3395-1,COCAINE,15
46980-9,DESALKYLFLURAZEPAM,4
74110-8,TRAMADOL,12
34177-6,OPIATES CONFIRMATION,14
3390-2,"BENZODIAZEPINES SCREEN, URINE",5
73935-9,TETRAHYDROCANNABINOL,14
48955-9,LORAZEPAM,4
8236-2,"PHENCYCLIDINE, IA",9
9776-6,DEZMETHYLCHLORDIAZEPOXIDE BLOOD,4
72400-5,"METHADONE SCREEN, BLOOD",1
74656-0,DRUG CONFIRMATION OPIATES UR,3
20421-4,"BARBITURATES, IA",9
3869-5,NORMEPERIDINE,4
72750-3,OXYCODONE,7
3747-3,MEPERIDINE,4
74670-1,COCAINE AND METABO,1
48938-5,ALPRAZOLAM,4
17719-6,"TRAMADOL, UR",16
19289-8,"CANNABINOID SCREEN, URINE",6
10338-2,BARBITURATES,10
72630-7,PENTOBARBITAL,2
40801-3,CANNABINOIDS,14
42662-7,"BENZODIAZEPINES SCREEN, BLOOD",1
3394-4,BENZOYLECGONINE UR,21
16201-6,OXAZEPAM,6
3935-4,PHENCYCLIDINE,1
19648-5,OXYMORPHONE UR,7
40802-1,COCAINE AND METABOLITES-BLD,14
3392-8,BENZOYLECGONINE,2
19321-9,"6-ACETYLMORPHINE, URINE",6
3827-3,MORPHINE,1
3779-6,METHAMPHETAMINE,24
72632-3,BUTALBITAL,2
3937-0,PHENCYCLIDINE,10
3393-6,COCAINE AND METABOLITES-BLD,4
9652-9,DESALKYFLURAZEPAM,1
3637-6,FENTANYL URINE,15
48950-0,FLURAZEPAM,4
3948-7,"PHENOBARBITAL, SERUM",46
72744-6,NORHYDROCODONE,7
3507-1,CODEINE URINE,3
48945-0,CHLORDIAZEPOXIDE,4
3349-8,"AMPHETAMINES SCREEN, URINE",1
3746-5,MEPERIDINE,10
51690-6,"AMPHETAMINES SCREEN, BLOOD",1
59595-9,AMINOCLONAZEPAM,4
49747-9,COCAINE (METAB.),9
19289-8,CANNABINOID,2
12308-3,HYDROCODONE UR,3
3683-0,HYDROMORPHONE,6
3830-7,MORPHINE URINE,3
48965-8,TEMAZEPAM,4
19642-8,OXYCODONE SCREEN URINE,1
3530-3,MARIJUANA METABOLITE,280
72752-9,MORPHINE,7
11071-8,BUTALBITAL,68
72407-0,COCAINE AND METABOLITES-BLD,1
8219-8,"OPIATES, IA",9
48948-4,DIAZEPAM,4
3724-2,LORAZEPAM,3
16228-9,NORDIAZEPAM,26
72735-4,METHAMPHETAMINE,1
11024-7,BENZODIAZEPINES,1
72733-9,HYDROMORPHONE,7
3543-6,PROPOXYPHENE,1
19346-6,AMPHETAMINE GC/MS UR,2
72451-8,BARBITURATES CONFIRMATION,2
74678-4,MARIJUANA (THC),2
72628-1,PHENOBARBITAL,2
72756-0,ALPRAZOLAM,2
40481-4,MDMA,2
72402-1,"OXYCODONE SCREEN, BLOOD",1
50561-0,PROTEIN URINE,11
48959-1,DESMETHYLDIAZEPAM BLOOD,4
74811-1,DIHYDROCODEINE,7
66129-8,FENTANYL URINE,3
73936-7,FENTANYL,1
3393-6,"COCAINE (METAB.) SCREEN, URINE",3
72755-2,CLONAZEPAM,2
3393-6,COCAINE METAB QUANT UR,4
3394-4,BENZOYLECGONINE,41
48944-3,CARBOXY THC,10
3312-6,ALPRAZOLAM,2
61046-9,MDA,2
72738-8,TEMAZEPAM,2
3530-3,CANNABINOID SCRN UR,9
11246-6,OXYCODONE UR,7
74679-2,BENZOYLECGONINE,1
74671-9,COCAINE,1
8170-3,CANNABINOIDS,1
3893-5,OXYCODONE,3
72485-6,TAPENTADOL,1
3774-7,METHADONE,22
59640-3,CLONAZEPAM,4
30112-7,AMPHETAMINE,2
51692-2,"PHENCYCLIDINE SCREEN, BLOOD",1
72401-3,"PROPOXYPHENE SCREEN, BLOOD",1
3436-3,MARIJUANA METABOLITE UR,1
72610-9,DIAZEPAM,2
48944-3,CARBOXY-THC,4
3506-3,CODEINE,1
3040-3,LIPASE,130238
20507-0,"BLOOD SEROLOGY, QUALITATIVE",1188
1920-8,AST (POC),76
2965-2,SP GR-U,2166
20454-5,PROTEIN UA,108585
33006-8,CMV DNA  QUANT RT PCR,19240
20454-5,PROTEIN,17297
16933-4,HEPATITIS B CORE TOTAL ANTIBODY,5717
43180-9,HSV-2 IGG SUPPLEMENTAL TEST,183
48159-8,SIGNAL TO CUT OFF,7908
13952-7,HEP B CORE ANTIBODY TOTAL  WITH RFLX TO IGM,88
5195-3,HEPATITIS B SURFACE ANTIGEN,13195
20409-9,RBC UA,79383
20454-5,PROTEIN  POC,7958
16128-1,HEPATITIS C ANTIBODY,26980
20507-0,RPR (DX) W/REFL TITER AND CONFIRMATORY TESTING,2456
20416-4,HCV RNA,453
20447-9,HIV-1 RNA VIRAL LOAD,334
1968-7,BILIRUBIN  DIRECT,4791
42606-4,HSV 2 IGM SCREEN,226
21570-7,INTERPRETATION,22
10900-9,HEPATITIS B SURFACE ANTIBODY QL,248
12187-1,CREATINE KINASE-MB,49
2888-6,URINE PROTEIN/URINE CREAT RATIO,2176
43180-9,HSV2 IGG INHIBITION ELISA,26
3016-3,TSH  3RD GENERATION,20034
1971-1,BILIRUBIN  INDIRECT,4579
33006-8,CMV DNA  QN PCR,302
13952-7,HEPATITIS B CORE AB TOTAL (REFL),57
5292-8,VDRL  SERUM,109
2889-4,PROT 24HR CALCULATED,662
1920-8,AST (SGOT),826184
13955-0,HEPATITIS C VIRUS,8
4537-7,ERYTHROCYTE SEDIMENTATION RATE,16085
6690-2,WHITE BLOOD CELL COUNT,738421
1971-1,INDIRECT BILIRUBIN  CALCULATED,679
1988-5,C-REACTIVE PROTEIN,50933
5390-0,INTERPRETATION,8
10900-9,HEPATITIS B SURFACE ANTIBODY QL (REFL),31
3016-3,TSH  3RD GENERATION W/REFLEX TO FT4,8536
24113-3,HEPATITIS B CORE ANTIBODY (IGM),1150
40678-5,IGM ELISA,8
11259-9,HCV RNA  QUAL.  TMA,2
16934-2,POLYMERASE MUTATIONS:,7
13457-7,CALCULATED LDL,28647
32286-7,HCV GENOTYPE  LIPA,68
,MRSA (BAL),159
94500-6,COVID 19 RT PCR  NASAL SWAB,121327
58413-6,NUCLEATED RED BLOOD CELLS,79701
5770-3,BILIRUBIN UA,10446
26450-7,EOSINOPHILS RELATIVE PERCENT,78755
5799-2,LEUKOCYTE ESTERASE UA,10464
,CITROBACTER,286
94500-6,COVID 19 ACCULA RNA NAAT,31483
94500-6,COVID 19 RT PCR,24518
25428-4,GLUCOSE UA,10874
5794-3,OCCULT BLOOD,419
41499-5,LEGIONELLA ANTIGEN  URINE,343
704-7,BASOPHILS ABSOLUTE COUNT,206
51584-1,IMMATURE GRANULOCYTES ABSOLUTE,76165
5802-4,NITRITE UA,10446
80677-8,ENTEROTOXIGENIC E. COLI LT/ST GENES (ETEC),565
20405-7,UROBILINOGEN UA,10386
82162-9,CORONAVIRUS NL63,501
2514-8,KETONES UA,10453
80350-2,SHIGELLA SPP/ENTEROINVASIVE E.COLI (EIEC),566
704-7,ABS BASOPHILS,58153
,UNIT RH TYPE,10328
,HUMAN RHINOVIRUS/ENTEROVIRUS,1098
92690-7,ADENOVIRUS F 40/41,566
95209-3,POCT COVID 19 ANTIGEN,2896
76078-5,INFLUENZA A  RNA RT-PCR  QL,443
82206-4,CYCLOSPORA CAYETANENSIS,760
76087-6,PARAINFLUENZA 4,1097
49432-8,PARVOVIRUS B19 DNA QN PCR,45
76085-0,PARAINFLUENZA 2,1098
76078-5,INFLUENZA A,1097
82212-2,ROTAVIRUS A RNA,193
,PAN-ASPERGILLUS,166
,CORONAVIRUS,597
3397-7,COCAINE METABOLITES URINE,653
92687-3,GIARDIA LAMBLIA,565
82197-5,C DIFFICILE TOXIN A/B,192
2106-3,POC PREG QL URINE,1542
38518-7,IMMATURE GRANULOCYTES PERCENT,77831
79385-1,YERSINIA ENTEROCOLITICA,566
,P. AERUGINOSA,335
770-8,NEUTROPHILS,83732
82163-7,CORONAVIRUS 229E,501
92691-5,ASTROVIRUS,565
94500-6,SARS-COV-2 AB  IGG,440
26450-7,ABS EOSINOPHILS,58447
43874-7,RAPID INFLUENZA A ANTIGEN,392
80350-2,SHIGELLA/ENTEROINVASIVE E COLI,192
23860-0,BLOOD UA,10393
742-7,ABS MONOCYTE,58851
,STREPTOCOCCUS,332
77022-2,RSV A,596
731-0,LYMPHOCYTES ABSOLUTE COUNT,82383
,NITRITE  URINE,251
70296-9,CAMPYLOBACTER,566
,HHV-6 QUANT  REAL TIME PCR,100
50941-4,ACID FAST CULTURE,986
3349-8,AMPHETAMINE (CLASS),653
80680-2,VIBRIO CHOLERAE,565
,CULTURE,26383
94505-5,SARS COV 2 AB (IGG) SPIKE  SEMI QN,494
43895-2,RAPID INFLUENZA B AGN,555
18481-2,RAPID STREP A SCREEN,1738
76084-3,PARAINFLUENZA 1,1103
,NDM - CARBAPENEMASE,248
13945-1,RBC URINE,444
79388-5,NOROVIRUS GI/GII,565
2119-6,PREGNANCY  SERUM,921
77023-0,RSV B,599
,INFLUENZA A - H1N1-09 (BAL) TEM-PCR,289
,ENTEROBACTER,285
77028-9,INFLUENZA A H1-2009,601
,E. COLI/SHIGELLA,287
24387-3,BRUCELLA ANTIBODY IGG  EIA,10
,HUMAN METAPNEUMOVIRUS (BAL),280
,STAPHYLOCOCCUS EPIDERMIDIS,336
,QUANTIFERON-TB PLUS 1T,28
80677-8,ENTEROPATHOGENIC E. COLI (EPEC),566
5802-4,NITRITE,162
82198-3,PLESIOMONAS SHIGELLOIDES  DNA,758
,MYCOPLASMA PNEUMONIAE (BAL),160
76080-1,INFLUENZA B  RNA RT-PCR QL,442
,LISTERIA MONOCYTOGENES,50
57901-1,C DIFFICILE GLUTAMATE DEHYDROGENASE,562
80349-4,ENTEROAGGREGATIVE E. COLI (EAEC),566
94500-6,SARS-COV-2  NAA,2848
76086-8,PARAINFLUENZA 3,1099
5802-4,NITRITE  POC,66
,METHICILLIN RESISTANCE,136
,ANTIBODY SCREEN (TUBE METHOD),134
751-8,NEUTROPHILS ABSOLUTE COUNT,82508
,CRYPTOCOCCAL AG LPA,154
15861-8,CLASS  MOUSE URINE PROTEINS (E72) IGE,29
34468-9,CLOSTRIDIUM DIFF TOXIN A/B,562
12347-1,METOLAZONE,1
15766-9,CLASS  HAZELNUT (F17) IGE,4
92689-9,CRYPTOSPORIDIUM,565
,ACINETOBACTER,285
79389-3,ROTAVIRUS A,565
736-9,LYMPHOCYTES,83375
,BORDETELLA PERTUSSIS (PTXP),501
,CANDIDA AURIS RT-PCR,454
76070-2,ADENOVIRUS,1100
,IMP - CARBAPENEMASE,248
76080-1,INFLUENZA B,1100
,K. PNEUMONIAE,287
77028-9,INFLUENZA A H1,598
92723-6,VIBRIO,565
82203-1,E. COLI-SHIGA/TOXIN STX1/STX2 GENES (STEC),567
,STREPTOCOCCUS ANGINOSUS GROUP,282
,PROTEUS,335
14316-4,BENZODIAZEPINE (CLASS),653
17296-5,M TUBERCULOSIS COMPLEX,89
94500-6,SARS-COV-2 IGG,180
80685-1,C. DIFFICILE-TOXIN TCDA/TCDB GENES,565
92577-6,CHLAMYDOPHILA PNEUMONIAE,597
85772-2,ENTEROBACTER CLOACAE COMPLEX,50
,ACINETOBACTER BAUMANNII (BAL),159
23979-8,LYME IGG WB INTERP.,14
,STAPHYLOCOCCUS AUREUS,333
16074-7,CLASS  WALNUT (F256) IGE,4
,INHIBITOR-PT,702
14211-7,HEPATITIS E IGG,6
11483-5,VZV REAL TIME PCR,36
,STREPTOCOCCUS AGALACTIAE,331
,BETA LACTAMASE  CTX-M,249
29904-0,TOXOPLASMA GONDII DNA,111
82164-5,CORONAVIRUS OC43,501
49340-3,ADENOVIRUS DNA  QN PCR,354
77024-8,HUMAN METAPNEUMOVIRUS,1098
2615-3,METHB,7351
,KLEBSIELLA PNEUMONIAE (BAL),159
43305-2,NEISSERIA GONORRHOEAE RNA  TMA,45
92689-9,ENTAMOEBA HISTOLYTICA,566
60489-2,STREPTOCOCCUS PYOGENES  PCR QL,71
5821-4,WBC URINE,8923
19295-5,OPIATES AS CLASS,655
,PARAINFLUENZA (BAL),280
43874-7,RAPID INFLUENZA A AGN,556
82161-1,CORONAVIRUS HKU1,501
2514-8,KETONES,419
3377-9,BARBITURATE CLASS,656
,HUMAN CORONAVIRUS (BAL),280
82191-8,HERPES SIMPLEX VIRUS 2 DNA CSF,57
80349-4,ENTEROAGGREGATIVE E COLI,192
,STREPTOCOCCUS PYOGENES,332
11545-1,ACID FAST SMEAR,972
50559-4,BLOOD  POC,64
94769-7,SARS COV 2 AB  TOTAL SPIKE SEMI QN,51
,KPC - CARBAPENEMASE,248
,ENTEROVIRUS/RHINOVIRUS,281
3282-1,HEXAGONAL PHASE PHOSPHOLIPID,42
,DIFF TYPE,79827
43895-2,RAPID INFLUENZA B ANTIGEN,390
,PANTON-VALENTINE (BAL),159
82207-2,ENTAMOEBA HISTOLYTICA DNA,192
43305-2,GONOCOCCUS BY NAA,128
17284-1,MITOCHONDRIAL AB SCREEN,9
,MYCOPLASMA PNEUMONIAE,1098
,CHLAMYDIA PNEUMONIAE,502
806-0,WBC CSF,397
,STREPTOCOCCUS PNEUMONIAE AG  UR,186
77027-1,INFLUENZA A H3,600
,A.TERREUS,166
711-2,EOSINOPHILS ABSOLUTE COUNT,208
15530-9,CLASS  ALTERNARIA ALTERNATA (M6) IGE,30
,PAN LEGIONELLA (BAL),96
,ADENOVIRUS (BAL),280
82200-7,VIBRIO CHOLERAE+PARAHAEMOLYTICUS+VULNIFICUS DNA,193
,QUANTIFERON(R)-TB GOLD PLUS  4T  INCUBATED,7
,ANTI PLATELET FACTOR 4,144
,ADENOVIRUS QPCR (BAL) 7500,30
82185-0,NEISSERIA MENINGITIDIS DNA CSF,56
92694-9,SAPOVIRUS,566
58791-5,COXSACKIE A9 IGM,11
,STREPTOCOCCUS PNEUMONIAE,333
,INFLUENZA B (BAL) TEM-PCR,289
,GRAM NEGATIVE ENTERIC,50
,NEISSERIA MENINGITIDIS (BAL),164
96302-5,CANDIDA AURIS,50
41499-5,L. PNEUMOPHILA SEROGP 1 UR AG,283
,LISTERIA,281
43304-5,CHLAMYDIA BY NAA,129
,RESULTS,76
32585-2,EBV DNA  QN PCR,422
90827-7,AGNA/SOX1 AB  IFA  CSF,10
94563-4,SARS COV 2 AB IGG,42
11555-0,BASE EXCESS (I-STAT),2186
80348-6,ENTEROPATHOGENIC E COLI  DNA,192
,L. PNEUMOPHILA (BAL),96
16014-3,CLASS  SESAME SEED (F10) IGE,4
25428-4,GLUCOSE URINE  POC,66
32575-3,BARTONELLA HENSELAE IGG,16
,TB1-NIL,30
94500-6,COVID 19 RT PCR  BAL,148
,CMV QUANT REAL-TIME PCR (BAL),56
85773-0,ESCHERICHIA COLI,50
1006-6,DAT IGG,181
31208-2,S. PNEUMONIAE ANTIGENS  URINE,233
82213-0,SAPOVIRUS GENOGROUPS I+II+IV+V RNA,193
15697-6,CLASS  ELM (T8) IGE,29
,PSEUDOMONAS AERUGINOSA (BAL),159
5048-4,ANTINUCLEAR ANTIBODIES  IFA,333
12234-1,MESOTHELIAL  %,99
54067-4,CLOSTRIDIUM DIFFICILE TOXIN B  QL PCR,366
,A. FUMIGATUS,166
,SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2),502
92988-5,BACTEROIDES FRAGILIS,50
,FYA ANTIGEN,4
,HHV6 QPCR (BAL) 6500,21
82211-4,NOROVIRUS GENOGROUP I+II RNA,192
,STREPTOCOCCUS PYOGENES A (BAL),163
,HUMAN BOCAVIRUS (BAL),284
,DIRECT COOMBS,147
,VANCOMYCIN B RESISTANCE,27
2030-5,COHB,9216
13988-1,BETA GLOBULIN  U,8
,STAPHYLOCOCCUS LUGDUNENSIS,331
46217-6,QUANTIFERON TB1 AG VALUE,324
69002-4,HPV RNA  HR E6/E7  TMA,5
82201-5,VIBRIO CHOLERAE DNA,192
82199-1,SALMONELLA SPP,615
,INFLUENZA A - HUMAN (BAL) TEM-PCR,289
15609-1,CLASS  CAT DANDER (E1) IGE,29
,PCA1 (YO) AB  IFA  CSF,10
13951-9,HEPATITIS A AB  TOTAL,17
,RESPIRATORY SYNCYTIAL (BAL) TEM-PCR,289
5005-4,EPSTEIN-BARR VIRUS REAL TIME,75
31204-1,HEPATITIS B CORE IGM ANTIBODY,324
6808-0,A.FUMIGATUS #1 ABS,5
,MUCORALES REAL-TIME PCR (BAL),106
,CHLAMYDOPHILA PNEUMONIAE (BAL),159
92988-5,ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX,51
11282-1,CELLS COUNTED,434
15924-4,CLASS  PENICILLIUM NOTATUM (M1) IGE,30
,MORAXELLA CATARRHALIS (BAL),163
82209-8,ADENOVIRUS F(40+41) DNA,192
96303-3,CRYPTOCOCCUS NEOFORMANS/GATTII,50
94500-6,SARS-COV-2 IGM,404
94563-4,DIASORIN SARS-COV-2 AB  IGG,215
5799-2,LEUKOCYTE EST  POC,97
20405-7,UROBILINOGEN  POC,66
48506-0,IB/IX ANTIBODY,7
82192-6,HERPES VIRUS 6 DNA CSF,56
94564-2,SARS-COV-2 ANTIBODY  IGM,62
82183-5,HAEMOPHILUS INFLUENZAE DNA CSF,56
6412-1,GIARDIA ANTIGEN STOOL,4
,STREPTOCOCCUS PNEUMONIAE (BAL),163
57836-9,BASOPHILS  %,100
,BORDETELLA PERTUSSIS (BAL),159
34645-2,CHLAMYDOPHILA PNEUMONIAE  PCR,152
2106-3,PREGNANCY TEST URINE,209
,VIM - CARBAPENEMASE,248
,NOCARDIA RT PCR (BAL),77
,ENTEROCOCCUS FAECALIS,331
85777-1,SERRATIA MARCESCENS,50
85784-7,CANDIDA PARAPSILOSIS,50
,BORDETELLA PARAPERTUSSIS (IS1001),501
94500-6,COVID 19 RT PCR  OROPHARYNGEAL,13
43399-5,JAK2 V617F MUTATION DETECTION,8
1925-7,BASE EXCESS ARTERIAL,9817
,STAPHYLOCOCCUS,336
31418-7,HETEROPHILE ANTIBODIES,92
29569-1,WEST NILE VIRUS  IGM,18
5799-2,LEUKOCYTE ESTERASE,162
46154-1,TRICH VAG BY NAA,130
,K. OXYTOCA,335
,LEGIONELLA PNEUMOPHILA (BAL),159
13956-8,M. TUBERCULOSIS BY PCR,29
48505-2,IIB/IIIA ANTIBODY,7
12209-3,EOSINOPHILS  %,100
,STAPHYLOCOCCUS AUREUS (BAL),159
,STRONGYLOIDES IGG ANTIBODY,183
85783-9,CANDIDA KRUSEI,50
,PNEUMOCYSTIS JIROVECI CARINI(PCP)QPCR,155
16124-0,CRYPTOCOCCUS ANTIBODIES  QUANT,12
82194-2,ENTEROVIRUS RNA CSF,56
71693-6,IMMATURE PLATELET FRACTION,18237
,BORDETELLA PERTUSSIS PLUS RT PCR PANEL  BAL,48
25835-0,HIV 1 RNA  QL TMA,4
90843-4,PCA2 AB  IFA  CSF,10
82188-4,VARICELLA ZOSTER VIRUS DNA CSF,56
,DAT COMPLEMENT,169
12210-1,EOSINOPHIL  URINE,8
4058-4,TOBRAMYCIN RANDOM,117
,STACLOT LA CLOTTING TIME,54
3281-3,LUPUS RESULT,54
2514-8,KETONES  POC,65
13987-3,ALPHA-2-GLOBULIN  U,8
94762-2,SARS-COV-2 SEMI-QUANT TOTAL AB,101
,OXA 48  CLASS D CARBAPENEMASE,228
82190-0,HERPES SIMPLEX VIRUS 1 DNA CSF,58
13951-9,HEPATITIS A TOTAL ANTIBODY,129
82196-7,CAMPYLOBACTER COLI+JEJUNI+UPSALIENSIS DNA,194
71776-9,QUANTIFERON NIL VALUE,324
15737-0,CLASS  BAHIA GRASS (G17) IGE,29
82210-6,ASTROVIRUS SUBTYPES 1-8 RNA,192
,ENTEROCOCCUS FAECIUM,332
24388-1,BRUCELLA ANTIBODY IGM  EIA,10
15647-1,CLASS  COCKROACH (I6) IGE,29
,ANTINUCLEAR AB IGG BY ELISA,13
,MTBCOMPLEX/RIFAMPIN PCR,55
,SARS-COV-2 SPIKE AB INTERP,72
,SARS-COV-2 SEMI-QUANT IGG AB,35
82193-4,PARECHOVIRUS A RNA CSF,56
80351-0,ENTEROTOXIGENIC E COLI  DNA,192
26954-8,ALLERGEN  ASPERGILLUS FUMIGATUS,8
42254-3,ANA SCREEN,50
,METHEMOGLOBIN  MIXED VENOUS,746
,KELL ANTIGEN,11
,NEISSERIA MENINGITIDIS,50
82184-3,LISTERIA MONOCYTOGENES DNA CSF,56
20563-3,CARBOXYHEMOGLOBIN,27160
15607-5,CLASS  CASHEW NUT (F202) IGE,4
96312-4,STENOTROPHOMONAS MALTOPHILIA,50
16054-9,CLASS  TIMOTHY GRASS (G6) IGE,29
42921-7,JC VIRUS DNA  PCR,10
,FECAL GLOBIN RESULT:,109
85781-3,CANDIDA ALBICANS,50
31208-2,SOURCE,3640
82187-6,STREPTOCOCCUS PNEUMONIAE DNA CSF,56
2106-3,PREGNANCY TEST URINE  POC,52
9425-0,ACETONE BLOOD,147
,LYME (B. BURGDORFERI) PCR,1
,HAEMOPHILUS INFLUENZAE (BAL),163
29257-3,MYCOPLASMA PNEUMONIAE  PCR,152
,RESPIRATORY SYNCYTIAL VIRUS,501
49702-4,"NATEGLINIDE",5
94500-6,COVR  SARS COV 2 RNA,51
15738-8,CLASS  BERMUDA GRASS (G2) IGE,29
82182-7,ESCHERICHIA COLI K1 DNA CSF,56
85785-4,CANDIDA TROPICALIS,50
15549-9,CLASS  ASPERGILLUS FUMIGATUS (M3) IGE,30
82203-1,SHIGA-TOXIN-PRODUCING E COLI,192
85774-8,KLEBSIELLA PNEUMONIAE GROUP,50
,HSV 1 IGM SCREEN,59
5770-3,BILIRUBIN  POC,66
49493-0,INTERPRETATION:,25
62427-0,BORDETELLA HOLMESII,48
,ALLEN TEST  VENOUS,453
10362-2,ENDOMYSIAL IGA ANTIBODY,7
22314-9,HEPATITIS A IGM ANTIBODY,309
6320-6,LYME WESTERN BLOT IGG,12
29723-4,BORDETELLA PARA&PERTUSSIS PCR,48
15680-2,CLASS  DERMATOPHAGOIDES FARINAE (D2) IGE,29
15585-3,CLASS  MAPLE (BOX ELDER) (T1) IGE,29
700-5,PNEUMOCYSTIS SMEAR  DFA,19
30167-1,HPV DNA (HIGH RISK),1
85778-9,HAEMOPHILUS INFLUENZAE,50
32644-7,Q FEVER IGG PHASE I SCREEN,4
,LEUKOCYTE ESTERASE URINE,250
43304-5,CHLAMYDIA TRACHOMATIS RNA  TMA,47
45152-6,ANTI-OJ AB (RDL),13
15615-8,CLASS  MOUNTAIN CEDAR (T6) IGE,29
82186-8,STREPTOCOCCUS AGALACTIAE DNA CSF,56
,URINE POTASSIUM/URINE CREAT RATIO,1365
15642-2,CLASS  CLADOSPORIUM HERBARUM (M2) IGE,30
15872-5,CLASS  NETTLE (W20) IGE,29
5005-4,EBV DNA BY PCR,18
46083-2,INFLUENZA B ANTIGEN,31
788-0,RED CELL DISTRIBUTION WIDTH,95767
23860-0,RBC FLUID,821
704-7,ABSOLUTE BASOPHILS,1125
,INTERPRETATION:,103
23820-4,ALLERGEN  ASPERGILLUS FLAVUS,8
,HAEMOPHILUS INFLUENZAE B (BAL),163
8116-6,ABSOLUTE CD19 COUNT,136
29891-9,RESULT:,12
,VANCOMYCIN A RESISTANCE,27
86221-9,MCR-1,17
547-0,STREP A CULTURE,7
85782-1,CANDIDA GLABRATA,50
96308-2,KLEBSIELLA AEROGENES,50
56888-1,HIV SCREEN 4TH GENERATION WRFX,2762
29567-5,WEST NILE VIRUS  IGM,9
48309-9,BK VIRUS DAN  QN PCR,74
49413-8,JC VIRUS (JCV) QN REAL-TIME PCR  PLASMA,16
,METHEMOGLOBIN  VENOUS,498
,PCA TR (DNER) AB  IFA,13
10894-4,ALLERGEN  ASPERGILLUS NIGER,8
40469-9,HYDROFLUMETHIAZIDE,2
59579-3,COXSACKIE A24 IGM,11
,A-A GRADIENT,9781
10539-5,GLIPIZIDE,14
,INHIBITOR-APTT,40
,AGNA/SOX1 AB  IFA,13
15936-8,CLASS  ROUGH PIGWEED (W14) IGE,29
59581-9,COXSACKIE A7 IGM,11
46217-6,QUANTIFERON TB2 AG VALUE,325
711-2,ABSOLUTE EOSINOPHILS,1127
5372-8,STRIATION ABS SERUM,4
,MOG AB CBA  SERUM,25
713-8,EOSINOPHILS,1123
19075-1,NUMBER OF CELLS CSF,58
13931-1,STRIATED MUSCLE AB W/REF TITER,14
82181-9,CRYPTOCOCCUS GATTII NEOFORMANS DNA CSF,56
,E ANTIGEN,14
,AMPHIPHYSIN AB  IFA,13
43304-5,CHLAMYDIA TRACHOMATIS  NAA,5
49738-8,HU AB  IFA  SERUM,3
,TOXOPLASMA GONDII QN RT PCR  BAL,37
,GLYCOPROTEIN IV ANTIBODY,7
49738-8,ANTI-HU ANTIBODIES*,10
38542-7,REPAGLINIDE,5
,PCA2 AB  IFA,13
15527-5,CLASS  ALMOND (F20) IGE,4
26019-0,MACRO TYPE 1,10
,HSV 1,25
62460-1,C. ALBICANS  DNA,2
,INFECTIOUS MONO,33
15388-2,MYCOPLASMA HOMINIS,6
,CARBOXYHEMOGLOBIN  VENOUS,529
29497-5,PLATELET AB DIRECT (IGG),5
13989-9,GAMMA GLOBULIN  U,9
,AQUAPORIN 4 AB  IFA  CSF,10
,ANTI-SRP AB (RDL),13
57458-2,NEISSERIA GONORRHOEAE  NAA,5
49395-7,HHV-7 QPCR (BAL) 7000,19
14196-0,RETICULOCYTE ABSOLUTE COUNT,810
15685-1,CLASS  DOG DANDER (E5) IGE,29
14241-4,PARIETAL CELL AB SCREEN,2
6733-0,ALLERGEN  PIGEON SERUM,2
6025-1,ALLERGEN  ASPERGILLUS FUMIGATUS IGG4,2
16006-9,CLASS  SALMON (F41) IGE,4
2112-1,HCG  QL  URINE,1
,TB2-NIL,29
32576-1,BARTONELLA HENSELAE IGM,16
44768-0,ANNA1 (HU) AB  IFA  CSF,10
15904-6,CLASS  PARROT/PARAKEET DROPPINGS (E77) IGE,1
,PCA1 (YO) AB  IFA,13
,GAD65 AB  IFA  CSF,10
9361-7,B. QUINTANA IGM,16
,SARS-COV-2 NEUT AB,46
15048-2,CK-BB,27
,HGB C,22
14212-5,HEPATITIS E IGM,13
17780-8,H PYLORI ANTIGEN STOOL,21
5393-4,FTA ABS,6
,ANTI-PL-12 AB (RDL),13
,CRMP5/CV2 AB  IFA  CSF,10
,HSV 2,25
5781-0,CRYSTALS  SYNOVIAL FLUID,26
,AQUAPORIN 4 AB (IGG)  CBA,33
50559-4,BLOOD URINE  POC,65
33772-5,ANTI-PL-7 AB (RDL),13
32577-9,BARTONELLA QUINTANA IGG,16
33358-3,MONOCLONAL SPIKE,63
16016-8,CLASS  SHEEP SORREL (W18) IGE,29
,ANTI-KU AB (RDL),13
30178-8,WEST NILE VIRUS  IGG,18
90815-2,AMPHIPHYSIN AB  IFA  CSF,11
34265-9,CHLORIDE/CREAT RATIO,1324
,TOTAL CALCIUM SCORE,11
47938-6,SOURCE FLUID,795
15894-9,CLASS  ORANGE (F33) IGE,1
18485-3,ANTI-MI-2 AB (RDL),13
59580-1,COXSACKIE A16 IGM,11
,CHLAMYDIA TRACHOMATIS  NAA,5
34720-3,CMV DNA  QN REAL TIME PCR,9
29566-7,WEST NILE VIRUS  IGG,9
40982-1,INFLUENZA B RNA  PCR,1
14094-7,TRYPANOSOMA CRUZI IGG ANTIBODY,8
,TOXOPLASMA QPCR (WHBLD),8
94762-2,SARS-COV-2 ANTIBODIES,9
30361-0,HIV 2 AB,25
26020-8,MACRO TYPE 2,10
11483-5,VARICELLA ZOSTER DNA PCR,13
29901-6,HTLV I/II ANTIBODIES,12
11075-9,NORFENTANYL,22
15650-5,CLASS  CODFISH (F3) IGE,4
,JKA ANTIGEN,6
,EBV DNA PCR (CSF),30
41480-5,BK VIRUS DNA  QN REAL TIME PCR  URINE,33
5876-8,RSV AG  EIA,3
38379-4,MTB COMPLEX,9
46082-4,INFLUENZA A ANTIGEN,30
,BASE EXCESS  VENOUS,544
59263-4,HPV16 DNA  INVADER(R),1
29893-5,HIV 1 AB,25
,RH FACTOR,2
22112-7,BLASTOMYCES ABS  QN  DID,13
,OXA-48-LIKE - CARBAPENEMASE,19
5000-5,CMV PCR,14
48501-1,HLA CLASS 1 ANTIBODY,7
,PRESSURE SUPPORT,1407
8061-4,ANA DIRECT,17
5041-9,ADENOVIRUS GROUP AB  QN,2
5859-4,HSV CULTURE WITHOUT TYPING,15
,ELUTION,28
10366-3,COTININE,4
21751-3,TCRB RESULT,1
72495-5,C. PARAPSILOSIS  DNA,2
,M ANTIGEN,5
15581-2,CLASS  BLOMIA TROPICALIS (D201) IGE,29
14836-1,METHOTREXATE LEVEL,267
5022-9,M AVIUM COMPLEX,37
23985-5,LYME IGM WB INTERP.,14
,ANNA2 (RI) AB  IFA,13
,ANTI-TSH AUTOANTIBODY,5
6320-6,LYME DISEASE AB (IGG) WB,2
84924-0,ANTI-YO ANTIBODIES,7
4061-8,TOLBUTAMIDE,14
17852-5,UREAPLASMA UREALYTICUM,6
15014-4,INTESTINAL FRAC.:,9
30073-1,VGCC ANTIBODY,6
44357-2,ASPERGILLUS ANTIGEN,5
62261-3,VANA/B,5
43225-2,TOXOCARA AB (IGG)  SERUM,10
,ANNA3 AB  IFA,13
15975-6,CLASS  COMMON RAGWEED (SHORT) (W1) IGE,29
,CALR EXON 9 MUTATION,1
,PARVOVIRUS B19 QPCR  (BAL) 1500,2
12209-3,PRODUCT EOSINOPHILS PERCENT,8
,CRYPTOCOCCAL AG SOURCE,157
,HTLV 2,4
8061-4,ANACHOICE(TM) SCREEN,8
42482-0,M-SPIKE  MG/24 HR,8
12209-3,EOSINOPHILS FLUID,72
,HTLV 1,4
45149-2,ANTI-EJ AB (RDL),13
3377-9,BARBITURATES  URINE,2
,PEEP,4390
,MOG AB CBA  CSF,12
2110-5,HCG  TOTAL  QL,10
57289-1,N. GONORRHOEAE  NAA  PHARYN,13
6321-4,LYME WESTERN BLOT IGM,12
,N ANTIGEN,3
15599-4,CLASS  CANDIDA ALBICANS (M5) IGE,1
27007-4,ACETOHEXAMIDE,5
23826-1,B.PERTUSSIS DNA,2
49545-7,JC VIRUS PCR (CSF),23
34487-9,INFLUENZA A RNA,2
34468-9,C DIFFICILE TOXINS A+B  EIA,4
,RESULT  CLASS I,4
5213-4,HETEROPHILE  MONO SCREEN,4
13317-3,MRSA SCREENING CULTURE,1
14277-8,C ANCA TITER,9
43187-4,ANTI-RI ANTIBODIES,7
6457-6,DNA AB (DS) CRITHIDIA IFA,9
49963-2,ANTI-U3 RNP (FIBRILLARIN)(RDL),13
50008-2,DRVVT MIX INTERPRETATION:,6
,CRMP5/CV2 AB  IFA,13
15917-8,CLASS  PEANUT (F13) IGE,4
,CARBOXYHEMOGLOBIN  MIXED VENOUS,815
56959-0,ANNA2 (RI) AB  IFA  CSF,10
6818-9,ALLERGEN  MICROPOLYSPORA FAENI,2
9629-7,TOLAZAMIDE,14
2955-3,URINE SODIUM/URINE CREATININE RATIO,1297
,ANNA3 AB  IFA  CSF,10
4057-6,TOBRAMYCIN PEAK,43
3391-0,COCAINE,2
15875-8,CLASS  OAK (T7) IGE,29
43305-2,NEISSERIA GONORRHOEAE  NAA,5
96309-0,MECA/C MREJ (MRSA),3
21262-1,E COLI SHIGA TOXIN ASSAY,1
48065-7,D-DIMER,3017
15862-6,CLASS  MUCOR RACEMOSUS (M4) IGE,1
59582-7,COXSACKIE A24 IGG,11
26466-3,WBC FLUID,825
32623-1,MEAN PLATELET VOLUME,95835
,FREE KAPPA/LAMBDA RATIO,130
90845-9,PCA TR (DNER) AB  IFA CSF,10
,GIARDIA LAMBLIA IGA,6
6321-4,LYME DISEASE AB (IGM) WB,2
,LEPTOSPIRA DNA  QL,3
27417-5,CANDIDA ANTIBODIES IGA,3
33516-6,IMMATURE RETIC FRACT,805
,JK(B) AG TYPE,5
,RESULT  LUMINEX SCREEN CLASS II,2
10540-3,GLYBURIDE,13
69573-4,C5 1,2
19141-1,PROPOXYPHENE  URINE,2
27170-0,TOLBUTAMIDE  UR,1
15755-2,CLASS,2
15846-9,CLASS  MILK (F2) IGE,4
3474-4,CHLORPROPAMIDE,14
15682-8,CLASS  D. PTERONYSSINUS (D1) IGE,29
13931-1,STRIATED MUSCLE AB TITER,4
5769-5,BACTERIA,8944
43305-2,NEISSERIA GONORRHOEAE RNA  TMA  RECTAL,1
,LITTLE C ANTIGEN,6
68549-5,ANTI-U2 RNP AB (RDL),14
57836-9,PRODUCT BASOPHILS PERCENT,7
6821-3,THERMOACTINOMYCES VULGARIS IGG,5
4576-5,HGB F,34
43304-5,CHLAMYDIA TRACHOMATIS RNA  TMA  THROAT,13
82204-9,E COLI O157,193
,HHV-8 QUANT REAL-TIME PCR,4
,LITTLE E ANTIGEN,4
5052-6,ASPERGILLUS AB,2
,PRESSURE SUPPORT  VENOUS,126
17123-1,% CD19,138
,FRANCISELLA TULARENSIS IGG,2
,RESULT  POST TX LUMINEX SAB CLASS II,2
,MECA/C,6
34892-0,NGI WEST NILE VIRUS RT PCR,3
69563-5,C. GLABRATA  DNA,2
,BASE EXCESS  MIXED VENOUS,817
,ANNA1 (HU) AB  IFA,13
13984-0,ALPHA-1-GLOBULIN  U,8
43305-2,NEISSERIA GONORRHOEAE RNA  TMA  THROAT,13
,CMV QUANT REAL-TIME PCR (CSF),5
42484-6,M-SPIKE  %,9
16065-5,CLASS  TUNA (F40) IGE,4
6821-3,ALLERGEN  T. VULGARIS,2
3435-5,MARIJUANA METABOLITE,6
19261-7,AMPHETAMINES  URINE,2
42254-3,ANA SCREEN (IFA),2
31314-8,Q FEVER IGG PHASE II SCREEN,4
59584-3,COXSACKIE A7 IGG,11
2613-8,METHEMOGLOBIN,108
57391-5,EOSINOPHILS  %,1
58714-7,OXIDANT,2
17849-1,RETICULOCYTE COUNT PCT,809
3676-4,HYDROCHLOROTHIAZIDE,1
41476-3,ROCKY MOUNTAIN SPOTTED FEVER IGG ANTIBODY,5
3660-8,FUROSEMIDE,1
40414-5,BENZODIAZEPINES,2
52756-4,DRVVT CONFIRM,12
5213-4,MONO QUAL W/RFLX QN,2
46154-1,TRICHOMONAS VAGINALIS RNA QUALITATIVE TMA,2
32645-4,Q FEVER IGM PHASE I SCREEN,4
16018-4,CLASS  SHRIMP (F24) IGE,4
,CLASS II AB SCREEN,1
73690-0,"NATEGLINIDE  UR",1
94562-6,SARS-COV-2 ANTIBODY  IGA,4
47084-9,IA/IIA ANTIBODY,7
,ENTEROVIRUS QPCR,3
,BETA-2 TRANSFERRIN,3
5213-4,HETEROPHILE  MONO SCREEN (REFL),1
70173-0,JCV ANTIBODY,6
5213-4,MONONUCLEOSIS TEST  QUAL,2
,DRB4*-2 EQUIVALENT,7
,INTERPRETATION,392
,DRB4*-1 EQUIVALENT,6
8117-4,CD19 B CELL,16
24475-6,PROTHROMBIN GENE ANALYSIS,2
15568-9,CLASS  SOYBEAN (F14) IGE,4
5106-0,COXSACKIE B2 ANTIBODY,3
11584-0,A. PULLULANS ABS,5
17813-7,ALPHA-2-GLOBULINS,1
47251-4,BK VIRUS DNA  PCR,2
31315-5,Q FEVER IGM PHASE II SCREEN,4
3284-7,PLATELET NEUTRALIZATION,1
69002-4,HPV MRNA E6/E7  SUREPATH VIAL,1
13971-7,HISTOPLASMA ANTIGEN,147
,RATE,3724
3399-3,BENZTHIAZIDE,1
95425-5,COVID-19 NAA  SALIVA,6
27166-8,TOLAZAMIDE  UR,1
13048-4,SEZARY CELLS,11
57288-3,C. TRACHOMATIS  NAA  PHARYN,13
16085-3,CLASS  WHEAT (F4) IGE,4
49580-4,RAPID HIV 1 AND 2,68
,FYB ANTIGEN,3
,CSF3R EXON 14/17 MUTATION,1
,BLASTOMYCES ANTIBODY BY I.D.,2
8116-6,CD19 ABSOLUTE,16
29893-5,HIV-1 ANTIBODY,1
13248-0,HEPATITIS DELTA ANTIBODY,3
40465-7,GLIMEPIRIDE,5
73689-2,REPAGLINIDE  UR,1
5633-3,COPPER 24 HOUR URINE,2
,HCG,13
7172-0,CANDIDA ANTIBODIES IGG,3
5880-0,ROTAVIRUS ANTIGEN,3
6733-0,PIGEON SERUM ABS,5
73895-5,RETIC (HGB),804
72493-0,CMV QUANT DNA PCR (PLASMA),3
40978-9,HUMAN METAPNEUMOVIRUS RNA,1
5803-2,PH UA,11093
58792-3,COXSACKIE A9 IGG,11
12967-6,UREA NITROGEN 24 HOUR URINE,100
32014-3,EOSINOPHIL URINE,6
2161-8,POC CREATININE URINE,1
5110-2,COXSACKIE B4 ANTIBODY,3
,ADENO QPCR  CSF,1
22070-7,RESULT,5
40990-4,RHINOVIRUS RNA  REAL TIME PCR,1
32032-5,ANTIPHOSPHATIDYLSERINE IGG,1
10894-4,ASPERGILLUS NIGER AB,1
29901-6,HTLV-I-II ABS  (EIA),5
59264-2,HPV18 DNA  INVADER(R),1
33930-9,HEXAGONAL PHASE CONFIRM,3
13990-7,ALPHA-1-GLOBULIN  U,1
,MEGASPHAERA SPECIES,42
33559-6,KAPPA/LAMBDA RATIO U,6
5645-7,ETHANOL  URINE,1
5108-6,COXSACKIE B3 ANTIBODY,3
,HDV QRT-PCR (SERUM),2
27025-6,GLIPIZIDE  UR,1
23820-4,ASPERGILLUS FLAVUS,1
21561-6,THERMOACT. SACCHARII,5
,JAK2 V617F MUTATION,1
,S ANTIGEN,4
15689-3,CLASS  EGG WHITE (F1) IGE,4
6432-9,HTLV-I IB,2
,C ANTIGEN,5
,T PALLIDUM ANTIBODY  EIA,1
6371-9,CRYPTOSPORIDIUM AG  EIA,4
46216-8,QUANTIFERON MITOGEN VALUE,324
72391-6,C. TROPICALIS  DNA,2
,CLASS 1 AB SCREEN,1
27391-2,CANDIDA ANTIBODIES IGM,3
6825-4,CRYSTALS  FLUID,11
3409-0,BUMETANIDE,1
4546-8,HEMOGLOBIN A,2
5112-8,COXSACKIE B5 ANTIBODY,3
,AQUAPORIN 4 AB  CBA  SERUM,2
6818-9,MICROPOLYSPORA FAENI IGG,5
3349-8,AMPHETAMINES SCREEN  URINE,2
27164-3,ACETOHEXAMIDE  UR,1
5274-6,PARVOVIRUS B19 IGM ANTIBODY,10
59583-5,COXSACKIE A16 IGG,11
,CSF DIFF TYPE,223
16011-9,CLASS  SCALLOP (F338) IGE,4
69565-0,ATOPOBIUM VAGINAE,4
23821-2,ASPERGILLUS FUMIGATUS AB,1
17815-2,BETA GLOBULIN  U,1
,LEISHMANIA IGG,1
,PEEP  MIXED VENOUS,332
3396-9,COCAINE,1
43225-2,TOXOCARA ANTIBODY  ELISA (SERUM),1
588-4,LEGIONELLA PNEUMOPHILA DFA,1
6349-5,CHLAMYDIA TRACHOMATIS CULT,3
21089-8,BABESIA MICROTI  PCR,1
73691-8,GLIMEPIRIDE  UR,1
40988-8,RSV RNA  QUALITATIVE PCR,1
12396-8,CHLORPROPAMIDE  UR,1
26656-9,HTLV-II IB,2
,ENTEROVIRUS QN REAL-TIME RT-PCR  CSF,2
5811-5,SPECIFIC GRAVITY UA,10752
3637-6,FENTANYL,15
21823-0,P190 BCR ABL1,1
60260-7,CHIKUNGUNYA VIRUS RNA  QL REAL TIME PCR,1
21822-2,P210 BCR ABL1,1
17817-8,GAMMA GLOBULINS,1
3282-1,HEXAGONAL PHOSPHOLIPID NEUTRALIZAT TEST,1
31208-2,SITE,7221
10894-4,ASPERGILLUS NIGER ANTIBODIES,1
40412-9,BARBITURATES,2
5114-4,COXSACKIE B6 ANTIBODY,3
2334-1,GASTROCULT,1
17815-2,BETA GLOBULINS,1
19550-3,METHADONE SCREEN  URINE,2
78016-3,DRB4* 2 EQUIVALENT,6
41010-0,PARAINFLUENZA 4 RNA,1
26971-2,SMOOTH MUSCLE AB SCREEN,1
5095-5,COCCIDIODES AB,1
,HHV-6 QUANT DNA PCR,1
21753-9,TCRG RESULT,1
9522-4,ENTAMOEBA HISTOLYTICA IGG.,1
32033-3,ANTIPHOSPHATIDYLSERINE IGM,1
5803-2,PH  POC,66
15174-6,CRYOGLOBULIN %,2
3478-5,CHLORTHALIDONE,1
789-8,RED BLOOD CELL COUNT,98233
9593-5,41 KD (IGG) BAND,2
57287-5,CHLAMYDIA TRACHOMATIS RNA  TMA  RECTAL,1
,FRANCISELLA TULARENSIS IGM,2
,GRAM NEGATIVE ID,288
29891-9,H PYLORI BREATH TEST,1
17813-7,ALPHA-2-GLOBULIN  U,1
30226-5,FDP,39
15729-7,CLASS  GLUTEN (F79) IGE,1
17811-1,ALPHA-1-GLOBULINS,1
27226-0,COCAETHYLENE,1
42181-8,MYOCARDIAL AB  IF,1
27175-9,GLYBURIDE  UR,1
5104-5,COXSACKIE B1 ANTIBODY,3
25397-1,ECHINOCOCCUS ANTIBODY,1
32998-7,T-TRANSGLUTAMINASE (TTG) IGG,10
39528-5,ADENOVIRUS DNA  QL PCR,1
,ALLEN TEST  MIXED VENOUS,689
,PERCENT POSITIVE  POST TX LUMINEX SAB CLASS II,2
94500-6,"COVID-19 PCR,TMH",23120
,Nucleated RBCs/100 WBCs,9061
706-2,Automated Count Percent Basophils,35689
713-8,Automated Count Percent Eosinophils,35681
704-7,Absolute Count Basophils,36628
711-2,Absolute Count Eosinophils,37041
5866-9,Influenza B Antigen,2997
5862-8,Influenza A Antigen,2997
94500-6,"COVID-19 PCR, Referred to FSU",477
30405-5,"Leukocytes, UR",25372
32710-6,"Nitrite, UR",25374
2887-8,"Protein, UR",25365
1977-8,"Bilirubin, UR",25370
33903-6,"Ketones, UR",25366
5794-3,"Blood, UR",25369
25428-4,"Glucose, UR",25372
713-8,Eosinophil,2252
26477-0,Atypical Lymphocyte,1142
706-2,Basophil,1686
3879-4,"Opiates, UR",5357
18282-4,"Cannabinoids, UR",5349
53743-1,"Cocaine Metabolites, UR",5356
14267-9,"Ecstasy, UR",5319
10998-3,"Oxycodone, UR",5347
3349-8,"Amphetamines, UR",5351
3377-9,"Barbituates, UR",5351
3390-2,"Benzodiazepines, UR",5351
2106-3,Pregnancy Test - Urine,7721
94558-4,"COVID-19, POC Rapid Antigen-ED ONLY",951
14869-2,MB Interpretation,2080
24113-3,Hepatitis B Core M Antibody,590
48159-8,Hepatitis C Antibody,822
5905-5,Manual Count Monocyte,4396
742-7,Absolute Count Monocytes,38788
13950-1,"Hepatitis A Antibody, IgM",485
5196-1,Hep B Surface Antigen,1219
94309-2,"COVID-19, NAA",562
56888-1,HIV ANTIGEN/ANTIBODY COMBO,634
2110-5,Beta Hcg Qual,143
,"Chlamydia DNA Probe, Referred",87
,"GC DNA Probe, Referred",87
2335-8,"Occult Blood, Feces",374
,"Cryptosporidium Ag, Feces",31
6412-1,"Giardia Ag, Feces",103
71773-6,Quantiferon TB Gold Plus,26
71776-9,Quantiferon NIL Value,26
46217-6,Quantiferon TB1 AG Value,27
46217-6,Quantiferon TB2 AG Value,26
13951-9,"Hep A Ab, Total",19
13952-7,Hep B Core-Total AB,64
13950-1,"Hep A Ab, IGM",19
711-2,EOS ABSOLUTE,87
704-7,BASO ABSOLUTE,87
51584-1,IMMATURE GRANS (ABS),82
23820-4,Aspergillus Flavus Antibody,6
23821-2,Aspergillus Fumigatus Antibody,6
10894-4,Aspergillus Niger Antibody,6
5048-4,ANA Direct,46
8061-4,"ANA Screen, Indirect IFA",125
11555-0,"Base Excess, ISTAT POC",4121
12179-8,Fluid Basophils,518
26452-3,Fluid Eosinophils,516
42483-8,"M-Spike,%",4
50564-4,"Leukocytes, UR",104
50564-4,"Nitrite, UR",102
50564-4,"Protein, UR",111
50564-4,"Bilirubin, UR",106
50564-4,"Ketones, UR",110
50564-4,"Blood, UR",107
50564-4,"Glucose, UR",104
2640-1,"Myoglobin Screen, UR",26
30230-7,Fluid Segs,519
736-9,Automated Count Percent Lymphocytes,35672
8251-1,RESP.Data. LPM,895
,"COVID-19 PCR, Referred to FSU",405
24356-8,"Bilirubin, UR",52
24356-8,"Blood, UR",52
24356-8,"Glucose, UR",52
24356-8,"Leukocytes, UR",52
24356-8,"Nitrite, UR",52
24356-8,"Protein, UR",52
2334-1,Gastroccult Occult Blood,15
48054-1,ISTAT ACT,728
26446-5,Blast,55
13927-9,Islet Cell Antibody,13
58077-9,"Bilirubin, UR",13
58077-9,"Blood, UR",13
58077-9,"Ketones, UR",13
58077-9,"Leukocytes, UR",13
58077-9,"Nitrite, UR",13
58077-9,"Protein, UR",13
5568-1,Acetone - Serum,397
5905-5,Automated Count Percent Monocytes,35679
5193-8,Hep B Antibody (Anti-HBs),240
56598-6,Mononucleosis Screen,258
58410-2,Nucleated RBC,2245
58413-6,Nucleated RBC,85568
94500-6,"""""COVID-19 PCR,TMH""""""""""""""""""""",704
69739-1,"Cannabinoids, UR",14
30039-2,Anaplasma Phagocytophilium PCR,10
48850-2,"Ehrlichia chaffeensis Ab, IgM",9
23877-4,"Human Granulocytic Ehrlichiosis Ab, IgG",9
23878-2,"Human Granulocytic Ehrlichiosis Ab, IgM",9
27994-3,Ehrlichia Chaffeensis PCR,10
47405-6,"Ehrlichia chaffeensis Ab, IgG",9
5876-8,RSV,28
3270-6,Anti Xa Activity Level,732
26464-8,"WBC, BF",380
41499-5,Legionella Urine Antigen,108
789-8,"RBC, BF",386
31788-3,Cryptococcal AG CSF,57
13519-4,"Basophils, CSF",43
12208-5,"Eosinophils, CSF",59
25428-4,"""""Glucose, UR""""""""""""""""""""",3309
30405-5,"""""Leukocytes, UR""""""""""""""""""""",3307
2887-8,"""""Protein, UR""""""""""""""""""""",3300
32710-6,"""""Nitrite, UR""""""""""""""""""""",3297
5794-3,"""""Blood, UR""""""""""""""""""""",3300
1977-8,"""""Bilirubin, UR""""""""""""""""""""",3306
33903-6,"""""Ketones, UR""""""""""""""""""""",3302
50564-4,"""""Glucose, UR""""""""""""""""""""",36
50564-4,"""""Ketones, UR""""""""""""""""""""",43
50564-4,"""""Nitrite, UR""""""""""""""""""""",47
53743-1,"""""Cocaine Metabolites, UR""""""""""""""""""""",715
3349-8,"""""Amphetamines, UR""""""""""""""""""""",715
3377-9,"""""Barbituates, UR""""""""""""""""""""",715
3390-2,"""""Benzodiazepines, UR""""""""""""""""""""",715
18282-4,"""""Cannabinoids, UR""""""""""""""""""""",715
14267-9,"""""Ecstasy, UR""""""""""""""""""""",715
3879-4,"""""Opiates, UR""""""""""""""""""""",715
10998-3,"""""Oxycodone, UR""""""""""""""""""""",715
13950-1,"""""Hepatitis A Antibody, IgM""""""""""""""""""""",40
69739-1,"Barbituates, UR",12
69739-1,"Oxycodone, UR",16
1971-1,"Bilirubin Indirect, HFPA",558
17780-8,"H. pylori Stool Ag, EIA",15
34556-1,"RBC, BF",193
57803-9,"Cryptosporidium Ag, Feces",26
57803-9,"Giardia Ag, Feces",4
13969-1,MB Interpretation,37
13503-8,"Lyme IgM AB, Western Blot Interp.",2
13502-0,"Lyme IgG AB, Western Blot Interp.",2
69739-1,"Amphetamines, UR",12
69739-1,"Benzodiazepines, UR",12
29580-8,Fluid Basophils,7
29580-8,Fluid Eosinophils,9
3282-1,Hexagonal Phospholipid Neutral,10
32032-5,Antiphosphatidylserine IgG,10
32033-3,Antiphosphatidylserine IgM,10
2615-3,Methemoglobin,1634
48067-3,D-Dimer,3947
38518-7,IMMATURE GRANULOCYTES,82
11555-0,Base Excess,1640
2335-8,"""""Occult Blood, Feces""""""""""""""""""""",46
8061-4,ANA Screen,18
12202-8,"Cryoglobulin, 48 Hour Reading",9
5117-7,"Cryoglobulin, Final",9
4991-6,Borrelia Burgdorferi PCR,12
8251-1,"RESP.Data, FIO2",1933
29566-7,"West Nile Virus Ab, IGG",4
29567-5,"West Nile Virus Ab, IGM",4
1927-3,"Base Excess, VBG",225
26498-6,Myelocyte,283
58077-9,"Glucose, UR",13
736-9,Manual Count Lymphocyte,4485
789-8,"""""RBC, BF""""""""""""""""""""",28
26490-3,Fluid Monos,519
11555-0,"""""Base Excess, ISTAT POC""""""""""""""""""""",90
708-8,Absolute Count Blasts,35
5229-0,Influenza Type A Antibodies,6
5230-8,Influenza Type B Antibodies,6
17780-8,"""""H. pylori Stool Ag, EIA""""""""""""""""""""",1
11031-2,Fluid Lymphs,519
31790-9,Cryptococcal AG Serum,9
26499-4,Absolute Count Neutrophils,38676
24356-8,"Ketones, UR",52
26499-4,Absolute Neutrophil Count,236
26492-9,"Monocytes, CSF",38
14107-7,"Segs, CSF",38
11259-9,"HCV RNA, PCR, Qualitative",13
57803-9,"""""Cryptosporidium Ag, Feces""""""""""""""""""""",2
6412-1,"""""Giardia Ag, Feces""""""""""""""""""""",14
10328-3,"Lymphs, CSF",38
69739-1,"Cocaine Metabolites, UR",8
41459-9,"COVID-19 PCR, Referred to FSU",42
41459-9,"COVID-19, POC Rapid Antigen-ED ONLY",376
49580-4,HIV1/HIV2 ANTIBODY,9
94500-6,"COVID-19, NAA",52
789-8,"RBC, CSF",139
26508-2,Manual Count Band Neutrophil,2709
740-1,Metamyelocyte,444
,"COVID-19, POC Rapid Antigen-ED ONLY",2749
13457-7,Cholesterol LDL,50546
34556-1,"WBC, BF",195
26465-5,"WBC, CSF",136
8061-4,ANA Direct,2
7905-3,Hep B Surface AG Confirmation,2
,RESP.Data. RR,2016
8251-1,"RESP.Data, SPON TIDAL VOLUME",662
8251-1,"RESP.Data, SPON RR",742
731-0,Absolute Count Lymphocytes,38853
6825-4,"Crystals, BF",42
2640-1,"""""Myoglobin Screen, UR""""""""""""""""""""",1
41479-7,"BK Virus DNA, Quantitative PCR",3
69739-1,"Ecstasy, UR",9
69739-1,"Opiates, UR",6
48850-2,"""""Ehrlichia chaffeensis Ab, IgM""""""""""""""""""""",1
23877-4,"""""Human Granulocytic Ehrlichiosis Ab, IgG""""""""""""""""""""",1
23878-2,"""""Human Granulocytic Ehrlichiosis Ab, IgM""""""""""""""""""""",1
47405-6,"""""Ehrlichia chaffeensis Ab, IgG""""""""""""""""""""",1
94309-2,"""""COVID-19, NAA""""""""""""""""""""",210
24321-2,Anion Gap,319
3282-1,Lupus Anticoag. - HEX PHOSPHOLIPID,1
,"""""Cryptosporidium Ag, Feces""""""""""""""""""""",12
8061-4,"""""ANA Screen, Indirect IFA""""""""""""""""""""",12
770-8,Automated Count Percent Neutrophils,35684
769-0,Manual Count Segmented Neutrophil,4509
15014-4,"Fractionated Alkaline Phos., Intestinal",7
30466-7,Promonocytes,15
24336-0,Carboxyhemoglobin (Carbon Monoxide),31
2030-5,Carboxyhemoglobin (Carbon Monoxide),1645
41487-0,"Cryptosporidium Ag, Feces",50
6864-3,Sickle Cell Screen,1
10362-2,Endomysial Antibody IgA,1
11259-9,"""""HCV RNA, PCR, Qualitative""""""""""""""""""""",2
783-1,Promyelocyte,81
2335-8,ER POC OB,639
32764-3,Wet Prep - Clue Cells,232
26019-0,CK Isoenzyms Macro Type 1,1
26020-8,"CK Isoenzymes, Macro Type 2",1
94507-1,COVID-19 IGM AB,4
24325-3,Bilirubin Direct,106
9360-9,B. Quintana IgG Screen (Cat Scratch Ab),1
9361-7,B. Quintana IgM Screen (Cat Scratch Ab),1
9571-1,Parvovirus B19 PCR,2
18310-3,HGB VARIANT,2
13989-9,"Gamma Globulin,UR",4
13990-7,"Alpha-1-Globulin, UR",4
13987-3,"Alpha-2-Globulin,UR",4
13988-1,"Beta Globulin,UR",4
5196-1,Hep B Surface AG,10
21198-7,"Beta Hcg, Quant",879
2518-9,"Lactate, ISTAT POC",1567
24336-0,Methemoglobin,25
4537-7,Westergren Sed Rate,3210
5106-0,"Coxsackie B-2, AB",4
5104-5,"Coxsackie B-1, AB",4
5108-6,"Coxsackie B-3, AB",4
5110-2,"Coxsackie B-4, AB",4
5112-8,"Coxsackie B-5, AB",4
5114-4,"Coxsackie B-6, AB",4
50564-4,"""""Bilirubin, UR""""""""""""""""""""",38
50564-4,"""""Blood, UR""""""""""""""""""""",44
50564-4,"""""Leukocytes, UR""""""""""""""""""""",39
,"Macroscopic Comment, UR",18128
50564-4,"""""Protein, UR""""""""""""""""""""",44
48054-1,"Activated Clotting Time, High Range",303
5274-6,Parvovirus B19 IgM,6
12208-5,"""""Eosinophils, CSF""""""""""""""""""""",3
13519-4,"""""Basophils, CSF""""""""""""""""""""",3
24356-8,"""""Bilirubin, UR""""""""""""""""""""",2
24356-8,"""""Ketones, UR""""""""""""""""""""",1
24356-8,"""""Nitrite, UR""""""""""""""""""""",2
24356-8,"""""Protein, UR""""""""""""""""""""",2
24356-8,"""""Glucose, UR""""""""""""""""""""",1
12202-8,"""""Cryoglobulin, 48 Hour Reading""""""""""""""""""""",1
5117-7,"""""Cryoglobulin, Final""""""""""""""""""""",1
58077-9,"""""Bilirubin, UR""""""""""""""""""""",2
58077-9,"""""Blood, UR""""""""""""""""""""",2
58077-9,"""""Glucose, UR""""""""""""""""""""",2
58077-9,"""""Ketones, UR""""""""""""""""""""",2
58077-9,"""""Nitrite, UR""""""""""""""""""""",2
58077-9,"""""Protein, UR""""""""""""""""""""",2
58410-2,Platelet Count (k/mm3),1311
1927-3,"""""Base Excess, VBG""""""""""""""""""""",22
24323-8,Anion Gap,457
13950-1,"""""Hep A Ab, IGM""""""""""""""""""""",1
13951-9,"""""Hep A Ab, Total""""""""""""""""""""",1
94500-6,COVID-19 PCR Comment,36
69945-4,ROM Plus,1
,BCR Interpretation:,2
24015-0,Influenza A Antigen,1
42956-3,COVID-19 IGM AB,61
,RESP.Data. PEEP,988
2519-7,"Lactate, ISTAT POC",557
8251-1,COVID-19 PCR Comment,519
5372-8,Antistriated Muscle Antibody,1
,"Chlamydia trachomatis, NAA",985
2106-3,Urine Pregnancy POC,2840
50558-6,Nitrite,7589
50559-4,Urine Blood,7148
,"In the past 12 months, have you worried that your food would run out before you had money to buy mo",211
,Rapid Strep,318
,"Amphetamine Screen, Urine",1361
,Urobilinogen,491
53327-3,Bilirubin,6614
,Basos,4163
,"Morphine Screen, Urine",1323
,Rapid Mono Antibody,222
50561-0,Protein,8452
,Ketones,935
80382-5,"Influenza A, EIA",2896
78012-2,Rapid Strep,2402
,"Hep A Ab, Total",9
,"Benzodiazepine Screen, Urine",1323
53328-1,Glucose Urine,7623
,Occult Blood,992
,"Propoxyphene Screen, Urine",1360
,"Influenza A, EIA",545
50557-8,Ketone,7561
,Leukocytes,520
,"Nitrite, Urine",992
,"Phencyclidine Screen, Urine",1360
,MDMA (Ecstasy),1323
,BASOPHIL,882
,Blood,532
,"NEISSERIA GONORRHOEAE RNA, TMA",700
,KETONES,371
,"Buprenorphine Screen, Urine",1320
,LEUKOCYTE ESTERASE,371
,Immature Granulocytes,4157
,Bilirubin,511
,WBC Esterase,908
,URN BLOOD,421
,"Oxycodone/Oxymorphone, Urine",59
80383-3,"Influenza B, EIA",2877
,C19 PCR Result,2141
,"Methadone Screen, Urine",1386
60026-2,Leukocytes,7688
,Occult Blood - Feces,388
,"Opiate Screen, Urine",37
,Immature Grans (Abs),4114
,Baso (Absolute),4099
,"C. GLABRATA, DNA",40
,"CHLAMYDIA TRACHOMATIS RNA, TMA",695
94309-2,SARS CoV 2 RNA,487
,"Oxycodone Screen, Urine",1323
,"Neisseria gonorrhoeae, NAA",962
,URN BILIRUBIN,421
,Nitrite,518
,OCCULT BLOOD,373
,Glucose,46
,"Methamphetamine Screen, Urine",1323
,URINE PROTEIN,488
,URINE NITRITE,421
,LACTOBACILLUS SPECIES,40
,Eos (Absolute),4141
,ANA Direct,137
,"Cocaine Screen, Urine",1323
,"Tricyclic Antidepressants, urine",1126
50563-6,Urobilinogen,5953
2345-7,Glucose,509880
,"Meperidine Screen, Urine",37
,"Barbiturate Screen, Urine",1323
,Glucose Urine,517
,URINE GLUCOSE,421
,BARBITURATES,26
,URINE KETONES,421
,Phencyclidine,104
,"Candida albicans, NAA",92
,HBsAg Screen,402
,"THC - Cannabinoid, Urine",1323
,Rh Factor,58
,PPD Skin Test,80
94500-6,"SARS-CoV-2, NAA",2203
,Occult Blood - Feces (DRE),316
,"Influenza B, EIA",535
,Methamphetamine,32
,Edema,1099
,Barbiturate,77
,URINE LEUKOCYTES,421
,"ANA SCREEN, IFA",170
,"Hep B Core Ab, IgM",119
,Urine Blood,470
,SARS CoV 2 RNA,4
,Trich vag by NAA,195
,Essential Frailty Toolkit Score,56
,Occult Blood- Feces 2,235
,"ALCOHOL, ETHYL (U)",7
,"Occult Blood, Fecal IA",62
,"C. TROPICALIS, DNA",40
,"Antinuclear Antibodies, IFA",221
,"In the past 12 months, has the food you bought ran out before you had money to buy more?",211
50558-6,NITRITE,349
,"Hep B Core Ab, Tot",179
,"CHLAMYDIA TRACHOMATIS RNA, TMA, THROAT",8
50560-2,pH,6383
,Urine Pregnancy POC,168
94309-2,SARS-CoV-2 RNA:,17
,Protein,559
,NRBC?s per 100 WBC?s,159
,Macro Type 2,32
,Eos,4151
,Ketone,519
,"Fentanyl, Urine",37
,"Mononucleosis Test, Qual",11
,"Gamma Globulin, U",10
94563-4,"DiaSorin SARS-CoV-2 Ab, IgG",90
,COVID-19 Rapid Test,518
,Strep Screen,49
94564-2,"SARS-CoV-2 Antibody, IgM",25
,"SURESWAB(R) TRICHOMONAS VAGINALIS RNA, QL TMA",71
,H pylori Breath Test,36
,"C difficile Toxins A+B, EIA",61
94563-4,"Abbott SARS-CoV-2 Ab, IgG",43
,Oxymorphone,22
,Cannabinoid,72
,ABSOLUTE BASO COUNT,882
,"M-Spike, %",10
,Beta Strep Gp A Culture,60
,Chair Raises Score,61
,"HETEROPHILE, MONO SCREEN",5
,Trichomonas vaginalis,15
,Occult Blood- Feces 3,234
,"Buprenorphine, Urine",37
42957-1,SARS CoV 2 AB IGG,35
,Goal Setting: Monitoring,84
,Oxidant,23
,Antibody Screen,57
,Goal Setting: Miscellaneous,3
,Lorazepam,16
,E. chaffeensis IgG Titer,6
,CK-MB,40
,H. pylori Breath Test,5
,RESULT:,32
,"Barbiturates Screen, Urine",37
,Goal Setting: Nutrition,61
,SOURCE:,69
,"H. pylori Stool Ag, EIA",25
,"Occult Blood, Fecal, IA",87
,"Benzodiazepines Screen, Urine",37
,HLA-B27,34
,PHENCYCLIDINE,20
,"C. PARAPSILOSIS, DNA",40
,MARIJUANA,7
,"Amphetamines, Urine",79
,NORHYDROCODONE,3
,EOSINOPHIL,895
,Opiates,120
,"SARS-CoV-2 Antibody, IgG",5
,Diabetes Pathophysiology,255
,Barbiturates,24
,Cocaine (Metab.),59
,Hydrocodone,24
,Hgb Solubility,26
,"Tramadol Screen, Urine",37
,"CHLAMYDIA TRACHOMATIS,TMA (ALTERNATE TARGET)",6
,ABSOLUTE BASOPHILS,1926
,Chlamydia by NAA,67
,"C. trachomatis NAA, Confirm",15
,KOH Microscopy,18
,Gonococcus by NAA,63
,Candida species,17
,AMPHETAMINE,11
,GLUCOSE,287
,BENZODIAZEPINES,33
,PROTEIN,22
,Propoxyphene,21
,Lyme IgG WB Interp.,11
,"Cannabinoid Screen, Urine",37
,"SARS-CoV-2 Antibody, IgM",1
,ABSOLUTE EOSINOPHILS,1926
,Benzodiazepines,106
,"Hep A Ab, IgM",117
,RSV,10
,"Pregnancy Test, Urine",65
94500-6,PAN-SARS RNA:,10
,Methadone,52
,BASOPHILS,1926
,Vaginal Yeast Culture,1
,QuantiFERON-TB Gold Plus,56
,"Cocaine (Metab.) Screen, Urine",37
,Hgb Variant,28
,NITRITE,22
,Alprazolam,4
,"Candida glabrata, NAA",92
,Cognitive Score,61
,PAN-SARS RNA:,8
94500-6,OVERALL RESULT:,10
,HEROIN METABOLITE,7
,"NEISSERIA GONORRHOEAE RNA, TMA, THROAT",8
,Oxycodone,45
,"Propoxyphene, Urine",26
,METHADONE,22
,Alphahydroxytriazolam,12
,MARIJUANA METABOLITES$(50 ng/mL SCREEN),26
,Morphine,21
,Mono Qual W/Rflx Qn,6
,RAPID GRP A BETA STREP,63
,"SARS-CoV-2, NAA 2 DAY TAT",309
,"Ethanol, Urine",14
,"Giardia lamblia Ag, EIA",45
,Ketones (Urine),67
,"N. Gonorrhoeae, NAA, Pharyn",7
,"Eosinophils, Fluid",7
,PATIENT SYMPTOMATIC?,9
,Oxazepam,17
,Influenza B,107
,Standards of Care,215
,HYDROMORPHONE,14
,BILIRUBIN,22
,ABSOLUTE EOSIN COUNT,895
,Hydromorphone,23
,Amphetamines,48
,COMMENT,1991
,"Alpha-1-Globulin, U",10
,Goal Setting: Activity,25
,Amphetamine,33
,NUCLEATED RBC,1202
,EOSINOPHILS,1926
,"HPV mRNA E6/E7, SUREPATH VIAL",19
,"HCG, TOTAL, QL",17
,ENTEROHEMORRHAGIC e COLI,66
,Cocaine Metabolite,23
,HSV 2 DNA,4
,OPIATES,33
,COCAINE METABOLITES,26
,Goal Setting: Medication,8
,Strep Gp B NAA,36
,"C. ALBICANS, DNA",40
,Oxycodone/Oxymorph,13
,Lyme IgM WB Interp.,11
,ATOPOBIUM VAGINAE,40
,HEPATITIS B SURFACE ANTIBODY QL,24
,QuantiFERON TB2 Ag Value,56
,AMPHETAMINES,7
,INFLUENZA A,3
,Miscellaneous Testing,13
,"hCG,Beta Subunit,Qual,Serum",42
,FECAL GLOBIN BY IMMUNOCHEMISTRY,15
,Hgb S,28
,ATYPICAL LYMPHOCYTE,13
,Endomysial Antibody IgA,12
,HPV Test Result (if applicable),6
,HBsAg Confirmation,1
,CODEINE,10
,TAPENTADOL,7
,Hgb C,28
,"Alpha-2-Globulin, U",10
,HSV-1 DNA,8
,SOURCE,54
,Intestinal Frac.:,11
,"C. Trachomatis, NAA, Pharyn",8
,"Beta Globulin, U",10
,METHAQUALONE,14
,"SARS CoV2 RNA (COVID-19), RT PCR",8
,HSV TYPE 2:,10
,Hep Be Ag,8
,INFLUENZA TYPE B,24
,Alcohol Metabolites,5
,Temazepam,16
,Monocytes(Absolute),4163
,BUPRENORPHINE,9
,Diabetes Support,54
,"BARBITURATES, URINE",1
,Macro Type 1,32
,Nordiazepam,17
,Rapid RSV Antigen Result,2
,Flurazepam,4
,CK-BB,39
,OVERALL RESULT:,6
,HGE IgG Titer,6
,Alphahydroxymidazolam,12
,"NEISSERIA GONNORHOEAE,TMA (ALTERNATE TARGET)",2
,Marijuana Metabolite,31
,ANCA SCREEN,7
,TRAMADOL,7
,CYTOLOGY SUREPATH,673
,Gardnerella vaginalis,15
,Cologuard Result,4
,"Lining Cells, Synovial",7
,OB Immunoassay,10
,Aminoclonazepam,12
,"Influenza B, NAA",1
,Hgb F,28
,Codeine,21
,FENTANYL,9
,GARDNERELLA VAGINALIS,40
,Hydroxyethylflurazepam,12
,Tramadol,27
,INFLUENZA TYPE A,25
,Alphahydroxyalprazolam,12
,FLUNITRAZEPAM,1
,LYME DISEASE AB (IGM) WB,2
,Frailty Score,57
,"LYME DISEASE (BORRELIA SPP) DNA, QL, BLOOD",1
,"HCG, QL, URINE",4
,Meal Plan Type,229
,COVID-19,8
,SARS-CoV-2 Semi-Quant Total Ab,13
,PROPOXYPHENE,14
,DIHYDROCODEINE,3
,"HEP B CORE AB, TOT",1
,FECAL GLOBIN BY IMMUNOCHEM. (MEDICARE),9
,SARS-CoV-2 Spike Ab Interp,15
,"COCAINE METAB, URINE",1
,Meperidine,21
,Fetal Heart Tones,1080
,CF RESULT,9
,HYDROCODONE,16
,AMPHETAMINES$(1000 ng/mL SCREEN),26
,OXAZEPAM,1
,Mammogram Result,44
,"BASOPHILS, %",5
,OXYCODONE,3
,Ethanol,1
,"CANNABINOIDS, URINE",1
,dsDNA Crithidia luciliae IFA,5
,HGE IgM Titer,6
,"BILIRUBIN, DIRECT",182
,"Folate (Folic Acid), Serum",807
,HSV 1 DNA,3
,"HETEROPHILE, MONO SCREEN (REFL)",1
,RPR (DX) W/REFL TITER AND$CONFIRMATORY TESTING,188
,HSV-2 DNA,7
,"RMSF, IgG, EIA",2
,SMOOTH MUSCLE AB SCREEN,3
,Norhydrocodone,9
,"OPIATES, URINE",1
,"N. gonorrhoeae NAA, Confirm",4
,FTA-ABS,7
,HIV 2 Ab,4
,,451
,B. quintana IgG,1
,HEPATITIS B CORE AB TOTAL,100
,Fecal Occult Blood Immunoassay (Historical),1
,"TRICHOMONAS VAGINALIS RNA QUALITATIVE TMA, MALES",10
,DIAZEPAM,1
,"M-Spike, mg/24 hr",1
,Cocaine (Metabolite),21
,"BENZODIAZEPINES, UR",1
,COCAINE,7
,E. chaffeensis (HME) IgM Titer,6
,Strep Gp B NAA+Rflx,4
,Hep Be Ab,4
,B. quintana IgM,1
,Cannabinoids,21
,QuantiFERON TB1 Ag Value,56
,URINE PREGNANCY,3
,ANA PATTERN,71
,"SARS-CoV-2 Antibody, IgA",1
,Triazolam,4
,"AMPHETAMINES, URINE",1
,INFLUENZA B,3
,Aspergillus flavus Antibodies,1
,Behavioral Change Strategies,209
,Secobarbital,6
,Clonazepam,4
,MORPHINE,10
,CLASS,7
,LYME DISEASE AB (IGG) WB,2
,"OXYCODONE, URINE",1
,MONONUCLEOSIS SCRN,2
,Basos (Absolute),6
,"Influenza A, NAA",1
,OXYMORPHONE,3
53326-5,Specific Gravity,7508
,FLURAZEPAM,1
,SIGNAL TO CUT-OFF,111
,Lymphs (Absolute),4148
,FX02-IgE Food Mix (Seafoods),10
,B. henselae IgG,1
,"RSV Ag, EIA",6
,41 KD (IGG) BAND,2
,Acute Complication and Skin Care,259
,ISLET CELL ANTIBODY SCREEN,2
,TEST NAME:,13
,OH-Alprazolam,1
,QuantiFERON Nil Value,66
,6 Acetylmorphine,9
,Midazolam,4
,RESULT,1
,Basophil (Absolute),72
,HIV 1 Ab,4
,TEMAZEPAM,1
,B. henselae IgM,1
,Yeast Exam,7
,"DNA AB (DS) CRITHIDIA,IFA",3
,HSV TYPE 1:,2
,Exercise,238
,Phenobarbital,6
,ANACHOICE(R) SCREEN,1
,"Urobilinogen,Semi-Qn",992
,Nutrition Management,265
,ECSTASY,1
,WBCs Quantitative,1
,MITOGEN-NIL,32
,Amobarbital,6
,Pentobarbital,6
,Vitamin B12,1336
,SARS-CoV-2 Semi-Quant IgG Ab,6
,NOROXYCODONE,3
,23 KD (IGM) BAND,2
,MIDAZOLAM,1
,CLONAZEPAM,1
,HCV RNA NAA Qualitative,2
,Cocaine,1
,TRIAZOLAM,1
,LORAZEPAM,1
5770-3,UA Bile,220815
2106-3,Ur Pregnancy POC,67779
20454-5,UA Albumin,220861
706-2,Basophils,631806
711-2,Abs Eosinophil Cnt,631495
713-8,Eosinophils,631810
704-7,Abs Basophil Cnt,631491
43985-1,Ur Cocaine Scrn,35514
14308-1,Ur Amphetamine Scr,35513
70151-6,Ur Opiate Scrn,33864
1927-3,VBG Base Excess,27496
14312-3,Ur THC Scr,35514
70149-0,Ur Methadone Scr,35517
70155-7,Ur Barbiturate Scr,35513
19312-8,Ur Tricyclics Scr,35512
70141-7,Ur Benzodiazepine Scr,35513
19642-8,Ur Oxycodone Scr,35517
20994-0,Beta hCG Qual,27439
30229-9,Abs Band Cnt,83451
35332-6,Bands,83690
5905-5,Monocytes,631823
742-7,Abs Monocyte Cnt,631510
5769-5,UA Bacteria,158022
42757-5,Troponin POC IStat,8735
11277-1,UA Squamous Epithelials,158021
23826-1,Bord pertussis PCR,13366
29909-9,Parainfluenza 2 PCR,18732
55465-9,Influenza A H1 2009 PCR,18730
49521-8,Influenza A H1 PCR,18731
39528-5,Adenovirus PCR,18733
40991-2,Rhinovirus/Enterovirus PCR,18735
29908-1,Parainfluenza 1 PCR,18732
41010-0,Parainfluenza 4 PCR,18732
34645-2,Chl pneumoniae PCR.,18732
29910-7,Parainfluenza 3 PCR,18732
49524-2,Influenza A H3 PCR,18730
38917-1,Metapneumovirus PCR.,18732
29257-3,Mycopl pneumoniae PCR,18732
40988-8,Resp Syncytial Virus PCR,18766
41009-2,Coronavirus OC43 PCR,7246
29723-4,Bord parapertussis PCR,12538
6556-5,Rapid Beta Strep A Throat,7902
1925-7,ABG Base Excess,81460
770-8,Neutrophils,695665
751-8,Abs Neutrophil Cnt,631549
34468-9,Feces C difficile Toxin EIA,8623
57901-1,Feces C difficile Ag.,9407
5880-0,Feces Rotavirus,329
26621-3,Ur Legionella Ag,8311
24027-5,Ur Strep pneumo Ag,8611
13945-1,UA RBCs,158021
2106-3,Ur Beta hCG Qual,10620
24111-7,GC DNA PCR,18725
21613-5,Chl trachomatis DNA PCR,18712
10330-9,Fl Monocytes,9148
12234-1,Fl Mesothelials,5894
57905-2,Feces Occult Blood 1,9985
57768-4,Feces Campylobacter Ag,136
16182-8,Alk Phos Other,346
5195-3,Hep B Surf Ag,19881
20507-0,RPR Screen,9693
61404-0,MSSA PCR,5455
33051-4,Ur Blood POC,3373
50949-7,Ur Protein POC,3373
5770-3,Ur Bile POC,3373
2514-8,Ur Ketone POC,3373
25428-4,Ur Glucose Qual POC,3373
5802-4,Ur Nitrite POC,3373
5799-2,Ur Leuk Est POC,3373
56888-1,HIV 1/2 Ag/Ab Scrn,6553
31204-1,Hep B Core IgM,10469
22314-9,Hep A IgM,10216
16128-1,Hepatitis C Ab,13351
31830-3,Feces Giardia Ag,1518
21233-2,Feces Cryptosporidium Ag,1376
29905-7,Feces E histolytica Ag,1108
74669-3,Lactobacillus species PCR,232
72495-5,Candida parapsilosis PCR,232
72391-6,Candida tropicalis PCR,232
69563-5,Candida glabrata PCR,232
62460-1,Candida albicans PCR,232
31545-7,ANA,8496
5297-7,RF,3414
6873-4,BHBT,8894
5821-4,UA WBCs,158022
56490-6,Feces Occult Blood 2,1217
44243-4,Wet Prep Bacteria,16366
45323-3,Quantiferon TB Interp,2072
40703-1,Feces Lactoferrin.,2922
16960-7,CSF HSV 2 PCR Qual,380
16952-4,CSF HSV 1 PCR Qual,380
46994-0,Class I PRA,3115
46995-7,Class II PRA,3115
35734-3,Ur Histo Ag Scr,229
13971-7,Ur Histo Ag Qnt,229
34701-3,Heparin Ab Interp,1756
57905-2,Feces Occult Bld Scr 1,3878
21523-6,Smith Ab Interp,738
20781-1,Feces Parasitology Stain,80
11483-5,Varicella zoster PCR,190
12209-3,Fl Eosinophils,9146
31864-2,Fl Influenza B Ag,9260
31859-2,Fl Influenza A Ag,9261
16933-4,Hep B Core Total Ab,1762
17355-9,ANCA,2651
58465-6,Double Strand DNA Ab,1843
731-0,Abs Lymphocyte Cnt,631518
736-9,Lymphocytes,631829
41276-7,AGAP IStat POC,37589
20447-9,HIV Quant,1144
29541-0,HIV Log Copies/mL,1144
30339-6,EBV NAG Ab,202
30339-6,EBV VCA IgG Ab,1097
30340-4,EBV VCA IgM Ab,901
22295-0,EBV EAG Ab,797
17780-8,Feces Hel. pylori Ag,849
6306-5,Feces Adenovirus 40 41,212
35459-7,Flow XM T Cell Result,1540
38357-0,Flow XM B Cell Result,1540
16131-5,Misc Specm HSV 2 PCR Qual,1790
16130-7,Misc Specm HSV 1 PCR Qual,1793
43180-9,Herpes 2 IgG,914
51916-5,Herpes 1 IgG,914
72494-8,CMV Log IU/mL,3960
72493-0,CMV PCR Quant IU/mL,3960
31626-5,SSB Ab Interp,912
31625-7,SSA Ab Interp,959
8041-6,T. pallidum Confirm,612
12230-9,Fl Macrophages,9148
64084-7,Quantiferon TB1 Antigen minus Nil,1934
10701-1,Feces Ova and Parasites,676
667-6,KOH Prep,1929
45210-2,HSV 2 IgM Scrn,421
40466-5,HSV 1 IgM Scrn,423
56490-6,Feces Occult Bld Scr 2,281
42921-7,JC Virus DNA PCR,118
46128-5,Tis Transglutam IgA,123
13956-8,M TB Complex PCR Qual,239
56491-4,Feces Occult Blood 3,743
13248-0,Hep D Ab,57
62423-9,Coronavirus HKU1 PCR (not COVID19),11486
41009-2,Coronavirus OC43 PCR (not COVID19),11486
44332-5,Jo1 Ab Interp,252
41005-0,Coronavirus NL63 PCR (not COVID19),11486
23929-3,RNP Ab Interp,548
41003-5,Coronavirus 229E PCR (not COVID19),11486
21518-6,SCL70 Ab Interp,601
48683-7,Group B Strep DNA (Intrapartum),551
5290-2,CSF VDRL,541
13532-7,CSF Xanthochromia,1908
12210-1,Ur Eosinophils,2179
35275-7,Rubeola IgG,404
15410-4,Varicella IgG,719
6476-6,Mumps IgG Interp,356
24119-0,CMV IgM Ab,918
40678-5,Toxoplasma IgM,121
40677-7,Toxoplasma IgG,413
13949-3,CMV IgG Ab,955
43305-2,"Neis Gonorrhoeae RNA, TMA",231
43304-5,"Chl Trachomatis RNA, TMA",231
11282-1,Cells Cntd,4701
33978-8,Ur BK Virus PCR Interp,82
46154-1,Trich vaginalis RNA Qual TMA,232
2030-5,Hgb CO POC,1150
79388-5,Feces Norovirus PCR,4299
70242-3,Feces Shigella spp PCR,3407
79383-6,Feces Salmonella spp PCR,4578
79382-8,Feces Campylobacter Grp PCR,4581
79389-3,Feces Rotavirus PCR,4290
79387-7,Feces E coli Shiga Toxin 2 PCR,3074
79386-9,Feces E coli Shiga Toxin 1 PCR,3074
79385-1,Feces Y enterocolitica PCR,4578
79384-4,Feces Vibrio spp PCR,4578
44099-0,Aspergillus Ag Interp,887
44357-2,Aspergillus Ag Index,887
30324-8,Bld Crypto Ag,504
29891-9,Breath Test H pylori,417
39528-5,Misc Adenovirus PCR Interp,114
5386-8,Toxocara Ab,12
48683-7,Group B Strep DNA (Antepartum),669
87755-5,Feces C difficile 027/B1/NAP1,949
54067-4,Feces C difficile tcdB Gene PCR,1177
5000-5,CMV PCR Qual..,1113
48398-2,HBV Log IU/mL,546
42595-9,HBV Quant,546
5213-4,Mono Scrn,1041
32362-6,BK Virus PCR Interp,1311
6521-9,Pn jirovecii PCR,1212
9788-1,ASO,970
24111-7,GC Aptima,194
21613-5,Chl trachomatis Aptima,195
13941-0,Fl Lymphocytes,9147
29904-0,Toxoplasma gondii PCR,67
17284-1,Mitochondrial Ab Scr,1864
30557-3,Smooth Muscle Ab Scr,1929
52816-6,CSF Nucleated Cells,1910
20575-7,Hep A Total Ab,1158
11555-0,BBG Base Excess,10041
21363-7,Legionella pneumophila PCR,295
49616-6,Legionella species PCR,296
28005-7,MTHFR Mutation: c665C>T,157
13576-4,Bld Oxycodone Scr,815
8172-9,Bld THC (Marijuana) Scr,815
8236-2,Bld PCP Scr,815
8219-8,Bld Opiates Scr,815
3777-0,Bld Methamphetamine Scr,816
59705-4,Bld Methadone Scr,816
8191-9,Bld Cocaine Scr,816
46976-7,Bld Benzodiazepines Scr,816
20421-4,Bld Barbiturates Scr,815
8149-7,Bld Amphetamines Scr,817
54452-8,Fern Test,744
74762-6,Megasphaera species PCR,232
74668-5,Gardnerella vaginalis PCR,232
74667-7,Atopobium vaginae PCR,232
56131-6,Chikungunya IgM Scrn,9
56129-0,Chikungunya IgG Scrn,9
64084-7,Quantiferon TB2 Antigen minus Nil,1933
13532-7,CSF Xanthochromia Add'l Tube,564
9819-4,CSF Crypto Ag,230
5000-5,CMV PCR Qual Nonblood,348
10843-1,DQ2,25
41283-3,DQ8(3),25
9306-2,Fl Neutrophils,9150
20404-0,Fibronectin Rslt,485
38180-6,HCV Log IU/mL,1454
20416-4,HCV Quant,1455
28060-2,MTHFR Mutation: c1286A>C,157
29591-5,Enterovirus PCR,70
29901-6,HTLV 1 and 2 Ab,123
82182-7,CSF E coli K1 PCR,463
82187-6,CSF S pneumoniae PCR,463
82192-6,CSF Herpesvirus 6 PCR,463
82186-8,CSF S agalactiae PCR,463
82191-8,CSF HSV 2 PCR,463
82190-0,CSF HSV 1 PCR,464
82185-0,CSF N meningitidis PCR,463
82194-2,CSF Enterovirus PCR,463
82188-4,CSF Varicella zoster PCR,463
82184-3,CSF L monocytogenes PCR,463
82181-9,CSF Cryptococcus PCR,463
82193-4,CSF Parechovirus PCR,463
82189-2,CSF CMV PCR,463
82183-5,CSF H influenza PCR,463
29963-6,Parietal Cell Ab Scr,53
9572-9,Parvovirus B19 DNA PCR,207
55433-7,Immature Cells,807
60489-2,Grp A Streptococcus PCR,817
2617-9,VBG Methgb,2538
12244-0,CSF Neutrophils,515
12208-5,CSF Eosinophils,513
12229-1,CSF Macrophages,513
72328-8,Class I DSA Diluted 1:8,1394
12208-5,CSF Eosinophils Add'l Tube,148
12229-1,CSF Macrophages Add'l Tube,148
5005-4,EBV by PCR,87
1759-0,A/G Ratio,597715
6321-4,Lyme IgM West Blot,97
6320-6,Lyme IgG West Blot,103
791-4,CSF RBCs,1908
46154-1,T vaginalis TMA,16
24042-4,Ehrlichia chaffeensis PCR,20
33986-1,Bartonella henselae PCR,46
57910-2,Bartonella quintana PCR,47
29560-0,Anaplasma phagocytophilum PCR,19
21055-9,Adenovirus PCR Quant Interp,138
24375-8,Platelet Antibody Indirect,140
32683-5,Hgb S,2044
9537-2,IF Blocking Ab,86
5257-1,Mycopl. pneumoniae IgM,291
14116-8,CSF IgG Synthesis Rate,277
12782-9,CSF Oligoclonal Bands,253
49852-7,Oligoclonal Bands Number,253
4991-6,Lyme DNA PCR,91
74661-0,Phosphatidylethanol Lvl,339
6864-3,Sickle Cell Scr,171
50385-4,Amnio Fl Membrane Rupture Test,434
13203-5,CSF Lyme IgM West Blot,19
13202-7,CSF Lyme IgG West Blot,19
50727-7,SRA Unfract Heparin High Dose,195
62365-2,CSF EBV PCR Quant Interp,28
21695-2,C282y Mutation,220
38380-2,s65c Mutation,217
21696-0,H63d Mutation,217
4999-9,Ur CMV PCR Qual,7
29257-3,Mycopl. pneumoniae PCR,91
49291-8,Ur Porphyrins Interp,31
29966-9,Centromere IgG,278
23860-0,Fl RBCs,6167
2334-1,Gastric Occult Blood,182
19234-4,MVBG Base Excess,1240
17859-0,Hel. pylori IgG,105
34376-4,Stronglyloides IgG,697
5818-0,UA Urobilinogen,220813
78012-2,Rapid Beta Strep A Thr POC,14
82380-7,HCV NS5a Subtype,5
2615-3,ABG MetHgb,1150
4532-8,Tot Complement,555
45224-3,Mycopl. pneumoniae IgG,92
10466-1,AGAP,952883
41607-3,MVBG Methemoglobin,1552
25835-0,HIV 1 RNA Qual TMA,19
54142-5,Candida species Probe,218
54144-1,Trichomonas vaginalis Probe,218
54143-3,Gardnerella vaginalis Probe,218
52816-6,CSF Nucleated Cells Add'l Tube,564
5117-7,Cryoglobulins,155
56491-4,Feces Occult Bld Scr 3,326
32701-5,Feces Microsporidia,128
29893-5,HIV 1 Ab,81
30361-0,HIV 2 Ab,82
49026-8,LDL 6 Fraction,11
57938-3,LDL 5 Fraction,11
49027-6,LDL 7 Fraction,11
5014-6,HSV DNA PCR,146
24116-6,Rubella IgM,125
11034-6,Acetylchol Bind Ab,268
30192-9,Acetylchol Mod Ab,197
2640-1,Ur Myoglobin,189
49392-4,Serum Herpesvir 6 Qnt,72
46725-8,Tropheryma whipplei PCR,11
48719-9,Q Fever IgG Phase 2 Screen,20
48720-7,Q Fever IgG Phase 1 Screen,20
25841-8,HIV 2 PCR,31
44542-9,HTLV 2 PCR,24
44537-9,HTLV 1 PCR,24
9306-2,Nasal Smr Polys,21
13941-0,Nasal Smr Lymph,21
9727-9,Nasal Smr Eos,21
10330-9,Nasal Smr Mono,21
14105-1,Nasal Smr WBCs,21
10329-1,CSF Monocytes Add'l Tube,148
29538-6,CSF West Nile Virus IgM,75
54218-3,CD4/CD8 Ratio,1704
50734-3,SRA Unfract Heparin Porcine,210
50728-5,SRA Unfract Heparin Low Dose,195
80824-6,Zika IgM Ab,9
735-1,Atyp Lymphs,31421
10611-2,Immotile Sperm,49
10620-3,Non Progressive Sperm,49
6800-7,Total Motility Prog+NonProg,49
14194-5,Progressive Sperm,49
14883-3,Porphyrins Interp,11
42937-3,Acetylchol Block Ab,220
41871-5,Volt Gated K Chnl Ab,63
26020-8,CK Macro Type II,79
26019-0,CK Macro Type I,79
15048-2,CK BB,79
21418-9,Neutrophil Ab,35
6349-5,Chl trachomatis Cult,6
31024-3,Volt Gated Ca Chnl Ab,24
6864-3,Sickle Cell Scr Electro,130
49391-6,WB Herpesvir 6 Qnt,44
791-4,CSF RBCs Add'l Tube,564
3282-1,Staclot LA,256
30326-3,CSF CMV PCR Qual,72
10328-3,CSF Lymphocytes,515
10329-1,CSF Monocytes,514
71774-4,Quantiferon TB Mitogen minus Nil,1987
30319-8,Tis Lactase,176
29495-9,Herpes Virus 6 PCR,30
39803-2,Infliximab Activity,48
12244-0,CSF Neutrophils Add'l Tube,150
69937-1,T vaginalis PCR,177
6952-6,Tolbutamide Lvl,38
6951-8,Tolazamide Lvl,38
38542-7,Repaglinide Lvl,38
49702-4,Nateglinide Lvl,38
6945-0,Glyburide Lvl,38
6944-3,Glipizide Lvl,38
40465-7,Glimepiride Lvl,38
47392-6,Chlorpropamide Lvl,38
27007-4,Acetohexamide Lvl,38
6428-7,Histoplasma Ag,37
32364-2,Herpes Virus 8 PCR,13
30050-9,Ur Hydroxylysine,3
28610-4,Ur Sarcosine,3
28593-2,Ur Gamma Aminobutyric Acid,3
56674-5,Ur Beta Alanine,3
11060-1,Feces Reducing Subs,30
55793-4,Fl Nucleated Cells,6168
2429-9,Homocystine Lvl,8
55876-7,Homocitrulline Lvl,8
32227-1,Argininosuccinic Acid Lvl,8
26607-2,AA Cystathionine,8
26599-1,Anserine Lvl,8
5221-7,HIV Western Blot,12
7883-2,EBV NAG Ab,572
16982-1,HTLV 1 and 2 WB,13
21262-1,E coli Shiga-like Toxin,121
29945-3,Ur BJ Alpha 1,7
29946-1,Ur BJ Albumin,7
13993-1,Ur BJ Alpha 2,7
29899-2,Ur BJ Gamma,7
29951-1,Ur BJ Beta,7
46718-3,CSF Aquapor 4 Rec IgG,23
29723-4,B. parapertussis PCR,9
23826-1,B. pertussis PCR,9
81732-0,PM1 Ab,21
13291-0,Tryp. cruzi IgG,165
72623-2,Infliximab Neutralizing Ab,49
60260-7,Chikungunya PCR Qual,6
43928-1,Q Fever IgM Phase 2 Screen,16
32645-4,Q Fever IgM Phase 1 Screen,16
94309-2,SARS CoV 2 PCR COVID19,130849
5005-4,EBV PCR Interp,634
31545-7,ANA Interpretation,5434
94316-7,SARS CoV 2 PCR COVID19,1818
51753-2,Histoplasma Ag Qnt,37
58375-7,Ur Ethyl Glucuronide Scr,12
30246-3,CMV PCR Interp,2650
34892-0,West Nile Virus PCR,16
25137-1,Ur Succinylacetone,6
25083-7,Ur Methylvaleric Acid,6
25085-2,Ur Isovaleric Acid,6
25084-5,Ur Isocaproic Acid,6
25134-8,Ur Sebacic Acid,6
31950-9,Fl RSV Ag,144
30312-3,C18-1-OH 3-OH-Oleyl,8
35656-8,C18-OH 3-OH-Stearoyl,8
30237-2,C18-2-OH 3-OH-Linoleyl,8
30238-0,C14-OH 3-OH-Tetradecanoyl,8
30566-4,C14-1 Tetradecenoyl,8
30565-6,C14 Tetradecanoyl,8
30233-1,C12-OH 3-OH-Dodecanoyl,8
30531-8,C5-OH 3-OH Isovaleryl,8
30235-6,C16-1-OH 3-OH-Palmitoleyl,8
30234-9,C16-OH 3-OH-Palmitoyl,8
30190-3,C14-1-OH 3-OH-Tetradecenoyl,8
30332-1,C12-1 Dodecenoyl,8
94500-6,SARS CoV 2 PCR COVID19,15497
94762-2,SARS CoV 2 Total Ab COVID19,1413
68913-3,CSF Volt Gated K Chnl Ab,10
31023-5,MAG Ab Western Blot,5
13227-4,Diphtheria IgG,25
5213-4,Heterophile Ab Screen,31
34645-2,Chl pneumoniae PCR,14
38175-6,Ur Heptacarboxylate,31
2032-1,VBG Hgb CO,2538
29558-4,CSF Enterovirus PCR Qual,148
49388-2,CSF Herpesvir 6 Qnt,8
25757-6,Schistosoma Ab,17
85478-6,Influenza B PCR,16757
85477-8,Influenza A PCR,16757
85479-4,Resp Syncytial Virus PCR,495
62467-6,Bronch Aspergillus Ag Index,1667
26885-4,Fl Ova and Parasite,34
57749-4,Amphiphysin Ab IgG,10
29498-3,Platelet Ab Direct IgM,20
29497-5,Platelet Ab Direct IgG,20
71776-9,Quantiferon TB Nil,1987
62362-9,Bld Chrom Colonies Cntd,4
5404-9,Varicella IgM,187
48176-2,M TB Rifamin PCR Qual,6
8117-4,Tot B Cells,292
13636-6,Ribosomal P Prot Ab,43
13876-8,Beta 2 Transferrin,22
1926-5,CBG Base Excess,17
29591-5,Enterovirus PCR.,24
783-1,Promyelocytes,3076
73654-6,HCV NS3 Subtype,4
72328-8,Virtual XM DSA Class 1 with MFI,666
72323-9,Virtual XM DSA Class 2 with MFI,663
17781-6,21 Hydroxylase Ab,10
12258-0,Squam Epi Ur Smear,637
31208-2,SARS CoV 2 PCR Specimen,127473
41401-1,Yersinia IgG WB,8
41400-3,Yersinia IgA WB,8
15151-4,Asp fumigatus 3,85
39528-5,Adenovirus PCR Quant Interp,20
46217-6,Quantiferon TB Rslt,139
64084-7,Quantiferon TB Antigen minus Nil,54
73819-5,Heparin Ab IgG Interp,59
53835-5,GlycoMark,838
44446-3,GBM Ab,36
31201-7,Rapid HIV 1/2 Ab,69
18396-2,Rapid HIV1 p24 Ag,69
6969-0,Myeloperoxidase Ab,41
4755-5,HLA Bw4 Locus,33
4789-4,HLA Bw6 Locus,32
4969-2,DR 52 Ag,30
32621-5,DR 51 Ag,30
4971-8,DR 53 Ag,30
43393-8,LDL 4 Fraction,11
6968-2,Serine Protease 3 Ab,40
61430-5,Aquaporin 4 Recept Ab,58
72328-8,Specificity FHSPHD,34
6825-4,Fl Crystals,426
11256-5,Hem. influenzae IgG,18
5052-6,Aspergillus Ab,109
79190-5,Plasma Zika Virus PCR,3
29951-1,Ur Beta Prot Electro,2
29945-3,Ur Alpha 1 Prot Electro,2
13993-1,Ur Alpha 2 Prot Electro,2
29899-2,Ur Gamma Prot Electro,2
29946-1,Ur Albumin Prot Electro,2
53307-5,Other Crystals,21
19157-7,CSF Tube Number,1904
27175-9,Ur Glyburide,20
27170-0,Ur Tolbutamide,20
27166-8,Ur Tolazamide,20
27164-3,Ur Acetohexamide,20
12396-8,Ur Chlorpropamide,20
709-6,Blasts,2790
71693-6,Immature Platelet Fraction,85
71692-8,Abs Immature Platelet Fraction,85
27025-6,Ur Glipizide,20
55199-4,Prod Concep Chrom Metaphases Ktyped,14
62360-3,Prod Concep Chrom Metaphases Anyl,14
62361-1,Prod Concep Chrom Metaphases Cntd,14
17783-2,Ur Hemosiderin,8
62361-1,Tis Chrom Metaphases Cntd,1
55199-4,Tis Chrom Metaphases Ktyped,1
62360-3,Tis Chrom Metaphases Anyl,1
53335-6,Other Casts,77
41648-7,MVBG Hgb CO,1552
9651-1,Metolazone Lvl,6
9649-5,Hydroflumethazide Lvl,6
3479-3,Chlorthalidone Lvl,6
3400-9,Benzthiazide Lvl,6
3410-8,Bumetanide Lvl,6
3659-0,Furosemide (Lasix) Lvl,8
3677-2,Hydrochlorothiazide Lvl,6
9648-7,Chlorothiazide Lvl,6
15432-8,Percent Free Testosterone,1094
2991-8,Testosterone Free Adult Male,1175
49692-7,Striated Muscle IgG Scr,12
13175-5,Liver Cytosolic 1 IgG,7
80383-3,Rapid Influenza B Ag POC,3
80382-5,Rapid Influenza A Ag POC,3
6818-9,Micropolyspor faeni,112
30531-8,C5 Isovalecyl/2Mebutyryl,8
65810-4,Epi proColon PCR Rslt,2
14628-2,Bile Acids,149
14563-1,Feces Occult Blood 1,498
72323-9,Specificity FLDRHD,31
72323-9,Class II Donor Specific Ab,144
31161-3,Allergy Feather Mix,4
42186-7,Path Number Containers Rcvd,14253
27389-6,Pneumococ IgG 23f,132
24374-1,Platelet Ab Direct,2
27094-2,Pneumococ IgG 4,132
31183-7,Pneumococ IgG 5,132
52768-9,Intem Clot Formation Time,667
30358-6,C6 Hexanoyl,8
6810-6,Aureo pullulans,112
6318-0,CSF Lyme Ab,94
6563-1,Trichinella Ab,5
10613-8,Sperm Viability,39
32043-2,Ur Uroporphyrin,32
29334-0,Asp fumigatus 2,85
26613-0,AA Sarcosine,8
26609-8,AA Gamma Amino Butyric Acid,8
26610-6,Hydroxylysine Lvl,8
26604-9,AA Beta-Alanine,8
41398-9,Allo Isoleucine Lvl,8
25101-7,Ur Fumaric Acid,6
29519-6,Ur Phenylpyruvic Acid,6
29524-6,Ur Acetoacetic Acid,6
25089-4,Ur Phenyllactic Acid,6
20932-0,Parasite ID Macro,3
3184-9,ACT POC IStat,13215
53115-2,Abs Immature Granulocyte Cnt,238
46985-8,LDL 3 Fraction,11
2164-2,Ur Creat Clear,676
19228-6,MVBG Reduced Hgb,1552
27113-0,Pneumococ IgG 8,132
27374-8,Pneumococ IgG 12f,132
27092-6,Pneumococ IgG 1,132
19048-8,NRBC,18564
63440-2,NNA Tr/DNER IgG Immunoblot,15
12853-8,NNA Yo IgG Immunoblot,15
33008-4,NNA Ri IgG Immunoblot,15
41769-1,NNA Hu IgG Immunoblot,15
94534-5,SARS CoV 2 RNA COVID19,15
786-4,MCHC,2942610
39087-2,MAG IgM Index,6
53813-2,Plt Function P2Y12,1152
43730-1,EBV PCR Quant IU/mL,1015
41284-1,NonSquam Epithelials,4
44246-7,Wet Prep Yeast,16565
40734-6,Class 1 DSA Titer 16,4
40734-6,Class 1 DSA Titer 128,4
43305-2,Neis Gonorrhoeae RNA TMA,1
43304-5,Chl Trachomatis RNA TMA,1
25135-5,Ur Suberic Acid,6
80677-8,Feces Enterotoxogenic E coli PCR,1504
80679-4,Feces Shiga Toxin 1/2 PCR,1169
70296-9,Feces Plesiomonas spp PCR,1169
70242-3,Feces Shigella spp/EIEC PCR,1171
92694-9,Feces Sapovirus PCR,1314
92691-5,Feces Astrovirus PCR,1314
88539-2,Feces Adenovirus PCR,1314
92687-3,Feces Giardia lamblia PCR,701
92689-9,Feces E histolytica PCR,701
92688-1,Feces Cryptosporidium spp PCR,701
10622-9,Normal Sperm,44
10328-3,CSF Lymphocytes Add'l Tube,150
72389-0,Vag Path Pnl Candida krusei PCR,1
69563-5,Vag Path Pnl Candida glabrata PCR,1
62460-1,Vag Path Pnl Candida Grp PCR,1
92702-0,Vag Path Pnl Bact Vaginosis PCR,1
92699-8,Vag Path Pnl Candidiasis PCR,1
62461-9,Vag Path Pnl Trich vaginalis PCR,1
7905-3,HBSAG Confirm,11
94558-4,SARS CoV 2 Ag,467
21026-0,Virtual XM Interp,664
6821-3,Thermoact vulgaris 1,112
21560-8,Thermoact candidus,85
22572-2,Saccharomon viridis,85
13362-9,Coll Hrs Copper,74
28009-9,Tot Vol Copper,72
10834-0,Globulin Lvl,587765
5256-3,Mycopl. pneumoniae IgM Index,292
2874-6,PE Abs Gamma,3896
2871-2,PE Abs Beta,3897
2868-8,PE Abs Alpha 2,3897
2865-4,PE Abs Alpha 1,3897
2862-1,PE Abs Albumin,3897
41172-8,Budding Yeast,4797
50956-2,HLA B5701,21
70296-9,Feces P shigelloides PCR,335
80679-4,Feces Shiga Toxin Producing Org PCR,335
6746-2,Prolymphocytes,107
2471-1,CSF IgM,43
14884-1,Feces Prophyrins Interp,2
71695-1,Immature Granulocytes,244
49392-4,Plasma Herpesvir 6 Qnt,1
17861-6,Calcium Lvl,995157
33935-8,Cyclic Citrull Pep Ab IgG,1273
56634-9,ANA Titer,1460
85622-9,Serum Zika Virus PCR,2
17314-6,MAG IgM,4
31208-2,Specimen Type Resp PCR,18800
44094-1,Wet Prep Epi Cells,16371
53225-9,Wet Prep WBCs,16369
44242-6,Wet Prep RBCs,16368
44244-2,Wet Prep Trich,16369
3154-2,Stone Mass,2096
1831-7,Alpha 1 Antitryp Z Allele,21
1829-1,Alpha 1 Antitryp S Allele,21
46995-7,Class II DSA Titer 16,2
46995-7,Class II DSA Titer 4,2
46995-7,Class II DSA Titer 128,2
77013-1,MT21 Trisomy 13 Patau Syn,4
77012-3,MT21 Trisomy 18 Edwards Syn,4
77011-5,MT21 Trisomy 21 Down Syn,4
31208-2,SARS CoV 2 Influenza PCR Specimen,16264
92702-0,Bacterial Vaginosis TMA,6
62461-9,Trichomonas vaginalis TMA,6
69563-5,Candida glabrata TMA,6
62460-1,Candida species TMA,6
18319-4,Vacuolated Neutrophils,696
29950-3,ANA Scrn ELISA Referred,4
15376-7,Abnormal Sperm,44
28639-3,VCBG Base Excess,7
11125-2,Platelet Morphology,31461
5193-8,Hep B Surf Ab,8325
33006-8,Fl CMV PCR Quant,61
92902-6,MT21 8q24 del Langer Giedion,2
92899-4,MT21 11q23 del Jacobsen,2
92900-0,MT21 4p16 del Wolf Hirschhorn,2
92903-4,MT21 15q11 del PW Angelman,2
42757-5,I-STAT Troponin I Qn,87
26479-6,Lymph CSF,25
20565-8,TCO2 iSTAT,247
13950-1,Hep A IgM,59
13955-0,Hep C Ab,126
24113-3,Hep B Core IgM,63
10900-9,Hep Bs Ab,240
,Enceph Eval NMDA-R Ab CBA CSF,2
,VGKC-complex Ab IPA CSF,4
,"CASPR2-IgG CBA, CSF",14
,"LGI1-CBA, CSF",3
,GABA-B-R Ab CBA CSF,4
94356-3,ANNA-1 CSF,4
,AMPA-R Ab CBA CSF,4
,ANNA-3 CSF,4
,ANNA-2 CSF,4
94362-1,PCA-1 CSF,4
94355-5,AGNA-1 CSF,4
,PCA-2 CSF,4
,PCA-Tr CSF,4
,Amphiphysin Ab CSF,4
35385-4,CRMP-5-IgG CSF,4
,Protriptyline Lvl Antidep Scr Ur,7
,Desmethyldoxepin Lvl Antidep Scr Ur,7
,Maprotiline Lvl Antidep Scr Ur,7
,Trimipramine Lvl Antidep Scr Ur,7
,Paroxetine Lvl Antidep Scr Ur,7
,Desipramine Lvl Antidep Scr Ur,7
,Amitrip Lvl AntidepScr Ur,7
,Nortrip Lvl Antidep Scr Ur,7
3692-1,Imipramine Lvl Antidep Scr Ur,7
,Norfluoxetine Lvl Antidep Scr Ur,7
,Sertraline Lvl Antidep Scr Ur,7
,Desmethylsertraline Lvl Antidep Scr Ur,7
,Fluoxetine Lvl AntidepScr Ur,7
,Doxepin Lvl Antidep Scr Ur,7
,Clomipramine Lvl Antidep Scr Ur,7
,Desmethylclomipramine Lvl Antidep Scr Ur,7
,Cyclobenzaprine Lvl Antidep Scr Ur,7
,BE Ven Pump,14
40725-4,Hep B Core IgG,13
,Asp flavus IgE Class,1
24119-0,CMV Ab IgM (Mayo),1
11156-7,WBC MORPHOLOGY,25961
13992-3,"Albumin ELP, Urine",102
43305-2,"NEISSERIA GONORRHOEAE$RNA, TMA, THROAT",26
43305-2,"NEISSERIA GONORRHOEAE$RNA, TMA, RECTAL",11
53533-6,HSV IGG FLUID,3
43304-5,"CHLAMYDIA TRACHOMATIS$RNA, TMA, THROAT",26
43304-5,"CHLAMYDIA TRACHOMATIS$RNA, TMA, RECTAL",11
5213-4,"HETEROPHILE, MONO SCREEN$(REFL)",1
45324-1,ETHYL GLUCURONIDE,1
15841-0,CLASS,1
40419-4,AMPHETAMINES/METAMPHET,23
15014-4,INTESTINE ISOENZYME,1
4576-5,HEMOGLOBIN F,1
15016-9,PLACENTAL ISOENZYME,1
9830-1,CHOLEST/HDL RATIO,54264
6693-6,"Mercury, Urine 24 Hr",4
70155-7,BARBITUATES,23
15947-5,CLASS,1
19659-2,"Phencyclidine, Urine",1
10331-7,INFANT RH TYPE,7
10331-7,MOTHER'S ABORH,7
58450-8,BILIRUBIN URINE,1051
7905-3,HEP B SURF AG RFLX NEUTRALIZATION,252
57747-8,BLOOD UA,666
16933-4,HEP B CORE AB,30
51914-0,HEP B C TOTAL AB,24
25542-2,TOXOPLASMA IGM,1
26485-3,MONOCYTES,3807
10998-3,OXYCODONE URINE SCREEN,255
3427-2,THC,255
19268-2,AMPHETAMINE SCRN UR,255
9428-4,"BENZODIAZEPINE SCREEN, URINE",255
3773-9,METHADONE URINE,255
3427-2,CANNABINOIDS URINE INTERP,37
19141-1,PROPOXYPHENE-U,7
72753-7,HYDROCODONE,9
72754-5,LORAZEPAM,2
3528-7,DELTA 9 THC,4
3349-8,"AMPHETAMINE SCREEN, URINE",159
19659-2,PCP SCRN UR,31
32106-7,PERPHENAZINE,1
32061-4,CHLORPROMAZINE,1
32066-3,CLOZAPINE,1
18187-5,LORAZEPAM,3
9351-8,ALPRAZOLAM,2
16195-0,BENZODIAZEPINES,3
3861-2,NORDIAZEPAM,3
12361-2,OXAZEPAM,2
3654-1,FLURAZEPAM,3
19245-0,CLONAZEPAM,3
14192-9,TRIAZOLAM,3
19586-7,MIDAZOLAM,3
3426-4,CANNABINOID SCRN UR,156
10998-3,OXYCODONE SCREEN URINE,156
3349-8,AMPHETAMINE UR INTERP,8
72740-4,TRAMADOL,2
72746-1,NORBUPRENORPHINE,2
72621-6,PROPOXYPHENE,2
72760-2,FENTANYL,3
40806-2,OPIOIDS URINE INTERP,2
72762-8,BUPRENORPHINE,2
57304-8,COCAINE,2
40799-9,AMPHETAMINE,2
65807-0,TAPENTADOL,3
65808-8,NORTAPENTADOL,3
59680-9,GABAPENTIN LVL,3
47414-8,PREGABALIN,3
29598-0,MDMA,2
3755-6,MEPROBAMATE,3
16114-1,AMITRIPTYLINE,2
3875-2,NORTRIPTYLINE,2
3418-1,BUTABARBITAL,2
3338-1,AMOBARBITAL,2
3924-8,PENTOBARBITAL,8
4028-7,SECOBARBITAL,2
3948-7,PHENOBARBITAL,81
8040-8,TOXOPLASMA IGM,3
20585-6,LYMPHS ABS,5476
43180-9,HSV 2 IGG TYPE SPECIFIC AB,28
51916-5,HSV 1 IGG TYPE SPECIFIC AB,28
24467-3,BILIRUBIN DIRECT,139
54206-8,CMV DNA-PCR,307
4537-7,SED RATE,10283
30325-5,CMV IGM,3
8039-0,TOXOPLASMA IGG ANTIBODY,948
22244-8,CMV IGG CSF,1
40466-5,HERPES SIMPLX VIRUS AB IGM SCN,6
5290-2,VDRL (CSF),32
41653-7,POC GLUCOSE,3837
29610-3,HEPATITIS B VIRUS DNA  QL REAL TIME PCR,3
22459-2,VDRL CSF,47
34563-7,"RBC, CSF",5
58410-2,Automated Count Percent Basophils,1
19152-8,Pregnancy Test - Urine Specific Gravity,5826
30237-2,C18:2 Hydroxy,1
35656-8,C18 Hydroxy,1
30312-3,C18:1 Hydroxy,1
,Baso,89
,Immature Granulocytes (Abs),42
,"SYNOVIOCYTES, %",5
,RBCs,41
,Glucose.,62
,Neisseria Gonorrhoeae,2
,VZV Real Time PCR,1
,Crystals,739
,"YEAST, WET PREP",6
,WBCs,41
,QUANTIFERON(R)-TB GOLD,3
,"Ethanol U, Quan",16
,Treponema pallidum Antibodies,13
,Mucus,41
,Rapid Strep Screen,8
,Casts,739
,Other,42
,QuantiFERON TB Gold,10
,Baso(Absolute),42
,"hCG, Beta Subunit, Qual, Serum",1
,MACROHEPATIC ISOENZYMES,1
,"Chlamydia, Nucleic Acid, Amp",2
,HEPATITIS B SURFACE$ANTIGEN,27
,PLACENTAL ISOENZYMES,1
,Eosinophils (Absolute),72
,"Occult Blood, Fecal",5
,INTESTINAL ISOENZYMES,1
,WBC Esterace,22
,"EOSINOPHILS, %",5
,Trichomonas Exam,2
,TB-NIL,3
,"HEPATITIS A AB, TOTAL",3
,"West Nile Virus, IgM",1
,"West Nile Virus, IgG",1
,B51,1
,Hep B Surface Ag,4
,REPORT STATUS:,2
,ENDOMYSIAL ANTIBODY SCR$(IGA) W/REFL TO TITER,1
14565-6,Feces Occult Bld Scr 3,27
14564-9,Feces Occult Bld Scr 2,25
14563-1,Feces Occult Bld Scr 1,259
14564-9,Feces Occult Blood 2,75
14565-6,Feces Occult Blood 3,51
4821-5,HLA B27 Ag,14
19157-7,CSF Tube Number Add'l Tube,564
35671-7,Bronch Wash Aspergillus Ag,13
35738-4,Int Scr2 Inhibin MoM,7
20466-9,Int Scr2 UE3 MoM,7
20465-1,Int Scr2 HCG MoM,7
20450-3,Int Scr2 AFP MoM,7
32123-2,Int Scr2 PAPP-A MoM,7
48683-7,Group B Streptococcus PCR,5
55465-9,2009 H1N1 RNA,23
7898-0,Hantavirus IgM,2
7897-2,Hantavirus IgG,2
9781-6,Acanthamoeba Cult,1
79190-5,Zika PCR Qual,1
38917-1,Metapneumovirus PCR,1
16129-9,Hepatitis C IgG,91
54206-8,CMV Log Copies/mL,38
30247-1,CMV PCR Quant,38
20444-6,HSV PCR Qual Nonblood,12
40729-6,HSV IgM,11
54905-5,Norovirus 1 PCR,9
54906-3,Norovirus 2 PCR,9
59734-4,Bld Propoxyphene Scr,8
62365-2,EBV PCR Quant Interp,5
57296-6,Molecular DRB5 Locus 1,1
57295-8,Molecular DRB4 Locus 1,1
57294-1,Molecular DRB3 Locus 1,1
57761-9,Heparin Ab,5
56888-1,Rapid HIV 1/2 Ag/Ab Scrn,4
,Chylo Chol LipMetab,1
,Beta VLDL Chol LipMetab,1
,Beta VLDL Trig LipMetab,1
,Chylo Trig LipMetab,1
,LpX Chol LipMetab,1
,+<83>-AMINO-n-BUTYRIC ACID (Quantitative),16
,EBV DNA Quant,4
18309-5,NRBC Man,21
2746-6,pH Ven,629
2027-1,CO2 Totl Ven,629
14627-4,HCO3 Ven,629
16130-7,HSV 1 PCR QL (Tissue),1
16131-5,HSV 2 PCR QL (Tissue),1
5809-9,U Reduc Subst,2
,ENA Scr Interp,2
15924-4,CLASS,1
15592-9,CLASS,1
26581-9,"GAMMA AMINO BUTYRIC ACID, URINE",9
15904-6,CLASS,1
33633-9,PRECORE MUTATION,1
22707-4,"HOMOCYSTINE, URINE",9
13236-5,Epstein-Barr Anti-Diffuse,2
63420-4,tTG/DGP Screen,1
29993-3,URINE EOSINOPHIL SMR,818
3393-6,Cocaine + Metabolite,1
33320-3,TOXOPLASMA IGG FLUID,1
5196-1,HEPATITIS B SURFACE$ANTIGEN (REFL),18
13951-9,"HEPATITIS A AB, TOTAL$(REFL)",2
3414-0,BUPRENORPHINE SCREEN,1
20521-1,"MARIJUANA METABOLITE,$QUANTITATIVE, URINE",1
15530-9,CLASS,1
25133-0,"SARCOSINE, URINE",9
15642-2,CLASS,1
54210-0,BCP MUTATIONS,1
15549-9,CLASS,1
30355-2,HSV 1/2 IGM CONFIRMATORY$IFA,5
25110-8,"HYDROXYPROLINE, URINE",9
15862-6,CLASS,1
14267-9,"MDMA/MDA SCREEN WITH CONFIRMATION, URINE",1
19555-2,METHAMPHETAMINE,1
19344-1,AMPHETAMINE,1
32093-7,METHADONE,3
19141-1,PROPOXYPHENE SCREEN,1
14314-9,"COCAINE(METAB.) SCREEN, URINE",1
19270-8,BARBITURATES SCREEN POS/NEG,1
10998-3,"OXYCODONE (U) QL, NO CONFIRM",1
67126-3,"SYNTHETIC CANNABINOIDS, QL, (U)",1
14267-9,ECSTASY,1
3377-9,BARBITURATES INTERPINTERP,3
19570-1,MDMA,3
11259-9,HEPATITIS C RNA-PCR,3
20507-0,RPR (SYPHILLIS SEROLOGY),219
29610-3,"HEPATITIS B VIRUS DNA, QL REAL TIME PCR",1
26927-4,HSV 2 IGM  IFA,16
13503-8,"""""Lyme IgM AB, Western Blot Interp.""""""""""""""""""""",1
13502-0,"""""Lyme IgG AB, Western Blot Interp.""""""""""""""""""""",1
20569-0,CKMB Percent,2661
32673-6,CKMB Percent,1
34556-1,"""""RBC, BF""""""""""""""""""""",6
34556-1,"Cell Count Method, BF",171
,Platelet Neutralization,1
,QFT TB Ag minus Nil Value,9
,NRBC,5935
,MITOCHONDRIAL AB SCREEN,1
,HEPATITIS B SURFACE$ANTIBODY QL,4
,HLA B*57,1
,"C Difficile Toxin Gene, NAA",1
,C difficile Toxins A+B,1
,HIV 1 RNA Qualitative,2
,Interpretation:,114
,Eosinophil #,86
,E coli Shiga Toxin EIA,2
,ANTIBODY IDENTIFICATION:,3
,Lyme (B. burgdorferi) PCR,1
,HEPATITIS A IGM,57
,HIV-2 Ab-O.D. Ratio,1
52768-9,Heptem Clot Formation Time,366
62362-9,Prod Concep Chrom Colonies Cntd,1
30226-5,FSP,467
25389-8,Cystocercosis Ab,10
777-3,Platelet Count,1251659
5097-1,Cold Agglutinin,1
,PROTIME-INR,11373
,CBC,117752
,BEDSIDE GLUCOSE UNSOLICITED RESULTS,46119
,APTT,2071
2571-8,LIPID PANEL,34407
2093-3,LIPID PANEL,34407
,LIPID PANEL,59573
11054-4,LIPID PANEL,23076
2345-7,COMPREHENSIVE METABOLIC PANEL,158116
2951-2,COMPREHENSIVE METABOLIC PANEL,158089
46099-8,COMPREHENSIVE METABOLIC PANEL,95871
1920-8,COMPREHENSIVE METABOLIC PANEL,158220
1742-6,COMPREHENSIVE METABOLIC PANEL,158220
33037-3,COMPREHENSIVE METABOLIC PANEL,138149
18182-6,COMPREHENSIVE METABOLIC PANEL,138150
6768-6,COMPREHENSIVE METABOLIC PANEL,158223
2823-3,COMPREHENSIVE METABOLIC PANEL,158091
2075-0,COMPREHENSIVE METABOLIC PANEL,158098
2028-9,COMPREHENSIVE METABOLIC PANEL,158202
17861-6,COMPREHENSIVE METABOLIC PANEL,158157
2885-2,COMPREHENSIVE METABOLIC PANEL,158213
,B-TYPE NATRIURETIC PEPTIDE,1714
,MAGNESIUM,13114
,BETA HYDROXYBUTYRATE,96
,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,2552
,TROPONIN I,6747
,LACTIC ACID (VENOUS) ALERT LEGACY,579
,CK,663
19123-9,MAGNESIUM,366821
3097-3,BASIC METABOLIC PANEL,3667
2951-2,BASIC METABOLIC PANEL,124266
2345-7,BASIC METABOLIC PANEL,124276
17861-6,BASIC METABOLIC PANEL,124270
2028-9,BASIC METABOLIC PANEL,124268
3094-0,BASIC METABOLIC PANEL,124271
2160-0,BASIC METABOLIC PANEL,124271
77147-7,BASIC METABOLIC PANEL,271
48643-1,BASIC METABOLIC PANEL,271
2823-3,BASIC METABOLIC PANEL,124270
2075-0,BASIC METABOLIC PANEL,124271
36916-5,"KAPPA LIGHT CHAIN, FREE, SERUM",22
33944-0,"LAMBDA LIGHT CHAIN, FREE, SERUM",16
785-6,CBC WITH DIFFERENTIAL,16021
786-4,CBC WITH DIFFERENTIAL,16021
6690-2,CBC WITH DIFFERENTIAL,16056
751-8,CBC WITH DIFFERENTIAL,15994
731-0,CBC WITH DIFFERENTIAL,16007
776-5,CBC WITH DIFFERENTIAL,12634
736-9,CBC WITH DIFFERENTIAL,16006
770-8,CBC WITH DIFFERENTIAL,16012
789-8,CBC WITH DIFFERENTIAL,16022
718-7,CBC WITH DIFFERENTIAL,16021
4544-3,CBC WITH DIFFERENTIAL,16021
787-2,CBC WITH DIFFERENTIAL,16021
788-0,CBC WITH DIFFERENTIAL,16019
777-3,CBC WITH DIFFERENTIAL,16022
2857-1,"PSA, TOTAL AND FREE",513
10886-0,"PSA, TOTAL AND FREE",510
12841-3,"PSA, TOTAL AND FREE",821
1989-3,VITAMIN D 25 HYDROXY,3492
2132-9,B12/ FOLATE LEVEL,5909
2284-8,B12/ FOLATE LEVEL,988
4548-4,HEMOGLOBIN A1C,144833
1759-0,COMPREHENSIVE METABOLIC PANEL,20073
10834-0,COMPREHENSIVE METABOLIC PANEL,20071
77147-7,COMPREHENSIVE METABOLIC PANEL,2089
48643-1,COMPREHENSIVE METABOLIC PANEL,2089
43396-1,LIPID PANEL,9451
2085-9,LIPID PANEL,11314
13457-7,LIPID PANEL,11314
9830-1,LIPID PANEL,10254
43396-1,"LIPID PANEL, STANDARD",2713
2093-3,"LIPID PANEL, STANDARD",2712
2085-9,"LIPID PANEL, STANDARD",2712
2571-8,"LIPID PANEL, STANDARD",2712
13457-7,"LIPID PANEL, STANDARD",2713
9830-1,"LIPID PANEL, STANDARD",2713
69405-9,BASIC METABOLIC PANEL,80251
33037-3,BASIC METABOLIC PANEL,120605
18182-6,BASIC METABOLIC PANEL,120615
,"PH, BODY FLUID",118
5803-2,URINALYSIS WITH CULTURE IF INDICATED,37441
53326-5,URINALYSIS WITH CULTURE IF INDICATED,37042
5902-2,PROTIME-INR,35238
6301-6,PROTIME-INR,35244
785-6,CBC WITH AUTO DIFFERENTIAL,139259
786-4,CBC WITH AUTO DIFFERENTIAL,139259
789-8,CBC WITH AUTO DIFFERENTIAL,139254
718-7,CBC WITH AUTO DIFFERENTIAL,139253
4544-3,CBC WITH AUTO DIFFERENTIAL,139258
787-2,CBC WITH AUTO DIFFERENTIAL,139257
788-0,CBC WITH AUTO DIFFERENTIAL,139259
777-3,CBC WITH AUTO DIFFERENTIAL,139255
69405-9,COMPREHENSIVE METABOLIC PANEL,93516
31017-7,CELIAC DISEASE COMPREHENSIVE PANEL,30
2458-8,CELIAC DISEASE COMPREHENSIVE PANEL,30
27822-6,PROTEIN S ACTIVITY,367
27819-2,PROTEIN C ACTIVITY,19
3182-3,"CARDIOLIPIN ANTIBODY, IGM",13
13590-5,ACTIVATED PROTEIN C RESISTANCE WITH REFLEX TO FACTOR V (LEIDEN) MUTATION,1
88294-4,COMPREHENSIVE METABOLIC PANEL,17094
88293-6,COMPREHENSIVE METABOLIC PANEL,17092
27811-9,ANTITHROMBIN III,146
2498-4,IRON AND TIBC,7373
2500-7,IRON AND TIBC,7360
2502-3,IRON AND TIBC,7339
2276-4,FERRITIN,159372
2498-4,"IRON, TIBC AND FERRITIN PANEL",415
2500-7,"IRON, TIBC AND FERRITIN PANEL",412
2502-3,"IRON, TIBC AND FERRITIN PANEL",400
2276-4,"IRON, TIBC AND FERRITIN PANEL",415
2161-8,URINE MICROALBUMIN,5100
14957-5,URINE MICROALBUMIN,4391
9318-7,URINE MICROALBUMIN,2873
3016-3,THYROID FUNCTION CASCADE,5079
,LIPASE,1418
2339-0,BEDSIDE GLUCOSE UNSOLICITED RESULTS,342329
14979-9,APTT,286930
3097-3,COMPREHENSIVE METABOLIC PANEL,19977
42637-9,B-TYPE NATRIURETIC PEPTIDE,20036
,POCT ESTIMATED GFR UNSOLICITED RESULTS,472
,LAB WB INR,163
32693-4,"LACTIC ACID, PLASMA",20082
11546-9,"IGP, APTIMA HPV, RFX 16/18,45",294
,"IGP,APTIMA HPV,CTNG AGE GDLN",66
48065-7,"D-DIMER, QUANTITATIVE",9201
11054-4,L - LIPID PANEL WITH LDL/HDL RATIO 235010,87
2093-3,L - LIPID PANEL WITH LDL/HDL RATIO 235010,87
2571-8,L - LIPID PANEL WITH LDL/HDL RATIO 235010,87
2085-9,L - LIPID PANEL WITH LDL/HDL RATIO 235010,87
13458-5,L - LIPID PANEL WITH LDL/HDL RATIO 235010,87
13457-7,L - LIPID PANEL WITH LDL/HDL RATIO 235010,87
11580-8,TSH,88186
2093-3,L - LIPID PANEL 303756,1372
2571-8,L - LIPID PANEL 303756,1372
2085-9,L - LIPID PANEL 303756,1372
13458-5,L - LIPID PANEL 303756,1372
13457-7,L - LIPID PANEL 303756,1372
718-7,HEMOGLOBIN,2368920
1558-6,GESTATIONAL DIABETIC (3 HR) TOLERANCE,311
12646-6,GESTATIONAL DIABETIC (3 HR) TOLERANCE,189
12610-2,GESTATIONAL DIABETIC (3 HR) TOLERANCE,189
1530-5,GESTATIONAL DIABETIC (3 HR) TOLERANCE,311
1504-0,GESTATIONAL DIABETIC (1 HR) SCREEN,1418
,FIBRINOGEN,192
,PLATELET COUNT,5624
,HEMOGLOBIN,1507
,"GLUCOSE TOLERANCE, 1 HOUR",22
,SALICYLATE LEVEL,115
,THYROID FUNCTION CASCADE,1536
,ACETAMINOPHEN LEVEL,124
,IRON AND TIBC,3839
38483-4,POCT CREATININE UNSOLICITED RESULTS,2757
77147-7,POCT CREATININE UNSOLICITED RESULTS,2739
3051-0,"T3, FREE",4031
3024-7,"T4, FREE",8761
2143-6,CORTISOL,5584
5821-4,URINALYSIS WITH MICROSCOPIC LEGACY,293
5811-5,URINALYSIS WITH MICROSCOPIC LEGACY,266
2243-4,ESTRADIOL,1241
785-6,CBC,113153
786-4,CBC,113153
776-5,CBC,2350
789-8,CBC,113147
718-7,CBC,113147
4544-3,CBC,113151
787-2,CBC,113152
788-0,CBC,113154
777-3,CBC,113154
10501-5,LUTEINIZING HORMONE,2251
15067-2,FOLLICLE STIMULATING HORMONE,855
,C-REACTIVE PROTEIN,1880
,HEMOGLOBIN A1C,4164
,URINE MICROALBUMIN,2289
,VITAMIN B12,1431
11277-1,URINALYSIS WITH CULTURE IF INDICATED,309
5811-5,URINALYSIS WITH CULTURE IF INDICATED,330
20447-9,"HIV-1 RNA, PCR (NONGRAPH) RFX/GENO",28
11546-9,"IGP, RFX APTIMA HPV ASCU",67
4544-3,T-HELPER CELLS (CD4) COUNT,72
787-2,T-HELPER CELLS (CD4) COUNT,72
24467-3,T-HELPER CELLS (CD4) COUNT,70
742-7,T-HELPER CELLS (CD4) COUNT,71
731-0,T-HELPER CELLS (CD4) COUNT,71
736-9,T-HELPER CELLS (CD4) COUNT,71
777-3,T-HELPER CELLS (CD4) COUNT,71
770-8,T-HELPER CELLS (CD4) COUNT,71
788-0,T-HELPER CELLS (CD4) COUNT,72
751-8,T-HELPER CELLS (CD4) COUNT,71
713-8,T-HELPER CELLS (CD4) COUNT,71
5905-5,T-HELPER CELLS (CD4) COUNT,71
8123-2,T-HELPER CELLS (CD4) COUNT,70
6690-2,T-HELPER CELLS (CD4) COUNT,72
789-8,T-HELPER CELLS (CD4) COUNT,72
718-7,T-HELPER CELLS (CD4) COUNT,72
785-6,T-HELPER CELLS (CD4) COUNT,72
786-4,T-HELPER CELLS (CD4) COUNT,72
,GESTATIONAL GLUCOSE BASELINE PERFORMABLE,35
,GESTATIONAL GLUCOSE 2 HR PERFORMABLE,35
,GESTATIONAL GLUCOSE 3 HR PERFORMABLE,35
,"HEMOGLOBIN AND HEMATOCRIT, BLOOD",4486
,GESTATIONAL DIABETIC (1 HR) SCREEN,680
2132-9,VITAMIN B12,28548
,FERRITIN,1508
2857-1,PSA,4802
,LACTATE DEHYDROGENASE,510
5643-2,ETHANOL,1974
,PHOSPHORUS,4120
,CANCER ANTIGEN 27.29,56
1504-0,"GLUCOSE, GESTATIONAL SCREEN (50G)-140 CUTOFF",585
,CEA,203
33762-6,NT-PRO B-TYPE NATRIURETIC PEPTIDE (BNP),1524
21198-7,"HCG, QUANTITATIVE",2791
13458-5,LIPID PANEL,1863
5803-2,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
5811-5,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
19161-9,POCT URINE CHEMISTRY UNSOLICITED RESULTS,7054
,HCV AB W/RFLX TO VERIFICATION,20
,"SEDIMENTATION RATE, AUTOMATED",1081
5803-2,URINALYSIS WITH REFLEX MICROSCOPIC,9736
53326-5,URINALYSIS WITH REFLEX MICROSCOPIC,7043
1763-2,ALDOSTERONE,204
2915-7,RENIN ACTIVITY,181
,"LACTIC ACID, PLASMA",724
5403-1,"VARICELLA ZOSTER ANTIBODY, IGG",544
5334-8,"RUBELLA ANTIBODY, IGG",584
,RETICULOCYTES,3072
,"D-DIMER, QUANTITATIVE",571
2161-8,"PROTEIN / CREATININE RATIO, URINE",6165
2888-6,"PROTEIN / CREATININE RATIO, URINE",6165
785-6,Q PLATELET ESTIMATION,7
786-4,Q PLATELET ESTIMATION,7
6690-2,Q PLATELET ESTIMATION,7
713-8,Q PLATELET ESTIMATION,7
5905-5,Q PLATELET ESTIMATION,7
742-7,Q PLATELET ESTIMATION,7
751-8,Q PLATELET ESTIMATION,7
731-0,Q PLATELET ESTIMATION,7
776-5,Q PLATELET ESTIMATION,7
736-9,Q PLATELET ESTIMATION,7
704-7,Q PLATELET ESTIMATION,7
770-8,Q PLATELET ESTIMATION,7
711-2,Q PLATELET ESTIMATION,7
789-8,Q PLATELET ESTIMATION,7
706-2,Q PLATELET ESTIMATION,7
5334-8,Q PLATELET ESTIMATION,7
718-7,Q PLATELET ESTIMATION,7
4544-3,Q PLATELET ESTIMATION,7
787-2,Q PLATELET ESTIMATION,7
788-0,Q PLATELET ESTIMATION,7
777-3,Q PLATELET ESTIMATION,7
5811-5,URINALYSIS WITH REFLEX MICROSCOPIC,2314
88294-4,BASIC METABOLIC PANEL,3290
88293-6,BASIC METABOLIC PANEL,3286
,POCT CREATININE UNSOLICITED RESULTS,3233
,ANTI XA-HEPARIN,1591
,PROCALCITONIN TEST,919
6948-4,LAMOTRIGINE LEVEL,63
30341-2,"SEDIMENTATION RATE, AUTOMATED",8210
1920-8,HEPATIC FUNCTION PANEL,3183
1742-6,HEPATIC FUNCTION PANEL,3185
2885-2,HEPATIC FUNCTION PANEL,3183
1751-7,HEPATIC FUNCTION PANEL,3181
6768-6,HEPATIC FUNCTION PANEL,3183
,POCT INR,10869
,"CALCIUM, IONIZED",2119
,CONVERT BMP TO CMP,2442
,T4,120
,T3,110
,AMMONIA,436
770-8,"Q DIFFERENTIAL, MANUAL",105
736-9,"Q DIFFERENTIAL, MANUAL",104
751-8,"Q DIFFERENTIAL, MANUAL",105
732-8,"Q DIFFERENTIAL, MANUAL",105
785-6,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
786-4,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
6690-2,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
776-5,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
789-8,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
718-7,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
4544-3,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
787-2,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
788-0,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
777-3,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,53
17849-1,RETICULOCYTES,2451
14196-0,RETICULOCYTES,80
5821-4,UR MICROSCOPIC 333328,434
13945-1,UR MICROSCOPIC 333328,434
5787-7,UR MICROSCOPIC 333328,434
2965-2,URINALYSIS WITH REFLEX MICROSCOPIC,380
20405-7,URINALYSIS WITH REFLEX MICROSCOPIC,486
788-0,HEMOGLOBIN ELECTROPHORESIS,119
789-8,HEMOGLOBIN ELECTROPHORESIS,120
718-7,HEMOGLOBIN ELECTROPHORESIS,119
4544-3,HEMOGLOBIN ELECTROPHORESIS,119
787-2,HEMOGLOBIN ELECTROPHORESIS,119
785-6,HEMOGLOBIN ELECTROPHORESIS,119
4551-8,HEMOGLOBIN ELECTROPHORESIS,119
3016-3,TSH W/REFLEX TO FT4,2260
,POCT HBA1C,450
11580-8,TSH REFLEX TO T4F,108
3097-3,"METABOLIC PANEL (14), COMPREHENSIVE",111
2951-2,"METABOLIC PANEL (14), COMPREHENSIVE",111
2345-7,"METABOLIC PANEL (14), COMPREHENSIVE",111
1742-6,"METABOLIC PANEL (14), COMPREHENSIVE",112
1920-8,"METABOLIC PANEL (14), COMPREHENSIVE",112
1751-7,"METABOLIC PANEL (14), COMPREHENSIVE",111
17861-6,"METABOLIC PANEL (14), COMPREHENSIVE",111
2885-2,"METABOLIC PANEL (14), COMPREHENSIVE",111
2028-9,"METABOLIC PANEL (14), COMPREHENSIVE",112
6768-6,"METABOLIC PANEL (14), COMPREHENSIVE",112
1759-0,"METABOLIC PANEL (14), COMPREHENSIVE",111
1975-2,"METABOLIC PANEL (14), COMPREHENSIVE",112
10834-0,"METABOLIC PANEL (14), COMPREHENSIVE",111
3094-0,"METABOLIC PANEL (14), COMPREHENSIVE",111
2160-0,"METABOLIC PANEL (14), COMPREHENSIVE",111
88294-4,"METABOLIC PANEL (14), COMPREHENSIVE",111
88293-6,"METABOLIC PANEL (14), COMPREHENSIVE",111
2823-3,"METABOLIC PANEL (14), COMPREHENSIVE",111
2075-0,"METABOLIC PANEL (14), COMPREHENSIVE",111
1547-9,"GTT, FASTING",149
,CORRECTED CALCIUM LEGACY,346
,"PROTEIN, URINE, 24 HOUR",531
,PSA,144
,LITHIUM LEVEL,34
,IRON,67
,"T4, FREE",1669
,B12/ FOLATE LEVEL,1292
,VITAMIN D 25 HYDROXY,887
,"IGG, IGA, IGM",234
5821-4,"UA/M W/RFLX CULTURE, COMP",633
5796-8,"UA/M W/RFLX CULTURE, COMP",611
11277-1,"UA/M W/RFLX CULTURE, COMP",611
5811-5,"UA/M W/RFLX CULTURE, COMP",630
5803-2,"UA/M W/RFLX CULTURE, COMP",709
2986-8,TESTOSTERONE,1302
5821-4,URINALYSIS WITH CULTURE IF INDICATED,311
2991-8,"TESTOSTERONE, FREE, TOTAL",985
5157-3,"EPSTEIN-BARR VIRUS VCA, IGG",9
2160-0,"CREATININE, SERUM",3660
,"CREATININE, SERUM",2140
3084-1,URIC ACID,90816
3016-3,TSH+FREE T4,192
6892-4,TSH+FREE T4,15
4537-7,"SEDIMENTATION RATE, AUTOMATED",1067
,"CREATININE, URINE, 24 HOUR",39
,"METANEPHRINES FRACTIONATED 24HR, URINE",15
,"METANEPHRINES, FRACTIONATED FREE-MAYO",20
,"HCG, QUANTITATIVE",273
3094-0,BUN,635708
69405-9,"CREATININE, SERUM",2408
30934-4,B-TYPE NATRIURETIC PEPTIDE,1060
,"PTH, INTACT",381
2774-8,PHOSPHORUS,35226
,POCT CORD BLOOD GAS UNSOLICITED RESULTS,402
11580-8,THYROID FUNCTION CASCADE,245
83112-3,"PSA, TOTAL AND FREE",311
83113-1,"PSA, TOTAL AND FREE",311
13969-1,CK TOTAL AND CKMB,3054
1798-8,AMYLASE,15807
16362-6,AMMONIA,4217
2731-8,"PTH, INTACT (ICMA) AND IONIZED CALCIUM",17
17861-6,"PTH, INTACT (ICMA) AND IONIZED CALCIUM",15
17863-2,"PTH, INTACT (ICMA) AND IONIZED CALCIUM",15
9830-1,LIPID PANEL W/ CHOL/HDL RATIO,368
2093-3,LIPID PANEL W/ CHOL/HDL RATIO,368
2571-8,LIPID PANEL W/ CHOL/HDL RATIO,368
2085-9,LIPID PANEL W/ CHOL/HDL RATIO,368
13458-5,LIPID PANEL W/ CHOL/HDL RATIO,368
13457-7,LIPID PANEL W/ CHOL/HDL RATIO,368
38483-4,POCT CREATININE & LACTIC ACID VENOUS UNSOLICITED RESULTS,32
77147-7,POCT CREATININE & LACTIC ACID VENOUS UNSOLICITED RESULTS,32
2519-7,POCT CREATININE & LACTIC ACID VENOUS UNSOLICITED RESULTS,32
2283-0,B12/ FOLATE LEVEL,4919
14979-9,PT AND PTT,174
6301-6,PT AND PTT,145
5902-2,PT AND PTT,145
14957-5,MICROALBUMIN LEVEL URINE LEGACY,173
62292-8,VITAMIN D 25 HYDROXY,6026
2161-8,"COMPLIANCE DRUG ANALYSIS, UR",24
58368-2,"COMPLIANCE DRUG ANALYSIS, UR",24
58360-9,"COMPLIANCE DRUG ANALYSIS, UR",24
58361-7,"COMPLIANCE DRUG ANALYSIS, UR",24
,PT AND PTT,60
,RHEUMATOID FACTOR,379
,"T3, UPTAKE",52
785-6,"CBC, NO DIFFERENTIAL/PLATELET",15
786-4,"CBC, NO DIFFERENTIAL/PLATELET",15
6690-2,"CBC, NO DIFFERENTIAL/PLATELET",15
789-8,"CBC, NO DIFFERENTIAL/PLATELET",15
718-7,"CBC, NO DIFFERENTIAL/PLATELET",15
4544-3,"CBC, NO DIFFERENTIAL/PLATELET",15
787-2,"CBC, NO DIFFERENTIAL/PLATELET",15
788-0,"CBC, NO DIFFERENTIAL/PLATELET",15
,"PROTEIN, BODY FLUID",166
,"GLUCOSE, BODY FLUID",145
,"LACTATE DEHYDROGENASE, BODY FLUID",151
,COAGULATION SCREEN,346
,CA 125,69
,POTASSIUM,1553
,CARDIAC DEVICE CHECK - IN CLINIC,636
2532-0,LACTATE DEHYDROGENASE,3402
13945-1,URINALYSIS WITH REFLEX MICROSCOPIC,1027
5821-4,URINALYSIS WITH REFLEX MICROSCOPIC,1027
,ESTRADIOL,149
2986-8,"TESTOSTERONE, FREE, TOTAL",950
3026-2,T4,3813
3053-6,T3,1804
,AST,210
,URIC ACID,723
,ALT,206
,ESOPHAGEAL EPITHELIAL EOSINOPHILIC MARKERS,12
6768-6,CONVERT BMP TO CMP,1587
2885-2,CONVERT BMP TO CMP,1587
1751-7,CONVERT BMP TO CMP,1587
1975-2,CONVERT BMP TO CMP,1587
1742-6,CONVERT BMP TO CMP,1587
1920-8,CONVERT BMP TO CMP,1587
3034-6,IRON AND TIBC,4572
,BUN,923
718-7,"HEMOGLOBIN AND HEMATOCRIT, BLOOD",12981
4544-3,"HEMOGLOBIN AND HEMATOCRIT, BLOOD",12981
12616-9,"GLUCOSE TOLERANCE, 3 HOURS",116
1558-6,"GLUCOSE TOLERANCE, 3 HOURS",116
12615-1,"GLUCOSE TOLERANCE, 3 HOURS",116
12617-7,"GLUCOSE TOLERANCE, 3 HOURS",116
1834-1,"AFP, MAT SERUM, OPEN SPINA BIFIDA",659
23811-3,"AFP, MAT SERUM, OPEN SPINA BIFIDA",654
786-4,"HEMOGLOBIN AND HEMATOCRIT, BLOOD",12622
62290-2,"VITAMIN D 1,25 DIHYDROXY",462
2823-3,POTASSIUM,1913776
,PROGESTERONE,54
,TESTOSTERONE,124
,ETHANOL,3504
8099-4,THYROID PEROXIDASE ANTIBODY,867
60474-4,RETICULOCYTES,2349
3024-7,"Q T4, FREE",231
2039-6,CEA,6528
,PROLACTIN,156
,FOLLICLE STIMULATING HORMONE,123
,LUTEINIZING HORMONE,96
5388-4,TOXOPLASMA ABS IGG/IGM,68
40678-5,TOXOPLASMA ABS IGG/IGM,49
13969-1,CK,6612
11277-1,URINALYSIS WITH REFLEX MICROSCOPIC,999
1971-1,HEPATIC FUNCTION PANEL,383
10834-0,HEPATIC FUNCTION PANEL,383
1759-0,HEPATIC FUNCTION PANEL,383
11546-9,"IGP, CTNG, RFX APTIMA HPV ASCU",100
3024-7,TSH+FREE T4,302
,CALCIUM,331
2345-7,RENAL FUNCTION PANEL,2460
2160-0,RENAL FUNCTION PANEL,2460
2951-2,RENAL FUNCTION PANEL,2460
,RENAL FUNCTION PANEL,3721
18182-6,RENAL FUNCTION PANEL,2436
2774-8,RENAL FUNCTION PANEL,2436
33037-3,RENAL FUNCTION PANEL,2436
46099-8,RENAL FUNCTION PANEL,2244
2823-3,RENAL FUNCTION PANEL,2460
2075-0,RENAL FUNCTION PANEL,2460
2028-9,RENAL FUNCTION PANEL,2460
3094-0,RENAL FUNCTION PANEL,2460
17861-6,RENAL FUNCTION PANEL,2460
1751-7,RENAL FUNCTION PANEL,2460
39017-9,QUANTIFERON-TB GOLD PLUS,3540
2986-8,"TESTOSTERONE, FREE+TOTAL LC/MS",71
2991-8,"TESTOSTERONE, FREE+TOTAL LC/MS",71
2965-2,"UA/M W/RFLX CULTURE, ROUTINE",108
20405-7,"UA/M W/RFLX CULTURE, ROUTINE",136
5803-2,"UA/M W/RFLX CULTURE, ROUTINE",137
785-6,CBC/DIFF AMBIGUOUS DEFAULT,722
786-4,CBC/DIFF AMBIGUOUS DEFAULT,722
6690-2,CBC/DIFF AMBIGUOUS DEFAULT,721
736-9,CBC/DIFF AMBIGUOUS DEFAULT,725
770-8,CBC/DIFF AMBIGUOUS DEFAULT,726
751-8,CBC/DIFF AMBIGUOUS DEFAULT,726
731-0,CBC/DIFF AMBIGUOUS DEFAULT,726
789-8,CBC/DIFF AMBIGUOUS DEFAULT,722
718-7,CBC/DIFF AMBIGUOUS DEFAULT,722
4544-3,CBC/DIFF AMBIGUOUS DEFAULT,721
787-2,CBC/DIFF AMBIGUOUS DEFAULT,722
788-0,CBC/DIFF AMBIGUOUS DEFAULT,720
777-3,CBC/DIFF AMBIGUOUS DEFAULT,722
,"LDL CHOLESTEROL, DIRECT",135
48159-8,HEPATITIS C VIRUS (HCV) AB W/RFL TO QN RT PCR,41
4542-7,HCV FIBROSURE,2
1869-7,HCV FIBROSURE,2
48795-9,HCV FIBROSURE,2
1743-4,HCV FIBROSURE,2
48792-6,HCV FIBROSURE,2
1835-8,HCV FIBROSURE,2
1975-2,HCV FIBROSURE,2
2324-2,HCV FIBROSURE,2
,GTT 3 HOUR,9
,GTT 1 HOUR,6
,"GTT, FASTING",6
,GTT 2 HOUR,6
9804-6,STONE ANALYSIS,58
,LACTIC ACID LEGACY,151
3298-7,ACETAMINOPHEN LEVEL,1588
4024-6,SALICYLATE LEVEL,1338
2498-4,IRON,89627
,HEPATIC FUNCTION PANEL,1946
2839-9,PROGESTERONE,936
13967-5,SEX HORMONE BINDING GLOBULIN,115
2986-8,"TESTOSTERONE, TOTAL MS",197
2857-1,PROSTATE SPECIFIC ANTIGEN TOTAL,270
,SODIUM,845
2284-8,FOLATE,20270
,THYROGLOBULIN ANTIBODY,54
,THYROID PEROXIDASE ANTIBODY,151
,THYROGLOBULIN TUMOR MARKER,9
,"T3, FREE",288
14334-7,LITHIUM LEVEL,212
2161-8,"CREATININE, URINE, RANDOM",1017
,"GLUCOSE, FASTING",9
5803-2,"DRUG PANEL, URINE",1224
,PH  URINE DIPSTICK,76
3052-8,"T3 REVERSE, LC/MS/MS",48
,VON WILLEBRAND FACTOR ANTIGEN,5
,VON WILLEBRAND FACTOR ACTIVITY,7
,FACTOR VIII (8) ACTIVITY,22
,CORTISOL,278
3013-0,THYROGLOBULIN PANEL,146
8098-6,THYROGLOBULIN PANEL,146
,LAB WB LACTIC ACID ARTERIAL LEGACY,42
,"VANCOMYCIN, TROUGH",220
48398-2,HEPATITIS B VIRAL DNA QUANT-MAYO,33
53962-7,AFP TUMOR MARKER,2468
5803-2,URINALYSIS WITH MICROSCOPIC LEGACY,360
,"CREATININE CLEARANCE, URINE, 24 HOUR PERFORMABLE",255
81323-8,"CREATININE CLEARANCE, URINE, 24 HOUR PERFORMABLE",172
28009-9,"CREATININE CLEARANCE, URINE, 24 HOUR PERFORMABLE",172
2161-8,"CREATININE CLEARANCE, URINE, 24 HOUR PERFORMABLE",172
35591-7,"CREATININE CLEARANCE, URINE, 24 HOUR PERFORMABLE",172
2160-0,"CREATININE CLEARANCE, URINE, 24 HOUR PERFORMABLE",172
28009-9,"PROTEIN, URINE, 24 HOUR",355
2888-6,"PROTEIN, URINE, 24 HOUR",397
,"VANCOMYCIN, RANDOM",197
11546-9,"IGP,CTNGTV,RFX APTIMA HPV ASCU",30
2345-7,"GLUCOSE, RANDOM",200
41653-7,BEDSIDE GLUCOSE UNSOLICITED RESULTS,67536
1501-6,GESTATIONAL DIABETIC (3 HR) TOLERANCE,122
1514-9,GESTATIONAL DIABETIC (3 HR) TOLERANCE,122
14959-1,URINE MICROALBUMIN,1685
,PREPARE RBC,135758
,ASPIRIN PFA,22
,PLAVIX PLATELET FUNC ANALYSIS,23
,"GLUCOSE, RANDOM",27
20448-7,"INSULIN LEVEL, TOTAL",573
26505-8,MANUAL DIFF CELLAVISION,8150
26478-8,MANUAL DIFF CELLAVISION,7944
28541-1,MANUAL DIFF CELLAVISION,2360
94874-5,"CYCLIC CITRUL PEPTIDE ANTIBODY, IGG",230
,HAPTOGLOBIN,168
,EOSINOPHIL URINE,479
,"ELECTROLYTES, URINE",756
1649-3,"VITAMIN D 1,25 DIHYDROXY",797
62291-0,"VITAMIN D 1,25 DIHYDROXY",131
89324-8,CARDIO IQ INSULIN RESISTANCE PANEL WITH SCORE,41
1986-9,CARDIO IQ INSULIN RESISTANCE PANEL WITH SCORE,41
92845-7,CARDIO IQ INSULIN RESISTANCE PANEL WITH SCORE,41
11054-4,LIPID PANEL WITH RATIOS,151
43396-1,LIPID PANEL WITH RATIOS,151
2093-3,LIPID PANEL WITH RATIOS,151
2085-9,LIPID PANEL WITH RATIOS,151
2571-8,LIPID PANEL WITH RATIOS,151
13457-7,LIPID PANEL WITH RATIOS,151
9830-1,LIPID PANEL WITH RATIOS,151
2965-2,URINALYSIS WITH MICROSCOPIC LEGACY,94
20405-7,URINALYSIS WITH MICROSCOPIC LEGACY,114
,ANTITHROMBIN III,24
,"HOMOCYSTEINE, SERUM",48
,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,717
,PROTEIN C AND S ACTIVITY,203
17842-6,CANCER ANTIGEN 27.29,910
13046-8,MANUAL DIFF CELLAVISION,2601
,GROWTH HORMONE,4
,THYROGLOBULIN PANEL,24
,"VALPROIC ACID LEVEL, TOTAL",53
,"INSULIN LEVEL, TOTAL",61
,"AMYLASE, BODY FLUID",64
,"CEA, BODY FLUID",8
,TRANSESOPHAGEAL ECHOCARDIOGRAM,102
,TACROLIMUS LEVEL,99
,T LYMPH PROFILE,713
17863-2,"CALCIUM, IONIZED",58
11277-1,URINALYSIS WITH MICROSCOPIC LEGACY,249
10334-1,CA 125,2972
,"PROTEIN, CSF",82
,"GLUCOSE, CSF",71
2501-5,IRON AND TIBC,477
,"IGP,APTIMA HPV AGE GDLN, CTNG",132
11546-9,"IGP,CTNG,APTIMAHPV,RFX16/18,45",104
15067-2,FSH AND LH,218
10501-5,FSH AND LH,218
1518-0,GTT 2 HOUR,78
1507-3,GTT 1 HOUR,107
1533-9,GTT 3 HOUR,52
,CBC WITH PLATELET NO DIFFERENTIAL LEGACY,11690
75241-0,PROCALCITONIN TEST,3250
2842-3,PROLACTIN,863
,"IGP,APTIMA HPV AGE GDLN,CTNGTV",34
3046-0,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
2091-7,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
2093-3,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
35388-8,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
2571-8,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
1884-6,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
2085-9,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
2089-1,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
3047-8,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
,IGA,50
,TISSUE TRANSGLUTAMINASE ANTIBODY IGA AND IGG PROFILE,6
13945-1,URINALYSIS WITH CULTURE IF INDICATED,311
,OSMOLALITY,72
,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,262
,"BETA 2 MICROGLOBULIN, SERUM",28
,FRACTIONAL EXCRETION OF SODIUM,54
,GESTATIONAL GLUCOSE 1 HR PERFORMABLE,35
,REFLEX HBA1C IF GLUC>120,20
30437-8,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",633
55793-4,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",666
32623-1,PLATELET COUNT,2690
,"CREATININE LEVEL, BODY FLUID",22
14979-9,PTT HEPARIN THERAPY,3062
1834-1,SEQUENTIAL 2 LEGACY,1
76348-2,SEQUENTIAL 2 LEGACY,1
48407-1,SEQUENTIAL 2 LEGACY,1
2250-9,SEQUENTIAL 2 LEGACY,1
19080-1,SEQUENTIAL 2 LEGACY,1
32166-1,SEQUENTIAL 2 LEGACY,1
23811-3,SEQUENTIAL 2 LEGACY,1
23883-2,SEQUENTIAL 2 LEGACY,1
36904-1,SEQUENTIAL 2 LEGACY,1
21264-7,SEQUENTIAL 2 LEGACY,1
20572-4,HEMOGLOBINOPATHY EVALUATION,25
4552-6,HEMOGLOBINOPATHY EVALUATION,25
32166-1,LC SEQUENTIAL 1,1
19080-1,LC SEQUENTIAL 1,1
76348-2,LC SEQUENTIAL 1,1
48407-1,LC SEQUENTIAL 1,1
2885-2,"PROTEIN, TOTAL",87693
2868-8,"PROTEIN ELECTROPHORESIS, SERUM",1470
2871-2,"PROTEIN ELECTROPHORESIS, SERUM",1358
2862-1,"PROTEIN ELECTROPHORESIS, SERUM",1470
2885-2,"PROTEIN ELECTROPHORESIS, SERUM",1438
2865-4,"PROTEIN ELECTROPHORESIS, SERUM",1470
2874-6,"PROTEIN ELECTROPHORESIS, SERUM",1470
785-6,OBSTETRIC PANEL WITHOUT HIV,324
786-4,OBSTETRIC PANEL WITHOUT HIV,324
6690-2,OBSTETRIC PANEL WITHOUT HIV,326
5905-5,OBSTETRIC PANEL WITHOUT HIV,322
742-7,OBSTETRIC PANEL WITHOUT HIV,321
751-8,OBSTETRIC PANEL WITHOUT HIV,323
731-0,OBSTETRIC PANEL WITHOUT HIV,321
776-5,OBSTETRIC PANEL WITHOUT HIV,325
736-9,OBSTETRIC PANEL WITHOUT HIV,322
770-8,OBSTETRIC PANEL WITHOUT HIV,322
789-8,OBSTETRIC PANEL WITHOUT HIV,324
5334-8,OBSTETRIC PANEL WITHOUT HIV,326
718-7,OBSTETRIC PANEL WITHOUT HIV,324
4544-3,OBSTETRIC PANEL WITHOUT HIV,324
787-2,OBSTETRIC PANEL WITHOUT HIV,324
788-0,OBSTETRIC PANEL WITHOUT HIV,324
777-3,OBSTETRIC PANEL WITHOUT HIV,324
,IGG,52
1959-6,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8068
30313-1,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8311
11558-4,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8065
11556-8,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8065
11557-6,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8066
2714-4,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,8312
,POCT CORD PH UNSOLICITED RESULTS,442
749-2,"Q DIFFERENTIAL, MANUAL",35
30433-7,"Q DIFFERENTIAL, MANUAL",32
30446-9,"Q DIFFERENTIAL, MANUAL",37
740-1,"Q DIFFERENTIAL, MANUAL",31
3274-8,ANTI XA-HEPARIN,10870
,"SODIUM, URINE, RANDOM",40
,"POTASSIUM, URINE, RANDOM",8
,"CHLORIDE, URINE, RANDOM",6
,"PROTEIN, URINE, RANDOM",14
,"PHOSPHORUS, URINE, RANDOM",3
,"OSMOLALITY, URINE",261
2518-9,"LACTIC ACID, PLASMA (ARTERIAL)",1728
50410-0,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,269
34571-0,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,266
5902-2,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,278
14979-9,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,278
6303-2,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,266
57838-5,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,266
75506-6,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,266
75884-7,LUPUS SCREEN/CONFIRM PANEL PERFORMABLE,269
,FASTING GLUCOSE TOLERANCE,45
,"CALCIUM, URINE, 24 HOUR",13
789-8,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
718-7,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
2276-4,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,17
786-4,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
788-0,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
785-6,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
4551-8,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,20
4544-3,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
787-2,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
23811-3,"AFP, SERUM, OPEN SPINA BIFIDA",36
48803-1,"AFP, SERUM, OPEN SPINA BIFIDA",36
1834-1,"AFP, SERUM, OPEN SPINA BIFIDA",37
10535-3,DIGOXIN LEVEL,1186
,POCT HGB,599
83073-7,"AFP, MAT SERUM, OPEN SPINA BIFIDA",29
,AMYLASE,123
30078-0,"FECAL FAT, QUANTITATIVE",38
35745-9,"FECAL FAT, QUANTITATIVE",36
25907-7,"PANCREATIC ELASTASE, FECAL",82
,"REGIONAL ALLERGY PROFILE, IGE",268
,DHEA,6
,"PSA, TOTAL AND FREE",129
2695-5,"OSMOLALITY, URINE",1840
2692-2,OSMOLALITY,7405
2965-2,"URINALYSIS, ROUTINE W/RFX",16
20405-7,"URINALYSIS, ROUTINE W/RFX",17
5803-2,"URINALYSIS, ROUTINE W/RFX",16
,PR GLUCOSE TOLERANCE TEST (GTT),1
,"CREATININE, URINE, RANDOM",71
3968-5,"PHENYTOIN LEVEL, TOTAL",212
3255-7,FIBRINOGEN,8442
33935-8,CYCLIC CITRULLINATED PEPTIDE (CCP) AB (IGG),125
18309-5,MANUAL DIFF CELLAVISION,2538
13047-6,MANUAL DIFF CELLAVISION,72
14979-9,PTT ANTICOAGULANT THERAPY,108
731-0,"AUTO DIFFERENTIAL, ADD ON",553
770-8,"AUTO DIFFERENTIAL, ADD ON",556
736-9,"AUTO DIFFERENTIAL, ADD ON",556
5905-5,"AUTO DIFFERENTIAL, ADD ON",556
46099-8,CONVERT BMP TO CMP,1231
4086-5,"VALPROIC ACID LEVEL, TOTAL",448
34660-1,HEMOGLOBIN ELECTROPHORESIS,2
5905-5,OB PANEL W/HIV,155
736-9,OB PANEL W/HIV,155
785-6,OB PANEL W/HIV,153
4544-3,OB PANEL W/HIV,153
787-2,OB PANEL W/HIV,153
718-7,OB PANEL W/HIV,153
770-8,OB PANEL W/HIV,155
788-0,OB PANEL W/HIV,153
777-3,OB PANEL W/HIV,153
786-4,OB PANEL W/HIV,153
731-0,OB PANEL W/HIV,155
751-8,OB PANEL W/HIV,155
742-7,OB PANEL W/HIV,155
5334-8,OB PANEL W/HIV,155
6690-2,OB PANEL W/HIV,153
789-8,OB PANEL W/HIV,153
5390-0,TOXOPLASMA ABS IGG/IGM,19
11580-8,TSH W/REFLEX TO FT4,313
8123-2,T LYMPH PROFILE,460
24467-3,T LYMPH PROFILE,460
6690-2,T LYMPH PROFILE,374
736-9,T LYMPH PROFILE,48
731-0,T LYMPH PROFILE,460
8124-0,T LYMPH PROFILE,460
8122-4,T LYMPH PROFILE,460
17146-2,T LYMPH PROFILE,374
14135-8,T LYMPH PROFILE,460
24108-3,CA 19-9,1078
8098-6,THYROGLOBULIN W/ANTITHYROGLOBIN AB,8
11580-8,TSH+FREE T4,125
45194-8,"HCG, QUANTITATIVE",111
3024-7,T4F,34
11546-9,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
11580-8,T4 AND TSH,13
3026-2,T4 AND TSH,13
,LOOP RECORDER INSERTION,24
18262-6,"LDL CHOLESTEROL, DIRECT",723
788-0,Q HEMOGLOBINOPATHY EVALUATION,3
4546-8,Q HEMOGLOBINOPATHY EVALUATION,15
789-8,Q HEMOGLOBINOPATHY EVALUATION,3
718-7,Q HEMOGLOBINOPATHY EVALUATION,3
4544-3,Q HEMOGLOBINOPATHY EVALUATION,3
787-2,Q HEMOGLOBINOPATHY EVALUATION,3
785-6,Q HEMOGLOBINOPATHY EVALUATION,3
4576-5,Q HEMOGLOBINOPATHY EVALUATION,15
4551-8,Q HEMOGLOBINOPATHY EVALUATION,15
,TRANSTHORACIC ECHO (TTE) COMPLETE,205
,"ALBUMIN, BODY FLUID",27
,"TRIGLYCERIDES, BODY FLUID",38
33959-8,PROCALCITONIN TEST,3570
6768-6,ALKALINE PHOSPHATASE,321542
11031-2,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",623
2748-2,"PH, BODY FLUID",246
2955-3,"ELECTROLYTES, URINE",2009
2828-2,"ELECTROLYTES, URINE",2009
2078-4,"ELECTROLYTES, URINE",2009
,THROMBOELASTOGRAPH CLOTTING PROFILE,834
,"ANTI-DNA ANTIBODY, DOUBLE-STRANDED",76
,VITAMIN B6 (PLP),12
,"VITAMIN B1, WHOLE BLOOD",18
,OFFICE SPIROMETRY,145
,PLATELET FUNCTION ANALYSIS,10
,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,16
32764-3,"WET PREP, GENITAL",402
14367-7,"WET PREP, GENITAL",402
2458-8,"IGG, IGA, IGM",848
2465-3,"IGG, IGA, IGM",848
2472-9,"IGG, IGA, IGM",848
,CD4-CD8 PANEL LEGACY,12
,HIV 1 RNA QN PCR LEGACY,2
,TRIGLYCERIDES,240
,PREALBUMIN,95
785-6,HEMOGRAM,17
786-4,HEMOGRAM,17
6690-2,HEMOGRAM,17
789-8,HEMOGRAM,17
718-7,HEMOGRAM,17
4544-3,HEMOGRAM,17
787-2,HEMOGRAM,17
788-0,HEMOGRAM,17
2731-8,"PTH, INTACT",2144
2857-1,PSA TOTAL (REFLEX TO FREE),129
,POCT LACTIC ACID VENOUS UNSOLICITED RESULTS,77
,FOLATE,206
2149-3,"CREATINE, 24-HOUR URINE",1
2150-1,"CREATINE, 24-HOUR URINE",1
18488-7,"CALCIUM, 24HR URINE",4
6874-2,"CALCIUM, 24HR URINE",4
10834-0,"PROTEIN ELECTROPHORESIS, SERUM",57
1759-0,"PROTEIN ELECTROPHORESIS, SERUM",57
2742-5,ANGIOTENSIN CONVERTING ENZYME,115
2888-6,"PROTEIN ELECTROPHORESIS, URINE",15
2283-0,FOLATE,1305
,PTT HEPARIN THERAPY,347
48404-8,ANCA PANEL FOR VASCULITIS-MAYO,341
74106-6,ANCA PANEL FOR VASCULITIS-MAYO,341
2324-2,GAMMA GT,439
,"LACTIC ACID, PLASMA (ARTERIAL)",233
38445-3,CALPROTECTIN STOOL-MAYO,149
,"AFP, SERUM, OPEN SPINA BIFIDA",412
2777-1,RENAL FUNCTION PANEL,25
77147-7,RENAL FUNCTION PANEL,1
48643-1,RENAL FUNCTION PANEL,1
8098-6,THYROID PEROXIDASE AND THYROGLOBULIN ANTIBODIES,48
8099-4,THYROID PEROXIDASE AND THYROGLOBULIN ANTIBODIES,48
,HIGH SENSITIVITY CRP,74
,"PHENYTOIN LEVEL, TOTAL",19
13945-1,URINALYSIS WITH MICROSCOPIC LEGACY,293
,LACTIC ACID (ARTERIAL) ALERT LEGACY,43
,CARDIAC DEVICE CHECK CHECK - REMOTE,148
18262-6,Q DIRECT LDL,118
5124-3,CMV ABS IGG/IGM,7
5126-8,CMV ABS IGG/IGM,7
20509-6,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,56
20570-8,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,954
39791-9,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,954
39789-3,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,954
41649-5,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,61
41645-3,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,954
2339-0,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,119
,"AMIKACIN LEVEL, TROUGH",11
,"AMIKACIN LEVEL, PEAK",1
11546-9,"PAP IG, CT-NG",24
6690-2,PRENATAL PROFILE I,105
5905-5,PRENATAL PROFILE I,105
786-4,PRENATAL PROFILE I,105
787-2,PRENATAL PROFILE I,105
785-6,PRENATAL PROFILE I,105
4544-3,PRENATAL PROFILE I,105
736-9,PRENATAL PROFILE I,105
777-3,PRENATAL PROFILE I,105
770-8,PRENATAL PROFILE I,105
788-0,PRENATAL PROFILE I,105
742-7,PRENATAL PROFILE I,105
751-8,PRENATAL PROFILE I,105
731-0,PRENATAL PROFILE I,105
5334-8,PRENATAL PROFILE I,106
789-8,PRENATAL PROFILE I,105
718-7,PRENATAL PROFILE I,105
1994-3,"CALCIUM, IONIZED",12522
,"METABOLIC PANEL (14), COMPREHENSIVE",1996
,AFP TUMOR MARKER,99
46128-5,"TISSUE TRANSGLUTAMINASE, IGA",34
6771-0,ALPHA-1-ANTITRYPSIN,106
3094-0,BUN/CREATININE RATIO,14
2160-0,BUN/CREATININE RATIO,14
88294-4,BUN/CREATININE RATIO,14
88293-6,BUN/CREATININE RATIO,14
,SOLUBLE TRANSFERRIN RECEPTOR (STFR)-MAYO,4
2157-6,CK,251
2955-3,"SODIUM, URINE, RANDOM",824
2951-2,SODIUM,1891679
,SPECIFIC GRAVITY URINE,30
,METHOTREXATE LEVEL,37
2494-3,IODINE LEVEL-MAYO,66
2345-7,"GLUCOSE, FASTING",19
2991-8,"TESTOSTERONE, FREE, DIRECT",52
5796-8,URINALYSIS WITH REFLEX MICROSCOPIC,995
2078-4,"CHLORIDE, URINE, RANDOM",89
2828-2,"POTASSIUM, URINE, RANDOM",86
3289-6,FACTOR II (2) ACTIVITY,28
,ANTISTREPTOLYSIN O (ASO) ANTIBODIES,28
2093-3,"CHOLESTEROL, TOTAL",2303
2162-6,"PROTEIN, TOTAL W/CREAT, 24 HOUR URINE",60
13801-6,"PROTEIN, TOTAL W/CREAT, 24 HOUR URINE",118
2889-4,"PROTEIN, TOTAL W/CREAT, 24 HOUR URINE",59
1690-7,5'NUCLEOTIDASE,3
,"METHYLMALONIC ACID, SERUM",23
2731-8,"PTH, INTACT AND CALCIUM",66
17861-6,"PTH, INTACT AND CALCIUM",60
2258-2,"ESTROGENS, FRACTIONATED E1 AND E2 [LAB980]",61
2243-4,"ESTROGENS, FRACTIONATED E1 AND E2 [LAB980]",61
58350-0,MANUAL DIFF CELLAVISION,3
776-5,OB PANEL W/HIV,112
5206-8,"HSV 1/2 IGG,TYPE SPECIFIC AB",135
5209-2,"HSV 1/2 IGG,TYPE SPECIFIC AB",134
,GYNECOLOGIC PAP TEST AGE-BASED GUIDELINE FOR CERVICAL CANCER (APTIMA),31
5803-2,URINALYSIS CHEM ONLY,287
53326-5,URINALYSIS CHEM ONLY,220
,"TESTOSTERONE, FREE, TOTAL",136
,"VITAMIN D 1,25 DIHYDROXY",35
62292-8,"25-HYDROXYVITAMIN D2 AND D3, SERUM",45
49054-0,"25-HYDROXYVITAMIN D2 AND D3, SERUM",45
1989-3,"25-HYDROXYVITAMIN D2 AND D3, SERUM",45
1742-6,HEPATIC FUNCTION PANEL (6),4
1751-7,HEPATIC FUNCTION PANEL (6),4
1975-2,HEPATIC FUNCTION PANEL (6),4
1968-7,HEPATIC FUNCTION PANEL (6),7
6768-6,HEPATIC FUNCTION PANEL (6),4
1920-8,HEPATIC FUNCTION PANEL (6),4
,TPA FIBRINOGEN,23
,POCT LACTIC ACID ARTERIAL UNSOLICITED RESULTS,90
71774-4,QUANTIFERON-TB GOLD PLUS,194
2571-8,TRIGLYCERIDES,270089
,"LACTOFERRIN QUANTITATIVE, FECAL",52
3050-2,THYROID PANEL WITH TSH,160
3026-2,THYROID PANEL WITH TSH,160
32215-6,THYROID PANEL WITH TSH,160
3016-3,THYROID PANEL WITH TSH,113
713-8,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
5905-5,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
742-7,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
751-8,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
731-0,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
736-9,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
770-8,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
711-2,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
,CK ISOENZYMES,45
2965-2,URINALYSIS WITH CULTURE IF INDICATED,69
20405-7,URINALYSIS WITH CULTURE IF INDICATED,92
6687-8,URO RISK(R) DIAGNOSTIC PROFILE,28
2956-1,URO RISK(R) DIAGNOSTIC PROFILE,28
3167-4,URO RISK(R) DIAGNOSTIC PROFILE,28
34736-9,URO RISK(R) DIAGNOSTIC PROFILE,28
2829-0,URO RISK(R) DIAGNOSTIC PROFILE,28
2162-6,URO RISK(R) DIAGNOSTIC PROFILE,28
24447-5,URO RISK(R) DIAGNOSTIC PROFILE,28
43423-3,URO RISK(R) DIAGNOSTIC PROFILE,28
42673-4,URO RISK(R) DIAGNOSTIC PROFILE,28
27378-9,URO RISK(R) DIAGNOSTIC PROFILE,28
6874-2,URO RISK(R) DIAGNOSTIC PROFILE,28
2701-1,URO RISK(R) DIAGNOSTIC PROFILE,28
3087-4,URO RISK(R) DIAGNOSTIC PROFILE,28
26889-6,URO RISK(R) DIAGNOSTIC PROFILE,28
2779-7,URO RISK(R) DIAGNOSTIC PROFILE,28
1986-9,C-PEPTIDE,418
15069-8,FRUCTOSAMINE,548
,Q AWN TEST REFUSAL,72
11546-9,PAP IG (IMAGE GUIDED),88
2161-8,"PROTEIN, TOTAL W/CREAT, RANDOM URINE",10
2890-2,"PROTEIN, TOTAL W/CREAT, RANDOM URINE",20
2888-6,"PROTEIN, TOTAL W/CREAT, RANDOM URINE",10
28009-9,"CREATININE, URINE, 24 HOUR",66
2161-8,"CREATININE, URINE, 24 HOUR",71
20624-3,"CREATININE, URINE, 24 HOUR",66
28009-9,"CALCIUM, URINE, 24 HOUR",19
17862-4,"CALCIUM, URINE, 24 HOUR",19
6874-2,"CALCIUM, URINE, 24 HOUR",30
9830-1,LIPID PANEL AND CHOL/HDL RATIO LEGACY,4
2093-3,LIPID PANEL AND CHOL/HDL RATIO LEGACY,4
2571-8,LIPID PANEL AND CHOL/HDL RATIO LEGACY,4
2085-9,LIPID PANEL AND CHOL/HDL RATIO LEGACY,4
13458-5,LIPID PANEL AND CHOL/HDL RATIO LEGACY,4
13457-7,LIPID PANEL AND CHOL/HDL RATIO LEGACY,4
88294-4,CMP14 LC,1
88293-6,CMP14 LC,1
2345-7,CMP14 LC,1
6768-6,CMP14 LC,1
1975-2,CMP14 LC,1
17861-6,CMP14 LC,1
2075-0,CMP14 LC,1
2028-9,CMP14 LC,1
2823-3,CMP14 LC,1
1759-0,CMP14 LC,1
1751-7,CMP14 LC,1
10834-0,CMP14 LC,1
2885-2,CMP14 LC,1
4548-4,CMP14 LC,1
1742-6,CMP14 LC,1
1920-8,CMP14 LC,1
27353-2,CMP14 LC,1
3094-0,CMP14 LC,1
2160-0,CMP14 LC,1
3097-3,CMP14 LC,1
2951-2,CMP14 LC,1
5124-3,"CYTOMEGALOVIRUS ANTIBODY, IGG",18
5126-8,CYTOMEGALOVIRUS ANTIBODY (IGM),104
2191-5,DHEA-SULFATE,355
,"POCT GLUCOSE, QUAN BLOOD",15
11546-9,"PAP IG, HPV, RFX 16/18 (SP)",56
77147-7,"CREATININE, SERUM",10
48643-1,"CREATININE, SERUM",10
,C4 COMPLEMENT,91
,C3 COMPLEMENT,88
,ALLERGEN TOTAL IGE,30
718-7,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,898
2746-6,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,1
32693-4,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,1
14370-1,"WET PREP, GENITAL",402
2965-2,"UA/M W/RFLX CULTURE, COMP",80
20405-7,"UA/M W/RFLX CULTURE, COMP",99
2990-0,"TESTOSTERONE, TOTAL AND BIOAVAILABLE-MAY",19
2986-8,"TESTOSTERONE, TOTAL AND BIOAVAILABLE-MAY",19
2472-9,IGM,483
2465-3,IGG,365
80515-0,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,1069
80516-8,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,1069
80517-6,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,1069
2458-8,IGA,519
11580-8,THYROID PANEL WITH TSH,47
5811-5,URINALYSIS CHEM ONLY,56
1668-3,17-HYDROXYPROGESTERONE,80
18262-6,LP+LDL DIRECT,4
2093-3,LP+LDL DIRECT,4
2571-8,LP+LDL DIRECT,4
2085-9,LP+LDL DIRECT,4
13458-5,LP+LDL DIRECT,4
13457-7,LP+LDL DIRECT,4
69405-9,RENAL FUNCTION PANEL,1666
32721-3,TACROLIMUS LEVEL,1083
5273-8,PARVOVIRUS B19 ANTIBODY (IGG),22
5334-8,"RUBELLA ANTIBODIES (IGG,IGM) DIAGNOSTIC",1
5335-5,"RUBELLA ANTIBODIES (IGG,IGM) DIAGNOSTIC",1
1558-6,GESTATIONAL GLUCOSE BASELINE PERFORMABLE,88
20438-8,GESTATIONAL GLUCOSE 1 HR PERFORMABLE,90
20437-0,GESTATIONAL GLUCOSE 3 HR PERFORMABLE,84
20436-2,GESTATIONAL GLUCOSE 2 HR PERFORMABLE,89
10449-7,"GLUCOSE, POSTPRANDIAL/ 1 HOUR",5
30392-5,CBC WITH DIFFERENTIAL,10
30433-7,CBC WITH DIFFERENTIAL,9
26507-4,CBC WITH DIFFERENTIAL,11
30446-9,CBC WITH DIFFERENTIAL,10
19048-8,CBC WITH DIFFERENTIAL,10
749-2,CBC WITH DIFFERENTIAL,10
764-1,CBC WITH DIFFERENTIAL,11
740-1,CBC WITH DIFFERENTIAL,9
6768-6,"ALKALINE PHOSPHATASE, ISOENZYMES",45
15013-6,"ALKALINE PHOSPHATASE, ISOENZYMES",51
15015-1,"ALKALINE PHOSPHATASE, ISOENZYMES",23
30567-2,THYROID STIMULATING IMMUNOGLOBULIN,157
11546-9,"PAP IG, RFX HPV ASCU,16/18 (SP)",6
,HEPATITIS C VIRUS (HCV) AB WITH REFLEX TO HCV AB VERIFICATION,8
2162-6,"CREATININE, URINE, 24 HOUR",37
2923-1,VITAMIN A,606
1823-4,VITAMIN E,85
1834-1,QUAD SCREEN,71
23811-3,QUAD SCREEN,69
36904-1,QUAD SCREEN,69
23841-0,QUAD SCREEN,38
23883-2,QUAD SCREEN,69
21198-7,QUAD SCREEN,38
2250-9,QUAD SCREEN,69
21264-7,QUAD SCREEN,69
17861-6,CALCIUM,1667980
1777-2,"ALKALINE PHOSPHATASE, ISOENZYMES",28
15348-6,"ALKALINE PHOSPHATASE, ISOENZYMES",28
13874-3,"ALKALINE PHOSPHATASE, ISOENZYMES",28
15349-4,"ALKALINE PHOSPHATASE, ISOENZYMES",28
13875-0,"ALKALINE PHOSPHATASE, ISOENZYMES",28
7691-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",123
6242-2,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",124
6076-4,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",65
19113-0,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",52
6273-7,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",123
6106-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",123
6276-0,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",124
6087-1,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",66
6082-2,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",123
6174-7,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",110
6206-7,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",123
6246-3,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",123
7138-1,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",52
7155-5,"REGIONAL ALLERGY PROFILE, IGE",82
10921-5,"REGIONAL ALLERGY PROFILE, IGE",62
6032-7,"REGIONAL ALLERGY PROFILE, IGE",62
6189-5,"REGIONAL ALLERGY PROFILE, IGE",82
6186-1,"REGIONAL ALLERGY PROFILE, IGE",83
6095-4,"REGIONAL ALLERGY PROFILE, IGE",82
6085-5,"REGIONAL ALLERGY PROFILE, IGE",82
6098-8,"REGIONAL ALLERGY PROFILE, IGE",82
7604-2,"REGIONAL ALLERGY PROFILE, IGE",82
6178-8,"REGIONAL ALLERGY PROFILE, IGE",82
6109-3,"REGIONAL ALLERGY PROFILE, IGE",82
6152-3,"REGIONAL ALLERGY PROFILE, IGE",62
6096-2,"REGIONAL ALLERGY PROFILE, IGE",82
6020-2,"REGIONAL ALLERGY PROFILE, IGE",82
15749-5,"REGIONAL ALLERGY PROFILE, IGE",62
6265-3,"REGIONAL ALLERGY PROFILE, IGE",82
15283-5,"REGIONAL ALLERGY PROFILE, IGE",82
6244-8,"REGIONAL ALLERGY PROFILE, IGE",82
6212-5,"REGIONAL ALLERGY PROFILE, IGE",82
19113-0,"REGIONAL ALLERGY PROFILE, IGE",82
6833-8,"REGIONAL ALLERGY PROFILE, IGE",82
6181-2,"REGIONAL ALLERGY PROFILE, IGE",82
7407-0,"REGIONAL ALLERGY PROFILE, IGE",62
6025-1,"REGIONAL ALLERGY PROFILE, IGE",82
6034-3,"REGIONAL ALLERGY PROFILE, IGE",83
6041-8,"REGIONAL ALLERGY PROFILE, IGE",82
6075-6,"REGIONAL ALLERGY PROFILE, IGE",82
6078-0,"REGIONAL ALLERGY PROFILE, IGE",82
9830-1,Q CHOL/HDLC RATIO,98
2085-9,HDL CHOLESTEROL,120551
13457-7,Q LDL-CHOLESTEROL,98
43396-1,Q NON HDL CHOLESTEROL,98
11054-4,Q LDL/HDL RATIO,3
20447-9,"HIV-1 RNA, REAL TIME PCR (GRAPH)",54
8124-0,T/B LYMPH PROFILE,150
8123-2,T/B LYMPH PROFILE,150
770-8,T/B LYMPH PROFILE,37
777-3,T/B LYMPH PROFILE,37
4544-3,T/B LYMPH PROFILE,37
789-8,T/B LYMPH PROFILE,37
718-7,T/B LYMPH PROFILE,37
6690-2,T/B LYMPH PROFILE,150
788-0,T/B LYMPH PROFILE,37
785-6,T/B LYMPH PROFILE,37
786-4,T/B LYMPH PROFILE,37
787-2,T/B LYMPH PROFILE,37
8122-4,T/B LYMPH PROFILE,150
5905-5,T/B LYMPH PROFILE,37
736-9,T/B LYMPH PROFILE,37
731-0,T/B LYMPH PROFILE,150
742-7,T/B LYMPH PROFILE,37
751-8,T/B LYMPH PROFILE,37
24467-3,T/B LYMPH PROFILE,150
14135-8,T/B LYMPH PROFILE,150
8101-8,T/B LYMPH PROFILE,37
13945-1,"UA/M W/RFLX CULTURE, COMP",633
17146-2,T/B LYMPH PROFILE,113
26478-8,T/B LYMPH PROFILE,113
18267-5,T/B LYMPH PROFILE,113
20402-4,T/B LYMPH PROFILE,113
56540-8,GLUTAMIC ACID DECARBOXYLASE,1
31209-0,"ISLET ANTIGEN 2 (IA-2) ANTIBODY, SERUM",1
76651-9,ZINC TRANSPORTER 8 (ZNT8) ANTIBODY,2
,TSH+FREE T4,40
,"ADRENOCORTICOTROPIC HORMONE (ACTH), PLASMA",45
20447-9,"RNA, PCR (GRAPH) RFX/GENO",1
4552-6,HEMOGLOBIN ELECTROPHORESIS,302
32682-7,HEMOGLOBIN ELECTROPHORESIS,302
33762-6,NT PROBNP,189
,FOLATE RBC,28
2254-1,"ESTROGENS, TOTAL",63
1834-1,"INTEGRATED SCREEN, PART 2",25
23883-2,"INTEGRATED SCREEN, PART 2",25
2250-9,"INTEGRATED SCREEN, PART 2",25
21264-7,"INTEGRATED SCREEN, PART 2",25
23841-0,"INTEGRATED SCREEN, PART 2",18
48407-1,"INTEGRATED SCREEN, PART 2",25
32123-2,"INTEGRATED SCREEN, PART 2",18
36904-1,"INTEGRATED SCREEN, PART 2",25
23811-3,"INTEGRATED SCREEN, PART 2",25
21198-7,"INTEGRATED SCREEN, PART 2",18
88294-4,"CREATININE, SERUM",189
88293-6,"CREATININE, SERUM",189
10886-0,"Q PSA, FREE",16
12841-3,"Q PSA, FREE",16
38494-1,"METANEPHRINES, FRACTIONATED FREE, PLASMA",19
57462-4,"METANEPHRINES, FRACTIONATED FREE, PLASMA",19
29142-7,"METANEPHRINES, FRACTIONATED FREE, PLASMA",19
3167-4,"CORTISOL, FREE 24-HOUR URINE LC/MS/MS",6
2147-7,"CORTISOL, FREE 24-HOUR URINE LC/MS/MS",6
2162-6,"CORTISOL, FREE 24-HOUR URINE LC/MS/MS",6
,TRANSFERRIN,109
48407-1,INTEGRATED SCREEN-GENZYME,11
11546-9,"IGP, APTIMA HPV",26
77307-7,"LEAD, BLOOD",3
731-0,LYMPHOCYTE SUBSET PANEL 4,69
8123-2,LYMPHOCYTE SUBSET PANEL 4,69
24467-3,LYMPHOCYTE SUBSET PANEL 4,69
8101-8,LYMPHOCYTE SUBSET PANEL 4,69
14135-8,LYMPHOCYTE SUBSET PANEL 4,69
54218-3,LYMPHOCYTE SUBSET PANEL 4,69
,IGM,36
,"HIV-1 RNA, REAL TIME PCR (GRAPH)",8
,"CALCIUM, URINE, RANDOM",6
9813-7,CORTISOL AM,31
14957-5,"Q ALBUMIN, RANDOM URINE W/CREATININE",48
9318-7,"Q ALBUMIN, RANDOM URINE W/CREATININE",48
,"T3, REVERSE",10
2889-4,"PROTEIN, URINE, 24 HOUR",109
2164-2,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",65
2160-0,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",44
88294-4,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",44
88293-6,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",44
2161-8,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",34
2162-6,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",62
14628-2,"BILE ACIDS, TOTAL",98
,CA 19-9,117
788-0,HEMOGLOBINOPATHY INDICES,12
789-8,HEMOGLOBINOPATHY INDICES,12
718-7,HEMOGLOBINOPATHY INDICES,12
4544-3,HEMOGLOBINOPATHY INDICES,12
787-2,HEMOGLOBINOPATHY INDICES,12
785-6,HEMOGLOBINOPATHY INDICES,12
,"ESTROGENS, FRACTIONATED E1 AND E2 [LAB980]",22
,ALBUMIN,233
,"UREA NITROGEN, URINE",51
,REFLEX HGBA1C IF GLUC>150,3
5206-8,"HSV 1 ANTIBODY, IGG",20
5209-2,"HSV 2 ANTIBODY, IGG",17
48159-8,HCV AB W/RFLX TO VERIFICATION,30
5206-8,"HSV 1 AND 2-SPEC AB, IGG W/RFX",37
5209-2,"HSV 1 AND 2-SPEC AB, IGG W/RFX",37
2951-2,ELECTROLYTE PANEL,13
2823-3,ELECTROLYTE PANEL,13
2075-0,ELECTROLYTE PANEL,13
2028-9,ELECTROLYTE PANEL,13
33037-3,ELECTROLYTE PANEL,11
3016-3,THYROID STIMULATING HORMONE,53766
1959-6,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,294
11558-4,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,294
11556-8,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,294
11557-6,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,294
11555-0,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,294
35384-7,ESTRADIOL AND ESTRONE,3
2258-2,ESTRADIOL AND ESTRONE,3
2986-8,"TESTOSTERONE, BIOAVAILABLE, TOTAL, FREE",12
2991-8,"TESTOSTERONE, BIOAVAILABLE, TOTAL, FREE",12
2990-0,"TESTOSTERONE, BIOAVAILABLE, TOTAL, FREE",12
,"CARBON MONOXIDE, BLOOD",1
8099-4,THYROID ANTIBODIES,11
8098-6,THYROID ANTIBODIES,11
6075-6,RESPIRATORY ALLERGY PANEL REGION IV,26
6096-2,RESPIRATORY ALLERGY PANEL REGION IV,26
6078-0,RESPIRATORY ALLERGY PANEL REGION IV,26
10921-5,RESPIRATORY ALLERGY PANEL REGION IV,26
6020-2,RESPIRATORY ALLERGY PANEL REGION IV,26
6098-8,RESPIRATORY ALLERGY PANEL REGION IV,26
6833-8,RESPIRATORY ALLERGY PANEL REGION IV,26
6041-8,RESPIRATORY ALLERGY PANEL REGION IV,26
6178-8,RESPIRATORY ALLERGY PANEL REGION IV,26
7155-5,RESPIRATORY ALLERGY PANEL REGION IV,26
6109-3,RESPIRATORY ALLERGY PANEL REGION IV,26
6189-5,RESPIRATORY ALLERGY PANEL REGION IV,26
6095-4,RESPIRATORY ALLERGY PANEL REGION IV,26
6244-8,RESPIRATORY ALLERGY PANEL REGION IV,26
6034-3,RESPIRATORY ALLERGY PANEL REGION IV,26
6265-3,RESPIRATORY ALLERGY PANEL REGION IV,26
7604-2,RESPIRATORY ALLERGY PANEL REGION IV,26
6085-5,RESPIRATORY ALLERGY PANEL REGION IV,26
6181-2,RESPIRATORY ALLERGY PANEL REGION IV,26
6186-1,RESPIRATORY ALLERGY PANEL REGION IV,26
19113-0,RESPIRATORY ALLERGY PANEL REGION IV,26
6212-5,RESPIRATORY ALLERGY PANEL REGION IV,26
6025-1,RESPIRATORY ALLERGY PANEL REGION IV,26
6248-9,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",71
6270-3,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
6718-1,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
6136-6,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
6237-2,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
6019-4,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",58
1975-2,"BILIRUBIN, TOTAL",3832
,DIC PROFILE,240
,GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY(G6PD) SEQUENCING LEGACY,4
2986-8,"TESTOSTERONE, TOTAL AND FREE AND SEX HORMONE BINDING GLOBULIN",39
2991-8,"TESTOSTERONE, TOTAL AND FREE AND SEX HORMONE BINDING GLOBULIN",39
13967-5,"TESTOSTERONE, TOTAL AND FREE AND SEX HORMONE BINDING GLOBULIN",39
,PREGNENOLONE,12
4532-8,"COMPLEMENT, TOTAL (CH50)",103
2986-8,"TESTOSTERONE, FREE, BIOAVAILABLE AND TOTAL, MS",43
2991-8,"TESTOSTERONE, FREE, BIOAVAILABLE AND TOTAL, MS",43
2990-0,"TESTOSTERONE, FREE, BIOAVAILABLE AND TOTAL, MS",43
13967-5,"TESTOSTERONE, FREE, BIOAVAILABLE AND TOTAL, MS",43
1751-7,"TESTOSTERONE, FREE, BIOAVAILABLE AND TOTAL, MS",43
,"VANCOMYCIN, PEAK",9
,THYROID STIMULATING IMMUNOGLOBULIN,21
,CARDIAC DEVICE CHECK CHECK - REMOTE ALERT,66
20448-7,INSULIN,361
5796-8,URINALYSIS WITH MICROSCOPIC LEGACY,247
2161-8,"NTX-TELOPEPTIDE MAYO, U",7
35334-2,"NTX-TELOPEPTIDE MAYO, U",4
44308-5,"NTX-TELOPEPTIDE MAYO, U",4
2157-6,CREATINE KINASE ISOENZYME PANEL,4
15049-0,CREATINE KINASE ISOENZYME PANEL,4
21582-2,TRYPTASE,133
,ANTI  XA - ENOXAPARIN LEVEL,27
13965-9,"HOMOCYSTEINE, SERUM",300
3024-7,FREE THYROXINE + T4,7
3026-2,FREE THYROXINE + T4,6
2141-0,"ADRENOCORTICOTROPIC HORMONE (ACTH), PLASMA",911
,"CARBAMAZEPINE LEVEL, TOTAL",64
,ALDOSTERONE,16
4090-7,"VANCOMYCIN, PEAK",147
26524-9,MANUAL DIFF CELLAVISION,420
3034-6,TRANSFERRIN,43900
27816-8,VON WILLEBRAND FACTOR ANTIGEN,18
36916-5,"KAPPA/LAMBDA LIGHT CHAINS FREE WITH RATIO, SERUM",98
33944-0,"KAPPA/LAMBDA LIGHT CHAINS FREE WITH RATIO, SERUM",98
48378-4,"KAPPA/LAMBDA LIGHT CHAINS FREE WITH RATIO, SERUM",98
11558-4,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,897
1959-6,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,516
30350-3,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,517
11558-4,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,516
2705-2,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,517
11557-6,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,516
2716-9,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,517
18182-6,OSMOLALITY,420
11572-5,"ANA SCREEN,IFA,REFLEX TITER/PATTERN,REFLEX MPLX 11 AB CASCADE WITH IDENTRA",12
33935-8,"ANA SCREEN,IFA,REFLEX TITER/PATTERN,REFLEX MPLX 11 AB CASCADE WITH IDENTRA",12
75880-5,"ANA SCREEN,IFA,REFLEX TITER/PATTERN,REFLEX MPLX 11 AB CASCADE WITH IDENTRA",12
,ADAMTS13 EVALUATION-MAYO,6
,"VISCOSITY, SERUM",2
3128-6,"VISCOSITY, SERUM",8
,IRON AND TOTAL IRON BINDING CAPACITY-MAY,20
11011-4,HCV RNA QUANT VIRAL LOAD,394
38180-6,HCV RNA QUANT VIRAL LOAD,186
11546-9,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
11572-5,"ANA SCREEN, IFA, W/REFLEX TO TITER AND PATTERN/RHEUMATOID ARTHRITIS PANEL 2",3
33935-8,"ANA SCREEN, IFA, W/REFLEX TO TITER AND PATTERN/RHEUMATOID ARTHRITIS PANEL 2",3
75880-5,"ANA SCREEN, IFA, W/REFLEX TO TITER AND PATTERN/RHEUMATOID ARTHRITIS PANEL 2",3
57800-5,POCT WHOLE BLOOD OXIMETRY (HC) UNSOLICITED RESULTS,242
,FILTER IONIZED CALCIUM LEVEL,13
,ALKALINE PHOSPHATASE,211
,ERYTHROPOIETIN,32
,"ANGIOTENSIN CONVERTING ENZYME, CSF",17
,HM HBA1C,126
3184-9,POCT ACTIVATED CLOTTING TIME UNSOLICTED RESULTS,423
,LAB WB LACTIC ACID VENOUS LEGACY,3
5193-8,HEPATITIS B SURFACE ANTIBODY(HBIG) TITER,27
,ASPERGILLUS GALACTOMANNAN ANTIGEN,19
5388-4,"TOXOPLASMA GONDII ANTIBODY, IGG",29
51969-4,MATERNIT GENOME (9W+),1
,TRANSTHORACIC ECHO (TTE) LIMITED,85
4548-4,HEMOGLOBIN A1C WITH EAG,10
27353-2,HEMOGLOBIN A1C WITH EAG,10
53553-4,HEMOGLOBIN A1C WITH EAG,2
,RAPID TEG ACT,26
,ANCA PANEL FOR VASCULITIS-MAYO,49
,"JC VIRUS DNA, QUANTITATIVE-, PLASMA - MAYO",28
,"TISSUE TRANSGLUTAMINASE, IGA",119
,CELIAC DISEASE COMPREHENSIVE CASCADE-MAY,46
,"AMIKACIN LEVEL, RANDOM",14
2193-1,DHEA,52
,"HEPATITIS C RNA, QUANTITATIVE, PCR LEGACY",8
31254-6,GLOMERULAR BASEMENT MEMBRANE ANTIBODIES,45
,GLOMERULAR BASEMENT MEMBRANE ANTIBODIES,3
5796-8,URINALYSIS WITH CULTURE IF INDICATED,310
,PTT ANTICOAGULANT THERAPY,111
11546-9,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
2880-3,"PROTEIN, CSF",421
,BEDSIDE GLUCOSE,68
74097-7,TACROLIMUS HIGHLY SENSITIVE LC/MS/MS,4
2857-1,"PSA, TOTAL WITH REFLEX TO PSA, FREE (REFL)",8
4548-4,HB A1C+ALB/CRT RU,1
2161-8,HB A1C+ALB/CRT RU,1
14957-5,HB A1C+ALB/CRT RU,1
9318-7,HB A1C+ALB/CRT RU,1
,TRYPTASE,5
,"CHOLESTEROL, TOTAL",109
3270-6,ANTI  XA - ENOXAPARIN LEVEL,183
,VITAMIN A,15
,VITAMIN E,12
,ALPHA-1-ANTITRYPSIN,7
3255-7,TPA FIBRINOGEN,194
,"CYCLIC CITRUL PEPTIDE ANTIBODY, IGG",16
5273-8,"PARVOVIRUS B19, IGG LEGACY",3
5273-8,"PARVOVIRUS B19 ANTIBODY, IGG AND IGM",48
32554-8,"VITAMIN B1, WHOLE BLOOD",192
13964-2,"METHYLMALONIC ACID, SERUM",225
,INHIBITOR (MIXING) STUDY,45
,C-PEPTIDE,47
,GAMMA GT,42
3024-7,"THYROXINE (T4) FREE, DIRECT, S",21
11572-5,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
2837-3,PREGNENOLONE,115
3055-1,"T3, UPTAKE",60
2986-8,"TESTOSTERONE,F/WKLYBD+T LC/MS",3
6891-6,"TESTOSTERONE,F/WKLYBD+T LC/MS",3
2990-0,"TESTOSTERONE,F/WKLYBD+T LC/MS",3
2641-9,MYOGLOBIN URINE-MAYO,12
5209-2,"HSV 2 IGG, W/REFL HSV 2 INHIBITION",6
,"LACTIC ACID, CSF",10
5631-7,"COPPER, SERUM",97
4544-3,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
787-2,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
742-7,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
731-0,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
736-9,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
777-3,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
770-8,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
788-0,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
751-8,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
713-8,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
5905-5,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
711-2,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
6690-2,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
789-8,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
718-7,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
785-6,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
786-4,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",13
,"PHENYTOIN LEVEL, FREE(CALC)",40
3160-9,"SEMEN ANALYSIS, POST-VASECTOMY",3
40851-8,"METANEPHRINES, FRACTIONATED FREE-MAYO",66
49700-8,"METANEPHRINES, FRACTIONATED FREE-MAYO",66
,LEVETIRACETAM LEVEL,31
20570-8,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,479
2339-0,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,480
39791-9,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,480
39789-3,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,480
41649-5,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,480
41645-3,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,480
20509-6,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,127
38483-4,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,480
77147-7,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,475
13820-6,"URIC ACID, 24 HOUR URINE (W/CREATININE) LEGACY",1
3087-4,"URIC ACID, 24 HOUR URINE (W/CREATININE) LEGACY",1
2162-6,"URIC ACID, 24 HOUR URINE (W/CREATININE) LEGACY",1
,MDA REF LAB SEND OUT LEGACY,78
30896-5,TEST AUTHORIZATION LEGACY,146
,CHROMIUM LEVEL,1
30552-4,VITAMIN B6 PROFILE-MAYO,65
1688-1,VITAMIN B6 PROFILE-MAYO,65
32220-6,LIVER/KIDNEY MICROSOME TYPE 1 AB-MAYO,97
14819-7,"CELL PROFILE, BAL",177
14823-9,"CELL PROFILE, BAL",186
81620-7,"CELL PROFILE, BAL",200
32804-7,"CELL PROFILE, BAL",198
63487-3,"CELL PROFILE, BAL",110
19113-0,IGE,50
5130-0,Q DNA (DS) ANTIBODY,7
2900-9,VITAMIN B6 (PLP),24
5763-8,ZINC,950
1903-4,VITAMIN C,26
1751-7,ALBUMIN,1500141
,"BILIRUBIN LEVEL TOTAL, BODY FLUID",3
,PREPARE FRESH FROZEN PLASMA,11228
48803-1,QUAD SCREEN,69
19080-1,QUAD SCREEN,31
49090-4,QUAD SCREEN,69
34714-6,"POCT INR, MANUAL  RESULTS",1
8101-8,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
13333-0,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
8122-4,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
788-0,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
786-4,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
789-8,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
54218-3,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
6690-2,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
18350-9,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
785-6,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
4544-3,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
787-2,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
718-7,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
8124-0,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
742-7,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
5905-5,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
770-8,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
736-9,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
777-3,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
731-0,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
751-8,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
24467-3,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
8123-2,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
14135-8,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
26997-7,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
13338-9,LYMPHOCYTE ACTIVITY PROFILE LEGACY,5
20447-9,REALTIME ABBOTT,1
,DHEA-SULFATE,38
2465-3,"IGG SUBCLASSES  1, 2, 3, AND 4",70
2466-1,"IGG SUBCLASSES  1, 2, 3, AND 4",70
2467-9,"IGG SUBCLASSES  1, 2, 3, AND 4",70
2468-7,"IGG SUBCLASSES  1, 2, 3, AND 4",70
2469-5,"IGG SUBCLASSES  1, 2, 3, AND 4",70
48159-8,HP5,1
71772-8,LC QUANTIFERON-TB GOLD PLUS,3
770-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
736-9,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
4544-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
787-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
785-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
786-4,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
788-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
777-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
5905-5,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
713-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
11580-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
1742-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
2093-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
2571-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
2085-9,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
13458-5,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
13457-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
789-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
718-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
71695-1,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
706-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
751-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
731-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
742-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
711-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
1759-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
1975-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
2075-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
2028-9,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
17861-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
2885-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
1751-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
10834-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
6768-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
1920-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
6690-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C,1
,ALDOLASE,10
4049-3,THEOPHYLLINE LEVEL,46
5244-9,"MMR (IGG) PANEL (MEASLES, MUMPS, RUBELLA)",28
25418-5,"MMR (IGG) PANEL (MEASLES, MUMPS, RUBELLA)",28
5334-8,"MMR (IGG) PANEL (MEASLES, MUMPS, RUBELLA)",28
5209-2,"HSV 2 IGG, TYPE SPECIFIC AB",202
,LIPOPROTEIN A (LPA),8
,"PROTEIN S ANTIGEN, TOTAL",9
,PROTEIN S ANTIGEN PLASMA MAYO LEGACY,5
,"PROTEIN C ANTIGEN, TOTAL",20
50970-3,AB SCR+ANTIBODY ID 114041,19
43396-1,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
54434-6,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
2093-3,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
1884-6,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
17782-4,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
43729-3,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
30522-7,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
86951-1,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
43583-4,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
2085-9,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
2571-8,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
13457-7,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
9830-1,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,6
43727-7,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
86222-7,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
,"CORTISOL, TOTAL LEGACY",10
,"PTH, INTACT AND CALCIUM",70
,ACTH STIMULATION LEGACY,12
42176-8,"(1, 3) BETA-D-GLUCAN (FUNGITELL), S",445
44357-2,ASPERGILLUS GALACTOMANNAN ANTIGEN,192
35741-8,"PSA, POST PROSTATECTOMY WITH HAMA TREATMENT",3
,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",224
2191-5,"DHEA-SULFATE, SERUM",5
785-6,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
786-4,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
6690-2,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
713-8,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
5905-5,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
742-7,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
751-8,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
731-0,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
776-5,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
736-9,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
704-7,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
770-8,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
711-2,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
789-8,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
706-2,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
718-7,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
4544-3,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
787-2,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
788-0,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
777-3,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
32731-2,"PROTEIN ELECTROPHORESIS, SERUM",112
32730-4,"PROTEIN ELECTROPHORESIS, SERUM",112
5244-9,RUBEOLA ANTIBODY IGG,26
62290-2,"VITAMIN D, 1,25 + 25-HYDROXY",27
62292-8,"VITAMIN D, 1,25 + 25-HYDROXY",27
,"MAGNESIUM, URINE, 24 HOUR",3
2484-4,IGF-1 WITH Z-SCORE,1
73561-3,IGF-1 WITH Z-SCORE,1
,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",181
,"BILIRUBIN, TOTAL",217
,CSF ADDITIONAL CELL COUNT,46
,17-HYDROXYPROGESTERONE,9
20448-7,CARDIO IQ INSULIN,1
,CERULOPLASMIN,21
1558-6,"GLUCOSE, FASTING",451
62361-1,"CHROMOSOME, BLOOD, ROUTINE",4
62360-3,"CHROMOSOME, BLOOD, ROUTINE",4
55199-4,"CHROMOSOME, BLOOD, ROUTINE",4
62358-7,"CHROMOSOME, BLOOD, ROUTINE",4
5583-0,HEAVY METALS SCREEN,19
77307-7,HEAVY METALS SCREEN,19
5609-3,HEAVY METALS SCREEN,19
5685-3,HEAVY METALS SCREEN,19
30518-5,"BILE ACIDS, FRACTIONATED AND TOTAL, SERUM LEGACY",2
30520-1,"BILE ACIDS, FRACTIONATED AND TOTAL, SERUM LEGACY",2
30519-3,"BILE ACIDS, FRACTIONATED AND TOTAL, SERUM LEGACY",2
14628-2,"BILE ACIDS, FRACTIONATED AND TOTAL, SERUM LEGACY",2
3052-8,"T3, REVERSE",61
12190-5,"CREATININE LEVEL, BODY FLUID",185
2344-0,"GLUCOSE, BODY FLUID",425
,PREPARE PLATELET PHERESIS,17094
2161-8,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
2890-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",22
2888-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
17819-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
2888-6,"PROTEIN, URINE, RANDOM",93
48803-1,"AFP, MAT SERUM, OPEN SPINA BIFIDA",665
2145-1,"CORTISOL FREE, SERUM",61
,ZINC,14
48159-8,HCV ANTIBODY CASCADE(PCR/GENO),4
,PREPARE CONVALESCENT PLASMA,77
20509-6,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,150
20570-8,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,757
39791-9,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,758
14627-4,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,173
51731-8,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,151
2021-4,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,173
48391-7,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,150
39789-3,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,758
41649-5,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,710
41645-3,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,758
2339-0,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,757
2746-6,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,173
2705-2,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,264
,PANCREATIC ENZYME FLUID COLLECTION 2,30
,PANCREATIC ENZYME FLUID COLLECTION 4,30
,PANCREATIC ENZYME FLUID COLLECTION 3,30
3255-7,VON WILLEBRAND DISEASE PANEL,19
3209-4,VON WILLEBRAND DISEASE PANEL,19
27816-8,VON WILLEBRAND DISEASE PANEL,19
68324-3,VON WILLEBRAND DISEASE PANEL,19
,VON WILLEBRAND DISEASE PANEL,49
,PLATELET CTAD,9
,RENIN ACTIVITY,10
43208-8,PENTA SCREEN,9
23841-0,PENTA SCREEN,9
2250-9,PENTA SCREEN,9
21264-7,PENTA SCREEN,9
23883-2,PENTA SCREEN,9
36904-1,PENTA SCREEN,9
40583-7,PENTA SCREEN,9
,POCT PT-INR,123
,"BILE ACIDS, TOTAL",13
,POCT ELECTROLYTES UNSOLICITED RESULTS,18
41645-3,POCT IONIZED CALCIUM UNSOLICITED RESULTS,57
11546-9,"PAP IG, CT-NG, RFX HPV ALL",13
45142-7,"RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL, COMPREHENSIVE",11
33314-6,"RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL, COMPREHENSIVE",11
33313-8,"RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL, COMPREHENSIVE",11
11573-3,"RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL, COMPREHENSIVE",11
33935-8,"RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL, COMPREHENSIVE",11
33569-5,"RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL, COMPREHENSIVE",11
,"HEMOGLOBIN, BODY FLUID",4
,"PROTEIN, TOTAL",228
,CHLORIDE,269
,LAMOTRIGINE LEVEL,7
38476-8,ANTIMULLERIAN HORMONE (AMH),12
,GASTRIN - MAYO,4
,PARIETAL CELL ANTIBODY IGG-MAYO,1
,ALLERGEN CRAB IGE,1
,ALLERGEN RICE,1
,ALLERGEN BEEF,1
,ALLERGEN STRAWBERRY,1
,ALLERGEN DOG DANDER,2
,"ALLERGEN CAT HAIR/DANDER,STANDARD IGE",2
,ALLERGEN LOBSTER,1
10886-0,%FPSA REFLEX,10
12841-3,%FPSA REFLEX,10
2857-1,PSA (REFLEX TO FREE) (SERIAL),5
70241-5,HIV RNA QUANT VIRAL LOAD,289
29541-0,HIV RNA QUANT VIRAL LOAD,143
32998-7,TISSUE TRANSGLUTAMINASE ANTIBODY IGA AND IGG PROFILE,5
31017-7,TISSUE TRANSGLUTAMINASE ANTIBODY IGA AND IGG PROFILE,5
5821-4,URINALYSIS ONLY MICROSCOPIC,29
13945-1,URINALYSIS ONLY MICROSCOPIC,29
11277-1,URINALYSIS ONLY MICROSCOPIC,29
,FACTOR II (2) ACTIVITY,2
43995-0,QUAD SCREEN,69
32166-1,QUAD SCREEN,31
2161-8,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
2756-5,"DRUG MONITOR, PANEL 1, W/CONF, URINE",8
51435-6,"PROTEIN ELECTROPHORESIS, SERUM",32
1744-2,ALT/SGPT,139659
48643-1,GFR-African Am,376583
19123-9,Magnesium Level,59825
48642-3,GFR-Non-African American,75199
788-0,RDW,1928557
770-8,Neut %,18937
789-8,RBC,2925926
2028-9,CO2 Content,329397
1988-5,C-Reactive Protein,17326
4548-4,Hgb A1c,81340
718-7,Hemoglobin,341634
,MPV,65192
2951-2,"Sodium, Serum/Plasma",334667
785-6,MCH,2926655
41653-7,Bedside Glucose - Electronic  (POCT),170153
17861-6,"Calcium, Serum/Plasma",64154
3097-3,Blood Urea Nitrogen/Creatinine ratio,64004
6768-6,Alkaline Phosphatase,198636
1920-8,Aspartate Aminotransferase (AST),23568
10839-9,Troponin I Quant,61153
10839-9,Troponin Alert,7008
2075-0,"Chloride, Serum/Plasma",64020
2160-0,"Creatinine, Serum/Plasma",66025
18182-6,Osmolality Calculated,152589
2823-3,"Potassium, Serum/Plasma",68902
787-2,MCV,2891402
4544-3,Hematocrit,333916
2518-9,Lactic Acid Arterial,701
,FiO2-,2709
2345-7,"Glucose, Serum/Plasma",64089
2519-7,Lactic Acid Venous (WB),2260
1751-7,"Albumin, Serum",146468
2132-9,B12 Cobalamine,840
2019-8,Arterial pCO2,4019
2744-1,Arterial pH,4019
1960-4,Arterial HCO3,4019
31043-3,--Moxifloxacin,91
28-1,--Ampicillin,1347
141-2,--Ceftriaxone,1414
2714-4,Arterial O2Hb,3695
2283-0,Folate Level,5093
2143-6,"Cortisol, Serum",394
30934-4,Brain Natriuretic Peptide,3953
1975-2,"Bilirubin, Total",144653
14775-1,Arterial Hgb,3695
1839-0,Ammonia,1151
5803-2,-- pH.,1014
2885-2,"Protein Total, Serum",139608
33959-8,Procalcitonin,7352
13945-1,"RBC, Urine",5652
5902-2,Protime Patient,11050
20405-7,-- Urobilinogen,1014
5821-4,"WBC, Urine",5804
,Rate,1225
2519-7,Lactic Acid Venous,4862
6301-6,INR,682977
3040-3,"Lipase, Serum/Plasma",24298
5803-2,"Ph, Urine",8389
2774-8,"Phosphorous, Inorganic",10104
2828-2,"Potassium, Urine",698
4024-6,Salicylate Level,1691
,POCT GFR-African American,268
,POCT Creatinine,311
,P Peak,477
,PEEP-,2046
51733-4,Arterial sO2,4019
5769-5,"Bacteria, Urine",5606
5811-5,-- Specific Gravity,1014
13969-1,Creatine Kinase,7480
4092-3,Vancomycin Trough,13980
,SpO2-,3915
2085-9,High Density Lipoprotein,2444
14334-7,Lithium Level,147
,EtCO2-,1848
3024-7,Free T4,24865
14979-9,APTT Patient,5209
2703-7,Arterial pO2,4019
5811-5,"Specific Gravity, Urine",8412
2078-4,"Chloride, Urine",694
74353-4,POCT Sodium,3136
1994-3,Ionized Calcium,22583
2744-1,POCT Arterial pH,2511
51733-4,POCT Arterial O2-Saturation,1994
2019-8,POCT Arterial pCO2,2075
,POCT Arterial HCO3 calc,2075
74353-4,POCT Potassium,3144
,POCT Arterial TCO2 calc,2074
2703-7,POCT Arterial pO2,2075
2069-3,POCT Chloride,2543
718-7,POCT Hemoglobin,2993
2339-0,POCT Glucose,2570
,POCT Hematocrit calc,2984
1798-8,"Amylase, Serum/Plasma",184
9830-1,Cholesterol/HDL Ratio,2441
,NTpro BNP,184
48065-7,D-Dimer Quant,2300
2089-1,Low Density Lipoprotein Cholesterol,2441
30341-2,Sedimentation Rate,1429
,Est. Free PTN-Normal Renal Fx,48
5796-8,"Hyaline Cast, Urine",1080
3968-5,Phenytoin/Dilantin Level,133
3016-3,Thyroid Stimulating Hormone,3611
3255-7,Fibrinogen,3992
2276-4,"Ferritin, Level",7665
,Flow,1334
2502-3,Iron Saturation Percent,843
2498-4,"Iron, Serum/Plasma",5482
3034-6,Transferrin,9575
2500-7,Total Iron Binding Capacity,843
,Anti Xa-Heparin.,5395
41691-7,--Daptomycin,665
193-3,--Clindamycin,532
6652-2,--Meropenem,1678
1994-3,POCT Ionized Calcium,3137
,POCT Hemoglobin calc,150
2705-2,POCT Venous pO2,448
46420-6,"WBC Clumps, Urine",583
,Vt,1494
496-0,--Tetracycline,329
412-7,--Piperacillin/Tazobactam,1500
6644-9,--Cefepime,1669
524-9,--Vancomycin,778
12951-0,Triglycerides,2718
392-1,--Penicillin IV,67
2532-0,Lactate Dehydrogenase,1078
2746-6,POCT Venous pH,586
,POCT Venous TCO2 calc,451
4544-3,POCT Hematocrit,149
,Est. Free PTN-Renal Dysfuntion,48
2518-9,Lactic Acid Arterial (WB),309
,POCT Venous HCO3 calc,451
,POCT Venous O2-Saturation calc,28
2021-4,POCT Venous pCO2,451
73818-7,Optical Density,115
2888-6,"Protein Total, Urine",3571
35788-9,--Daptomycin,665
233-7,--Erythromycin,588
31037-5,--Moxifloxacin,91
108-1,--Cefotaxime,45
2093-3,Cholesterol,95597
20578-1,Vancomycin Timed,582
,CPAP,137
29254-0,--Linezolid,309
2161-8,"Creatinine, Urine",1865
744-3,Monocytes,2039
32-3,--Ampicillin/Sulbactam,981
8099-4,Thyroperoxidase Antibody,149
4542-7,"Haptoglobin, Serum",221
2039-6,Carcinoembryonic Antigen (ICMA),141
70241-5,HIV RNA Quant.,325
11282-1,Cell Count,113
14338-8,Prealbumin/Transthyretin,149
44-8,--Aztreonam,1331
,HIV RNA Quant Log,65
5643-2,"Alcohol, Ethyl",912
735-1,Variant Lymphocytes,523
2889-4,"Total Protein, 24 Hour Urine Result",55
,TV Protein,54
4086-5,Valproic Acid/Depakene Level,129
5793-5,"Granular Cast, Urine",117
51731-8,POCT Venous O2-Saturation,423
2880-3,"Protein, CSF",119
,POCT GFR-Non-African American,268
363-2,--Nitrofuratoin,910
2955-3,"Sodium, Urine",822
2868-8,Alpha 2 Globulin,111
2871-2,Beta Globulin,111
6301-6,LWB INR,86
2865-4,Alpha 1 Globulin,111
6873-4,Beta Hydroxybutyrate,146
24108-3,Cancer Antigen 19-9,84
2874-6,Gamma Globulin,785
25156-1,"Eosinophils, Urine",134
1795-4,Amylase (BF),76
,CEA BF,13
,--Ceftazidime/Avibactam,38
12-5,--Amikacin,1516
3084-1,Uric Acid,3194
,Red Bl Cell Cnt retic,257
58470-6,"White Bl Cells/ Nucleated Cell Cnt, CSF",118
2695-5,"Osmolality, Urine",488
18182-6,"Osmolality, Blood",111
10535-3,Digoxin Level,576
2842-3,Prolactin (ICMA),42
2342-4,"Glucose, CSF",111
1974-5,"Bilirubin, Total (BF)",7
12228-3,Triglycerides (BF),66
17849-1,Reticulocyte Percent,256
52778-8,TEG MA,271
30089-7,"Transitional Epithelial, Urine",506
3209-4,Factor VIII Assay,59
,Mitogen Minus Nil,88
6014-5,von Willebrand Factor Activity,33
52789-5,TEG R,271
52768-9,TEG K,271
6013-7,Von Willebrand Antigen,16
66748-5,TEG A,271
2118-8,HCG Quant - Serum,149
3053-6,Total T3,558
383-0,--Oxacillin,309
,TB1 Minus Nil,88
,TB2 Minus Nil,88
2465-3,Immunoglobulin G,66
2518-9,POCT Lactic Acid Arterial,182
26052-1,"Renal Epithelial, Urine",23
2458-8,Immunoglobulin A,115
,iNO,14
2731-8,Intact PTH Routine,294
718-7,Hemoglobin WB,3
2021-4,Venous pCO2,210
51731-8,Venous sO2,210
52123-7,APTT Heparin Patient,1213
185-9,--Ciprofloxacin,1700
2746-6,Venous pH,210
1927-3,Venous BE,210
2705-2,Venous pO2,210
14627-4,Venous HCO3,210
20448-7,Insulin Level,49
1986-9,C-Peptide,93
14196-0,Reticulocyte Absolute Number,256
11572-5,Rheumatoid Factor,3700
11558-4,Ph WB,3
6298-4,Potassium WB,16
19072-8,ICAL Corr to pH 7.4 WB,3
1994-3,Ionized Calcium WB,17
4544-3,Hematocrit WB,16
2947-0,Sodium WB,16
8124-0,CD3%,141
508-2,--Tobramycin,1652
731-0,T Lymphs,140
6690-2,Tot WBC,879
14135-8,CD8,140
8122-4,CD3,140
8123-2,CD4%,878
26478-8,T Lymph%,141
24467-3,CD4,879
8101-8,CD8%,141
225-3,--Doxycycline,694
18946-4,--Metronidazole,36
18862-3,--Amoxicilin/Clavulanic Acid,45
,IPAP-,410
,Anti Xa-Enoxaparin.,100
35801-0,--Ertapenem,1334
3026-2,Thyroxine T4,841
,--Ceftolozane/Tazobactam,37
2716-9,Venous O2Hb,112
76769-9,Venous Hgb,112
14873-4,POCT Cord pH,296
,EPAP-,121
28646-8,POCT Cord pH,296
14168-9,Small Bowel Disacch Palatinase,11
,Small Bowel Disacch Glucoamylase,11
1815-0,Small Bowel Disacch Maltase,11
30319-8,Small Bowel Disacch Lactase,11
30372-7,Small Bowel Disacch Sucrase,11
,Vt exp,229
,T insp,200
,P delta,212
29638-4,Small Bowel Biopsy Weight,11
28648-4,POCT Cord pO2,77
,POCT Cord  O2-Saturation,74
28644-3,POCT Cord pCO2,77
,POCT Cord Base Excess calc,77
,POCT Cord TCO2 calc,77
,POCT Cord HCO3 calc,77
49135-7,FENa Test,38
3055-1,T3 Uptake,124
,Parathyroid Hormone Intact (intraop),7
2857-1,Prostatic Specific Antigen (PSA),61
2519-7,POCT Lactic Acid Venous,94
12190-5,Creatinine (BF),40
52770-5,TEG ACT.,16
7032-6,--Minocycline,46
13834-7,Allergy - Total IgE Allergen,35
32721-3,Tacrolimus Level,57
4498-2,C4 Complement,220
2157-6,CK-MB,246
62292-8,25-Hydroxyvitamin D,135
2324-2,Gamma GT,211
17862-4,"Calcium, Urine",7
4485-9,C3 Complement,226
12189-7,MB Index,150
5370-2,Anti Streptolysin O Titer,25
42355-8,--Tigecycline,12
5807-3,"RBC Cast, Urine",2
35809-3,--Fosfomycin,103
29261-5,Abn Immature Lymph,25
18262-6,LDL Cholesterol Direct,82
3086-6,"Uric Acid, Urine",4
35668-3,Gentamicin Timed,7
516-5,--Trimeth-Sulfa,1883
49011-0,Platelet Function Analysis ASPIRIN,81
49010-2,PF Plavix,69
,"Bronchial Lining Cells, Fluid",65
12238-2,Neutrophils (BF),304
7045-8,--Rifampin,239
428-3,--Rifampin,239
1504-0,Gestational Diabetic 1 Hour Tolerance,6
792-2,RBC Add CSF,4
3319-1,Amikacin Peak,55
58470-6,WBC/Nucleat Add CSF,4
32677-7,DNA Antibody (Double Stranded),77
2520-5,"Lactic Acid, CSF",5
10334-1,Cancer Antigen 125,48
21394-2,Monocyte/ Macrophage (BF),302
,Beta 2 Microglobulin*,12
6741-3,Red Bl Cell Cnt (BF),211
2344-0,"Glucose, (BF)",158
35669-1,Amikacin Timed,1
2529-6,Lactic Acid Dehydrogenase (BF),166
,Diff Cell Count BF,199
76-0,--Cefazolin,1346
55793-4,White Bl Cells/ Nucleated Cell Cnt (BF),211
2881-1,Protein (BF),180
2748-2,Ph Meter (BF),129
4552-6,Hemoglobin A2,24
2472-9,Immunoglobulin M,97
12234-1,Mesothelial Cells (BF),126
32682-7,Hemoglobin F,24
1751-7,Albumin (BF),310
13965-9,Homocysteine,52
27822-6,Protein S,39
27818-4,Protein C,41
3255-7,TPA-Fibrinogen,540
3714-3,Lidocaine Level,15
,SCT Screen,45
,HCV RNA Quant Log,63
,Dilute Russell Viper Venom (dRVVT) Total Ratio,45
11011-4,HCV RNA Quant,215
20402-4,CD16+56,30
18267-5,CD16+56%,30
,SCT Total Ratio,45
27811-9,Anti Thrombin III,51
57838-5,Dilute Russell Viper Venom (dRVVT Confirm),45
6303-2,Dilute Russell Viper Venom (dRVVT Screen),45
,SCT Confirm,45
72493-0,CMV Qnt,42
,POCT Cord O2-Saturation calc,2
10328-3,"Lymphocytes, CSF",70
20998-1,Fluid Diff Cell Count,44
23904-6,"Monocyte/ Macrophage, CSF",64
1994-3,Filter Ionized Calcium WB,234
30522-7,C-Reactive Protein Ultrasensitive,9
267-5,--Gentamicin,1668
3432-2,Carbamazepine/Tegretol Level Timed,13
53962-7,Alpha Fetoprotein,140
,Microalbumin,19
14959-1,Microalbumin/Creatinine Ratio,19
8098-6,Thyroglobulin Antibody,12
3013-0,Thyroglobulin Tumor Marker,7
4090-7,Vancomycin Peak,63
11153-4,Hematocrit (BF),8
33509-1,Hemoglobin (BF),3
13362-9,* Hours of Collection,30
28009-9,"* Volume, Urine",30
12195-4,* Patient BSA,32
3167-4,"* Volume, Urine",30
3051-0,"Triiodothyronine, Free (T3, Free)",47
42186-7,Num of tubes BF,9
3095-7,"Urea Nitrogen, Urine",60
2243-4,Estradiol 17-B,4
7019-3,--Imipenem,12
3193-0,Factor V Assay,1
,--Micafungin,27
2164-2,Creatinine Clear,30
,Ceruloplasmin*,15
17842-6,Cancer Antigen 27-29,17
2093-3,Cholesterol (BF),30
15067-2,Follicular Stimulating Hormone,9
10501-5,Luteinizing Hormone,22
6995-5,--Ceftazidime,13
5820-6,"WBC Cast, Urine",5
,GTT 3 Hr,1
1552-9,GTT Baseline,1
,GTT 1 Hr,1
,GTT 2 Hr,1
15061-5,Erythropoietin Level,32
42186-7,Total Tubes CSF,4
,pH AMP,1
19157-7,"Tube#, CSF",118
24471-5,Collagen EPI,6
,"Lymphoma Cell, CSF",12
4049-3,Theophylline Level,59
,Height cms,8
54176-3,--Casopofungin,15
,Weight kgs,9
,POCT Arterial O2-Saturation calc,81
,Atypical/Abnormal cell BF,8
2986-8,Testosterone Total,10
30341-2,"Sedimentation Rate, Westergren",1
,Pepsin C Activity AMP,1
,Pepsin A Acvtivity AMP,1
,Total Pepsin Activity AMP,1
,CMV Qnt Log,13
2857-1,Prostatic Specific Antigen Screen (PSA),3
,TV Urea,2
6981-5,--Azithromycin,10
6212-5,Allergy - Penicillium. IgE,6
,Allergy - Mouse Urine Proteins,3
15283-5,Allergy - Silver Birch. IgE,3
6186-1,Allergy - Nettle. IgE,3
6020-2,Allergy - Alternaria alternata. IgE,7
6265-3,Allergy - Timothy Grass. IgE,3
6209-1,Allergy - White Hickory (Pecan Tree). IgE,6
6152-3,Allergy - Johnson Grass. IgE,6
6244-8,Allergy - Sorrel (sheep). IgE,3
6109-3,Allergy - Elm. IgE,6
6032-7,Allergy - Australian Pine. IgE,3
6034-3,Allergy - Bahia Grass. IgE,3
6098-8,Allergy - Dog Dander. IgE,6
6075-6,Allergy - Cladosporium. IgE,3
,Allergy - Dust Mites DF. IgE,6
6085-5,Allergy - Common Ragweed. IgE,6
711-2,Eosinophil Cnt,2
3187-2,Factor IX Assay,14
5946-9,Inhibitor Screen APTT 50%,7
3226-8,Factor XI Assay,4
26049-7,Allergy - Mountain Cedar. IgE,3
,Allergy - Dust Mites DP. IgE,6
6189-5,Allergy - Oak. IgE,7
7369-2,Allergy - June Grass. IgE,6
6078-0,Allergy - Cockroach German. IgE,6
7604-2,Allergy - Common Pigweed. IgE,3
6025-1,Allergy - Aspergillus Fumigatus. IgE,6
7155-5,Allergy - Box Elder/Maple. IgE,3
6041-8,Allergy - Bermuda Grass. IgE,6
6833-8,Allergy - Cat Dander. IgE,6
10921-5,Allergy - Blomia tropicalis. IgE,3
6276-0,Allergy - Wheat. IgE,5
14979-9,APTT Anticoagulation Therapy,147
,-Eravacycline,2
6082-2,Allergy - Codfish. IgE,5
6232-3,Allergy - Rough Marsh Elder. IgE,5
33803-8,Immature Eosinophils,1
6248-9,Allergy - Soybean. IgE,5
6169-7,Allergy - Meadow Fescue. IgE,5
6273-7,Allergy - Walnut-Food. IgE,5
7425-2,Allergy - House Dust HS. IgE,5
,I:E ratio,214
15361-9,Inhibitor Screen APTT 80%,7
6208-3,Allergy - Pecan-Food. IgE,5
6174-7,Allergy - Milk. IgE,5
6206-7,Allergy - Peanut. IgE,5
6106-9,Allergy - Egg White. IgE,5
3232-6,Factor XII Assay,2
2839-9,Progesterone (ICMA),3
3218-5,Factor X Assay,3
35651-9,Synovial Lining Cells (BF),2
20629-2,--Levofloxacin,6
81643-9,vWD:Ac/vWD Ag Ratio,8
18861-5,--Amoxicilin,1
249-3,--Fluconazole,26
18969-6,--Piperacillin,1
,Neutrophil %,8706
,-Imipenem/Relebactam,1
,S/C Index,166
3948-7,Phenobarbital Level,73
13586-3,"Vancomycin, CSF",6
51385-3,"Plasma Cells, CSF",1
14152-3,Direct Bilirubin (BF),2
,Gran. Absolute,140
,Gran. %,140
,Protein PEA,16
,Trypsin PEA,16
,pH PEA,16
,Lipase PEA,16
,Amylase PEA,16
,Chymotrypsin PEA,16
,PEA Assay Date,4
,Elastase PEA,16
53230-9,Inhibitor Screen PT 80%,3
,POCT Cord Hemoglobin,5
24472-3,Collagen ADP,10
5959-2,Inhibitor Screen PT 50%,3
2283-0,Folate Red Cell (ICMA),2
17803-8,Plasma Cells (BF),2
,Atypical/Abnormal cell,7
33804-6,"RBC Cast, Urine",2
,Eosinophil-derived neurotoxin,2
35670-9,Tobramycin Timed,1
4059-2,Tobramycin Trough,38
4057-6,Tobramycin Peak,20
3096-5,"Urea Nitrogen, 24 Hour Urine Result",2
62858-6,Micromegakaryocyte,1
28644-3,Cord pCO2,4
28646-8,Cord pH-,4
28638-5,Cord BE,4
28640-1,Cord HCO3,4
28648-4,Cord pO2,4
,POCT Cord Hematocrit calc,5
,TEG A HEP,13
,TEG R HEP,13
,TEG MA HEP,13
,TEG K HEP,13
,Cord sO2,4
6025-1,"Allergy - Aspergillus Fumigatus, IgE",1
6189-5,"Allergy - Oak, IgE",1
6192-9,"Allergy - Olive, IgE",1
6222-4,"Allergy - Palm Queen, IgE",1
6209-1,"Allergy - White Hickory (Pecan tree), IgE",1
6232-3,"Allergy - Rough Marsh Elder, IgE",1
33982-0,"Allergy - Walnut Tree, IgE",1
6169-7,"Allergy - Meadow Fescue, IgE",1
6186-1,"Allergy - Nettle, IgE",1
6078-0,"Allergy - Cockroach(German), IgE",1
6098-8,"Allergy - Dog Dander, IgE",1
,"Allergy - Cockroach(German), IgE",1
7369-2,"Allergy - June Grass, IgE",1
7604-2,"Allergy - Common Pigweed, IgE",1
26049-7,"Allergy - Mountain Cedar, IgE",1
6244-8,"Allergy - Sorrel (sheep), IgE",1
6095-4,"Allergy - House Dust Mites/D.F., IgE",1
7425-2,"Allergy - House Dust/H-S Lab, IgE",1
6110-1,"Allergy - English Plantain, IgE",1
6124-2,"Allergy - Giant Ragweed, IgE",1
6109-3,"Allergy - Elm, IgE",1
6275-2,"Allergy - Western Ragweed, IgE",1
6034-3,"Allergy - Bahia Grass, IgE",1
6041-8,"Allergy - Bermuda Grass, IgE",1
6281-0,"Allergy - Mulberry, IgE",1
6096-2,"Allergy - House Dust Mites/D.P., IgE",1
6265-3,"Allergy - Timothy Grass, IgE",1
6183-8,"Allergy - Mugwort, IgE",1
6260-4,"Allergy - Sweet Gum, IgE",1
6032-7,"Allergy - Australian Pine, IgE",1
6156-4,"Allergy - Lambs Quarter, IgE",1
15283-5,"Allergy - Silver Birch, IgE",1
6833-8,"Allergy - Cat Dander, IgE",1
7123-3,"Allergy - Bayberry, IgE",1
6085-5,"Allergy - Common Ragweed, IgE",1
7155-5,"Allergy - Box Eld/Maple, S, IgE",1
9828-5,"Allergy - House Dust Greer, IgE",1
6151-5,"Allergy - Cypress, Italian, IgE",1
6152-3,"Allergy - Johnson Grass, IgE",1
6113-5,"Allergy - Eucalyptus, IgE",1
6874-2,"Calcium, 24 Hour Result",2
,TV Calcium,2
49229-8,Nucleated Red Bl Cells (BF),4
,T low,17
,P high,17
,T high,17
2162-6,"Creatinine, 24 Hour Urine Result",2
16703-1,"Cyclosporin, Parent Monoclonal",6
58080-3,--Penicillin (Meningitis),3
18965-4,--Penicillin (Oral),2
1558-6,"Glucose, Fasting",96
13521-0,"Blasts, CSF",2
24106-7,Hairy Cell,6
2778-9,"Phosphorus, Urine",1
3321-7,Amikacin Trough,110
51732-6,POCT Capillary O2-Saturation,1
2704-5,POCT Capillary pO2,1
,POCT Lactic Acid Capillary-,1
2745-8,POCT Capillary pH,1
,POCT Capillary HCO3 calc,1
2020-6,POCT Capillary pCO2,1
,POCT Capillary Base Excess calc,1
,POCT Capillary TCO2 calc,1
3665-7,Gentamicin Trough,131
,--Flucytosine,8
29247-4,Sirolimus Level,2
2823-3,"Potassium, Serum/Pla",284023
2500-7,Total Iron Binding C,4058
1920-8,Aspartate Aminotrans,116060
48642-3,GFR-Non-African Amer,301437
41653-7,Bedside Glucose - El,546489
17861-6,"Calcium, Serum/Plasm",265751
2075-0,"Chloride, Serum/Plas",265341
2345-7,"Glucose, Serum/Plasm",265555
2160-0,"Creatinine, Serum/Pl",273693
2085-9,High Density Lipopro,19687
2089-1,Low Density Lipoprot,19681
9830-1,Cholesterol/HDL Rati,19676
2502-3,Iron Saturation Perc,4068
3051-0,"Triiodothyronine, Fr",925
2889-4,"Total Protein, 24 Ho",455
1798-8,"Amylase, Serum/Plasm",1041
1994-3,Filter Ionized Calci,790
30522-7,C-Reactive Protein U,128
,TV Creatinine,4
,Abnormal Plasma Cell,10
74170-2,--Ceftaroline,1
51644-3,Megakaryocytic Element,1
14836-1,Methotrexate Level,9
50633-7,--Ceftriaxone-Meningitis,2
52128-6,--Cefotaxime-Meningitis,2
,--Cefotaxime-Non Meningitis,2
,--Ceftriaxone-NonMeningitis,2
11054-4,L - LIPID PANEL WITH LDL/HDL RATIO 320064,3
2093-3,L - LIPID PANEL WITH LDL/HDL RATIO 320064,3
2571-8,L - LIPID PANEL WITH LDL/HDL RATIO 320064,3
2085-9,L - LIPID PANEL WITH LDL/HDL RATIO 320064,3
13458-5,L - LIPID PANEL WITH LDL/HDL RATIO 320064,3
13457-7,L - LIPID PANEL WITH LDL/HDL RATIO 320064,3
,TEST IN QUESTION- UNLABELED LEGACY,8
785-6,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
786-4,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
6690-2,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
713-8,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
5905-5,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
742-7,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
751-8,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
731-0,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
776-5,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
736-9,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
704-7,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
770-8,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
711-2,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
789-8,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
706-2,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
718-7,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
4544-3,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
787-2,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
788-0,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
777-3,CBC (INCLUDES DIFF/PLT) REFLEX QUEST LEGACY,5
30518-5,"BILE ACIDS, FRACTIONATED AND TOTAL, PREGNANCY",18
30520-1,"BILE ACIDS, FRACTIONATED AND TOTAL, PREGNANCY",16
30519-3,"BILE ACIDS, FRACTIONATED AND TOTAL, PREGNANCY",16
14628-2,"BILE ACIDS, FRACTIONATED AND TOTAL, PREGNANCY",16
,ADALIMUMAB DRUG LEVEL AND ANTI-DRUG ANTIBODY FOR IBD (Q),4
,UR MICROSCOPIC 333328,108
32546-4,GLUCOSE 6 PHOSPHATE DEHYDROGENASE,21
5130-0,"ANTI-DNA ANTIBODY, DOUBLE-STRANDED",65
4498-2,COMPLEMENT COMPONENT C4C,52
4485-9,COMPLEMENT COMPONENT C3C,51
63370-1,VITAMIN E,16
17864-0,"CALCIUM, IONIZED",46
11572-5,RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL 1,8
33935-8,RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL 1,8
764-1,"Q DIFFERENTIAL, MANUAL",23
26507-4,"Q DIFFERENTIAL, MANUAL",24
,"GLUCOSE TOLERANCE, 3 HOURS",2
,"GLUCOSE TOLERANCE, 2 HOURS",2
26523-1,"Q DIFFERENTIAL, MANUAL",2
20495-8,"GLIADIN (DEAMIDATED) AB (IGG, IGA)",6
20496-6,"GLIADIN (DEAMIDATED) AB (IGG, IGA)",6
1834-1,ALPHA-FETOPROTEIN (AFP) AND AFP-L3,4
42332-7,ALPHA-FETOPROTEIN (AFP) AND AFP-L3,4
62361-1,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
62360-3,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
55199-4,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
62358-7,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
718-7,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,607
1959-6,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,585
11557-6,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,585
20565-8,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,585
11558-4,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,585
11556-8,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,494
5060-9,LYME DISEASE AB TOTAL W/REFL WB (IGG IGM),13
,SWEAT CHLORIDE,4
3097-3,BMP8+EGFR,11
2951-2,BMP8+EGFR,11
2345-7,BMP8+EGFR,11
17861-6,BMP8+EGFR,11
2028-9,BMP8+EGFR,11
3094-0,BMP8+EGFR,11
2160-0,BMP8+EGFR,11
88294-4,BMP8+EGFR,11
88293-6,BMP8+EGFR,11
2823-3,BMP8+EGFR,11
2075-0,BMP8+EGFR,11
11011-4,"HCV RNA, QUANTITATIVE REAL TIME PCR",39
38180-6,"HCV RNA, QUANTITATIVE REAL TIME PCR",1089
2161-8,URINE DRUG SCREEN PANEL 5,1
2756-5,URINE DRUG SCREEN PANEL 5,1
11546-9,"PAP IG, CT-NG TV HPV-HR",2
,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,810
718-7,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,357
6299-2,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,357
2026-3,POCT CHEM 8 PROFILE UNSOLICITED RESULTS,357
1835-8,FIBROTEST-ACTITEST,42
48795-9,FIBROTEST-ACTITEST,41
,FIBROTEST-ACTITEST,75
2324-2,FIBROTEST-ACTITEST,43
1742-6,FIBROTEST-ACTITEST,30
1975-2,FIBROTEST-ACTITEST,43
48792-6,FIBROTEST-ACTITEST,41
4542-7,FIBROTEST-ACTITEST,29
1869-7,FIBROTEST-ACTITEST,42
,PSA TOTAL (REFLEX TO FREE),47
48159-8,ACUTE HEPATITIS,4
5206-8,"HSV 1/2 IGG, W/REFL HSV2 INHIBITION",14
5209-2,"HSV 1/2 IGG, W/REFL HSV2 INHIBITION",14
1751-7,"TESTOSTERONE FREE, PROFILE II",1
2986-8,"TESTOSTERONE FREE, PROFILE II",1
13967-5,"TESTOSTERONE FREE, PROFILE II",1
2991-8,"TESTOSTERONE FREE, PROFILE II",1
2282-2,"FOLATE, RBC LEGACY",26
2283-0,"FOLATE, RBC LEGACY",26
2923-1,VITAMIN A AND E LEGACY,15
1823-4,VITAMIN A AND E LEGACY,15
63370-1,VITAMIN A AND E LEGACY,15
2519-7,POCT LACTIC ACID VENOUS UNSOLICITED RESULTS,65
4544-3,"FOLATE, RBC LEGACY",2
5902-2,COAGULATION SCREEN,602
6301-6,COAGULATION SCREEN,602
14979-9,COAGULATION SCREEN,602
3255-7,COAGULATION SCREEN,602
5796-8,URINALYSIS ONLY MICROSCOPIC,29
26746-8,"MAGNESIUM, RBC",36
14805-6,LACTATE DEHYDROGENASE,111
,"CHOLESTEROL, BODY FLUID",18
,FACTOR IX (9) ACTIVITY,4
2093-3,LP,3
2571-8,LP,3
2085-9,LP,3
13458-5,LP,3
13457-7,LP,3
23883-2,INHIBIN A AND B TUMOR MARKER - MAYO,26
56940-0,INHIBIN A AND B TUMOR MARKER - MAYO,26
,HEPARIN ANTI-XA LEGACY,1
,POCT ACT KAOLIN UNSOLICITED RESULTS,214
83107-3,"NT-PRO BNP, S (MAYO)",92
1952-1,"BETA 2 MICROGLOBULIN, SERUM",194
,TRANSESOPHAGEAL ECHO INTRAOPERATIVE,251
8101-8,T LYMPH PROFILE,86
11556-8,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4010
11558-4,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4010
41650-3,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4132
32717-1,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4353
32713-0,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4353
11557-6,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4010
1959-6,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4009
20565-8,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4009
20570-8,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4354
2339-0,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4351
718-7,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4021
34581-9,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4353
6901-3,INSULIN FREE AND TOTAL - MAYO,8
20448-7,INSULIN FREE AND TOTAL - MAYO,7
27882-0,PROINSULIN,52
1795-4,"AMYLASE, BODY FLUID",306
68324-3,VON WILLEBRAND FACTOR ACTIVITY,47
6059-0,ALLERGEN CANDIDA ALBICANS,5
6121-8,ALLERGEN MICROORGANISM: FUSARIUM PROLIFERATUM (F. MONILIFORME) IGE,4
6138-2,ALLERGEN HELMINTHOSPORIUM SATIVIUM,2
4485-9,C3 COMPLEMENT,436
1761-6,ALDOLASE,525
32677-7,"ANTI-DNA ANTIBODY, DOUBLE-STRANDED",337
,POCT B-TYPE NATRIURETIC PEPTIDE UNSOLICITED RESULTS,3
2161-8,FRACTIONAL EXCRETION OF SODIUM (URINE),97
2955-3,FRACTIONAL EXCRETION OF SODIUM (URINE),97
49010-2,PLAVIX PLATELET FUNC ANALYSIS - PERFORMABLE,149
71772-8,QUANTIFERON-TB GOLD PLUS,25
6110-1,ALLERGEN ENGLISH PLANTAIN,1
6232-3,"ALLERGEN MARSH ELDER, ROUGH IGE",1
6182-0,ALLERGEN MUCOR,1
6156-4,ALLERGEN LAMB'S QUARTER IGE,1
6183-8,ALLERGEN MUGWORT IGE,1
6152-3,ALLERGEN JOHNSON GRASS IGE,3
6178-8,"ALLERGEN CEDAR, MOUNTAIN IGE",1
7123-3,ALLERGEN BAYBERRY/SWEET GALE IGE,1
32677-7,RHEUMATOID PANEL,104
5902-2,POCT PROTIME-INR BSP UNSOLICITED RESULTS,219
34714-6,POCT PROTIME-INR BSP UNSOLICITED RESULTS,219
2881-1,"PROTEIN, BODY FLUID",475
2529-6,"LACTATE DEHYDROGENASE, BODY FLUID",399
73818-7,HEPARIN-INDUCED PLATELET ANTIBODY,306
2502-3,IRON AND TOTAL IRON BINDING CAPACITY-MAY,1131
2498-4,IRON AND TOTAL IRON BINDING CAPACITY-MAY,1132
2500-7,IRON AND TOTAL IRON BINDING CAPACITY-MAY,1132
62467-6,"ASPERGILLUS ANTIGEN, BRONCHOALVEOLAR LAV",58
53326-5,SPECIFIC GRAVITY URINE,140
4542-7,HAPTOGLOBIN,4355
18309-5,CBC WITH AUTO DIFFERENTIAL,43
26450-7,CBC WITH AUTO DIFFERENTIAL,238
26505-8,CBC WITH AUTO DIFFERENTIAL,437
26485-3,CBC WITH AUTO DIFFERENTIAL,420
26478-8,CBC WITH AUTO DIFFERENTIAL,436
26499-4,CBC WITH AUTO DIFFERENTIAL,436
30180-4,CBC WITH AUTO DIFFERENTIAL,163
5385-0,THYROTROPIN RECEPTOR ANTIBODY,24
19075-1,"CELL COUNT WITH DIFFERENTIAL, CSF",195
26451-5,"CELL COUNT WITH DIFFERENTIAL, CSF",124
30436-0,"CELL COUNT WITH DIFFERENTIAL, CSF",188
2520-5,"LACTIC ACID, CSF",81
32660-3,"THIOPURINE METABOLITE, B (MAYO)",4
32654-6,"THIOPURINE METABOLITE, B (MAYO)",4
,"14-3-3 ETA PROTEIN, SERUM (MAYO)",28
72493-0,CMV QUANT VIRAL LOAD,255
72494-8,CMV QUANT VIRAL LOAD,85
27811-9,ANTITHROMBIN (AT) DEFICIENCY PROFILE LEGACY,4
27812-7,ANTITHROMBIN (AT) DEFICIENCY PROFILE LEGACY,4
51775-5,ENA+DNA + 160024,4
17791-5,ENA+DNA + 160024,4
5130-0,ENA+DNA + 160024,4
53982-5,ENA+DNA + 160024,4
11565-9,ENA+DNA + 160024,4
17792-3,ENA+DNA + 160024,4
11090-8,ENA+DNA + 160024,4
27416-7,ENA+DNA + 160024,4
29374-6,ENA+DNA + 160024,4
5076-5,"ANTICARDIOLIPIN ANTIBODY, IGA, IGG, AND IGM, QUANTITATIVE",18
3181-5,"ANTICARDIOLIPIN ANTIBODY, IGA, IGG, AND IGM, QUANTITATIVE",18
3182-3,"ANTICARDIOLIPIN ANTIBODY, IGA, IGG, AND IGM, QUANTITATIVE",18
2874-6,"IFE, PE AND FLC, SERUM LEGACY",4
2871-2,"IFE, PE AND FLC, SERUM LEGACY",4
2472-9,"IFE, PE AND FLC, SERUM LEGACY",4
2465-3,"IFE, PE AND FLC, SERUM LEGACY",4
2458-8,"IFE, PE AND FLC, SERUM LEGACY",4
2336-6,"IFE, PE AND FLC, SERUM LEGACY",4
36916-5,"IFE, PE AND FLC, SERUM LEGACY",4
48378-4,"IFE, PE AND FLC, SERUM LEGACY",4
1759-0,"IFE, PE AND FLC, SERUM LEGACY",4
33944-0,"IFE, PE AND FLC, SERUM LEGACY",4
2868-8,"IFE, PE AND FLC, SERUM LEGACY",4
2862-1,"IFE, PE AND FLC, SERUM LEGACY",4
2865-4,"IFE, PE AND FLC, SERUM LEGACY",4
2885-2,"IFE, PE AND FLC, SERUM LEGACY",4
16136-4,"BETA 2 GLYCOPROTEIN I AB (IGG,IGA,IGM)",22
16135-6,"BETA 2 GLYCOPROTEIN I AB (IGG,IGA,IGM)",22
21108-6,"BETA 2 GLYCOPROTEIN I AB (IGG,IGA,IGM)",22
2484-4,INSULIN LIKE GROWTH FACTOR 1,83
2963-7,GROWTH HORMONE,50
2078-4,"ELECTROLYTE PANEL, URINE",512
2955-3,"ELECTROLYTE PANEL, URINE",512
2828-2,"ELECTROLYTE PANEL, URINE",512
4498-2,C4 COMPLEMENT,434
26478-8,T LYMPH PROFILE,326
30471-7,LEVETIRACETAM LEVEL,209
3209-4,FACTOR VIII (8) ACTIVITY,145
6209-1,"REGIONAL ALLERGY PROFILE, IGE",21
29247-4,SIROLIMUS LEVEL,52
2458-8,CELIAC DISEASE COMPREHENSIVE CASCADE-MAY,73
46127-7,FIBROTEST-ACTITEST,13
1743-4,FIBROTEST-ACTITEST,13
83104-0,ANTIMULLERIAN HORMONE (AMH),37
,PFT BEDSIDE (RT PERFORMED),316
34714-6,LAB WB INR,202
33358-3,"IFE, PE AND FLC, SERUM LEGACY",4
49831-1,"COMPLIANCE DRUG ANALYSIS, UR",24
58394-8,"COMPLIANCE DRUG ANALYSIS, UR",24
58392-2,"COMPLIANCE DRUG ANALYSIS, UR",24
15061-5,ERYTHROPOIETIN,191
19113-0,ALLERGEN TOTAL IGE,148
2064-4,CERULOPLASMIN,1059
44706-0,ACTIN (SMOOTH MUSCLE) ANTIBODY (IGG),8
13967-5,TESTOSTERONE FREE BIOVAILABLE AND TOTAL MALES (ADULT) IMMUNOASSAY,20
2986-8,TESTOSTERONE FREE BIOVAILABLE AND TOTAL MALES (ADULT) IMMUNOASSAY,20
1751-7,TESTOSTERONE FREE BIOVAILABLE AND TOTAL MALES (ADULT) IMMUNOASSAY,20
2990-0,TESTOSTERONE FREE BIOVAILABLE AND TOTAL MALES (ADULT) IMMUNOASSAY,20
2991-8,TESTOSTERONE FREE BIOVAILABLE AND TOTAL MALES (ADULT) IMMUNOASSAY,20
31443-5,INTRINSIC FACTOR BLOCKING ANTIBODY,4
8087-9,ANTI-PARIETAL ANTIBODY,2
83083-6,CANCER ANTIGEN 15-3,36
2019-8,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,406
2744-1,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,406
2703-7,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,406
2026-3,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,301
1960-4,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,406
51733-4,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,357
14338-8,PREALBUMIN,8283
21587-1,"KIDNEY STONE, URINE/SATURATION",3
2779-7,"KIDNEY STONE, URINE/SATURATION",3
18488-7,"KIDNEY STONE, URINE/SATURATION",3
26888-8,"KIDNEY STONE, URINE/SATURATION",3
20624-3,"KIDNEY STONE, URINE/SATURATION",3
24447-5,"KIDNEY STONE, URINE/SATURATION",3
27039-7,"KIDNEY STONE, URINE/SATURATION",3
32169-5,"KIDNEY STONE, URINE/SATURATION",3
27378-9,"KIDNEY STONE, URINE/SATURATION",3
26889-6,"KIDNEY STONE, URINE/SATURATION",3
2695-5,"KIDNEY STONE, URINE/SATURATION",3
2179-0,"KIDNEY STONE, URINE/SATURATION",3
2162-6,"KIDNEY STONE, URINE/SATURATION",3
3167-4,"KIDNEY STONE, URINE/SATURATION",6
16264-4,"KIDNEY STONE, URINE/SATURATION",3
25308-8,"KIDNEY STONE, URINE/SATURATION",3
16257-8,"KIDNEY STONE, URINE/SATURATION",3
12512-0,"KIDNEY STONE, URINE/SATURATION",3
13496-5,"KIDNEY STONE, URINE/SATURATION",3
16259-4,"KIDNEY STONE, URINE/SATURATION",3
,"KIDNEY STONE, URINE/SATURATION",3
2828-2,"KIDNEY STONE, URINE/SATURATION",3
6687-8,"KIDNEY STONE, URINE/SATURATION",3
3087-4,"KIDNEY STONE, URINE/SATURATION",3
19124-7,"KIDNEY STONE, URINE/SATURATION",3
21194-6,"KIDNEY STONE, URINE/SATURATION",3
2701-1,"KIDNEY STONE, URINE/SATURATION",3
2829-0,"KIDNEY STONE, URINE/SATURATION",3
21203-5,"KIDNEY STONE, URINE/SATURATION",3
2079-2,"KIDNEY STONE, URINE/SATURATION",3
2700-3,"KIDNEY STONE, URINE/SATURATION",3
21458-5,"KIDNEY STONE, URINE/SATURATION",3
21525-1,"KIDNEY STONE, URINE/SATURATION",3
2956-1,"KIDNEY STONE, URINE/SATURATION",3
6874-2,"KIDNEY STONE, URINE/SATURATION",3
30248-9,SOLUBLE TRANSFERRIN RECEPTOR (STFR)-MAYO,17
11557-6,VENOUS BLOOD GAS UNSOLICITED RESULTS,149
11558-4,VENOUS BLOOD GAS UNSOLICITED RESULTS,149
2705-2,VENOUS BLOOD GAS UNSOLICITED RESULTS,192
1959-6,VENOUS BLOOD GAS UNSOLICITED RESULTS,149
24471-5,PLATELET FUNCTION ANALYSIS - PERFORMABLE,47
9728-7,LYMPHOCYTE SUBSET PANEL 1,16
8112-5,LYMPHOCYTE SUBSET PANEL 1,16
8123-2,LYMPHOCYTE SUBSET PANEL 1,16
8124-0,LYMPHOCYTE SUBSET PANEL 1,16
8122-4,LYMPHOCYTE SUBSET PANEL 1,16
8116-6,LYMPHOCYTE SUBSET PANEL 1,16
731-0,LYMPHOCYTE SUBSET PANEL 1,16
54218-3,LYMPHOCYTE SUBSET PANEL 1,16
8101-8,LYMPHOCYTE SUBSET PANEL 1,16
14135-8,LYMPHOCYTE SUBSET PANEL 1,16
24467-3,LYMPHOCYTE SUBSET PANEL 1,16
2258-2,ESTRONE,28
17817-8,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
17815-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
13801-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",10
2162-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
17813-7,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
17819-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
17811-1,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
2889-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
16162-0,PTH INTRAOPERATIVE,18
4548-4,REFLEX HGBA1C IF GLUC>150,80
13964-2,METHYLMALONIC ACID/HOMOCYSTEINE,1
13965-9,METHYLMALONIC ACID/HOMOCYSTEINE,1
30083-0,EBV ACUTE INFECTION ANTIBODIES,7
5159-9,EBV ACUTE INFECTION ANTIBODIES,7
5157-3,EBV ACUTE INFECTION ANTIBODIES,7
2196-4,DHEA,42
86951-1,LP PLA2 ACTIVITY,1
9500-0,"CANDIDA ALBICANS ANTIBODIES (IGG,IGA,IGM) LEGACY",1
7172-0,"CANDIDA ALBICANS ANTIBODIES (IGG,IGA,IGM) LEGACY",1
9498-7,"CANDIDA ALBICANS ANTIBODIES (IGG,IGA,IGM) LEGACY",1
86222-7,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
43727-7,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
2571-8,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
2093-3,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
2085-9,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
43729-3,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
1884-6,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
17782-4,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
43583-4,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
54434-6,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
9830-1,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
43396-1,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
13457-7,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
5803-2,PH  URINE DIPSTICK,193
2889-4,"PROTEIN / CREATININE RATIO, URINE",16
2162-6,"PROTEIN / CREATININE RATIO, URINE",16
86609-5,"COMPLIANCE DRUG ANALYSIS, UR",24
58395-5,"COMPLIANCE DRUG ANALYSIS, UR",24
61423-0,"COMPLIANCE DRUG ANALYSIS, UR",24
58396-3,"COMPLIANCE DRUG ANALYSIS, UR",24
2216-0,"CATECHOLAMINES, FRACTIONATED, PLASMA",25
2666-6,"CATECHOLAMINES, FRACTIONATED, PLASMA",25
2230-1,"CATECHOLAMINES, FRACTIONATED, PLASMA",25
2668-2,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",27
13362-9,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",16
3167-4,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",25
2218-6,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",27
2232-7,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",27
2019-8,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,244
2744-1,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,244
2703-7,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,244
1960-4,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,244
2708-6,ARTERIAL BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,244
6025-1,ALLERGEN ASPERGILLUS FUMIGATUS,59
32677-7,"DNA(DS) AB, HIGH AVIDITY",5
718-7,POCT HEMOGLOBIN MANUAL RESULTS,13
11558-4,POCT CORD PH UNSOLICITED RESULTS,377
38370-3,VORICONAZOLE LEVEL,21
1759-0,"PROTEIN ELEC + INTERP, SERUM",4
2868-8,"PROTEIN ELEC + INTERP, SERUM",4
2862-1,"PROTEIN ELEC + INTERP, SERUM",4
2865-4,"PROTEIN ELEC + INTERP, SERUM",4
10834-0,"PROTEIN ELEC + INTERP, SERUM",4
2874-6,"PROTEIN ELEC + INTERP, SERUM",4
33358-3,"PROTEIN ELEC + INTERP, SERUM",4
2871-2,"PROTEIN ELEC + INTERP, SERUM",4
2458-8,IMMUNOFIXATION ELECTROPHORESIS,31
2465-3,IMMUNOFIXATION ELECTROPHORESIS,34
2472-9,IMMUNOFIXATION ELECTROPHORESIS,34
12183-0,"CHOLESTEROL, BODY FLUID",74
2019-8,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,344
2703-7,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,344
51733-4,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,332
2026-3,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,228
1960-4,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,344
2744-1,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,344
20509-6,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,332
,PEDIATRIC STRESS TEST - PULMONARY TEST,4
2465-3,"IMMUNOFIXATION IMMUNOGLOBULIN IGA, IGG, IGM QT. SERUM",16
2458-8,"IMMUNOFIXATION IMMUNOGLOBULIN IGA, IGG, IGM QT. SERUM",16
2472-9,"IMMUNOFIXATION IMMUNOGLOBULIN IGA, IGG, IGM QT. SERUM",16
35668-3,"GENTAMICIN LEVEL, RANDOM",47
11557-6,POCT CORD BLOOD GAS UNSOLICITED RESULTS,235
11558-4,POCT CORD BLOOD GAS UNSOLICITED RESULTS,235
11556-8,POCT CORD BLOOD GAS UNSOLICITED RESULTS,235
20565-8,POCT CORD BLOOD GAS UNSOLICITED RESULTS,235
1959-6,POCT CORD BLOOD GAS UNSOLICITED RESULTS,235
2093-3,CA+CHOL+CREAT+GLU+K+NA,1
88294-4,CA+CHOL+CREAT+GLU+K+NA,1
2345-7,CA+CHOL+CREAT+GLU+K+NA,1
2160-0,CA+CHOL+CREAT+GLU+K+NA,1
17861-6,CA+CHOL+CREAT+GLU+K+NA,1
2951-2,CA+CHOL+CREAT+GLU+K+NA,1
2823-3,CA+CHOL+CREAT+GLU+K+NA,1
88293-6,CA+CHOL+CREAT+GLU+K+NA,1
3255-7,"FIBRINOGEN ACTIVITY, CLAUSS",169
26508-2,CBC WITH AUTO DIFFERENTIAL,360
15087-0,PTH-RELATED PEPTIDE,44
,PREPARE RBC (IN ML),546
2609-6,"METANEPHRINES FRACTIONATED 24HR, URINE",47
19049-6,"METANEPHRINES FRACTIONATED 24HR, URINE",48
2671-6,"METANEPHRINES FRACTIONATED 24HR, URINE",48
3167-4,"METANEPHRINES FRACTIONATED 24HR, URINE",47
13362-9,"METANEPHRINES FRACTIONATED 24HR, URINE",31
20572-4,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,4
20567-4,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,4
46128-5,TISSUE TRANSGLUTAMINASE ANTIBODY IGA AND IGG PROFILE,36
56537-4,TISSUE TRANSGLUTAMINASE ANTIBODY IGA AND IGG PROFILE,36
1975-2,"BILIRUBIN, TOTAL AND DIRECT",2
1968-7,"BILIRUBIN, TOTAL AND DIRECT",3
2019-8,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,118
2744-1,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,118
2703-7,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,118
2026-3,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,118
1960-4,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,118
51733-4,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,114
41171-0,C TELOPEPTIDE (CTX),19
2874-6,"IFE AND PE, SERUM",5
2472-9,"IFE AND PE, SERUM",5
2465-3,"IFE AND PE, SERUM",5
2458-8,"IFE AND PE, SERUM",5
1759-0,"IFE AND PE, SERUM",5
2336-6,"IFE AND PE, SERUM",5
2871-2,"IFE AND PE, SERUM",5
2865-4,"IFE AND PE, SERUM",5
2868-8,"IFE AND PE, SERUM",5
2862-1,"IFE AND PE, SERUM",5
6218-2,ALLERGEN PINEAPPLE IGE,2
6276-0,ALLERGEN WHEAT IGE,2
5370-2,STREPTOCOCCAL ANTIBODIES PROFILE-MAYO,7
5133-4,STREPTOCOCCAL ANTIBODIES PROFILE-MAYO,7
2518-9,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,104
52768-9,THROMBOELASTOGRAPH CLOTTING PROFILE,700
52789-5,THROMBOELASTOGRAPH CLOTTING PROFILE,701
52778-8,THROMBOELASTOGRAPH CLOTTING PROFILE,701
66748-5,THROMBOELASTOGRAPH CLOTTING PROFILE,701
8251-1,ABN TEST REFUSAL LEGACY,110
26498-6,IMMATURE CELLS 115399,12
2518-9,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,463
2283-0,FOLATE RBC,137
,CARDIOVERSION ELECTRICAL EXTERNAL,202
3968-5,"PHENYTOIN LEVEL, FREE(CALC)",23
3969-3,"PHENYTOIN LEVEL, FREE(CALC)",126
1751-7,"PHENYTOIN LEVEL, FREE(CALC)",23
2339-0,POCT GLUCOSE UNSOLICITED RESULTS,48
,HM NEPHROPATHY MICROALBUMINURIA,51
19151-0,INSULIN RESPONSE TO GLUCOSE 3 SPECIMENS,9
50501-6,INSULIN RESPONSE TO GLUCOSE 3 SPECIMENS,3
50503-2,INSULIN RESPONSE TO GLUCOSE 3 SPECIMENS,3
50502-4,INSULIN RESPONSE TO GLUCOSE 3 SPECIMENS,3
3095-7,"UREA NITROGEN, URINE",243
53982-5,ENA+ ABS 160014,3
11565-9,ENA+ ABS 160014,3
11090-8,ENA+ ABS 160014,3
5130-0,ENA+ ABS 160014,2
29374-6,ENA+ ABS 160014,3
51775-5,ENA+ ABS 160014,3
17792-3,ENA+ ABS 160014,3
17791-5,ENA+ ABS 160014,3
27416-7,ENA+ ABS 160014,3
43583-4,LIPOPROTEIN (A),35
11546-9,"PAP IG, CT-NG, HPV-HR",8
21198-7,"HCG, TUMOR MARKER",1
28541-1,CBC WITH AUTO DIFFERENTIAL,73
3714-3,LIDOCAINE LEVEL,84
1986-9,"C PEPTIDE, ULTRASENSITIVE, ES",1
3050-2,"T3, UPTAKE",14
1558-6,GTT 2 HOUR,1
1507-3,GTT 2 HOUR,1
91142-0,TPMT ACTIVITY - MAYO,9
91141-2,TPMT ACTIVITY - MAYO,9
91143-8,TPMT ACTIVITY - MAYO,9
51495-0,"SALIVARY CORTISOL X2, TIMED",1
51494-3,"SALIVARY CORTISOL X2, TIMED",1
94875-2,CONNECTIVE TISSUE CASCADE,10
94874-5,CONNECTIVE TISSUE CASCADE,10
44053-7,RBC ENZYME EVALUATION MAYO,14
72664-6,RBC ENZYME EVALUATION MAYO,14
32546-4,RBC ENZYME EVALUATION MAYO,14
2383-8,RBC ENZYME EVALUATION MAYO,14
44054-5,RBC ENZYME EVALUATION MAYO,14
44051-1,RBC ENZYME EVALUATION MAYO,14
44050-3,RBC ENZYME EVALUATION MAYO,14
49216-5,RBC ENZYME EVALUATION MAYO,14
32552-2,RBC ENZYME EVALUATION MAYO,14
1558-6,GLUCOSE FASTING AND 2HR LEGACY,1
1521-4,GLUCOSE FASTING AND 2HR LEGACY,1
46717-5,THROMBIN TIME,31
27818-4,PROTEIN C AND S ACTIVITY,134
27822-6,PROTEIN C AND S ACTIVITY,134
14979-9,DIC PROFILE PERFORMABLE,202
5902-2,DIC PROFILE PERFORMABLE,202
6301-6,DIC PROFILE PERFORMABLE,202
48065-7,DIC PROFILE PERFORMABLE,202
3255-7,DIC PROFILE PERFORMABLE,202
31017-7,"TISSUE TRANSGLUTAMINASE, IGA",22
33314-6,RHEUMATOID FACTOR (IGG),415
33313-8,RHEUMATOID FACTOR (IGA),219
11573-3,RHEUMATOID FACTOR (IGM),205
26446-5,MANUAL DIFF CELLAVISION,454
2519-7,POCT WHOLE BLOOD PROFILE UNSOLICITED RESULTS,56
35669-1,"AMIKACIN LEVEL, RANDOM",55
19072-8,"CALCIUM, IONIZED",76
55928-6,"IODINE/CREATININE RATIO, RANDOM, URINE",3
2495-0,"IODINE/CREATININE RATIO, RANDOM, URINE",2
2161-8,"IODINE/CREATININE RATIO, RANDOM, URINE",3
12228-3,"TRIGLYCERIDES, BODY FLUID",129
3198-9,FACTOR VII (7) ACTIVITY,10
734-4,MANUAL DIFFERENTIAL,29
3051-0,T3FREE,8
51967-8,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
62360-3,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
62361-1,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
55199-4,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
62358-7,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
2890-2,PROT+CREATU (RANDOM),71
2161-8,PROT+CREATU (RANDOM),71
2888-6,PROT+CREATU (RANDOM),68
11557-6,CORD BLOOD GAS UNSOLICITED RESULTS,20
11558-4,CORD BLOOD GAS UNSOLICITED RESULTS,20
11556-8,CORD BLOOD GAS UNSOLICITED RESULTS,20
11555-0,CORD BLOOD GAS UNSOLICITED RESULTS,20
1959-6,CORD BLOOD GAS UNSOLICITED RESULTS,20
14873-4,POCT CORD PH UNSOLICITED RESULTS,17
770-8,CBC/DIFFERENTIAL (NO PLATELET),4
788-0,CBC/DIFFERENTIAL (NO PLATELET),4
718-7,CBC/DIFFERENTIAL (NO PLATELET),4
6690-2,CBC/DIFFERENTIAL (NO PLATELET),4
789-8,CBC/DIFFERENTIAL (NO PLATELET),4
5905-5,CBC/DIFFERENTIAL (NO PLATELET),4
742-7,CBC/DIFFERENTIAL (NO PLATELET),4
736-9,CBC/DIFFERENTIAL (NO PLATELET),4
706-2,CBC/DIFFERENTIAL (NO PLATELET),4
713-8,CBC/DIFFERENTIAL (NO PLATELET),4
731-0,CBC/DIFFERENTIAL (NO PLATELET),4
751-8,CBC/DIFFERENTIAL (NO PLATELET),4
711-2,CBC/DIFFERENTIAL (NO PLATELET),4
786-4,CBC/DIFFERENTIAL (NO PLATELET),4
787-2,CBC/DIFFERENTIAL (NO PLATELET),4
785-6,CBC/DIFFERENTIAL (NO PLATELET),4
4544-3,CBC/DIFFERENTIAL (NO PLATELET),4
11031-2,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,12
,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,12
26513-2,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,11
30437-8,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,12
3013-0,THYROGLOBULIN TUMOR MARKER,117
8122-4,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
27071-0,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
8124-0,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
20402-4,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
8112-5,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
54218-3,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
14135-8,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
24467-3,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
8101-8,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
8123-2,"QUANTITATIVE LYMPHOCYTE SUBSETS: T, B, AND NATURAL KILLER (NK)",5
28543-7,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",32
3051-0,"Q T3, FREE",18
2888-6,PREECLAMPSIA MONITORING PROFILE,8
2164-2,PREECLAMPSIA MONITORING PROFILE,8
2160-0,PREECLAMPSIA MONITORING PROFILE,8
788-0,PREECLAMPSIA MONITORING PROFILE,8
713-8,PREECLAMPSIA MONITORING PROFILE,8
786-4,PREECLAMPSIA MONITORING PROFILE,8
731-0,PREECLAMPSIA MONITORING PROFILE,8
770-8,PREECLAMPSIA MONITORING PROFILE,8
751-8,PREECLAMPSIA MONITORING PROFILE,8
777-3,PREECLAMPSIA MONITORING PROFILE,8
5905-5,PREECLAMPSIA MONITORING PROFILE,8
736-9,PREECLAMPSIA MONITORING PROFILE,8
3084-1,PREECLAMPSIA MONITORING PROFILE,8
711-2,PREECLAMPSIA MONITORING PROFILE,8
742-7,PREECLAMPSIA MONITORING PROFILE,8
3094-0,PREECLAMPSIA MONITORING PROFILE,8
2532-0,PREECLAMPSIA MONITORING PROFILE,8
718-7,PREECLAMPSIA MONITORING PROFILE,8
2889-4,PREECLAMPSIA MONITORING PROFILE,8
785-6,PREECLAMPSIA MONITORING PROFILE,8
1742-6,PREECLAMPSIA MONITORING PROFILE,8
787-2,PREECLAMPSIA MONITORING PROFILE,8
1920-8,PREECLAMPSIA MONITORING PROFILE,8
789-8,PREECLAMPSIA MONITORING PROFILE,8
6690-2,PREECLAMPSIA MONITORING PROFILE,8
4544-3,PREECLAMPSIA MONITORING PROFILE,8
2162-6,PREECLAMPSIA MONITORING PROFILE,8
88293-6,PREECLAMPSIA MONITORING PROFILE,8
2161-8,PREECLAMPSIA MONITORING PROFILE,8
88294-4,PREECLAMPSIA MONITORING PROFILE,8
19124-7,"MAGNESIUM, URINE",19
35669-1,"AMIKACIN LEVEL, TROUGH",40
,POCT REAGENT STRIP BLOOD GLUCOSE,15
,SEMEN ANALYSIS,30
2752-4,SEMEN ANALYSIS,15
3160-9,SEMEN ANALYSIS,15
32998-7,"TISSUE TRANSGLUTAMINASE, IGG",8
7258-7,"ALLERGEN: FOOD ALLERGY PROFILE, IGE",13
58709-7,"GLIADIN ANTIBODIES EVAL, IGG AND IGA, SERUM",1
58710-5,"GLIADIN ANTIBODIES EVAL, IGG AND IGA, SERUM",1
17792-3,ANTI ENA 2,14
17791-5,ANTI ENA 2,14
6186-1,"ALLERGY PANEL, REGION 3, WEEDS",5
6110-1,"ALLERGY PANEL, REGION 3, WEEDS",5
6286-9,"ALLERGY PANEL, REGION 3, WEEDS",5
6244-8,"ALLERGY PANEL, REGION 3, WEEDS",5
6156-4,"ALLERGY PANEL, REGION 3, WEEDS",5
4551-8,HEMOGLOBINOPATHY EVALUATION,52
4576-5,HEMOGLOBINOPATHY EVALUATION,52
4544-3,HEMOGLOBINOPATHY EVALUATION,52
789-8,HEMOGLOBINOPATHY EVALUATION,53
718-7,HEMOGLOBINOPATHY EVALUATION,52
4546-8,HEMOGLOBINOPATHY EVALUATION,53
785-6,HEMOGLOBINOPATHY EVALUATION,52
788-0,HEMOGLOBINOPATHY EVALUATION,52
787-2,HEMOGLOBINOPATHY EVALUATION,52
29541-0,"HIV-1 RNA, REAL TIME PCR (GRAPH)",54
49011-0,ASPIRIN PFA,78
5370-2,ANTISTREPTOLYSIN O (ASO) ANTIBODIES,51
,"AMYLASE, URINE, RANDOM",3
27818-4,PROTEIN C ACTIVITY,8
26498-6,CBC WITH AUTO DIFFERENTIAL,75
21365-2,VECTRA(R),9
75628-8,VECTRA(R),9
1988-5,VECTRA(R),9
75633-8,VECTRA(R),9
1847-3,VECTRA(R),9
75630-4,VECTRA(R),9
75632-0,VECTRA(R),9
48663-9,VECTRA(R),9
75631-2,VECTRA(R),9
14049-1,VECTRA(R),9
26881-3,VECTRA(R),9
75629-6,VECTRA(R),9
75627-0,VECTRA(R),9
11011-4,"HCV RT-PCR, QUANT (NON-GRAPH) 55036",4
38180-6,"HCV RT-PCR, QUANT (NON-GRAPH) 55036",2
2075-0,CMP14+LP+CBC/D/PLT+TSH,4
2823-3,CMP14+LP+CBC/D/PLT+TSH,4
2160-0,CMP14+LP+CBC/D/PLT+TSH,4
2571-8,CMP14+LP+CBC/D/PLT+TSH,4
11580-8,CMP14+LP+CBC/D/PLT+TSH,4
2093-3,CMP14+LP+CBC/D/PLT+TSH,4
718-7,CMP14+LP+CBC/D/PLT+TSH,4
13458-5,CMP14+LP+CBC/D/PLT+TSH,4
789-8,CMP14+LP+CBC/D/PLT+TSH,4
2085-9,CMP14+LP+CBC/D/PLT+TSH,4
11054-4,CMP14+LP+CBC/D/PLT+TSH,4
13457-7,CMP14+LP+CBC/D/PLT+TSH,4
6690-2,CMP14+LP+CBC/D/PLT+TSH,4
2345-7,CMP14+LP+CBC/D/PLT+TSH,4
787-2,CMP14+LP+CBC/D/PLT+TSH,4
770-8,CMP14+LP+CBC/D/PLT+TSH,4
4544-3,CMP14+LP+CBC/D/PLT+TSH,4
713-8,CMP14+LP+CBC/D/PLT+TSH,4
786-4,CMP14+LP+CBC/D/PLT+TSH,4
5905-5,CMP14+LP+CBC/D/PLT+TSH,4
785-6,CMP14+LP+CBC/D/PLT+TSH,4
777-3,CMP14+LP+CBC/D/PLT+TSH,4
788-0,CMP14+LP+CBC/D/PLT+TSH,4
736-9,CMP14+LP+CBC/D/PLT+TSH,4
3094-0,CMP14+LP+CBC/D/PLT+TSH,4
17861-6,CMP14+LP+CBC/D/PLT+TSH,4
1975-2,CMP14+LP+CBC/D/PLT+TSH,4
2028-9,CMP14+LP+CBC/D/PLT+TSH,4
1742-6,CMP14+LP+CBC/D/PLT+TSH,4
1751-7,CMP14+LP+CBC/D/PLT+TSH,4
1920-8,CMP14+LP+CBC/D/PLT+TSH,4
2885-2,CMP14+LP+CBC/D/PLT+TSH,4
1759-0,CMP14+LP+CBC/D/PLT+TSH,4
10834-0,CMP14+LP+CBC/D/PLT+TSH,4
6768-6,CMP14+LP+CBC/D/PLT+TSH,4
751-8,CMP14+LP+CBC/D/PLT+TSH,4
742-7,CMP14+LP+CBC/D/PLT+TSH,4
731-0,CMP14+LP+CBC/D/PLT+TSH,4
711-2,CMP14+LP+CBC/D/PLT+TSH,4
2951-2,CMP14+LP+CBC/D/PLT+TSH,4
88293-6,CMP14+LP+CBC/D/PLT+TSH,4
3097-3,CMP14+LP+CBC/D/PLT+TSH,4
88294-4,CMP14+LP+CBC/D/PLT+TSH,4
42772-4,FIBRINOGEN ANTIGEN,1
75880-5,14.3.3 ETA PROTEIN,192
6085-5,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6082-2,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6020-2,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6208-3,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6276-0,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6206-7,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6232-3,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6212-5,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6273-7,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
7138-1,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
15749-5,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
19113-0,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6209-1,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6095-4,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6152-3,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6098-8,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6189-5,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6106-9,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6174-7,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6096-2,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
7425-2,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6109-3,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6169-7,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6078-0,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6041-8,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6833-8,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
6025-1,"ALLERGEN: SOUTHEASTERN ALLERGY PROFILE, IGE",37
41647-9,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,116
3665-7,"GENTAMICIN LEVEL, TROUGH",28
42637-9,POCT B-TYPE NATRIURETIC PEPTIDE UNSOLICITED RESULTS,17
66133-0,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",9
15049-0,CK ISOENZYMES,2
2157-6,CK ISOENZYMES,2
1974-5,"BILIRUBIN LEVEL TOTAL, BODY FLUID",22
47255-5,PROCOLLAGEN TYPE 1 INTACT N TERMINAL PROPEPTIDE (P1NP),6
2458-8,CELIAC DISEASE COMPREHENSIVE PANEL WITH GLIADIN ANTIBODY (IGG),13
31017-7,CELIAC DISEASE COMPREHENSIVE PANEL WITH GLIADIN ANTIBODY (IGG),13
47393-4,"GLIADIN ANTIBODIES EVAL, IGG AND IGA, SERUM",25
47394-2,"GLIADIN ANTIBODIES EVAL, IGG AND IGA, SERUM",25
98979-8,BASIC METABOLIC PANEL,2
27057-9,SEROTONIN SERUM - MAYO,15
35559-4,"PROTEIN ELECTROPHORESIS, SERUM",5
6034-3,"ALLERGY PANEL, REGION 3, GRASSES",6
6265-3,"ALLERGY PANEL, REGION 3, GRASSES",6
6195-2,"ALLERGY PANEL, REGION 3, GRASSES",6
6228-1,"ALLERGY PANEL, REGION 3, GRASSES",6
6153-1,"ALLERGY PANEL, REGION 3, GRASSES",6
6171-3,"ALLERGY PANEL, REGION 3, TREES",5
6178-8,"ALLERGY PANEL, REGION 3, TREES",5
7155-5,"ALLERGY PANEL, REGION 3, TREES",5
6282-8,"ALLERGY PANEL, REGION 3, TREES",5
6109-3,"ALLERGY PANEL, REGION 3, TREES",5
,PLAVIX PLATELET ANALYSIS ADP,89
,PLAVIX PLATELET COUNT TOTAL,31
1521-4,"GLUCOSE, 2 HOUR POSTPRANDIAL",5
12841-3,PSA TOTAL (REFLEX TO FREE),1
10886-0,PSA TOTAL (REFLEX TO FREE),1
2021-4,VENOUS BLOOD GAS UNSOLICITED RESULTS,43
2746-6,VENOUS BLOOD GAS UNSOLICITED RESULTS,43
14627-4,VENOUS BLOOD GAS UNSOLICITED RESULTS,43
51731-8,VENOUS BLOOD GAS UNSOLICITED RESULTS,44
57093-7,CCP ANTIBODIES IGG/IGA,52
1514-9,"GLUCOSE TOLERANCE TEST, GEST, 4SPEC 100G W/NDDG",12
1558-6,"GLUCOSE TOLERANCE TEST, GEST, 4SPEC 100G W/NDDG",12
1501-6,"GLUCOSE TOLERANCE TEST, GEST, 4SPEC 100G W/NDDG",12
1530-5,"GLUCOSE TOLERANCE TEST, GEST, 4SPEC 100G W/NDDG",12
9622-2,VITAMIN K,39
5724-0,SELENIUM SERUM,15
33203-1,"ALZHEIMER'S EVALUATION, CSF",1
41027-4,"ALZHEIMER'S EVALUATION, CSF",1
72260-3,"ALZHEIMER'S EVALUATION, CSF",1
30160-6,"ALZHEIMER'S EVALUATION, CSF",1
9811-1,CHROMOGRANIN A-MAYO,58
1518-0,"GLUCOSE TOLERANCE, 2 HOURS",39
1558-6,"GLUCOSE TOLERANCE, 2 HOURS",39
1507-3,"GLUCOSE TOLERANCE, 2 HOURS",39
,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
25166-0,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
34314-5,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
25167-8,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
2811-8,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
34352-5,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
19113-0,IMMUNOGLOBULINS A/E/G/M SERUM LEGACY,7
75880-5,"14.3.3 ETA, RHEUM. ARTHRITIS",5
11090-8,SMITH ANTIBODIES,197
89502-9,ANTI-SCL-70 AB (RDL),5
,TSH W/REFLEX TO FT4,741
3182-3,"CARDIOLIPIN ANTIBODIES IGG, IGM QUANT",11
5076-5,"CARDIOLIPIN ANTIBODIES IGG, IGM QUANT",11
3181-5,"CARDIOLIPIN ANTIBODIES IGG, IGM QUANT",11
14152-3,"BILIRUBIN LEVEL DIRECT, BODY FLUID",9
,"TESTOSTERONE, FREE, DIRECT",1
43583-4,LIPOPROTEIN A (LPA),51
,SEX HORMONE BINDING GLOBULIN,8
20447-9,"HIV-1 RNA, REAL TIME PCR (NON-GRAPH)",24
,L - LIPID PANEL 303756,82
,INSULIN LIKE GROWTH FACTOR 1,2
58413-6,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",1
35332-6,IMMATURE CELLS 115399,14
28541-1,IMMATURE CELLS 115399,10
26446-5,IMMATURE CELLS 115399,2
,"SODIUM, URINE, 24 HOUR",8
28009-9,"SODIUM, URINE, 24 HOUR",8
2955-3,"SODIUM, URINE, 24 HOUR",8
,URINE FOR TRANSFUSION REACTION WK-UP,1
2756-5,791042 10+CRT-BUND,1
2161-8,791042 10+CRT-BUND,1
59615-5,791042 10+CRT-BUND,1
52789-5,RAPID TEG ACT,44
30465-9,MANUAL DIFF CELLAVISION,23
56537-4,"TISSUE TRANSGLUTAMINASE, IGG",12
35166-8,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35165-0,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35155-1,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35160-1,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35177-5,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35182-5,FATTY ACID PROFILE ESSENTIAL- MAYO,7
24461-6,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35411-8,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35179-1,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35170-0,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35176-7,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35175-9,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35178-3,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35150-2,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35157-7,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35149-4,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35169-2,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35167-6,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35180-9,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35168-4,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35181-7,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35173-4,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35171-8,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35172-6,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35174-2,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35164-3,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35161-9,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35163-5,FATTY ACID PROFILE ESSENTIAL- MAYO,7
35162-7,FATTY ACID PROFILE ESSENTIAL- MAYO,7
24472-3,PLATELET FUNCTION ANALYSIS - PERFORMABLE,17
2518-9,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
2019-8,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
2744-1,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
2703-7,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
2026-3,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
1960-4,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
51733-4,POCT ARTERIAL BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,65
20449-5,LYME AB SCREEN LEGACY,5
11572-5,LUPUS SCREEN/CONFIRM PANEL,21
44706-0,LUPUS SCREEN/CONFIRM PANEL,21
4485-9,LUPUS SCREEN/CONFIRM PANEL,21
8087-9,LUPUS SCREEN/CONFIRM PANEL,21
8099-4,LUPUS SCREEN/CONFIRM PANEL,21
4498-2,LUPUS SCREEN/CONFIRM PANEL,21
39789-3,"POCT POTASSIUM, GLUCOSE AND HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS",7
2339-0,"POCT POTASSIUM, GLUCOSE AND HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS",7
2885-2,"PROTEIN, TOTAL LEGACY",9
2868-8,Q PROTEIN ELECTROPHORESIS,1
2862-1,Q PROTEIN ELECTROPHORESIS,1
2865-4,Q PROTEIN ELECTROPHORESIS,1
32731-2,Q PROTEIN ELECTROPHORESIS,1
2874-6,Q PROTEIN ELECTROPHORESIS,1
32730-4,Q PROTEIN ELECTROPHORESIS,1
53622-7,ADAMTS13 EVALUATION-MAYO,35
16935-9,HEPATITIS B SURFACE ANTIBODY(HBIG) TITER,15
6939-3,IGA SUBCLASSES BY NEPH-MAYO,6
2458-8,IGA SUBCLASSES BY NEPH-MAYO,6
6886-6,IGA SUBCLASSES BY NEPH-MAYO,6
43215-3,ACTH STIMULATION BASELINE,6
12566-6,ACTH STIMULATION 30 MIN,6
9318-7,"ALBUMIN/CREAT RATIO, RANDOM UR",14
2161-8,"ALBUMIN/CREAT RATIO, RANDOM UR",14
14957-5,"ALBUMIN/CREAT RATIO, RANDOM UR",14
14135-8,T-HELPER CELLS CD4/CD8 %,5
24467-3,T-HELPER CELLS CD4/CD8 %,3
8123-2,T-HELPER CELLS CD4/CD8 %,3
54218-3,T-HELPER CELLS CD4/CD8 %,5
8101-8,T-HELPER CELLS CD4/CD8 %,5
51969-4,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,1
4485-9,COMPLEMENT COMP C3 + C4 LEGACY,11
4498-2,COMPLEMENT COMP C3 + C4 LEGACY,11
62858-6,MANUAL DIFF CELLAVISION,7
71772-8,QFT-TB GOLD PLUS 182880,37
2823-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2951-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
3094-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2093-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
11054-4,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
1742-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
789-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2085-9,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
6690-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2571-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
13457-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
13458-5,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
11580-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2345-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
4544-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
777-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
718-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
5905-5,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
785-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
736-9,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
787-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
788-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
786-4,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
770-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
4548-4,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2028-9,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
1759-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2075-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
1920-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2885-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
6768-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
17861-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
10834-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
1751-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
1975-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
706-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
704-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
713-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
731-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
751-8,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
711-2,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
742-7,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
3097-3,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
88294-4,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
88293-6,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
2160-0,CMP14+LP+CBC/D/PLT+TSH+HB A1C 246767,1
5130-0,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
17861-6,INTACT PTH (INCLUDES CALCIUM),4
2731-8,INTACT PTH (INCLUDES CALCIUM),4
12515-3,"CEA, BODY FLUID",28
6125-9,ALLERGEN GLUTEN IGE,11
2519-7,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,72
2021-4,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
2746-6,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
2705-2,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
48391-7,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
14627-4,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
51731-8,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,14
11155-9,"CORTISOL FREE RANDOM, URINE",6
2161-8,"CORTISOL FREE RANDOM, URINE",6
2708-6,ARTERIAL BLOOD GAS UNSOLICITED RESULTS,42
12567-4,ACTH STIMULATION 1 HOUR,6
,POCT ACTIVATED CLOTTING TIME,112
19080-1,"INTEGRATED SCREEN, PART 2",7
32166-1,"INTEGRATED SCREEN, PART 2",7
76348-2,"INTEGRATED SCREEN, PART 2",7
51969-4,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",33
2458-8,CELIAC DISEASE SEROLOGY CASCADE-MAYO,27
5761-2,"ZINC, RED BLOOD CELLS (ARUP)",3
52789-5,RAPID TEG ACT PERFORMABLE,40
,PREPARE LIQUID PLASMA,21
85991-8,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
85977-7,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86080-9,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
40974-8,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
27395-3,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
40969-8,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
30153-1,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
85954-6,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86039-5,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86024-7,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86098-1,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86009-8,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
40973-0,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86052-8,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
25296-5,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86045-2,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
27118-9,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86064-3,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86122-9,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86130-2,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86147-6,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
86107-0,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
48654-8,DIPHTHERIA / TETANUS ANTIBODY PANEL,4
53935-3,DIPHTHERIA / TETANUS ANTIBODY PANEL,4
29239-1,T3 FREE TRACER DIALYSIS,1
3053-6,T3 FREE TRACER DIALYSIS,1
1825-9,ALPHA-1-ANTITRYPSIN,21
98979-8,COMPREHENSIVE METABOLIC PANEL,21
31019-3,OXCARBAZEPINE LEVEL,18
58364-1,"COMPLIANCE DRUG ANALYSIS, UR",24
3187-2,FACTOR IX (9) ACTIVITY,16
4548-4,A1C W/GLYCOMARK(R) REFLEX,2
27353-2,A1C W/GLYCOMARK(R) REFLEX,2
,PREPARE CRYOPRECIPITATE,1197
14003-8,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
14873-4,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
14864-3,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
34728-6,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
32300-6,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
14151-5,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
2713-6,POCT CORD BLOOD GAS UNSOLICITED RESULTS,11
27416-7,SCLERODERMA DIAGNOSTIC PROFILE LEGACY,3
29374-6,RNP ANTIBODIES LEGACY,5
8099-4,Q THYROID PEROXIDASE ANTIBODIES,38
50544-6,EVEROLIMUS-MAYO,2
49500-2,STONE ANALYSIS,11
38252-3,STONE ANALYSIS,12
3086-6,"URIC ACID, URINE",16
,PREPARE WHOLE BLOOD,364
3520-4,CYCLOSPORINE LEVEL,47
1994-3,FILTER IONIZED CALCIUM LEVEL,632
2132-9,B12+FOLIC,2
2284-8,B12+FOLIC,2
11580-8,TSH REFLEX TO T4 LEGACY,3
2028-9,CMP14+CBC/D/PLT,1
2075-0,CMP14+CBC/D/PLT,1
2160-0,CMP14+CBC/D/PLT,1
787-2,CMP14+CBC/D/PLT,1
770-8,CMP14+CBC/D/PLT,1
4544-3,CMP14+CBC/D/PLT,1
713-8,CMP14+CBC/D/PLT,1
786-4,CMP14+CBC/D/PLT,1
5905-5,CMP14+CBC/D/PLT,1
785-6,CMP14+CBC/D/PLT,1
777-3,CMP14+CBC/D/PLT,1
788-0,CMP14+CBC/D/PLT,1
736-9,CMP14+CBC/D/PLT,1
2345-7,CMP14+CBC/D/PLT,1
751-8,CMP14+CBC/D/PLT,1
706-2,CMP14+CBC/D/PLT,1
742-7,CMP14+CBC/D/PLT,1
731-0,CMP14+CBC/D/PLT,1
704-7,CMP14+CBC/D/PLT,1
711-2,CMP14+CBC/D/PLT,1
3094-0,CMP14+CBC/D/PLT,1
2885-2,CMP14+CBC/D/PLT,1
1742-6,CMP14+CBC/D/PLT,1
17861-6,CMP14+CBC/D/PLT,1
718-7,CMP14+CBC/D/PLT,1
1975-2,CMP14+CBC/D/PLT,1
789-8,CMP14+CBC/D/PLT,1
1751-7,CMP14+CBC/D/PLT,1
1920-8,CMP14+CBC/D/PLT,1
6768-6,CMP14+CBC/D/PLT,1
6690-2,CMP14+CBC/D/PLT,1
2823-3,CMP14+CBC/D/PLT,1
88293-6,CMP14+CBC/D/PLT,1
2951-2,CMP14+CBC/D/PLT,1
88294-4,CMP14+CBC/D/PLT,1
62292-8,"LC VITAMIN D, 25-HYDROXY",6
30083-0,EPSTEIN BARR VIRUS (EBNA+ EBV NUCLEAR AG AB LEGACY,1
35384-7,"ESTRADIOL, LCMS, ENDO SCI",2
2839-9,"PROGESTERONE LCMS, ENDO SCI",1
48382-6,OMEGACHECK(TM) (EPA+DPA+DHA),1
35178-3,OMEGACHECK(TM) (EPA+DPA+DHA),1
20509-6,POCT HEMOGLOBIN CALC & HEMATOCRIT UNSOLICITED RESULTS,5
20570-8,POCT HEMOGLOBIN CALC & HEMATOCRIT UNSOLICITED RESULTS,5
28544-5,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,5
17862-4,"CALCIUM, URINE, RANDOM",14
2161-8,COMPL DRUG ANL W/ETG+NICOTINE,7
58395-5,COMPL DRUG ANL W/ETG+NICOTINE,7
85359-8,PHOSPHATIDYLSERINE ANTIBODIES,2
85358-0,PHOSPHATIDYLSERINE ANTIBODIES,2
46717-5,DIC PROFILE PERFORMABLE,7
2519-7,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
2021-4,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
2746-6,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
2705-2,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
48391-7,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
1927-3,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
14627-4,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
51731-8,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
,CONGENITAL TRANSTHORACIC ECHO (TTE) COMPLETE,4
13771-1,"METANEPHRINES, FRACTIONATED RANDOM URINE",17
9645-3,"METANEPHRINES, FRACTIONATED RANDOM URINE",17
13783-6,"METANEPHRINES, FRACTIONATED RANDOM URINE",17
2161-8,"METANEPHRINES, FRACTIONATED RANDOM URINE",17
32215-6,THYROID PANEL,4
3050-2,THYROID PANEL,4
3026-2,THYROID PANEL,4
62360-3,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
62361-1,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
51967-8,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
12254-9,ASPIRATION MARKER PANEL,34
1795-4,ASPIRATION MARKER PANEL,34
2748-2,ASPIRATION MARKER PANEL,34
,ASPIRATION MARKER PANEL,170
80831-1,ASPIRATION MARKER PANEL,34
81622-3,STONE ANALYSIS,5
21198-7,PENTA SCREEN,8
23811-3,PENTA SCREEN,8
1834-1,PENTA SCREEN,8
,PATIENT ID APPROVAL TIQ DOCUMENTATION LEGACY,24
2276-4,LC FERRITIN,4
777-3,CBC/D/PLT,6
788-0,CBC/D/PLT,6
718-7,CBC/D/PLT,6
6690-2,CBC/D/PLT,6
789-8,CBC/D/PLT,6
736-9,CBC/D/PLT,6
731-0,CBC/D/PLT,6
770-8,CBC/D/PLT,6
713-8,CBC/D/PLT,6
711-2,CBC/D/PLT,6
5905-5,CBC/D/PLT,6
751-8,CBC/D/PLT,6
742-7,CBC/D/PLT,6
786-4,CBC/D/PLT,6
787-2,CBC/D/PLT,6
785-6,CBC/D/PLT,6
4544-3,CBC/D/PLT,6
2075-0,COMP. METABOLIC PANEL (14),5
2823-3,COMP. METABOLIC PANEL (14),5
2160-0,COMP. METABOLIC PANEL (14),5
2345-7,COMP. METABOLIC PANEL (14),5
3094-0,COMP. METABOLIC PANEL (14),5
17861-6,COMP. METABOLIC PANEL (14),5
1975-2,COMP. METABOLIC PANEL (14),5
2028-9,COMP. METABOLIC PANEL (14),5
1742-6,COMP. METABOLIC PANEL (14),5
1751-7,COMP. METABOLIC PANEL (14),5
1920-8,COMP. METABOLIC PANEL (14),5
2885-2,COMP. METABOLIC PANEL (14),5
1759-0,COMP. METABOLIC PANEL (14),5
10834-0,COMP. METABOLIC PANEL (14),5
6768-6,COMP. METABOLIC PANEL (14),5
2951-2,COMP. METABOLIC PANEL (14),5
88293-6,COMP. METABOLIC PANEL (14),5
3097-3,COMP. METABOLIC PANEL (14),5
88294-4,COMP. METABOLIC PANEL (14),5
34661-9,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
2498-4,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
2500-7,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
2501-5,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
14251-3,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
1825-9,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
2276-4,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
2064-4,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
2502-3,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
48159-8,RPR+HBSAG+HCVAB+HIV+HTLV I/II,1
48159-8,HEPATITIS C VIRUS (HCV) AB W/RFL TO QN NAA,22
19099-1,LEUKEMIA/LYMPHOMA EVALUATION,11
33194-2,LEUKEMIA/LYMPHOMA EVALUATION,11
709-6,"Q DIFFERENTIAL, MANUAL",1
19048-8,"Q DIFFERENTIAL, MANUAL",9
30392-5,"Q DIFFERENTIAL, MANUAL",9
30376-8,"Q DIFFERENTIAL, MANUAL",1
2075-0,BMP8+EGFR 335362,7
2823-3,BMP8+EGFR 335362,7
2160-0,BMP8+EGFR 335362,7
2345-7,BMP8+EGFR 335362,7
3094-0,BMP8+EGFR 335362,7
17861-6,BMP8+EGFR 335362,7
2028-9,BMP8+EGFR 335362,7
2951-2,BMP8+EGFR 335362,7
88293-6,BMP8+EGFR 335362,7
3097-3,BMP8+EGFR 335362,7
88294-4,BMP8+EGFR 335362,7
11565-9,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
51775-5,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
29374-6,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
53982-5,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
17791-5,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
27416-7,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
17792-3,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
11090-8,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",3
785-6,T-HELPER CELLS CD4/CD8 %,2
787-2,T-HELPER CELLS CD4/CD8 %,2
742-7,T-HELPER CELLS CD4/CD8 %,2
788-0,T-HELPER CELLS CD4/CD8 %,2
786-4,T-HELPER CELLS CD4/CD8 %,2
731-0,T-HELPER CELLS CD4/CD8 %,2
770-8,T-HELPER CELLS CD4/CD8 %,2
751-8,T-HELPER CELLS CD4/CD8 %,2
777-3,T-HELPER CELLS CD4/CD8 %,2
5905-5,T-HELPER CELLS CD4/CD8 %,2
736-9,T-HELPER CELLS CD4/CD8 %,2
4544-3,T-HELPER CELLS CD4/CD8 %,2
789-8,T-HELPER CELLS CD4/CD8 %,2
718-7,T-HELPER CELLS CD4/CD8 %,2
6690-2,T-HELPER CELLS CD4/CD8 %,2
2075-0,COMP. METABOLIC PANEL (13),3
2823-3,COMP. METABOLIC PANEL (13),3
2160-0,COMP. METABOLIC PANEL (13),3
2345-7,COMP. METABOLIC PANEL (13),3
3094-0,COMP. METABOLIC PANEL (13),3
17861-6,COMP. METABOLIC PANEL (13),3
1975-2,COMP. METABOLIC PANEL (13),3
2028-9,COMP. METABOLIC PANEL (13),3
1751-7,COMP. METABOLIC PANEL (13),3
1920-8,COMP. METABOLIC PANEL (13),3
2885-2,COMP. METABOLIC PANEL (13),3
1759-0,COMP. METABOLIC PANEL (13),3
10834-0,COMP. METABOLIC PANEL (13),3
6768-6,COMP. METABOLIC PANEL (13),3
2951-2,COMP. METABOLIC PANEL (13),3
88293-6,COMP. METABOLIC PANEL (13),3
3097-3,COMP. METABOLIC PANEL (13),3
88294-4,COMP. METABOLIC PANEL (13),3
12480-0,"ANGIOTENSIN CONVERTING ENZYME, CSF",1
11565-9,ANA,3
51775-5,ANA,3
29374-6,ANA,3
5130-0,ANA,2
53982-5,ANA,2
17791-5,ANA,2
27416-7,ANA,3
17792-3,ANA,2
11090-8,ANA,2
21525-1,"SODIUM, URINE, RANDOM",5
,HDL CHOLESTEROL,103
5811-5,"UA/M W/RFLX CULTURE, ROUTINE",29
21108-6,B2 GLYCOPROTEIN I (IGA)AB,7
16135-6,B2 GLYCOPROTEIN I (IGG)AB,16
16136-4,B2 GLYCOPROTEIN I (IGM)AB,17
5076-5,"CARDIOLIPIN ANTIBODY, IGA",10
3181-5,"CARDIOLIPIN ANTIBODY, IGG",11
14957-5,"MICROALBUMINURIA, 24-HOUR COLLECTION, URINE LEGACY",1
1755-8,"MICROALBUMINURIA, 24-HOUR COLLECTION, URINE LEGACY",1
2755-7,"PH, STOOL LEGACY",1
,I STAT LACTATE POCT LEGACY,10
61430-5,NMO IGG AUTOANTIBODIES,13
27821-8,"PROTEIN S AG,PLASMA-MAYO",26
721-1,"PLASMA FREE HEMOGLOBIN, P MAYO",17
87437-0,"PLASMA FREE HEMOGLOBIN, P MAYO",17
3432-2,"CARBAMAZEPINE LEVEL, TOTAL",8
,POCT PROTIME-INR BSP UNSOLICITED RESULTS,241
1751-7,IGG INDEX CSF-MAYO,16
1746-7,IGG INDEX CSF-MAYO,16
14117-6,IGG INDEX CSF-MAYO,16
2464-6,IGG INDEX CSF-MAYO,16
6782-7,IGG INDEX CSF-MAYO,16
2465-3,IGG INDEX CSF-MAYO,16
2470-3,IGG INDEX CSF-MAYO,16
6303-2,LUPUS ANTICOAGULANT EVALUATION WITH REFLEX,39
34571-0,LUPUS ANTICOAGULANT EVALUATION WITH REFLEX,39
2874-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
2862-1,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
2885-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
32731-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
2868-8,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
32730-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
2865-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
26479-6,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,4
19075-1,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,4
26512-4,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,3
30374-3,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,1
30436-0,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,4
14979-9,LUPUS ANTICOAG CONFIRM CONSULT,4
5902-2,LUPUS ANTICOAG CONFIRM CONSULT,4
6301-6,LUPUS ANTICOAG CONFIRM CONSULT,4
21108-6,LUPUS ANTICOAG CONFIRM CONSULT,4
3182-3,LUPUS ANTICOAG CONFIRM CONSULT,4
3181-5,LUPUS ANTICOAG CONFIRM CONSULT,4
16136-4,LUPUS ANTICOAG CONFIRM CONSULT,4
16135-6,LUPUS ANTICOAG CONFIRM CONSULT,4
6303-2,LUPUS ANTICOAG CONFIRM CONSULT,4
3243-3,LUPUS ANTICOAG CONFIRM CONSULT,4
27822-6,PROTEIN S-FUNCTIONAL LEGACY,3
27818-4,PRT C ACTIVITY (CHROMOGENIC),26
2956-1,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
2162-6,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
3087-4,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
25308-8,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
2694-8,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
93746-6,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
3096-5,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
6874-2,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
2829-0,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
27378-9,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
2079-2,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
2701-1,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
24447-5,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
26889-6,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
2779-7,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
14862-7,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
3167-4,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
,"SUPERSATURATION PROFILE, 24 HOUR, URINE",19
13362-9,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
,ANTIBODY TITER,33
15069-8,LC FRUCTOSAMINE,1
46266-3,ANCA PANEL FOR VASCULITIS-MAYO,18
46267-1,ANCA PANEL FOR VASCULITIS-MAYO,18
14979-9,LUPUS ANTICOAGULANT LEGACY,4
5902-2,LUPUS ANTICOAGULANT LEGACY,4
6301-6,LUPUS ANTICOAGULANT LEGACY,4
75506-6,LUPUS ANTICOAGULANT LEGACY,4
21108-6,LUPUS ANTICOAGULANT LEGACY,4
3282-1,LUPUS ANTICOAGULANT LEGACY,4
3182-3,LUPUS ANTICOAGULANT LEGACY,4
3181-5,LUPUS ANTICOAGULANT LEGACY,4
16136-4,LUPUS ANTICOAGULANT LEGACY,4
16135-6,LUPUS ANTICOAGULANT LEGACY,4
6303-2,LUPUS ANTICOAGULANT LEGACY,4
3243-3,LUPUS ANTICOAGULANT LEGACY,4
88725-7,MYOMARKER 3 PROFILE (RDL),2
88739-8,MYOMARKER 3 PROFILE (RDL),2
35333-4,MYOMARKER 3 PROFILE (RDL),2
31562-2,MYOMARKER 3 PROFILE (RDL),2
82425-0,MYOMARKER 3 PROFILE (RDL),2
70257-1,MYOMARKER 3 PROFILE (RDL),2
57662-9,MYOMARKER 3 PROFILE (RDL),2
3034-6,"TRANSFERRIN, S MAYO",69
6020-2,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15680-2,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6248-9,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6078-0,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6273-7,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6096-2,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6075-6,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
15682-8,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6246-3,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6174-7,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6181-2,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
19113-0,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6833-8,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6206-7,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6098-8,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6106-9,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6276-0,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6095-4,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
6082-2,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
46267-1,"PROTEINASE 3 ANTIBODIES, IGG, SERUM LEGACY",12
46266-3,MYELOPEROXIDASE AB,12
41171-0,"BETA-CROSSLAPS (B-CTX), S (MAYO)",8
17791-5,SJOGREN'S ANTIBODY (SS-B),2
5130-0,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",2
30170-5,"ALLERGENS, ZONE 4",3
6034-3,"ALLERGENS, ZONE 4",3
6833-8,"ALLERGENS, ZONE 4",3
6213-3,"ALLERGENS, ZONE 4",3
6110-1,"ALLERGENS, ZONE 4",3
6281-0,"ALLERGENS, ZONE 4",3
7287-6,"ALLERGENS, ZONE 4",3
7124-1,"ALLERGENS, ZONE 4",3
6244-8,"ALLERGENS, ZONE 4",3
6164-8,"ALLERGENS, ZONE 4",3
6085-5,"ALLERGENS, ZONE 4",3
6222-4,"ALLERGENS, ZONE 4",3
6156-4,"ALLERGENS, ZONE 4",3
6096-2,"ALLERGENS, ZONE 4",3
6095-4,"ALLERGENS, ZONE 4",3
6075-6,"ALLERGENS, ZONE 4",3
6109-3,"ALLERGENS, ZONE 4",3
6212-5,"ALLERGENS, ZONE 4",3
6151-5,"ALLERGENS, ZONE 4",3
6182-0,"ALLERGENS, ZONE 4",3
7155-5,"ALLERGENS, ZONE 4",3
6025-1,"ALLERGENS, ZONE 4",3
6252-1,"ALLERGENS, ZONE 4",3
6020-2,"ALLERGENS, ZONE 4",3
6113-5,"ALLERGENS, ZONE 4",3
6152-3,"ALLERGENS, ZONE 4",3
6041-8,"ALLERGENS, ZONE 4",3
7369-2,"ALLERGENS, ZONE 4",3
6098-8,"ALLERGENS, ZONE 4",3
6106-9,F001-IGE EGG WHITE LEGACY,1
7258-7,F002-IGE MILK,3
3024-7,TSH+T4F+T3FREE,7
11580-8,TSH+T4F+T3FREE,7
3051-0,TSH+T4F+T3FREE,7
20450-3,"AFP, MAT SERUM, OPEN SPINA BIFIDA",11
2161-8,DRUG PROFILE 764875 LEGACY,2
8116-6,LYMPHOCYTE SUBSET PANEL 2,5
8123-2,LYMPHOCYTE SUBSET PANEL 2,5
8124-0,LYMPHOCYTE SUBSET PANEL 2,5
8122-4,LYMPHOCYTE SUBSET PANEL 2,5
731-0,LYMPHOCYTE SUBSET PANEL 2,5
54218-3,LYMPHOCYTE SUBSET PANEL 2,5
8101-8,LYMPHOCYTE SUBSET PANEL 2,5
14135-8,LYMPHOCYTE SUBSET PANEL 2,5
24467-3,LYMPHOCYTE SUBSET PANEL 2,5
42176-8,"FUNGITELL ASSAY FOR (1,3)-B-D-GLUCAN",5
2498-4,FE+TIBC+FER LEGACY,22
2500-7,FE+TIBC+FER LEGACY,22
2501-5,FE+TIBC+FER LEGACY,22
2276-4,FE+TIBC+FER LEGACY,22
2502-3,FE+TIBC+FER LEGACY,18
2075-0,BASIC METABOLIC PANEL (7),29
2823-3,BASIC METABOLIC PANEL (7),29
2160-0,BASIC METABOLIC PANEL (7),29
2345-7,BASIC METABOLIC PANEL (7),29
3094-0,BASIC METABOLIC PANEL (7),29
2028-9,BASIC METABOLIC PANEL (7),29
2951-2,BASIC METABOLIC PANEL (7),29
88293-6,BASIC METABOLIC PANEL (7),29
3097-3,BASIC METABOLIC PANEL (7),29
88294-4,BASIC METABOLIC PANEL (7),29
3093-2,"BLOOD UREA NITROGEN, BODY FLUID-MAYO",13
1992-7,CALCITONIN,219
48159-8,ACUTE HEPATITIS PANEL (REFL) LEGACY,9
35669-1,"AMIKACIN LEVEL, PEAK",5
39789-3,POCT POTASSIUM UNSOLICITED RESULTS,16
11065-0,PRE-DIALYSIS BUN,7
3094-0,POST-DIALYSIS BUN,14
11546-9,"PAP, W/RFL TO HPV ALL",11
53835-5,"GLYCOMARK (1,5-ANHYDROGLUCITOL)",5
4548-4,HGB A1C WITH EAG ESTIMATION,8
27353-2,HGB A1C WITH EAG ESTIMATION,8
19055-3,"COMPLIANCE DRUG ANALYSIS, UR",24
8098-6,COMPREHENSIVE THYROGLOBULIN,4
3013-0,COMPREHENSIVE THYROGLOBULIN,8
2164-2,Q CREATININE CLEARANCE CRLSB,24
2162-6,Q CREATININE CLEARANCE CRLSB,24
88293-6,Q CREATININE SBCRE,24
2160-0,Q CREATININE SBCRE,24
88294-4,Q CREATININE SBCRE,24
20521-1,"THC (MARIJUANA), URINE, CONFIRMATION",5
87407-3,"GOLIMUMAB AND ANTI-GOLIMUMAB ANTIBODY, DOSEASSURE GOL",3
34148-7,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
5064-1,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
1952-1,BETA-2-MICROGLOBULIN,12
34190-9,HYPERSENSITIVITY PNEUMONITIS PANEL IGG- MAYO,10
26948-0,HYPERSENSITIVITY PNEUMONITIS PANEL IGG- MAYO,10
26954-8,HYPERSENSITIVITY PNEUMONITIS PANEL IGG- MAYO,10
2749-0,GASTROCCULT,6
2731-8,"Q PTH,INTACT",7
17861-6,Q CALCIUM,9
,CORD BLOOD GAS UNSOLICITED RESULTS,58
1834-1,"ALPHA FETOPROTEIN, L3 PERCENT",2
42332-7,"ALPHA FETOPROTEIN, L3 PERCENT",2
2236-8,"QUESTASSURED 25-OH VIT D, (D2,D3), LC/MS/MS",9
62292-8,"QUESTASSURED 25-OH VIT D, (D2,D3), LC/MS/MS",9
1990-1,"QUESTASSURED 25-OH VIT D, (D2,D3), LC/MS/MS",9
11011-4,HCV RNA QUAN PROGRESSIVE TO GENOTYPING,12
38180-6,HCV RNA QUAN PROGRESSIVE TO GENOTYPING,12
2571-8,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
2093-3,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
2085-9,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
44733-4,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
9830-1,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
43396-1,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
13457-7,LIPID PANEL W/ TRIGLYCERIDES/HDL-C,6
49038-3,VITAMIN B2,4
20468-5,"VITAMIN B1 (THIAMINE), LC/MS/MS",7
2276-4,FERRITIN 302005,2
1989-3,"VITAMIN D, 25-HYDROXY 481950",1
2075-0,COMP. METABOLIC PANEL (12),18
2823-3,COMP. METABOLIC PANEL (12),18
2160-0,COMP. METABOLIC PANEL (12),18
2345-7,COMP. METABOLIC PANEL (12),18
3094-0,COMP. METABOLIC PANEL (12),18
2885-2,COMP. METABOLIC PANEL (12),18
6768-6,COMP. METABOLIC PANEL (12),18
17861-6,COMP. METABOLIC PANEL (12),18
10834-0,COMP. METABOLIC PANEL (12),18
1751-7,COMP. METABOLIC PANEL (12),18
1975-2,COMP. METABOLIC PANEL (12),18
1759-0,COMP. METABOLIC PANEL (12),18
1920-8,COMP. METABOLIC PANEL (12),18
2951-2,COMP. METABOLIC PANEL (12),18
88293-6,COMP. METABOLIC PANEL (12),18
3097-3,COMP. METABOLIC PANEL (12),18
88294-4,COMP. METABOLIC PANEL (12),18
88293-6,RENAL FUNCTION PANEL,23
3097-3,RENAL FUNCTION PANEL,24
88294-4,RENAL FUNCTION PANEL,23
6087-1,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6065-7,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6220-8,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6174-7,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6106-9,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6831-2,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6206-7,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6246-3,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6205-9,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6230-7,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6155-6,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
7770-1,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6190-3,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
57883-1,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6219-0,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6207-5,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6204-2,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
19113-0,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6071-5,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
7674-5,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6039-2,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6107-7,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6082-2,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6271-1,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6719-9,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
7138-1,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6035-0,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6276-0,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6718-1,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6061-6,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6021-0,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6037-6,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6019-4,ALLERGEN: GI FOOD ALLERGY PROFILE II (EOE),9
6078-0,"ALLERGEN INSECT: COCKROACH, GERMAN (BLATELLA GERMANICA) IGE",2
6242-2,ALLERGEN SESAME SEED IGE,4
42924-1,"LACTOFERRIN QUANTITATIVE, FECAL",7
34648-6,"FECAL LIPIDS, TOTAL",3
22763-7,AMMONIA,3901
1434-0,"DEXAMETHASONE SUPPRESSION TEST (DST), 1 SPECIMEN",5
1518-0,"GLUCOSE TOLERANCE TEST, GEST, 3 SPEC (75G)",4
1558-6,"GLUCOSE TOLERANCE TEST, GEST, 3 SPEC (75G)",4
1507-3,"GLUCOSE TOLERANCE TEST, GEST, 3 SPEC (75G)",4
26524-9,CBC WITH AUTO DIFFERENTIAL,12
93493-5,HMGCR AB (IGG),6
26454-9,CSF ADDITIONAL CELL COUNT,36
3167-4,"5 HIAA, URINE, QUANTITATIVE, 24 HOUR",16
1695-6,"5 HIAA, URINE, QUANTITATIVE, 24 HOUR",16
13362-9,"5 HIAA, URINE, QUANTITATIVE, 24 HOUR",13
,FREE THYROXINE INDEX,10
3026-2,FREE THYROXINE INDEX,10
3055-1,FREE THYROXINE INDEX,10
51969-4,MATERNIT21 PLUS CORE+SCA,24
51969-4,SMN1 COPY NUMBER ANALYSIS,10
51969-4,CYSTIC FIBROSIS MUTATION PANEL,15
35670-9,"TOBRAMYCIN LEVEL, RANDOM",7
14121-8,PYRUVIC ACID,4
2905-8,PYRUVIC ACID,4
33358-3,"PROTEIN ELECTROPHORESIS, SERUM",56
15066-4,"FATTY ACIDS, FREE (NONESTER) LEGACY",1
40678-5,Q TOXOPLASMA ANTIBODY (IGM),4
2085-9,LC LP,1
2093-3,LC LP,1
2571-8,LC LP,1
13457-7,LC LP,1
13458-5,LC LP,1
35332-6,CBC WITH DIFFERENTIAL,3
25418-5,"MMRV IMMUNE STATUS PROFILE, SERUM",9
5334-8,"MMRV IMMUNE STATUS PROFILE, SERUM",9
5244-9,"MMRV IMMUNE STATUS PROFILE, SERUM",9
26498-6,CBC WITH DIFFERENTIAL,2
11090-8,ANACHOICE(R) SCREEN WITH REFLEX,2
29374-6,ANACHOICE(R) SCREEN WITH REFLEX,2
17791-5,ANACHOICE(R) SCREEN WITH REFLEX,2
17792-3,ANACHOICE(R) SCREEN WITH REFLEX,2
53982-5,CENTROMERE B ANTIBODY,334
14168-9,DISACCHARIDASES,4
14178-8,DISACCHARIDASES,4
1815-0,DISACCHARIDASES,4
,CARDIOPULMONARY EXERCISE TEST (CPET),41
5959-2,INHIBITOR (MIXING) STUDY,28
5902-2,INHIBITOR (MIXING) STUDY,14
14979-9,INHIBITOR (MIXING) STUDY,15
33890-5,INHIBITOR (MIXING) STUDY,28
3226-8,FACTOR XI (11) ACTIVITY,12
3232-6,FACTOR XII (12) ACTIVITY,8
3330-8,AMIODARONE LEVEL,1
6774-4,AMIODARONE LEVEL,1
29541-0,"HIV-1 RNA, PCR (NONGRAPH) RFX/GENO",28
49573-9,REFLEX TO GENOSURE(R) MG,3
29996-6,ANTIHISTONE ANTIBODIES LEGACY,4
1832-5,"AFP,AMNIOTIC FLUID W/REFL TO ACHE AND FETAL HGB",4
29595-6,"AFP,AMNIOTIC FLUID W/REFL TO ACHE AND FETAL HGB",4
30374-3,"CELL COUNT WITH DIFFERENTIAL, CSF",14
17713-9,TOPIRAMATE LEVEL,15
30894-0,RENIN ACTIVITY AND ALDOSTERONE,3
1763-2,RENIN ACTIVITY AND ALDOSTERONE,3
2915-7,RENIN ACTIVITY AND ALDOSTERONE,3
1989-3,"VITAMIN D, 25-HYDROXY, TOTAL",6
11580-8,TSH W/REFLEX LEGACY,1
74811-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72753-7,"DRUG ANALYSIS,COMP,ORAL FLUID",2
1825-9,ALPHA-1-ANTITRYPSIN PHENOTYPE,1
34661-9,"ANTI-SMOOTH MUSCLE ANTIBODY, IGG",6
3948-7,PHENOBARBITAL LEVEL,38
58357-5,"COMPLIANCE DRUG ANALYSIS, UR",24
86224-3,"COMPLIANCE DRUG ANALYSIS, UR",24
58363-3,"COMPLIANCE DRUG ANALYSIS, UR",24
3167-4,"CORTISOL FREE, 24 HOUR URINE",9
14158-0,"CORTISOL FREE, 24 HOUR URINE",8
13362-9,"CORTISOL FREE, 24 HOUR URINE",8
31017-7,CELIAC DISEASE COMPREHENSIVE,7
58709-7,CELIAC DISEASE COMPREHENSIVE,7
58710-5,CELIAC DISEASE COMPREHENSIVE,7
2458-8,CELIAC DISEASE COMPREHENSIVE,7
32998-7,CELIAC DISEASE COMPREHENSIVE,7
53596-3,IBD EXPANDED PROFILE,1
47321-5,IBD EXPANDED PROFILE,1
53594-8,IBD EXPANDED PROFILE,1
53597-1,IBD EXPANDED PROFILE,1
6246-3,IGE ALLERGENS (11) LEGACY,1
6248-9,IGE ALLERGENS (11) LEGACY,1
7258-7,IGE ALLERGENS (11) LEGACY,1
19113-0,IGE ALLERGENS (11) LEGACY,1
6106-9,IGE ALLERGENS (11) LEGACY,1
6076-4,IGE ALLERGENS (11) LEGACY,1
7691-9,IGE ALLERGENS (11) LEGACY,1
6273-7,IGE ALLERGENS (11) LEGACY,1
6206-7,IGE ALLERGENS (11) LEGACY,1
6276-0,IGE ALLERGENS (11) LEGACY,1
6087-1,IGE ALLERGENS (11) LEGACY,1
6082-2,IGE ALLERGENS (11) LEGACY,1
6246-3,ALLERGEN SHRIMP,4
6076-4,ALLERGEN CLAMS,4
7691-9,ALLERGEN SCALLOP IGE,4
6087-1,ALLERGEN CORN,3
13969-1,CK-MB (CK-2),5
39803-2,INFLIXIMAB LEVEL AND ANTI-DRUG ANTIBODY FOR IBD,12
72623-2,INFLIXIMAB LEVEL AND ANTI-DRUG ANTIBODY FOR IBD,8
,"BETA 2 GLYCOPROTEIN I AB (IGG,IGA,IGM)",6
,CARDIOLIPIN ANTIBODY,9
,LUPUS ANTICOAGULANT EVALUATION WITH REFLEX,21
,G6PD RBC LEGACY,1
,ANGIOTENSIN CONVERTING ENZYME,14
,"SJOGREN'S ANTIBODIES (SS-A,SS-B)",12
,COPPER LEGACY,1
,VITAMIN B6 PLASMA LEGACY,1
,"HCV RNA, QUANTITATIVE REAL TIME PCR",10
,HOMOCYSTEINE LEGACY,4
,"CALPROTECTIN, STOOL LEGACY",2
,CELIAC DISEASE COMPREHENSIVE PANEL WITH GLIADIN ANTIBODY (IGG),3
26954-8,ASPERGILLUS ANTIBODIES,27
,PANCREATIC ELASTASE-1 LEGACY,1
,"ELECTROLYTE PANEL, URINE",3
2132-9,LC VITAMIN B12,1
4548-4,COMP. METABOLIC PANEL (14),2
777-3,CBC/D/PLT W/ REFLEX FERRITIN,1
788-0,CBC/D/PLT W/ REFLEX FERRITIN,1
718-7,CBC/D/PLT W/ REFLEX FERRITIN,1
6690-2,CBC/D/PLT W/ REFLEX FERRITIN,1
789-8,CBC/D/PLT W/ REFLEX FERRITIN,1
736-9,CBC/D/PLT W/ REFLEX FERRITIN,1
731-0,CBC/D/PLT W/ REFLEX FERRITIN,1
770-8,CBC/D/PLT W/ REFLEX FERRITIN,1
704-7,CBC/D/PLT W/ REFLEX FERRITIN,1
713-8,CBC/D/PLT W/ REFLEX FERRITIN,1
711-2,CBC/D/PLT W/ REFLEX FERRITIN,1
5905-5,CBC/D/PLT W/ REFLEX FERRITIN,1
751-8,CBC/D/PLT W/ REFLEX FERRITIN,1
706-2,CBC/D/PLT W/ REFLEX FERRITIN,1
742-7,CBC/D/PLT W/ REFLEX FERRITIN,1
786-4,CBC/D/PLT W/ REFLEX FERRITIN,1
787-2,CBC/D/PLT W/ REFLEX FERRITIN,1
785-6,CBC/D/PLT W/ REFLEX FERRITIN,1
4544-3,CBC/D/PLT W/ REFLEX FERRITIN,1
11054-4,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
2085-9,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
2093-3,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
2571-8,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
56469-0,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
13457-7,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
9830-1,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
13458-5,LP+CHOL/HDL+LDL/HDL+CHD RISK,1
3013-0,LC THYROGLOBULIN BY IMA,5
2333-3,GASTRIN - MAYO,15
4548-4,LC HEMOGLOBIN A1C,7
1848-1,DIHYDROTESTOSTERONE,14
2458-8,"IGA, IMMUNOGLOBULIN A (RDL)",2
2472-9,"IGM, IMMUNOGLOBULIN M (RDL)",2
2465-3,"IGG, IMMUNOGLOBULIN G (RDL)",2
705-4,MANUAL DIFFERENTIAL,17
8098-6,"TGAB THYROGLOBULIN,IMA OR LCMS LEGACY",3
3013-0,"TGAB THYROGLOBULIN,IMA OR LCMS LEGACY",2
2965-2,"URINALYSIS, COMPLETE",2
5803-2,"URINALYSIS, COMPLETE",4
20405-7,"URINALYSIS, COMPLETE",4
48774-4,MULTIPLE SCLEROSIS PROFILE SERUM AND SPINAL FLUID,13
25418-5,"MUMPS ANTIBODY, IGG",12
2868-8,PROTEIN ELECTROPHORESIS,7
2862-1,PROTEIN ELECTROPHORESIS,7
2865-4,PROTEIN ELECTROPHORESIS,7
32731-2,PROTEIN ELECTROPHORESIS,7
2874-6,PROTEIN ELECTROPHORESIS,7
32730-4,PROTEIN ELECTROPHORESIS,7
,IRON AND UIBC,354
2498-4,IRON AND UIBC,177
2502-3,IRON AND UIBC,177
,"HCV RNA BY PCR, QN RFX GENO",9
59297-2,"LACOSAMIDE, SERUM",6
55433-7,MANUAL DIFF CELLAVISION,4
28541-1,CBC/DIFF AMBIGUOUS DEFAULT,3
35332-6,CBC/DIFF AMBIGUOUS DEFAULT,3
26498-6,CBC/DIFF AMBIGUOUS DEFAULT,4
2823-3,CMP12+LP+6AC,2
2951-2,CMP12+LP+6AC,2
3094-0,CMP12+LP+6AC,2
1742-6,CMP12+LP+6AC,2
2085-9,CMP12+LP+6AC,2
1920-8,CMP12+LP+6AC,2
9830-1,CMP12+LP+6AC,2
2498-4,CMP12+LP+6AC,2
13457-7,CMP12+LP+6AC,2
2324-2,CMP12+LP+6AC,2
2571-8,CMP12+LP+6AC,2
2093-3,CMP12+LP+6AC,2
13458-5,CMP12+LP+6AC,2
2345-7,CMP12+LP+6AC,2
56469-0,CMP12+LP+6AC,2
3084-1,CMP12+LP+6AC,2
17861-6,CMP12+LP+6AC,2
1759-0,CMP12+LP+6AC,2
2075-0,CMP12+LP+6AC,2
2532-0,CMP12+LP+6AC,2
2885-2,CMP12+LP+6AC,2
6768-6,CMP12+LP+6AC,2
2777-1,CMP12+LP+6AC,2
10834-0,CMP12+LP+6AC,2
1751-7,CMP12+LP+6AC,2
1975-2,CMP12+LP+6AC,2
3097-3,CMP12+LP+6AC,2
88294-4,CMP12+LP+6AC,2
88293-6,CMP12+LP+6AC,2
2160-0,CMP12+LP+6AC,2
58413-6,CBC,9
1854-9,ANDROSTENEDIONE,11
30471-7,"LEVETIRACETAM, S LEGACY",5
98980-6,COMPREHENSIVE METABOLIC PANEL,6
11040-3,"CORTISOL FREE RANDOM, URINE",5
2147-7,"CORTISOL FREE RANDOM, URINE",5
2345-7,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),3
1751-7,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),3
1742-6,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),3
777-3,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),5
1920-8,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),4
,INSULIN,14
,PROTEIN C ACTIVITY,2
,PROTEIN S ACTIVITY,2
,THROMBIN TIME,3
48404-8,"MYELOPEROXIDASE ANTIBODIES, IGG, SERUM- MAYO",9
5126-8,"CYTOMEGALOVIRUS ANTIBODY, IGM",5
,"ESTROGENS, TOTAL",2
2075-0,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2823-3,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2160-0,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2345-7,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
3094-0,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
17861-6,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
1975-2,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2028-9,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
1742-6,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
1751-7,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
1920-8,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2885-2,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
1759-0,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
10834-0,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
6768-6,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2951-2,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
88293-6,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
3097-3,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
88294-4,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2075-0,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2823-3,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2160-0,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
13457-7,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
789-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
13458-5,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
787-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
4544-3,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
11580-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
6690-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
718-7,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2345-7,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
786-4,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
5905-5,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
785-6,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
751-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
777-3,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
788-0,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
736-9,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
770-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
713-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
3094-0,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
17861-6,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2324-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2028-9,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2085-9,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
1975-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2571-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
1751-7,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
1742-6,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
1920-8,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2093-3,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
742-7,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
731-0,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
711-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
53115-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
71695-1,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
2951-2,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
88293-6,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
3097-3,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
88294-4,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
,"ACETYLCHOLINE RECEPTOR, BLOCKING",1
,CYCLIC CITRULLINATED PEPTIDE (CCP) AB (IGG),176
,"HEPATITIS B VIRUS DNA, QN PCR W/REFL HBV GENOTYPE",2
,ANTITHROMBIN III ACTIVATED LEGACY,1
,DRVVT SCREEN W/REFL DRVVT CONF AND DRVVT 1:1 MIX LEGACY,3
1884-6,"APOLIPOPROTEIN B, MAYO",5
41282-5,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",3
3638-4,FLECAINIDE LEVEL,8
,"GLYCOMARK (1,5-ANHYDROGLUCITOL)",10
5787-7,MICROSCOPIC EXAMINATION LEGACY,6
13945-1,MICROSCOPIC EXAMINATION LEGACY,6
731-0,TOTAL LYMPH COUNT,1
5612-7,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
5587-1,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
21074-0,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
5677-0,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
3167-4,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
6693-6,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
13362-9,"HEAVY METALS SCREEN  WITH REFLEX, 24HR URINE",2
8098-6,THYROID CANCER (THYROGLOBULIN) MONITOR,3
3013-0,Q THYROGLOBULIN,3
709-6,CBC WITH DIFFERENTIAL,7
30376-8,CBC WITH DIFFERENTIAL,7
5993-1,PLATELET AGGREGATION STUDY,4
5995-6,PLATELET AGGREGATION STUDY,4
5992-3,PLATELET AGGREGATION STUDY,4
5998-0,PLATELET AGGREGATION STUDY,4
74097-7,TACROLIMUS LEVEL,7
27822-6,PROTEIN S PANEL,4
27823-4,PROTEIN S PANEL,4
27821-8,PROTEIN S PANEL,4
2991-8,TESTOSTERONE FREE MS/DIALYSIS,3
2986-8,TESTOSTERONE FREE MS/DIALYSIS,3
15432-8,TESTOSTERONE FREE MS/DIALYSIS,3
58413-6,CBC/DIFF AMBIGUOUS DEFAULT,4
2075-0,LC COMP. METABOLIC PANEL (14),3
2823-3,LC COMP. METABOLIC PANEL (14),3
2160-0,LC COMP. METABOLIC PANEL (14),3
2345-7,LC COMP. METABOLIC PANEL (14),3
3094-0,LC COMP. METABOLIC PANEL (14),3
17861-6,LC COMP. METABOLIC PANEL (14),3
1975-2,LC COMP. METABOLIC PANEL (14),3
2028-9,LC COMP. METABOLIC PANEL (14),3
1742-6,LC COMP. METABOLIC PANEL (14),3
1751-7,LC COMP. METABOLIC PANEL (14),3
1920-8,LC COMP. METABOLIC PANEL (14),3
2885-2,LC COMP. METABOLIC PANEL (14),3
1759-0,LC COMP. METABOLIC PANEL (14),3
10834-0,LC COMP. METABOLIC PANEL (14),3
6768-6,LC COMP. METABOLIC PANEL (14),3
2951-2,LC COMP. METABOLIC PANEL (14),3
88293-6,LC COMP. METABOLIC PANEL (14),3
3097-3,LC COMP. METABOLIC PANEL (14),3
88294-4,LC COMP. METABOLIC PANEL (14),3
34913-4,MANUAL DIFF CELLAVISION,10
32009-3,"CORTISOL FREE, 24 HOUR URINE",1
2147-7,"CORTISOL FREE, 24 HOUR URINE",1
2162-6,"CORTISOL FREE, 24 HOUR URINE",1
1763-2,"Q ALDOSTERONE, LC/MS",3
2915-7,"PLASMA RENIN ACTIVITY, LC/MS/MS",3
30894-0,"PLASMA RENIN ACTIVITY, LC/MS/MS",3
2639-3,"MYOGLOBIN, SERUM MAYO",22
32693-4,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,22
2027-1,POCT WHOLE BLOOD PROFILE WITH VENOUS BLOOD GAS UNSOLICITED RESULTS,23
35384-7,"ESTRADIOL, SENSITIVE",2
47320-7,"INFLAMMATORY BOWEL DISEASE PANEL, S (MAYO-DHI)",5
47321-5,"INFLAMMATORY BOWEL DISEASE PANEL, S (MAYO-DHI)",5
2669-0,"METANEPHRINES, FRACTIONATED FREE-MAYO",6
38494-1,"METANEPHRINES, FRACTIONATED FREE-MAYO",6
2075-0,HRT FEMALE PRE PELLET,1
2823-3,HRT FEMALE PRE PELLET,1
2160-0,HRT FEMALE PRE PELLET,1
62292-8,HRT FEMALE PRE PELLET,1
2986-8,HRT FEMALE PRE PELLET,1
2132-9,HRT FEMALE PRE PELLET,1
6690-2,HRT FEMALE PRE PELLET,1
3051-0,HRT FEMALE PRE PELLET,1
2243-4,HRT FEMALE PRE PELLET,1
11580-8,HRT FEMALE PRE PELLET,1
8099-4,HRT FEMALE PRE PELLET,1
3024-7,HRT FEMALE PRE PELLET,1
15067-2,HRT FEMALE PRE PELLET,1
2345-7,HRT FEMALE PRE PELLET,1
718-7,HRT FEMALE PRE PELLET,1
788-0,HRT FEMALE PRE PELLET,1
789-8,HRT FEMALE PRE PELLET,1
736-9,HRT FEMALE PRE PELLET,1
787-2,HRT FEMALE PRE PELLET,1
770-8,HRT FEMALE PRE PELLET,1
4544-3,HRT FEMALE PRE PELLET,1
786-4,HRT FEMALE PRE PELLET,1
785-6,HRT FEMALE PRE PELLET,1
777-3,HRT FEMALE PRE PELLET,1
3094-0,HRT FEMALE PRE PELLET,1
17861-6,HRT FEMALE PRE PELLET,1
1975-2,HRT FEMALE PRE PELLET,1
2028-9,HRT FEMALE PRE PELLET,1
1742-6,HRT FEMALE PRE PELLET,1
1751-7,HRT FEMALE PRE PELLET,1
1920-8,HRT FEMALE PRE PELLET,1
2885-2,HRT FEMALE PRE PELLET,1
1759-0,HRT FEMALE PRE PELLET,1
10834-0,HRT FEMALE PRE PELLET,1
6768-6,HRT FEMALE PRE PELLET,1
713-8,HRT FEMALE PRE PELLET,1
711-2,HRT FEMALE PRE PELLET,1
5905-5,HRT FEMALE PRE PELLET,1
751-8,HRT FEMALE PRE PELLET,1
742-7,HRT FEMALE PRE PELLET,1
731-0,HRT FEMALE PRE PELLET,1
2951-2,HRT FEMALE PRE PELLET,1
88293-6,HRT FEMALE PRE PELLET,1
3097-3,HRT FEMALE PRE PELLET,1
88294-4,HRT FEMALE PRE PELLET,1
3125-2,VASOACTIVE INTESTINAL PEPTIDE (VIP),3
5685-3,MERCURY (B),2
2518-9,POCT LACTIC ACID ARTERIAL UNSOLICITED RESULTS,38
,"CREATININE CLEARANCE, SERUM AND 24-HOUR URINE",9
6085-5,"ALLERGY EVALUATION 2, SOUTHEAST",2
6041-8,"ALLERGY EVALUATION 2, SOUTHEAST",2
6020-2,"ALLERGY EVALUATION 2, SOUTHEAST",2
6095-4,"ALLERGY EVALUATION 2, SOUTHEAST",2
7604-2,"ALLERGY EVALUATION 2, SOUTHEAST",2
6098-8,"ALLERGY EVALUATION 2, SOUTHEAST",2
6153-1,"ALLERGY EVALUATION 2, SOUTHEAST",2
6189-5,"ALLERGY EVALUATION 2, SOUTHEAST",2
6075-6,"ALLERGY EVALUATION 2, SOUTHEAST",2
6833-8,"ALLERGY EVALUATION 2, SOUTHEAST",2
33863-2,CYSTATIN C WITH EGFR,2
50210-4,CYSTATIN C WITH EGFR,2
2085-9,L - LIPID PANEL 339981,2
2093-3,L - LIPID PANEL 339981,2
2571-8,L - LIPID PANEL 339981,2
13457-7,L - LIPID PANEL 339981,2
13458-5,L - LIPID PANEL 339981,2
44712-8,"NTX-TELOPEPTIDE MAYO, U",3
27939-8,"NTX-TELOPEPTIDE MAYO, U",3
27811-9,ANTITHROMBIN III ACTIVITY AND ANTIGEN,3
1868-9,ANTITHROMBIN III ACTIVITY AND ANTIGEN,3
81322-0,SMALL BOWEL DISACCHARIDASE,28
29638-4,SMALL BOWEL DISACCHARIDASE,28
81314-7,SMALL BOWEL DISACCHARIDASE,28
30315-6,SMALL BOWEL DISACCHARIDASE,28
30372-7,SMALL BOWEL DISACCHARIDASE,28
30319-8,SMALL BOWEL DISACCHARIDASE,28
,"GLIADIN (DEAMINDATED) AB,IGA-MAYO",6
5193-8,"HEPATITIS B SURFACE AB IMMUNITY,QN TO ENDPOINT",3
6771-0,ALPHA-1-ANTITRYPSIN PHENOTYPE,5
51437-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",2
40661-1,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",3
51440-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",1
5622-6,CHROMIUM LEVEL,7
5627-5,COBALT,10
,NUMBER OF RHIG VIALS,1
6025-1,MITE AND MOLD GROUPING,6
6095-4,MITE AND MOLD GROUPING,6
6096-2,MITE AND MOLD GROUPING,6
6020-2,MITE AND MOLD GROUPING,6
6075-6,MITE AND MOLD GROUPING,6
6212-5,MITE AND MOLD GROUPING,6
6875-9,CA 15-3,124
33762-6,"CARDIO IQ PROBNP, N-TERMINAL",5
77307-7,"LEAD, BLOOD - MAYO",3
,CSF MANUAL DIFFERENTIAL - LAB ONLY - BSP,2
3124-5,"VANILLYLMANDELIC ACID (VMA) AND HOMOVANILLIC ACID (HVA), RANDOM, URINE",1
11146-8,"VANILLYLMANDELIC ACID (VMA) AND HOMOVANILLIC ACID (HVA), RANDOM, URINE",1
,UREA NITROGEN LEVEL 24 HOUR URINE,7
28009-9,UREA NITROGEN LEVEL 24 HOUR URINE,4
3095-7,UREA NITROGEN LEVEL 24 HOUR URINE,4
4625-0,HEMOGLOBINOPATHY EVALUATION,4
30413-9,MANUAL DIFF CELLAVISION,12
4059-2,"TOBRAMYCIN LEVEL, TROUGH",4
3024-7,"T4,FREE(DIRECT)",1
3051-0,FREE T-3,1
21365-2,VECTRA(R) WITH CV RISK,1
75628-8,VECTRA(R) WITH CV RISK,1
1988-5,VECTRA(R) WITH CV RISK,1
75633-8,VECTRA(R) WITH CV RISK,1
1847-3,VECTRA(R) WITH CV RISK,1
75630-4,VECTRA(R) WITH CV RISK,1
75632-0,VECTRA(R) WITH CV RISK,1
48663-9,VECTRA(R) WITH CV RISK,1
75631-2,VECTRA(R) WITH CV RISK,1
14049-1,VECTRA(R) WITH CV RISK,1
26881-3,VECTRA(R) WITH CV RISK,1
75629-6,VECTRA(R) WITH CV RISK,1
75627-0,VECTRA(R) WITH CV RISK,1
16142-2,"FECAL LIPIDS, TOTAL",3
13363-7,"FECAL LIPIDS, TOTAL",3
41282-5,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,1
28543-7,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,1
26452-3,BF MANUAL DIFFERENTIAL - LAB ONLY - BSP,2
2483-6,IGFBP-3 INSULIN-LIKE GROWTH FACT 3,6
2857-1,"PSA, SERUM (SERIAL MONITOR)",4
5583-0,ARSENIC BLOOD-MAYO LEGACY,1
77307-7,LEAD (VENOUS),1
11562-6,ACETYLCHOLINE RECEPTOR MODULATING ANTIBODY LEGACY,2
51797-9,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
88727-3,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
17342-7,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
13926-1,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
12854-6,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
54918-8,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
84923-2,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
33423-5,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
88740-6,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
41871-5,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
88726-5,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
11034-6,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
88734-9,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
33979-6,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
88743-0,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
31024-3,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
2823-3,CMP12+7AC,2
2951-2,CMP12+7AC,2
3094-0,CMP12+7AC,2
1920-8,CMP12+7AC,2
2532-0,CMP12+7AC,2
2324-2,CMP12+7AC,2
1742-6,CMP12+7AC,2
2571-8,CMP12+7AC,2
2093-3,CMP12+7AC,2
2345-7,CMP12+7AC,2
3084-1,CMP12+7AC,2
18182-6,CMP12+7AC,2
10834-0,CMP12+7AC,2
2075-0,CMP12+7AC,2
6768-6,CMP12+7AC,2
2777-1,CMP12+7AC,2
1975-2,CMP12+7AC,2
17861-6,CMP12+7AC,2
1751-7,CMP12+7AC,2
2885-2,CMP12+7AC,2
1759-0,CMP12+7AC,2
3097-3,CMP12+7AC,2
88294-4,CMP12+7AC,2
88293-6,CMP12+7AC,2
2160-0,CMP12+7AC,2
3024-7,"LC T4, FREE",7
3053-6,LC T3,1
88725-7,MYOSITIS SPECIFIC 11 AB PANEL,3
88733-1,MYOSITIS SPECIFIC 11 AB PANEL,3
56745-3,MYOSITIS SPECIFIC 11 AB PANEL,3
56731-3,MYOSITIS SPECIFIC 11 AB PANEL,3
56744-6,MYOSITIS SPECIFIC 11 AB PANEL,3
82425-0,MYOSITIS SPECIFIC 11 AB PANEL,3
88739-8,MYOSITIS SPECIFIC 11 AB PANEL,3
88732-3,MYOSITIS SPECIFIC 11 AB PANEL,3
69557-7,MYOSITIS SPECIFIC 11 AB PANEL,3
63559-9,MYOSITIS SPECIFIC 11 AB PANEL,3
45149-2,MYOSITIS SPECIFIC 11 AB PANEL,3
2028-9,BMP8,2
2075-0,BMP8,2
2160-0,BMP8,2
2345-7,BMP8,2
3094-0,BMP8,2
17861-6,BMP8,2
2823-3,BMP8,2
88293-6,BMP8,2
2951-2,BMP8,2
88294-4,BMP8,2
51969-4,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
2924-9,VITAMIN B2,7
2161-8,"COMPLIANCE DRUG ANALY, NO THC",8
2950-4,"SODIUM, BODY FLUID",4
2821-7,"POTASSIUM, BODY FLUID",5
2895-1,LEAD STANDARD PROFILE BLOOD LEGACY,1
2075-0,"BASIC METABOLIC PANEL, PLASMA",3
2823-3,"BASIC METABOLIC PANEL, PLASMA",3
2160-0,"BASIC METABOLIC PANEL, PLASMA",3
2345-7,"BASIC METABOLIC PANEL, PLASMA",3
3094-0,"BASIC METABOLIC PANEL, PLASMA",3
17861-6,"BASIC METABOLIC PANEL, PLASMA",3
2028-9,"BASIC METABOLIC PANEL, PLASMA",3
2951-2,"BASIC METABOLIC PANEL, PLASMA",3
88293-6,"BASIC METABOLIC PANEL, PLASMA",3
88294-4,"BASIC METABOLIC PANEL, PLASMA",3
18262-6,LDL CHOLESTEROL (DIRECT),2
11546-9,GYN REPORT,1
33559-6,"IMMUNOGLOBULIN TOTAL LIGHT CHAINS, URINE",11
27365-6,"IMMUNOGLOBULIN TOTAL LIGHT CHAINS, URINE",11
27394-6,"IMMUNOGLOBULIN TOTAL LIGHT CHAINS, URINE",11
,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),3
77216-0,EARLY SJOGRENS SYNDROME PROFILE,1
77214-5,EARLY SJOGRENS SYNDROME PROFILE,1
77209-5,EARLY SJOGRENS SYNDROME PROFILE,1
77210-3,EARLY SJOGRENS SYNDROME PROFILE,1
77208-7,EARLY SJOGRENS SYNDROME PROFILE,1
77215-2,EARLY SJOGRENS SYNDROME PROFILE,1
77211-1,EARLY SJOGRENS SYNDROME PROFILE,1
77213-7,EARLY SJOGRENS SYNDROME PROFILE,1
77212-9,EARLY SJOGRENS SYNDROME PROFILE,1
721-1,PLASMA FREE HEMOGLOBIN,32
11580-8,TSH 328821,1
3013-0,THYROGLOBULIN W/ANTITHYROGLOBIN AB,3
14979-9,LUPUS ANTICOAGULANT PROFILE LEGACY,1
5902-2,LUPUS ANTICOAGULANT PROFILE LEGACY,1
6301-6,LUPUS ANTICOAGULANT PROFILE LEGACY,1
6303-2,LUPUS ANTICOAGULANT PROFILE LEGACY,1
34571-0,LUPUS ANTICOAGULANT PROFILE LEGACY,1
88725-7,MYOMARKER 3 PLUS PROFILE (RDL),2
88739-8,MYOMARKER 3 PLUS PROFILE (RDL),2
35333-4,MYOMARKER 3 PLUS PROFILE (RDL),2
82992-9,MYOMARKER 3 PLUS PROFILE (RDL),2
82425-0,MYOMARKER 3 PLUS PROFILE (RDL),2
31562-2,MYOMARKER 3 PLUS PROFILE (RDL),2
57662-9,MYOMARKER 3 PLUS PROFILE (RDL),2
70257-1,MYOMARKER 3 PLUS PROFILE (RDL),2
25418-5,RUB AB+VARAB+RUBEOAB+MUMIGG,1
5334-8,RUB AB+VARAB+RUBEOAB+MUMIGG,1
5244-9,RUB AB+VARAB+RUBEOAB+MUMIGG,1
5403-1,RUB AB+VARAB+RUBEOAB+MUMIGG,1
14251-3,"MITOCHONDRIAL ANTIBODIES, M2",5
6273-7,F256-IGE WALNUT LEGACY,1
6190-3,F007-IGE OAT,1
6082-2,F003-IGE CODFISH,3
6246-3,F024-IGE SHRIMP,3
6248-9,F014-IGE SOYBEAN,3
6276-0,F004-IGE WHEAT LEGACY,1
6087-1,F008-IGE CORN,3
7691-9,F338-IGE SCALLOP,3
6125-9,L - F079-IGE GLUTEN - 602497 LEGACY,1
8099-4,ANTI-TPO AB (RDL),1
3013-0,THYROGLOBULIN BY RIA,4
31406-2,"ANTIGLOMERULAR BM AB, QN LEGACY",2
5133-4,ANTI-DNASE B (STREPTOCOCCAL) ANTIBODIES,5
11572-5,RHEUMATOID ARTHRITIS PROFILE LEGACY,5
57093-7,RHEUMATOID ARTHRITIS PROFILE LEGACY,5
2828-2,"POTASSIUM, URINE LEGACY",4
21194-6,"CHLORIDE, URINE LEGACY",3
18488-7,"CALCIUM, RANDOM URINE LEGACY",1
2357-2,GLUCOSE 6 PHOSPHATE DEHYDROGENASE,1
49502-8,GLUCOSE 6 PHOSPHATE DEHYDROGENASE,6
17791-5,LC ANA,1
17792-3,LC ANA,1
29374-6,LC ANA,1
11090-8,LC ANA,1
5130-0,LC ANA,1
6078-0,ALLERGENS W/TOTAL IGE AREA 2,1
6152-3,ALLERGENS W/TOTAL IGE AREA 2,1
6095-4,ALLERGENS W/TOTAL IGE AREA 2,1
6281-0,ALLERGENS W/TOTAL IGE AREA 2,1
6209-1,ALLERGENS W/TOTAL IGE AREA 2,1
7604-2,ALLERGENS W/TOTAL IGE AREA 2,1
6085-5,ALLERGENS W/TOTAL IGE AREA 2,1
6181-2,ALLERGENS W/TOTAL IGE AREA 2,1
6244-8,ALLERGENS W/TOTAL IGE AREA 2,1
19113-0,ALLERGENS W/TOTAL IGE AREA 2,1
6096-2,ALLERGENS W/TOTAL IGE AREA 2,1
6075-6,ALLERGENS W/TOTAL IGE AREA 2,1
6178-8,ALLERGENS W/TOTAL IGE AREA 2,1
6212-5,ALLERGENS W/TOTAL IGE AREA 2,1
6090-5,ALLERGENS W/TOTAL IGE AREA 2,1
6020-2,ALLERGENS W/TOTAL IGE AREA 2,1
6109-3,ALLERGENS W/TOTAL IGE AREA 2,1
6025-1,ALLERGENS W/TOTAL IGE AREA 2,1
15283-5,ALLERGENS W/TOTAL IGE AREA 2,1
7155-5,ALLERGENS W/TOTAL IGE AREA 2,1
6189-5,ALLERGENS W/TOTAL IGE AREA 2,1
6265-3,ALLERGENS W/TOTAL IGE AREA 2,1
6098-8,ALLERGENS W/TOTAL IGE AREA 2,1
6041-8,ALLERGENS W/TOTAL IGE AREA 2,1
6833-8,ALLERGENS W/TOTAL IGE AREA 2,1
87408-1,"USTEKINUMAB QN WITH ANTIBODIES, S (MAYO)",1
87409-9,"USTEKINUMAB QN WITH ANTIBODIES, S (MAYO)",1
2571-8,CARDIO IQ(R) LIPID PANEL WITH REFLEX TO DIRECT LDL LEGACY,1
2093-3,CARDIO IQ(R) LIPID PANEL WITH REFLEX TO DIRECT LDL LEGACY,1
2085-9,CARDIO IQ(R) LIPID PANEL WITH REFLEX TO DIRECT LDL LEGACY,1
9830-1,CARDIO IQ(R) LIPID PANEL WITH REFLEX TO DIRECT LDL LEGACY,1
43396-1,CARDIO IQ(R) LIPID PANEL WITH REFLEX TO DIRECT LDL LEGACY,1
13457-7,CARDIO IQ(R) LIPID PANEL WITH REFLEX TO DIRECT LDL LEGACY,1
3530-3,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
2236-8,"VITAMIN D, 1,25 + 25-HYDROXY",13
1990-1,"VITAMIN D, 1,25 + 25-HYDROXY",13
1649-3,"VITAMIN D, 1,25 + 25-HYDROXY",13
62291-0,"VITAMIN D, 1,25 + 25-HYDROXY",13
86894-3,ADALIMUMAB QUANTITATIVE WITH REFLEX TO ANTIBODY- MAYO,6
74868-1,"IGG HEAVY LIGHT CHAINS(HLC), S",1
74862-4,"IGG HEAVY LIGHT CHAINS(HLC), S",1
74863-2,"IGG HEAVY LIGHT CHAINS(HLC), S",1
74870-7,"IGM HEAVY LIGHT CHAINS(HLC), S",1
74866-5,"IGM HEAVY LIGHT CHAINS(HLC), S",1
74867-3,"IGM HEAVY LIGHT CHAINS(HLC), S",1
74869-9,"IGA HEAVY LIGHT CHAINS(HLC), S",1
74864-0,"IGA HEAVY LIGHT CHAINS(HLC), S",1
74865-7,"IGA HEAVY LIGHT CHAINS(HLC), S",1
3226-8,PROLONGED APTT,1
3209-4,PROLONGED APTT,1
3187-2,PROLONGED APTT,1
34571-0,PROLONGED APTT,1
6303-2,PROLONGED APTT,1
3232-6,PROLONGED APTT,1
2077-6,SWEAT CHLORIDE RIGHT,2
2077-6,SWEAT CHLORIDE LEFT,2
6265-3,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6034-3,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6096-2,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6085-5,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6209-1,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6244-8,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
7604-2,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6181-2,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6186-1,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
19113-0,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6212-5,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
15283-5,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6078-0,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6109-3,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6025-1,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6189-5,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6075-6,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
7155-5,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6020-2,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6178-8,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6041-8,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6833-8,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6098-8,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
6095-4,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
30089-7,URINALYSIS WITH REFLEX MICROSCOPIC,6
10579-1,SEMEN ANALYSIS,15
2085-9,L - LIPID PANEL 337877,4
2093-3,L - LIPID PANEL 337877,4
2571-8,L - LIPID PANEL 337877,4
13457-7,L - LIPID PANEL 337877,4
18262-6,L - LIPID PANEL 337877,2
13458-5,L - LIPID PANEL 337877,4
6212-5,ALLERGENS W/TOTAL IGE AREA 8,1
6078-0,ALLERGENS W/TOTAL IGE AREA 8,1
6095-4,ALLERGENS W/TOTAL IGE AREA 8,1
6209-1,ALLERGENS W/TOTAL IGE AREA 8,1
6232-3,ALLERGENS W/TOTAL IGE AREA 8,1
33982-0,ALLERGENS W/TOTAL IGE AREA 8,1
6085-5,ALLERGENS W/TOTAL IGE AREA 8,1
6281-0,ALLERGENS W/TOTAL IGE AREA 8,1
7604-2,ALLERGENS W/TOTAL IGE AREA 8,1
6234-9,ALLERGENS W/TOTAL IGE AREA 8,1
6181-2,ALLERGENS W/TOTAL IGE AREA 8,1
19113-0,ALLERGENS W/TOTAL IGE AREA 8,1
6096-2,ALLERGENS W/TOTAL IGE AREA 8,1
6025-1,ALLERGENS W/TOTAL IGE AREA 8,1
6109-3,ALLERGENS W/TOTAL IGE AREA 8,1
6075-6,ALLERGENS W/TOTAL IGE AREA 8,1
6278-6,ALLERGENS W/TOTAL IGE AREA 8,1
7155-5,ALLERGENS W/TOTAL IGE AREA 8,1
6090-5,ALLERGENS W/TOTAL IGE AREA 8,1
6020-2,ALLERGENS W/TOTAL IGE AREA 8,1
6189-5,ALLERGENS W/TOTAL IGE AREA 8,1
6178-8,ALLERGENS W/TOTAL IGE AREA 8,1
15285-0,ALLERGENS W/TOTAL IGE AREA 8,1
6265-3,ALLERGENS W/TOTAL IGE AREA 8,1
6098-8,ALLERGENS W/TOTAL IGE AREA 8,1
6041-8,ALLERGENS W/TOTAL IGE AREA 8,1
6833-8,ALLERGENS W/TOTAL IGE AREA 8,1
21108-6,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,7
16135-6,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,9
5076-5,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,7
3181-5,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,9
3182-3,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,9
16136-4,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,9
34571-0,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,6
6303-2,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,8
3181-5,"CARDIOLIPIN AB (IGG,IGM)",6
3182-3,"CARDIOLIPIN AB (IGG,IGM)",6
27822-6,PROTEIN S ACTIVITY W/REFL PROTEIN S ANTIGEN TOTAL,1
28657-5,"FACTOR X, CHROMOGENIC",1
2885-2,"PROTEIN ELEC + INTERP, SERUM",1
4532-8,C3+C4+COMPT LEGACY,2
4485-9,C3+C4+COMPT LEGACY,2
4498-2,C3+C4+COMPT LEGACY,2
2075-0,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2823-3,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2160-0,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2093-3,CMP14+LP+NONHDL+GGT+CBC/PLT,5
43396-1,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2324-2,CMP14+LP+NONHDL+GGT+CBC/PLT,5
718-7,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2085-9,CMP14+LP+NONHDL+GGT+CBC/PLT,5
789-8,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2571-8,CMP14+LP+NONHDL+GGT+CBC/PLT,5
13457-7,CMP14+LP+NONHDL+GGT+CBC/PLT,5
13458-5,CMP14+LP+NONHDL+GGT+CBC/PLT,5
6690-2,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2345-7,CMP14+LP+NONHDL+GGT+CBC/PLT,5
787-2,CMP14+LP+NONHDL+GGT+CBC/PLT,5
4544-3,CMP14+LP+NONHDL+GGT+CBC/PLT,5
786-4,CMP14+LP+NONHDL+GGT+CBC/PLT,5
785-6,CMP14+LP+NONHDL+GGT+CBC/PLT,5
777-3,CMP14+LP+NONHDL+GGT+CBC/PLT,5
788-0,CMP14+LP+NONHDL+GGT+CBC/PLT,5
3094-0,CMP14+LP+NONHDL+GGT+CBC/PLT,5
17861-6,CMP14+LP+NONHDL+GGT+CBC/PLT,5
1975-2,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2028-9,CMP14+LP+NONHDL+GGT+CBC/PLT,5
1742-6,CMP14+LP+NONHDL+GGT+CBC/PLT,5
1751-7,CMP14+LP+NONHDL+GGT+CBC/PLT,5
1920-8,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2885-2,CMP14+LP+NONHDL+GGT+CBC/PLT,5
1759-0,CMP14+LP+NONHDL+GGT+CBC/PLT,5
10834-0,CMP14+LP+NONHDL+GGT+CBC/PLT,5
6768-6,CMP14+LP+NONHDL+GGT+CBC/PLT,5
2951-2,CMP14+LP+NONHDL+GGT+CBC/PLT,5
88293-6,CMP14+LP+NONHDL+GGT+CBC/PLT,5
3097-3,CMP14+LP+NONHDL+GGT+CBC/PLT,5
88294-4,CMP14+LP+NONHDL+GGT+CBC/PLT,5
11565-9,"ANTI-JO 1 ANTIBODY, IGG",2
16998-7,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
2756-5,MONITOR DRUG PROFILE 10 (MW) LEGACY,3
16252-9,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
2161-8,MONITOR DRUG PROFILE 10 (MW) LEGACY,3
67151-1,TROPONIN T,7
30316-4,ALPHA SUBUNIT LEGACY,1
3024-7,TSH REFLEX TO T4F,2
51435-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",4
35559-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",1
1920-8,LC AST+CREAT,1
6222-4,"ALLERGEN PALM, QUEEN IGE",2
6124-2,ALLERGEN GIANT RAGWEED,2
6077-2,W013-IGE COCKLEBUR,2
7287-6,ALLERGEN: DOG FENNEL IGE LEGACY,2
7272-8,"ALLERGEN CYPRESS, BALD (WHITE) IGE LEGACY",2
7195-1,ALLERGEN CEDAR RED (JUNIPERUS VIRGINIANA IGE LEGACY,2
6252-1,M010-IGE STEMPHYLIUM HERBARUM,2
6094-7,ALLERGEN CURVULARIA LUNATA LEGACY,2
6860-1,M205-IGE TRICHOPHYTON RUBRUM,1
6232-3,W016-IGE ROUGH MARSHELDER LEGACY,2
7419-5,E003-IGE HORSE DANDER LEGACY,1
6091-3,E004-IGE COW DANDER,1
6195-2,G003-IGE ORCHARD GRASS,2
6278-6,"WHITE ASH, IGE LEGACY",2
6171-3,ALLERGEN MELALEUCA IGE LEGACY,2
6164-8,VIRGINIA LIVE OAK (RT218) IGE LEGACY,2
6156-4,ALLERGEN LAMB'S QUARTERS (GOOSE FOOT),2
7155-5,ALLERGEN MAPLE/BOX ELDER IGE,2
6212-5,M001-IGE PENICILLIUM CHRYSOGEN,22
6265-3,"TIMOTHY GRASS, IGE LEGACY",2
6034-3,ALLERGEN BAHIA GRASS,2
7369-2,ALLERGEN PERENNIAL RYE GRASS,2
3181-5,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
5076-5,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
21108-6,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
16135-6,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
3182-3,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
14246-3,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
13069-0,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
14245-5,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
16136-4,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
34148-7,LYME ANTIBODY/LINE BLOT REFLEX,1
5064-1,LYME ANTIBODY/LINE BLOT REFLEX,1
2667-4,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",2
11046-0,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",2
2217-8,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",2
6085-5,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6041-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6020-2,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6095-4,"ALLERGY EVALUATION 3, SUBTROPICAL",1
7604-2,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6098-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6152-3,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6189-5,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6075-6,"ALLERGY EVALUATION 3, SUBTROPICAL",1
6833-8,"ALLERGY EVALUATION 3, SUBTROPICAL",1
13080-7,ANTIPHOSPHOTIDYL AB PANEL I,1
13082-3,ANTIPHOSPHOTIDYL AB PANEL I,1
13084-9,ANTIPHOSPHOTIDYL AB PANEL I,1
13079-9,ANTIPHOSPHOTIDYL AB PANEL I,1
13081-5,ANTIPHOSPHOTIDYL AB PANEL I,1
13083-1,ANTIPHOSPHOTIDYL AB PANEL I,1
5970-9,PLASMINOGEN ACTIVITY,6
,VITAMIN B3,2
8099-4,THYROID PEROXIDASE (TPO) AB,74
53115-2,WHITE BLOOD COUNT AND DIFFERENTIAL,6
770-8,WHITE BLOOD COUNT AND DIFFERENTIAL,10
6690-2,WHITE BLOOD COUNT AND DIFFERENTIAL,12
71695-1,WHITE BLOOD COUNT AND DIFFERENTIAL,6
731-0,WHITE BLOOD COUNT AND DIFFERENTIAL,10
751-8,WHITE BLOOD COUNT AND DIFFERENTIAL,10
742-7,WHITE BLOOD COUNT AND DIFFERENTIAL,10
706-2,WHITE BLOOD COUNT AND DIFFERENTIAL,10
5905-5,WHITE BLOOD COUNT AND DIFFERENTIAL,10
713-8,WHITE BLOOD COUNT AND DIFFERENTIAL,10
736-9,WHITE BLOOD COUNT AND DIFFERENTIAL,10
1558-6,"GLUCOSE TOLERANCE TEST, 2 SPECIMENS (75G)",2
1518-0,"GLUCOSE TOLERANCE TEST, 2 SPECIMENS (75G)",2
33314-6,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
33313-8,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
33935-8,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
11573-3,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
8099-4,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
75880-5,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
3182-3,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
16136-4,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
4498-2,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
16135-6,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
4485-9,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
3181-5,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
5076-5,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
21108-6,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
6833-8,"ALLERGEN CAT HAIR/DANDER,STANDARD IGE",4
6106-9,"CHILDHOOD ALLERGY PROFILE, IGE",3
6098-8,"CHILDHOOD ALLERGY PROFILE, IGE",3
6075-6,"CHILDHOOD ALLERGY PROFILE, IGE",3
6020-2,"CHILDHOOD ALLERGY PROFILE, IGE",3
6833-8,"CHILDHOOD ALLERGY PROFILE, IGE",3
6206-7,"CHILDHOOD ALLERGY PROFILE, IGE",3
19113-0,"CHILDHOOD ALLERGY PROFILE, IGE",3
6174-7,"CHILDHOOD ALLERGY PROFILE, IGE",3
7138-1,"CHILDHOOD ALLERGY PROFILE, IGE",3
6246-3,"CHILDHOOD ALLERGY PROFILE, IGE",3
6276-0,"CHILDHOOD ALLERGY PROFILE, IGE",3
6273-7,"CHILDHOOD ALLERGY PROFILE, IGE",3
6096-2,"CHILDHOOD ALLERGY PROFILE, IGE",3
6082-2,"CHILDHOOD ALLERGY PROFILE, IGE",3
6095-4,"CHILDHOOD ALLERGY PROFILE, IGE",3
6078-0,"CHILDHOOD ALLERGY PROFILE, IGE",3
90780-8,INFLIXIMAB LEVEL AND ANTI-DRUG ANTIBODY FOR IBD,4
1558-6,GLUCOSE/PLASMA NAF,16
33935-8,"ANA, IFA RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL WITH REFLEX TITER/PATTERN",6
11572-5,"ANA, IFA RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL WITH REFLEX TITER/PATTERN",6
32024-2,"MAGNESIUM, URINE, 24 HOUR",5
28009-9,"MAGNESIUM, URINE, 24 HOUR",5
19124-7,"MAGNESIUM, URINE, 24 HOUR",5
87408-1,"USTEKINUMAB QUANTITATION WITH ANTIBODIES, SERUM",1
87409-9,"USTEKINUMAB QUANTITATION WITH ANTIBODIES, SERUM",1
,"VEDOLIZUMAB QUANTITATION WITH ANTIBODIES, SERUM",3
5159-9,"EPSTEIN-BARR VIRUS VCA, IGM",9
2085-9,LC LP+NON-HDL CHOLESTEROL,1
2093-3,LC LP+NON-HDL CHOLESTEROL,1
2571-8,LC LP+NON-HDL CHOLESTEROL,1
13457-7,LC LP+NON-HDL CHOLESTEROL,1
43396-1,LC LP+NON-HDL CHOLESTEROL,1
13458-5,LC LP+NON-HDL CHOLESTEROL,1
11034-6,"ACETYLCHOLINE RECEPTOR AB, ALL LEGACY",3
11561-8,"ACETYLCHOLINE RECEPTOR AB, ALL LEGACY",3
1558-6,"GLUCOSE (2 SPEC, WHO) TOLER,S",2
1518-0,"GLUCOSE (2 SPEC, WHO) TOLER,S",2
55180-4,"HE4, OVARIAN CANCER MONITORING",1
2991-8,"TESTOSTERONE, FREE WITH SHBG-ESOTERIX",2
2986-8,"TESTOSTERONE, FREE WITH SHBG-ESOTERIX",2
15432-8,"TESTOSTERONE, FREE WITH SHBG-ESOTERIX",2
13967-5,"TESTOSTERONE, FREE WITH SHBG-ESOTERIX",2
6078-0,ALLERGENS W/TOTAL IGE AREA 1,1
6265-3,ALLERGENS W/TOTAL IGE AREA 1,1
6096-2,ALLERGENS W/TOTAL IGE AREA 1,1
6090-5,ALLERGENS W/TOTAL IGE AREA 1,1
7604-2,ALLERGENS W/TOTAL IGE AREA 1,1
15285-0,ALLERGENS W/TOTAL IGE AREA 1,1
6281-0,ALLERGENS W/TOTAL IGE AREA 1,1
6181-2,ALLERGENS W/TOTAL IGE AREA 1,1
6278-6,ALLERGENS W/TOTAL IGE AREA 1,1
6183-8,ALLERGENS W/TOTAL IGE AREA 1,1
6085-5,ALLERGENS W/TOTAL IGE AREA 1,1
6244-8,ALLERGENS W/TOTAL IGE AREA 1,1
19113-0,ALLERGENS W/TOTAL IGE AREA 1,1
6075-6,ALLERGENS W/TOTAL IGE AREA 1,1
6178-8,ALLERGENS W/TOTAL IGE AREA 1,1
6212-5,ALLERGENS W/TOTAL IGE AREA 1,1
33982-0,ALLERGENS W/TOTAL IGE AREA 1,1
6020-2,ALLERGENS W/TOTAL IGE AREA 1,1
6109-3,ALLERGENS W/TOTAL IGE AREA 1,1
6025-1,ALLERGENS W/TOTAL IGE AREA 1,1
15283-5,ALLERGENS W/TOTAL IGE AREA 1,1
7155-5,ALLERGENS W/TOTAL IGE AREA 1,1
6189-5,ALLERGENS W/TOTAL IGE AREA 1,1
6041-8,ALLERGENS W/TOTAL IGE AREA 1,1
6833-8,ALLERGENS W/TOTAL IGE AREA 1,1
6098-8,ALLERGENS W/TOTAL IGE AREA 1,1
6095-4,ALLERGENS W/TOTAL IGE AREA 1,1
2965-2,URINALYSIS CHEM ONLY,11
20405-7,URINALYSIS CHEM ONLY,11
2756-5,"DRUG PANEL, URINE",3
2161-8,"DRUG PANEL, URINE",3
17864-0,"PTH, INTACT (ICMA) AND IONIZED CALCIUM",2
718-7,POCT HEMOGLOBIN & HEMATOCRIT CALC UNSOLICITED RESULTS,7
20570-8,POCT HEMOGLOBIN & HEMATOCRIT CALC UNSOLICITED RESULTS,7
5404-9,"VARICELLA ZOSTER ANTIBODY, IGM",30
,ANTIBODY TITER- PREVIOUS,8
1798-8,AMYLASE AND LIPASE,7
3040-3,AMYLASE AND LIPASE,7
41649-5,POCT ELECTROLYTES UNSOLICITED RESULTS,13
39791-9,POCT ELECTROLYTES UNSOLICITED RESULTS,13
39789-3,POCT ELECTROLYTES UNSOLICITED RESULTS,13
41645-3,POCT ELECTROLYTES UNSOLICITED RESULTS,13
2161-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
58396-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
58395-5,TOXASSURE SELECT (LABCORP MEDWATCH),5
86609-5,TOXASSURE SELECT (LABCORP MEDWATCH),5
61423-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
5193-8,HEPATITIS B SURFACE AB QUAL/QUANT-MAYO,8
,"POTASSIUM, URINE, 24 HOUR",5
28009-9,"POTASSIUM, URINE, 24 HOUR",5
2828-2,"POTASSIUM, URINE, 24 HOUR",5
2079-2,"CHLORIDE, URINE, 24 HOUR",1
28009-9,"CHLORIDE, URINE, 24 HOUR",1
2078-4,"CHLORIDE, URINE, 24 HOUR",1
3087-4,"URIC ACID, URINE, 24 HOUR",4
28009-9,"URIC ACID, URINE, 24 HOUR",4
3086-6,"URIC ACID, URINE, 24 HOUR",4
16251-1,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
26515-7,PLATELET ANTIBODY-MAYO,3
,PREPARE FRESH FROZEN PLASMA (IN ML),6349
53982-5,ANA COMPREHENSIVE PANEL,9
11565-9,ANA COMPREHENSIVE PANEL,9
11090-8,ANA COMPREHENSIVE PANEL,9
5130-0,ANA COMPREHENSIVE PANEL,9
29374-6,ANA COMPREHENSIVE PANEL,9
51775-5,ANA COMPREHENSIVE PANEL,9
17792-3,ANA COMPREHENSIVE PANEL,9
17791-5,ANA COMPREHENSIVE PANEL,9
27416-7,ANA COMPREHENSIVE PANEL,9
80659-6,POCT ACT KAOLIN UNSOLICITED RESULTS,50
74117-3,ADALIMUMAB+AB (SERIAL MONITOR),5
74116-5,ADALIMUMAB+AB (SERIAL MONITOR),6
58368-2,TOXASSURE SELECT (LABCORP MEDWATCH),5
58367-4,TOXASSURE SELECT (LABCORP MEDWATCH),5
58369-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
3193-0,FACTOR V (5) ACTIVITY,9
1794-7,PANCREATIC ENZYME FLUID COLLECTION 3,7
2748-2,PANCREATIC ENZYME FLUID COLLECTION 3,7
3059-3,PANCREATIC ENZYME FLUID COLLECTION 3,7
2123-8,PANCREATIC ENZYME FLUID COLLECTION 3,7
15212-4,PANCREATIC ENZYME FLUID COLLECTION 3,7
1794-7,PANCREATIC ENZYME FLUID COLLECTION 4,7
2748-2,PANCREATIC ENZYME FLUID COLLECTION 4,7
3059-3,PANCREATIC ENZYME FLUID COLLECTION 4,7
2123-8,PANCREATIC ENZYME FLUID COLLECTION 4,7
15212-4,PANCREATIC ENZYME FLUID COLLECTION 4,7
1794-7,PANCREATIC ENZYME FLUID COLLECTION 1,7
2748-2,PANCREATIC ENZYME FLUID COLLECTION 1,7
3059-3,PANCREATIC ENZYME FLUID COLLECTION 1,7
2123-8,PANCREATIC ENZYME FLUID COLLECTION 1,7
15212-4,PANCREATIC ENZYME FLUID COLLECTION 1,7
1794-7,PANCREATIC ENZYME FLUID COLLECTION 2,7
2748-2,PANCREATIC ENZYME FLUID COLLECTION 2,7
3059-3,PANCREATIC ENZYME FLUID COLLECTION 2,7
2123-8,PANCREATIC ENZYME FLUID COLLECTION 2,7
15212-4,PANCREATIC ENZYME FLUID COLLECTION 2,7
87408-1,ANTIBODY TEST FOR STELARA,4
88992-3,ANTIBODY TEST FOR STELARA,4
62467-6,ASPERGILLUS AG BAL/SERUM LEGACY,1
6189-5,REGIONAL PANEL 3,1
6038-4,REGIONAL PANEL 3,1
6153-1,REGIONAL PANEL 3,1
6244-8,REGIONAL PANEL 3,1
6077-2,REGIONAL PANEL 3,1
6041-8,REGIONAL PANEL 3,1
15285-0,REGIONAL PANEL 3,1
6115-0,REGIONAL PANEL 3,1
6109-3,REGIONAL PANEL 3,1
6128-3,REGIONAL PANEL 3,1
6090-5,REGIONAL PANEL 3,1
6156-4,REGIONAL PANEL 3,1
6285-1,REGIONAL PANEL 3,1
6085-5,REGIONAL PANEL 3,1
7407-0,REGIONAL PANEL 3,1
6110-1,REGIONAL PANEL 3,1
15283-5,REGIONAL PANEL 3,1
6034-3,REGIONAL PANEL 3,1
7155-5,REGIONAL PANEL 3,1
6152-3,REGIONAL PANEL 3,1
5232-4,"GAD65, IA-2, AND INSULIN AUTOANTIBODY",3
56540-8,"GAD65, IA-2, AND INSULIN AUTOANTIBODY",3
56718-0,"GAD65, IA-2, AND INSULIN AUTOANTIBODY",3
6081-4,ALLERGEN COCONUT IGE,1
6136-6,ALLERGEN HAZELNUT/FILBERT IGE,1
6718-1,ALLERGEN CASHEW,1
6208-3,ALLERGEN PECAN NUT IGE,1
6270-3,ALLERGEN TUNA,1
6165-5,ALLERGEN LOBSTER,1
6082-2,ALLERGEN CODFISH,2
39545-9,ALLERGEN CRAB IGE,2
6019-4,ALLERGEN ALMONDS,2
6206-7,ALLERGEN PEANUT,1
17803-8,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",8
777-3,CBC+PLATELET+HEM REVIEW,3
788-0,CBC+PLATELET+HEM REVIEW,3
718-7,CBC+PLATELET+HEM REVIEW,3
6690-2,CBC+PLATELET+HEM REVIEW,3
789-8,CBC+PLATELET+HEM REVIEW,3
737-7,CBC+PLATELET+HEM REVIEW,3
732-8,CBC+PLATELET+HEM REVIEW,3
23761-0,CBC+PLATELET+HEM REVIEW,3
744-3,CBC+PLATELET+HEM REVIEW,3
753-4,CBC+PLATELET+HEM REVIEW,3
743-5,CBC+PLATELET+HEM REVIEW,3
786-4,CBC+PLATELET+HEM REVIEW,3
787-2,CBC+PLATELET+HEM REVIEW,3
785-6,CBC+PLATELET+HEM REVIEW,3
4544-3,CBC+PLATELET+HEM REVIEW,3
6014-5,VON WILLEBRAND PANEL,1
3209-4,VON WILLEBRAND PANEL,1
27816-8,VON WILLEBRAND PANEL,1
14979-9,VON WILLEBRAND PANEL,1
2779-7,STONERISK(R) DIAGNOSTIC PROFILE,2
26889-6,STONERISK(R) DIAGNOSTIC PROFILE,2
6874-2,STONERISK(R) DIAGNOSTIC PROFILE,2
3167-4,STONERISK(R) DIAGNOSTIC PROFILE,2
27378-9,STONERISK(R) DIAGNOSTIC PROFILE,2
25308-8,STONERISK(R) DIAGNOSTIC PROFILE,2
43423-3,STONERISK(R) DIAGNOSTIC PROFILE,2
24447-5,STONERISK(R) DIAGNOSTIC PROFILE,2
2162-6,STONERISK(R) DIAGNOSTIC PROFILE,2
42678-3,STONERISK(R) DIAGNOSTIC PROFILE,2
2829-0,STONERISK(R) DIAGNOSTIC PROFILE,2
42673-4,STONERISK(R) DIAGNOSTIC PROFILE,2
34736-9,STONERISK(R) DIAGNOSTIC PROFILE,2
53811-6,STONERISK(R) DIAGNOSTIC PROFILE,2
2956-1,STONERISK(R) DIAGNOSTIC PROFILE,2
3087-4,STONERISK(R) DIAGNOSTIC PROFILE,2
6687-8,STONERISK(R) DIAGNOSTIC PROFILE,2
2701-1,STONERISK(R) DIAGNOSTIC PROFILE,2
94097-3,CYTOSOLIC 5' NUCLEOTIDASE 1A (CN 1A) AB (IGG),1
50410-0,LUPUS ANTICOAG CONFIRM CONSULT,4
57838-5,LUPUS ANTICOAG CONFIRM CONSULT,4
28541-1,CBC WITH DIFFERENTIAL,1
58394-8,"COMPLIANCE DRUG ANALY, NO THC",8
58393-0,"COMPLIANCE DRUG ANALY, NO THC",8
61420-6,"COMPLIANCE DRUG ANALY, NO THC",8
64131-6,"COMPLIANCE DRUG ANALY, NO THC",8
27048-8,SMITH/RNP ANTIBODIES,2
6181-2,ALLERGEN MOUSE URINE IGE,6
,ANTI-DNASE B (STREPTOCOCCAL) ANTIBODIES,2
58777-4,ALLERGEN PEANUT PROFILE,1
58779-0,ALLERGEN PEANUT PROFILE,1
58778-2,ALLERGEN PEANUT PROFILE,1
63477-4,ALLERGEN PEANUT PROFILE,1
64965-7,ALLERGEN PEANUT PROFILE,1
87718-3,ALLERGEN PEANUT PROFILE,1
30522-7,"C-REACTIVE PROTEIN, HIGH SENS, S (MAYO FOR DHI ONLY)",3
2075-0,CMP14+LP+TSH,1
2823-3,CMP14+LP+TSH,1
2160-0,CMP14+LP+TSH,1
2571-8,CMP14+LP+TSH,1
11054-4,CMP14+LP+TSH,1
2093-3,CMP14+LP+TSH,1
13458-5,CMP14+LP+TSH,1
2085-9,CMP14+LP+TSH,1
9830-1,CMP14+LP+TSH,1
13457-7,CMP14+LP+TSH,1
11580-8,CMP14+LP+TSH,1
2345-7,CMP14+LP+TSH,1
3094-0,CMP14+LP+TSH,1
17861-6,CMP14+LP+TSH,1
1975-2,CMP14+LP+TSH,1
2028-9,CMP14+LP+TSH,1
1742-6,CMP14+LP+TSH,1
1751-7,CMP14+LP+TSH,1
1920-8,CMP14+LP+TSH,1
2885-2,CMP14+LP+TSH,1
1759-0,CMP14+LP+TSH,1
10834-0,CMP14+LP+TSH,1
6768-6,CMP14+LP+TSH,1
2951-2,CMP14+LP+TSH,1
88293-6,CMP14+LP+TSH,1
3097-3,CMP14+LP+TSH,1
88294-4,CMP14+LP+TSH,1
9407-8,"ALPHA-1-ANTITRYPSIN, STOOL",4
50210-4,CYSTATIN C-MAYO,8
33863-2,CYSTATIN C-MAYO,8
5811-5,SPECIFIC GRAVITY URINE,11
19055-3,COMPL DRUG ANL W/ETG+NICOTINE,7
3243-3,THROMBIN TIME,159
5902-2,MIXING STUDY,2
34571-0,MIXING STUDY,2
3209-4,VON WILLEBRAND COMPREHENSIVE PANEL,4
14979-9,VON WILLEBRAND COMPREHENSIVE PANEL,4
6014-5,VON WILLEBRAND COMPREHENSIVE PANEL,4
27816-8,VON WILLEBRAND COMPREHENSIVE PANEL,4
10723-5,"TOXOPLASMA GONDII AB (IGA), ELISA, SERUM.",1
63557-3,"HEPATITIS B SURFACE AG,QN MONITOR (NOT FOR DIAG)",4
13964-2,METHYLMALONIC ACID AND HOMOCYSTEINE,5
13965-9,METHYLMALONIC ACID AND HOMOCYSTEINE,5
57093-7,"ANTI-CCP AB, IGG + IGA (RDL)",2
6041-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
6095-4,RESPIRATORY ALLERGY PROFILE REGION XII,3
6025-1,RESPIRATORY ALLERGY PROFILE REGION XII,3
6189-5,RESPIRATORY ALLERGY PROFILE REGION XII,3
6020-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
6192-9,RESPIRATORY ALLERGY PROFILE REGION XII,3
6178-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
6096-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
6109-3,RESPIRATORY ALLERGY PROFILE REGION XII,3
6183-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
6090-5,RESPIRATORY ALLERGY PROFILE REGION XII,3
6015-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
6085-5,RESPIRATORY ALLERGY PROFILE REGION XII,3
7369-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
6075-6,RESPIRATORY ALLERGY PROFILE REGION XII,3
6152-3,RESPIRATORY ALLERGY PROFILE REGION XII,3
6078-0,RESPIRATORY ALLERGY PROFILE REGION XII,3
6212-5,RESPIRATORY ALLERGY PROFILE REGION XII,3
6234-9,RESPIRATORY ALLERGY PROFILE REGION XII,3
7604-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
6181-2,RESPIRATORY ALLERGY PROFILE REGION XII,3
19113-0,RESPIRATORY ALLERGY PROFILE REGION XII,3
6098-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
6833-8,RESPIRATORY ALLERGY PROFILE REGION XII,3
11034-6,MYASTHENIA GRAVIS PANEL 1,1
718-7,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
789-8,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
4552-6,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,4
20572-4,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,4
787-2,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
4544-3,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
786-4,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
785-6,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
777-3,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
788-0,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
6690-2,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
2276-4,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,4
40960-7,PARIETAL CELL ANTIBODY IGG-MAYO,12
3181-5,"ANTICARDIOLIPIN ANTIBODY, IGG AND IGM, QUANTITATIVE",6
3182-3,"ANTICARDIOLIPIN ANTIBODY, IGG AND IGM, QUANTITATIVE",6
4532-8,"C3, C4, COMPLEMENT CH50",1
4485-9,"C3, C4, COMPLEMENT CH50",1
4498-2,"C3, C4, COMPLEMENT CH50",1
51967-8,"CHROMOSOME, BLOOD, ROUTINE",3
51969-4,MATERNIT21 PLUS CORE+ESS,4
39803-2,"INFLIXIMAB LEVEL, IBD",2
90780-8,"INFLIXIMAB AB, IBD",2
6109-3,TREE GROUPING TREA,6
6189-5,TREE GROUPING TREA,6
6209-1,"ALLERGEN TREE: PECAN, HICKORY (CARYA PECAN) IGE LEGACY",5
6265-3,GRASS GROUPING,6
6041-8,GRASS GROUPING,6
6034-3,GRASS GROUPING,6
7604-2,WEED GROUPING,6
6085-5,WEED GROUPING,6
6186-1,WEED GROUPING WED3,6
6244-8,WEED GROUPING WED3,6
6098-8,DANDER GROUPING,6
6833-8,DANDER GROUPING,6
6078-0,COCKROACH (I6) IGE,6
15283-5,TREE GROUPING TRE3,5
7155-5,TREE GROUPING TRE3,5
6178-8,TREE GROUPING TRE3,5
2258-2,"ESTRONE, LC/MS/MS",1
86898-4,"VEDOLIZUMAB AND ANTI-VEDOLIZUMAB ANTIBODY, DOSEASSURE VDZ",2
86899-2,"VEDOLIZUMAB AND ANTI-VEDOLIZUMAB ANTIBODY, DOSEASSURE VDZ",2
2469-5,IMMUNOGLOBULIN G SUBCLASS 4 LEGACY,1
11557-6,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,2
11558-4,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,2
11556-8,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,2
20565-8,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,2
11555-0,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,2
1959-6,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,2
44706-0,ANTI-SMOOTH MUSCLE/MITOCHOND. LEGACY,1
14251-3,ANTI-SMOOTH MUSCLE/MITOCHOND. LEGACY,2
1869-7,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
4542-7,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
48792-6,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
48795-9,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
2324-2,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
2571-8,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
1975-2,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
30239-8,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
1743-4,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
2345-7,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
2093-3,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
1835-8,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
2472-9,IMMUNOGLOBULINS A/E/G/M SERUM LEGACY,3
2465-3,IMMUNOGLOBULINS A/E/G/M SERUM LEGACY,3
2458-8,IMMUNOGLOBULINS A/E/G/M SERUM LEGACY,3
2075-0,CHLORIDE,1874408
2028-9,"CO2, TOTAL",2
16237-0,"BARBITURATES CONFIRMATION, U",1
17718-8,"COMPLIANCE DRUG ANALY, NO THC",8
86454-6,"COMPLIANCE DRUG ANALY, NO THC",8
18338-4,"COMPLIANCE DRUG ANALY, NO THC",8
32693-4,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,11
2708-6,POCT WHOLE BLOOD PROFILE WITH ARTERIAL BLOOD GAS UNSOLICITED RESULTS,12
2085-9,LP+LDLDIR LEGACY,1
2093-3,LP+LDLDIR LEGACY,1
2571-8,LP+LDLDIR LEGACY,1
18262-6,LP+LDLDIR LEGACY,1
9830-1,LP+LDLDIR LEGACY,1
29541-0,"HIV-1 RNA, REAL TIME PCR (NON-GRAPH)",24
789-8,GLUCOSE 6 PHOSPHATE DEHYDROGENASE,3
3016-3,TSH WITH REFLEX FT4 (BAYFRONT),2
2990-0,TESTOSTERONE FREE AND WEAKLY BOUND LEGACY,3
2986-8,TESTOSTERONE FREE AND WEAKLY BOUND LEGACY,3
6891-6,TESTOSTERONE FREE AND WEAKLY BOUND LEGACY,3
30894-0,ALDOSTERONE/PLASMA RENIN ACTIVITY RATIO LC/MS/MS,14
1763-2,ALDOSTERONE/PLASMA RENIN ACTIVITY RATIO LC/MS/MS,14
2915-7,ALDOSTERONE/PLASMA RENIN ACTIVITY RATIO LC/MS/MS,14
20448-7,"INSULIN AND C-PEPTIDE, SERUM",3
1986-9,"INSULIN AND C-PEPTIDE, SERUM",3
16111-7,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",9
75880-5,RHEUMASSURE LC,1
11572-5,RHEUMASSURE LC,1
57093-7,RHEUMASSURE LC,1
6109-3,"T008-IGE ELM, AMERICAN",2
49831-1,"COMPLIANCE DRUG ANALY, NO THC",8
58392-2,"COMPLIANCE DRUG ANALY, NO THC",8
86224-3,"COMPLIANCE DRUG ANALY, NO THC",8
58363-3,"COMPLIANCE DRUG ANALY, NO THC",8
5811-5,"URINALYSIS, COMPLETE",2
,TESTOSTERONE TOTAL LC-MS/MS LEGACY,1
55147-3,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",3
69380-4,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",3
11580-8,TSH+T3+T4F,2
3024-7,TSH+T3+T4F,2
3053-6,TSH+T3+T4F,2
,TRANSFUSE UNMATCHED O-NEGATIVE RBC,14
,"TRANSFERRIN, S MAYO",1
792-2,"CELL COUNT WITH DIFFERENTIAL, CSF",1
806-0,"CELL COUNT WITH DIFFERENTIAL, CSF",1
41649-5,POCT CHLORIDE UNSOLICITED RESULTS,1
48378-4,"FREE K+L LT CHAINS,QN,S SERIAL LEGACY",1
36916-5,"FREE K+L LT CHAINS,QN,S SERIAL LEGACY",1
33944-0,"FREE K+L LT CHAINS,QN,S SERIAL LEGACY",1
2638-5,"MYELIN BASIC PROTEIN, CSF",4
1746-7,"IGG SYNTHESIS RATE/INDEX, CSF",3
14116-8,"IGG SYNTHESIS RATE/INDEX, CSF",3
14117-6,"IGG SYNTHESIS RATE/INDEX, CSF",3
2465-3,"IGG SYNTHESIS RATE/INDEX, CSF",3
1751-7,"IGG SYNTHESIS RATE/INDEX, CSF",3
2464-6,"IGG SYNTHESIS RATE/INDEX, CSF",3
3167-4,"COPPER, URINE, 24 HOUR",4
5633-3,"COPPER, URINE, 24 HOUR",4
13362-9,"COPPER, URINE, 24 HOUR",4
3218-5,FACTOR X (10) ACTIVITY,24
4563-3,HEMOGLOBINOPATHY EVALUATION,1
2539-5,LD ISOENZYMES LEGACY,2
2532-0,LD ISOENZYMES LEGACY,2
2536-1,LD ISOENZYMES LEGACY,2
2545-2,LD ISOENZYMES LEGACY,2
2548-6,LD ISOENZYMES LEGACY,2
2542-9,LD ISOENZYMES LEGACY,2
16135-6,"BETA-2 GLYCOPROTEIN I AB,G,A,M LEGACY",2
16136-4,"BETA-2 GLYCOPROTEIN I AB,G,A,M LEGACY",2
1869-7,APOLIPOPROTEIN A1 LEGACY,1
26524-9,CBC/DIFF AMBIGUOUS DEFAULT,1
,IMAGING PROCEDURE NOT PERFORMED,3
1942-2,DISACCHARIDASES,2
86465-2,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),6
61122-8,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
61121-0,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73902-9,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73904-5,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73903-7,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73898-9,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73900-3,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73899-7,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
73901-1,"CD57, CD3, CD8, FLOW CYTOMETRY LEGACY",1
5722-4,"SELENIUM, BLOOD",2
11038-7,VITAMIN E,9
13965-9,CARDIO IQ(R) HOMOCYSTEINE,1
4537-7,"SED RATE BY MODIFIED WESTERGREN, MANUAL",3
58393-0,"COMPLIANCE DRUG ANALYSIS, UR",24
58366-6,"COMPLIANCE DRUG ANALYSIS, UR",24
61420-6,"COMPLIANCE DRUG ANALYSIS, UR",24
64131-6,"COMPLIANCE DRUG ANALYSIS, UR",24
53774-6,"EBV DNA, QUANTITATIVE, REAL-TIME PCR",5
32585-2,"EBV DNA, QUANTITATIVE, REAL-TIME PCR",4
11580-8,TSH+T3 FREE,1
3051-0,TSH+T3 FREE,1
98980-6,"CREATININE, SERUM",1
51969-4,REFLEX TO GENOSURE PRIME(R),1
2778-9,"PHOSPHORUS, URINE, 24 HOUR",2
28009-9,"PHOSPHORUS, URINE, 24 HOUR",2
21458-5,"PHOSPHORUS, URINE, 24 HOUR",2
3021-3,THYROXINE BINDING GLOBULIN,5
51969-4,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
11011-4,"HCV RT-PCR, QUANT (GRAPH) LEGACY",1
38180-6,"HCV RT-PCR, QUANT (GRAPH) LEGACY",1
2865-4,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
2885-2,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
2862-1,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
44429-9,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
2871-2,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
2874-6,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
2868-8,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
5683-8,MANGANESE,1
,"%CORTISOL, LC/MS, SALIVA, SAMPLE 2",3
33882-2,"%CORTISOL, LC/MS, SALIVA, SAMPLE 2",3
,"%CORTISOL, LC/MS, SALIVA, SAMPLE 3",3
33882-2,"%CORTISOL, LC/MS, SALIVA, SAMPLE 3",3
,"%CORTISOL, LC/MS, SALIVA, SAMPLE 4",3
33882-2,"%CORTISOL, LC/MS, SALIVA, SAMPLE 4",3
,"%CORTISOL, LC/MS, SALIVA, SAMPLE 1",3
33882-2,"%CORTISOL, LC/MS, SALIVA, SAMPLE 1",3
2986-8,"TESTOSTERONE, TOTAL, MALES (ADULT),IA (REFL) LEGACY",5
,"HIV-1 RNA, REAL TIME PCR (NON-GRAPH)",2
14282-8,"CARNITINE, SERUM",3
14288-5,"CARNITINE, SERUM",3
14286-9,"CARNITINE, SERUM",3
30193-7,"CARNITINE, SERUM",3
17791-5,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
17792-3,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
5130-0,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
13636-6,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
51775-5,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
53982-5,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
11565-9,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
27416-7,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
11090-8,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
27048-8,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
29374-6,ENA+DNA/DS+ANTICH+CENTRO+FA...,2
13972-5,"PROTEIN ELECTROPHORESIS, CSF",1
13973-3,"PROTEIN ELECTROPHORESIS, CSF",1
13974-1,"PROTEIN ELECTROPHORESIS, CSF",1
13976-6,"PROTEIN ELECTROPHORESIS, CSF",1
13977-4,"PROTEIN ELECTROPHORESIS, CSF",1
13975-8,"PROTEIN ELECTROPHORESIS, CSF",1
35651-9,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",2
27057-9,"SEROTONIN, SERUM",5
9811-1,"CHROMOGRANIN A, LC/MS/MS",6
,ADAMTS13 BETHESDA TITER,3
2161-8,"COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTX), U",3
14115-0,"COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTX), U",3
53022-0,ANTI-U1 RNP AB (RDL),1
2258-2,"ESTROGENS FRACTIONATED, S",1
2243-4,"ESTROGENS FRACTIONATED, S",1
48494-9,"C1 ESTERASE INHIBITOR, FUNCTIONAL",14
48309-9,"BK VIRUS DNA, QN REAL TIME PCR, PLASMA",1
5244-9,RUBEOLA (MEASLES) AB IGG AND IGM-MAYO,2
33569-5,SJOGREN'S ANTIBODY (SS-A),14
3167-4,"VMA 24HR, URINE",2
3122-9,"VMA 24HR, URINE",2
13362-9,"VMA 24HR, URINE",2
2162-6,"5 HIAA, URINE, QUANTITATIVE, 24 HOUR",3
,ELECTROLYTE PANEL,15
2161-8,"HEAVY METALS PROFILE, URINE, LEGACY",1
15158-9,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
15207-4,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
15202-5,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
88713-3,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
29911-5,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
73571-2,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
2693-0,"ELECTROLYTE AND OSMOLALITY PANEL, FECES",5
16229-7,"BENZODIAZEPINES CONFIRM, URINE",1
30552-4,"PYRIDOXAL 5-PHOSPHATE (PLP), PLASMA",1
4625-0,Q HEMOGLOBINOPATHY EVALUATION,1
8098-6,THYROGLOBULIN TUMOR MARKER,3
16135-6,"BETA 2 GLYCOPROTEIN I ANTIBODIES (IGG, IGM)",4
16136-4,"BETA 2 GLYCOPROTEIN I ANTIBODIES (IGG, IGM)",4
6892-4,"THYROXINE (T4), FREE BY DIALYSIS",7
2098-2,"CHOLINESTERASE, SERUM",1
6713-2,INFLAMMATORY BOWEL DISEASE-IBD LEGACY,1
31032-6,INFLAMMATORY BOWEL DISEASE-IBD LEGACY,1
64084-7,QFT-TB PLUS (CLIENT INCUBATED),2
88517-8,QFT-TB PLUS (CLIENT INCUBATED),2
71772-8,QFT-TB PLUS (CLIENT INCUBATED),2
5130-0,ANACHOICE(R) SCREEN WITH REFLEX,1
8098-6,"TGAB+THYROGLOBULIN,IMA OR RIA",1
2161-8,"TOXASSURE SELECT 15, UR DLRFX",2
58393-0,"TOXASSURE SELECT 15, UR DLRFX",2
61420-6,"TOXASSURE SELECT 15, UR DLRFX",2
18338-4,TOXASSURE SELECT (LABCORP MEDWATCH),5
17718-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
86454-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
32660-3,THIOPURINE METABOLITES,1
32654-6,THIOPURINE METABOLITES,1
5403-1,"VARICELLA ZOSTER ABS, IGG/IGM",2
5404-9,"VARICELLA ZOSTER ABS, IGG/IGM",2
5130-0,Q TIER 1,5
,PREVIOUS ANTIBODY TITER 2,1
58367-4,"COMPLIANCE DRUG ANALY, NO THC",8
58369-0,"COMPLIANCE DRUG ANALY, NO THC",8
58368-2,"COMPLIANCE DRUG ANALY, NO THC",8
10334-1,"CA 125, SERUM (SERIAL)",5
2161-8,"HOMOCYSTEINE, URINE",1
32020-0,"HOMOCYSTEINE, URINE",1
26582-7,"HOMOCYSTEINE, URINE",1
40595-1,"PROTHROMBIN ANTIBODY, IGG LEGACY",1
5076-5,"LC ANTICARDIOLIPIN AB, IGA, QN",1
27416-7,ANTI-SCLERODERMA ANTIBODY,2
16252-9,"OPIATES, URINE",1
16998-7,"OPIATES, URINE",1
5255-5,MYCOPLASMA PNEU. IGG/IGM ABS LEGACY,1
5256-3,MYCOPLASMA PNEU. IGG/IGM ABS LEGACY,1
24007-7,"EBV EARLY ANTIGEN AB, IGG LEGACY",1
41148-8,"HHV-6, IGG ANTIBODIES, QUANT - 161075 LEGACY",1
29374-6,ANTIEXTRACTABLE NUCLEAR AG LEGACY,2
11090-8,ANTIEXTRACTABLE NUCLEAR AG LEGACY,2
58710-5,"ANTIGLIADIN ABS, IGG",1
6713-2,SACCHAROMYCES CEREVISIAE PANEL LEGACY,1
31032-6,SACCHAROMYCES CEREVISIAE PANEL LEGACY,1
58709-7,"ANTIGLIADIN ABS, IGA",1
35331-8,"L - OXCARBAZEPINE (TRILEPTAL),S - 716928 LEGACY",1
2951-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
3097-3,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
3084-1,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2157-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2498-4,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
6768-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2571-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
1920-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2093-3,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2532-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2324-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
1742-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2276-4,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2345-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
13458-5,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
3026-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2085-9,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
1988-5,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
9830-1,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
32215-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
13457-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
11580-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
56469-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
3050-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
4548-4,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2075-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
1751-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2823-3,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
1975-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2777-1,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
1759-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
17861-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2885-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
19123-9,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
10834-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
787-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
788-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
789-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
786-4,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
6690-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
4544-3,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
718-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
785-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
88293-6,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
71695-1,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
704-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
4537-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
53115-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
2160-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
88294-4,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
770-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
751-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
777-3,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
711-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
5905-5,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
742-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
736-9,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
706-2,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
713-8,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
731-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
3094-0,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
13636-6,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
51775-5,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
11090-8,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
5130-0,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
29374-6,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
53982-5,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
11565-9,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
17791-5,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
27416-7,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
17792-3,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
27048-8,ANA COMPREHENSIVE PLUS PROFILE LEGACY,3
86169-0,STREP PNEUMONIAE ANTIBODY SEROTYPES,22
48391-7,VENOUS BLOOD GAS UNSOLICITED RESULTS,2
46267-1,ANTIPROTEINASE 3 (PR-3) ABS,103
4478-4,"COMPLEMENT C1Q, QUANTITATIVE",1
46266-3,ANTIMYELOPEROXIDASE (MPO) ABS LEGACY,1
21525-1,"SODIUM, URINE, 24 HOUR",1
2956-1,"SODIUM, URINE, 24 HOUR",1
17395-5,"OXYCODONE/OXYMORPHONE, URINE",1
16249-5,"OXYCODONE/OXYMORPHONE, URINE",1
16251-1,MONITOR DRUG PROFILE 14(MW),1
16998-7,MONITOR DRUG PROFILE 14(MW),1
16252-9,MONITOR DRUG PROFILE 14(MW),1
2756-5,MONITOR DRUG PROFILE 14(MW),1
2965-2,MONITOR DRUG PROFILE 14(MW),1
2161-8,MONITOR DRUG PROFILE 14(MW),1
16237-0,MONITOR DRUG PROFILE 14(MW),1
16234-7,MONITOR DRUG PROFILE 14(MW),1
26975-3,SCLERODERMA COMP PROFILE (RDL),1
63329-7,SCLERODERMA COMP PROFILE (RDL),1
785-6,"CBC WITH DIFF, PLATELET, NLR",2
786-4,"CBC WITH DIFF, PLATELET, NLR",2
6690-2,"CBC WITH DIFF, PLATELET, NLR",2
704-7,"CBC WITH DIFF, PLATELET, NLR",2
711-2,"CBC WITH DIFF, PLATELET, NLR",2
713-8,"CBC WITH DIFF, PLATELET, NLR",2
736-9,"CBC WITH DIFF, PLATELET, NLR",2
5905-5,"CBC WITH DIFF, PLATELET, NLR",2
770-8,"CBC WITH DIFF, PLATELET, NLR",2
742-7,"CBC WITH DIFF, PLATELET, NLR",2
751-8,"CBC WITH DIFF, PLATELET, NLR",2
731-0,"CBC WITH DIFF, PLATELET, NLR",2
706-2,"CBC WITH DIFF, PLATELET, NLR",2
789-8,"CBC WITH DIFF, PLATELET, NLR",2
718-7,"CBC WITH DIFF, PLATELET, NLR",2
4544-3,"CBC WITH DIFF, PLATELET, NLR",2
787-2,"CBC WITH DIFF, PLATELET, NLR",2
788-0,"CBC WITH DIFF, PLATELET, NLR",2
777-3,"CBC WITH DIFF, PLATELET, NLR",2
,FSH AND LH,26
,"TESTOSTERONE, TOTAL MS",5
45335-7,LOWER RESPIRATORY CULTURE,3157
16249-5,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
17395-5,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
,"CBC, NO DIFFERENTIAL/PLATELET",67
,DOBUTAMINE STRESS ECHO,2
,FRUCTOSAMINE,6
,POCT HEMOGLOBIN MANUAL RESULTS,1
11546-9,"PAP IG, RFX APTIMA HPV ASCU 16/18,45",6
,CYCLOSPORINE LEVEL,5
5627-5,"COBALT, PLASMA LEGACY",1
5622-6,"CHROMIUM, PLASMA",1
2333-3,"GASTRIN, SERUM LEGACY",1
,ANDROSTENEDIONE,2
,"CORTISOL FREE, 24 HOUR URINE",9
5902-2,DIC PROFILE,9
6301-6,DIC PROFILE,9
14979-9,DIC PROFILE,9
3255-7,DIC PROFILE,9
48065-7,DIC PROFILE,9
,SMALL BOWEL LACTASE,45
,ALLERGEN SALMON IGE,1
,ALLERGEN CASHEW,1
,ALLERGEN ALMONDS,1
,ALLERGEN SHRIMP,1
2230-1,"CATECHOLAMINES, FRAC AND TOTAL (P)",1
2666-6,"CATECHOLAMINES, FRAC AND TOTAL (P)",1
2216-0,"CATECHOLAMINES, FRAC AND TOTAL (P)",1
2056-0,"CATECHOLAMINES, FRAC AND TOTAL (P)",1
,"TESTOSTERONE, BIOAVAILABLE, TOTAL, FREE",15
32215-6,T4,3
,"GLIADIN ANTIBODIES EVAL, IGG AND IGA, SERUM",13
,CALPROTECTIN STOOL-MAYO,7
,POCT GLUCOSE UNSOLICITED RESULTS,45
740-1,OBSTETRIC PANEL WITHOUT HIV,1
30433-7,OBSTETRIC PANEL WITHOUT HIV,1
32998-7,"Q TISSUE TRANSGLUTAMINASE AB, IGG",2
,PHENOBARBITAL LEVEL,3
,CELIAC DISEASE SEROLOGY CASCADE-MAYO,6
,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,22
,"ASPERGILLUS ANTIGEN, BRONCHOALVEOLAR LAV",3
,"COPPER, SERUM",7
,VORICONAZOLE LEVEL,2
,"TOBRAMYCIN LEVEL, TROUGH",7
,VITAMIN C,2
,IODINE LEVEL-MAYO,3
5159-9,EPSTEIN BARR VIRUS ANTIBODY PANEL,2
5157-3,EPSTEIN BARR VIRUS ANTIBODY PANEL,2
30083-0,EPSTEIN BARR VIRUS ANTIBODY PANEL,2
,CALCITONIN,3
,THEOPHYLLINE LEVEL,5
,FACTOR XI (11) ACTIVITY,1
,"C5 COMPLEMENT, FUNCTIONAL-MAYO",1
,FACTOR V (5) ACTIVITY,2
,ASPERGILLUS ANTIBODIES,4
,IGFBP-3 INSULIN-LIKE GROWTH FACT 3,1
,SIROLIMUS LEVEL,9
,MAN DIFF ONLY LEGACY,23
30170-5,"ALLERGEN: AMERICAN COCKROACH, IGE LEGACY",2
7604-2,"W014-IGE PIGWEED, COMMON",2
6095-4,DERMATOPHAGOIDES FARINAE (D2) IGE LEGACY,3
6041-8,ALLERGEN BERMUDA GRASS,3
6020-2,ALLERGEN MICROORGANISM: ALTERNARIA ALTERNATA IGE,4
6085-5,"ALLERGEN RAGWEED, SHORT/COMMON IGE",3
6098-8,ALLERGEN DOG DANDER,3
6096-2,ALLERGEN MITE: DERMATOPHAGOIDES PTERONYSSINUS (HOUSE DUST MITE) IGE,3
,VASOACTIVE INTESTINAL PEPTIDE (VIP),2
,"HIV 1 RNA, QUANTITATIVE REAL TIME PCR",12
,"BETA-2 GLYCOPROTEIN I AB,G,A,M LEGACY",3
,LUPUS ANTICOAGULANT REFLEX LEGACY,8
,LYMPHOCYTE SUBSET PANEL 4,81
,GLUCOSE 6 PHOSPHATE DEHYDROGENASE,1
,URO RISK(R) DIAGNOSTIC PROFILE,74
,"HEPATITIS B SURFACE AB IMMUNITY,QN TO ENDPOINT",1
,INTERLEUKIN-6,1
,FACTOR VII (7) ACTIVITY,3
,FACTOR X (10) ACTIVITY,6
2951-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2823-3,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2345-7,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
1742-6,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
1920-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
10834-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2885-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
1751-7,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2777-1,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2532-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
1975-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
6768-6,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
1759-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
3084-1,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
11580-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
11054-4,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2085-9,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2093-3,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2571-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2324-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
56469-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
13457-7,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
9830-1,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
13458-5,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
3094-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
786-4,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
785-6,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
6690-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
3050-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
32215-6,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
3026-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
787-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
718-7,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
4544-3,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
789-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2160-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
742-7,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
731-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
736-9,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
777-3,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
770-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
788-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
751-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
713-8,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
706-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
5905-5,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
3097-3,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
704-7,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
711-2,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
2075-0,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
17861-6,CMP12+LP+TP+TSH+5AC+CBC/D/P...,2
,"PANCREATIC ELASTASE, FECAL",5
,"URIC ACID, URINE",3
,LIDOCAINE LEVEL,2
,SELENIUM SERUM,1
25419-3,"MUMPS VIRUS AB, IGG AND IGM, S-MAYO",2
25418-5,"MUMPS VIRUS AB, IGG AND IGM, S-MAYO",2
,HIV1/HIV2 DIFFERENTIATION,12
,"TOBRAMYCIN LEVEL, RANDOM",8
1657-6,11-DEOXYCORTISOL,1
,"ALLERGEN INSECT: COCKROACH, GERMAN (BLATELLA GERMANICA) IGE",1
,ALLERGEN CLADOSPORIUM,1
,ALLERGEN MITE: DERMATOPHAGOIDES PTERONYSSINUS (HOUSE DUST MITE) IGE,1
,"ALLERGEN OAK, WHITE IGE",1
,ALLERGEN PENICILLIUM,1
,ALLERGEN MITE: DERMATOPHAGOIDES FARINAE (HOUSE DUST MITE) IGE,1
,ALLERGEN BERMUDA GRASS,1
,ALLERGEN MICROORGANISM: ALTERNARIA ALTERNATA IGE,1
,ALLERGEN ASPERGILLUS FUMIGATUS,3
,ALLERGEN BAHIA GRASS,1
,"COMPLEMENT, TOTAL (CH50)",25
,ESTRONE,4
6271-1,ALLERGEN TURKEY IGE,1
,"INTEGRATED SCREEN, PART 2",67
11054-4,LP+LDL DIRECT LEGACY,1
18262-6,LP+LDL DIRECT LEGACY,1
2093-3,LP+LDL DIRECT LEGACY,1
2571-8,LP+LDL DIRECT LEGACY,1
2085-9,LP+LDL DIRECT LEGACY,1
13457-7,LP+LDL DIRECT LEGACY,1
9830-1,LP+LDL DIRECT LEGACY,1
,"VITAMIN D, 25-HYDROXY, TOTAL",9
41399-7,"HSV NON-SPECIFIC ANTIBODY, IGM",1
30525-0,"AFP, MAT SERUM, OPEN SPINA BIFIDA",520
6273-7,FOOD ALLERGY PROFILE WITH REFLEXES,9
6106-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
6242-2,FOOD ALLERGY PROFILE WITH REFLEXES,9
6248-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
6174-7,FOOD ALLERGY PROFILE WITH REFLEXES,9
7691-9,FOOD ALLERGY PROFILE WITH REFLEXES,9
6246-3,FOOD ALLERGY PROFILE WITH REFLEXES,9
6270-3,FOOD ALLERGY PROFILE WITH REFLEXES,9
6718-1,FOOD ALLERGY PROFILE WITH REFLEXES,9
6136-6,FOOD ALLERGY PROFILE WITH REFLEXES,9
6237-2,FOOD ALLERGY PROFILE WITH REFLEXES,9
6019-4,FOOD ALLERGY PROFILE WITH REFLEXES,9
6206-7,FOOD ALLERGY PROFILE WITH REFLEXES,9
6276-0,FOOD ALLERGY PROFILE WITH REFLEXES,9
6082-2,FOOD ALLERGY PROFILE WITH REFLEXES,9
,"ALPHA-1-ANTITRYPSIN, STOOL",1
,LIVER/KIDNEY MICROSOME TYPE 1 AB-MAYO,3
,EOSINOPHIL COUNT,1
4478-4,COMPLEMENT C1Q-MAYO,4
35384-7,"ESTRADIOL,ULTRASENSITIVE, LC/MS",1
2056-0,"CATECHOLAMINES, FRACTIONATED, PLASMA",3
30089-7,URINALYSIS WITH CULTURE IF INDICATED,1
,"TISSUE TRANSGLUTAMINASE, IGG",6
,"GLIADIN (DEAMINDATED) AB,IGG-MAYO",6
5583-0,"HEAVY METALS, BLOOD",1
77307-7,"HEAVY METALS, BLOOD",1
5685-3,"HEAVY METALS, BLOOD",1
10535-3,"LC DIGOXIN, RANDOM, SERUM",1
,PLATELET FUNCTION ANALYSIS - PERFORMABLE,54
48159-8,HEPATITIS PANEL (REFL) LEGACY,2
,CYSTATIN C-MAYO,2
33951-5,"SODIUM WITH CREATININE, RANDOM URINE",5
2955-3,"SODIUM WITH CREATININE, RANDOM URINE",5
2161-8,"SODIUM WITH CREATININE, RANDOM URINE",5
734-4,"Q DIFFERENTIAL, MANUAL",1
13046-8,"Q DIFFERENTIAL, MANUAL",1
,PTH-RELATED PEPTIDE,1
,THYROID PANEL WITH TSH,16
,"TOBRAMYCIN LEVEL, PEAK",1
1558-6,"GLUCOSE, FASTING + POSTPRANDIAL 2 HOUR",2
1521-4,"GLUCOSE, FASTING + POSTPRANDIAL 2 HOUR",2
,PHOSPHATIDYLSERINE ANTIBODIES,6
6182-0,ALLERGY MOLD PANEKM COMPLETE,1
6020-2,ALLERGY MOLD PANEKM COMPLETE,1
6252-1,ALLERGY MOLD PANEKM COMPLETE,1
6025-1,ALLERGY MOLD PANEKM COMPLETE,1
6075-6,ALLERGY MOLD PANEKM COMPLETE,1
6212-5,ALLERGY MOLD PANEKM COMPLETE,1
,"NTX-TELOPEPTIDE MAYO, U",6
,WBC,7951
,ANGIOTENSIN I LEGACY,1
30089-7,URINALYSIS WITH MICROSCOPIC LEGACY,1
6194-5,ALLERGEN ORANGE IGE,2
6131-7,ALLERGEN FOOD: GRAPEFRUIT (CITRUS PARADISI) IGE,1
6266-1,ALLERGEN TOMATO IGE,2
23883-2,INHIBIN A,41
34319-4,INHIBIN B,44
13363-7,"FECAL FAT, QUANTITATIVE",38
16142-2,"FECAL FAT, QUANTITATIVE",2
2965-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
,STONE ANALYSIS,359
4548-4,Glycohemoglobin HPLC,2653
15014-4,ISOENZYME PATTERN,1
15013-6,ISOENZYME PATTERN,1
15015-1,ISOENZYME PATTERN,1
30341-2,"Sedimentation Rate,",3494
777-3,Platelet Cnt,248
2947-0,I-Stat Na,1197
6298-4,I-Stat K,1194
1994-3,I-Stat ICal,1193
20570-8,I-St Hct,1191
20509-6,I-St Hgb,1184
20565-8,I-Stat TCO2,1185
,POCT ACT KAOLIN,7
38483-4,Creatinine (WB),49
2157-6,"CREATINE KINASE ISOENZYME REFLEX, SERUM",14
,"INTEGRATED SCREEN, PART 1",91
20509-6,"POCT POTASSIUM, GLUCOSE AND HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS",1
20570-8,"POCT POTASSIUM, GLUCOSE AND HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS",1
51969-4,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
2339-0,I-STAT Glucose POCT.,39
14627-4,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
48391-7,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2746-6,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2705-2,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2021-4,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
51731-8,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
1927-3,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
20509-6,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
20570-8,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
,IRON SATURATION LEGACY,39
8123-2,LYMPHOCYTE SUBSETS 5,8
24467-3,LYMPHOCYTE SUBSETS 5,8
731-0,LYMPHOCYTE SUBSETS 5,8
11580-8,LC TSH REFLEX TO T4,1
48159-8,HEPATITIS C AB W/REFL TO HCV RNA QN PCR LEGACY,6
3016-3,THYROID FUNCTION ADULT,4
3026-2,THYROID FUNCTION ADULT,4
3053-6,THYROID FUNCTION ADULT,4
2745-8,CAPILLARY BLOOD GAS UNSOLICITED RESULTS,1
,CAPILLARY BLOOD GAS UNSOLICITED RESULTS,17
2704-5,CAPILLARY BLOOD GAS UNSOLICITED RESULTS,1
11557-6,CAPILLARY BLOOD GAS UNSOLICITED RESULTS,1
1926-5,CAPILLARY BLOOD GAS UNSOLICITED RESULTS,1
1961-2,CAPILLARY BLOOD GAS UNSOLICITED RESULTS,1
15049-0,CREATINE KINASE$ISOENZYMES W/O TOTAL,2
,STRESS ECHOCARDIOGRAM,2
2965-2,UA+URINE CULTURE,1
20405-7,UA+URINE CULTURE,1
5803-2,UA+URINE CULTURE,1
2888-6,"PROTEIN,TOTAL,URINE LEGACY",1
3097-3,LC CMP14,1
2951-2,LC CMP14,1
2345-7,LC CMP14,1
1742-6,LC CMP14,1
1920-8,LC CMP14,1
1751-7,LC CMP14,1
17861-6,LC CMP14,1
2885-2,LC CMP14,1
2028-9,LC CMP14,1
6768-6,LC CMP14,1
1759-0,LC CMP14,1
1975-2,LC CMP14,1
10834-0,LC CMP14,1
3094-0,LC CMP14,1
2160-0,LC CMP14,1
88294-4,LC CMP14,1
88293-6,LC CMP14,1
2823-3,LC CMP14,1
2075-0,LC CMP14,1
6687-8,Q URO RISK(R) DIAGNOSTIC PROFILE,2
2956-1,Q URO RISK(R) DIAGNOSTIC PROFILE,2
3167-4,Q URO RISK(R) DIAGNOSTIC PROFILE,2
34736-9,Q URO RISK(R) DIAGNOSTIC PROFILE,2
2829-0,Q URO RISK(R) DIAGNOSTIC PROFILE,2
2162-6,Q URO RISK(R) DIAGNOSTIC PROFILE,2
24447-5,Q URO RISK(R) DIAGNOSTIC PROFILE,2
43423-3,Q URO RISK(R) DIAGNOSTIC PROFILE,2
42678-3,Q URO RISK(R) DIAGNOSTIC PROFILE,2
42673-4,Q URO RISK(R) DIAGNOSTIC PROFILE,2
27378-9,Q URO RISK(R) DIAGNOSTIC PROFILE,2
6874-2,Q URO RISK(R) DIAGNOSTIC PROFILE,2
2701-1,Q URO RISK(R) DIAGNOSTIC PROFILE,2
3087-4,Q URO RISK(R) DIAGNOSTIC PROFILE,2
26889-6,Q URO RISK(R) DIAGNOSTIC PROFILE,2
2779-7,Q URO RISK(R) DIAGNOSTIC PROFILE,2
2729-2,PTH-RELATED PEPTIDE,1
88294-4,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2965-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5803-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
20454-5,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
88293-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
20405-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2345-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
6768-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
1975-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2777-1,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2075-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
17861-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2823-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
1759-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
1751-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
10834-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2885-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
15069-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2571-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2093-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2324-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
1920-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
1742-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2532-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2502-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2501-5,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2498-4,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2500-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
3084-1,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2857-1,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
32215-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
9830-1,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
13458-5,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
13457-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2085-9,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
3050-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
11580-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
3026-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
56469-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
3094-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
770-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
777-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
4544-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
789-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
718-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
6690-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
788-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
785-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
786-4,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
787-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2160-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
704-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
706-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5905-5,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
713-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
736-9,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
711-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
731-0,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
742-7,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
751-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
3097-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
2951-2,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
11177-3,ALLERGEN BETA LACTALBUMIN,1
7445-0,"ALPHA-LACTOALBUMIN, IGE-MAYO",1
6252-1,ALLERGEN STEMPHYLIUM BOTRYOSUM IGE,1
6229-9,ALLERGEN RHIZOPUS NIGRICANS IGE,1
6095-4,ALLERGEN MITE: DERMATOPHAGOIDES FARINAE (HOUSE DUST MITE) IGE,1
6212-5,ALLERGEN PENICILLIUM,1
11572-5,%RHEUMATOID FACTOR,6
35741-8,"PSA, POST-PROSTATECTOMY",2
777-3,VWB Platelet Count,3
,SCL-70 ANTIBODY,123
,I STAT 8 PROFILE POCT LEGACY,407
6075-6,ALLERGEN CLADOSPORIUM,2
10921-5,ALLERGEN MITE: BLOMIA TROPICALIS (HOUSE DUST MITE) IGE,2
10835-7,LIPOPROTEIN A (LPA),14
2093-3,"CARDIO IQ CHOLESTEROL, TOTAL",1
,AFB CULTURE,1010
36913-2,"FRAGILE X, PCR REFLEX SOUTHERN",6
14288-5,"CARNITINE, PLASMA",2
14286-9,"CARNITINE, PLASMA",2
14282-8,"CARNITINE, PLASMA",2
43396-1,"LIPID PANEL, CARDIO IQ(R)",1
2093-3,"LIPID PANEL, CARDIO IQ(R)",1
2085-9,"LIPID PANEL, CARDIO IQ(R)",1
2571-8,"LIPID PANEL, CARDIO IQ(R)",1
13457-7,"LIPID PANEL, CARDIO IQ(R)",1
9830-1,"LIPID PANEL, CARDIO IQ(R)",1
,TEST IN QUESTION- MISLABELED NAME LEGACY,6
,LACOSAMIDE LEGACY,1
,COMPLEMENT COMPONENT C4C,87
,COMPLEMENT COMPONENT C3C,88
,HISTONE ANTIBODY LEGACY,1
,DS DNA ANTIBODY LEGACY,3
,ANCA VASCULITIDES AB LEGACY,14
,"INTERLEUKIN-6, HIGHLY SENSITIVE ELISA LEGACY",2
,LYME DISEASE AB TOTAL W/REFL WB (IGG IGM),2
,"G-6-PD, RBC LEGACY",1
,RENIN LEVEL LEGACY,2
,CULTURE VIRUS LEGACY,279
5821-4,MICROSCOPIC EXAMINATION LEGACY,6
,"ANTIGLOMERULAR BM AB, QN LEGACY",1
,HERPES SIMPLEX VIRUS CULTURE,57
,"HSV 1 ANTIBODY, IGG",1
,HCV RNA (IU/ML) LEGACY,1
,TISSUE CULTURE,19
,"KAPPA/LAMBDA LIGHT CHAINS TOTAL, SERUM LEGACY",3
,VITAMIN B1 PLASMA LEGACY,3
,IGE,3
,MYELIN BASIC PROTEIN LEGACY,2
,"HSV 1&2  DNA PCR, CSF LEGACY",2
,"TOXOPLASMA GONDII IGG AND IGM, CSF LEGACY",2
2339-0,WB Glucose (POCT),12
5403-1,"VARICELLA ZOSTER ANTIBODY, IGM , IGG- MAYO",1
43291-4,HLA TYPING FOR CELIAC DISEASE,2
44728-4,HLA TYPING FOR CELIAC DISEASE,2
5176-3,"H. PYLORI ANTIBODY, IGG",1
30192-9,"ACETYLCHOLINE RECEPTOR AB, ALL LEGACY",3
,LYME DISEASE ANTIBODY CONFIRMATION CSF-,2
2986-8,"TESTOSTERONE FREE, PROFILE I",1
13967-5,"TESTOSTERONE FREE, PROFILE I",1
2991-8,"TESTOSTERONE FREE, PROFILE I",1
6298-4,LAB WB POTASSIUM,6
6948-4,"LAMOTRIGINE (LAMICTAL), SERUM LEGACY",1
33949-9,"POTASSIUM W/CREATININE, RANDOM URINE",1
2828-2,"POTASSIUM W/CREATININE, RANDOM URINE",1
2161-8,"POTASSIUM W/CREATININE, RANDOM URINE",1
34265-9,"CHLORIDE WITH CREATININE, RANDOM URINE",2
2078-4,"CHLORIDE WITH CREATININE, RANDOM URINE",2
2161-8,"CHLORIDE WITH CREATININE, RANDOM URINE",2
34571-0,LUPUS ANTICOAGULANT REFLEX LEGACY,3
6303-2,LUPUS ANTICOAGULANT REFLEX LEGACY,3
14979-9,APTT MIXING STUDIES,2
5902-2,PT MIXING STUDY,1
6301-6,PT MIXING STUDY,1
6014-5,VON WILLEBRAND FACTOR ACTIVITY,1
783-1,"Q DIFFERENTIAL, MANUAL",1
13069-0,"PHOSPHATIDYLSERINE AB (IGA,IGG,IGM)",1
14245-5,"PHOSPHATIDYLSERINE AB (IGA,IGG,IGM)",1
14246-3,"PHOSPHATIDYLSERINE AB (IGA,IGG,IGM)",1
6765-2,17-HYDROXYPREGNENOLONE,2
1975-2,CP 308506 LEGACY,2
1920-8,CP 308506 LEGACY,2
1742-6,CP 308506 LEGACY,2
13210-0,"BRUCELLA ANTIBODY SCREEN IGG, IGM (REFLEX TO AGGLUTINATION)",1
5070-8,"BRUCELLA ANTIBODY SCREEN IGG, IGM (REFLEX TO AGGLUTINATION)",1
51967-8,FOLLOW UP CMA QPCR UNKNOWN VAR LEGACY,1
,FOLLOW UP CMA QPCR UNKNOWN VAR LEGACY,1
2731-8,"Q PTH2, INTACT",2
13591-3,FACTOR INHIBITOR ASSAY,5
2778-9,"PHOSPHORUS, URINE, RANDOM",1
2458-8,%IMMUNOGLOBULIN A,1
31017-7,"%TISSUE TRANSGLUTAMINASE AB, IGA",1
,PREPARE GRANULOCYTES,7
2708-6,POCT ARTERIAL BLOOD GAS UNSOLICITED RESULTS,4
7155-5,TREE GROUPING TRE4,1
6178-8,TREE GROUPING TRE4,1
2148-5,CREATINE,3
6014-5,RISTOCETIN COFACTOR-MAYO,2
,"Q DIFFERENTIAL, MANUAL",67
2161-8,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
2756-5,"DRUG MONITOR, PANEL 8, W/CONF, URINE",1
11011-4,"HCV RNA BY PCR, QN RFX GENO",4
38180-6,"HCV RNA BY PCR, QN RFX GENO",4
32149-7,STONE ANALYSIS,1
,NURSING COMMUNICATION,1
,PREPARE GRANULOCYTES (IN ML),35
13717-4,"Q CALCIUM, 24 HOUR URINE (W/ CREATININE)",2
6874-2,"Q CALCIUM, 24 HOUR URINE (W/ CREATININE)",2
3167-4,"PHOSPHATE, 24 HOUR URINE (W/CREATININE)",1
2779-7,"PHOSPHATE, 24 HOUR URINE (W/CREATININE)",1
13795-0,"PHOSPHATE, 24 HOUR URINE (W/CREATININE)",1
2162-6,"PHOSPHATE, 24 HOUR URINE (W/CREATININE)",1
,"Q SED RATE BY MODIFIED WESTERGREN, MANUAL",1
2529-6,"LACTATE DEHYDROGENASE, CSF",3
26447-3,"CELL COUNT WITH DIFFERENTIAL, CSF",1
6174-7,ALLERGEN MILK,1
3271-4,ANTI XA-ENOXAPARIN PEDIATRIC,1
9804-6,STONE ANALYSIS W/O IMAGE,1
74117-3,"Q ADALIMUMAB LEVEL, IBD",3
90779-0,"Q ADALIMUMAB AB, IBD",3
48159-8,HCV ANTIBODY,2
5946-9,APTT MIXING STUDIES,2
30323-0,APTT MIXING STUDIES,2
44950-4,APTT MIXING STUDIES,1
25419-3,"MUMPS ANTIBODY, IGM -MAYO",2
8087-9,"GASTRIC PARIETAL CELL ANTIBODY, ELISA LEGACY",4
73818-7,HEPARIN INDUCED PLATELET,1
6075-6,RESPIRATORY ALLERGY PROFILE REGION X,1
6096-2,RESPIRATORY ALLERGY PROFILE REGION X,1
7155-5,RESPIRATORY ALLERGY PROFILE REGION X,1
6833-8,RESPIRATORY ALLERGY PROFILE REGION X,1
6020-2,RESPIRATORY ALLERGY PROFILE REGION X,1
6078-0,RESPIRATORY ALLERGY PROFILE REGION X,1
6098-8,RESPIRATORY ALLERGY PROFILE REGION X,1
6189-5,RESPIRATORY ALLERGY PROFILE REGION X,1
6178-8,RESPIRATORY ALLERGY PROFILE REGION X,1
15283-5,RESPIRATORY ALLERGY PROFILE REGION X,1
6278-6,RESPIRATORY ALLERGY PROFILE REGION X,1
6090-5,RESPIRATORY ALLERGY PROFILE REGION X,1
6095-4,RESPIRATORY ALLERGY PROFILE REGION X,1
6265-3,RESPIRATORY ALLERGY PROFILE REGION X,1
6209-1,RESPIRATORY ALLERGY PROFILE REGION X,1
6109-3,RESPIRATORY ALLERGY PROFILE REGION X,1
6041-8,RESPIRATORY ALLERGY PROFILE REGION X,1
6281-0,RESPIRATORY ALLERGY PROFILE REGION X,1
6186-1,RESPIRATORY ALLERGY PROFILE REGION X,1
7604-2,RESPIRATORY ALLERGY PROFILE REGION X,1
6085-5,RESPIRATORY ALLERGY PROFILE REGION X,1
6244-8,RESPIRATORY ALLERGY PROFILE REGION X,1
6232-3,RESPIRATORY ALLERGY PROFILE REGION X,1
6212-5,RESPIRATORY ALLERGY PROFILE REGION X,1
19113-0,RESPIRATORY ALLERGY PROFILE REGION X,1
6181-2,RESPIRATORY ALLERGY PROFILE REGION X,1
6025-1,RESPIRATORY ALLERGY PROFILE REGION X,1
35538-8,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35542-0,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35537-0,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35533-9,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35554-5,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35547-9,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35535-4,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
53829-8,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35534-7,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
35546-1,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
49099-5,FOOD SPECIFIC IGG ALLERGY (ADULT) PANEL,1
90364-1,OXIDIZED LDL,1
,"SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), DISEASE ACTIVITY PANEL",4
88293-6,CMP12+LP+TP+TSH+5AC+CBC/D/P...,1
88294-4,CMP12+LP+TP+TSH+5AC+CBC/D/P...,1
14208-3,"FILARIASIS ANTIBODIES, IGG4",1
11011-4,"HEPATITIS C VIRAL RNA, QN REAL TIME PCR W/REFLS",21
38180-6,"HEPATITIS C VIRAL RNA, QN REAL TIME PCR W/REFLS",21
88741-4,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
88742-2,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
27416-7,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
88735-6,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
88736-4,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
81742-9,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
82390-6,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
53982-5,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
88737-2,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
88738-0,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
59026-5,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
82393-0,SYSTEMIC SCLEROSIS 12 AB PANEL 2,1
53893-4,RNA POLYMERASE III AB,2
75880-5,Q 14.3.3 ETA PROTEIN,1
17811-1,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
17813-7,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
2161-8,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
2890-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",4
2888-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
17819-4,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
17815-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
17817-8,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
32731-2,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
2874-6,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
2885-2,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
15189-4,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
11051-0,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
2862-1,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
2865-4,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
2868-8,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
32730-4,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
11050-2,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
23915-2,"OSMOTIC FRAGILITY, RBC",1
23918-6,"OSMOTIC FRAGILITY, RBC",1
23920-2,"OSMOTIC FRAGILITY, RBC",1
23921-0,"OSMOTIC FRAGILITY, RBC",1
57662-9,"ANA PROFILE 11, POSITIVE",1
33569-5,"ANA PROFILE 11, POSITIVE",1
4498-2,"ANA PROFILE 11, POSITIVE",1
4485-9,"ANA PROFILE 11, POSITIVE",1
47299-3,"ANA PROFILE 11, POSITIVE",1
11090-8,"ANA PROFILE 11, POSITIVE",1
45142-7,"ANA PROFILE 11, POSITIVE",1
26975-3,"ANA PROFILE 11, POSITIVE",1
20447-9,"RNA, PCR (NONGRAPH) RFX/PS",2
29541-0,"RNA, PCR (NONGRAPH) RFX/PS",2
20447-9,RNA PCR(NONGRAPH)RFX/PSGT+IN,1
29374-6,LUPUS PROFILE LEGACY,2
11090-8,LUPUS PROFILE LEGACY,2
5130-0,LUPUS PROFILE LEGACY,2
11546-9,PAP LB (LIQUID-BASED),2
2171-7,"VIT B12 BINDING CAPACITY, UNSAT (TRANSCOBALAMIN) LEGACY",1
3097-3,HRT MALE PRE PELLET,1
2951-2,HRT MALE PRE PELLET,1
2345-7,HRT MALE PRE PELLET,1
1742-6,HRT MALE PRE PELLET,1
1920-8,HRT MALE PRE PELLET,1
1751-7,HRT MALE PRE PELLET,1
17861-6,HRT MALE PRE PELLET,1
2885-2,HRT MALE PRE PELLET,1
2028-9,HRT MALE PRE PELLET,1
6768-6,HRT MALE PRE PELLET,1
1759-0,HRT MALE PRE PELLET,1
1975-2,HRT MALE PRE PELLET,1
10834-0,HRT MALE PRE PELLET,1
3094-0,HRT MALE PRE PELLET,1
2243-4,HRT MALE PRE PELLET,1
2991-8,HRT MALE PRE PELLET,1
3051-0,HRT MALE PRE PELLET,1
62292-8,HRT MALE PRE PELLET,1
11580-8,HRT MALE PRE PELLET,1
2132-9,HRT MALE PRE PELLET,1
2986-8,HRT MALE PRE PELLET,1
8099-4,HRT MALE PRE PELLET,1
2857-1,HRT MALE PRE PELLET,1
3024-7,HRT MALE PRE PELLET,1
2160-0,HRT MALE PRE PELLET,1
770-8,HRT MALE PRE PELLET,1
777-3,HRT MALE PRE PELLET,1
4544-3,HRT MALE PRE PELLET,1
789-8,HRT MALE PRE PELLET,1
718-7,HRT MALE PRE PELLET,1
6690-2,HRT MALE PRE PELLET,1
788-0,HRT MALE PRE PELLET,1
785-6,HRT MALE PRE PELLET,1
786-4,HRT MALE PRE PELLET,1
787-2,HRT MALE PRE PELLET,1
88294-4,HRT MALE PRE PELLET,1
706-2,HRT MALE PRE PELLET,1
5905-5,HRT MALE PRE PELLET,1
713-8,HRT MALE PRE PELLET,1
736-9,HRT MALE PRE PELLET,1
711-2,HRT MALE PRE PELLET,1
731-0,HRT MALE PRE PELLET,1
742-7,HRT MALE PRE PELLET,1
751-8,HRT MALE PRE PELLET,1
88293-6,HRT MALE PRE PELLET,1
2823-3,HRT MALE PRE PELLET,1
2075-0,HRT MALE PRE PELLET,1
,"AFP, MAT SERUM, OPEN SPINA BIFIDA",856
2161-8,"PREGNANCY DRUG PROFILE, UR, 10",1
2756-5,"PREGNANCY DRUG PROFILE, UR, 10",1
40678-5,TOXO IGM EIA,1
27811-9,ANTITHROMBIN ACTIVITY LEGACY,1
27820-0,PROTEIN C AG/FVII ANTIGEN,1
49870-9,PROTEIN C AG/FVII ANTIGEN,1
27438-1,PROTEIN C AG/FVII ANTIGEN,1
27820-0,"PROTEIN C ANTIGEN, TOTAL",2
2639-3,"MYOGLOBIN, SERUM LEGACY",1
5390-0,"TOXOPLASMA GONDII AB,IGM,QN LEGACY",4
6198-6,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
6844-5,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
6280-2,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
6740-5,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
6288-5,"ALLERGY PANEL 13,$STINGING INSECT GROUP",2
6740-5,ALLERGY INSECT VENOM PANEL,1
6844-5,ALLERGY INSECT VENOM PANEL,1
6198-6,ALLERGY INSECT VENOM PANEL,1
6117-6,ALLERGY INSECT VENOM PANEL,1
6280-2,ALLERGY INSECT VENOM PANEL,1
13986-5,"IFE AND PE, RANDOM URINE",2
2885-2,"IFE AND PE, SERUM",2
2888-6,"PE(RFX IFE), RANDOM UR LEGACY",1
17819-4,PROTEIN ELECTROPHORESIS Q,1
17811-1,PROTEIN ELECTROPHORESIS Q,1
17813-7,PROTEIN ELECTROPHORESIS Q,1
17815-2,PROTEIN ELECTROPHORESIS Q,1
17817-8,PROTEIN ELECTROPHORESIS Q,1
1533-9,GLUCOSE TOLERANCE (4 SP BLOOD),1
1558-6,GLUCOSE TOLERANCE (4 SP BLOOD),1
1507-3,GLUCOSE TOLERANCE (4 SP BLOOD),1
1518-0,GLUCOSE TOLERANCE (4 SP BLOOD),1
6041-8,IGE ALLERGENS(16) LEGACY,1
6153-1,IGE ALLERGENS(16) LEGACY,1
7604-2,IGE ALLERGENS(16) LEGACY,1
6020-2,IGE ALLERGENS(16) LEGACY,1
6212-5,IGE ALLERGENS(16) LEGACY,1
6025-1,IGE ALLERGENS(16) LEGACY,1
30170-5,IGE ALLERGENS(16) LEGACY,1
6085-5,IGE ALLERGENS(16) LEGACY,1
6109-3,IGE ALLERGENS(16) LEGACY,1
6209-1,IGE ALLERGENS(16) LEGACY,1
6189-5,IGE ALLERGENS(16) LEGACY,1
19113-0,IGE ALLERGENS(16) LEGACY,1
6096-2,IGE ALLERGENS(16) LEGACY,1
6833-8,IGE ALLERGENS(16) LEGACY,1
6098-8,IGE ALLERGENS(16) LEGACY,1
6152-3,IGE ALLERGENS(16) LEGACY,1
6034-3,IGE ALLERGENS(16) LEGACY,1
43396-1,LIPID PANEL (REFL),2
2093-3,LIPID PANEL (REFL),2
2085-9,LIPID PANEL (REFL),2
2571-8,LIPID PANEL (REFL),2
13457-7,LIPID PANEL (REFL),2
9830-1,LIPID PANEL (REFL),2
27819-2,PROTEIN C AND S ACTIVITY W/REFLEX TO ANTIGEN,1
27822-6,PROTEIN C AND S ACTIVITY W/REFLEX TO ANTIGEN,1
,CONGENITAL TRANSESOPHAGEAL ECHO COMPLETE,1
12722-5,IGF BINDING PROTEIN 1 (IGFBP 1),1
1558-6,GLUCOSE FASTING AND GESTATIONAL-130 CUTOFF LEGACY,1
1504-0,GLUCOSE FASTING AND GESTATIONAL-130 CUTOFF LEGACY,1
3050-2,T3 UPTAKE LEGACY,1
2159-2,"CREATININE LEVEL, AMNIOTIC FLUID",1
2344-0,"GLUCOSE LEVEL, AMNIOTIC FLUID",1
6875-9,CANCER ANTIGEN 15-3,1
2823-3,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
2075-0,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
2345-7,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
1759-0,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
1751-7,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
10834-0,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
2885-2,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
1742-6,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
6768-6,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
1920-8,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
1975-2,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
3094-0,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
2160-0,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
2951-2,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
2028-9,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
17861-6,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
,POCT CHEM 8 PROFILE,22
2536-1,LACTATE DEHYDROGENASE ISOENZYMES,1
2539-5,LACTATE DEHYDROGENASE ISOENZYMES,1
2542-9,LACTATE DEHYDROGENASE ISOENZYMES,1
2545-2,LACTATE DEHYDROGENASE ISOENZYMES,1
2548-6,LACTATE DEHYDROGENASE ISOENZYMES,1
88997-2,OMEGA 3 AND 6 FATTY ACIDS,3
88995-6,OMEGA 3 AND 6 FATTY ACIDS,3
88998-0,OMEGA 3 AND 6 FATTY ACIDS,3
48382-6,OMEGA 3 AND 6 FATTY ACIDS,3
88996-4,OMEGA 3 AND 6 FATTY ACIDS,3
88994-9,OMEGA 3 AND 6 FATTY ACIDS,3
49748-7,NMR LIPOPROFILE+LIPIDS,2
43727-7,NMR LIPOPROFILE+LIPIDS,2
54434-6,NMR LIPOPROFILE+LIPIDS,2
13457-7,NMR LIPOPROFILE+LIPIDS,2
2085-9,NMR LIPOPROFILE+LIPIDS,2
2571-8,NMR LIPOPROFILE+LIPIDS,2
2093-3,NMR LIPOPROFILE+LIPIDS,2
17782-4,NMR LIPOPROFILE+LIPIDS,2
62255-5,NMR LIPOPROFILE+LIPIDS,2
11561-8,"ACETYLCHOLINE RECEPTOR, BLOCKING",2
34661-9,ANTI-SMOOTH MUSCLE/MITOCHOND. LEGACY,1
,"KAPPA/LAMBDA LIGHT CHAINS FREE WITH RATIO, SERUM",3
81623-1,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
6687-8,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
81622-3,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
51716-9,"LC MUSK ABS, SERUM",1
14288-5,CARNITINE,1
14286-9,CARNITINE,1
40869-0,CARNITINE,1
2162-6,PHEOCHROMOCYTOMA  EVALUATION,1
3167-4,PHEOCHROMOCYTOMA  EVALUATION,1
16111-7,PHEOCHROMOCYTOMA  EVALUATION,1
43247-6,PHEOCHROMOCYTOMA  EVALUATION,1
2609-6,PHEOCHROMOCYTOMA  EVALUATION,1
35644-4,PHEOCHROMOCYTOMA  EVALUATION,1
16136-4,"BETA-2 GLYCOPROTEIN I ANTIBODY, IGM",2
16135-6,"BETA-2 GLYCOPROTEIN I ANTIBODY, IGG",2
48952-6,HISTOPLASMA GAL'MANNAN ANTIGEN URINE LEGACY,1
2756-5,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
2161-8,"DRUG MONITOR, PANEL 5, SCREEN, URINE",2
51716-9,"MUSK ABS, SERUM",1
11034-6,MYASTHENIA GRAVIS PROFILE,1
11561-8,MYASTHENIA GRAVIS PROFILE,1
30192-9,MYASTHENIA GRAVIS PROFILE,1
22761-1,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
22671-2,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
30194-5,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
30195-2,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
30197-8,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
30196-0,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
30198-6,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
30550-8,"FATTY ACIDS PROFILE, PEROXISOMAL - MAYO",2
46266-3,INFLAMMATORY BOWEL DISEASE DIFFERENTIATION PANEL,1
46267-1,INFLAMMATORY BOWEL DISEASE DIFFERENTIATION PANEL,1
47321-5,INFLAMMATORY BOWEL DISEASE DIFFERENTIATION PANEL,1
47320-7,INFLAMMATORY BOWEL DISEASE DIFFERENTIATION PANEL,1
3051-0,T3 REVERSE+T3 FREE,1
3052-8,T3 REVERSE+T3 FREE,1
2143-6,DHEA S+CORT+PREGNENOLONE,1
2191-5,DHEA S+CORT+PREGNENOLONE,1
2837-3,DHEA S+CORT+PREGNENOLONE,1
18262-6,LIPID PANEL AND CHOL/HDL RATIO LEGACY,1
3097-3,CMP12+1AC,1
2951-2,CMP12+1AC,1
2345-7,CMP12+1AC,1
2324-2,CMP12+1AC,1
10834-0,CMP12+1AC,1
2885-2,CMP12+1AC,1
1751-7,CMP12+1AC,1
17861-6,CMP12+1AC,1
1920-8,CMP12+1AC,1
1975-2,CMP12+1AC,1
6768-6,CMP12+1AC,1
1759-0,CMP12+1AC,1
3094-0,CMP12+1AC,1
2160-0,CMP12+1AC,1
88294-4,CMP12+1AC,1
88293-6,CMP12+1AC,1
2823-3,CMP12+1AC,1
2075-0,CMP12+1AC,1
27939-8,"N-TELOPEPTIDE, URINE LEGACY",1
2161-8,"N-TELOPEPTIDE, URINE LEGACY",1
14115-0,"N-TELOPEPTIDE, URINE LEGACY",1
3016-3,TSH+T3+T4FREE+T3FREE+T3REVERSE,1
3053-6,TSH+T3+T4FREE+T3FREE+T3REVERSE,1
3051-0,TSH+T3+T4FREE+T3FREE+T3REVERSE,1
3052-8,TSH+T3+T4FREE+T3FREE+T3REVERSE,1
6892-4,TSH+T3+T4FREE+T3FREE+T3REVERSE,1
2839-9,FSH+TESTT+LH+DHEA S+PROG+E2...,1
2191-5,FSH+TESTT+LH+DHEA S+PROG+E2...,1
2986-8,FSH+TESTT+LH+DHEA S+PROG+E2...,1
14115-0,FSH+TESTT+LH+DHEA S+PROG+E2...,1
2161-8,FSH+TESTT+LH+DHEA S+PROG+E2...,1
2991-8,FSH+TESTT+LH+DHEA S+PROG+E2...,1
15432-8,FSH+TESTT+LH+DHEA S+PROG+E2...,1
10501-5,FSH+TESTT+LH+DHEA S+PROG+E2...,1
15067-2,FSH+TESTT+LH+DHEA S+PROG+E2...,1
35384-7,FSH+TESTT+LH+DHEA S+PROG+E2...,1
27939-8,FSH+TESTT+LH+DHEA S+PROG+E2...,1
2495-0,"IODINE, RANDOM URINE LEGACY",1
88293-6,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
3097-3,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2345-7,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
1920-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
6768-6,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2885-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2028-9,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
17861-6,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2075-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
1975-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
10834-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
1759-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
1751-7,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
4548-4,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
787-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
4544-3,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
3051-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
11580-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
3024-7,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
1742-6,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
718-7,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
6690-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
789-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
62292-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
3094-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
751-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
777-3,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
786-4,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
788-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
785-6,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
713-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
736-9,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
5905-5,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
770-8,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2160-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
742-7,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
711-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
731-0,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
88294-4,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2951-2,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
2823-3,LC CMP14+CBC/D/PLT+TSH+HB A1C+...,1
51495-0,"SALIVARY CORTISOL X4, TIMED",1
51494-3,"SALIVARY CORTISOL X4, TIMED",1
51493-5,"SALIVARY CORTISOL X4, TIMED",1
51492-7,"SALIVARY CORTISOL X4, TIMED",1
32215-6,Free Thyroid Index C,4
2077-6,SWEAT CHLORIDE,4
34148-7,LYME DISEASE SEROLOGY-MAYO,2
3160-9,"POST-VAS SPERM EVALUATION,QUAL LEGACY",3
14979-9,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,2
5902-2,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,2
6301-6,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,2
3243-3,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,2
,COAG STUDIES INTERP REPORT,3
6198-6,"ALLERGEN WASP, PAPER IGE",1
6117-6,ALLERGEN FIRE ANT (INVICTA) IGE,1
11572-5,CRYOGLOBULIN,1
32286-7,Q HEPATITIS C VIRAL RNA W/ RFL NS5A DRUG RESIST,4
14956-7,"MICROALBUMINURIA, 24HR URINE",2
2162-6,"MICROALBUMINURIA, 24HR URINE",1
5622-6,"CHROMIUM, SERUM",4
17819-4,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
2162-6,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
85974-4,PNEUMOCOCCAL AB (23 SEROTYPE),1
85992-6,PNEUMOCOCCAL AB (23 SEROTYPE),1
85955-3,PNEUMOCOCCAL AB (23 SEROTYPE),1
47356-1,PNEUMOCOCCAL AB (23 SEROTYPE),1
40911-0,PNEUMOCOCCAL AB (23 SEROTYPE),1
86061-9,PNEUMOCOCCAL AB (23 SEROTYPE),1
86046-0,PNEUMOCOCCAL AB (23 SEROTYPE),1
86053-6,PNEUMOCOCCAL AB (23 SEROTYPE),1
86038-7,PNEUMOCOCCAL AB (23 SEROTYPE),1
86129-4,PNEUMOCOCCAL AB (23 SEROTYPE),1
86099-9,PNEUMOCOCCAL AB (23 SEROTYPE),1
86123-7,PNEUMOCOCCAL AB (23 SEROTYPE),1
40905-2,PNEUMOCOCCAL AB (23 SEROTYPE),1
86081-7,PNEUMOCOCCAL AB (23 SEROTYPE),1
47349-6,PNEUMOCOCCAL AB (23 SEROTYPE),1
40915-1,PNEUMOCOCCAL AB (23 SEROTYPE),1
40926-8,PNEUMOCOCCAL AB (23 SEROTYPE),1
40913-6,PNEUMOCOCCAL AB (23 SEROTYPE),1
86108-8,PNEUMOCOCCAL AB (23 SEROTYPE),1
86148-4,PNEUMOCOCCAL AB (23 SEROTYPE),1
86166-6,PNEUMOCOCCAL AB (23 SEROTYPE),1
86010-6,PNEUMOCOCCAL AB (23 SEROTYPE),1
86021-3,PNEUMOCOCCAL AB (23 SEROTYPE),1
11257-3,HAEMOPHILUS INFLUENZAE B AB IGG,1
33662-8,PI-LINKED ANTIGEN-MAYO,1
13458-5,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,1
2338-2,GLUCAGON,3
27821-8,"PROTEIN S ANTIGEN, FREE",6
2093-3,CHOL+TRIG+HDL+LDL-D,1
2571-8,CHOL+TRIG+HDL+LDL-D,1
2085-9,CHOL+TRIG+HDL+LDL-D,1
18262-6,CHOL+TRIG+HDL+LDL-D,1
,LYMPHOCYTE SUBSET PANEL 2,15
,PULMONARY STRESS TEST - PEDS CARDIAC CONGENITAL CLINIC,3
3854-7,NICOTINE AND METABOLITES URINE,1
10366-3,NICOTINE AND METABOLITES URINE,1
58366-6,"COMPLIANCE DRUG ANALY, NO THC",8
5335-5,"RUBELLA ANTIBODY, IGM",3
789-8,RED BLOOD COUNT,93
52789-5,TEG FOR TRAUMA,10
52768-9,TEG FOR TRAUMA,10
66748-5,TEG FOR TRAUMA,10
52778-8,TEG FOR TRAUMA,10
3097-3,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2951-2,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2345-7,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
1742-6,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
1920-8,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
1751-7,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
17861-6,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2885-2,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2028-9,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
6768-6,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
1759-0,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
1975-2,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
10834-0,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
3094-0,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2160-0,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
88294-4,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
88293-6,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2823-3,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
2075-0,"COMPREHENSIVE METABOLIC PANEL, PLASMA",1
,"ADALUMUMAB AB REFLEX, S",1
58413-6,PRENATAL PROFILE I,1
3289-6,FACTOR II INHIBITOR ASSAY,1
5902-2,FACTOR II INHIBITOR ASSAY,1
14979-9,FACTOR II INHIBITOR ASSAY,1
2157-6,CK TOTAL AND CKMB,2
1848-1,"DIHYDROTESTOSTERONE, LC/MS/MS",1
33569-5,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
45142-7,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
4532-8,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
5130-0,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
34416-8,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
29374-6,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
43182-5,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
4485-9,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
4498-2,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 3",2
39803-2,INFLIXIMAB QUANT W/REFLEX TO AB - MAYO,1
,"INFLIXIMAB AB, S",2
1989-3,QUESTASSURED FOR INFANTS 25-HYDROXYVITAMIN D,1
1990-1,QUESTASSURED FOR INFANTS 25-HYDROXYVITAMIN D,1
2236-8,QUESTASSURED FOR INFANTS 25-HYDROXYVITAMIN D,1
3167-4,"HYDROXYINDOLEACETIC ACID, 5-,URINE,24 HR",3
1695-6,"HYDROXYINDOLEACETIC ACID, 5-,URINE,24 HR",3
29374-6,ENA ANTIBODY PANEL LEGACY,1
11090-8,ENA ANTIBODY PANEL LEGACY,1
17792-3,ENA ANTIBODY PANEL LEGACY,1
17791-5,ENA ANTIBODY PANEL LEGACY,1
27416-7,ENA ANTIBODY PANEL LEGACY,1
1971-1,"BILIRUBIN, TOTAL AND DIRECT",1
,PEDIATRIC EXERCISE STRESS TEST,2
5334-8,HBV+MMR+VZ,1
5244-9,HBV+MMR+VZ,1
25418-5,HBV+MMR+VZ,1
5403-1,HBV+MMR+VZ,1
5274-6,"PARVOVIRUS B19, IGM LEGACY",1
13717-4,"CALCIUM, 24HR, UR W/CREATININE",1
6874-2,"CALCIUM, 24HR, UR W/CREATININE",1
2162-6,"CALCIUM, 24HR, UR W/CREATININE",1
27823-4,"PROTEIN S, TOTAL AND FREE",1
27821-8,"PROTEIN S, TOTAL AND FREE",1
27819-2,PROTEIN C ACTIVITY AND ANTIGEN,1
27820-0,PROTEIN C ACTIVITY AND ANTIGEN,1
69569-2,ROMA(TM) (RISK OF OVARIAN MALIGNANCY ALGORITHM),2
69570-0,ROMA(TM) (RISK OF OVARIAN MALIGNANCY ALGORITHM),2
10334-1,ROMA(TM) (RISK OF OVARIAN MALIGNANCY ALGORITHM),2
55180-4,ROMA(TM) (RISK OF OVARIAN MALIGNANCY ALGORITHM),2
,CANCER ANTIGEN 15-3,1
62361-1,FISH FOLLOW-UP KNOWN VARIANT LEGACY,1
62360-3,FISH FOLLOW-UP KNOWN VARIANT LEGACY,1
,"GENTAMICIN LEVEL, TROUGH",1
9802-0,STONE ANALYSIS,14
,"ALKALINE PHOSPHATASE, BONE SPECIFIC",2
,WHITE BLOOD COUNT AND DIFFERENTIAL,1
1975-2,"BILIRUBIN, FRACTIONATED",3
1968-7,"BILIRUBIN, FRACTIONATED",3
1971-1,"BILIRUBIN, FRACTIONATED",3
,THYROID PEROXIDASE AND THYROGLOBULIN ANTIBODIES,2
,COMPLEMENT COMP C3 + C4 LEGACY,2
,LYMPHOCYTE SUBSET PANEL 1,28
,CORTISOL AM,2
,ARSENIC BLOOD-MAYO LEGACY,1
36916-5,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,4
33944-0,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,4
48378-4,IMMUNOGLOBULIN FREE LT CHAINS BLOOD,4
30522-7,CARDIO IQ(R) HS CRP,1
,ALLERGEN CANDIDA ALBICANS,1
,POCT SODIUM,6
11011-4,"HEPATITIS C RNA, QUANTITATIVE, PCR LEGACY",3
38180-6,"HEPATITIS C RNA, QUANTITATIVE, PCR LEGACY",1
7556-4,Q EGG COMPONENT PANEL,2
7557-2,Q EGG COMPONENT PANEL,2
4625-0,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,1
4563-3,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,1
,US FETAL LIMITED,1
18262-6,LP+LDL DIRECT+DLDL/HDL RATIO,1
11054-4,LP+LDL DIRECT+DLDL/HDL RATIO,1
2093-3,LP+LDL DIRECT+DLDL/HDL RATIO,1
2571-8,LP+LDL DIRECT+DLDL/HDL RATIO,1
2085-9,LP+LDL DIRECT+DLDL/HDL RATIO,1
13458-5,LP+LDL DIRECT+DLDL/HDL RATIO,1
13457-7,LP+LDL DIRECT+DLDL/HDL RATIO,1
,THYROXINE BINDING GLOBULIN,1
5335-5,RUBELLA ANTIBODIES,1
,"HIV-1 RNA, PCR (NONGRAPH) RFX/GENO",31
,PLAVIX PLATELET FUNC ANALYSIS - PERFORMABLE,1
,"BILIRUBIN LEVEL DIRECT, BODY FLUID",2
,"CORTISOL FREE RANDOM, URINE",2
,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",6
6248-9,"ALLERGEN PROFILE, BASIC FOOD",1
6219-0,"ALLERGEN PROFILE, BASIC FOOD",1
6080-6,"ALLERGEN PROFILE, BASIC FOOD",1
7291-8,"ALLERGEN PROFILE, BASIC FOOD",1
7258-7,"ALLERGEN PROFILE, BASIC FOOD",1
6276-0,"ALLERGEN PROFILE, BASIC FOOD",1
6087-1,"ALLERGEN PROFILE, BASIC FOOD",1
6206-7,"ALLERGEN PROFILE, BASIC FOOD",1
6039-2,"ALLERGEN PROFILE, BASIC FOOD",1
5130-0,ENA+DNA/DS+SJOGREN'S 016123,1
29374-6,ENA+DNA/DS+SJOGREN'S 016123,1
11090-8,ENA+DNA/DS+SJOGREN'S 016123,1
17792-3,ENA+DNA/DS+SJOGREN'S 016123,1
17791-5,ENA+DNA/DS+SJOGREN'S 016123,1
21422-1,"METANEPHRINES FRACTIONATED 24HR, URINE",1
19050-4,"METANEPHRINES FRACTIONATED 24HR, URINE",1
51416-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30531-8,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30191-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
55940-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30540-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
55871-8,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
39001-3,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
39615-0,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30358-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30541-7,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
90237-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
90238-7,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30236-4,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
43235-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
59195-8,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
39002-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
51415-8,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30328-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30327-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
53471-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30331-3,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30349-5,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30332-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
82478-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30551-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30235-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30356-0,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30565-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30564-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30566-4,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30233-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30357-8,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30190-3,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30238-0,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
39014-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
79628-4,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30560-7,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30534-2,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30542-5,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30234-9,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30237-2,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
30312-3,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
55855-1,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
43243-5,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
39000-5,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
74540-6,"ACYLCARNITINES, PLASMA, QUANTITATIVE",1
8101-8,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
54218-3,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
8122-4,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
5905-5,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
736-9,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
785-6,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
4544-3,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
787-2,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
718-7,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
770-8,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
788-0,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
777-3,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
786-4,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
24467-3,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
731-0,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
706-2,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
751-8,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
713-8,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
711-2,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
704-7,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
742-7,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
14135-8,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
8124-0,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
8123-2,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
6690-2,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
789-8,T-LYMPHOCYTE HELPER/SUPPRESSOR,1
27815-0,FACTOR XIII FUNCTIONAL LEGACY,1
14979-9,VON WILLEBRAND SCREEN,1
3209-4,VON WILLEBRAND SCREEN,1
27816-8,VON WILLEBRAND SCREEN,1
6014-5,VON WILLEBRAND SCREEN,1
3198-9,PROLONGED PROTIME PROFILE,1
3218-5,PROLONGED PROTIME PROFILE,1
75508-2,PROLONGED PROTIME PROFILE,1
75884-7,PROLONGED PROTIME PROFILE,1
3255-7,PROLONGED PROTIME PROFILE,1
3289-6,PROLONGED PROTIME PROFILE,1
3193-0,PROLONGED PROTIME PROFILE,1
5975-8,PLASMINOGEN ACTIVATOR INHIBITOR,1
10921-5,ALLERGENS W/TOTAL IGE AREA 4 LEGACY,1
6282-8,ALLERGENS W/TOTAL IGE AREA 4 LEGACY,1
3271-4,ANTI XA-HEPARIN,2
3663-2,"GENTAMICIN LEVEL, PEAK",1
44405-9,"Q SODIUM WITH CREATININE, 24 HOUR URINE",1
2956-1,"Q SODIUM WITH CREATININE, 24 HOUR URINE",1
56143-1,"Q POTASSIUM, W/CREATININE, 24 HOUR URINE",1
2829-0,"Q POTASSIUM, W/CREATININE, 24 HOUR URINE",1
3167-4,"OXALIC ACID, 24-HOUR  URINE",1
2701-1,"OXALIC ACID, 24-HOUR  URINE",1
13788-5,"OXALIC ACID, 24-HOUR  URINE",1
2162-6,"OXALIC ACID, 24-HOUR  URINE",1
3167-4,"MAGNESIUM, 24-HOUR URINE (WITH CREATININE)",1
24447-5,"MAGNESIUM, 24-HOUR URINE (WITH CREATININE)",1
44336-6,"MAGNESIUM, 24-HOUR URINE (WITH CREATININE)",1
2162-6,"MAGNESIUM, 24-HOUR URINE (WITH CREATININE)",1
13820-6,"Q URIC ACID, 24 HOUR URINE (W/CREATININE)",1
3087-4,"Q URIC ACID, 24 HOUR URINE (W/CREATININE)",1
777-3,%92133SB NAFLD FIBROSIS SCORE,2
1751-7,%92133SB NAFLD FIBROSIS SCORE,2
2345-7,%92133SB NAFLD FIBROSIS SCORE,2
1920-8,%92133SB NAFLD FIBROSIS SCORE,2
1742-6,%92133SB NAFLD FIBROSIS SCORE,2
75508-2,LUPUS ANTICOAGULANT COMP LEGACY,1
75884-7,LUPUS ANTICOAGULANT COMP LEGACY,1
3243-3,LUPUS ANTICOAGULANT COMP LEGACY,1
34571-0,LUPUS ANTICOAGULANT COMP LEGACY,1
6303-2,LUPUS ANTICOAGULANT COMP LEGACY,1
58413-6,OB PANEL W/HIV,1
2756-5,"DRUG MONITOR, PANEL 1, SCREEN, URINE",1
2161-8,"DRUG MONITOR, PANEL 1, SCREEN, URINE",2
49748-7,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
43727-7,NMR LIPOPROFILE+LIPIDS+IR+GPH,2
54434-6,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
17782-4,NMR LIPOPROFILE+LIPIDS+IR+GPH,2
43729-3,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
62254-8,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
62255-5,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
62253-0,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
13457-7,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
2085-9,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
2571-8,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
2093-3,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
43728-5,NMR LIPOPROFILE+LIPIDS+IR+GPH,1
7445-0,Q MILK COMPONENT PANEL,1
6042-6,Q MILK COMPONENT PANEL,1
6062-4,Q MILK COMPONENT PANEL,1
2951-2,CMP14 326585,1
2823-3,CMP14 326585,1
2345-7,CMP14 326585,1
1742-6,CMP14 326585,1
10834-0,CMP14 326585,1
2885-2,CMP14 326585,1
1751-7,CMP14 326585,1
17861-6,CMP14 326585,1
1920-8,CMP14 326585,1
1975-2,CMP14 326585,1
6768-6,CMP14 326585,1
1759-0,CMP14 326585,1
3094-0,CMP14 326585,1
2160-0,CMP14 326585,1
88294-4,CMP14 326585,1
88293-6,CMP14 326585,1
2075-0,CMP14 326585,1
2028-9,CMP14 326585,1
32546-4,"G6PD,QN,BLD AND HGB",1
80695-0,DNA SEQUENCING PR-RT,1
53761-3,"JAK2 V617F, QUANTITATIVE",1
3209-4,VON WILLEBRAND PROFILE,1
27816-8,VON WILLEBRAND PROFILE,1
6014-5,VON WILLEBRAND PROFILE,1
,%92133SB NAFLD FIBROSIS SCORE,2
3097-3,CMP14,1
2951-2,CMP14,1
2345-7,CMP14,1
1920-8,CMP14,1
6768-6,CMP14,1
2885-2,CMP14,1
10466-1,CMP14,1
17861-6,CMP14,1
2028-9,CMP14,1
1975-2,CMP14,1
10834-0,CMP14,1
1759-0,CMP14,1
1751-7,CMP14,1
3094-0,CMP14,1
1742-6,CMP14,1
2160-0,CMP14,1
88294-4,CMP14,1
88293-6,CMP14,1
2823-3,CMP14,1
2075-0,CMP14,1
10366-3,"COTININE, URINE",1
4552-6,"HGB A2, QUANT",1
29247-4,"SIROLIMUS (RAPAMUNE), BLOOD LEGACY",1
17713-9,TOPIRAMATE,1
7369-2,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6265-3,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6034-3,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6182-0,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6041-8,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6169-7,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6152-3,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6153-1,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6020-2,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6075-6,"SEASONAL ALLRGNS, SUMMER-GRASS",1
6156-4,"SEASONAL ALLRGNS, FALL--WEED",1
6232-3,"SEASONAL ALLRGNS, FALL--WEED",1
6286-9,"SEASONAL ALLRGNS, FALL--WEED",1
7604-2,"SEASONAL ALLRGNS, FALL--WEED",1
6239-8,"SEASONAL ALLRGNS, FALL--WEED",1
6085-5,"SEASONAL ALLRGNS, FALL--WEED",1
6738-9,"SEASONAL ALLRGNS, FALL--WEED",1
6077-2,"SEASONAL ALLRGNS, FALL--WEED",1
6110-1,"SEASONAL ALLRGNS, FALL--WEED",1
6128-3,"SEASONAL ALLRGNS, FALL--WEED",1
6118-4,"SEASONAL ALLRGNS, FALL--WEED",1
6183-8,"SEASONAL ALLRGNS, FALL--WEED",1
7641-4,"SEASONAL ALLRGNS, FALL--WEED",1
2874-6,"L - PE AND FLC, SERUM",1
2885-2,"L - PE AND FLC, SERUM",1
33944-0,"L - PE AND FLC, SERUM",1
36916-5,"L - PE AND FLC, SERUM",1
48378-4,"L - PE AND FLC, SERUM",1
2862-1,"L - PE AND FLC, SERUM",1
2865-4,"L - PE AND FLC, SERUM",1
2868-8,"L - PE AND FLC, SERUM",1
2871-2,"L - PE AND FLC, SERUM",1
10834-0,"L - PE AND FLC, SERUM",1
1759-0,"L - PE AND FLC, SERUM",1
6174-7,"MILK PROCESSED, IGE",1
74117-3,ADALIMUMAB LEVEL FOR RHEUMATIC DISEASEDISEASES,1
,STREP PNEUMONIAE ANTIBODY SEROTYPES,46
11546-9,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
30896-5,MPN PROFILE,2
46983-3,"COMPLIANCE DRUG ANALYSIS, UR",24
49753-7,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",1
3415-7,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",1
2276-4,FERRITIN (REFL) LEGACY,1
17864-0,"CALCIUM+CALCIUM, IONIZED LEGACY",1
3530-3,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",1
35148-6,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35158-5,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35145-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35173-4,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35149-4,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35163-5,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35162-7,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35161-9,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35155-1,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35167-6,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35165-0,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35166-8,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35164-3,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35147-8,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
30194-5,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35160-1,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35169-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35172-6,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35171-8,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35168-4,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35182-5,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35181-7,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35180-9,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35174-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35146-0,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35177-5,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35176-7,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
30197-8,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
30195-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
33036-5,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35170-0,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35175-9,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
22671-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35411-8,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
22761-1,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35151-0,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35179-1,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
24461-6,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35178-3,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35150-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35157-7,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
35154-4,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
2258-2,"ESTROGENS, FRACTIONATED, LC/MS",1
35384-7,"ESTROGENS, FRACTIONATED, LC/MS",1
2251-7,"ESTROGENS, FRACTIONATED, LC/MS",1
14062-4,DEXAMETHASONE,68
15067-2,LC FOLLICLE STIMULATING HORMONE,1
,GHRELIN TOTAL - MAYO,1
14627-4,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,1
2746-6,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,1
2021-4,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,1
1927-3,VENOUS  BLOOD GAS WITH CO-OXIMETRY UNSOLICITED RESULTS,1
5060-9,TICK BORNE DISEASE AB PANEL,1
8101-8,T-LYMPH MARKERS + NK,1
9728-7,T-LYMPH MARKERS + NK,1
8122-4,T-LYMPH MARKERS + NK,1
736-9,T-LYMPH MARKERS + NK,1
770-8,T-LYMPH MARKERS + NK,1
787-2,T-LYMPH MARKERS + NK,1
718-7,T-LYMPH MARKERS + NK,1
4544-3,T-LYMPH MARKERS + NK,1
789-8,T-LYMPH MARKERS + NK,1
777-3,T-LYMPH MARKERS + NK,1
786-4,T-LYMPH MARKERS + NK,1
788-0,T-LYMPH MARKERS + NK,1
785-6,T-LYMPH MARKERS + NK,1
8124-0,T-LYMPH MARKERS + NK,1
751-8,T-LYMPH MARKERS + NK,1
713-8,T-LYMPH MARKERS + NK,1
706-2,T-LYMPH MARKERS + NK,1
5905-5,T-LYMPH MARKERS + NK,1
704-7,T-LYMPH MARKERS + NK,1
742-7,T-LYMPH MARKERS + NK,1
711-2,T-LYMPH MARKERS + NK,1
731-0,T-LYMPH MARKERS + NK,1
24467-3,T-LYMPH MARKERS + NK,1
8123-2,T-LYMPH MARKERS + NK,1
14135-8,T-LYMPH MARKERS + NK,1
8112-5,T-LYMPH MARKERS + NK,1
6690-2,T-LYMPH MARKERS + NK,1
777-3,PLATELET CTAD,1
11546-9,"PAP IG, CT-NG TV",1
,PROTEIN S-ANTIGEN LEGACY,1
,PROTEIN S PANEL,1
58393-0,COMPL DRUG ANL W/ETG+NICOTINE,7
64131-6,COMPL DRUG ANL W/ETG+NICOTINE,7
61420-6,COMPL DRUG ANL W/ETG+NICOTINE,7
58394-8,COMPL DRUG ANL W/ETG+NICOTINE,7
43583-4,CARDIO IQ(R) LIPOPROTEIN (A),1
2857-1,PROSTATE SPECIFIC ANTIGEN,1
,"TESTOSTERONE, TOTAL AND FREE AND SEX HORMONE BINDING GLOBULIN",3
49573-9,RFLX TO GENOSURE(R) MG,1
32215-6,"T3, UPTAKE",1
,CARDIAC DEVICE CHECK CHECK - TTM,1
2161-8,CREAT U+PROT U LEGACY,1
2888-6,CREAT U+PROT U LEGACY,1
2890-2,CREAT U+PROT U LEGACY,1
11572-5,RHEUMATOID ARTHRITIS DIAGNOSTIC IDENTRA(R) PANEL 2,2
33935-8,RHEUMATOID ARTHRITIS DIAGNOSTIC IDENTRA(R) PANEL 2,2
75880-5,RHEUMATOID ARTHRITIS DIAGNOSTIC IDENTRA(R) PANEL 2,2
74117-3,ADALIMUMAB DRUG LEVEL AND ANTI-DRUG ANTIBODY FOR IBD (Q),1
90779-0,ADALIMUMAB DRUG LEVEL AND ANTI-DRUG ANTIBODY FOR IBD (Q),1
,"PSA, TOTAL WITH REFLEX TO PSA, FREE (REFL)",1
3026-2,T4F+T3FREE LEGACY,1
3051-0,T4F+T3FREE LEGACY,1
3053-6,T4F+T3FREE LEGACY,1
3024-7,T4F+T3FREE LEGACY,1
3126-0,ANTIDIURETIC HORMONE PROFILE LEGACY,1
2692-2,ANTIDIURETIC HORMONE PROFILE LEGACY,1
27923-2,"COENZYME Q10, TOTAL",1
,POCT HR-ACT UNSOLICITED RESULTS,6
,POCT HDR UNSOLICITED RESULTS,16
5793-5,"UA/M W/RFLX CULTURE, COMP",2
2955-3,"SODIUM W/O CREATININE, RANDOM URINE",1
17718-8,"COMPLIANCE DRUG ANALYSIS, UR",24
86454-6,"COMPLIANCE DRUG ANALYSIS, UR",24
18338-4,"COMPLIANCE DRUG ANALYSIS, UR",24
4537-7,"Q SED RATE BY MODIFIED WESTERGREN, MANUAL",1
2857-1,PSA TOTAL+% FREE (SERIAL),1
10886-0,PSA TOTAL+% FREE (SERIAL),1
12841-3,PSA TOTAL+% FREE (SERIAL),1
16249-5,OXYCODONE/OXYMORPHONE CONFIRM,1
17395-5,OXYCODONE/OXYMORPHONE CONFIRM,1
2857-1,PSA TOTAL (REFLEX TO FREE) LEGACY,1
35384-7,FREE ESTRADIOL-MAYO,1
14960-9,FREE ESTRADIOL-MAYO,1
2240-0,FREE ESTRADIOL-MAYO,1
55159-8,"BILE ACIDS, FRACTIONATED LCMS",1
30518-5,"BILE ACIDS, FRACTIONATED LCMS",1
30519-3,"BILE ACIDS, FRACTIONATED LCMS",1
30520-1,"BILE ACIDS, FRACTIONATED LCMS",1
14628-2,"BILE ACIDS, FRACTIONATED LCMS",1
6193-7,ALLERGEN ONION IGE,1
6257-0,ALLERGEN STRAWBERRY,1
6219-0,ALLERGEN PORK IGE,1
3167-4,"CITRIC ACID,24 HOUR URINE (WITH CREATININE)",1
6687-8,"CITRIC ACID,24 HOUR URINE (WITH CREATININE)",1
44306-9,"CITRIC ACID,24 HOUR URINE (WITH CREATININE)",1
2162-6,"CITRIC ACID,24 HOUR URINE (WITH CREATININE)",1
706-2,DIFFERENTIAL/TOTAL WBC COUNT,1
751-8,DIFFERENTIAL/TOTAL WBC COUNT,1
6690-2,DIFFERENTIAL/TOTAL WBC COUNT,1
71695-1,DIFFERENTIAL/TOTAL WBC COUNT,1
770-8,DIFFERENTIAL/TOTAL WBC COUNT,1
736-9,DIFFERENTIAL/TOTAL WBC COUNT,1
5905-5,DIFFERENTIAL/TOTAL WBC COUNT,1
713-8,DIFFERENTIAL/TOTAL WBC COUNT,1
731-0,DIFFERENTIAL/TOTAL WBC COUNT,1
742-7,DIFFERENTIAL/TOTAL WBC COUNT,1
,"PSA, POST PROSTATECTOMY WITH HAMA TREATMENT",1
61423-0,"COMPLIANCE DRUG ANALY, NO THC",8
58396-3,"COMPLIANCE DRUG ANALY, NO THC",8
58364-1,COMPL DRUG ANL W/ETG+NICOTINE,7
86609-5,COMPL DRUG ANL W/ETG+NICOTINE,7
61423-0,COMPL DRUG ANL W/ETG+NICOTINE,7
58396-3,COMPL DRUG ANL W/ETG+NICOTINE,7
14118-4,"LACTIC ACID, PLASMA",128
5176-3,"H. PYLORI ANTIBODY, IGM, IGG, AND  IGA",1
7901-2,"H. PYLORI ANTIBODY, IGM, IGG, AND  IGA",1
7903-8,"H. PYLORI ANTIBODY, IGM, IGG, AND  IGA",1
2416-6,"HISTAMINE, PLASMA",2
11054-4,LIPID PANEL WITH LDL/HDL RATIO LEGACY,1
2093-3,LIPID PANEL WITH LDL/HDL RATIO LEGACY,1
2571-8,LIPID PANEL WITH LDL/HDL RATIO LEGACY,1
2085-9,LIPID PANEL WITH LDL/HDL RATIO LEGACY,1
13458-5,LIPID PANEL WITH LDL/HDL RATIO LEGACY,1
13457-7,LIPID PANEL WITH LDL/HDL RATIO LEGACY,1
2888-6,"IFE AND PE, RANDOM URINE",1
15680-2,DERMATOPHAGOIDES FARINAE (D2) IGE LEGACY,1
6153-1,RYE GRASS (LOLIUM PERENNE),1
15685-1,ALLERGEN DOG DANDER,1
7604-2,"ALLERGEN PIGWEED, ROUGH IGE",1
6189-5,"ALLERGEN OAK, WHITE IGE",1
15609-1,"ALLERGEN CAT HAIR/DANDER,STANDARD IGE",1
3887-7,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
12382-8,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
15372-6,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
19648-5,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
61425-5,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
11246-6,"DRUG MONITOR, PANEL 1, W/CONF, URINE",1
58382-3,"COMPLIANCE DRUG ANALYSIS, UR",24
58380-7,"COMPLIANCE DRUG ANALYSIS, UR",24
8123-2,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
14135-8,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
8116-6,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
788-0,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
786-4,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
789-8,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
8112-5,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
6690-2,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
9728-7,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
785-6,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
4544-3,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
787-2,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
718-7,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
8117-4,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
711-2,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
742-7,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
5905-5,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
770-8,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
736-9,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
777-3,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
731-0,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
706-2,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
751-8,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
713-8,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
8122-4,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
71695-1,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
8124-0,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
24467-3,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
8101-8,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
54218-3,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
1994-3,Ionized Calcium iSTAT,2369
2951-2,"NA iSTAT",2876
2823-3,K iSTAT,2403
11282-1,Cells Counted,4237
702-1,Anisocytosis,55665
779-9,Poik,2591
802-9,Spherocyte,1550
800-3,Schistocyte,1139
774-0,Ovalocyte,1286
7791-7,Tear Drop Cell,1672
3968-5,Phenytoin Lvl,1889
,Temp Ven,625
2021-4,pCO2 Ven,629
2705-2,pO2 Ven,629
718-7,Hgb.,6375
4544-3,Hct,988506
777-3,Platelet,6375
1975-2,Bili Total,4087
1751-7,Albumin Lvl,4980
6768-6,Alk Phos,592061
2885-2,Total Protein,55690
2336-6,Globulin,1156
2345-7,Glucose Lvl,994469
1988-5,CRP,11200
2951-2,Sodium Lvl,1004902
2160-0,Creatinine,541084
3097-3,BUN/Creat Ratio,6630
2823-3,Potassium Lvl,1024029
2075-0,Chloride,537380
2028-9,CO2,1660398
38445-3,Calprotectin Stool,162
62292-8,25 OH Vit D Tot,538
4086-5,Valpro Acid Lvl,78
,PT Patient Mean,895
3173-2,PTT,83367
3255-7,Fibrinogen Assay,164
5902-2,PT,296129
11274-8,Elliptocyte,630
3969-3,Phenytoin Free,158
3968-5,Phenytoin Total,158
19123-9,Magnesium Lvl,270635
2777-1,Phosphorus,7312
,Temp Cap,1818
2020-6,pCO2 Cap,1826
2704-5,pO2 Cap,1826
32693-4,Lactic Acid iSTAT,1263
728-6,Hypochromia,2596
50562-8,U SG Automated,2459
5803-2,UA pH,2459
2157-6,Total CK,1393
21198-7,Beta hCG Qnt,86
,Macrocytic,1487
4537-7,Sed Rate,724
2339-0,Glucose PCx,821
,Anti-CBir1 ELISA,30
,ASCA IgA ELISA,30
47321-5,ASCA IgG ELISA,30
,Anti-OmpC IgA ELISA,30
,Anti-FlaX IgG ELISA,30
,Anti-A4-Fla2 IgG ELISA,30
,VCAM-1,30
,ICAM-1,30
,CRP IBS,30
34694-0,VEGF,30
,SAA,30
63459-2,DGP IgG,38
46128-5,AHTT IgA,38
63453-5,DGP IgA,38
2458-8,Total Serum IgA,38
,Dialysis-Hgb,589
6690-2,Dialysis-WBC,589
,Dialysis-Hct,589
777-3,Dialysis-Plt,589
2777-1,Dialysis-Phosphorus,872
,Microcytic,1718
20578-1,Vanco Lvl,20
,Requestor's Phone Number,66
64084-7,TB2 - Nil,414
64084-7,TB1 - Nil,413
71774-4,Mitogen - Nil,414
7790-9,Crenated Cell,465
10378-8,Polychrom,1787
2703-7,pO2 Art,988
2019-8,pCO2 Art,988
,Temp Art,987
22763-7,Ammonia Level,142
,Solano Temp,446
10374-7,Helmet Cell,244
,Ab to inflix (ATI) conc,204
,Serum inflix (IFX) conc,204
42637-9,BNP iSTAT,203
2571-8,Trig,344
2143-6,Cortisol Lvl,5897
2532-0,LDH,10917
10381-2,Target Cell,688
2161-8,U Creatinine,260
2890-2,U Prot/Creat,198
2888-6,U Protein,206
17862-4,U Calcium,47
2731-8,PTH Intact,12169
3948-7,Phenobarb Lvl,515
17849-1,Retic Cnt Auto,611
7790-9,Burr Cell,205
4092-3,Vanco Tr,93
3040-3,Lipase Lvl,86264
1798-8,Amylase Lvl,225
2498-4,Iron Level,3654
,Dialysis-Sodium Lvl,297
,Dialysis-Potassium Lvl,311
17861-6,Dialysis-Calcium Lvl,828
,Dialysis-CO2,298
2345-7,Dialysis-Glucose Lvl,297
,Dialysis-Magnesium Lvl,299
14420-4,Dialysis-Total Bilirubin,297
2276-4,Ferritin Lvl,43258
2500-7,Iron Binding Capacity Tot,376
19113-0,IgE,2554
2472-9,IgM,3431
2465-3,IgG,3986
2458-8,IgA,3496
30471-7,Levetiracetam Lvl,3160
2342-4,Glucose CSF,263
2880-3,Protein CSF,263
10329-1,Monocyte CSF,25
3494-2,Clonazepam Lvl,7
28059-4,7-Aminoclonazepam,1
,AB to Vedolizumab (ATV) conc,20
,Serum Vedolizumab (VDZ) conc,20
3487-6,Clobazam Lvl,6
,Desmethylclobazam Lvl,6
10380-4,Stomatocytes,1050
42678-3,Uric Acid,219
3024-7,T4 Free,32619
,Vitamin E Lvl,19
17527-3,Vitamin A (Free Retinol),28
,POC Ur Dipstick Spec Gravity,125
,POC Ur Dipstick pH,125
20405-7,POC Ur Dipstick Urobilinogen,125
2483-6,IGF Bind Prot-3,2
3053-6,T3 Total,1546
42176-8,Fungitell (Serum),30
,URDGS Cassette Lot Number,171
,Liv/Kid Micros Ab,15
2064-4,Ceruloplasmin (Mayo),12
1825-9,A-1 Antitrypsin,3
5724-0,Selenium Lvl,126
9830-1,Chol/HDL,238
,HDL/LDL Ratio,238
2085-9,HDL,205347
2093-3,Chol,247
13457-7,LDL,68953
2692-2,Osmolality,5604
14338-8,Prealbumin,3820
2695-5,U Osmolality,47
2955-3,Ur Sodium,84
,Prot Tot BF (Mayo),9
5763-8,Zinc Lvl,712
,Serum adalimumab (ADA) conc,20
,Ab to adalimumab (ATA) conc,20
38256-4,Cells Counted BF,13
10330-9,Monocyte BF,24
13941-0,Lymph BF,23
30453-5,Segs BF,24
,Count/Diff BF,18
2344-0,Glucose BF,9
5631-7,Copper Lvl,621
14803-1,LDH Tot BF,9
,Pancreatic Elastase-1,9
6873-4,Beta HB Qnt,41
2484-4,IGF-1,6
749-2,Myelo Man,286
46128-5,TTG IgA,24
7789-1,Acanthocyte,152
2161-8,Creat Ur for Microalb,6
,Microalb Ur for Group,6
14957-5,U Microalb,6
14958-3,Microalb/Creat Ratio,6
,PLT_Clumps?,5545
,RBC_Agglutination?,8780
,Blasts/Abn_Lympho?,8084
,Left_Shift?,3703
8074-7,Insulin Ab,75
,Atypical_Lympho?,4987
,Fragments?,2521
2243-4,Estradiol Lvl,1732
2191-5,DHEAS,6
703-9,Basophilic Stippling,94
1747-5,Albumin BF,2
15067-2,FSH,2260
10501-5,LH,36
2842-3,Prolactin,1232
803-7,Toxic Gran,56
3051-0,T3 Free,8239
40969-8,S Pneu Serotype 33F (70),8
86039-5,S Pneu Serotype 2(2),8
85954-6,S Pneu Serotype 1(1),8
86169-0,S Pneu Serotype 9N (9),8
86080-9,S Pneu Serotype 3 (3),8
86107-0,S Pneu Serotype 4 (4),8
86147-6,S Pneu Serotype 8 (8),8
86045-2,S Pneu Serotype 20 (20),8
85977-7,S Pneu Serotype 12F (12),8
85991-8,S Pneu Serotype 14 (14),8
86009-8,S Pneu Serotype 17F (17),8
86024-7,S Pneu Serotype 19F (19),8
86122-9,S Pneu Serotype 11A (43),8
86052-8,S Pneu Serotype 22F (22),8
86064-3,S Pneu Serotype 23F (23),8
86098-1,S Pneu Serotype 10A (34),8
30153-1,S Pneu Serotype 9V (68),8
25296-5,S Pneu Serotype 7F (51),8
40973-0,S Pneu Serotype 15B (54),8
,S PneuSerotype 18C (56),8
40974-8,S Pneu Serotype 19A (57),8
801-1,Sickle Cell,175
6092-1,Crab IgE,2
6048-3,Blue Mussel IgE,2
,Mold Panel,2
7691-9,Scallop IgE,87
6246-3,Shrimp IgE,3
4049-3,Theoph Lvl,9
6095-4,House Dust Mites/DF,6
6096-2,House Dust Mites/DP,6
19113-0,IgE Mayo,3
6034-3,Bahia Grass IgE,5
6099-6,Dog Epith IgE,7
6833-8,Cat Epith IgE,7
6265-3,Timothy Grs IgE,5
6041-8,Bermuda Grass IgE,5
6020-2,Alt Tenuis IgE,6
6212-5,Penicillium IgE,4
6078-0,Cockroach IgE,7
6025-1,Asp Fumigat IgE,8
,Cladospori  IgE,6
6085-5,Short Ragweed IgE,5
6178-8,Mtn Cedar IgE,3
7155-5,Maple/Box Elder IgE,5
,Austrl Pine IgE,5
6189-5,Oak Tree IgE,5
6244-8,Red Sorrel IgE,3
6233-1,Rgh Pigweed IgE,5
,Blomia Trop IgE,4
6186-1,Nettle IgE,3
11256-5,H influenzae B IgG Ab,8
4552-6,HGB A2 %.,35
,Mycopl IgG Indx,11
,C3 CC,22
,HGBE Retic Count Auto,36
,HGBE Hct,36
,HGBE Hgb,36
,HGBE RBC,36
,HGBE MCV,36
2748-2,pH BF,6
2132-9,Vitamin B12 Lvl,28463
11572-5,RF,92
45142-7,SSB Ab Units,60
,ANA Scr Index,69
33569-5,SSA Ab Units,60
8099-4,Thyroid Peroxidase Ab,13
3013-0,Thyroglob (ICMA),10
8098-6,AntiThyroglb Ab,14
19075-1,Cells Counted CSF,17
,HYDROXYPROLINE (Quantitative),16
,TAURINE (Quantitative),16
,ASPARTIC ACID (Quantitative),16
,GLUTAMINE (Quantitative),16
,THREONINE (Quantitative),16
,SERINE (Quantitative),16
,ASPARAGINE (Quantitative),16
,GLUTAMIC ACID (Quantitative),16
,ALANINE (Quantitative),16
,PROLINE (Quantitative),16
,GLYCINE (Quantitative),16
,METHIONINE (Quantitative),16
,CITRULLINE (Quantitative),16
,VALINE (Quantitative),16
,CYSTINE (Quantitative),16
,ARGININE (Quantitative),16
,HISTIDINE (Quantitative),16
,ISOLEUCINE (Quantitative),16
,TYROSINE (Quantitative),16
,LEUCINE (Quantitative),16
,PHENYLALANINE (Quantitative),16
,TRYPTOPHAN (Quantitative),16
,ETHANOLAMINE (Quantitative),16
,ORNITHINE (Quantitative),16
,LYSINE (Quantitative),16
2216-0,Dopamine Lvl,112
2666-6,Norepineph Lvl,11
2230-1,Epinephrine Lvl,112
718-7,Hgb Total,109
11559-2,O2 Hgb,109
,O2 Cap,109
57800-5,O2 CT,109
35670-9,Tobra Lvl,3
53935-3,Tetanus Tox IgG Value,11
32683-5,Hgb S %,33
,A Galactomann (Serum),85
2078-4,U Chloride,10
,Food Panel,12
5380-1,Thyroglob (TG-RIA),10
27811-9,Antithromb III,65
,pH Art Pump,26
,Temp Art Pump,26
,pO2 Art Pump,26
2019-8,pCO2 Art Pump,26
,CO2 Totl Art Pump,26
,HCO3 Art Pump,26
,O2 Sat Art Pump,26
,Temp Ven Pump,14
2021-4,pCO2 Ven Pump,14
,pH Ven Pump,14
,pO2 Ven Pump,14
,HCO3 Ven Pump,14
,O2 Sat Ven Pump,14
,CO2 Totl Ven Pump,14
12190-5,Creatinine BF,17
25549-7,Urea BF,39
5385-0,TSH Receptor Ab,1
,PFA Plt Ct Assay,8
24471-5,Collagen Epi,8
4544-3,PFA HCT,8
16935-9,"HBs Ab, Quant",34
35331-8,Trileptal Level,24
33863-2,Cystatin C,17
50210-4,eGFR by Cystatin C (Mayo),1
5574-9,Aluminum,24
,C H pyl MIC Panel-Amox,4
,C H pyl MIC Panel-Metronid,5
,C H pyl MIC Panel-Tetracyc,5
11253-2,Tacrolimus Lvl,25880
5774-5,UA CA Ox Crystal,2046
2079-2,U24 Chloride,1
,TV Chloride,1
,Ur Chloride,1
,Collctn Duratn-COP,1
3167-4,Urine Vol-COP,1
,"Copper, 24 Hr, U",1
2991-8,Testoster Total (Free),10
2991-8,Free Testost,10
15432-8,% Free Testost,10
1854-9,Androstenedione,1
,ds-DNA Quant,136
2524-7,Lactic Acid Lvl,127140
14836-1,MethotrexateLvl,108
2986-8,Testoster Total,14
2141-0,ACTH,9
,UA Caudate Epi,2
3052-8,T3 Reverse.,4
6282-8,White Pine IgE,2
,Privet Tree IgE,1
,Guinea Pig Epi IgE,1
6110-1,English Plantain IgE,1
,Queen Palm IgE,1
6109-3,Elm Tree IgE,3
,Mucor racem IgE,1
6156-4,Lambs Qrtr IgE,1
4024-6,Salicylate Lvl,13613
3298-7,Acetaminoph Lvl,22
,Asp Niger IgE,1
,Bald Cypress IgE,1
,Baybry/Waxy IgE,1
1668-3,17 Hydroxyprog,5
6948-4,Lamotrigine Lvl,357
35333-4,JO 1 Ab Units,57
,SCL70 Ab Units,58
,SM Ab Index,57
27048-8,RNP Ab Units,56
,A-1-AT S,6
,TPOG Quant,65
2077-6,Sweat Cl Right,4
33514-1,Sweat Right Vol,4
10535-3,Digoxin Lvl,2100
6070-7,Chicken Fthrs IgE,1
6100-2,Duck Feathers IgE,1
6129-1,Goose Feathers IgE,1
9828-5,House Dust/Greer,1
6195-2,Orchard Grass IgE,2
,West Ragwd IgE,1
6115-0,False Ragweed IgE,1
,A Fetoprotein,21
,FMR1 (Allele 2),2
,FMR1 (Allele 1),2
7792-5,Dohle Bodies,1258
62290-2,"Vit D 1,25 Di OH",35
4542-7,Haptoglobin,4843
,Ganciclovir Lvl,2
,Parrot Fthr IgE,1
6090-5,Cottonwood IgE,1
6077-2,Cocklebur IgE,1
,Pig Epi IgE,1
6143-2,Horse Dander IgE,1
6181-2,Mouse Ur Pr IgE,2
6153-1,June Grass IgE,1
6152-3,Johnson Grass IgE,1
6192-9,Olive Tree IgE,1
,Silvr Birch IgE,1
6178-8,Cedar Tree IgE,1
6097-0,Dandelion IgE,1
2284-8,Folate Lvl,17811
,Mucosal Healing Index Score,13
30522-7,hsCRP,13
,IL 7,13
,CEACAM 1,13
,TGFa,13
,Ang 2,13
,Ang 1,13
,VCAM 1,13
,MMP 9,13
,SAA 1,13
,EMMPRIN,13
,MMP 3,13
,MMP 1,13
,MMP 2,13
10886-0,PSA Free,1
2857-1,PSA Total,1
1970-3,Bili Delta,17
,Cyclic Citr Pep,4
6273-7,Walnut IgE,2
6019-4,Almond IgE,2
6718-1,Cashew IgE,3
6276-0,Wheat IgE,10
6270-3,Tuna IgE,90
6136-6,Hazelnut IgE,3
6242-2,Sesame Seed IgE,2
6237-2,Salmon IgE,2
6206-7,Peanut IgE,112
6248-9,Soybean IgE,97
6082-2,Cod IgE,5
6174-7,Milk IgE,13
6106-9,Egg White IgE,98
6899-9,Felbamate Lvl,1
17713-9,Topiramate Lvl,73
8249-5,UA Transit Epi,2136
5817-2,UA Uric Ac Crys,2127
6219-0,Pork Meat IgE,2
,Mononuclear BF,8
30453-5,Polymorph BF,8
2333-3,Gastrin,2
30567-2,TSI,9
1547-9,Gluc Baseline,4
20438-8,Gluc 1 Hr,4
20439-6,Gluc 30 Min,4
20436-2,Gluc 2 Hr,4
19346-6,Am U Amphetamin,5
3520-4,CyclosporineLvl,7
49054-0,25-Hydroxy D2,19
1989-3,25-Hydroxy D3,19
,25-Hydroxy D Tot,19
20496-6,Gliadin IgG,1
20495-8,Gliadin IgA,1
,QC Lot Number,10
,% alpha/beta-TCR DNT,4
,alpha/beta-TCR DNT,4
56537-4,TTG IgG,7
,Mitochon Ab,1
5807-3,UA RBC Casts,2146
21582-2,Tryptase,81
8101-8,%CD3+CD8+ (T Cytotoxic/Suppressor),31
14135-8,Absolute CD3+CD8+,31
54218-3,CD4:CD8 Ratio,31
,%CD16+CD56+/CD3- (NK Cells),31
9728-7,Absolute NK Cells,31
24467-3,Absolute CD3+CD4+,31
8124-0,%CD3+ (T-Cells),31
8122-4,Absolute CD3+,31
8123-2,%CD3+CD4+ (T Helper/Inducer),31
27816-8,VWF Ag,4
3209-4,Factor VIII Activity Assay,4
38370-3,Voriconazole Lvl,212
1975-2,Bili Total Neo,1
2815-9,Porphyrins Totl,2
2466-1,IgG1,3
2465-3,Total IgG,3
2467-9,IgG2,3
2468-7,IgG3,3
2469-5,IgG4,3
94563-4,SARS CoV-2 IgG,10
94564-2,SARS CoV-2 IgM,10
2460-4,IgD,32
2915-7,Renin Activity,26
,Reg3 alpha aGVHD,4
,aGVHD Onset Alg,2
33863-2,Cystatin C.,101
4532-8,Complement Tot,4
25907-7,"Pancreatic Elastase, Feces",8
9407-8,A-1-AT Stool,9
,Pyruvic Ac mg/dL,2
,Pyruvic Ac mmol/L,2
,Biotinidase (Quantitative),3
2641-9,U Myoglobin,7
13965-9,Homocysteine Total Pl,5
27822-6,Protein S Act,4
27819-2,Protein C Act,4
,"JC Virus DNA, QN",1
14116-8,Synthe Rate CSF,1
14117-6,IgG (IgG Idx),1
1756-6,Alb (IgG Idx),1
6782-7,IgG/Alb,1
2470-3,IgG/Alb CSF,1
,IgG Idx CSF Note,1
14117-6,IgG CSF (IgG Idx),1
1756-6,Alb CSF (IgG Idx),1
1761-6,Aldolase,549
2742-5,ACE,69
14334-7,Lithium Lvl,674
32546-4,G6PD RBC Quant,2
7774-3,Whey IgE,6
6062-4,Casein IgE,6
6190-3,Oat IgE,6
6037-6,Barley IgE,4
46266-3,Myeloperoxidase Ab,3
74106-6,Proteinase 3 IgG,2
34714-6,INR iSTAT,33
5964-2,PT iSTAT,33
,Porph RBC Eval Total,1
2828-2,U Potassium,19
26881-3,Interleukin-6,21
30522-7,CRP High Sensitive,1
53819-9,TPMT Enzyme Activity,4
85991-8,Pneumo Ab Type 14,3
86107-0,Pneumo Ab Type 4,3
86147-6,Pneumo Ab Type 8,3
86166-6,Pneumo Ab Type 9 (9N),3
85977-7,Pneumo Ab Type 12 (12F),3
40913-6,Pneumo Ab Type 56 (18C),3
86021-3,Pneumo Ab Type 19 (19F),3
86061-9,Pneumo Ab Type 23 (23F),3
40905-2,Pneumo Ab Type 26 (6B),3
40911-0,Pneumo Ab Type 51 (7F),3
86080-9,Pneumo Ab Type 3,3
85952-0,Pneumo Ab Type 1,3
46267-1,Proteinase-3 Ab,4
46266-3,MPO Ab,4
26954-8,Asp fumigatus IgG,2
86130-2,S Pneu Serotype 5 (5),8
27118-9,S Pneu Serotype 6B (26),8
2862-1,Albumin SPE,4
2885-2,Tot Protein SPE,4
44429-9,A/G Ratio SPE,4
,A-2 Globulin SPE,4
,A-1 Globulin SPE,4
,G-Globulin SPE,4
,B-Globulin SPE,4
20448-7,Insulin Lvl,4112
3122-9,Child VMA,2
13760-4,Child HVA,2
3872-9,Nortriptyline Level,6
3333-2,Amitriptyline Level,6
7674-5,Rye IgE,3
4090-7,Vanco Pk,4
16137-2,Centromere Antibodies,1
2091-7,VLDL,7948
13539-2,U Phos,2
59297-2,Lacosamide Lvl,171
31209-0,ICA 512 AutoAb,3
13926-1,GAD-65,12
35669-1,"Amikacin Lvl, Random",2
44447-1,B2 GP1 IgA,3
44448-9,B2 GP1 IgG,6
16136-4,B2 GP1 IgM,6
6165-5,Lobster IgE,2
6076-4,Clam IgE,1
7558-0,Oyster IgE,1
,Beta hCG TM,7
1763-2,Aldosterone,667
,N gene Ct Value,12
,ORF1ab Ct Value,12
,S gene Ct Value,6
,aGVHD Post Alg,2
,Aspergillus Ag,5
2193-1,DHEA (Esoterix),1
33762-6,NT-proBNP,3
,Food-Nut Panel 2,1
,Food-Nut Panel 1,3
,HIT Reactivity,2
,ADAMTS13 Activity & Inhibitor,3
,Factor X Activity Assay,1
,WBC Instr BM,1
,MCH Harvest BM,1
,RBC Harvest BM,1
,WBC for Calc BM,1
,MCV Harvest BM,1
,HCT Harvest BM,1
,Lymph Auto BM,1
,RDW Harvest BM,1
,MCHC Harvest BM,1
,Neut Auto BM,1
,MPV Harvest BM,1
,Lymph Abs BM,1
,Eos Auto BM,1
11112-0,Mono Auto BM,1
,Neut Abs BM,1
,Baso Auto BM,1
,Mono Abs BM,1
34319-4,"Inhibin B, Ser",5
,Interleukin-2 Receptor,1
1690-7,5' Nucleotidase,1
,Co U Benzoylecg,1
,HHV-6 Result,1
2339-0,Glucose POCT,34
32682-7,Hgb F %,1
3616-0,Ethosux Lvl,1
13967-5,SHBG,3
3086-6,U Uric Acid,9
13227-4,Dipht Tox IgG Value,6
24108-3,Carbohydrate Ag 19-9 (CA 19-9),2
22568-0,ASO Titer,7
14207-5,"Anti-DNase B Titer, S",1
29247-4,Sirolimus Lvl,10
1795-4,Amylase BF (Mayo),1
12228-3,Trig BF,6
,Isobutyrglyc Ur,1
,Ethylmal Ac Ur,1
13748-9,Glutar Ac Ur (AG),1
,2-Methylsuc Ac Ur,1
,n-Octanoylgl Ur,1
,2-Methylbutyr Ur,1
,n-Butyrylgly Ur,1
13753-9,n-Hexanoylgly Ur,1
,Isovalerylgl Ur,1
,Tetradeca Ac Ur,1
,Suberylglyc Ur,1
,3-Phenylprop Ur,1
,Dodecaned Ac Ur,1
,trans-Cinnam Ur,1
,Hexadecan Ac Ur,1
3432-2,Carbamaz Lvl,1
,IgG CC,22
,Dialysis-Fibrinogen,5
,Dialysis-PTT,5
,Dialysis-PT,5
5814-9,UA Trip Pho Crys,2127
49700-8,Metaneph Free,1
40851-8,Normetaneph Free,1
2077-6,Sweat Cl Left,4
33514-1,Sweat Left Vol,4
,ChickenMeat IgE,3
6107-7,Egg Yolk IgE,4
,Food-Seafood Panel,3
,Max Prolif PWM %CD3,2
,Viab of Lymphs Day 0 Mito,2
,Max Prolif PWM %CD45,2
,Max Prolif PWM %CD19,2
,Max Prolif PHA %CD45,2
,Max Prolif PHA %CD3,2
55776-9,Anti-IgG,1
,Fungitell (Bronch Lavage),1
2639-3,Myoglobin,56
,Amitrip and Nortrip,3
6844-5,Honey Bee IgE,1
,Yellow Jack IgE,1
13176-3,Wasp Venom IgE,1
,Whi Hornet IgE,1
6288-5,Yellow Hornet IgE,1
,Heparin Unfrac,2
2999-1,Vitamin B1 Lvl,3
27815-0,Factor XIII Assay,4
,A Galactomann(Bal),1
,TV Phosphorus,1
,Ur Phos,1
2779-7,U24 Phosphorus,1
6080-6,Cacao/Cocoa IgE,1
6837-9,Cinnamon IgE,1
21215-9,N-Telopeptide,8
9622-2,Vitamin K1 Lvl,3
53962-7,AFP Tumor Mark,2
3665-7,Gent Tr,2
3663-2,Gent Pk,3
,"BK Qnt Ur, IU/mL",3
19124-7,U Magnesium,2
15061-5,Erythropoiet Lvl,1
3126-0,ADH Lvl,2
,TOP Platelet,133
,TOP MCHC,133
788-0,TOP RDW,133
32623-1,TOP MPV,133
,TOP Neutro Auto,133
5905-5,TOP Mono Auto,133
,TOP Lymph Auto,133
742-7,TOP Mono Absolute,133
751-8,TOP Neutro Absolute,133
731-0,TOP Lymph Absolute,133
,TOP Blasts/Abn_Lympho?,133
,TOP RBC_Agglutination?,133
789-8,TOP RBC,133
,TOP Instr WBC,133
6690-2,TOP WBC,133
,TOP MCH,133
718-7,TOP Hgb,133
4544-3,TOP Hct,133
787-2,TOP MCV,133
2324-2,TOP GGT,133
4548-4,TOP Hgb A1c,133
19123-9,TOP Magnesium Lvl,133
43396-1,TOP Non HDL Chol,133
2093-3,TOP Chol,133
2571-8,TOP Trig,133
2085-9,TOP HDL,133
,TOP Homocysteine Total Pl,133
62292-8,TOP 25 OH Vit D Tot,133
2276-4,TOP Ferritin Lvl,133
2132-9,TOP Vitamin B12 Lvl,133
2284-8,TOP Folate Lvl,133
90736-0,PNH Monocytes.,1
6829-6,Amoxicillin IgE,1
,Penicill G IgE,1
,Penicill V IgE,1
,Tot Vol Cr Clr,1
2160-0,Creat Clr Serum,3
,U Creat Clr Wt,3
,U Creat Clr BSA,3
,U12 Uncorr Creat Clear,1
,U12 Corr Creat Clear,1
,U Creat Clr Ht,3
,Hrs Coll CreaCl,3
2161-8,Ur Creat,3
6271-1,Turkey Meat IgE,1
6155-6,Lamb IgE,1
6039-2,Beef IgE,2
28648-4,pO2 Art Cord,1
28646-8,pH Art Cord,1
28644-3,pCO2 Art Cord,1
,BE Art Cord,1
28640-1,HCO3 Art Cord,1
,CO2 Totl Art Cord,1
,O2 Sat Art Cord,1
2164-2,U24 Corr Creat Clear,2
,U24 Uncorr Creat Clear,2
5335-5,"Rubella Ab, IgM",1
1903-4,Vitamin C Lvl,2
38995-7,UA Cellular Cast,2128
25419-3,Mumps IgM Index,1
6193-7,Onion IgE,2
7713-1,Squash IgE,1
13629-1,Interleukin-1 Beta,3
6230-7,Rice IgE,1
6266-1,Tomato IgE,1
6208-3,Pecan Food IgE,1
7613-3,Pistachio IgE,1
6087-1,Corn/Maize IgE,2
6050-9,Brazilnut IgE,1
7458-3,Lentil IgE,1
41479-7,BK Virus Copies/mL,4
17864-0,IONIZED CALCIUM,69592
6189-5,"T007 Oak, White",232
20634-2,"ALPHA-AMINO BUTYRIC ACID, PLASMA",30
6019-4,Almonds,94
5793-5,Granular Casts,10
6298-4,"K, PULMONARY",63360
2026-3,"CALCULATED CO2, PULMONARY",30628
20635-9,"3-METHYLHISTIDINE, PLASMA",25
20645-8,"HISTIDINE, PLASMA",30
14875-9,"PHENYLALANINE, PLASMA",15
30560-7,C18,4
29525-3,ACONITATE/CREATININE,8
2823-3,Potassium,536232
10886-0,Free PSA,1235
14957-5,"MICROALBUMIN, URINE",6508
5803-2,pH,19090
3026-2,T4 TOTAL,8900
94533-7,SARS-COV-2 (COVID-19) N GENE,1819
2161-8,URINE CREATININE,13887
2500-7,TOTAL IRON BINDING CAPACITY,44461
2283-0,RBC FOLATE M/O,216
1742-6,ALT (SGPT),823512
2501-5,UIBC,4928
3122-9,VMA 24HR URINE,15
2888-6,"Protein, Total Urine",4293
12293-7,COTININE,176
2890-2,,4004
38178-0,"LAMBDA LIGHT CHAIN, FREE, URINE",451
2093-3,CHOLESTEROL,194912
2828-2,URINE POTASSIUM,4913
2458-8,IMMUNOGLOBULIN A,2606
16136-4,B2 GLYCOPROTEIN IGM,691
3182-3,"Anticardiolipin Ab, IgM",123
3281-3,Dilute Viper Venom Time,98
2862-1,Albumin Electrophoresis,675
13945-1,RBC,15593
20496-6,GLIADIN AB IGG,290
13980-8,% ALBUMIN,1556
2986-8,TOTAL TESTOSTERONE WITH FREE,710
6968-2,PROTEINASE AB,676
8099-4,THYROID MICROSOMAL AB,1563
2991-8,FREE TESTOSTERONE,1448
28541-1,Metamyelocytes,168
13362-9,TIME,380
14196-0,Retic Ct Abs,252
1501-6,"Glucose, 1 Hour",1044
30433-7,Absolute Metamyelocytes,113
33944-0,"FREE LAMBDA, SERUM",117
30894-0,ALDO/PRA RATIO,104
11051-0,SERUM LAMBDA,86
10886-0,FREE PSA,894
15432-8,"Testosterone, Free",221
4498-2,Complement C4,924
38176-4,"KAPPA LIGHT CHAIN, FREE, URINE",453
5902-2,PROTIME,111246
2756-5,PH Urine,84
11090-8,ENA Smith (SM) Ab,1056
53774-6,log10 EBV DNA Qn PCR,5
40851-8,"Normetanephrine, Free",91
29374-6,ENA RNP Ab,966
2039-6,CARCIOEMBRYONIC ANTIGEN (CEA),243
8098-6,THYROGLOBULIN AB,486
,Absolute CD 4 Helper,559
32218-0,CCP ANTIBODY IGG,933
2160-0,"CREATININE,BLOOD",531062
2147-7,"CORTISOL, FREE, URINE",121
2701-1,OXALATE 24HR,4
14650-6,CITRATE 24HR URINE,2
2779-7,24 HR UR PHOSPHORUS,1
87409-9,"USTEKINUMAB AB, S",27
27353-2,eAG (mg/dL),267
2465-3,TOTAL IGG,1169
11038-7,BETA-GAMA TOCOPHEROL,165
5157-3,"EBV Ab VCA, IgG",62
17791-5,ENA SSB (LA) Ab,1164
31017-7,"TISSUE TRANSGLUTAMINASE$ANTIBODY, IGA",750
2731-8,PTH,2199
,SARS-COV-2 (COVID-19)-<e1>RDPP GENE,883
6924-5,GLIADIN AB IGA,317
49986-3,HERPES SIMPLEX VIRUS 1 DNA,10
33944-0,Ig Lambda Free Light Chain,89
26507-4,Bands Absolute,91
88992-3,ANTI-USTEKINUMAB ANTIBODY,26
31203-3,"5-HIAA, URINE",36
6420-4,"H. pylori, IgA Abs",17
19049-6,METANEPHRINES 24HR URINE,78
2232-7,"EPINEPHRINE, 24 HR URINE",20
48398-2,HEPATITIS B VIRUS DNA,912
3167-4,TOTAL VOLUME,569
39803-2,inFLIXimab,136
6874-2,Urine 24 hr calcium,65
7966-5,RESULT,188
32585-2,"EBV DNA, QN PCR",23
5390-0,Toxoplasma IgM,79
48642-3,EST GFR NON AFRICAN AMERICAN,461419
3209-4,Factor VIII Activity,7
18488-7,URINE CALCIUM,100
5130-0,dsDNA Ab,1121
23906-1,MPA GLUCURONIDE,33
1518-0,"Glucose, 2 Hour",118
5273-8,PARVO (B19) IGG,64
5157-3,EPSTEIN BARR VIRUS VCA ANTIBODY (IGG),171
14960-9,"Free Estradiol, Percent",5
,SARS-COV-2 (COVID-19) NSP2 GENE,1935
2890-2,"PROTEIN/CREATININE,UR",63
2232-7,EPINEPHRINE 24 HR URINE,47
20438-8,"GLUCOSE,  1 HR",258
2465-3,SERUM IGG,27
5685-3,MERCURY BLOOD,82
3969-3,"DILANTIN, FREE",25
3948-7,Phenobarbital,86
56744-6,PL-7 AB,93
19113-0,IMMUNOGLOBULIN E,825
32352-7,ALK PHOS HEAT STABLE,82
,Tetanus Antitoxoid IgG Ab,81
38180-6,"HCV RNA, QUANTITATIVE$REAL TIME PCR",23
33278-3,"AChR Blocking Abs, Serum",45
2258-2,"Estrone, LC/MS/MS",335
1521-4,"GLUCOSE, POSTPRANDIAL/$2 HOUR",26
2828-2,"POTASSIUM, RANDOM URINE",14
1975-2,TOTAL BILIRUBIN,318637
29541-0,log10 HIV-1 RNA,73
49539-0,CYTOMEGALOVIRUS IGM AB BLOOD,72
2692-2,Osmolality Meas,25
3122-9,"VMA, 24 HR URINE",10
2915-7,Renin,26
1507-3,"Glucose, 1 hour",14
12270-5,UROPORPHYRIN I,8
62361-1,Cells Counted,17
42607-2,Monomeric Prolactin (ICMA)*,3
24447-5,URINE 24 HR MG,9
90779-0,"ADALIMUMAB AB, IBD",165
53594-8,ACCA,5
86899-2,ANTI-VEDOLIZUMAB ANTIBODY,14
5677-0,LEAD 24 HR URINE,12
5583-0,ARSENIC BLOOD,89
6687-8,Citrate 24hr Urine,13
31703-2,WEST NILE IGM (CSF),14
2056-0,"CATECHOLAMINES, TOTAL",6
31209-0,IA-2 ANTIBODY,56
27353-2,Estim. Avg Glu (eAG),29
33640-4,"TETANUS TOXOID, STIMULATION INDEX",16
1695-6,"5 HIAA, 24 HOUR URINE",11
21108-6,B2 GLYCOPROTEIN IGA,649
1507-3,1 HOUR SPECIMEN,28
14251-3,"MITOCHONDRIA M2 ANTIBODY (IGG), EIA",40
20436-2,GLUCOSE 2 HOUR,1009
737-7,% LYMPHOCYTES,4
13362-9,"MICROALBUMIN, URINE",3232
27394-6,"LAMBDA LIGHT CHAIN, TOTAL RANDOM URINE",3
48642-3,eGFR,11
6007-9,PROTEIN C ACTIVITY,321
1765-7,ALDOSTERONE URINE,3
77147-7,eGFR Non-African American,44552
15174-6,"CRYOCRIT, %",23
6774-4,DESETHYLAMIODARONE,11
3050-2,T3 Uptake,4074
9410-2,"HISTAMINE, 24 HR URINE",7
27394-6,"Free Lambda Lt Chains,Ur",33
11561-8,ACETYLCHOLINE RECEPTOR$BLOCKING ANTIBODY,100
43312-8,DESMOGLEIN 3 ANTIBODY,18
3094-0,UREA NITROGEN (BUN),3020
19049-6,Metaneph 24h Ur-mRate,2
2232-7,"Epinephrine, U, 24hr",3
3122-9,"VMA, Urine, 24hr",1
5256-3,M pneumoniae IgM Abs,2
11228-4,UROPORPHYRIN I,21
20625-0,"LEAD, 24 HOUR URINE",1
48159-8,HEP C VIRUS AB,5455
29595-6,MULTIPLE OF THE MEDIAN,5
48662-1,"PHA, SI",17
33639-6,"CANDIDA ANTIGEN, STIMULATION INDEX",16
33641-2,"TUBERCULIN PPD, STIMULATION INDEX",15
81315-4,LACTASE,1
3086-6,"URIC ACID, RANDOM URINE",5
64096-1,Colonies,3
,"Protein S Ag, Free",7
27816-8,VWF 8 ANTIGEN,123
5901-4,PT,10
9738-6,FECAL FAT COLLECTION DURATION,3
1986-9,C PEPTIDE,214
13457-7,LDL Calculated,14059
48642-3,eGFR African American,21439
30446-9,Absolute Myelocytess,108
5587-1,ARSENIC URINE,29
3013-0,Thyroglobulin (ICMA),3
2161-8,"CREATININE, RANDOM$URINE",4
4498-2,"Complement C4, Serum",252
5334-8,"Rubella Antibodies, IgG",4382
20660-7,"TYROSINE, PLASMA",15
20637-5,"ARGININE, PLASMA",30
20660-7,TYROSINE,17
32227-1,"ARGININOSUCCINATE, PLASMA",5
30542-5,C18:1,2
,LABORATORY COMMENT,4969
3284-7,PTT Lupus Anticoagulant,153
27394-6,URINE LAMBDA,78
38178-0,"FREE LAMBDA,URINE",38
,DATE OF BIRTH,15
2283-0,"FOLATE, RBC",88
2666-6,NOREPINEPHRINE,21
2162-6,"Creatinine, 24 hr urine",299
3167-4,Urine Volume (Preservative),2
17719-6,Tramadol,4
1884-6,Apolipoprotein B,63
14286-9,"CARNITINE, FREE",5
33472-2,ACETYLCARTININE,13
1695-6,"5-HIAA, 24 HOUR URINE",14
13362-9,COLLECTION DURATION,1
14286-9,"Carnitine, Free",3
2889-4,"Protein 24 hr Urine, Calculated",135
2230-1,Epinephrine,5
71840-3,TOTAL HEMOGLOBIN CONCENTRATION,475
21198-7,HCG QUANTITATIVE,3219
1813-5,"ALPHA GALACTOSIDASE,S",3
32654-6,6-MMPN,16
2829-0,"POTASSIUM, 24 HOUR URINE",3
2161-8,"CREATININE, RANDOM URINE",343
50970-3,Antibody Titer 1,66
35384-7,"ESTRADIOL, ULTRASENSITIVE$LC/MS/MS",5
6035-0,BANANA (F92) IGE,2
45142-7,SJOGREN'S ANTIBODIES(SSB),65
2756-5,pH,29
2157-6,CPK,42139
1765-7,"ALDOSTERONE, URINE",3
2956-1,"SODIUM, 24 HOUR URINE",10
50378-9,RATIO (CBA/VW AG),11
25112-4,LACTIC ACID,8
2145-1,"CORTISOL, FREE, LC/MS/MS",5
15202-5,FECAL K RESULT,27
6891-6,"Testost., % Free&Weakly Bound",1
50453-0,SPECIMEN 1,2
31032-6,"Saccharomyces cerevisiae, IgA",8
2986-8,"Testosterone, total",1264
13986-5,Albumin,10
34476-2,Cortisol Stimulated,2
29536-0,WEST NILE VIRUS IGM,8
,AGE,1
20639-1,"ASPARTIC ACID, PLASMA",30
5671-3,"LEAD, BLOOD",132
30520-1,DEOXYCHOLIC ACID,5
3834-9,"N-Acetylprocainamide, serum",6
10366-3,Cotinine,2
,Free Thyroxine Index,4080
2842-3,"PROLACTIN, DILUTED",9
3969-3,"Phenytoin, Free, Serum",2
2701-1,"OXALIC ACID, 24-HR URINE",2
20657-3,"TAURINE, PLASMA",30
2436-4,HVA 24 HR URINE,2
2943-9,Lipid-Associated Sialic Acid,1
17862-4,"CALCIUM, PEDIATRIC URINE",7
53774-6,"EBV DNA Quant, PCR",27
5404-9,"Varicella-Zoster Ab, IgM",10
23830-3,BORDETELLA PERTUSSIS TOXIN(PT) AB (IGA),1
14056-6,"CARBAMAZEPINE METABOLITE, FREE",1
3113-8,"Uroporph(UP),24hr",1
2078-4,"CHLORIDE, RANDOM URINE",5
13457-7,LDL-C,9311
4485-9,"COMPLEMENT C3, SERUM",247
21422-1,"Normetanephrine, Ur",9
5232-4,INSULIN AUTOANTIBODY,74
1832-5,AFP Value,1
2161-8,Creatinine,29
30471-7,LEVETIRACETAM,315
13969-1,"Creatine Kinase (CK), MB",4
2956-1,24 Hr Urine Sodium,2
1765-7,"Aldosterone,U, Timed",1
62360-3,Cells Analyzed,17
3087-4,"URIC ACID, 24 HOUR URINE",2
15188-6,MEASURED KAPPA CHAINS,3
6939-3,IGA2,2
49432-8,"PARVOVIRUS B19 DNA,QN PCR",1
90780-8,inFLIXimab Ab,141
11046-0,,4
3124-5,"VMA/Crt, Random U",1
3872-9,NORTRIPTYLINE,10
2150-1,"CREATINE, URINE",1
87405-7,Anti-Certolizumab Ab Level,2
6766-0,"KETOSTEROIDS, 24 HR",1
6095-4,D. farinae,235
3026-2,"T4, TOTAL",2
6687-8,"Citric Acid, U, 24hr",1
4092-3,"Vancomycin Trough, Serum",1
48398-2,log10 HBV as IU/mL,1
24447-5,"MAGNESIUM, 24 HR URINE",1
29658-2,B pertussis IgM Ab,2
21036-9,17 OH CORTICOSTEROIDS 24HR URINE,1
2829-0,"Potassium, Urine",3
2407-5,Heptacarboxyl (7-CP),7
6273-7,Walnut IGE,87
13782-8,NOREPINEPHRINE,2
30551-6,C3,8
16078-8,CLASS,1
2161-8,Creatinine Urine,11036
13183-9,Elm Tree,213
,Donor Age: Egg Retrieval,2612
20661-5,"VALINE, PLASMA",30
26607-2,"CYSTATHIONINE, PLASMA",30
26604-9,"BETA-ALANINE, PLASMA",38
30534-2,C18:2,2
27378-9,"pH, 24 Hr Urine",2
20651-6,"METHIONINE, PLASMA",30
3436-3,MARIJUANA METABOLITE,15
26605-6,"BETA-AMINO ISOBUTYRIC ACID, PLASMA",30
35656-8,C18-Hydroxy,1
1842-4,"Ammonia, Urine",2
6041-8,Bermuda Grass,230
,FMF Ultrasonographer ID#,963
19124-7,Retic Ct Pct,441
26608-0,"ETHANOLAMINE, PLASMA",25
6209-1,Pecan/Hickory Tree IgE,11
20646-6,"HOMOCYSTINE, PLASMA",30
30312-3,C18:1-Hydroxy,1
,PRESSURE CONTROL,1389
13458-5,VLDL Cholesterol,10398
48643-1,EST GFR AFRICAN AMERICAN,461361
49090-4,DSR (By Age)          1 IN,442
26609-8,"GAMMA-AMINO BUTYRIC ACID, PLASMA",30
13136-7,Serotype 56 (18C),103
776-5,MPV,137370
6282-8,"T016 Pine, White",8
20659-9,"TRYPTOPHAN, PLASMA",30
2532-0,LD,39780
53471-9,"DECADIENOYLCARNITINE, C10:2",6
29522-0,5-OXOPROLINE/CREATININE,8
30238-0,C14-Hydroxy,1
26508-2,Bands,91
13046-8,% ATYPICAL LYMPOCYTES,17
2975-1,Sulfate Conc,2
7155-5,Box Elder IgE,213
,Number of Fetuses,2609
20652-4,"ORNITHINE, PLASMA",30
6281-0,T070 White Mulberry,13
41874-9,Birch,14
22670-4,"ALLOISOLEUCINE, PLASMA",5
30356-0,C16,4
2975-1,Urine Sulfate,52
20650-8,"LYSINE, PLASMA",30
29527-9,CITRATE/CREATININE,8
43243-5,C4,4
20648-2,"ISOLEUCINE, PLASMA",30
30357-8,C16:1,2
5796-8,Hyaline Casts,11220
49753-7,Norbuprenorphine,1
6178-8,Mountain Cedar Tree,213
20655-7,"PROLINE, PLASMA",30
6718-1,CASHEW NUT (F202) IGE,93
20633-4,"1-METHYLHISTIDINE, PLASMA",25
25111-6,ISOCITRATE/CREATININE,8
20649-0,"LEUCINE, PLASMA",30
30235-6,C16:1-Hydroxy,1
30234-9,C16-Hydroxy,1
13496-5,Struvite,51
,Common Ragweed,230
6034-3,Bahia Grass,213
2668-2,NOREPINEPHRINE 24HR,47
,DRVVT SCREEN,878
21194-6,URINE CHLORIDE,4866
2472-9,IMMUNOGLOBULIN M,1124
21725-7,% ALPHA-1,1555
6098-8,Dog Dander,235
6265-3,Timothy Grass,213
6233-1,Rough Pigweed  IgE,230
6186-1,Nettle,212
3167-4,VOLUME,385
2868-8,ALPHA 2,2227
48378-4,FREE KAPPA/LAMBDA RATIO,137
15189-4,KAPPA LAMBDA RATIO,154
1514-9,"Glucose, 2 Hour",312
12841-3,FREE PSA PERCENT,849
5076-5,CARDIOLIPIN AB (IGA),243
2468-7,IGG SUBTYPE 3,293
18488-7,Urine Calcium,50
24108-3,CA 19-9 RESULT,880
14044-2,"CORTISONE, 24 HR URINE",4
34660-1,Hgb A2,544
13795-0,PHOSPHATE/CREAT RATIO,1
53553-4,eAG (mmol/L),266
94642-6,SARS-COV-2 (COVID-19) S GENE,68
49989-7,HERPES SIMPLEX VIRUS 2 DNA,8
2671-6,NORMETANEPHRINE 24 HR,80
5076-5,"Anticardiolipin Ab, IgA",78
2668-2,"NOREPINEPHRINE, 24 HR UR",20
25418-5,"Mumps Abs, IgG",104
6280-2,WHITE-FACED HORNET (I2)$IGE,3
41759-2,Free Kappa/Lambda Ratio,66
,SALIVARY PROTEIN 1 (SP 1) IGM ANTIBODIES,78
1518-0,"Glucose, 2 hour",21
31209-0,IA-2 Autoantibodies,8
1971-1,"Bilirubin, Indirect",420
30083-0,EPSTEIN BARR VIRUS (EBNA)$ANTIBODY (IGG),143
2240-0,"Free Estradiol, Serum",5
1746-7,CSF ALBUMIN,76
56745-3,PL-12 AB,93
42718-7,ALK PHOS % STABLE,79
19050-4,METANEPHRINES TOTAL,87
9804-6,WEIGHT,463
2162-6,"CREATININE, URINE",251
48389-1,Percent Macroprolactin,3
43247-6,CATECHOLAMINE/CREAT RATIO,2
23920-2,0.65% NACL,2
4532-8,TOTAL COMPLEMENT,206
,Absolute CD 8 Suppressor,106
2162-6,"CREATININE, 24 HOUR URINE",120
15432-8,% Free Testosterone,6
1558-6,GLUCOSE FASTING,1317
6246-3,Shrimp,104
15049-0,CK-MM,27
5568-1,ACETONE,52
3167-4,Urine Volume,55
33559-6,"Kappa/Lambda Ratio,U",33
33194-2,Viability,39
11562-6,ACETYLCHOLINE RECEPTOR MODULATING ANTIBODY,109
3243-3,Thrombin Time,185
2161-8,CREATININE,2467
2667-4,"Norepinephrine, Rand Ur",4
21383-5,"MERCURY, 24 HOUR URINE",1
49748-7,HDL P,10
30372-7,SUCRASE,1
64092-0,Cells Analyzed,2
6014-5,Von Willebrand Factor,45
3097-3,BUN / CREAT RATIO,1524336
2778-9,FECAL FAT RESULT,4
,Serotype 4 (4),103
6081-4,COCONUT (F36) IGE,10
13463-5,"ARSENIC, RANDOM URINE",24
3051-0,FREE T3 RESULT,2844
11562-6,"AChR Modulating Abs, Serum",36
13735-6,"CATECHOLAMINES TOTAL,URINE",5
19074-4,CARNITINE ESTERS,5
3167-4,URINE VOLUME,1
40869-0,Esterified/Free,3
4546-8,Hgb A,9
2216-0,"Dopamine, Pl",5
44306-9,CITRIC ACID/CREATININE RATIO,8
2251-7,"ESTRIOL, LC/MS/MS, SERUM",5
56207-4,"CASEIN/COW MILK AGF78,IGG",9
49921-0,"CON A, CPM",27
11277-1,Squamous Epithelial Cells,10703
11579-0,TSH,53352
17792-3,ENA SSA (RO) Ab,1169
25132-2,PYRUVATE/CREATININE,8
4485-9,COMPLEMENT C3,1881
2076-8,FECAL CL RESULT,27
,"Testost., F&W Bound",1
,TIME 2,3
2243-4,ESTRADIOL M/O,723
2085-9,HDL-C,42
,"FECAL LIPIDS, 24 HR",3
20647-4,"HYDROXYPROLINE, PLASMA",30
30519-3,CHENODEOXYCHOLIC ACID,5
,GLUCOSE DRAW TIME 1 HOUR,152
3983-4,"Procainamide, total, SERUM",6
38163-2,HEPTACARBOXYPORPHYRIN,1
20437-0,GLUCOSE 3 HOUR,946
13986-5,"Albumin, U",6
13788-5,"OXALIC ACID, 24-HR URINE",2
13966-7,CYSTINE,1
2216-0,DOPAMINE,21
81258-6,MUTATION FREQUENCY,2
6042-6,BETA-LACTOGLOBULIN (F77)$IGE,6
2164-2,Creatinine Clearance,4
3432-2,"CARBAMAZEPINE, TOTAL",85
6198-6,PAPER WASP (I4) IGE,8
21383-5,"Mercury, Urine",20
9804-6,Weight,6
5821-4,WBC,15597
29253-2,"MOM, Amniotic Fluid",1
6092-1,Crab,18
51775-5,"Antichromatin IgG, Antibodies",211
24-0,AMPHOTERICIN B,2
14596-1,Amitriptyline/Nortriptyline,2
14115-0,N-telo/Creat. Ratio,2
63329-7,ANTI-RNA POLYMERASEIII (RDL),2
9321-1,Calcium/Creat.Ratio,25
19348-2,Amphetamine GC/MS Conf,2
25682-6,TOTAL KAPPA CHAINS,3
44336-6,"MAGNESIUM, 24 HOUR URINE",1
2885-2,TOTAL PROTEIN,1293896
7258-7,Milk IgE,88
27400-1,Hexacarboxyl (6-CP),7
13829-7,Copper /G Creat,1
13735-6,CALCULATED TOTAL (E+NE),1
55940-1,C3-Dicarboxylic,1
13965-9,HOMOCYSTEINE,397
6244-8,Sheep Sorrel IgE,212
26523-1,Absolute Promyelocytes,12
9309-6,"Ammonia, Urine",2
26600-7,"ALPHA-AMINO ADIPIC ACID, PLASMA",30
30237-2,C18:2-Hydroxy,1
16264-4,Calcium Oxalate,2
26613-0,"SARCOSINE, PLASMA",30
12512-0,Brushite,52
26610-6,"HYDROXYLYSINE, PLASMA",5
43396-1,Total Non-HDL-Chol (LDL+VLDL),213
16257-8,Monosodium Urate,2
14875-9,PHENYLALANINE,17
16259-4,Uric Acid,2
1759-0,A/G RATIO,117047
21264-7,uE3 MoM,434
6833-8,Cat Dander,236
20640-9,"CITRULLINE, PLASMA",30
57662-9,Anti-U1 RNP Ab (RDL),16
11050-2,Ig Kappa Free Light Chain,89
30089-7,"Trans Epithel, UA",8
2965-2,Specific Gravity,8
53471-9,C10:2,2
26524-9,Promyelocytes,14
26052-1,Renal Epithelial,87
2951-2,Sodium,535175
30934-4,B-NATRIURETIC PEPTIDE,35127
4548-4,HGB A1C,40328
2345-7,"glucose, Serum",22998
10334-1,CA-125,1247
53962-7,AFP-Tumor marker,2062
48065-7,D-DIMER TEST,15719
31017-7,t-Transglutaminase (tTG) IgG,525
38445-3,"CALPROTECTIN, STOOL",1104
12294-5,NICOTINE,176
2221-0,PANCREATIC ELASTASE-1,114
1825-9,ALPHA-1 ANTITRYPSIN,297
16935-9,Hepatitis B Surf Ab Quant,190
11253-2,TACROLIMUS (FK506),29961
14836-1,METHOTREXATE,482
6864-3,FREE HEMOGLOBIN,6943
12967-6,UREA NITROGEN URINE,895
21525-1,Urine Sodium,6614
3255-7,FIBRINOGEN LEVEL,11736
40665-2,RETIC,10508
4092-3,VANCOMYCIN TROUGH,11461
2524-7,LACTATE,8479
2465-3,IMMUNOGLOBULIN G,1440
2965-2,UR/FL SPECIFIC GRAV,1262
2695-5,URINE OSMOLALITY,3273
20470-1,ALCOHOL,6127
12190-5,FLUID CREATININE,478
45194-8,"hCG, Beta Chain, Quant, S",2165
2342-4,CSF GLUCOSE,829
2880-3,CSF TOTAL PROTEIN,1246
6873-4,B-HYDROXYBUTYRATE,2102
20578-1,VANCOMYCIN RANDOM,2500
12231-7,PROLACTIN,538
4498-2,COMPLEMENT C4,1066
1747-5,ALBUMIN FLUID,1145
2881-1,FLUID TOTAL PROTEIN,1186
4024-6,SALICYLATE,2532
3299-5,ACETAMINOPHEN,2781
14628-2,TOTAL BILE ACIDS,231
16135-6,B2 GLYCOPROTEIN IGG,692
3181-5,"Anticardiolipin Ab, IgG",123
5370-2,ANTI-STREPTOLYSIN O,10
11253-2,"TACROLIMUS, HIGHLY SENSITIVE, LC/MS/MS",336
11034-6,"ACETYLCHOLINE RECEPTOR BINDING ANTIBODY, SERUM",207
1952-1,BETA 2 MICROGLOBULIN,217
10368-9,"LEAD, CAPILLARY",17
2998-3,"VITAMIN B1, PLASMA",434
21563-2,TPMT ACTIVITY,526
57093-7,"Anti-CCP Ab, IgG + IgA (RDL)",11
6969-0,MYELOPEROXIDASE AB,676
29247-4,RAPAMUNE,1687
2963-7,GROWTH HORMONE (GH),14
,TOBRAMYCIN RANDOM,69
2639-3,MYOGLOBIN,1398
10535-3,Digoxin,525
5403-1,Varicella IgG,533
5404-9,"VZV AB IGM, EIA",86
35632-9,DILANTIN (PHENYTOIN),526
20416-4,HCV PCR QUANT,2924
1795-4,AMYLASE FLUID,909
2191-5,DHEA SULFATE M/O,317
30170-5,Cockroach,215
6096-2,D. pteronyssinus,217
6181-2,MOUSE URINE PROTEINS$(E72) IGE,216
6948-4,LAMOTRIGINE,248
2141-0,ACTH M/O,624
,THYROID STIM IMMUNOGLOBULIN,476
731-0,ABSOLUTE LYMPH COUNT,2369
14334-7,LITHIUM,396
1988-5,ANTI-SMOOTH MUSCLE AB,620
3187-2,FACTOR 9 LEVEL,70
2359-8,G-6PD LEVEL,225
2748-2,FLUID PH,330
2344-0,FLUID GLUCOSE,585
3052-8,T-3 REVERSE M/O,79
2742-5,ANGIOTENSIN ENZYME,300
1668-3,17 OH PROGESTERONE,174
2484-4,SOMATOMEDIN-C IGF-I,111
3174-0,ANTITHROMBIN III (3),351
2999-1,Vitamin B1,228
2254-1,ESTROGEN-TOTL M/O,115
2193-1,DHEA-Sulfate,177
5403-1,,192
88555-8,ASPERGILLUS AG BAL SOURCE,192
49774-3,GLOMERULAR BASEMENT MEMBRANE AB,168
4087-3,FREE VALPROIC ACID,166
40673-6,TSH RECEPTOR BINDING ANTIBODY (TRAB),33
3714-3,LIDOCAINE,379
48159-8,HCV Ab,261
36916-5,"FREE KAPPA, SERUM",119
11050-2,SERUM KAPPA,86
2742-5,ANGIOTENSIN-1-CONVERTING$ENZYME,107
2254-1,"ESTROGEN, TOTAL, SERUM",137
13964-2,METHYLMALONIC ACID,252
21365-2,LEPTIN,31
38476-8,Anti-Mullerian Hormone Assess,106
4086-5,VALPROIC ACID (DEPAKANE),929
2466-1,IGG SUBTYPE 1,293
14978-1,CYCLOSPORINE,133
2039-6,CEA TEST RESULT,858
1986-9,C PEPTIDE RESULT,221
33762-6,proBNP,11
13967-5,Sex Hormone Binding,30
1854-9,ANDROSTENDIONE RESULT,17
2986-8,"Testosterone, Total, LC/MS",91
9813-7,Cortisol - AM,170
15087-0,PTH RELATED PROTEIN,155
2638-5,MYELIN BASIC PROTEIN,185
49700-8,"Metanephrine, Free",94
25907-7,PANCREATIC ELASTASE-1,95
38445-3,"Calprotectin, Fecal",185
3013-0,THYROGLOBULIN,459
3209-4,FACTOR 8 LEVEL,109
3193-0,FACTOR 5 LEVEL,60
3198-9,FACTOR 7 LEVEL,32
8245-3,"Zinc, Whole Blood",3
12556-7,"COPPER, WB",1
13717-4,CALCIUM/CREATININE RATIO,80
25907-7,"Pancreatic Elastase, Fecal",24
5235-7,JO-1 ANTIBODY,138
,CHROMATIN RESULT,60
31562-2,SCLERODERMA AB,237
16137-2,CENTROMERE ANTIBODY,343
87408-1,USTEKINUMAB,53
35384-7,"Estradiol, Serum, MS",20
2258-2,"Estrone, Serum, MS",84
32554-8,"VIT B1, WHOLE BLOOD",79
2900-9,VITAMIN B6,502
1823-4,ALPHA-TOCOPHEROL,176
2695-5,OSMOLALITY (U),57
33951-5,Sodium/Creatinine Ratio,12
6873-4,BETA-HYDROXYBUTYRATE,38
1558-6,"Glucose, Plasma",25
2243-4,"Estradiol, Sensitive",221
35596-6,THEOPHYLLINE AMINOPHYLLINE,25
3086-6,URINE URIC ACID,55
5159-9,"EBV Ab VCA, IgM",39
30248-9,TRANSFERRIN RECEPTOR,38
20448-7,Insulin,182
51753-2,Histoplasma Gal'mannan Ag Qn S,1
17842-6,CA 27 29,78
3665-7,GENTAMICIN TROUGH,115
2464-6,CSF IGG,259
17819-4,ALBUMIN URINE ELP,215
17713-9,Topiramte,30
35741-8,"PSA, Ultrasensitive",37
5370-2,ANTISTREPTOLYSIN-O,67
43583-4,LIPOPROTEIN (a),60
50410-0,dRVVT Confirm,11
1974-5,FLUID TOTAL BILI,93
34148-7,Lyme Ab,100
35333-4,JO-1 ANTIBODY,293
41399-7,HSVI/II Comb IgM,62
32546-4,GLUCOSE-6-PHOSPHATE DEHYDROGENASE,81
2641-9,"MYOGLOBIN, URINE",5
42595-9,HEPATITIS B VIRUS DNA,923
1504-0,GDMS SCREEN,702
47255-5,PROCOLLAGEN TYPE I INTACT$N TERMINAL PROPEPTIDE,15
5633-3,"COPPER, 24 HOUR URINE",4
43171-8,INTERLEUKIN 2R,20
47318-1,LKM-1 ANTIBODY (IGG),27
74117-3,ADALIMUMAB DRUG LEVEL,216
6892-4,"T4, FREE, DIRECT DIALYSIS",86
8099-4,TPO AB ENDPOINT,17
3021-3,THYROID BIND GLOB,5
29996-6,ANTI-HISTONE AB,73
49340-3,"ADENOVIRUS DNA, QN PCR",3
5388-4,Toxoplasma  IgG,48
41171-0,"C-Telopeptide, Serum",23
5631-7,"COPPER, SERUM/PLASMA",226
6844-5,HONEY BEE (I1) IGE,8
,"SARS - COV-2 (COVID-19) AB, TOTAL SPIKE SEMI QN",8
32998-7,"TISSUE TRANSGLUTAMINASE$ANTIBODY, IGG",35
7445-0,ALPHA-LACTALBUMIN (F76)$IGE,6
25303-9,"ALPHA-1-ANTITRYPSIN, FECAL, QN",1
1434-0,CORTISOL,54
2905-8,Pyruvate,6
31024-3,VOLTAGE GATED CALCIUM CHANNEL (VGCC) AB ASSAY,26
41207-2,Wheat IgE,90
7556-4,OVALBUMIN (F232) IGE,2
3663-2,GENTAMICIN PEAK,91
2915-7,RENIN,227
2333-3,GASTRIN,67
9321-1,Calcium Creatinine Ratio,9
2482-8,Insulin AutoAb,32
4059-2,TOBRAMYCIN TROUGH,62
2641-9,URINE MYOGLOBIN,196
,"AMYLASE, URINE",2
38476-8,Anti-Mullerian Hormone (AMH),34
5159-9,EPSTEIN BARR VIRUS VCA ANTIBODY (IGM),167
3684-8,"HYDROXYCHLOROQUINE, (B)",11
45194-8,"HCG, Beta Chain, Quant, S",2
12480-0,ACE (CSF),37
4680-5,VWF ANTIGEN ACTIVITY,83
2857-1,PSA MEDICARE SCREEN,46
4484-2,C2 COMPLEMENT,19
5726-5,SELENIUM,8
21198-7,"HCG, TOTAL, QN",1
34661-9,SMOOTH MUSCLE AB TITER,73
89324-8,"INSULIN, INTACT, LC/MS/MS",1
5892-5,PROTEIN S ANTIGEN,96
6009-5,PROTEIN C ANTIGEN,133
1521-4,GLUCOSE 2 HR POSTPRANDIAL,50
20447-9,HIV-1 RNA by PCR,189
3226-8,FACTOR 11 LEVEL,18
13926-1,ANTI GAD 65 AB,100
47255-5,Propeptide Type I Collagen,4
1777-2,Tandem-R Ostase,3
38370-3,"VORICONAZOLE, HPLC",60
8087-9,GASTRIC PARIETAL CELL AB,8
3978-4,PRIMIDONE,16
56731-3,JO-1 EXTRACTABLE NUCLEAR AB,76
32220-6,LKM1 Ab,14
2692-2,OSMOLALITY (SERUM),45
6853-6,F255-IgE Plum,3
6205-9,F095-IgE Peach,3
3968-5,Dilantin (Phenytoin),19
1903-4,"VITAMIN C, LC/MS/MS",22
53828-0,"CYCLOSPORINE A TROUGH, BLOOD",50
35741-8,"PSA, HAMA",30
5124-3,CMV IgG,85
13590-5,APC RESISTANCE,24
34543-9,Total Bilirubin,11
10634-4,"C1 INHIBITOR, FUNCTIONAL",10
1504-0,"GLUCOSE, GESTATIONAL$SCREEN (50G)-140 CUTOFF",7
3002-3,THIOCYANATE,3
5671-3,"Lead, Blood",36
34148-7,LYME IGG/IGM AB,29
39804-0,LP-PLA2,5
3218-5,Factor X Activity,2
3289-6,COAG FACTOR II ACTIVITY,3
51716-9,MUSK ANTIBODY,7
25587-7,CHROMOGRANIN A,92
3319-1,AMIKACIN PEAK,47
2240-0,"ESTRADIOL, FREE",46
33949-9,POTASSIUM/CREAT RATIO,9
34439-0,"NATURAL KILLER CELLS, FUNCTIONAL",12
11011-4,Hepatitis C Quantitation,151
5644-0,Ethanol,5
8015-0,RUBELLA IGM AB,22
2608-8,METANEPHRINES,26
6082-2,Fish Cod,91
6299-2,"BUN, PULMONARY",396
8087-9,PARIETAL CELL AB,26
26881-3,INTERLEUKIN-6 QUANT SERUM,285
43231-0,HISTONE AB,32
35599-0,CARBAMAZEPINE (TEGRETOL),70
57738-7,BULLOUS PEMPHIGOID AG$(BP 180) AB,8
2171-7,VITAMIN B12 BINDING ASSAY,14
3289-6,Factor II Activity,3
1657-6,11-Deoxycortisol,1
6765-2,Pregnenolone,1
2139-4,Corticosterone,1
1656-8,"Deoxycorticosterone(DOC),Serum",2
2842-3,"Prolactin, Serum (ICMA)*",3
47321-5,gASCA,5
29620-2,Zonisamide,12
86898-4,VEDOLIZUMAB,14
5681-2,"MANGANESE, WHOLE BLOOD",3
21074-0,ARSENIC 24H URINE,3
44422-4,IL-2 RECEPTOR ALPHA,1
2142-8,"CORTISOL, LC/MS/MS, SALIVA",12
9811-1,"CHROMOGRANIN A, ECL",5
41236-1,WEST NILE VIRUS IGG (CSF),14
2589-0,"LYSOZYME,SERUM",7
21219-1,COPPER 24 HOUR URINE,21
14288-5,"CARNITINE, TOTAL",18
17838-4,"ALKALINE PHOSPHATASE,$BONE SPECIFIC",18
6075-6,Cladosporium Herbarum,239
6153-1,Blue Grass,19
2251-7,ESTRIOL,3
25587-7,Chromogranin A,21
2333-3,"Gastrin, Serum",3
3125-2,"VIP, Plasma",1
35668-3,GENTAMICIN RANDOM,27
4477-6,C1 ESTERASE INHIBITOR,29
2778-9,"PHOSPHORUS, URINE RANDOM",79
4478-4,C1Q COMPLEMENT,10
14274-5,UROPORPHYRIN,3
2963-7,HUMAN GROWTH HORMONE (HGH),34
3052-8,"Reverse T3, Serum",5
2338-2,GLUCAGON M/O,4
34694-0,VASCULAR ENDOTHELIAL$GROWTH FACTOR (VEGF),9
27365-6,"KAPPA LIGHT CHAIN, TOTAL,$RANDOM URINE",4
4690-4,VISCOSITY,15
35669-1,AMIKACIN RANDOM,82
31019-3,10-HYDROXYCARBAZEPINE,77
2589-0,"Lysozyme, Serum",5
9624-8,VMA/G CREATININE,5
5193-8,HEPATITIS B SURFACE$AB (QUANT TO ENDPOINT),3
3321-7,AMIKACIN TROUGH,47
44706-0,ACTIN (SMOOTH MUSCLE)$ANTIBODY (IGG),27
5209-2,"HSV 2 IGG, HERPESELECT$TYPE SPECIFIC AB",49
3330-8,"AMIODARONE, SERUM",1
1992-7,CALCITONIN M/O,138
2485-1,Insulin-Like Growth Factor II,1
22674-6,Soluble Transferrin Receptor,5
14118-4,"Lactate, Ven",18
6848-6,Mushroom,2
3433-0,"Carbamazepine, Free, Serum",9
2494-3,"IODINE, SERUM/PLASMA",2
2961-1,SOMATOSTATIN,12
5625-9,"COBALT, BLOOD",2
3968-5,"Phenytoin, Serum",3
5619-2,"CHROMIUM, BLOOD",1
1982-8,Biotinidase Serum,1
4477-6,"C1 Esterase Inhibitor, Serum",3
10634-4,C1 Est.Inhib.Funct.,5
2484-4,Insulin-Like GF-1,54
6033-5,AVOCADO (F96) IGE,1
6167-1,MANGO FRUIT (F91) IGE,2
6065-7,CELERY (F85) IGE,1
6158-0,LATEX (K82) IGE,15
10940-5,ALLERGEN SPECIFIC IGE$MILK (BOILED),1
42595-9,HBV as IU/mL,17
1854-9,"ANDROSTENEDIONE, LC/MS/MS",15
43311-0,DESMOGLEIN 1 ANTIBODY,18
9624-8,"VMA, Urine",1
5255-5,M pneumoniae IgG Abs,2
21074-0,"ARSENIC, 24 HOUR URINE",1
4087-3,"VALPROIC ACID, FREE",38
3125-2,VIP,2
3232-6,FACTOR XII LEVEL,11
1832-5,ALPHA-FETOPROTEIN,5
35741-8,"PSA, ICMA",63
10992-6,NORCLOZAPINE,27
3095-7,UREA NITROGEN (U) RANDOM,1
49922-8,"PHA, CPM",27
49923-6,"PWM, CPM",27
33193-4,CELL VIABILITY,27
,Plasminogen Act Inhibitor-1,1
21365-2,"Leptin, Serum",4
3089-0,URIC ACID/CREAT RATIO,5
64095-3,Cells Counted,2
14979-9,aPTT,11
3853-9,"NICOTINE, SERUM/PLASMA",2
,"HYDROXYCHLOROQUINE, WB",1
15207-4,"SODIUM, FECES",8
15202-5,"POTASSIUM, FECES",8
15158-9,"CHLORIDE, FECES",8
33007-6,ZINC PROTOPORPHYRIN (ZPP),2
2839-9,"PROGESTERONE, LC/MS/MS",5
3210-2,"FACTOR VIII, CHROMOGENIC",1
3432-2,Carbamazepine (Tegretol),17
8098-6,Anti-Thyroglobulin Antibodies*,3
30199-4,ALPHA SUBUNIT,2
23883-2,DIA Value,452
2467-9,IMMUNOGLOBULIN G,733
30331-3,C12,4
18262-6,LDL DIRECT CHOL,38510
10535-3,DIGOXIN,310
8087-9,"GASTRIC PARIETAL CELL$ANTIBODY, ELISA",21
6032-7,"T073 Pine, Australian",17
38176-4,"FREE KAPPA, URINE",38
6303-2,Dilute Viper Venom Time,96
4049-3,Theophylline,4
11034-6,ACETYLCHOLINE RECEPTOR$BINDING ANTIBODY,15
3274-8,Heparin Anti-Xa,3
22418-8,Mumps IgM,2
2230-1,EPINEPHRINE,22
3433-0,"CARBAMAZEPINE, FREE",28
5643-2,ETHYL ALCOHOL,47
1869-7,APOLIPOPROTEIN A1,32
24407-9,"ANDROSTENEDIONE, BASELINE",2
13857-8,"ANDROSTENEDIONE, 60$MINUTES",2
2886-0,"Protein, Total",18
5628-3,"COBALT, RANDOM URINE",9
44340-8,"N METHYLHISTAMINE, U",1
10535-3,"DIGOXIN, SERUM",5
9738-6,Gabapentin,9
14288-5,"Carnitine, Total",3
6695-1,"Vitamin B2, Whole Blood",4
4478-4,COMPLEMENT COMPONENT C1Q,14
27831-7,IMMUNE COMPLEX DETECTION$BY C1Q BINDING,2
3226-8,FACTOR XI ACTIVITY$CLOTTING,1
27815-0,FACTOR XIII ACTIVITY,2
2639-3,"MYOGLOBIN, SERUM",9
4479-2,C1Q Binding,1
4478-4,"Complement C1q, Quantitative",3
4484-2,Complement C2,3
27882-0,Proinsulin,3
6899-9,"FELBAMATE, SERUM",2
6091-3,COW DANDER (E4) IGE,1
6129-1,GOOSE FEATHERS (E70) IGE,1
6143-2,HORSE DANDER (E3) IGE,1
6070-7,CHICKEN FEATHERS (E85)$IGE,1
2666-6,"Norepinephrine, Pl",5
55141-6,HISTAMINE RELEASE (CHRONIC URTICARIA),7
11559-2,HB FRACTIONAL O2 SATURATION,475
5634-1,CYANIDE,7
11215-1,D-AMINOLEVULINIC ACID,1
82388-0,ANTI-HMGCR AB (RDL),3
32660-3,6-TGN,16
56143-1,POTASSIUM/CREAT RATIO,1
3494-2,CLONOPIN,1
3125-2,Vasoactive Intest Polypeptide,4
13474-2,"MAGNESIUM, RANDOM URINE",2
6039-2,Beef,1
6037-6,Barley,1
11011-4,HCV Quant Baseline,56
27941-4,CSF LDH,8
13483-3,"OXALIC ACID, RANDOM URINE",1
29207-8,AMIODARONE,9
4477-6,"C1 INHIBITOR, PROTEIN",6
33569-5,SJOGREN'S ANTIBODIES(SSA),65
6076-4,Clams,12
6165-5,Lobster,19
10839-9,Troponin I,94102
2842-3,"PROLACTIN, UNDILUTED",9
44405-9,SODIUM/CREAT RATIO,7
2143-6,"Cortisol, Serum LCMS",6
6892-4,Free T4 by Dialysis/Mass Spec,3
13728-1,DELTA AMINOLEVULINIC ACID$RANDOM URINE,2
13797-6,"PORPHOBILINOGEN, QN,$RANDOM URINE",3
13629-1,INTERLEUKIN 1 BETA,44
6025-1,Aspergillus fumigatus,220
6182-0,Mucor Racemosus,6
6212-5,Penicillium Notatum,217
6252-1,Stemphylium Botryosum,5
2251-7,"Estriol, Serum",1
50377-1,VWF: COLLAGEN BINDING,12
26881-3,"Interleukin-6, Serum",1
7272-8,Cypress,1
6278-6,White Ash Tree,1
42924-1,"LACTOFERRIN, QN, STOOL",2
14683-7,"CREATININE, RANDOM URINE",23
2143-6,"CORTISOL, TOTAL, LC/MS/MS",4
5574-9,ALUMINUM,5
43237-7,THROMBOPOIETIN (TPO),3
2722-7,Vitamin B5,2
35331-8,ESLICARBAZEPINE METABOLITE,1
,TIME 1,3
63109-3,ALLERGEN CASHEW NUT IGG,1
43240-1,"GANGLIOSIDE GM 1 ANTIBODY$(IGG), EIA",15
43241-9,GM 1 AB (IGM),15
6713-2,"Saccharomyces cerevisiae, IgG",8
15355-1,ESTRONE SULFATE,2
43215-3,Cortisol Baseline,2
34648-6,TOTAL SPECIMEN WEIGHT,3
49038-3,"VITAMIN B2 (RIBOFLAVIN),$PLASMA",4
34319-4,Inhibin B,3
29535-2,WEST NILE VIRUS IGG,8
10501-5,"LH, Pediatrics",10
5244-9,MEASLES (RUBEOLA)FLUID,1
23883-2,"Inhibin A, Ultrasensitive",1
3616-0,ETHOSUXIMIDE,1
30518-5,CHOLIC ACID,5
3016-3,"TSH, PREGNANCY",2
14975-7,"HUMAN ANTI-MOUSE AB$(HAMA), ELISA",1
3982-6,PROCAINAMIDE,10
73837-7,"GALACTOSE ALPHA 1, 3 GALACTOSE IGE",1
6219-0,"Allergen, Pork",1
3978-4,Primidone Lvl,30
19734-3,Chicken,1
5987-3,"TPA, EIA",3
3854-7,Nicotine,2
50969-5,EPSTEIN BARR VIRUS EARLY$ANTIGEN D AB (IGG),16
43292-2,% OXIDATION POSITIVE NEUTROPHILS,4
1975-2,"Bilirubin, Total, Neonatal",1
,"LIPASE, SERUM - EXTERNAL LAB RESULT",1
7850-1,CYSTICEROSIS AB,5
2880-3,"PROTEIN, TOTAL, CSF",10
2815-9,TOTAL PORPHYRINS,4
3487-6,CLOBAZAM$(URBANYL),1
61430-5,NMO IgG Autoantibodies,9
78987-5,"COPEPTIN, SERUM",6
6014-5,RISTOCETIN COFACTOR $ACTIVITY,4
14979-9,THROMBOPLASTIN TIME,9
12556-7,"COPPER, BLOOD",4
3251-6,"FDP, Plasma",1
1980-2,VITAMIN B7 (BIOTIN),2
9321-1,CALCIUM/CREATININE RATIO,7
5722-4,"Selenium, Blood",3
32552-2,"PYRUVATE KINASE, RBC",4
23831-1,BORDETELLA PERTUSSIS TOXIN(PT) AB (IGG),1
1848-1,"DIHYDROTESTOSTERONE,$LC/MS/MS",2
5761-2,"ZINC, RBC",5
40673-6,TBII (THYROTROPIN BINDING$INHIBIT IMMUNOGLOBULIN),5
3969-3,"PHENYTOIN, FREE",2
7613-3,PISTACHIO (F203) IGE,3
2755-7,FECAL PH,7
11228-4,Uroporphyrins (UP),2
6208-3,Pecan Nut,10
13469-2,"THALLIUM, RANDOM URINE",9
7963-2,"Rubeola Antibodies, IgM",2
14062-4,"Dexamethasone, Serum",2
2837-3,"Pregnenolone, MS",1
13829-7,"COPPER, RANDOM URINE",1
2880-3,"Protein, Total, CSF",2
47321-5,SACCHAROMYCES CEREVISIAE AB IGG,23
47320-7,SACCHAROMYCES CEREVISIAE AB IGA,23
11242-5,6MP,1
3198-9,Factor VII Activity,2
3232-6,Factor XII Activity,1
3226-8,Factor XI Activity,1
4505-4,COMPLEMENT C5,6
2494-3,"Iodine, Serum or Plasma",1
29997-4,Glomerular Basement Membrane Ab,7
3616-0,ETHOSUXIMIDE (ZARONTIN),1
1953-9,"Beta-2 Microglobulin, Urine",3
1869-7,Apolipoprotein A-1,2
33939-0,INTERLEUKIN 2 (IL-2) SERUM,2
6048-3,BLUE MUSSEL (F37) IGE,1
1980-2,Vitamin B7,2
1953-9,BETA 2 MICROGLOBULIN URINE,3
1764-0,"Aldosterone U,Random",1
15066-4,"FATTY ACIDS, FREE",1
13820-6,URIC ACID/CREAT RATIO,2
9622-2,Vitamin K1,2
6886-6,IGA1,2
4488-3,Complement C3a,1
9624-8,"VMA, Random Urine",1
32286-7,Hepatitis C Genotype,31
3333-2,AMITRIPTYLINE,15
7731-3,F302 Tangerine,1
6159-8,LEMON (F208) IGE,1
6131-7,GRAPEFRUIT (F209) IGE,1
20449-5,LYME AB SCREEN,5
27939-8,N-telopeptide,2
87404-0,Certolizumab DRUG Level,2
6124-2,GIANT RAGWEED (TALL) (W3)$IGE,1
8122-4,Absolute CD 3,1
21203-5,"Citric Acid, Urine",1
15212-4,"LIPASE, JP DRAINAGE",2
1797-0,"AMYLASE, PERITONEAL FLUID",1
4090-7,"Vancomycin Peak, Serum",1
12638-3,Glucose,1
20563-3,"Carbon Monoxide, Blood",1
5622-6,"Chromium, Plasma",1
5627-5,"Cobalt, Plasma",1
5723-2,"SELENIUM, RBC",3
13471-8,"CADMIUM, RANDOM URINE",9
3187-2,"FACTOR IX ACTIVITY,$CLOTTING",1
74214-8,APIXABAN,1
9363-3,B pertussis IgG Ab,3
2350-7,URINE GLUCOSE,2
16273-5,CALCIUM RBC,2
5724-0,"Selenium, S/P",1
5765-3,"ZINC, 24 HOUR URINE",1
5632-5,"Copper, Urine",1
2142-8,"Salivary Cortisol, MS",1
21410-6,MAG IgM,1
13734-9,EPINEPHRINE,2
30191-1,C2,4
4484-2,"C2, SERUM",1
2755-7,"pH, Stool",1
6073-1,Chocolate,1
33982-0,WALNUT TREE (T10) IGE,1
1518-0,GLUCOSE (POST DOSAGE),1
5632-5,"COPPER, URINE",1
3021-3,TBG,2
6195-2,ORCHARD GRASS (COCKSFOOT)$(G3) IGE,1
9407-8,"ALPHA-1-ANTITRYPSIN,$FECES",1
2837-3,"PREGNENOLONE, LC/MS/MS",2
2597-3,Magnesium RBC,1
73737-9,"PHOSPHOLIPASE A2 RECEPTOR (PLA2R) AB, ELISA",1
10449-7,"GLUCOSE, POSTPRANDIAL/$1 HOUR",1
36904-1,DIA MoM,434
2700-3,"Oxalate, Ur",2
20658-1,"THREONINE, PLASMA",30
22672-0,"Cystine, Pl",5
30565-6,C14,4
30376-8,Blasts Absolute,6
26449-9,Eosinophils Absolute,4
48803-1,OSBR Risk       1 IN,439
20636-7,"ALANINE, PLASMA",30
53279-6,WBC CAST,148
32166-1,hCG MoM,601
30566-4,C14:1,2
6218-2,F210-IgE Pineapple,1
43995-0,DSR (Second Trimester) 1 IN,434
55876-7,"HOMOCITRULLINE, PLASMA",5
30564-9,C14:2,2
2871-2,BETA,1746
19080-1,hCG Value,602
1834-1,AFP Value,279
20643-3,"GLUTAMINE, PLASMA",30
26561-1,NK CD16 and CD56 Abs,21
88739-8,TIF1-GAMMA AB,89
82425-0,MJ AB,89
20644-1,"GLYCINE, PLASMA",30
21198-7,"hCG, Serum",52
42355-8,TIGECYCLINE,12
,GLUCOSE DRAW TIME 3 HOUR,128
30349-5,C5-Dicarboxylic,1
12851-2,Interpretation(See Below),12
43729-3,"HDL, LARGE",53
12618-5,SPECIMEN 5,1
6877-5,"Coproporph(CP)I,24hr",1
31110-0,0.30% NACL,2
2028-9,CARBON DIOXIDE,68072
20405-7,Urobilinogen,6189
2874-6,GAMMA,1554
,Serotype 19 (19F),103
18267-5,NK CD16 And CD56,21
82992-9,"ANTI-SAE1 AB, IGG (RDL)",13
30358-6,C6,4
47254-8,Coproporphyrin (CP) III,1
21476-7,"Potassium, Urine",2
23883-2,Inhibin A,203
30540-9,C8,4
6878-3,"Copropor(CP)III,24hr",1
21194-6,"Chloride, Urine",2
2161-8,"Creatinine, Random U",19
30327-1,C10,4
70257-1,"Anti-SS-A 52kD Ab, IgG (RDL)",14
2250-9,uE3 Value,452
2079-2,Chloride Urine,2
30328-9,C10:1,2
6021-0,F049-IgE Apple,3
13981-6,% ALPHA-2,1555
1530-5,"Glucose, 3 Hour",312
2469-5,IGG SUBTYPE 4,293
2701-1,Urine Oxalate,50
16111-7,CALCULATED TOTAL (E+NE),20
2862-1,Albumin,58
814-4,TOTAL NUCLEATED CELL CT,34
27816-8,von Willebrand Factor Antigen,6
61151-7,SERUM ALBUMIN,27
45149-2,EJ AB,93
17782-4,LDL Size,7
20642-5,"GLUTAMIC ACID, PLASMA",30
53597-1,AMCA,5
23918-6,0.60% NACL,2
2829-0,URINE 24 HR K,7
8124-0,% CD 3 Pos. Lymph.,33
13457-7,LDL Cholesterol,4
2055-2,TOTAL CATECHOLAMINES,44
25434-2,HEPTACARBOXYPROPHYRIN,8
,eGFR,406
20624-3,"Creatinine,U",2
2609-6,"Metaneph, Total, 24H Ur",2
2668-2,"Norepinephrine,U,24h",3
24462-4,HEPTACARBOXYPORPHYRIN,3
81322-0,MALTASE,1
23860-0,"RBC, Fluid",7
,GLUCOSE DRAW TIME FASTING,153
90880-6,ARA H 6 (F447),4
40869-0,ESTERIFIED/FREE RATIO:,5
20624-3,CREATININE CONCENTRATION,2
50970-3,Antibody Titer 2,14
35534-7,"MAIZE/CORN F8, IGG",9
55940-1,"MALONYLCARNITINE, C3DC",6
50454-8,SPECIMEN 2,2
29369-6,"NAPA PA RATIO, SERUM",6
38164-0,HEXACARBOXYPORPHYRIN,1
2162-6,"CREATININE, 24-HR URINE",36
9415-1,CARBAMAZEPINE METABOLITE,2
24462-4,"Heptacab(7-CP),24hr",1
13771-1,Metaneph/Creat Ratio,2
62358-7,GTG Band Resolution Achieved,15
15187-8,MEASURED LAMBDA CHAINS,3
2079-2,URINE 24 HR CHLORIDE,1
21305-8,URINE 24 HR GLUC,1
11221-9,Pentacarboxyl (5-CP),7
5633-3,"Copper,Urine 24 Hr",1
13733-1,DOPAMINE,2
51413-3,C4,4
32731-2,BETA 2 GLOBULIN,482
13983-2,% GAMMA,1557
48407-1,PAPP-A,961
21203-5,Urine Citrate,50
,GLUCOSE DRAW  TIME HALF HOUR,34
38252-3,CALCIUM OXALATE MONOHYDRATE/TOTAL,4
14822-1,"LYMPHOCYTES, %",34
,CARBONIC ANHYDRASE VI (CA VI) IGM ANTIBODIES,78
63559-9,SIGNAL RECOGNITION PARTICLE AB,75
6208-3,F201-IgE Pecan Nut,5
43291-4,HLA-DQB1*,286
20656-5,"SERINE, PLASMA",30
31106-8,0.50% NACL,2
25494-6,PENTACARBOXYPORPHYIN,8
2218-6,"Dopamine , 24H Ur",3
9730-3,PENTACARBOXYPORPHYRIN,3
49500-2,CALCIUM OXALATE DIHYDRATE/TOTAL,3
13941-0,"Lymphocytes, Fluid",7
,GLUCOSE DRAW TIME 2 HOUR,152
33358-3,M-Spike,192
13465-0,Mercury/Creat. Ratio,2
50378-9,vWF Collagen Binding,5
7558-0,F290-IgE Oyster,6
50455-5,SPECIMEN 3,2
20638-3,"ASPARAGINE, PLASMA",30
13960-0,COPROPORPHYRIN I,9
29147-6,CARBAMAZEPINE METABOLITE,2
9527-3,"Hexacarb(6-CP),24hr",1
16268-5,Calcium phosphate,6
35546-1,"SOYBEAN F14, IGG",6
2217-8,"Dopamine, Rand Ur",4
15359-3,dRVVT/Confirm Ratio,3
9345-0,Coproporphyrin (CP) III,6
29508-9,3-HYDROXYADIPATE/CREATININE,8
12195-4,URINE CREAT CLEARNC,170
49587-9,Abnormal Protein Band 1,76
3160-9,VOLUME:,3071
88732-3,MI-2 ALPHA AB,75
31107-6,0.45% NACL,2
81622-3,HYDROXYAPATITE,4
2148-5,"Creatine, Serum",2
6740-5,YELLOW JACKET (I3) IGE,8
,CD4/8 RATIO:,74
30531-8,C5,4
6207-5,F094-IgE Pear,2
6228-1,RED TOP GRASS (G9) IGE,1
2218-6,"DOPAMINE, 24 HR URINE",20
,Maternal Age At EDD,447
2470-3,IGG/ALBUMIN RATIO,27
69557-7,OJ AB,93
6019-4,F020-IgE Almond,5
35644-4,METANEPHRINE/CREAT RATIO,2
31105-0,0.55% NACL,2
14157-2,COPROPORPHYRIN,2
9451-6,HEXACARBOXYPORPHYRIN,10
81314-7,PALATINASE,1
21383-5,"MERCURY, UR",9
33603-2,BPI IGG AUTOABS,3
50377-1,vWF Collagen Binding Act. **,3
,TIME 3,2
38161-6,PENTACARBOXYPORPHYRIN,1
29148-4,"CARBAMAZEPINE, BOUND",2
6117-6,FIRE ANT (I70) IGE,5
64093-8,GTG Band Resolution Achieved,1
16263-6,"Ca Oxalate,Dihydrate",5
9343-5,Coproporphyrin (CP) I,6
39000-5,C4-Hydroxy,1
22708-2,HOMOVANILLIC ACID,8
40583-7,"h-hCG, Serum",940
8112-5,% CD16+CD56 (NATURAL KILLER CELLS),184
2752-4,PH,395
88733-1,MI-2 BETA AB,75
2250-9,"Estriol, Unconjugated",202
31108-4,0.40% NACL,2
,% CD 8 Pos. Lymph,32
714-6,CSF EOSINOPHILS,70
21198-7,"HCG, SERUM",21
40998-7,CAHPO4 (BRUSHITE),1
38160-8,TOTAL PORPHYRINS,1
9730-3,"Pentacarb(5-CP),24hr",1
25452-4,ITRACONAZOLE,2
69573-4,C5:1,2
43208-8,h-hCG MoM,940
9728-7,ABSOLUTE NK CELLS$(CD16+CD56+CELLS),72
88725-7,MDA-5 AB,89
6288-5,YELLOW HORNET (I5) IGE,3
2815-9,"PORPHYRINS,TOTAL",8
31109-2,0.35% NACL,2
,CD4/CD8 Ratio,50
10885-2,"PORPHYRINS, TOTAL",3
6280-2,WH-FACED HORNET (I2) IGE,5
47253-0,Coproporphyrin (CP) I,1
51412-5,C5-Hydroxy,1
3094-0,UREA NITROGEN,1128017
30428-7,MCV,35728
1759-0,ALBUMIN/GLOBULIN RATIO,596633
2019-8,PCO2 ART,118959
3050-2,T3 UPTAKE RATIO,889
14627-4,BICARBONATE-VENOUS,45362
5193-8,HEPATITIS B SURFACE AB (QUANT),1466
3024-7,FREE T4,85764
69405-9,EGFR,1058321
5334-8,"RUBELLA ANTIBODIES, IGG",3140
21000-5,RDW,996419
1960-4,BICARBONATE-ARTERIAL,101273
10834-0,"GLOBULIN, TOTAL",30723
20570-8,HEMATOCRIT,702055
2703-7,PO2 ART,118964
2708-6,O2 SATURATION ARTERIAL (POC),7570
33037-3,ANION GAP (POINT OF CARE),6874
2711-0,O2 SATURATION VENOUS (POC),7951
48643-1,EGFR IF AFRICN AM,43225
51731-8,O2 SAT VEN,6341
14627-4,HCO3 VENOUS (POINT OF CARE),7951
26464-8,WBC,690090
53326-5,"SPECIFIC GRAVITY, URINE",140845
9830-1,LDL/HDL RATIO,42779
5209-2,HSV 2 IGG TYPE SPECIFIC AB,1402
2746-6,PH VEN,51679
48643-1,EGFR AFRICAN AMERICAN,107111
48642-3,GFR NON AFRICN AM,43676
2744-1,PH ART,118956
2965-2,SPEC GRAV UA,7443
2502-3,IRON SATURATION,53686
789-8,RBC.,559
11064-3,BUN POST DIALYSIS,3628
27353-2,ESTIMATED AVERAGE GLUCOSE,10269
2340-8,GLUCOSE (METER),413520
5811-5,SPEC GRAV UA,17673
27353-2,EST AVG GLUCOSE,84905
2708-6,O2 SATURATION DIRECT-ARTERIAL,101263
2888-6,"PROTEIN, TOTAL, RANDOM UR",3851
1834-1,MSAFP,1327
2711-0,O2 SATURATION DIRECT-VENOUS,45357
2500-7,TIBC,81099
1960-4,CALCULATED BICARBONATE,24045
10839-9,TROPONIN I HS,107912
17849-1,RETIC CT PCT,4351
2746-6,PH VENOUS (POINT OF CARE),7951
14957-5,MICROALBUMIN,8706
1960-4,HCO3 ARTERIAL (POINT OF CARE),7574
2823-3,BGPOTASSIUM,15198
11580-8,"TSH, 3RD GENERATION",14282
3051-0,T3 FREE,5991
34714-6,INR,55796
17849-1,"RETICULOCYTE COUNT, AUTOMATED",1044
1994-3,CALCIUM IONIZED,106458
1834-1,ALPHA FETO PROT,4648
30934-4,BNP,45277
14957-5,ALBUMIN URINE,1629
14805-6,LD,3726
6598-7,TROPONIN T,74895
2019-8,PCO2 ARTERIAL (POINT OF CARE),7577
8123-2,JAX CD4 %,1980
2862-1,ALBUMIN FRACTION,5239
2339-0,GLUCOSE-WB,32802
60474-4,ABSOLUTE RETICULOCYTE COUNT,3689
53553-4,EAG MMOL,20735
2862-1,ALBUMIN ELP,1249
20447-9,HIV-1 RNA BY PCR,2306
33762-6,NT PRO BNP,13826
20565-8,CO2,31814
23811-3,AFP MOM,1596
14196-0,RETIC CT ABS,1041
14957-5,MICROALB UR,8986
2777-1,PHOSPHORUS-BF,6528
8123-2,CD4 T CELL HELPER,1202
29541-0,LOG10 HIV-1 RNA,2277
23811-3,MSAFP MOM,507
2157-6,CK TOTAL,32741
2744-1,PH-ARTERIAL (POINT OF CARE),7581
1514-9,"GLUCOSE, 2 HOUR",1028
2703-7,PO2 ARTERIAL (POINT OF CARE),7520
42595-9,HBV AS IU/ML,1273
2339-0,GLUCOSE (METER),665244
5964-2,PROTIME,45529
54218-3,CD4/CD8 RATIO,5363
14979-9,PTT,1694
5126-8,"CMV AB, IGM CYTOMEGALOVIRUS",85
2161-8,"CREATININE, URINE",8735
2888-6,PROTEIN,129
1834-1,AFP VALUE,1371
20565-8,TOTAL CO2 (POINT OF CARE),20662
1558-6,GLUCOSE FASTING FOR TOLERANCE,1086
30313-1,HEMOGLOBIN BG,23376
1995-0,CALCIUM ION,1611
2069-3,CHLORIDE (POINT OF CARE),6878
5811-5,"SPECIFIC GRAVITY, URINE",488
740-1,METAMYLOCYTES PCT,2166
5334-8,RUBELLA IGG SCR,2462
1975-2,MAGNESIUM,1648
5964-2,PROTHROMBIN TIME,135664
731-0,ABSOLUTE LYMPHOCYTES,2731
2161-8,"CREATININE, URINE - PER VOLUME",692
33256-9,WBC PB THOU/UL,2607
24467-3,ABSOLUTE CD 4 HELPER,1724
13969-1,CK MB,16407
2524-7,LACTIC ACID PLASMA,4780
32133-1,LACTIC ACID,16862
30446-9,MYELOCYTES ABS,2011
26881-3,INTERLEUKIN 6,2132
16935-9,HEPATITIS B SURF AB QUANT,1387
1834-1,PATIENT AFP,300
6299-2,BLOOD UREA NITROGEN (POC),6931
20450-3,MOM FOR AFP,300
17864-0,CALCIUM ION,275
20570-8,HEMATOCRIT-WB,33145
16935-9,HEP B S AB,93
24467-3,JAX CD4(HELPER T CELLS),1979
1994-3,CALCIUM IONIZED (POINT OF CARE),9223
32215-6,FREE T4 INDEX (T7),3613
27948-9,HSV 1/2 IGG,1198
26498-6,MYELOCYTES,498
18262-6,LDL DIRECT,538
5206-8,"HSV 1 IGG, TYPE SPEC",739
2965-2,SPECIFIC GRAVITY,255
2532-0,"LACTATE DEHYDROGENASE, TOTAL",261
14118-4,LACTATE,77
2713-6,CALCULATED O2,9280
1514-9,GLUCOSE 2 HOUR GTT,280
32693-4,LACTIC ACID-WB,138670
2862-1,ALBUMIN ELECTROPHORESIS,1963
40665-2,RETIC COUNT- MANUAL CORRECTED,33
30522-7,CARDIO CRP,2900
53962-7,"AFP, SERUM, TUMOR MARKER",1479
9830-1,CHOL/HDL RATIO,412
26523-1,PROMYELOCYTES ABS,1482
43734-3,"APTT 1, 1 SALINE",141
33762-6,"PROBNP, N TERMINAL",819
5206-8,HSV 1 IGG TYPE SPECIFIC AB,736
6298-4,POTASSIUM (POINT OF CARE),9269
32324-6,"LD, BODY FLUID",1383
1961-2,BICARBONATE-CAPILLARY,30
2745-8,PH CAPPILLARY,38
30433-7,METAMYLOCYTES ABS,2162
5124-3,CMV IGG CSF,192
24467-3,CD4 T CELL ABS,1201
48642-3,EGFR,1446
2093-3,CHOLESTEROL TOTAL,75
52984-2,CMV IGG AVIDITY INDEX,85
38180-6,HCV LOG10,518
2951-2,BGSODIUM,15192
20570-8,HEMATOCRIT (POINT OF CARE),11460
54206-8,CMV QUANT PCR LOG COPY/ML,10546
48065-7,D DIMER QUANT,611
1558-6,GLUCOSE FASTING GTT,280
38483-4,CREATININE (POINT OF CARE),10338
8123-2,% CD 4 POS. LYMPH.,1723
26511-6,NEUTROPHILS%,118
48642-3,EGFR NON AFRICAN AMERICAN,6080
50210-4,EGFR,49
2708-6,O2 CONTENT OTHER,23
11011-4,"HCV RNA, Q-PCR",1159
17863-2,CALCIUM ION,362
2947-0,SODIUM-WB,33673
30313-1,HEMOGLOBIN-BG,121326
2162-6,CREATININE UR,24
9830-1,CHOLESTEROL/HDL RATIO,56267
2885-2,"PROTEIN, ELECTROPHORESIS",1984
2571-8,TRIGLYCERIDE-LIPID PANEL,6
11258-1,HEPATITIS B DNA QUANT,232
32215-6,FREE THYROXINE INDEX,456
2823-3,POTASSIUM (POC),53
2947-0,SODIUM (POINT OF CARE),9319
2951-2,"SODIUM, SERUM",3503
4621-9,HGB (SICKLE),195
718-7,HEMOGLOBIN (POINT OF CARE),15510
5388-4,TOXOPLASMA IGG ANTIBODY,267
11011-4,HEPATITIS C QUANTITATION,1738
1995-0,CALCIUM IONIZED,2155
3016-3,"TSH, 3RD GENERATION W/REFL TO FT4",328
2339-0,GLUCOSE (POINT OF CARE),9124
2502-3,TRANSFERRIN SATURATION,15
2283-0,RBC FOLATE,136
787-2,MEAN CELL VOLUME,72
2089-1,LDL CHOLSTEROL,59
2162-6,"CREATININE, URINE - PER 24H",615
2862-1,ALBUMIN,2853
13457-7,LDL CHOLESTEROL,27581
2336-6,"GLOBULIN, TOTAL",54
1518-0,"GLUCOSE, 2 HOUR",164
5126-8,CMV IGM,539
6298-4,POTASSIUM-WB,38265
15205-8,RHEUMATOID FACTOR,51
1834-1,"AFP, SERUM",99
13969-1,CK MB INDEX,44
11011-4,HCV RNA (INTERNATIONAL UNITS),31
71851-0,O2 SATURATION DIRECT-CAPILLARY,30
788-0,RED CELL DISTRI WIDTH,70
30180-4,NEUTROS PCT MAN,126
4548-4,A1C,832
48159-8,HCV AB,239
2708-6,O2 SATURATION DIRECT-OTHER,23
1960-4,BICARBONATE-OTHER,23
3173-2,BASELINE PTT,1949
28541-1,METAMYELOCYTES,528
11259-9,HEPATITIS C GENOTYPE,567
2162-6,CREATININE 24 HOUR UR,56
2089-1,LDL CALC,76
40678-5,TOXOPLASMA IGM,88
2638-5,MYELIN BASIC PROT CSF,120
2069-3,CHLORIDE (POC),53
2157-6,"CREATINE KINASE, TOTAL",652
2744-1,PH OTHER,23
2161-8,"CREATININE, U",237
4625-0,HGB S QUANTITAION,124
26499-4,ABSOLUTE NEUTROPHIL COUNT,75
62238-1,GFR NON AFRICN AM,933
38483-4,CREATININE (POC),54
5390-0,TOXOPLASMA IGM ANTIBODY,45
16859-1,FIBRINOGEN,35913
10368-9,LEAD,76
34581-9,POC IONIZED CALCIUM,4070
14627-4,HCO3 VENOUS ECMO (POC),2373
3218-5,FACTOR X ACTIVITY,100
2947-0,POC SODIUM,4072
2340-8,POC GLUCOSE,4072
54206-8,CMV QUANT PCR LOG IU/ML,7401
32713-0,POC POTASSIUM,4065
1960-4,HCO3 ARTERIAL ECMO (POC),2451
2708-6,O2 SATURATION ARTERIAL ECMO,2462
2744-1,PH ARTERIAL ECMO (POC),2463
32693-4,JX LACTIC ACID-WB,364
2746-6,PH VENOUS ECMO (POC),2378
48398-2,LOG10 HBV AS IU/ML,1228
71845-2,O2 SATURATION VENOUS ECMO,2378
2019-8,PCO2 ARTERIAL ECMO (POC),2463
49134-0,GLUCOSE 2 HOUR,58
2162-6,CREATININE URINE,153
2345-7,GLUCOSE (POC),98
3050-2,T3 UPTAKE,1024
1518-0,2 HOUR SPECIMEN,83
5124-3,CMV IGG,97
11572-5,RA LATEX TURBID,138
1743-4,ALT (SGPT) P5P,269
5770-3,UROBILINOGEN UA INFORM,350
1558-6,GLUCOSE FASTING FOR 2HR TOLERANCE,98
3026-2,FREE THYROXINE,25
5390-0,"TOXOPLASMA GONDII AB, IGM, QN",32
3173-2,HEP ABS PTT,317
38180-6,HIV-1 RNA PCR (LOG),908
41399-7,"HSV 1 AND/OR 2 ABS, IGM BY ELISA",121
32693-4,LACTATE - OTHER,23
1558-6,FASTING SPECIMEN,153
30341-2,SEDIMENTATION RATE,33
3217-7,F10 ACT,5
2019-8,PCO2 OTHER,23
1994-3,CALCIUM IONIZED - OTHER,23
30313-1,HEMOGLOBIN-OTHER,23
6298-4,POTASSIUM - OTHER,23
5206-8,"HSV 1 IGG, TYPE SPECIFIC AB",109
2703-7,PO2 OTHER,23
3289-6,FACTOR II ACTIVITY,9
3255-7,FIBRINOGEN ACTIVITY,4
5388-4,"TOXOPLASMA GONDII AB, IGG, QN",48
2862-1,ALBUMINS,1261
3052-8,"REVERSE T3, SERUM",73
33762-6,BNP,98
10368-9,LEAD BLOOD ADULT,32
34714-6,POCT PT W/INR,29
786-4,CHCM,7976
68453-0,LDH SYNOVIAL FLUID,2
4545-0,HCT-BF SPUN,50
5335-5,RUBELLA IGM,80
1968-7,"BILIRUBIN, CONJUGATED",4
5193-8,HEPATITIS B SURFACE AB,115
20624-3,"CREATININE, URINE",24
2947-0,SODIUM - OTHER,23
2161-8,"CREATININE, RANDOM U",92
30003-8,MICROALB 24H UR,2
2339-0,GLUCOSE-OTHER,23
20570-8,HEMATOCRIT - OTHER,23
2888-6,"TOTAL PROTEIN, URINE PER VOLUME",99
3024-7,"T4, FREE (DIRECT)",29
3051-0,FREE T3,11
30239-8,AST (SGOT) P5P,31
1834-1,AFP,5075
26524-9,PROMYELOCYTES,16
2345-7,"GLUCOSE, SERUM",31
5126-8,"CYTOMEGALOVIRUS (CMV) AB, IGM",123
26881-3,"IL-6, HIGHLY SENSITIVE",19
5902-2,PROTHROMBIN TIME,60
2161-8,"CREATININE(CRT), U",14
1558-6,SPECIMEN 1,145
2164-2,CREAT CLR (CORR.),1
53962-7,ALPHA FETO PROT,94
2089-1,LDL DIRECT,33
2019-8,"PCO ARTERIAL, NEONATAL",9
2703-7,PO2 ARTERIAL NEONATAL,9
42595-9,HBV IU/ML,7
1751-7,ALBUMIN (POC),49
14804-9,LACTATE DEHYDROGENASE TOTAL,31
62238-1,EGFR IF AFRICN AM,2878
2885-2,PROTEIN TOTAL (POC),4
2885-2,PROTEIN TOTAL,81
20564-1,O2 SATURATION DIRECT-ARTERIAL,8
11011-4,"HCV RNA PCR, QUANT",28
38180-6,"HCV RNA, Q-PCR",73
6892-4,FREE T4 BY DIALYSIS/MASS SPEC,27
4537-7,SEDIMENTATION RATE-WESTERGREN,3
2744-1,PH ART NEONATAL,9
48398-2,LOG10 HBV IU/ML,7
1558-6,"GLUCOSE, PLASMA",6
1992-7,"CALCITONIN, SERUM",8
12962-7,UREA NITROGEN-VENOUS,12
12963-5,UREA NITROGEN-PERIPHERAL,11
2160-0,POC CREATININE,674
2339-0,POC GLUCOSE,472
6301-6,POC INR,416
3016-3,TSHREI,231
5902-2,POC PROTHROMBIN TIME,412
69405-9,GFR,33
11579-0,"TSH, ULTRASENSITIVE",46
3026-2,"T4, TOTAL (THYROXINE)",37
26449-9,ABSOLUTE EOSINOPHIL,4
12961-9,UREA NITROGEN-ARTERIAL,11
5335-5,RUBELLA ANTIBODY (IGM),12
3289-6,PROTHROM ACTIVITY,3
5334-8,RUBELLA IGG QUANT,2
2502-3,%SATURATION,19
6301-6,PT INR,2
1975-2,BILIRUBIN NEONATAL,9
1798-8,TOTAL AMYLASE,5
2161-8,"(P) CREATININE, URINE",1
21482-5,"PROTEIN, URINE",1
2162-6,"CREATININE, U (PRESERVATIVE)",1
5403-1,VARICELLA-ZOSTER VIRUS IGG AB,581
13926-1,"GAD65 AB, WB",25
56540-8,GLUTAMIC ACID DECARB AB,168
5403-1,VARICELLA ZOSTER IGG,678
76651-9,ZINC T8 AUTOANTIBODY,71
56540-8,GAD-65,95
56540-8,GLUTAMIC ACID DECARBOXYLASE 65,74
8047-3,VZ IGG NUMERC,11
56718-0,IA-2 AUTOANTIBODIES,8
72523-4,"ZIC4 AB, LB",1
31209-0,IA-2 AUTOANTIBODIES,16
2889-4,"PROTEIN, URINE",1
13457-7,LDL-C (NIH CALC),3
14196-0,ABSOLUTE RETICULOCYTE CELL COUNT,21
17849-1,RETICULOCYTE CELL COUNT PERCENTAGE,21
42757-5,TROPONIN I (POINT OF CARE),14274
3026-2,THYROXINE,3
20565-8,TOTAL CO2 OTHER,59
71845-2,O2 SATURATION OTHER,55
5902-2,PT (THROMBOREL-S),3
3052-8,T3 REVERSE,58
6301-6,INR (THROMBOREL-S),3
20450-3,AFP MOM,26
1742-6,ALT (POC),38
2947-0,SODIUM,123
1783-0,ALKALINE PHOSPHATASE (POC),5
5334-8,RUBELLA AB (IGG) (REFL),5
5671-3,LEAD,27
41399-7,"HSV, IGM I/II COMBINATION",12
20570-8,HEMATOCRIT (CLIENT SUPPLIED),23
1975-2,"BILIRUBIN, TOTAL (POC)",4
6690-2,WHITE BLOOD COUNT,95
753-4,NEUTROPHILS ABSOLUTE,3
26485-3,MONOS PCT,1
2162-6,"24 HR CREATININE, URINE",1
2162-6,"CREATININE, 24-HOUR URINE",2
11580-8,TSH 3RD GENERATION,2
22496-4,RUBELLA IGG NUMERIC RESULT,1
718-7,HGB,301933
42593-4,"CALCIUM, SERUM",4
45161-7,HBV LOG10,2
42595-9,HEPATITIS B QUANTITATION,2
1988-5,C REACTIVE PROT (INFLAMMATION),4
1961-2,HCO3 CAPILLARY (POINT OF CARE),4
2162-6,"CREATININE, UR 24HR",4
20624-3,"CREATININE, U",4
2745-8,PH CAPILLARY (POINT OF CARE),4
1971-1,"BILIRUBIN, UNCONJUGATED",3
35663-4,VOLUME-ML PROTEIN URINE,2189
33863-2,CYSTATIN C,276
35663-4,"PROTEIN, TOTAL, RANDOM UR",93
3432-2,CARBAMAZEPINE LVL,529
17395-5,OXYMORPHONE CONFIRM,319
3432-2,CARBAMAZEPINE(TEGRETOL),51
3948-7,PHENOBARBITAL LVL,733
3725-9,LORAZEPAM UR QT,33
16228-9,"NORDIAZEPAM, URN, QUANT",20
31203-3,5 HIAA UR,116
35331-8,OXCARBAZEPINE,164
44288-9,"5-HIAA, URINE MG/GCR",62
20559-1,"TEMAZEPAM, URN, QUANT",20
51776-3,"7-AMINOCLONAZEPAM, URN, QUANT",20
16229-7,"CLONAZEPAM, URN, QUANT",20
3536-0,"NORBUPRENORPHINE GLUCURONIDE, URINE",31
3313-4,ALPRAZOLAM UR,73
1694-9,"5-HIAA, URINE",22
3349-8,AMPHETAMINE QUANT UR,63
49752-9,BUPRENORPHINE CONFIRM,24
3887-7,OXAZEPAM UR QT,122
11235-9,FENTANYL URINE,36
61425-5,NOROXMORHONE,28
11071-8,BUTALBITAL UR QT,47
20522-9,"CHLORDIAZEPOXIDE, URN, QUANT",20
1695-6,5 HIAA 24H UR,152
3433-0,CARBAMAZEPINE FREE,8
12382-8,TEMAZEPAM UR QT,123
16201-6,OXAZEPAM CONFIRMATION,30
3829-9,MORPHINE UR QUANT,124
3872-9,NORTRIPTYLINE LVL,16
49751-1,"NORBUPRENORPHINE, URINE",31
59615-5,"ALPRAZOLAM, URN, QUANT",20
11145-0,"5-HIAA, QN, RANDOM, UR",22
9738-6,GABAPENTIN LVL,24
34202-2,LINEZOLID CONCENTRATION,32
16229-7,CLONAZEPAM,20
11074-2,NORFENTANYL,36
3780-4,"METHAMPHETAMINE, URINE QUANT",13
49751-1,NORBUPRENORPHINE CONFIRM,25
3398-5,COCAINE URINE QUANT,112
16227-1,"DIAZEPAM, URN, QUANT",20
6896-5,CLOZAPINE AND METAB,17
15372-6,NORDIAZEPAM UR QT,110
19557-8,METHAMPHETAMINE QUANT UR,40
16998-7,HYDROMORPHONE GC/MS CONF,4
6896-5,CLOZAPINE LVL,19
59590-0,"ALPHA-HYDROXYMIDAZOLAM, URN, QUANT",20
3436-3,"11-NOR-9-CARBOXY-THC, URN, QUANT",56
3394-4,BENZOYLECGONINE UR QNT,194
16348-5,HYDROXYALPRAZ UR,82
16233-9,"MIDAZOLAM, URN, QUANT",20
49753-7,NORBUPRENORPHINE,4
3548-5,DIAZEPAM SERUM,15
3950-3,"PHENOBARBITAL, URINE QUANT",9
20559-1,TEMAZEPAM UR QT,39
17395-5,OXYMORPHONE UR QUANT,28
3537-8,NORDIAZEPAM,17
59615-5,ALPRAZOLAM GC/MS CONF,25
3506-3,CODEINE QUANT,3
19346-6,AMPHETAMINE QUANT UR,13
3644-2,FLUOXETINE LVL,8
1695-6,5-HIAA URINE 24HR,15
3335-7,AMITRIP+ NORTRIP,15
19593-3,"6-ACETYLMORPHINE, URINE",28
19695-6,"SECOBARBITAL, URINE QUANT",5
35107-2,DESMETHYLCLOBAZAM,5
3394-4,"BENZOYLECGONINE, URINE QUANT",16
3487-6,CLOBAZAM,14
3774-7,"METHADONE, URN, QUANT",4
6895-7,"BUTALBITAL, SERUM",15
3579-0,DOXEPIN LVL,6
17088-6,"LORAZEPAM, URN, QUANT",20
3457-9,CHLORDIAZEPOXIDE,15
3924-8,"PENTOBARBITAL, SERUM",15
9776-6,NORCHLORDIAZEPOXIDE,20
19570-1,"MDMA, URN, QUANT",13
58383-1,NORFENTANYL CONFIRM,9
3950-3,PHENO UR QT,21
3724-2,ATIVAN,2
20659-9,TRYPTOPHAN,28
16249-5,OXYCODONE UR QUANT,28
6896-5,CLOZAPINE N OXIDE,17
12788-6,6-ACETYLMORPHINE,3
27085-0,"MDEA, URN, QUANT",13
16201-6,"OXAZEPAM, URN, QUANT",20
16252-9,HYDROCODONE UR QUANT,28
3827-3,MORPHINE QNT,3
49751-1,NORBUPRENORPHINE URINE QUANT,21
72764-4,THC,2
3868-7,NORFLUOXETINE LVL,8
3333-2,"AMITRIPTYLINE, SERUM",8
20561-7,TRAMADOL URINE QUANT,10
16348-5,"ALPHA-HYDROXYALPRAZOLAM, URN, QUANT",20
20659-9,TRYPTOPHAN PL,5
17719-6,TRAMADOL URINE QUANT,9
3872-9,"NORTRIPTYLINE (AVENTYL), SERUM",11
3531-1,DESIPRAMINE,14
16998-7,HYDROMORPHONE CONFIRM,8
16226-3,BENZOYLECGONINE GC/MS CONF,4
3690-5,IMIPRAMINE LVL,7
17719-6,O-DESMETHYLTRAMADOL URINE QUANT,9
3926-3,"PENTOBARBITAL, URINE QUANT",9
11145-0,5 HIAA,9
3494-2,CLONAZEPAM LVL,8
50542-0,"EDDP, URN, QUANT",4
3415-7,BUPRENORPHINE,4
14313-1,CARBOXY THC GC/MS,4
3494-2,CLONAZEPAM,2
16252-9,HYDROCODONE GC/MS CONF,12
58383-1,NORFENTANYL,4
3491-8,CLOMIPRAMINE,1
72764-4,MARIJUANA (THC) CONF,2
8170-3,11 NOR CARBOXY THC,11
3669-9,"HALOPERIDOL (HALDOL), SERUM",5
16252-9,HYDRCODONE,3
3690-5,IMIPRAMINE,7
3491-8,CLOMIPRAMINE LVL,5
14697-7,DIAZEPAM,2
60467-8,OXYMORPHONE QNT,3
18355-8,"MDA, URN, QUANT",13
20561-7,TRAMADOL GC/MS CONF,5
9627-1,TOTAL (IMI+ DES),2
3493-4,TOTAL (CLO+ NORCLO),1
27059-5,"TRAZODONE LEVEL, ANTIDEPR PANEL",5
72752-9,MORPHINE CONFIRM,1
16250-3,CODEINE CONFIRM,3
3493-4,TOTAL (CLO+ DES),1
58381-5,FENTANYL CONFIRM,9
16201-6,NORDIAZEPAM,3
17395-5,OXYMORPHONE,1
19490-2,ALPRAZOLAM,1
58381-5,FENTANYL URINE QUANT,4
6896-5,CLOZAPINE,6
3862-0,NORDOXEPIN LVL,1
25139-7,TRYPTOPHAN/CREAT URINE,1
16251-1,MORPHINE CONFIRM,3
16150-5,DELTA 9 THC CARBOXY ACID,4
72737-0,"COCAINE CONFIRM, OF",1
72454-2,BUTALBITAL UR QT,2
3893-5,OXYCODONE QNT,3
3886-9,OXAZEPAM,1
16233-9,MIDAZOLAM UR QT,2
11246-6,OXYCODONE UR QUANT,1
9383-1,"9-OH-RISPERIDONE, SERUM",1
58429-2,EDDP,1
9627-1,COMBINED TOTAL,2
3536-0,"NORCLOMIPRAMINE, S",5
17088-6,LORAZEPAM CONFIRMATION,3
19588-3,MIDAZOLAM UR QT,17
6895-7,BUTALBITAL,7
9394-8,TOTAL (RISP+9-OH),1
3582-4,DOXEPIN+ NORDOXEPIN LVL,1
72763-6,6-ACETYLMORPHINE CONFIRM,1
3772-1,"METHADONE (DOLOPHINE), SERUM",3
3436-3,CARBOXY THC GC/MS,1
49752-9,BUPRENORPHINE URINE QUANT,4
3809-1,"METHYLPHENIDATE, URINE",1
57301-4,BENZOYLECGONINE CONFIRM,1
9393-0,RISPERIDONE,1
16249-5,OXYCODONE (GC/MS),2
72758-6,AMPHETAMINE,1
3335-7,TOTAL (AMI+ NOR),1
743-5,MONOCYTES(ABSOLUTE),2
712-0,EOS (ABSOLUTE VALUE),1
705-4,BASO(ABSOLUTE),1
732-8,LYMPHS(ABSOLUTE),1
2888-6,"PROTEIN,TOTAL,URINE",1
61152-5,ALBUMIN,1
33914-3,EGFR,19704
1751-7,"ALBUMIN, SERUM",41
26485-3,MONO%,1
5209-2,"HSV 2 IGG, TYPE SPEC",22
26450-7,EOS%,1
5209-2,HSV TYPE II ABS IGG,42
30180-4,BASO%,1
26515-7,PLT COUNT LB,1
777-3,"PLT COUNT, CITRATED BLD",3
11064-3,BUN PD RESULTED,3
26515-7,PLATELETS,3
3016-3,TSH-ICMA,2
11572-5,"RHEUMATOID FACTOR (RF), IGM",4
2028-9,CARBON DIOXIDE-PLASMA,1
48643-1,GFR MDRD AF AMER,647866
3094-0,BLOOD UREA NITROGEN,678096
2026-3,CO2 CONTENT,651275
6768-6,ALKALINE PHOSPHATASE  S,563211
48642-3,GFR MDRD NON AF AMER,649093
777-3,PLATELETS,655999
17861-6,CALCIUM  SERUM,745797
41653-7,POC GLU MONITORING DEVICE,488269
3026-2,THYROXINE (T4),8086
2862-1,SERUM ALBUMIN FRACTION,11986
17856-6,HEMOGLOBIN A1C,57591
2160-0,CREATININE  SERUM,91714
43396-1,NON HDL CHOLESTEROL,26900
3094-0,UREA NITROGEN(BUN),65216
2885-2,PROTEIN  TOTAL,63039
2500-7,IRON BINDING CAPACITY,9249
2093-3,CHOLESTEROL  TOTAL,37614
48643-1,EGFRAAFRICAN AMERICAN,90888
777-3,PLATELET  CITRATED BLOOD,551
1994-3,CALCIUM IONIZED (I-STAT),9157
2336-6,GLOBULIN  TOTAL,22813
2823-3,POTASSIUM (I-STAT),8411
48642-3,EGFR (NON AFRICAN-AMERICAN),25825
33762-6,NTPROBNP,18362
2885-2,PROTEIN  TOTAL  SERUM,36510
2502-3,IRON % SATURATION,22527
2524-7,LACTIC ACID,40817
2502-3,% SATURATION,9157
1975-2,BILIRUBIN  TOTAL,61355
4544-3,BLOOD GAS HEMATOCRIT,24958
8123-2,% CD4,3280
41399-7,HSVI/II COMB AB IGM,35
13457-7,LDL CHOLESTEROL CALCULATED,6625
2498-4,IRON  TOTAL,9546
17864-0,CALCIUM  IONIZED  SERUM,6694
4544-3,HEMATOCRIT (I-STAT),8184
2888-6,PROTEIN TOTAL URINE,7260
4537-7,SED RATE BY MODIFIED WESTERGREN,6646
5124-3,CYTOMEGALOVIRUS ANTIBODY (IGG),157
2324-2,GAMMA GLUTAMYL TRANSFERASE,395
11580-8,THYROID STIMULATING HORMONE,7507
30313-1,HEMOGLOBIN  ARTERIAL,25972
27353-2,ESTIM. AVG GLU (EAG),2079
2324-2,GGTP,3411
11572-5,RA LATEX TURBID.,748
2085-9,HIGH DENSITY CHOLESTEROL,10078
5124-3,CYTOMEGALOVIRUS (CMV) AB  IGG,257
718-7,HEMOGLOBIN (I-STAT),8181
13457-7,LDL CHOL CALC (NIH),3430
5193-8,HEPATITIS B SURFACE AB (QUANT TO ENDPOINT),51
5334-8,RUBELLA ANTIBODY (IGG),1203
24467-3,ABSOLUTE CD4+ CELLS,1952
2951-2,SODIUM (I-STAT),6813
24467-3,ABSOLUTE CD4 COUNT,3270
54218-3,HELPER/SUPPRESSOR RATIO,1613
2889-4,PROTEIN  TOTAL  24 HR UR,226
718-7,TOTAL HGB,2106
1754-1,MICROALBUM. U RANDOM,2002
3024-7,T4  FREE,7801
3026-2,T4 (THYROXINE)  TOTAL,1448
1754-1,MICROALBUMIN,3665
8123-2,% CD4 (HELPER CELLS),1963
2777-1,PHOSPHATE (AS PHOSPHORUS),2731
5388-4,TOXOPLASMA GONDII AB IGG QN,161
4548-4,HEMOGLOBIN A1C  POC,3014
6301-6,INR POC,6756
5193-8,HEPATITIS B SURFACE ANTIBODY (QUANT),3366
1834-1,AFP  SERUM,426
3053-6,T3  TOTAL,1730
2888-6,PROTEIN  TOTAL  RANDOM UR,1772
5209-2,HSV 2 IGG  TYPE SPEC,1325
5334-8,RUBELLA ANTIBODIES  IGG,677
33762-6,PROBNP,340
10834-0,GLOBULIN  TOTAL,889
25514-1,RUBELLA IGG SCREEN,457
5206-8,HSV 1 IGG  TYPE SPEC,1285
5126-8,CYTOMEGALOVIRUS (CMV) AB  IGM,204
30522-7,CARDIO CRP(R),594
5209-2,HSV 2 IGG  HERPESELECT TYPE SPECIFIC AB,135
5390-0,TOXOPLASMA GONDII AB IGM QN,97
16935-9,HEPATITIS B SURFACE AB QUANT.,356
5671-3,LEAD  BLOOD,136
1992-7,CALCITONIN  SERUM,210
3051-0,TRIIODOTHYRONINE FREE SERUM,372
30522-7,C-REACTIVE PROTEIN  CARDIAC,880
2283-0,FOLATE  RBC,438
3051-0,T3  FREE,1017
2638-5,MYELIN BASIC PROTEIN  CSF,88
40678-5,TOXOPLASMA IGM ANTIBODY,94
2823-3,POTASSIUM  HEPARIN PLASMA,66
3255-7,FIBRINOGEN ACTIVITY  CLAUSS,185
3256-5,FIBRINOGEN ANTIGEN,315
4625-0,HEMOGLOBIN S,183
11011-4,HCV RNA  QUANTITATIVE REAL TIME PCR,493
20447-9,HIV-1 RNA BY PCR  QN,8
3052-8,REVERSE T3  LC/MS/MS,61
1558-6,GLUCOSE  FASTING (P),255
24467-3,ABSOLUTE CD4,11
38180-6,HCV RNA  QUANTITATIVE REAL TIME PCR,487
1558-6,GLUCOSE  PLASMA,82
1834-1,MS ALPHA-FETOPROTEIN,30
9830-1,CHOL/HDL C,17
14118-4,LACTIC ACID  PLASMA,33
6892-4,T4  FREE DIRECT DIALYSIS,52
5206-8,HSV 1 IGG  HERPESELECT TYPE SPECIFIC AB,48
31178-7,TOXOPLASMA IGM CSF,37
30038-4,TOXOPLASMA IGG CSF,13
3026-2,T4  TOTAL,22
6892-4,T4  FREE  DIRECT DIALYSIS,14
30003-8,MICROALBUMIN 24 HOUR URINE,21
718-7,HGB  POC,42
1558-6,GLUCOSE  FASTING,6
2965-2,SPECIFIC GRAVITY  URINE,2
5335-5,RUBELLA ANTIBODIES  IGM,2
2089-1,LDL CHOLESTEROL,19
14118-4,LACTATE BLOOD VENOUS,6
26464-8,WBC  POC,14
1751-7,ALBUMIN  SERUM,24
23811-3,MSAFP-MOM,30
27353-2,MEAN PLASMA GLUCOSE,6
11011-4,HCV QUANTITATIVE BASELINE,12
4544-3,HCT  POC,14
777-3,PLATELET COUNT  POC,14
54206-8,LOG10 CMV QN DNA PL,81
1558-6,GLUCOSE  FASTING NDDG CUTOFF,2
1751-7,ALBUMIN SERUM,22
786-4,MEAN CORPUSCULAR HEMOGLOBIN CONC,96527
,AO ROOT DIAM,3227
2019-8,PCO2 ARTERIAL,9894
18182-6,OSMOLALITY CALCULATION,97263
785-6,MEAN CORPUSCULAR HEMOGLOBIN,96388
,BLOOD GAS HEMATOCRIT  MIXED VENOUS,795
2703-7,PO2 ARTERIAL,9921
11277-1,SQUAMOUS EPITHELIAL,4929
787-2,MEAN CORPUSCULAR VOLUME,96712
1960-4,HCO3 ARTERIAL,9816
,PT MIX WITH 50% NORMAL PLASMA,278
,PROCALCITONIN,4195
,ABGCA,2307
5643-2,ALCOHOL SCREEN SERUM,307
,BAND NEUTROPHIL %,2028
,UNIT ISBT ABO/RH TYPE,10954
26524-9,PROMYELOCYTES RELATIVE PERCENT,454
11557-6,PCO2 (I-STAT),2900
,PO2  VENOUS,543
,CRIT VALUE NOTIFIED TIME  ARTERIAL,3118
6075-6,ALLERGEN  CLADOSPORIUM HERBARUM (M2) IGE,30
,LVIDS 2D,3587
13969-1,CPK MB ISOENZYME,5923
,DEVICE  ARTERIAL,14958
,T UPTAKE  TBI (CALC),268
2357-2,G-6-PD  QUANT,227
,LVIDD 2D,3676
,MV E-WAVE VEL/E'TISSUE VEL AVERAGE,2350
,LVPWD 2D,3457
,UNIT EXPIRATION DATE,13425
2828-2,POTASSIUM URINE,1385
751-8,ABSOLUTE NEUTROPHILS,1124
,IVSD 2D,3433
,LVEF 2D,3821
35179-1,TOTAL W6,54
,AVS CORTISOL TOTAL,42
,ABGNA,2410
14979-9,PTT MIX WITH 50% NORMAL PLASMA,33
,TEMPERATURE  MIXED VENOUS,688
2132-9,VITAMIN B-12,1782
,ABGCL,2011
35411-8,TRIENE TETRAENE RATIO,55
1942-2,LACTASE,269
26498-6,%MYELOCYTE,1962
5130-0,ANTI-DNA (DS) AB QN,228
,EAG (MG/DL),2599
2744-1,PH,11528
11556-8,PO2 (I-STAT),2911
1959-6,HCO3 (I-STAT),2851
54438-7,CHOLESTEROL,1648
,FLOW,2198
15359-3,DRVV (LAC) RATIO,55
2881-1,PROTEIN FLUID,624
,FIO2  MIXED VENOUS,748
35383-9,ASPERGILLUS GALACTOMANNAN EIA,255
2714-4,O2HB,9658
,LAD 2D,3206
,PH  VENOUS,541
27416-7,SCLERODERMA (SCL-70) AB,193
20578-1,VANCOMYCIN  RANDOM,1197
,OXYHEMOGLOBIN  MIXED VENOUS,835
30166-3,THYROID STIM IMMUNOGLOBULIN,17
35162-7,PALMITOLEIC ACID  C16:1W7,55
,TEMPERATURE  VENOUS,452
2078-4,CHLORIDE URINE,1326
5796-8,HYALINE CASTS,1627
2744-1,POC PH (I-STAT),2889
,ADENOSINE DEAMINASE  PLEURAL,36
20405-7,UROBILINOGEN SEMIQUANT UR,73
19157-7,TUBE NUMBER CSF,397
26513-2,NEUTROPHIL  FLUID,780
6041-8,G002-IGE BERMUDA GRASS,19
28541-1,METAMYELOCYTES PERCENT,1493
2157-6,CREATINE KINASE TOTAL,23
,PCO2  MIXED VENOUS,816
,BLOOD GAS HEMATOCRIT  VENOUS,529
2955-3,SODIUM URINE,1945
4532-8,COMPLEMENT  TOTAL (CH50),71
2141-0,ACTH  PLASMA,145
742-7,ABSOLUTE MONOCYTES,1123
5811-5,SPECIFIC GRAVITY,418
,ABGK,2429
,PRESSURE SUPPORT  MIXED VENOUS,41
,FUNGITELL (BAL),178
2342-4,GLUCOSE CSF,401
,A*-2 EQUIVALENT  HLA NGS BM,11
6189-5,ALLERGEN  OAK (T7) IGE,30
1989-3,VITAMIN D  25-HYDROXY,286
,DEVICE ID  MIXED VENOUS,764
1649-3,VITAMIN D 1 25-DIHYDROXY,561
,INTERVAL,200
2161-8,URINE CREATININE CONC.RANDOM,1994
,PF4 SCREENING OD VALUE,146
6075-6,M002-IGE CLADOSPORIUM HERBARUM,20
1989-3,VITAMIN D 25-HYDROXY,907
,VWF COLLAGEN BINDING ACT,8
2778-9,PHOSPHORUS  URINE,17
6303-2,DILUTE RUSSELL VIPER VENOM TIME,43
14251-3,MITOCHONDRIAL (M2) ANTIBODY,92
3320-9,AMIKACIN RANDOM,43
,HEMOGLOBIN  MIXED VENOUS,821
,PO2  MIXED VENOUS,834
2344-0,GLUCOSE FLUID,572
26446-5,BLASTS,759
1989-3,VITAMIN D  25-OH  TOTAL,308
11031-2,LYMPHOCYTES (BF),802
86951-1,LP-PLA2 ACTIVITY,3
35167-6,VACCENIC ACID  C18:1W7,55
,C*-1  BM SSOP,11
,FIO2  VENOUS,473
,MONONUCLEAR (BF),579
14959-1,MICROALBUMIN/CREATININE RATIO,189
2695-5,OSMOLALITY URINE,1219
8247-9,MUCUS,315
8101-8,% CD8 (SUPPRESSOR T-CELLS),120
5255-5,M PNEUMONIAE IGG ABS,135
12228-3,TRIGLYCERIDES FLUID,492
735-1,ATYPICAL LYMPHS,2138
,PCO2  VENOUS,542
14168-9,PALATINASE,270
2161-8,CREATININE  URINE,30
14979-9,PARTIAL THROMBOPLASTIN TIME  ACTIVATED,67
3184-9,POC ACT. CLOTTING TIME LR,504
29374-6,RNP ANTIBODY,491
14135-8,ABSOLUTE CD8 COUNT,160
32731-2,SERUM BETA-2 GLOB. FRACTION,188
3086-6,URIC ACID URINE,50
9728-7,ABSOLUTE NK CELLS (CD16+CD56+CELLS),112
8122-4,ABSOLUTE CD3 COUNT,159
,HCO3  VENOUS,541
1823-4,VITAMIN E(ALPHA TOCOPHEROL),172
6181-2,MOUSE URINE PROTEINS (E72) IGE,35
,RATE  MIXED VENOUS,311
5076-5,ANTICARDIOLIPIN AB IGA QN,17
46266-3,MYELOPEROXIDASE MPO AUTOABS,102
,ASPERGILLUS AG  BAL/SERUM,956
,B*-1 EQUIVALENT  BM SSOP,11
17842-6,CA 27.29,42
1989-3,25-HYDROXY  VITAMIN D-3,84
14135-8,CD8 T CELL ABSOLUTE,16
33944-0,FREE LAMBDA,131
,NIL,32
62292-8,25-HYDROXY  VITAMIN D,84
32730-4,SERUM BETA-1 GLOB. FRACTION,188
33914-3,EGFRNAAN AFR. AMERICAN,1238
6178-8,ALLERGEN  MOUNTAIN CEDAR (T6) IGE,29
,HCO3  MIXED VENOUS,815
,FLOW  MIXED VENOUS,278
3095-7,UREA NITROGEN URINE,605
29247-4,SIROLIMUS LEVEL BLOOD,141
,UREA NITROGEN 24 HOUR VOLUME,100
,PRODUCT PLATELET CELL COUNT,8
35160-1,DOCOSENOIC ACID  C22:1,55
6025-1,M003-IGE ASPERGILLUS FUMIGATUS,25
53317-4,WBC CLUMPS,708
2143-6,CORTISOL  PLASMA,588
41760-0,INTERLEUKIN 12,42
,FUNGITELL,522
,NICOTINAMIDE,124
13458-5,VLDL CALCULATED,1657
4086-5,VALPROIC ACID LEVEL,170
,PH  MIXED VENOUS,814
,PNEUMO AB TYPE 19 (19F)*,14
62254-8,VLDL SIZE,9
5763-8,ZINC  PLASMA OR SERUM,198
2529-6,LACTATE DEHYDROGENASE FLUID,163
15432-8,TESTOST.  F&W BOUND,6
3182-3,ANTICARDIOLIPIN AB IGM QN,65
2731-8,PTH  INTACT,656
14979-9,PTT 2HR INC @ 37,33
,T UPTAKE,268
2467-9,IGG  SUBCLASS 2,35
88994-9,ARACHIDONIC ACID,3
15212-4,LIPASE (BF),432
3184-9,POC ACT. CLOTTING TIME PLUS,782
12190-5,CREATININE FLUID,88
6085-5,ALLERGEN  COMMON RAGWEED (SHORT)(W1) IGE,30
5820-6,WBC CASTS,3
17792-3,SJOGREN'S ANTIBODY (SS A),254
3181-5,ANTICARDIOLIPIN AB IGG QN,65
32554-8,VITAMIN B1  WHOLE BLOOD,302
17791-5,SJOGREN'S ANTIBODY (SS B),248
4551-8,HGB A2,22
,INTRAOPERATIVE PTH,19
2748-2,PH  BODY FLUID,472
11277-1,SQUAMOUS EPITHELIAL CELLS,370
1974-5,BILIRUBIN FLUID,38
3968-5,PHENYTOIN LEVEL,27
2161-8,CREATININE  RANDOM URINE,66
6273-7,ALLERGEN  WALNUT (F256) IGE,4
2986-8,TESTOSTERONE  TOTAL  LC/MS/MS,66
35168-4,ARACHIDONIC ACID  C20:4W6,55
35741-8,PSA  ULTRASENSITIVE,216
2482-8,INSULIN AUTOANTIBODY,18
26487-9,MONOCYTE  FLUID,93
19080-1,BETA-HCG,211
5404-9,VARICELLA-ZOSTER AB  IGM,11
17862-4,CALCIUM URINE,24
34661-9,ACTIN (SMOOTH MUSCLE) ANTIBODY,76
6186-1,ALLERGEN  NETTLE (W20) IGE,29
,INTRINSIC FACTOR ABS  SERUM,9
13941-0,LYMPHOCYTES  %,101
3074-2,TUMOR NECROSIS FACTOR ALPHA,47
6948-4,LAMOTRIGINE  SERUM,59
2464-6,IGG  CSF,4
20402-4,ABSOLUTE CD56 COUNT,128
742-7,MONOCYTES ABSOLUTE COUNT,206
10328-3,LYMPHOCYTES CSF (MANUAL),146
8124-0,% CD3,159
10886-0,PROSTATE SPECIFIC ANTIGEN FREE,65
2157-6,CREATINE KINASE  TOTAL,47
32998-7,TISSUE TRANSGLUTAMINASE AB  IGG,2
9622-2,VITAMIN K1,41
,MDA-5 AB,18
,HEMOGLOBIN  VENOUS,539
35172-6,MEAD ACID  C20:3W9,55
5681-2,MANGANESE  BLOOD,83
14135-8,ABSOLUTE CD8+ CELLS,121
35161-9,PALMITIC ACID  C16:0,55
2484-4,INSULIN-LIKE GROWTH FACTOR I,30
6085-5,W001-IGE RAGWEED  SHORT,20
1752-5,ALBUMIN,292
6695-1,VITAMIN B2  WHOLE BLOOD,153
2191-5,DHEA SULFATE,11
5631-7,COPPER  SERUM,194
39572-3,WEST NILE VIRUS IGG  CSF,55
,DEVICE ID  VENOUS,495
29239-1,FREE T3,304
2708-6,O2 SATURATION ARTERIAL,105
3167-4,PROTEIN 24 HOUR VOLUME,16
32220-6,LIVER-KIDNEY MICROSOMAL AB,76
20453-7,EPITHELIAL CELLS,701
8124-0,% CD3 (MATURE T CELLS),113
1763-2,AVS ALDOSTERONE,91
8101-8,% CD8,159
2865-4,ALPHA-1-GLOBULINS,17
30471-7,LEVETIRACETAM  S,82
4024-6,SALICYLATES,77
58786-5,HSV 1 IGG INDEX:,61
,PAN-ASPERGILLUS (BL),186
,SILICA CLOTTING TEST RATIO,54
,LVEF (MOD BI),338
3274-8,HEPARIN ANTI-XA,13
30083-0,EBV NUCLEAR ANTIGEN AB  IGG,59
1825-9,ALPHA-1-ANTITRYPSIN  SERUM,69
,CRIT VALUE NOTIFIED TIME  MIXED VENOUS,53
,OXYHEMOGLOBIN  VENOUS,543
38494-1,METANEPHRINE  PL,24
20453-7,EPITHELIAL CELLS (NON RENAL),67
24007-7,EBV EARLY ANTIGEN AB  IGG,36
35176-7,TOTAL MONOUNSATURATED ACID,54
,PROBNP  N TERMINAL,71
2868-8,ALPHA-2-GLOBULINS,17
53294-5,RENAL EPITHELIAL,86
,TOTAL VOLUME,98
,THERAPY,106
1815-0,MALTASE,269
,CRIT VALUE NOTIFIED TIME  VENOUS,117
2865-4,SERUM ALPHA 1 GLOB. FRACTION,171
6109-3,T008-IGE ELM  AMERICAN,19
2956-1,SODIUM URINE,1
2868-8,SERUM ALPHA 2 GLOB. FRACTION,171
15015-1,LIVER FRACTION:,9
,PEEP  VENOUS,230
9813-7,CORTISOL - AM,131
18262-6,LDL CHOLESTEROL DIRECT,31
20648-2,ISOLEUCINE,2
53731-6,POSACONAZOLE,208
2501-5,UNSATURATED IRON BINDING CAPACITY,16
24458-2,INTERLEUKIN 2 RECEPTOR (CD25)  SOLUBLE,48
13458-5,VLDL CHOLESTEROL CAL,122
12183-0,CHOLESTEROL FLUID,35
,VOLUME  VENOUS,140
80986,THYROGLOBULIN ANTIBODY,47
5724-0,SELENIUM  SERUM/PLASMA,145
6095-4,ALLERGEN  DERMATOPHAGOIDES FARINAE (D2) IGE,29
6109-3,ALLERGEN  ELM (T8) IGE,29
21394-2,MONOCYTE/MACROPHAGE %,100
6237-2,ALLERGEN  SALMON (F41) IGE,4
58709-7,GLIADIN DEAMIDATED AB (IGA),7
31017-7,T-TRANSGLUTAMINASE (TTG) IGA,12
13636-6,RIBOSOMAL P ANTIBODY,225
35182-5,DTA  C22:4W6,55
6041-8,ALLERGEN  BERMUDA GRASS (G2) IGE,30
27816-8,VON WILLEBRAND AG,17
83099-2,GALECTIN 3,8
,NEUTROPHILS,108
56718-0,IA-2 ANTIBODY,18
35178-3,TOTAL W3,56
,VBGCA,5
24461-6,TOTAL FATTY ACIDS,55
35155-1,HEXADECENOIC ACID  C16:1W9,55
73676-9,VORICONAZOLE  SERUM,102
24471-5,COLLAGEN EPINEPHRINE,55
36916-5,FREE KAPPA,131
31203-3,5-HIAA  URINE,3
8122-4,ABSOLUTE CD3+ CELLS,113
6095-4,D002-IGE D FARINAE,21
2458-8,IMMUNOGLOBULIN A  QN  SERUM,34
2150-1,CREATINE  URINE,13
14117-6,CSF IGG INDEX,32
13964-2,METHYLMALONIC ACID  SERUM,151
33211-4,INTERLEUKIN 8,41
1903-4,VITAMIN C LEVEL,154
,POC I-STAT CREATININE,14
50727-7,SRA  HIGH DOSE HEPARIN,68
6186-1,W020-IGE NETTLE,19
,% VIABILITY,20
33939-0,INTERLEUKIN 2 (IL 2),44
71840-3,O2 HGB,107
,DRB1*-1 EQUIVALENT,12
35165-0,LINOLEIC ACID  C18:2W6,55
,BW*-1  HLA NGS BM,11
6833-8,E001-IGE CAT DANDER,19
8098-6,THYROGLOBULIN ANTIBODIES,23
,RATE  VENOUS,174
,BW* 2 EQUIVALENT  BM SSOP,11
2874-6,GAMMA GLOBULIN,176
,NICOTINIC ACID,122
35173-4,EPA  C20:5W3,54
,VITAMIN E(GAMMA TOCOPHEROL),171
21198-7,HCG  TOTAL  QN,7
10921-5,ALLERGEN  BLOMIA TROPICALIS (D201) IGE,30
88995-6,DHA,3
11253-2,TACROLIMUS  HIGHLY SENSITIVE  LC/MS/MS,10
14178-8,SUCRASE,271
1986-9,C-PEPTIDE  SERUM,85
35169-2,ARACHIDIC ACID  C20:0,55
6106-9,ALLERGEN  EGG WHITE (F1) IGE,4
2216-0,DOPAMINE PLASMA,2
,PNEUMO AB TYPE 56 (18C)*,14
,FLOW  VENOUS,110
35164-3,A-LINOLENIC ACID  C18:3W3,55
,ALDOS/RENIN RATIO,35
2469-5,IGG  SUBCLASS 4,46
4536-9,HHB,108
2545-2,(LD) FRACTION 4,6
35180-9,DPA  C22:5W3,55
2857-1,PSA  TOTAL,83
2161-8,CREATININE(CRT) U,4
764-1,BAND NEUTROPHILS,4
,PERCENT POSITIVE  CLASS I,2
7155-5,ALLERGEN  MAPLE (BOX ELDER) (T1) IGE,30
19113-0,IGE (UNITS/VOLUME) IN SERUM,56
,HYDROXYAPATITE,1
35174-2,DHA  C22:6W3,55
35177-5,TOTAL POLYUNSATURATED ACID,54
2465-3,IMMUNOGLOBULIN G  QN  SERUM,110
,VOLTAGE GATED CALCIUM CHANNEL (VGCC) TYPE N AB,15
18267-5,% CD56,130
,MDC_IDC_SESS_DTM,47
39573-1,WEST NILE VIRUS IGM  CSF,53
,FATTY ACID PROFILE IMAGE,52
6034-3,ALLERGEN  BAHIA GRASS (G17) IGE,29
,PNEUMO AB TYPE 57 (19A)*,14
23992-1,DENGUE FEVER ANTIBODY (IGM),6
,VOLUME  MIXED VENOUS,286
,LYME DISEASE AB  QUANT  IGM,4
4498-2,COMPLEMENT C4  SERUM,62
35149-4,STEARIC ACID  C18:0,55
11257-3,HAEMOPHILUS INFLUENZAE B IGG,8
2923-1,VITAMIN A  SERUM,165
25907-7,PANCREATIC ELASTASE  FECAL,13
2460-4,IMMUNOGLOBULIN D  QUANT  SERUM,7
6098-8,E005-IGE DOG DANDER,19
,BW*-2 EQUIVALENT  HLA NGS BM,11
,GIARDIA LAMBLIA IGG ANTIBODY,6
21525-1,SODIUM 24 HOUR URINE,14
78015-5,DQB1* 1 EQUIVALENT,11
5622-6,CHROMIUM  SERUM,63
5256-3,M PNEUMONIAE IGM ABS,190
35175-9,TOTAL SATURATED ACID,54
6212-5,ALLERGEN  PENICILLIUM NOTATUM (M1) IGE,29
70072-4,ABETA 40,6
20657-3,TAURINE,2
13046-8,REACTIVE LYMPHOCYTES,1
5403-1,VARICELLA ZOSTER VIRUS AB (IGG),15
,AA ATP 0.5 MM,2
26487-9,PRODUCT MONOCYTES PERCENT,9
6096-2,ALLERGEN  DERMATOPHAGOIDES PTERONYSSINUS (D1) IGE,30
48065-7,D-DIMER  QUANTITATIVE,36
35181-7,DPA  C22:5W6,55
35171-8,H-G-LINOLENIC C20:3W6,55
7155-5,T001-IGE MAPLE/BOX ELDER,19
49054-0,25-HYDROXY  VITAMIN D-2,84
,A-A GRADIANT  VENOUS,18
3013-0,THYROGLOBULIN BY IMA,17
2162-6,CREATININE  24 HOUR URINE,16
1990-1,VITAMIN D  25 OH  D3,18
12238-2,NEUTROPHILS  %,122
30089-7,TRANSITIONAL EPITHELIAL,112
16135-6,BETA-2 GLYCOPROTEIN I AB  IGG,60
,B*-2 EQUIVALENT  BM SSOP,11
21203-5,CITRIC ACID  URINE,4
2991-8,FREE TESTOSTERONE(DIRECT),67
50544-6,EVEROLIMUS  BLOOD,40
,CLOBAZAM,5
25418-5,MUMPS ABS  IGG,13
31406-2,ANTIGLOMERULAR BM AB  QN,18
9318-7,MICROALBUMIN/CREATININE RATIO  RANDOM URINE,55
77728-4,SRA  LOW DOSE HEPARIN,67
2284-8,FOLATE  SERUM,54
8124-0,% CD 3 POS. LYMPH.,108
2236-8,VITAMIN D  25 OH  D2,18
35703-8,ADENOSINE DEAMINASE  CSF,13
15087-0,PTHRP (PTH-RELATED PEPTIDE),40
35163-5,G-LINOLENIC ACID  C18:3W6,55
,RAD ONC ARIA REFERENCE POINT SESSION DOSAGE GIVEN,7
35157-7,MYRISTIC ACID  C14:0,3
3209-4,FACTOR VIII ACTIVITY,49
6303-2,DRVVT SCREEN,7
749-2,MYELOCYTES,6
8072-1,INSULIN ANTIBODIES,3
90909-3,ARACHIDONIC ACID/EPA RATIO,2
3432-2,CARBAMAZEPINE LEVEL,21
,DQB1-2  BM SSOP,11
,C*-1 EQUIVALENT  HLA NGS BM,11
13926-1,GAD-65 AB,18
17863-2,CALCIUM  IONIZED,146
20652-4,ORNITHINE,2
,DQA1-2  BM SSOP,11
63559-9,SRP AB,18
58785-7,HSV 2 IGG INDEX:,60
5060-9,LYME AB SCREEN,4
,CD34+ CELLS BY ISHAGE GUIDELINES,13
,BW*-2  HLA NGS BM,11
78016-3,DRB1* 1 EQUIVALENT,11
3226-8,FACTOR XI ACTIVITY,10
,ANTI-XA LOW MOLEC.WEIGHT HEPARIN,22
,A*-1  BM SSOP,11
35150-2,LAURIC ACID  C12:0,56
,HGB O2 SATURATION VENOUS,5
,PATIENT WEIGHT IN KG,19
,PTT MIX 1:1 CONTROL,33
,URINE CREATININE CONC.  RANDOM,4
2468-7,IGG  SUBCLASS 3,35
17782-4,LDL SIZE,9
5811-5,SPECIFIC GRAVITY  POC,66
,PNEUMO AB TYPE 14*,14
5159-9,EBV AB VCA  IGM,64
11034-6,ACHR BINDING ABS  SERUM,11
1746-7,ALBUMIN  CSF,48
,MI-2 ALPHA AB,18
90910-1,OMEGA-6/OMEGA-3 RATIO,2
35170-0,NERVONIC ACID  C24:1W9,55
26848-2,INTERLEUKIN 10,41
,C*-2  BM SSOP,11
10365-5,COTININE,3
,C*-2 EQUIVALENT  HLA NGS BM,11
31017-7,TISSUE TRANSGLUTAMINASE ANTIBODY  IGA,14
6189-5,T007-IGE OAK  WHITE,19
6098-8,ALLERGEN  DOG DANDER (E5) IGE,29
2472-9,IMMUNOGLOBULIN M  QN  SERUM,28
42189-1,% NK (CD56/16),16
6025-1,ALLERGEN  ASPERGILLUS FUMIGATUS (M3) IGE,30
,PNEUMO AB TYPE 8*,14
57662-9,ANTI-U1 RNP AB (RDL),10
6874-2,CALCIUM 24 HOUR URINE,11
2147-7,CORTISOL 24H URINARY FREE,6
13733-1,DOPAMINE  RAND UR,6
38445-3,CALPROTECTIN  FECAL,72
2669-0,NORMETANEPHRINE FREE PLASMA,5
,PHOSPHOLIPASE A2 RECEPTOR ELISA S,10
,ADENOSINE DEAMINASE RBC,13
6096-2,D001-IGE D PTERONYSSINUS,20
33203-1,ABETA 42,6
11038-7,BETA-GAMMA-TOCOPHEROL,3
3175-7,ANTITHROMBIN ANTIGEN,3
,CD34 ABSOLUTE COUNT,20
33194-2,VIABILITY:,8
2466-1,IGG  SUBCLASS 1,36
5793-5,GRANULAR CASTS,17
,A-A GRADIANT  MIXED VENOUS,3
2915-7,RENIN ACTIVITY  PLASMA,69
9738-6,GABAPENTIN LEVEL,1
,DRB1*-2 EQUIVALENT,12
35157-7,MYRISTIC ACID  C:14:0,52
6265-3,ALLERGEN  TIMOTHY GRASS (G6) IGE,29
13965-9,HOMOCYST(E)INE  PLASMA,48
6244-8,ALLERGEN  SHEEP SORREL (W18) IGE,30
8122-4,ABSOLUTE CD 3,103
3181-5,CARDIOLIPIN AB (IGG),5
,DQA1-1  BM SSOP,11
,CD34 POSITIVE CELLS,20
2162-6,CREATININE 24 HOUR URINE,24
6302-4,PT 1:1NP,1
2464-6,IGG  QUANT  CSF,48
7604-2,ALLERGEN  ROUGH PIGWEED (W14) IGE,29
8101-8,CD8 % SUPPRESSOR T CELL,16
62292-8,VITAMIN D  1 25 (OH)2 TOTAL,7
12841-3,PROSTATE SPECIFIC ANTIGEN PERCENT FREE,66
,CAT DANDER (E1) IGE,2
,LYME IGG/IGM AB,7
7691-9,ALLERGEN  SCALLOP (F338) IGE,4
,AMPHIPHYSIN AB  WB,3
3193-0,FACTOR V ACTIVITY,9
35166-8,OLEIC ACID  C18:1W9,55
3174-0,ANTITHROMB III  FUNC,1
43729-3,LARGE HDL P,9
6178-8,T006-IGE CEDAR  MOUNTAIN,19
6020-2,ALLERGEN  ALTERNARIA ALTERNATA (M6) IGE,30
3219-3,FACTOR X CHROMOGENIC ASSAY,3
17609-9,FAT QUANTITATIVE STOOL WEIGHT,7
5157-3,EBV AB VCA  IGG,63
,COMPLEMENT C3  SERUM,63
5130-0,DNA (DS) ANTIBODY,12
2963-7,GROWTH HORMONE  SERUM,26
78016-3,DRB1* 2 EQUIVALENT,11
62253-0,HDL SIZE,9
11561-8,ACHR BLOCKING ABS  SERUM,12
56478-1,ETHANOL,9
13783-6,NORMETANEPHRINE URINE,4
2874-6,GAMMA GLOBULINS,17
2890-2,PROTEIN/CREATININE RATIO,6
,BETA 2 MICROGLOBULIN  SERUM,34
82334-4,INTERLEUKIN 17,41
,PRODUCT LYMPHOCYTES PERCENT,10
33822-8,INTERLEUKIN 13,43
,CORTISOL  FREE DIALYSIS,35
31562-2,ANTI-PM/SCL-100 AB (RDL),10
88725-7,ANTI-MDA-5-AB (CADM-140)(RDL),10
2589-0,LYSOZYME,8
30312-3,C18 1-HYDROXY,2
,B*-2 EQUIVALENT  HLA NGS BM,11
2162-6,CREATININE  UR 24HR,7
,SARS-COV-2 NEUT AB CONCENTRATION,40
33938-2,INTERLEUKIN 5,41
,DRB1-2  BM SSOP,11
,SO2,14
6034-3,G017-IGE BAHIA GRASS,19
12208-5,EOSINOPHILS CSF,9
30357-8,C16 1,2
6078-0,ALLERGEN  COCKROACH (I6) IGE,30
6687-8,CITRIC ACID  U  24HR,4
,LACOSAMIDE,11
48378-4,KAPPA/LAMBDA RATIO S,10
3210-2,FACTOR VIII ACTIVITY  CHROMOGENIC,4
27057-9,SEROTONIN  SERUM,11
45029-6,DQB1-1,12
27394-6,FREE LAMBDA LT CHAINS UR,6
19050-4,METANEPHRINES TOTAL URINE,5
,VITAMIN D 25-OH TOTAL,18
13965-9,HOMOCYSTEINE  CARDIOVASCULAR,9
55927-8,ST2  SOLUBLE,15
,A*-1 EQUIVALENT  HLA NGS BM,11
,INDEX VALUE,11
2722-7,VITAMIN B5,21
16136-4,BETA-2 GLYCOPROTEIN I AB  IGM,58
21074-0,ARSENIC 24 HOUR URINE,1
6743-9,TOTAL NUCLEATED CELL CT,122
2986-8,TESTOSTERONE  TOTAL,78
,PNEUMO AB TYPE 12 (12F)*,14
,NUMBER OF MARKERS:,4
,ISAVUCONAZOLE (CRESEMBA) LC-MS/MS,68
2666-6,NOREPINEPHRINE PLASMA,2
22483-2,ROCKY MTN SPOTTED FEVER  IGM,5
,PNEUMO AB TYPE 51 (7F)*,14
6833-8,ALLERGEN  CAT DANDER (E1) IGE,30
1763-2,ALDOSTERONE  LC/MS/MS,27
,IMMATURE GRANULOCYTES %,8
82425-0,ANTI-NXP-2 (P140) AB (RDL),10
25418-5,MUMPS VIRUS ANTIBODY (IGG),10
8099-4,THYROID PEROXIDASE ANTIBODIES,23
13986-5,ALBUMIN  U,8
20638-3,ASPARAGINE,2
,CD34 PRODUCT VOLUME,20
1668-3,17 HYDROXYPROGESTERONE  LC/MS/MS,6
39000-5,C4-HYDROXY,2
,PNEUMO AB TYPE 9 (9N)*,14
2669-0,NORMETANEPHRINE  PL,24
1649-3,VITAMIN D3  1 25 (OH)2,7
35384-7,ESTRADIOL  SERUM  MS,2
8087-9,ANTIPARIETAL CELL ANTIBODY,3
12841-3,% FREE PSA,14
33036-5,HEXACOSENOIC ACID  C26:1,1
6082-2,ALLERGEN  CODFISH (F3) IGE,4
,PNEUMO AB TYPE 3*,14
6020-2,M006-IGE ALTERNARIA ALTERNATA,20
20647-4,HYDROXYPROLINE,2
36916-5,KAPPA LIGHT CHAIN  FREE  SERUM,9
,TOXOPLASMA IGG  AB.   CSF,12
,FACTOR H (B1H) LEVEL,1
,COL ATP 2 UG/ML,2
,NXP-2 AB,18
2470-3,IGG/ALB RATIO  CSF,32
30235-6,C16 1-HYDROXY,2
40973-0,SEROTYPE 54 (15B),1
11034-6,ACETYLCHOLINE REC BINDING,5
2597-3,MAGNESIUM RBC,13
,VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB,15
27161-9,INTERLEUKIN 4,41
43727-7,SMALL LDL P,9
2693-0,OSMOLALITY STOOL,12
5761-2,ZINC  RBC,1
30471-7,LEVETIRACETAM (KEPPRA),1
39564-0,ACTH #2,1
17849-1,RETICULOCYTE COUNT  AUTOMATED,8
35333-4,ANTI-JO-1 AB (RDL),10
721-1,HEMOGLOBIN  FREE  PLASMA,5
46266-3,MYELOPEROXIDASE ANTIBODY,6
,ASPERGILLUS GALACTOMANNAN EIA (CSF),12
78016-3,DRB4* 1 EQUIVALENT,4
56731-3,JO-1 ANTIBODY,18
20408-1,WBC UA,67
,PNEUMO AB TYPE 2*,11
,A*-2  BM SSOP,11
2746-6,PH VENOUS,5
,DRB1-1  BM SSOP,11
14062-4,DEXAMETHASONE  SERUM,6
5693-7,METHANOL,9
,A*-2 EQUIVALENT  BM SSOP,11
5889-1,PROTEIN S ANTIGEN FREE,3
,VOLTAGE GATED CALCIUM CHANNEL (VGCC) AB ASSAY,14
,C* 1 EQUIVALENT  BM SSOP,11
,C* 2 EQUIVALENT  BM SSOP,11
,PNEUMO AB TYPE 70 (33F)*,11
,SODIUM 24 HOUR VOLUME,14
10921-5,D201-IGE BLOMIA TROPICALIS,20
,CITRATE/CREAT. RATIO,3
2865-4,ALPHA-1-GLOBULIN,5
12480-0,ANGIOTENSIN CONVERT ENZ  CSF,24
,URIC ACID 24 HOUR VOLUME,6
4087-3,VALPROIC ACID FREE,10
,ADAMTS-13 ACTIVITY,26
15158-9,CHLORIDE STOOL,13
6136-6,ALLERGEN  HAZELNUT (F17) IGE,4
38370-3,VORICONAZOLE  SERUM/PLASMA,9
5796-8,HYALINE CAST,369
2915-7,PLASMA RENIN ACTIVITY LC/MS/MS,5
,B*-1  BM SSOP,11
,VWF COLLAGEN BINDING,8
21587-1,URIC ACID 24 HOUR URINE,6
3494-2,CLONAZEPAM LEVEL,1
43728-5,LARGE VLDL P,9
,B*-1 EQUIVALENT  HLA NGS BM,11
6242-2,ALLERGEN  SESAME SEED (F10) IGE,4
27118-9,SEROTYPE 26 (6B),1
,PNEUMO AB TYPE 23 (23F)*,14
2821-7,POTASSIUM FLUID,1
7604-2,W014-IGE PIGWEED  COMMON,19
3949-5,PHENOBARBITAL,14
,PNEUMO AB TYPE 4*,14
,PNEUMOCOCCAL ANTIBODY TYPE 1,14
11034-6,ACETYLCHOLINE REC BINDING AB,14
3862-0,NORDOXEPIN,5
32024-2,MAGNESIUM 24 HOUR URINE,4
3074-2,TNF ALPHA  HIGHLY SENSITIVE,8
3968-5,PHENYTOIN,5
1884-6,APOLIPOPROTEIN B,9
3096-5,UREA NITROGEN  24 HR UR,2
,PNEUMO AB TYPE 68 (9V)*,14
2542-9,(LD) FRACTION 3,6
72608-3,APIXABAN,5
,GAD65 AB  WB,3
,DQB1 1  BM SSOP,11
27822-6,PROTEIN S  ACTIVITY,1
11221-9,PENTACARBOXYL (5-CP),5
9363-3,B PERTUSSIS IGG AB,3
7901-2,H. PYLORI  IGA ABS,4
,MODE,4149
,LDL SMALL,4
,DQB1*-2 EQUIVALENT,13
58710-5,GLIADIN (DEAMIDATED) ABS  IGG,9
29247-4,RAPAMYCIN (SIROLIMUS),5
,ESTRADIOL LEVEL,12
,TIF-1Y AB,18
51775-5,ANTICHROMATIN ANTIBODIES,1
3969-3,PHENYTOIN FREE,10
48952-6,HISTOPLASMA GALACTOMANN AG  UR,2
6265-3,G006-IGE TIMOTHY GRASS,19
27415-9,INTERFERON GAMMA,41
1980-2,VITAMIN B7,16
2148-5,CREATINE  SERUM,2
15013-6,BONE FRACTION:,9
30238-0,C14-HYDROXY,2
2350-7,GLUCOSE URINE,21
12722-5,IGF BINDING PROTEIN 1,1
5669-7,ISOPROPANOL,9
20634-2,ALPHA-AMINOBUTYRATE,2
,SODIUM FLUID,2
2955-3,SODIUM URINE UNCALCULATED,5
3198-9,FACTOR VII ACTIVITY,8
,PNEUMO AB TYPE 54 (15B)*,11
17782-4,LDL PARTICLE SIZE,4
5273-8,PARVOVIRUS B19 IGG ANTIBODY,8
13782-8,NOREPINEPH  RAND UR,6
,A*-1 EQUIVALENT  BM SSOP,11
3187-2,FACTOR IX ACTIVITY,12
11562-6,ACETYLCHOLINE REC MOD AB,5
,MDC_IDC_PG_SERIAL,46
2142-8,SALIVARY CORTISOL  MS,1
35538-8,YEAST (BAKERS/BREWERS) (F45) IGG,1
21476-7,POTASSIUM 24 HOUR URINE,10
27365-6,FREE KAPPA LT CHAINS UR,6
4680-5,RISTOCETIN CO-FACTOR,25
4478-4,COMPLEMENT C1Q,4
,DQB1*-1 EQUIVALENT,12
30446-9,ABSOLUTE MYELOCYTES,5
2161-8,CREATININE URINE,3
42332-7,AFP-L3%  SERUM,7
2254-1,ESTROGENS  TOTAL  SERUM,2
6078-0,I006-IGE COCKROACH  GERMAN,19
2143-6,CORTISOL  SERUM LCMS,3
3125-2,VIP  PLASMA,4
,DRB3*-2 EQUIVALENT,5
54434-6,LDL P,9
6181-2,E072-IGE MOUSE URINE,15
14196-0,RETICULOCYTE  ABSOLUTE,8
26607-2,CYSTATHIONINE,2
43182-5,SM ANTIBODY,80
6687-8,CITRATE URINE,1
,NUMBER OF MARKERS,1
,ASPERGILLUS ANTIGEN  EIA (MIRAVISTA),10
2143-6,CORTISOL TOTAL,5
2839-9,PROGESTERONE LEVEL,2
13797-6,PORPHOBILINOGEN R UR,7
2143-6,CORTISOL  TOTAL,11
1951-3,BETA2-MICROGLOB. CSF,5
,MI-2 BETA AB,18
49038-3,VITAMIN B2  PLASMA,1
42188-3,AB NK (CD56/16),16
5244-9,MEASLES ANTIBODY (IGG),11
,PNEUMO AB TYPE 26 (6B)*,14
2857-1,TOTAL PSA,14
1690-7,5-NUCLEOTIDASE,1
34571-0,PTT LA SCREEN,5
,DENGUE AB IGG,6
2484-4,IGF I  ECL,3
78016-3,DRB3* 1 EQUIVALENT,5
,PROTEIN/CREATININE RATIO,54
,ADP 10 UM,2
20396-8,LEVOFLOXACIN,22
25157-9,EPITHELIAL CASTS,54
20991-6,ANTITHROMBIN ACTIVITY,23
3548-5,DIAZEPAM,5
30392-5,ABSOLUTE NUCLEATED RBC,3
78015-5,DQB1* 2 EQUIVALENT,11
70257-1,ANTI-SS-A 52KD AB  IGG (RDL),10
40491-3,NEUTROPHILS  %,3
,DRB5*-2 EQUIVALENT,6
20636-7,ALANINE,2
,DRB5-2  BM SSOP,2
,HE4,1
29142-7,TOTAL  FREE (MN+NMN),5
,WEST NILE VIRUS ANTIBODY (IGG)  SERUM,1
,BW*-1 EQUIVALENT  HLA NGS BM,11
73561-3,Z SCORE (FEMALE),2
,GENTAMICIN RANDOM,16
2986-8,TESTOSTERONE SERUM,8
53982-5,ANTI-CENTROMERE B ANTIBODIES,10
2162-6,CREATININE (24H URINE),4
6282-8,WHITE PINE (T16) IGE,6
27816-8,VON WILLEBRAND FACTOR ACTIVITY,8
,COW DANDER IGE (E004),1
,CHIKUNGUNYA IGM SCREEN,2
32677-7,DNA(DS) AB  HIGH AVIDITY,5
,ABETA 42/40 RATIO,6
62291-0,VITAMIN D2  1 25 (OH)2,7
78015-5,B*-2 EQUIVALENT,1
55876-7,HOMOCITRULLINE,2
27816-8,VWF ANTIGEN,1
42673-4,BRUSHITE,1
40869-0,ESTERIFIED/FREE,5
40968-0,SEROTYPE 43 (11A),1
2520-5,LACTIC ACID  CSF,2
5892-5,PROTEIN S ANTIGEN TOTAL,26
88997-2,EPA,3
3854-7,NICOTINE  URINE,1
,DRB3*-1 EQUIVALENT,6
2742-5,ANGIOTENSIN 1 CONVERTING ENZYME,8
78015-5,B*-1 EQUIVALENT,1
,PNEUMO AB TYPE 43 (11A)*,11
20495-8,GLIADIN (DEAMIDATED) AB (IGA),2
4532-8,COMPLEMENT  TOTAL (CH50 UNITS),1
6244-8,W018-IGE SHEEP SORREL,19
,BW* 1  BM SSOP,11
,PNEUMO AB TYPE 5*,11
20655-7,PROLINE,2
48382-6,OMEGA 6/OMEGA 3 RATIO,1
20658-1,THREONINE,2
2147-7,CORTISOL  FREE  URINE,2
6367-7,TETANUS ANTITOXOID IGG AB,8
,ANTI-RNA POLYMERASE III (RDL),2
26613-0,SARCOSINE,2
13992-3,ALBUMIN URINE ELP,1
20661-5,VALINE,2
53471-9,C10 2,2
9318-7,MICROALB/CRT. RATIO,14
53962-7,AFP-TUMOR MARKER,3
,M013-IGE PHOMA BETAE,1
2871-2,BETA GLOBULIN,5
6032-7,T073-IGE PINE  AUSTRALIAN,14
6206-7,ALLERGEN  PEANUT (F13) IGE,4
45194-8,HCG BETA SUBUNIT QNT SERUM,4
20642-5,GLUTAMATE,2
23905-3,MYCOPHENOLIC ACID,3
29996-6,ANTI-HISTONE ABS,4
26507-4,ABSOLUTE BAND NEUTROPHILS,4
2589-0,LYSOZYME SERUM,4
6076-4,F207-IGE CLAM,2
22670-4,ALLOISOLEUCINE,2
35554-5,CACAO BEAN (CHOCOLATE) (F93) IGG,1
4086-5,VALPROIC ACID,2
48795-9,FIBROSIS SCORE,1
5807-3,RBC CASTS,4
6019-4,ALLERGEN  ALMOND (F20) IGE,4
2756-5,PH  URINE,2
23906-1,MYCOPHENOLIC ACID GLUCURONIDE,3
2641-9,MYOGLOBIN URINE,3
39010-4,C4-DICARBOXYLIC,2
27096-7,SEROTYPE 3 (3),1
8098-6,ANTI-THYROGLOBULIN ANTIBODIES*,1
1657-6,SPECIFIC COMPOUND S,1
19123-9,MAGNESIUM URINE,7
2705-2,PO2 VENOUS,5
,GOOSE FEATHERS (E70) IGE,2
31032-6,SACCHAROMYCES CEREVISIAE  IGA,15
15207-4,SODIUM STOOL,13
,ANTI-SAE1 AB  IGG (RDL),5
20646-6,HOMOCYSTINE,2
,VBGK,5
,SUSCEPTIBILITY  FLUCONAZO,1
,SACCHAROMYCES CEREVISIAE  IGG,15
,CPRA,2
2905-8,PYRUVIC ACID  BLOOD,3
2145-1,CORTISOL FREE  SERUM,8
5946-9,APTT 1:1 NORMAL PLASMA,12
,RAD ONC ARIA PLAN FRACTIONS TREATED TO DATE,2
16142-2,FAT (FECAL LIPIDS)QN,7
13771-1,METANEPH/CREAT RATIO,4
,M004-IGE MUCOR RACEMOSUS,1
,PNEUMO AB TYPE 17 (17F),11
,PNEUMO AB TYPE 34 (10A)*,11
88739-8,ANTI-TIF-1GAMMA AB (RDL),10
38252-3,CA OXALATE MONOHYDR.,2
,RISTO LOW 0.25 MG/ML,3
,DRB4-1  BM SSOP,4
,PRODUCT HEMATOCRIT CELL COUNT,8
2254-1,ESTROGENS  TOTAL,3
,AWN TEST REFUSED,1
53811-6,STRUVITE,1
2548-6,(LD) FRACTION 5,6
,RAD ONC ARIA COURSE TREATMENT ELAPSED DAYS,2
,POTASSIUM  STOOL,13
,ACETYLCHOLINE RECEPTOR GANGLIONIC (ALPHA 3) AB,16
30195-2,TETRACOSANOIC ACID  C24:0,2
78015-5,BW* 2 EQUIVALENT,1
32660-3,6 TG,1
43755-8,CASTS,751
35158-5,MYRISTOLEIC ACID  C14:1,1
5244-9,RUBEOLA AB  IGG,10
5632-5,COPPER URINE,3
46224-2,THROMBIN TIME (POST NEUTRALIZATION),10
1927-3,BASE EXCESS VENOUS,5
6683-7,REPTILASE TIME,2
14288-5,CARNITINE TOTAL,5
,GAD65 AB  LB  CSF,1
6242-2,F010-IGE SESAME SEED,2
22672-0,CYSTINE,2
7967-3,MUMPS ANTIBODIES  IGM,3
,PRODUCT NEUTROPHILS PERCENT,2
48309-9,BK VIRUS DNA  QN PCR,3
6276-0,F004-IGE WHEAT,2
2142-8,CORTISOL  SALIVA LC/MS/MS,1
40967-2,SEROTYPE 34 (10A),1
30433-7,ABSOLUTE METAMYELOCYTES,2
2171-7,VIT B12 BINDING CAPACITY  UNSAT (TRANSCOBALAMIN),2
30192-9,ACHR MODULATING AB,10
35154-4,HEXADECADIENOIC ACID  C16:2,1
33944-0,LAMBDA LIGHT CHAIN  FREE  SERUM,9
1869-7,APOLIPOPROTEIN A-1,1
2857-1,PROSTATE SPECIFIC AG,5
26610-6,HYDROXYLYSINE,2
2164-2,CREATININE CLEARANCE,7
,CREATININE  RANDOM U,9
,ANNA2 (RI) AB  LB  CSF,1
2407-5,HEPTACARBOXYL (7-CP),5
20468-5,VITAMIN B1 (THIAMINE)  LC/MS/MS,2
26600-7,ALPHA-AMINOADIPATE,2
52123-7,APTT  (POST HEPZYME),4
,GIARDIA LAMBLIA IGM,6
,PNEUMO AB TYPE 20*,11
,PRODUCT WBC CELL COUNT,9
,SUPERNATANT,397
,RAD ONC ARIA PLAN PRESCRIBED DOSE PER FRACTION,2
90911-9,OMEGA-3 TOTAL,2
8101-8,% CD 8 POS. LYMPH,5
2282-2,FOLATE  HEMOLYSATE,6
32174-5,GLUCOSE 24 HOUR URINE,3
11561-8,ACETYLCHOLINE REC BLOC AB,5
78015-5,BW* 1,1
26746-8,MAGNESIUM  RBC,2
21395-9,MONOCYTE/MACROPHAGE  %,1
57093-7,ANTI-CCP AB  IGG + IGA (RDL),2
6270-3,ALLERGEN  TUNA (F40) IGE,4
2668-2,NOREPINEPHRINE 24 HOUR URINE,3
,VBGCL,5
3013-0,THYROGLOBULIN  LC/MS/MS,2
53807-4,BULLOUS PEMPHIGOID BP230 IGG,4
,STEM CD3 POSITIVE ABSOLUTE COUNT,2
2196-4,DHEA  LC/MS/MS,1
,BULLOUS PEMPHIGOID 180 IGG ABS,1
,IL-2 RECEPTOR ALPHA,15
,VBGNA,5
19113-0,TOTAL IGE,8
2191-5,DHEA-SO4,6
,ANNA2 (RI) AB  WB,3
5683-8,MANGANESE  PLASMA,8
27400-1,HEXACARBOXYL (6-CP),5
8247-9,MUCOUS.,5064
2605-4,RESULT:,1
2890-2,PROTEIN/CREAT RATIO,2
,SCHISTOSOMA IGG,1
2701-1,OXALATES  URINE 24HR,4
38476-8,ANTI-MULLERIAN HORMONE (AMH),2
,LEAD  BLOOD (ADULT),2
,FREE INSULIN,2
43171-8,INTERLEUKIN 2 RECEPTOR,1
31183-7,SEROTYPE 5 (5),1
34416-8,CHROMATIN (NUCLEOSOMAL) ANTIBODY,7
27395-3,SEROTYPE 56 (18C),1
,ANNA1 (HU) AB  WB,3
14960-9,FREE ESTRADIOL  PERCENT,1
3182-3,CARDIOLIPIN AB (IGM),6
21108-6,BETA-2 GLYCOPROTEIN I AB  IGA,16
5092-2,TETANUS ANTITOXOID AB,2
2839-9,PROGESTERONE  LC/MS/MS,1
6182-0,ALLERGEN  MUCOR RACEMOSUS (M4) IGE,1
2536-1,(LD) FRACTION 1,6
14627-4,HCO3 VENOUS,5
5822-2,YEAST,9
14628-2,BILE ACIDS  TOTAL,3
740-1,METAMYELOCYTES,3
2218-6,DOPAMINE 24 HOUR URINE,3
,LACTOFERRIN  FECAL  QUANT.,10
82467-2,RITUXIMAB DRUG CONCENTRATION,1
5255-5,MYCOPLASMA PNEUMONIAE ANTIBODY (IGG),2
20643-3,GLUTAMINE,2
,TEST ORDERED ON REQ:,4
30564-9,C14 2,2
30542-5,C18 1,2
90916-8,OMEGA-6 TOTAL,2
35148-6,TETRADECADIENOIC ACID  C14:2,1
54434-6,LDL PARTICLES  TOTAL,4
9624-8,VMA  URINE,2
13210-0,BRUCELLA IGG,1
14286-9,CARNITINE FREE,5
5116-9,DIPHTHERIA ANTIBODY,4
6273-7,F256-IGE WALNUT,2
30349-5,C5-DICARBOXYLIC,2
40966-4,SEROTYPE 22 (22F),1
2232-7,EPINEPHRINE 24 HOUR URINE,3
,RAD ONC ARIA REFERENCE POINT DOSAGE GIVEN TO DATE,7
20640-9,CITRULLINE,2
2880-3,PROTEIN TOTAL CSF,3
,CHLORDIAZEPOXIDE,6
,B*-2  BM SSOP,11
90914-3,DPA,2
,PNEUMO AB TYPE 22 (22F)*,11
30083-0,EPSTEIN BARR VIRUS (EBNA) ANTIBODY (IGG),8
33358-3,M-SPIKE,5
,BW* 1 EQUIVALENT  BM SSOP,11
38420-6,ANTI-SLA  IGG,3
11228-4,UROPORPHYRINS (UP),5
6891-6,TESTOST.  % FREE&WEAKLY BOUND,6
5627-5,COBALT  PLASMA,1
15067-2,FOLLICLE STIMULATING HORMONE*,1
34660-1,HGB A2,12
2417-4,HISTAMINE UG/L U,1
32654-6,6 MMP,1
35147-8,DECENOIC ACID  C10:1,1
4551-8,HEMOGLOBIN A2 (QUANT),2
26891-2,NORDIAZEPAM,5
20649-0,LEUCINE,2
11153-4,HEMATOCRIT FLUID,3
,RAD ONC ARIA PLAN TOTAL FRACTIONS PRESCRIBED,2
,ANTI-IGA*,2
2539-5,(LD) FRACTION 2,6
,CRMP5/CV2 AB  LB  CSF,1
26609-8,GAMMA-AMINOBUTYRATE,2
,ANTI-FODRIN AB  IGA (RDL),2
2779-7,PHOSPHORUS 24 HOUR URINE,4
3013-0,THYROGLOBULIN (ICMA),1
48792-6,NECROINFLAMMAT ACTIVITY SCORE,1
35145-2,OCTANOIC ACID  C8:0,1
29658-2,B PERT IGM SER QL EIA,1
40964-9,SEROTYPE 2 (2),1
72257-9,COLLAGEN-ADP,12
47982-4,EPSTEIN-BARR DNA QUANT  PCR,1
6206-7,F013-IGE PEANUT,2
20650-8,LYSINE,2
,IMMUNOGLOBULIN A (IGA) LOW RANGE,2
13734-9,EPINEPHRINE  RAND UR,7
44733-4,TG/HDL C,3
88998-0,OMEGA 3 (EPA+DHA) INDEX,1
29141-9,METANEPHRINE  FREE,5
6718-1,ALLERGEN  CASHEW NUT (F202) IGE,4
6246-3,ALLERGEN  SHRIMP (F24) IGE,4
56417-9,WHEAT,1
78014-8,A*-1 EQUIVALENT,1
3122-9,VANILLYLMANDELIC ACID 24 HOUR URINE ADULT,1
,THROMBIN ATP 1.0U/ML,2
5176-3,H. PYLORI  IGG ABS,1
78016-3,DRB5* 2 EQUIVALENT,2
43729-3,HDL  LARGE,4
90782-4,F2-ISOPROSTANE,1
6174-7,ALLERGEN  MILK (F2) IGE,4
,LDL MEDIUM,4
29620-2,ZONISAMIDE,10
11040-3,CORTISOL F UG/L U,6
14030-1,SM/RNP ANTIBODY,81
2162-6,CREATININE  URINE,1
,STEM CD3% POSITIVE,2
3033-8,CORTISOL-BINDING GLOBULIN,1
38370-3,VORICONAZOLE  LC/MS/MS,1
20656-5,SERINE,2
14135-8,ABSOLUTE CD 8 (SUPP),5
,POSTMENOPAUSAL ROMA,1
13829-7,COPPER /G CREATININE,2
,ANTI-FODRIN AB  IGG (RDL),2
30153-1,SEROTYPE 68 (9V),1
42772-4,FIBRINOGEN ANTIGEN  NEPHELOMETRY,6
82466-4,ANTI-RITUXIMAB ANTIBODY LEVEL,1
41759-2,FREE KAPPA/LAMBDA RATIO,1
14116-8,IGG SYNTHETIC RATE,15
5685-3,MERCURY  BLOOD,2
6774-4,NORAMIODARONE S,3
30170-5,I206-IGE COCKROACH  AMERICAN,1
78015-5,BW* 1 EQUIVALENT,1
,PYRUVATE KINASE (PK),1
,DUCK FEATHERS (E086) IGE,1
,DONOR MRN,16
10366-3,COTININE  URINE,1
33193-4,VIABILITY (%),1
16362-6,AMMONIA (P),1
66853-3,MYELOPEROXIDASE,1
13590-5,ACTIVATED PROTEIN C RESISTANCE,4
35177-5,TOTAL POLYUNSATURATED,1
2700-3,OXALATES  URINE,4
46267-1,PROTEINASE-3 ANTIBODY,6
,FILARIA IGG4 ANTIBODIES,1
77211-1,CARBONIC ANHYDRASE VI IGA ABS,1
,BIOTIN/VIT B7,1
33951-5,SODIUM/CREAT RATIO,1
33571-1,ANTI JO-1 IGG,10
20637-5,ARGININE,2
26604-9,BETA-ALANINE,2
,BW*-2  BM SSOP,11
1835-8,ALPHA 2-MACROGLOBULINS  QN,1
,D-DIMER,5
,MANNOSE BINDING LECTIN,1
2868-8,ALPHA-2-GLOBULIN,5
40595-1,ANTIPROTHROMBIN ANTIBODY  IGG,1
,AMPHIPHYSIN AB  LB  CSF,1
1695-6,5-HIAA  URINE  24HR,3
,DOG DANDER (E5) IGE,2
9749-3,HEMOGLOBIN F,2
3167-4,24 HR URINE VOLUME,1
5116-9,DIPHTHERIA ANTITOXOID AB,2
49391-6,HERPESVIRUS 6 DNA  QN PCR,1
27389-6,SEROTYPE 23 (23F),1
26848-2,INTERLEUKIN-10  PLASMA,1
,CHICKEN FEATHERS (E85) IGE,1
10886-0,PSA  FREE,5
5070-8,BRUCELLA IGM,1
3243-3,THROMBIN CLOTTING TIME,2
,HUMAN TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1),1
,DESMETHYLCLOBAZAM,5
22671-2,PHYTANIC ACID,1
,HISTOPLASMA GAL'MANNAN AG SER,2
73561-3,Z SCORE (MALE),1
40673-6,TRAB,2
51412-5,C5-HYDROXY,2
21194-6,CHLORIDE 24 HOUR URINE,1
10501-5,LUTEINIZING HORMONE (LH) ECL,1
26975-3,SCL 70 ANTIBODY,14
,ABSOLUTE REACTIVE LYMPHOCYTES,1
6232-3,ROUGH MARSHELDER,1
13474-2,MAGNESIUM URINE,1
12841-3,PSA  % FREE,5
9321-1,CALCIUM/CREAT.RATIO,1
90917-6,LINOLEIC ACID,2
34736-9,CALCIUM OXALATE,1
,DRB4-2  BM SSOP,6
6106-9,F001-IGE EGG WHITE,2
,SETOMELANOMMA ROSTRAT IGE (M008),1
30237-2,C18 2-HYDROXY,2
10634-4,C1 EST.INHIB.FUNCT.,5
10365-5,COTININE  SERUM/PLASMA,1
28643-5,O2 SATURATION VENOUS,5
2338-2,GLUCAGON LEVEL,2
,RISTO HIGH 1.0 MG/ML,3
90908-5,EPA+DPA+DHA,2
,CANDIDA ALBICANS (M5) IGE,1
44706-0,ACTIN IGG ANTI SMOOTH MUSCLE AB,3
69380-4,BCR ABL1/ABL1 % (IS),1
,WEST NILE VIRUS ANTIBODY (IGM)  SERUM,1
,BANDS,1
27378-9,PH URINE,1
30934-4,B TYPE NATRIURETIC PEPTIDE (BNP),1
40969-8,SEROTYPE 70 (33F),1
6896-5,CLOZAPINE LEVEL,1
,CRMP5/CV2 AB  WB,3
27392-0,SEROTYPE 9 (9N),1
3330-8,AMIODARONE  SERUM,4
33325-2,TRYPSIN,2
,AGNA/SOX1 AB  LB  CSF,1
3074-2,TUMOR NECROSIS FACTOR-ALPHA,2
74669-3,LACTOBACILLUS SPECIES,2
30566-4,C14 1,2
,PREMENOPAUSAL ROMA,1
2828-2,POTASSIUM  RANDOM URINE,3
13463-5,ARSENIC  RANDOM URINE,1
20651-6,METHIONINE,2
40974-8,SEROTYPE 57 (19A),1
1952-1,BETA-2 MICROGLOBULIN  SERUM,3
32227-1,ARGININOSUCCINATE,1
17838-4,TANDEM-R OSTASE,3
3853-9,NICOTINE,3
19048-8,NUCLEATED RBC,3
,LAMBDA LIGHT CHAIN  FREE  URINE,1
5085-6,CHLAMYDIA ANTIBODIES  IGG,2
,DQB1-2  HLA NGS BM,11
1799-6,AMYLASE URINE,1
51435-6,ABNORMAL PROTEIN BAND 1,4
2467-9,IMMUNOGLOBULIN G SUBCLASS 2,2
,CK-MB (CK-2),5
25308-8,AMMONIUM URINE,1
2701-1,OXALATE URINE,1
49500-2,CA OXALATE DIHYDRATE,2
12375-2,TOTAL(CLOZ+NORCLOZ),1
27387-0,SEROTYPE 14 (14),1
38995-7,CELLULAR CASTS,2
,DRB3-1  BM SSOP,5
1668-3,17-OH PROGESTERONE LCMS,1
11145-0,5-HIAA  URINE,2
13626-7,MITOTANE,1
1825-9,ALPHA 1 ANTITRYPSIN QN,3
2021-4,PCO2 VENOUS,5
2465-3,IMMUNOGLOBULIN G  SERUM,1
53962-7,ALPHA FETOPROTEIN  TUMOR MARKER,2
,KAPPA LIGHT CHAIN  FREE  URINE,1
20639-1,ASPARTATE,2
3182-3,ANTICARDIOLIPIN IGM ANTIBODY,1
,TOTAL GLUTATHIONE,1
80981-4,ADMA,1
6410-5,GARDNERELLA VAGINALIS,2
55940-1,C3-DICARBOXYLIC,2
56207-4,CASEIN,1
18487-9,BROAD CASTS,1
,TOTAL INSULIN,2
20645-8,HISTIDINE,2
89579-7,TROPONIN T (HIGHLY SENSITIVE),4
30328-9,C10 1,2
2230-1,EPINEPHRINE PLASMA,2
6125-9,ALLERGEN  GLUTEN (F79) IGE,1
,ARACH ACID 0.5 MM,2
,C* 2 EQUIVALENT,1
14822-1,LYMPHOCYTES  %,1
25296-5,SEROTYPE 51 (7F),1
6248-9,ALLERGEN  SOYBEAN (F14) IGE,4
,PCA1 (YO) AB  WB,3
6059-0,ALLERGEN  CANDIDA ALBICANS (M5) IGE,1
35171-8,H-G-LINOLENIC ACID  C20:3W6,1
48952-6,HISTOPLASMA GALACTOMANNAN ANTIGEN  URINE,1
30194-5,DOCOSANOIC ACID  C22:0,1
6014-5,RISTOCETIN COFACTOR,1
73676-9,VORICONAZOLE  PLASMA,1
,30H COTININE SERUM/PLASMA,1
46183-0,COCCIDIOIDES AB IGM,1
1874-7,APOLIPOPROTEIN B/A1 RATIO,1
,C-PEPTIDE  LC/MS/MS,1
13969-1,CREATINE KINASE-MB INDEX,1
3579-0,DOXEPIN,5
33210-6,SOLUBLE TRANSFERRIN RECEPTOR,1
,RAD ONC ARIA PLAN TOTAL PRESCRIBED DOSE,2
40963-1,SEROTYPE 17 (17F),1
9345-0,COPROPORPHYRIN (CP) III,5
6030-1,ALLERGEN  PARROT/PARAKEET FEATHERS (E78) IGE,2
9343-5,COPROPORPHYRIN (CP) I,5
30197-8,HEXACOSANOIC ACID  C26:0,1
78016-3,DRB3* 2 EQUIVALENT,2
1504-0,GLUCOSE  GESTATIONAL SCREEN (50G) 140 CUTOFF,1
,A*-2 EQUIVALENT  CONF HLA TYPING BY NGS BM,1
14975-7,HUMAN ANTI-MOUSE ANTIBODIES,1
,M012 AUREOBASIDIUM PULLULAN,1
2056-0,TOTAL CATECHOLAMINES,1
5076-5,ANTICARDIOLIPIN IGA ANTIBODY,1
56540-8,GLUTAMIC ACID DECARBOXYLASE 65 AB,3
26889-6,SULFATE URINE,1
,ADP ATP RELEASE (10UM),2
27923-2,COENZYME Q10  TOTAL,2
3126-0,ADH,2
,DRB3-2  BM SSOP,2
,TESTS AFFECTED,1
53774-6,LOG10 EBV DNA QN PCR,1
3181-5,ANTICARDIOLIPIN AB  IGG,1
,DRB5*-1 EQUIVALENT,5
2485-1,INSULIN-LIKE GROWTH FACTOR II,1
27113-0,SEROTYPE 8 (8),1
,CALCIUM/CREATININE RATIO 24HR,4
,INSULIN  INTACT  LC/MS/MS,1
2466-1,IMMUNOGLOBULIN G SUBCLASS 1,1
26605-6,BETA-AMINOISOBUTYRATE,2
41057-1,RESULT,2
5634-1,CYANIDE BLOOD,1
21383-5,MERCURY 24 HOUR URINE,1
,C* 1 EQUIVALENT,1
133-9,CEFTAZIDIME,20
5256-3,MYCOPLASMA PNEUMONIAE ANTIBODY (IGM),2
90783-2,F2-ISOPROSTANE/CREAT RATIO,1
2692-2,OSMOLALITY MEASURED,1
18948-0,MINOCYCLINE,1
13965-9,HOMOCYST(E)INE,1
,TOTAL W6,1
,ANNA1 (HU) AB  LB  CSF,1
2240-0,FREE ESTRADIOL  SERUM,1
9410-2,HISTAMINE UG/24HR U,1
35656-8,C18-HYDROXY,2
2779-7,PHOSPHORUS URINE,1
19109-8,HISTOPLASMA CAPSULATUM AG (BAL),51
2469-5,IMMUNOGLOBULIN G SUBCLASS 4,2
14246-3,ANTIPHOSPHATIDYLSERINE IGM,1
,MOLD SUSCEPTIBILITY  AMPHOTERB,1
45142-7,ANTI-LA (SS-B) AB (RDL),1
20644-1,GLYCINE,2
20625-0,LEAD 24 HOUR URINE,1
14159-8,CORTISONE  SERUM,1
42598-3,ACTH #1,1
33569-5,ANTI-RO (SS-A) AB (RDL),1
3167-4,TOTAL URINE VOLUME,1
3312-6,ALPRAZOLAM (XANAX)  SERUM,1
13801-6,PROTEIN/CREATININE RATIO,2
6276-0,ALLERGEN  WHEAT (F4) IGE,4
54238-1,OXLDL,1
11215-1,DELTA ALA URINE,2
49448-4,TOXOPLASMA DNA  QN PCR,2
6652-2,MEROPENEM,3
8087-9,GASTRIC PARIETAL CELL ANTIBODY  ELISA,1
42176-8,FUNGITELL(R) (1-3) B D GLUCAN ASSAY,6
,M010-IGE STEMPHYLIUM HERBARUM,1
77210-3,SALIVARY PROTEIN 1 IGG ABS,1
3853-9,NICOTINE  SERUM/PLASMA,1
9335-1,APPEARANCE,1196
2078-4,CHLORIDE  RANDOM URINE,1
2567-6,PHOSPHOLIPIDS  SERUM,1
9407-8,A-1 ANTITRYPSIN STOOL,1
90781-6,SDMA,1
62467-6,ASPERGILLUS GALACTOMANNAN EIA,1
3638-4,FLECAINIDE,2
3232-6,FACTOR XII ACTIVITY,3
6874-2,CALCIUM URINE,1
30534-2,C18 2,2
2468-7,IMMUNOGLOBULIN G SUBCLASS 3,1
11145-0,5-HIAA QN RANDOM UR,2
32229-7,ARGININOSUCCINATE/CREATININE RATIO IN URINE,1
73958-1,LYSOSOMAL ACID LIPASE,1
5370-2,ANTI STREPTOLYSIN O,1
,INSULIN RESISTANCE SCORE,1
,ANTI-HMGCR AB (RDL),1
,EPA ACID  C20:5W3,1
35151-0,LAUROLEIC ACID  C12:1,1
,DRB5-1  BM SSOP,1
72216-5,PML BCR1-RARA TRANSCRIPT,4
46983-3,ETHANOL CONFIRM,1
35146-0,DECANOIC ACID  C10:0,1
27374-8,SEROTYPE 12 (12F),1
,COLLAGEN (2 UG/ML),2
,PCA1 (YO) AB  LB  CSF,1
13069-0,ANTIPHOSPHATIDYLSERINE IGA,1
34694-0,VEGF  SERUM,1
14245-5,ANTIPHOSPHATIDYLSERINE IGG,1
,NON-SQUAMOUS EPITHELIAL CELL,2
,DRB1-1  HLA NGS BM,11
,OVOMUCOID (F233) IGE,2
77209-5,SALIVARY PROTEIN 1 IGM ABS,1
30234-9,C16-HYDROXY,2
,DRB1-2  HLA NGS BM,11
,PCA TR (DNER) AB  LB  CSF,1
33944-0,FREE LAMBDA LT CHAINS S,1
36916-5,FREE KAPPA LT CHAINS S,1
46182-2,COCCIDIOIDES AB IGG,1
60467-8,OXYMORPHONE,1
40965-6,SEROTYPE 20 (20),1
2829-0,POTASSIUM URINE,1
,APOLIPOPROTEIN B/A1 RATIO,1
78015-5,BW*-2,1
,MELATONIN,1
77214-5,PAROTID SPEC PROTEIN IGA ABS,1
2053-7,CAROTENE,2
88996-4,EPA/ARACHIDONIC ACID RATIO,1
3128-6,VISCOSITY  SERUM,1
35175-9,TOTAL SATURATED,1
77215-2,PAROTID SPEC PROTEIN IGG ABS,1
77213-7,CARBONIC ANHYDRASE VI IGM ABS,1
,CHROMIUM  RBC,1
,CHIKUNGUNYA IGG SCREEN,2
77212-9,CARBONIC ANHYDRASE VI IGG ABS,1
77216-0,PAROTID SPEC PROTEIN IGM ABS,1
2839-9,PROGESTERONE  SERUM,1
77208-7,SALIVARY PROTEIN 1 IGA ABS,1
27092-6,SEROTYPE 1 (1),1
3087-4,URIC ACID URINE,1
43423-3,SODIUM URATE,1
,FLUID DIFF TYPE,782
22761-1,PRISTANIC ACID,1
9813-7,CORTISOL  A.M.,1
3520-4,CYCLOSPORINE  LC-MS/MS,1
42678-3,URIC ACID,1
,T4  FREE (DIRECT),1
27390-4,SEROTYPE 19 (19F),1
,TRIMETHOPRIM/ SULFAMETHOXAZOLE,1
35176-7,TOTAL MONOUNSATURATED,1
27094-2,SEROTYPE 4 (4),1
53731-6,POSACONAZOLE  LC/MS/MS,1
34714-6,PT INR,149939
20569-0,CPK Total,27672
42757-5,ISTAT Troponin I,39552
20565-8,"Total CO2 (Calc), ISTAT POC",3459
3173-2,APTT,22822
2027-1,"Total CO2 (Calc), ISTAT POC",658
2713-6,"O2 Sat ( Calc), ISTAT POC",4083
14627-4,"HCO3, ISTAT POC",658
2021-4,"PCO2, ISTAT POC",684
2746-6,"PH, ISTAT POC",684
2705-2,"PO2, ISTAT POC",684
,RESP.Data. PS,92
2823-3,K Level,94308
48643-1,"Est. GFR, African American",79153
48642-3,"Est. GFR, Non-African American",79157
2345-7,"Glucose, Bld",81029
2951-2,Na Level,90650
1920-8,SGOT,56869
1742-6,SGPT,55262
1975-2,Total Bilirubin,54811
27353-2,Estimated Average Glucose,8394
4548-4,Hemoglobin A1C,29772
4544-3,HCT,86902
9830-1,Total Cholesterol HDL Ratio,7983
2085-9,Cholesterol HDL,7986
2571-8,Triglycerides,91612
777-3,Platelet Count (k/mm3),84677
28542-9,MPV,23549
26515-7,Plt-Hep Infusion (k/mm3),1346
17861-6,Calcium Level,89862
3097-3,BUN/Creatinine Ratio,95813
2028-9,CO2 Level,89828
2075-0,Cl Level,89977
1751-7,Albumin Level,55021
8251-1,"RESP.Data, VT",886
8251-1,"RESP.Data, EPAP",599
8251-1,"RESP.Data, IPAP",538
2703-7,"PO2, ISTAT POC",3517
11558-4,"PH, ISTAT POC",3517
32771-8,"PO2, (Temp Correct), ISTAT POC",666
6298-4,"Potassium, ISTAT POC",3484
20509-6,"Hemoglobin (Calc), ISTAT POC",3430
2947-0,"Sodium, ISTAT POC",3444
2019-8,"PCO2, ISTAT POC",3517
33254-4,"PH, (Temp Correct), ISTAT POC",663
32771-8,"PCO2, (Temp Correct), ISTAT POC",664
1959-6,"HCO3, ISTAT POC",3459
24323-8,Albumin Level,550
24323-8,Alkaline Phosphatase,1134
24323-8,SGPT,1082
24323-8,Total Bilirubin,647
24323-8,Total Protein,1089
24323-8,BUN,895
24323-8,BUN/Creatinine Ratio,970
24323-8,Calcium Level,451
24323-8,Cl Level,339
24323-8,"Est. GFR, African American",713
24323-8,"Est. GFR, Non-African American",711
24323-8,"Glucose, Bld",814
24323-8,Na Level,310
24323-8,Osmolality Calculated,1098
2339-0,"Glucose, ISTAT POC",3453
20570-8,"Hematocrit, ISTAT POC",3450
2339-0,"Bedside Glucose, Bld",114417
42637-9,B-Type Natriuretic Peptide,9645
24321-2,"Est. GFR, Non-African American",545
24321-2,"Glucose, Bld",562
24321-2,Osmolality Calculated,809
24323-8,CO2 Level,381
2756-5,"PH, UR",25370
2965-2,"Specific Gravity, UR",25521
24321-2,"Est. GFR, African American",547
24321-2,BUN,603
24321-2,BUN/Creatinine Ratio,714
13969-1,CKMB,7408
24323-8,SGOT,1103
30522-7,"C-Reactive Protein, High Sensitivity",4638
75241-0,Procalcitonin,8240
16362-6,Ammonia Level,2098
20578-1,Vancomycin Trough,1611
20578-1,Vancomycin Level,705
19123-9,"Magnesium, Hemolyzed Repeat Sample",508
,"Lactic Acid, Hemolyzed Repeat",38
32133-1,Lactic Acid - Venous,7197
13945-1,"RBC Microscopic, UR",16364
5821-4,"WBC Microscopic, UR",16348
3107-0,"Urobilinogen , UR",25343
5643-2,Alcohol Level,4499
1798-8,Amylase Serum,230
17863-2,Ionized Calcium,945
3040-3,Lipase Level,8155
2284-8,Folate,3214
2955-3,"Sodium, UR",1176
2695-5,"Osmolality, UR",560
41276-7,"Anion Gap, ISTAT POC",1634
2069-3,"Chloride, ISTAT POC",1650
6299-2,"BUN, ISTAT POC",1650
38483-4,"Creatinine, ISTAT POC",2345
1994-3,"Ionized Calcium, ISTAT POC",2345
20565-8,"Total CO2 (Measured), ISTAT POC",1642
6873-4,Beta-Hydroxybutyrate,648
45390-2,Squamous Epithelial Cells,14471
20627-6,"Turbidity, UR",25367
58410-2,MPV,258
60474-4,"Absol. Retic Count, Automated",1500
17849-1,"Retic Percent, Automated",1737
2276-4,Ferritin Level,2119
58410-2,HCT,846
5796-8,"Hyaline Casts, UR",4931
2132-9,Vitamin B12 Level,3287
2502-3,Percent Iron Saturation,3144
58410-2,MCH,842
58410-2,RBC,834
58410-2,RDW,838
58410-2,WBC,2452
58410-2,MCHC,838
58410-2,MCV,833
34714-6,Whole Blood INR,378
3298-7,Acetaminophen Level,114
20468-5,"Vitamin B1 (Thiamine), Plasma",77
2731-8,Intact PTH,750
1989-3,"Vit D, 25-Hydroxy Level",802
3273-0,Unfractionated Heparin Assay,409
15013-6,"Fractionated Alkaline Phos., Bone",7
15015-1,"Fractionated Alkaline Phos., Liver",7
6768-6,"Fractionated Alkaline Phos., Total",7
24324-6,Alkaline Phosphatase,6
24324-6,SGOT,4
24324-6,SGPT,4
24324-6,Total Protein,5
1975-2,"Total Bilirubin, HFPA",671
1968-7,Bilirubin Direct,50915
1920-8,"SGOT, HFPA",659
1751-7,"Albumin, HFPA",677
6768-6,"Alkaline Phosphatase, HFPA",662
14805-6,LDH,1205
2143-6,Cortisol Level,499
2161-8,"Creatinine, UR",1081
31203-3,"5-HIAA, UR",1
,24-Hr Urine Volume,12
2141-0,ACTH Highly Sensitive,124
1695-6,"5-HIAA, UR, 24 Hr",1
3051-0,Free T3 (Triiodothyronine),182
19050-4,"Metanephrines, UR",12
,Units,16
19049-6,"Metanephrines, UR, 24Hr",3
21422-1,"Normetanephrine, UR",12
2671-6,"Normetanephrine, UR, 24Hr",3
24323-8,K Level,298
8251-1,"RESP.Data, PC",59
50262-5,"Retic Percent, Automated",235
50262-5,"Absol. Retic Count, Automated",238
14135-8,ABS. CD 8 SUPPRESSOR,87
8101-8,% CD 8 POS. LYMPH.,92
8117-4,% CD19+ LYMPHS,92
8116-6,ABS.CD19+ LYMPHS,87
29541-0,"HIV-1 RNA PCR, LOG10",80
46216-8,Quantiferon Mitogen Value,26
20447-9,"HIV-1 RNA PCR, Copies/ML",80
13965-9,Homocysteine-Ser Quant,15
13964-2,Methylmalonic Acid Level,29
731-0,LYMPH ABSOLUTE,87
785-6,MCH.,92
786-4,MCHC.,92
787-2,MCV.,92
742-7,MONO ABSOLUTE,87
751-8,NEUT ABSOLUTE,87
788-0,RDW.,92
777-3,PLATELETS.,92
2888-6,Protein UR,242
19113-0,Immunoglobulin E,16
31406-2,Anti-GBM,18
46266-3,Anti-Myeloperoxidase Antibody,79
46267-1,Anti-Proteinase-3 Antibody,79
5130-0,Anti-DS-DNA,67
11572-5,Rheumatoid Arthritis Factor,78
32771-8,PCO2 (Temp Corrected),1643
2714-4,Oxyhemoglobin,1631
2019-8,PCO2,1643
19255-9,PO2 (Temp Corrected),1643
33254-4,PH (Temp Corrected),1641
2703-7,PO2,1643
20565-8,Total CO2,1439
32713-0,Gas Potassium,541
2708-6,"Oxygen Saturation, Arterial",1370
4544-3,Gas Hematocrit,465
718-7,Gas Hemoglobin,465
2518-9,Arterial Blood Lactate,378
12228-3,"Triglyceride, Fluid",59
2748-2,"PH, Fluid",245
2881-1,"Total Protein, Fluid",430
60017-1,"LDH, Fluid",402
2344-0,"Glucose, Fluid",399
12515-3,"Carcinoembryonic Antigen, Fluid",45
3169-0,"Fluid Volume, BF",554
1747-5,"Albumin, Fluid",129
1795-4,"Amylase, Fluid",61
2465-3,Immunoglobulin  G,45
3298-7,Acetominophen Level,1285
2705-2,"PO2, VBG",226
2021-4,"PCO2, VBG",226
40619-9,"PCO2, VBG (Temp Corrected)",225
2746-6,"PH, VBG",226
39486-6,"PH, VBG (Temp Corrected)",225
19258-3,"PO2, VBG (Temp Corrected)",225
2027-1,"Total CO2, VBG",225
2518-9,Venous Lactic Acid,37
14627-4,"HCO3, VBG",225
2716-9,"Oxyhemoglobin, VBG",224
4485-9,Complement C3,67
49503-6,Atypical pANCA Ab.,79
16285-9,Protein Creatinine Ratio,85
2868-8,Alpha 2,36
2871-2,Beta,37
2874-6,Gamma,36
10834-0,Total Globulin,20
13992-3,Albumin UR,4
1759-0,A G Ratio,37
2862-1,Albumin Level,20
2865-4,Alpha 1,37
6948-4,Lamictal (Lamotrigine) Level,42
50564-4,"PH, UR",107
50564-4,"Turbidity, UR",111
24321-2,Cl Level,217
24321-2,Calcium Level,271
24321-2,CO2 Level,238
24321-2,K Level,230
24108-3,Ca 19-9 Antigen,50
3095-7,"Urea Nitrogen, UR",69
5793-5,"Granular Casts, UR",306
46136-8,Transitional Epithelial Cells,30
34556-1,"Fluid Volume, BF",25
50564-4,"Urobilinogen , UR",108
35668-3,Gentamicin Level,19
12841-3,"Prostate Specific AG, % Free",16
10886-0,"Prostate Specific AG, Free",16
2857-1,"Prostate Specific AG, Total",16
2571-8,Triglyceride Level,122
3968-5,Dilantin Level,491
39486-6,"PH, (Temp Correct), ISTAT POC",89
19258-3,"PO2, (Temp Correct), ISTAT POC",92
40619-9,"PCO2, (Temp Correct), ISTAT POC",93
42957-1,COVID-19 IGG AB,116
24356-8,"PH, UR",52
2749-0,Gastroccult PH,14
24321-2,Na Level,195
32133-1,"Lactic Acid, Hemolyzed Repeat",131
5064-1,"Lyme IGM Ab, QN",20
34148-7,"Lyme IGG/IGM Ab, EIA",21
38995-7,"Cellular Casts, UR",34
34661-9,"Smooth Muscle (Actin) Antibody, IgG",45
1825-9,Alpha-1-Antitrypsin,27
14251-3,Mitochondrial M2 AB,39
2064-4,Ceruloplasmin Level,27
24331-1,Triglycerides,45
24325-3,SGPT,67
13926-1,GAD-65 Autoantibody,10
14957-5,"Microalbumin Random, UR",37
14959-1,Albumin/Creatinine Ratio (MG/G),37
58077-9,"PH, UR",13
58077-9,"Specific Gravity, UR",5
4086-5,Valproic Acid Level,466
33944-0,"Free Lambda Light Chains, Serum",45
11050-2,"Free Kappa Light Chains, Serum",45
15189-4,"Kappa/Lambda Ratio, Serum",45
24336-0,HCO3,19
24336-0,ABG Correction Temperature,18
24336-0,Oxyhemoglobin,26
24336-0,"Oxygen Saturation, Arterial",22
24336-0,PO2,16
24336-0,PCO2,17
24336-0,PCO2 (Temp Corrected),17
24336-0,PH,18
24336-0,PH (Temp Corrected),19
24336-0,PO2 (Temp Corrected),17
24336-0,Total CO2,17
18262-6,"LDL, Direct",8
19076-9,Total Cells Counted,34
30166-3,Thyroid Stimul. IG,19
14338-8,Prealbumin Level,188
41171-0,"CTX, C-Terminal Telopeptide",22
5631-7,"Copper, Serum or Plasma",10
,"SRA, % Release Low Dose Heparin",37
50727-7,"SRA, % Release High Dose Heparin",37
30471-7,Levetiracetam (Keppra) Level,191
46133-5,"Epithelial Casts, UR",1
24331-1,Cholesterol,17
24331-1,Total Cholesterol HDL Ratio,39
,Cotinine Level,2
,Nicotine Level,2
53967-6,"Dysmorphic RBC, UR",4
2828-2,"Potassium, UR",41
20427-1,Acetylcholine Receptor AB,12
2964-5,"Specific Gravity, Fluid",183
49010-2,P2Y12 Reaction Units,189
3169-0,"Fluid Volume, CSF",141
19157-7,"Tube Number, CSF",141
2965-2,"""""Specific Gravity, UR""""""""""""""""""""",3308
2756-5,"""""PH, UR""""""""""""""""""""",3305
48643-1,"""""Est. GFR, African American""""""""""""""""""""",7961
48642-3,"""""Est. GFR, Non-African American""""""""""""""""""""",7961
2345-7,"""""Glucose, Bld""""""""""""""""""""",8163
2339-0,"""""Bedside Glucose, Bld""""""""""""""""""""",8078
3024-7,Total Protein,9265
13945-1,"""""RBC Microscopic, UR""""""""""""""""""""",2030
5821-4,"""""WBC Microscopic, UR""""""""""""""""""""",2030
3107-0,"""""Urobilinogen , UR""""""""""""""""""""",3310
50564-4,"""""Specific Gravity, UR""""""""""""""""""""",37
50564-4,"""""Turbidity, UR""""""""""""""""""""",40
42637-9,"BNP, Hemolyzed Repeat Sample",99
17849-1,"""""Retic Percent, Automated""""""""""""""""""""",220
60474-4,"""""Absol. Retic Count, Automated""""""""""""""""""""",218
30522-7,"""""C-Reactive Protein, High Sensitivity""""""""""""""""""""",324
1989-3,"""""Vit D, 25-Hydroxy Level""""""""""""""""""""",92
15087-0,PTH-Related Protein,18
50564-4,"""""PH, UR""""""""""""""""""""",42
2708-6,"""""Oxygen Saturation, Arterial""""""""""""""""""""",257
58710-5,"""""Gliadin Ab, IGG""""""""""""""""""""",2
58709-7,"""""Gliadin Ab, IGA""""""""""""""""""""",2
31017-7,t-Transglutaminase (tTG) IgA,19
20627-6,"""""Turbidity, UR""""""""""""""""""""",3304
5796-8,"""""Hyaline Casts, UR""""""""""""""""""""",686
2519-7,"""""Lactate, ISTAT POC""""""""""""""""""""",87
2028-9,Total CO2,204
45155-9,Heparin Induced Platelet,39
5793-5,"""""Granular Casts, UR""""""""""""""""""""",18
3174-0,Antithrombin III Level,9
13590-5,Activated Protein C Resistance,1
27821-8,"Protein S, Free",4
27819-2,Protein C Functional,11
5892-5,"Protein S, Total",4
2986-8,"Testosterone, Total",13
2842-3,Prolactin Level,31
2484-4,Somatomedin-C,20
35670-9,Tobramycin Level,1
32713-0,"Gas Potassium, VBG",17
15067-2,FSH Serum,15
19123-9,"""""Magnesium, Hemolyzed Repeat Sample""""""""""""""""""""",60
2955-3,"""""Sodium, UR""""""""""""""""""""",123
3432-2,Carbamazepine Level,41
1975-2,"""""Total Bilirubin, HFPA""""""""""""""""""""",48
1971-1,"""""Bilirubin Indirect, HFPA""""""""""""""""""""",42
1920-8,"""""SGOT, HFPA""""""""""""""""""""",48
1751-7,"""""Albumin, HFPA""""""""""""""""""""",48
6768-6,"""""Alkaline Phosphatase, HFPA""""""""""""""""""""",48
21198-7,"""""Beta Hcg, Quant""""""""""""""""""""",115
57093-7,Cyclic Citrul Peptide IgG Antibodies,46
2161-8,"""""Creatinine, UR""""""""""""""""""""",118
14627-4,"""""HCO3, VBG""""""""""""""""""""",22
2746-6,"""""PH, VBG""""""""""""""""""""",22
2716-9,"""""Oxyhemoglobin, VBG""""""""""""""""""""",22
2021-4,"""""PCO2, VBG""""""""""""""""""""",22
40619-9,"""""PCO2, VBG (Temp Corrected)""""""""""""""""""""",22
39486-6,"""""PH, VBG (Temp Corrected)""""""""""""""""""""",22
2705-2,"""""PO2, VBG""""""""""""""""""""",22
19258-3,"""""PO2, VBG (Temp Corrected)""""""""""""""""""""",22
2027-1,"""""Total CO2, VBG""""""""""""""""""""",22
50564-4,"Specific Gravity, UR",11
24323-8,"""""Glucose, Bld""""""""""""""""""""",31
24323-8,"""""Est. GFR, African American""""""""""""""""""""",24
24323-8,"""""Est. GFR, Non-African American""""""""""""""""""""",25
4548-4,Estimated Average Glucose,21
3095-7,"""""Urea Nitrogen, UR""""""""""""""""""""",13
50262-5,"""""Absol. Retic Count, Automated""""""""""""""""""""",46
1971-1,Bilirubin Indirect,83
3520-4,Cyclosporin Level,15
38483-4,"""""Creatinine, ISTAT POC""""""""""""""""""""",103
2339-0,"""""Glucose, ISTAT POC""""""""""""""""""""",93
1959-6,"""""HCO3, ISTAT POC""""""""""""""""""""",64
20570-8,"""""Hematocrit, ISTAT POC""""""""""""""""""""",93
20509-6,"""""Hemoglobin (Calc), ISTAT POC""""""""""""""""""""",92
2703-7,"""""PO2, ISTAT POC""""""""""""""""""""",64
1994-3,"""""Ionized Calcium, ISTAT POC""""""""""""""""""""",92
2713-6,"""""O2 Sat ( Calc), ISTAT POC""""""""""""""""""""",88
2019-8,"""""PCO2, ISTAT POC""""""""""""""""""""",64
11558-4,"""""PH, ISTAT POC""""""""""""""""""""",64
6298-4,"""""Potassium, ISTAT POC""""""""""""""""""""",91
2947-0,"""""Sodium, ISTAT POC""""""""""""""""""""",93
20565-8,"""""Total CO2 (Calc), ISTAT POC""""""""""""""""""""",64
,Troponin I High Sensitivity,52
4477-6,C1 Esterase Inhibitor,9
50262-5,"""""Retic Percent, Automated""""""""""""""""""""",44
5820-6,"WBC Casts, UR",12
2695-5,"""""Osmolality, UR""""""""""""""""""""",51
62292-8,"25 Hydroxy, Vitamin D",15
49054-0,"25 Hydroxy, Vitamin D-2",15
1989-3,"25 Hydroxy, Vitamin D-3",15
5048-4,"ANA Titer, Indirect IFA",39
4532-8,Total Complement,8
47938-6,Fluid Creatinine Source,5
12190-5,"Creatinine, Fluid",5
24351-9,Beta,75
24351-9,Alpha 1,75
24351-9,Alpha 2,76
24351-9,Gamma,76
24351-9,A G Ratio,75
24351-9,Albumin Level,76
5126-8,CMV AB IgM,17
5124-3,CMV AB IgG,17
5206-8,Herpes Simplex 1 IgG AB,6
5209-2,Herpes Simplex 2 IgG AB,6
2333-3,Gastrin Level,5
3125-2,Vasoactive Intestinal Polypep.,2
11090-8,Anti-SM Antibody,37
5076-5,Anticardiolipin IgA,34
3182-3,Anticardiolipin IgM,34
3181-5,Anticardiolipin IgG,34
29374-6,Anti-SM/RNP Antibody,37
17792-3,SS-A Antibody,35
27416-7,Scleroderma Antibody,30
17791-5,SS-B Antibody,35
11253-2,Tacrolimus Level,45
1649-3,"Vit D 1, 25-Dihydroxy Level",60
2742-5,Angiotensin Conv Enz - Serum,10
6303-2,DRVVT Screen Seconds,10
16135-6,"Beta-2 Glycoprotein I, IgG",10
40595-1,"Antiprothrombin Ab, IgG",10
21108-6,"Beta-2 Glycoprotein I, IgA",10
16136-4,"Beta-2 Glycoprotein I, IgM",10
2344-0,"""""Glucose, Fluid""""""""""""""""""""",20
3169-0,"""""Fluid Volume, BF""""""""""""""""""""",32
2881-1,"""""Total Protein, Fluid""""""""""""""""""""",21
2748-2,"""""PH, Fluid""""""""""""""""""""",14
2964-5,"""""Specific Gravity, Fluid""""""""""""""""""""",11
60017-1,"""""LDH, Fluid""""""""""""""""""""",20
24321-2,"""""Est. GFR, African American""""""""""""""""""""",30
24321-2,"""""Est. GFR, Non-African American""""""""""""""""""""",29
24321-2,"""""Glucose, Bld""""""""""""""""""""",29
24325-3,"""""Bilirubin Indirect, HFPA""""""""""""""""""""",5
5804-0,"Urine Total Protein, Electrophoresis",19
42637-9,"""""BNP, Hemolyzed Repeat Sample""""""""""""""""""""",12
2641-9,"Myoglobin QN, UR",9
2027-1,"""""Total CO2 (Calc), ISTAT POC""""""""""""""""""""",26
2705-2,"""""PO2, ISTAT POC""""""""""""""""""""",26
2746-6,"""""PH, ISTAT POC""""""""""""""""""""",26
2021-4,"""""PCO2, ISTAT POC""""""""""""""""""""",26
14627-4,"""""HCO3, ISTAT POC""""""""""""""""""""",26
3270-6,Low Molecular Weight Heparin,33
24331-1,Cholesterol HDL,32
35668-3,Gentamicin Trough,9
8098-6,Thyroglobulin AB,31
8099-4,Thyroid Peroxidase AB,31
17862-4,"Calcium, UR",12
58410-2,Plt-Hep Infusion (k/mm3),28
3128-6,Viscosity,58
11228-4,Uropophyrins (UP),5
2991-8,"Testosterone, Free Direct",9
2669-0,"Normetanephrines, Frac., Pl. Free",13
38494-1,"Metanephrines, Frac., Pl. Free",13
2243-4,Estradiol Level,8
24325-3,"Bilirubin Indirect, HFPA",116
13771-1,Metanephrine/Creatinine Ratio,10
2161-8,"Creatinine, UR, Metanephrine Screen",12
2193-1,DHEA Level,5
1668-3,17OH-Progesterone,4
2216-0,"Dopamine Level, Plasma",8
2230-1,"Epinephrine Level, Plasma",8
2666-6,"Norepinephrine Level, Plasma",8
1823-4,"Vitamin E, Alpha Tocopherol",3
63370-1,"Vitamin E, Gamma Tocopherol",3
,ISTAT INR,8
,ISTAT PT,8
5176-3,H. Pylori IgG AB,30
,Antibody To PM-Scl,1
53622-7,ADAMTS13 Activity result,5
5902-2,PT 1:1 Mix Immediate,5
5902-2,PT 1:1 Mix Incubated,6
50190-8,Percent Iron Saturation,25
50190-8,Iron Level,24
33254-4,"""""PH, (Temp Correct), ISTAT POC""""""""""""""""""""",13
32771-8,"""""PCO2, (Temp Correct), ISTAT POC""""""""""""""""""""",13
32771-8,"""""PO2, (Temp Correct), ISTAT POC""""""""""""""""""""",13
26464-8,"""""WBC, BF""""""""""""""""""""",29
10334-1,Ca 125,37
32713-0,"""""Gas Potassium, VBG""""""""""""""""""""",8
2078-4,"Chloride, UR",20
24331-1,VLDL,33
58077-9,"Urobilinogen , UR",13
,Gas Comment,1650
2106-3,Pregnancy Test - Urine Specific Gravity,9
34556-1,"""""WBC, BF""""""""""""""""""""",5
34661-9,"""""Smooth Muscle (Actin) Antibody, IgG""""""""""""""""""""",1
1747-5,"""""Albumin, Fluid""""""""""""""""""""",4
5048-4,ANA Titer,109
12841-3,"""""Prostate Specific AG, % Free""""""""""""""""""""",4
10886-0,"""""Prostate Specific AG, Free""""""""""""""""""""",4
2857-1,"""""Prostate Specific AG, Total""""""""""""""""""""",4
50727-7,"""""SRA, % Release High Dose Heparin""""""""""""""""""""",3
,"""""SRA, % Release Low Dose Heparin""""""""""""""""""""",3
48054-1,"""""Activated Clotting Time, High Range""""""""""""""""""""",22
20565-8,"""""Total CO2 (Measured), ISTAT POC""""""""""""""""""""",5
6299-2,"""""BUN, ISTAT POC""""""""""""""""""""",5
41276-7,"""""Anion Gap, ISTAT POC""""""""""""""""""""",5
2069-3,"""""Chloride, ISTAT POC""""""""""""""""""""",5
2216-0,"""""Dopamine Level, Plasma""""""""""""""""""""",5
2230-1,"""""Epinephrine Level, Plasma""""""""""""""""""""",5
2666-6,"""""Norepinephrine Level, Plasma""""""""""""""""""""",5
38494-1,"""""Metanephrines, Frac., Pl. Free""""""""""""""""""""",4
2669-0,"""""Normetanephrines, Frac., Pl. Free""""""""""""""""""""",4
31203-3,"""""5-HIAA, UR""""""""""""""""""""",1
1695-6,"""""5-HIAA, UR, 24 Hr""""""""""""""""""""",1
20468-5,"""""Vitamin B1 (Thiamine), Plasma""""""""""""""""""""",15
26465-5,"""""WBC, CSF""""""""""""""""""""",16
3169-0,"""""Fluid Volume, CSF""""""""""""""""""""",16
19157-7,"""""Tube Number, CSF""""""""""""""""""""",16
24446-7,"""""Porphobilinogen, UR""""""""""""""""""""",1
3218-5,"""""Factor X Activity, Clotting""""""""""""""""""""",2
5804-0,"""""Urine Total Protein, Electrophoresis""""""""""""""""""""",3
11050-2,"""""Free Kappa Light Chains, Serum""""""""""""""""""""",3
33944-0,"""""Free Lambda Light Chains, Serum""""""""""""""""""""",3
15189-4,"""""Kappa/Lambda Ratio, Serum""""""""""""""""""""",3
2986-8,"""""Testosterone, Total""""""""""""""""""""",1
2991-8,"""""Testosterone, Free Direct""""""""""""""""""""",1
1763-2,Aldosterone Serum,25
20624-3,"Creatinine, UR, 24Hr",26
30211-7,Coll Period (Hours),28
2191-5,"DHEA Sulfate, LCMS",10
3169-0,Volume (MLs),28
2915-7,Plasma Renin,26
2667-4,"Norephinephrine, UR.",2
2217-8,"Dopamine, UR",2
11046-0,"Epinephrine, UR",2
58709-7,"Gliadin Ab, IGA",6
58710-5,"Gliadin Ab, IGG",6
20447-9,"""""HIV-1 RNA PCR, Copies/ML""""""""""""""""""""",4
24356-8,"Urobilinogen , UR",52
9622-2,"Vitamin K1, Serum",2
1903-4,Vitamin C Level,3
2923-1,Vitamin A Level,4
14957-5,"""""Microalbumin Random, UR""""""""""""""""""""",2
5273-8,Parvovirus B19 IgG,6
711-2,Absolute Eosinophil Count (k/mm3),1
,G6PD Patient,5
718-7,G6PD Specimen Hemoglobin,5
,G6PD Control,5
38180-6,"""""HCV RNA PCR, LOG10""""""""""""""""""""",2
11011-4,"""""HCV RNA PCR, Quantitative""""""""""""""""""""",2
34539-7,"Urine Total Protein, Electrophoresis",10
38180-6,"HCV RNA PCR, LOG10",15
11011-4,"HCV RNA PCR, Quantitative",29
6303-2,Lupus Anticoag. - DRVVT,9
34571-0,Lupus Anticoag. - PTT LA,9
3193-0,Factor V,2
3209-4,Factor VIII,59
34569-4,Lupus Anticoag. - DRVVT MIX,4
27820-0,Protein C antigen,5
27822-6,Protein S Functional,9
34535-5,Albumin/Creatinine Ratio (MG/G),13
34535-5,"Microalbumin Random, UR",3
24356-8,"Turbidity, UR",52
24336-0,Base Excess,20
29580-8,Fluid Segs,6
29580-8,Fluid Lymphs,6
29580-8,Fluid Monos,6
3126-0,Arginine Vasopressin Level,1
41171-0,"""""CTX, C-Terminal Telopeptide""""""""""""""""""""",1
27882-0,Proinsulin Level,24
1952-1,Beta-2 Microglobulin - Serum,7
789-8,"""""RBC, CSF""""""""""""""""""""",16
2667-4,"""""Norephinephrine, UR.""""""""""""""""""""",1
2232-7,"""""Epinephrine, 24 Hr UR""""""""""""""""""""",1
11046-0,"""""Epinephrine, UR""""""""""""""""""""",1
2668-2,"""""Norephinephrine, 24 Hr UR""""""""""""""""""""",1
19050-4,"""""Metanephrines, UR""""""""""""""""""""",1
2161-8,"""""Creatinine, UR, Metanephrine Screen""""""""""""""""""""",1
21422-1,"""""Normetanephrine, UR""""""""""""""""""""",1
2217-8,"""""Dopamine, UR""""""""""""""""""""",1
2218-6,"""""Dopamine, 24 Hr UR""""""""""""""""""""",1
15069-8,Fructosamine Level,7
1761-6,Aldolase Level,7
49054-0,"""""25 Hydroxy, Vitamin D-2""""""""""""""""""""",3
62292-8,"""""25 Hydroxy, Vitamin D""""""""""""""""""""",3
1989-3,"""""25 Hydroxy, Vitamin D-3""""""""""""""""""""",3
45391-0,Renal Epithelial Cells,7
6774-4,Noramiodarone Level,7
3330-8,Amiodarone Level,7
39486-6,"""""PH, (Temp Correct), ISTAT POC""""""""""""""""""""",4
40619-9,"""""PCO2, (Temp Correct), ISTAT POC""""""""""""""""""""",4
19258-3,"""""PO2, (Temp Correct), ISTAT POC""""""""""""""""""""",4
48054-1,"Activated Clotting Time, Low Range",15
35331-8,Trileptal Level (10-Hydroxycarbazepine),21
24325-3,"SGOT, HFPA",25
24325-3,Total Protein,23
24325-3,"Alkaline Phosphatase, HFPA",25
18487-9,"Broad Casts, UR",4
16136-4,"Beta-2 Glycoprotein I Ab, IGM",4
21108-6,"Beta-2 Glycoprotein I Ab, IGA",4
16135-6,"Beta-2 Glycoprotein I Ab, IGG",4
24339-4,"Oxyhemoglobin, VBG",4
24339-4,"Base Excess, VBG",4
24339-4,"HCO3, VBG",4
24339-4,"Oxygen Saturation, Venous",4
24339-4,"PH, VBG (Temp Corrected)",4
24339-4,"PCO2, VBG",3
24339-4,"PCO2, VBG (Temp Corrected)",4
24339-4,"PH, VBG",3
24339-4,"PO2, VBG",3
24339-4,"PO2, VBG (Temp Corrected)",4
24339-4,"Total CO2, VBG",4
24339-4,VBG Correction Termperature,4
2218-6,"Dopamine, 24 Hr UR",2
2139-4,Corticosterone Level,1
2232-7,"Epinephrine, 24 Hr UR",2
2668-2,"Norephinephrine, 24 Hr UR",2
53982-5,Anticentromere Antibody,1
51775-5,Antichromatin Antibodies,1
5819-8,"""""Waxy Casts, UR""""""""""""""""""""",1
58077-9,"Turbidity, UR",12
15359-3,Lupus anticoag. - DRVVT CONFIRM,3
3289-6,"Factor II Activity, Clotting",2
5048-4,"ANA Titer 2, Indirect IFA",3
23906-1,Mycophenolic Acid Glucuronide,120
23905-3,Mycophenolic Acid Level,3
38180-6,HCV LOG10 (QNT PLUS),2
11011-4,HCV RNA -IU (QNT PLUS),2
2889-4,"Protein, UR, 24Hr",10
48398-2,HBV LOG 10,5
42595-9,Hepatitis B Quantitation,5
18262-6,"""""LDL, Direct""""""""""""""""""""",7
2778-9,"Phosphorus, UR",5
50190-8,Transferrin,23
50190-8,TIBC,24
2282-2,"FOLATE, HEMOLYSATE",1
34148-7,"""""Lyme IGG/IGM Ab, EIA""""""""""""""""""""",2
5064-1,"""""Lyme IGM Ab, QN""""""""""""""""""""",2
24325-3,"Albumin, HFPA",10
24325-3,"Total Bilirubin, HFPA",15
35668-3,Gentamicin Peak,3
1649-3,"""""Vit D 1, 25-Dihydroxy Level""""""""""""""""""""",5
24446-7,"Porphobilinogen, UR",1
50760-8,Lupus Anticoag. - PTT LA INC MIX,1
52134-4,Lupus Anticoag. - PTT LA MIX,1
2483-6,IGF Binding Protein-3,2
777-3,Platelet Function PLT (k/mm3),5
24472-3,Collagen with ADP,5
4544-3,Platelet Function HCT,5
41399-7,"Herpes Simplex, IgM I/II Combo",5
25418-5,Mumps IgG Antibody,1
7967-3,Mumps IgM Antibody,1
57838-5,DRVVT Confirm Seconds,10
50410-0,DRVVT Ratio,10
17713-9,"Topiramate (Topamax), Serum",7
17842-6,Ca 27.29,1
24336-0,"""""Oxygen Saturation, Arterial""""""""""""""""""""",1
3175-7,Antithrombin Ag,1
3494-2,Clonazepam Level,3
1992-7,Calcitonin Level,4
13969-1,CKMB Percent,2
2077-6,"""""Sweat Chloride, Site 1""""""""""""""""""""",1
5048-4,"""""ANA Titer, Indirect IFA""""""""""""""""""""",4
47255-5,"P1NP, N-Term PropeptideType1 Procollagen",3
6874-2,"Calcium, UR, 24Hr",1
24324-6,Total Bilirubin,3
2157-6,"CK,TOTAL",4
34535-5,"Creatinine, UR",3
2338-2,Glucagon Level,1
25303-9,"Alpha-1-Antitrypsin, Stool",1
5959-2,PT 1:1 Mix Incubated,8
5959-2,PT 1:1 Mix Immediate,8
6954-2,B. Henselae IgG Screen (Cat Scratch Ab),1
6955-9,B. Henselae IgM Screen (Cat Scratch Ab),1
1746-7,Albumin CSF,5
40824-5,ADAMTS13 Antibody,2
5388-4,"""""Toxoplasma Gondii AB, IgG, QN""""""""""""""""""""",1
5390-0,"""""Toxoplasma Gondii AB, IgM, QN""""""""""""""""""""",1
21527-7,"""""Sodium, UR, 24Hr""""""""""""""""""""",1
20624-3,"""""Creatinine, UR, 24Hr""""""""""""""""""""",2
29541-0,"""""HIV-1 RNA PCR, LOG10""""""""""""""""""""",4
51695-5,"""""Chloride, UR, 24Hr""""""""""""""""""""",1
5159-9,"EBV Capsid AB, IgM",4
5157-3,"EBV Capsid AB, IgG",4
30083-0,"EBV Nuclear AG AB, IgG",4
32220-6,Liver-Kidney Microsomal Ab,2
5388-4,"Toxoplasma Gondii AB, IgG, QN",7
5390-0,"Toxoplasma Gondii AB, IgM, QN",7
5255-5,"Mycoplasma pneumoniae AB, IgG",2
5256-3,"Mycoplasma pneumoniae AB, IgM",2
35670-9,Tobramycin Trough,1
3335-7,"Total, Amitriptyline Level",3
5763-8,"Zinc, Plasma or Serum",3
5724-0,Selenium Serum,1
9537-2,Intrinsic Factor Ab,1
17838-4,"Alk Phos.- Bone, Tandem R Ostase",1
13546-7,Amikacin Level,5
5574-9,Aluminum Level,2
5334-8,"Rubella Antibody, IgG",5
21527-7,"Sodium, UR, 24Hr",3
14246-3,Antiphosphatidylserine IgM Ab,2
13069-0,Antiphosphatidylserine IgA Ab,2
14245-5,Antiphosphatidylserine IgG Ab,2
31147-2,RPR Titer,15
30316-4,Alpha Subunit,1
50564-4,"""""Urobilinogen , UR""""""""""""""""""""",35
2077-6,"Sweat Chloride, Site 1",2
2077-6,"Sweat Chloride, Site 2",2
18487-9,"""""Broad Casts, UR""""""""""""""""""""",1
14979-9,PTT 1:1 Mix Incubated,2
14979-9,PTT 1:1 Mix Immediate,2
14875-9,"""""Phenylalanine, Plasma, QN""""""""""""""""""""",1
3086-6,"Uric Acid, UR",1
13546-7,Amikacin Trough,1
29263-1,FDP,49
10328-3,"""""Lymphs, CSF""""""""""""""""""""",3
26492-9,"""""Monocytes, CSF""""""""""""""""""""",3
14107-7,"""""Segs, CSF""""""""""""""""""""",3
1765-7,"""""Aldosterone, UR, 24Hr""""""""""""""""""""",1
1764-0,"""""Aldosterone, UR""""""""""""""""""""",1
24356-8,"""""Blood, UR""""""""""""""""""""",2
24356-8,"""""Specific Gravity, UR""""""""""""""""""""",2
24356-8,"""""PH, UR""""""""""""""""""""",2
24356-8,"""""Turbidity, UR""""""""""""""""""""",2
24356-8,"""""Urobilinogen , UR""""""""""""""""""""",1
5631-7,"""""Copper, Serum or Plasma""""""""""""""""""""",2
58077-9,"""""Specific Gravity, UR""""""""""""""""""""",1
58077-9,"""""PH, UR""""""""""""""""""""",1
5807-3,"RBC Casts, UR",8
,County Code,2
5583-0,Arsenic Level,2
,Hispanic Ethnicity,2
44805-0,Log10 BK Qn PCR,3
3218-5,"Factor X Activity, Clotting",2
,Factor VIII Bethesda Titer,2
27816-8,von Willebrand Factor (vWF) Ag.,1
50377-1,vWF Collagen Binding Activity,2
5946-9,aPTT 1:1 Normal Plasma,11
30323-0,"aPTT 1:1 Normal Plasma Mix, 60 min incub",1
38521-1,Factor VIII Antigen,2
29247-4,Sirolimus (Rapamycin) Level,1
30465-9,Prolymphocytes,1
2093-3,Cholesterol Total,12
3124-5,"VMA/g Creatinine, Random UR",3
9624-8,"VMA Random, UR",3
,RESP.Data. T PEEP,2
,RESP.Data. P HIGH,2
,RESP.Data. T HIGH,1
,"Misc. Fluid, Test Result",1
1764-0,"Aldosterone, UR",2
1765-7,"Aldosterone, UR, 24Hr",2
31032-6,Saccharomyces cerevisiae IGA,1
6713-2,Saccharomyces cerevisiae IGG,1
24324-6,Albumin Level,2
5685-3,Mercury Level,2
5671-3,Lead Level,2
38995-7,"""""Cellular Casts, UR""""""""""""""""""""",2
34556-1,"""""Fluid Volume, BF""""""""""""""""""""",2
1795-4,"""""Amylase, Fluid""""""""""""""""""""",3
12228-3,"""""Triglyceride, Fluid""""""""""""""""""""",3
24360-0,Gas Hemoglobin,2
24360-0,Gas Hematocrit,2
48054-1,"""""Activated Clotting Time, Low Range""""""""""""""""""""",3
47282-9,MCV,9270
,MONOCYTE,906
,ABSOLUTE MONOCYTES,1926
,WHITE BLOOD CELL COUNT,2792
1920-8,ALT (SGPT),6105
2160-0,"Creatinine, Serum",7880
46418-0,INR,2926
,ALT (SGPT),411
,INR,372
,LDL Chol Calc (NIH),1437
2075-0,"Chloride, Serum",6811
47278-7,MCH,9267
2345-7,"Glucose, Serum",7016
50044-7,eGFR NON-AFR. AMERICAN,2998
,Alkaline Phosphatase,392
50044-7,eGFR If Africn Am,6828
,T. Chol/HDL Ratio,4692
,Neutrophils (%),3780
,BUN CREATININE RATIO,1333
,NEUTROPHIL (%),869
11054-4,LDL Cholesterol Calc,3411
74400-3,Monocytes,3893
47277-9,RDW,9268
,Triglycerides,335
,Psychosocial Management,215
,Estimated Gestational Age,1121
11151-8,Hematocrit,5782
2951-2,"Sodium, Serum",6812
50044-7,eGFR If NonAfricn Am,6830
2089-1,LDL-CHOLESTEROL,2481
,Neutrophils (Absolute),4187
,SED RATE BY MODIFIED$WESTERGREN,400
,Lymphs (%),3744
2823-3,"Potassium, Serum",6822
,HDL Cholesterol,335
41653-7,Glucose Finger Stick,3831
,Platelets,5908
,MICROALBUMIN,395
,B-Type Natriuretic Peptide,779
,"Sodium, Serum",493
,eGFR If Africn Am,492
17861-6,"Calcium, Serum",6823
11151-8,HEMATOCRIT,3521
,"Microalbumin, Urine",1259
,"Chloride, Serum",493
,CHOL/HDLC RATIO,95
,"Est. GFR, NOT AFRICAN AMERICAN",1333
,Speckled Pattern,115
5964-2,Prothrombin Time,4564
,MCHC,605
10834-0,"Globulin, Total",5844
,URINE PH,421
13458-5,VLDL Cholesterol Cal,4226
,AST (SGOT),417
,FREE T4,101
,RA Latex Turbid.,444
,Antiproteinase 3 (PR-3) Abs,24
,"PTH, Intact",104
,"OSMOLALITY, CALCULATED",1331
50044-7,eGFR AFRICAN AMERICAN,2998
47279-5,MCHC,9245
,Anti-Centromere B Antibodies,265
,RDW,605
2093-3,NON-HDL CHOLESTEROL,1904
,Estim. Avg Glu (eAG),988
,"HSV 2 IgG, Type Spec",10
,LYMPHOCYTE (%),906
74400-3,MONOCYTES,1825
10839-9,Hemoglobin A1c,3918
,"25-Hydroxy, Vitamin D-2",64
2085-9,HDL Cholesterol,4516
,Epithelial Cells (non renal),698
,"T4,Free(Direct)",1510
,Blood Glucose Monitoring,276
,Specific Gravity,557
,RBC,7866
,ABSOLUTE LYMPH COUNT,906
2093-3,"Cholesterol, Total",4522
,eGFR AFRICAN AMERICAN,171
,White Blood Cell (WBC) Count,221
,URN SPECIFIC GRAV,421
,SGOT,845
2085-9,CHOL/HDLC RATIO,1904
,"Est. GFR, AFRICAN AMERICAN",1334
,Total Protein,394
,ABSOLUTE NEUTROPHILS,1925
,Desmethyltramadol,3
,ABSOLUTE NEUT COUNT,902
,RED BLOOD CELL COUNT,2822
50560-2,Ph,2133
,"Prostate Specific Ag, Serum",635
,ANION GAP,1360
,"Cholesterol, Total",335
,pH,561
,LYMPHOCYTES (%),1613
,"Free Lambda Lt Chains,S",4
,Ferritin,521
,"Calcium, Serum",495
,"25-Hydroxy, Vitamin D-3",68
,TOTAL CHOL/HDL RATIO,216
,Monocytes,254
,"Rubeola Ab, IgG",12
,FSH,220
,VLDL Cholesterol Cal,330
,NEUTROPHILS (%),1617
,SGPT,852
,Hematocrit,371
,Reticulocyte Count,46
,"VITAMIN D, 25-OH, TOTAL",950
,INR Goal,594
,"CORTISOL, TOTAL",10
,MCH,605
,LDL/HDL Ratio,122
,Sedimentation Rate-Westergren,769
,"Vitamin D, 25-Hydroxy",1925
,BUN/Creatinine Ratio,493
,Iron Bind.Cap.(TIBC),560
,Diabetes Medication,267
,UREA NITROGEN (BUN),171
,LDL-CHOLESTEROL,89
,CCP Antibodies IgG/IgA,303
,CARBON DIOXIDE,171
,"CHOLESTEROL, HDL",217
,DNA (DS) ANTIBODY,126
,5 meter Walk (Trial 2),49
,Microalb/Creat Ratio,647
,HGB,932
,"Bilirubin, Total",392
53326-5,SPECIFIC GRAVITY,633
,Antichromatin Antibodies,264
,ESR - Sedimentation Rate,10
,"Vit. B1, Whole Blood",19
,"Iron, Serum",574
,Long Term Care,207
,"PSA, TOTAL",286
,"Testosterone, Total, LC/MS",147
,"MICROALBUMIN/CREATININE$RATIO, RANDOM URINE",193
,CHA2DS2 VASc Score,45
,Hand Grip Right,62
,Total Carbon Dioxide (tCO2),136
,Hemoglobin,452
,"Glucose, Serum",493
,PT INR,74
,ABSOLUTE MONO COUNT,906
,Sjogren's Anti-SS-B,286
,"FOLATE, SERUM",378
,"Albumin, Serum",395
,Hand Grip Left,62
,"Amylase, Serum",100
,Bone Fraction:,11
,eAG (mmol/L),414
,Thyroid Peroxidase (TPO) Ab,67
,ALBUMIN/GLOBULIN RATIO,137
,UIBC,559
,"Potassium, Serum",497
,"C-Reactive Protein, Quant",827
,HSV 2 IGG TYPE SPECIFIC$AB,16
,aPTT,35
,"Levetiracetam, S",16
,B TYPE NATRIURETIC PEPTIDE,102
,Gamma Globulin,29
,IRON BINDING CAPACITY,230
,MCV,605
,Clinical Frailty Index Scale Score,56
,eGFR NON-AFR. AMERICAN,171
,QuantiFERON Mitogen Value,65
,Prothrombin Time,337
,O2 Saturation,2
,eAG (mg/dL),415
,ABSOLUTE LYMPHOCYTES,1936
,"Lipase, Serum",152
,"Immunoglobulin G, Qn, Serum",13
,EPSTEIN BARR VIRUS VCA AB (IGG),9
2089-1,"CHOLESTEROL, LDL",218
,"Uric Acid, Serum",597
10839-9,HEMOGLOBIN A1c,1662
,"Methylmalonic Acid, Serum",47
,"Magnesium, Serum",251
,"Normetanephrine, Pl",14
,CO2,589
,BEEF (BOS SPP) IGE,1
50560-2,PH,348
,Iron Saturation,560
,VARICELLA ZOSTER VIRUS$AB (IGG),13
17861-6,Calcium,306
,TURBIDITY,421
,Anti-Jo-1,263
,Antiscleroderma-70 Antibodies,266
,FEV1 (% Predicted),17
,LH,219
10839-9,HEMOGLOBIN A1C,153
,"Calcitriol(1,25 di-OH Vit D)",8
,NON-HDL CHOLESTEROL,95
,"25-Hydroxy, Vitamin D",71
,Protein/Creat Ratio,46
,"Complement C4, Serum",144
,VLDL,271
,CREATININE,51
,"IRON, TOTAL",241
,Blood Urea Nitrogen (BUN),135
,"Globulin, Total",394
,Beta Globulin,29
,"hCG,Beta Subunit,Qnt,Serum",71
,A/G Ratio,394
,"CPK, TOTAL",57
,Alpha-1-Globulin,29
,Hydrocodone Confirm,10
,"Complement C3, Serum",143
,% SATURATION,232
,LD,15
,WESTERGREN SED RATE,57
,Fundal Height,1057
,B TYPE NATRIURETIC$PEPTIDE (BNP),68
,RUBELLA ANTIBODY (IGG),50
,SQUAMOUS EPITHELIAL CELLS,316
,"pH, Urine",38
,"Calcium, Urine 24hr",4
,"Phosphorus, Serum",65
,Glucose Finger Stick,236
,eGFR If NonAfricn Am,492
,"Creatinine, Serum",352
,ALPHA-2-GLOBULINS,16
,LDH,15
,RNP Antibodies,276
,Gestational Diabetes Overview,36
,GLOBULIN,137
,STS Score,65
,Oxycodone Confirm,6
,Smith Antibodies,270
,"Creatine Kinase,Total,Serum",171
,ADJ MULTIPLE OF MEDIAN,47
,"Complement, Total (CH50)",83
,F256-IgE Walnut,2
,PTHrP (PTH-Related Peptide),3
,METHYLMALONIC ACID,26
2089-1,LDL,425
,"TESTOSTERONE, TOTAL,$LC/MS/MS",67
,MONOCYTES,101
,BETA GLOBULINS,5
,Anti-DNA (DS) Ab Qn,284
,FREE TESTOSTERONE,49
,Hep C Virus Ab,270
,"Immunoglobulin A, Qn, Serum",28
,Transferrin,40
,"VITAMIN D, 25-OH, D3",37
,Thyroxine (T4),97
,Cortisol - AM,19
,"Triiodothyronine,Free,Serum",125
,"EBV Early Antigen Ab, IgG",17
,"HIV 1 RNA, QN PCR",25
,CARDIO CRP(R),9
,"Protein,Total,Urine",56
,"EBV Ab VCA, IgG",23
,"GLUCOSE, GESTATIONAL$SCREEN (50G)-130 CUTOFF",37
,Bands,20
,Frailty Mortality Risk (%),55
20569-0,"CREATINE KINASE, TOTAL",105
,Sjogren's Anti-SS-A,286
,Amphetamine GC/MS Conf,13
,PHQ-9 Total Score,29
,Feeling overwhelmed by the demands of living with Diabetes:,25
,Gestational Diabetes Screen,33
,"HSV 2 IGG, HERPESELECT$TYPE SPECIFIC AB",5
,"Creatinine, Urine",40
,"Estrogens, Total",38
,ALPHA-1-ANTITRYPSIN QN,1
,"C-Reactive Protein, Cardiac",24
,"Mumps Abs, IgG",10
,CK-MM,40
,ESTIMATED AVERAGE GLUCOSE,152
,"W009-IgE Plantain, English",7
,"PARATHYROID HORMONE,$INTACT",35
,MYELOCYTES,274
,D-Dimer,29
,Heart Rate,6
,PT PATIENT,74
,Diastolic,18
,Alpha-2-Globulin,29
,"Preconception Care, Pregnancy, and Gestational Diabetes",30
,Peak Flow,74
,Cortisol,21
,Estimated CHD Risk,281
,"Testosterone, Free, Direct",100
,Antimyeloperoxidase (MPO) Abs,24
,URINE UROBILINOGEN,487
,BUN/CREATININE RATIO,171
,GAMMA GLOBULINS,16
,Thyroglobulin Antibody,28
,"H. pylori, IgA Abs",10
,E001-IgE Cat Dander,9
,FEV1/FVC Ratio,17
,PROTEINASE-3 ANTIBODY,7
,Varicella Zoster IgG,22
,DIRECT LDL,37
,"Beta-2 Glycoprotein I Ab, IgA",4
,Carboxy THC GC/MS Conf,12
,$MSAFP,12
,LITHIUM,9
,"Varicella-Zoster Ab, IgM",9
,5 meter Walk (Trial 1),50
,Sodium,4
,"T4,Free (Direct)",86
,HASBLED Score,41
,"Calcium, Ionized, Serum",38
,SEGMENTED NEUTROPHIL,36
,Weight,24
,"Anticardiolipin Ab, IgA",2
,"ANTICARDIOLIPIN AB, IGA, QN",1
,SPECIFIC GRAVITY,22
,"Rubella Antibodies, IgG",65
,Eosinophil,157
,Insulin,22
,Prolactin,73
,"ESTROGEN, TOTAL, SERUM",26
,"Testosterone, Serum",17
,"EBV Ab VCA, IgM",25
,"Lyme Disease Ab, Quant, IgM",13
,METAMYELOCYTE,3
,"C-Telopeptide, Serum",11
,"Albumin, U",10
,"H. pylori, IgG Abs",10
,BETA 2 GLOBULIN,11
,"GLUCOSE, 1 HOUR",2
,% CD4 (HELPER CELLS),9
,PT,51
,"Topiramate, Serum",1
,Hgb A,28
,"VITAMIN D, 25-OH, D2",37
1751-7,Albumin,141
,F024-IgE Shrimp,2
,"14.3.3 ETA, Rheum. Arthritis",6
,"AFP, Serum, Tumor Marker",11
,GGT,47
,Homogeneous Pattern,115
,"Bilirubin, Direct",50
718-7,Hemoglobin (i-STAT),32
,PH,22
,Hemoglobin A1C,32
,FREE T4 INDEX (T7),13
,Feeling that I am often failing with my diabetes routine:,25
,Apolipoprotein B,27
,"Homocyst(e)ine, Plasma",8
,LYME AB SCREEN,13
,HEPATITIS B SURFACE AB (QUANT TO ENDPOINT),2
,METANEPHRINE,3
,"VMA, Urine, 24hr",1
,"Calcium, ionized (i-STAT)",23
,HEPATITIS B VIRUS DNA,4
,Carboxy THC (GC/MS),3
,Vitamin B6,12
,"Ammonia, Plasma",17
,F008-IgE Corn,10
,"PROTEIN, TOTAL, RANDOM UR",27
,MYELOPEROXIDASE ANTIBODY,7
,TSI,8
,PHOSPHATE (AS PHOSPHORUS),11
,"HEPATITIS B SURFACE AG, QN, MONITORING",2
,Lyme IgG/IgM Ab,35
,VITAMIN B6,4
,"D DIMER, Quantitative",12
,"AMYLASE, SERUM",23
,Antiribosomal P Antibodies,4
,PHENYTOIN,5
,"T008-IgE Elm, American",8
,"LDL, MEDIUM",4
,"Nucleated Cells, Synovial Fld",7
,Growth and Development,20
,Chloride,4
,"Epinephrine, Pl",7
,Abs. CD 8 Suppressor,18
,"Parvovirus B19, IgM",2
,BAND NEUTROPHIL,19
,"EBV Nuclear Antigen Ab, IgG",23
,"Valproic Acid (Depakote),S",14
,Diabetes in Pregnancy Overview,9
,BUN (i-STAT),23
,SELENIUM,2
,Steatosis Score,3
,DSR (Second Trimester) 1 IN,4
,CO2 (i-STAT),23
,"RETICULOCYTE COUNT,$AUTOMATED",31
,Oxycodone (GC/MS),6
,"RBC, Fluid",7
,BAND NEUTROPHILS,276
,Small LDL-P,7
,HCV Ab,85
,D001-IgE D pteronyssinus,9
,Weight:,3
,"Lymphocytes, Fluid",6
,"VITAMIN D2, 1,25 (OH)2",7
,Oxymorphone (GC/MS),6
,"Digoxin, Serum",15
,6 Minute Walk,12
,Creatinine,26
,"BILIRUBIN, INDIRECT",34
,Mitochondrial (M2) Antibody,9
,METAMYELOCYTES,274
,"T4 (THYROXINE), TOTAL",19
,BLAST,2
,Albumin,4
,School and Caregivers,3
,"RETICULOCYTE, ABSOLUTE",32
,"Osmolality, Urine",9
,T3 Uptake,27
,"Beta-2 Glycoprotein I Ab, IgM",4
,F002-IgE Milk,10
,Anticoag Dosing at Visit,2383
,"Normetanephrine, Ur",5
,"VITAMIN D, 1,25 (OH)2, TOTAL",7
,"Norepinephrine, Pl",7
,NORMETANEPHRINE,3
,"Potassium, Urine",1
,Aldolase,3
,t-Transglutaminase (tTG) IgA,18
,HEMOGLOBIN A2 (QUANT),23
,F093-IgE Chocolate/Cacao,8
,Thyroid Stim Immunoglobulin,19
2162-6,"Creatinine, Ur 24hr",2
,"Cytomegalovirus (CMV) Ab, IgM",3
,Prealbumin,10
38483-4,Creatinine (i-STAT),28
,"LDL, PARTICLE SIZE",4
,"ESTIMATED AVERAGE GLUCOSE, PLASMA",1
,"Alpha-1-Antitrypsin, Serum",7
,uE3 Value,4
,"Metanephrine, Pl",14
,ALPHA-1-GLOBULINS,16
,"I206-IgE Cockroach, American",7
,HEMOGLOBIN F,22
,DEXAMETHASONE,2
,Thyroglobulin by IMA,5
,LDL/HDL RATIO,32
,Myelocytes,13
,MUMPS VIRUS$ANTIBODY (IGG),10
,Triiodothyronine (T3),59
,T3 UPTAKE,17
,THYROID PEROXIDASE ANTIBODIES,32
,"H pylori, IgM Abs",16
,"AChR Binding Abs, Serum",4
,DIGOXIN,20
,"T3, TOTAL",30
,"C-Peptide, Serum",10
,"TOTAL, FREE (MN+NMN)",4
,Liver Fraction:,11
,"Renin Activity, Plasma",11
2160-0,"Creatinine, Urine",7
,Insulin-Like Growth Factor I,10
,Carbohydrate Antigen 19-9,6
,"Lithium (Eskalith), Serum",9
,Ritalinic Acid,1
,Estradiol,39
,"Prot,24hr calculated",3
,MYELOCYTE,3
,"Anticardiolipin Ab, IgM",5
,"Immunoglobulin M, Qn, Serum",11
,"ACTH, Plasma",21
,Thyroglobulin by LCMS,1
,F004-IgE Wheat,10
,LDL Size,7
,HSV 1 IGG TYPE SPECIFIC$AB,16
,Lipoprotein (a),8
,VALPROIC ACID,6
,ABSOLUTE MYELOCYTES,274
,"PARTIAL THROMBOPLASTIN$TIME, ACTIVATED",16
,"T007-IgE Oak, White",8
,HIV-1 RNA by PCR,19
,"ACTH, PLASMA",8
,ALDO/PRA RATIO,4
,"ESTRIOL, UNCONJUGATED",12
718-7,HEMOGLOBIN A,32
,F013-IgE Peanut,10
,Hgb A2,28
,NOREPINEPHRINE,3
,Sodium (i-STAT),23
,GLUTAMIC ACID DECARBOXYLASE 65 AB,8
,BETA 1 GLOBULIN,11
2160-0,"Creatine Kinase, MB",3
,Systolic,18
,LDL-P,7
,G002-IgE Bermuda Grass,8
,MEASLES ANTIBODY (IGG),10
,"Free Lambda Lt Chains,Ur",1
,"LDL PARTICLES, TOTAL",4
,"CORTISOL, FREE, URINE",1
,"Beta-2 Glycoprotein I Ab, IgG",4
,"I006-IgE Cockroach, German",1
,M006-IgE Alternaria alternata,8
,Smith/RNP Antibodies,4
,ABSOLUTE NEUTROPHIL COUNT,4
,"Normetanephr.,U,24h",5
,"PSA, SCREENING",4
,M004-IgE Mucor racemosus,7
,"Norepinephrine, Ur",6
,"Dopamine, Pl",7
,Calcium,4
,"CATECHOLAMINES, TOTAL",3
,"Phenobarbital, Serum",3
,"IGF I, LC/MS",4
,Basophil,157
,ANA TITER,70
,Hydromorphone Confirm,5
,Fibrosis Score,3
,"SARS COV 2 AB (IGG) SPIKE, SEMI QN",3
,Eos (Absolute Value),6
,BETA 2 GLYCOPROTEIN I IGM,1
,Cancer Antigen (CA) 125,6
,Ceruloplasmin,9
,hCG Value,4
,IA-2 ANTIBODY,3
,ABSOLUTE CD4+ CELLS,9
,% CD 8 Pos. Lymph.,18
,AFP MoM,4
,ABSOLUTE BLASTS,271
,CA 27.29,1
,T011-IgE Maple Leaf Sycamore,7
,Glucose (i-STAT),23
10839-9,Hemoglobin A1C,3
,"Polys, Fluid",6
,"Cortisol,Free,LC/MS/MS",1
,LAMB/MUTTON (OVIS SPP)IGE,1
,17-OH Progesterone LCMS,5
,#1 Salivary Cortisol,3
,RNA Polymerase III IgG Abs,1
,G010-IgE Johnson Grass,7
,"Sirolimus, Blood",1
,"Calcium, Urine",4
,Amphetamine (GC/MS),11
,"Norepinephrine,U,24h",4
,"ALPHA FETOPROTEIN,$TUMOR MARKER",4
,Chloride (i-STAT),23
,HELPER/SUPPRESSOR RATIO,6
,Troponin I,5
,Potassium,3
,"Bilirubin, Indirect",2
,Luteinizing Hormone (LH) ECL,1
,EOS%,1
,OSBR Risk       1 IN,4
,ABSOLUTE METAMYELOCYTES,274
,Anion Gap (i-STAT),23
,EPSTEIN BARR VIRUS VCA AB (IGM),9
,Haptoglobin,6
,"5-HIAA,Qn,Random,Ur",1
,GLUCOSE:,143
,"Rocky Mtn Spotted Fever, IgM",4
,"Lead, Blood (Adult)",2
,Gest. Age on Collection Date,4
,"VMA, Urine",1
,"METANEPHRINE, FREE",4
,"Dopamine, Urine",6
,AST (SGOT) P5P,3
,Monocyte (Absolute),72
,"Kappa/Lambda Ratio,S",4
24326-1,CL,174
,"F245-IgE Egg, Whole",10
,Potassium (i-STAT),23
,F027-IgE Beef,8
,ALPHA-TOCOPHEROL,1
,M-Spike,29
,Progesterone,15
,Metamyelocytes,13
,G017-IgE Bahia Grass,8
,14.3.3 ETA PROTEIN,3
,Oxymorphone Confirm,4
,HEMOGLOBIN C,14
,"Sodium, Urine",5
,Calcium/Creat.Ratio,4
,vWF Activity,1
,% Free PSA,10
,"Arsenic (Total),U",1
,"Testosterone, Serum (Total)",12
,Apolipoprotein A-1,3
,"HCG, TOTAL, QN",26
,"PSA, Free",10
,"NASH Score",3
,F001-IgE Egg White,2
,dRVVT,2
,"Sex Horm Binding Glob, Serum",6
,t-Transglutaminase (tTG) IgG,2
,"TISSUE TRANSGLUTAMINASE AB, IGA",7
,ALBUMIN CREATININE RATI0,1
,"Copper, Serum",13
,ABSOLUTE NUCLEATED RBC,271
,Sex Hormone Binding Globulin,3
,F014-IgE Soybean,10
,"HOMOCYSTEINE,$CARDIOVASCULAR",7
,T211-IgE Sweet Gum,7
,ALT (SGPT) P5P,3
,BLASTS,271
,Bile Acids,1
,M003-IgE Aspergillus fumigatus,9
,% CD8 (SUPPRESSOR T CELLS),5
,Aldosterone,13
,EPSTEIN BARR VIRUS (EBNA) AB (IGG),9
,GAD-65,7
,"HDL, LARGE",4
,LDL-C,5
,"Anticardiolipin Ab, IgG",5
,Butalbital,6
,E072-IgE Mouse Urine,1
,"Epinephrine, Urine",6
,"Calcitonin, Serum",4
,Atypical pANCA,24
,ZINC TRANSPORTER 8 ANTIBODY,1
,Ethanol Confirm,1
,"Immunoglobulin E, Total",1
,"Free Kappa Lt Chains,S",4
,"Deamidated Gliadin Abs, IgA",6
,Propeptide Type 1 Collagen,7
,"Toxoplasma gondii Ab,IgM,Qn",1
,"HSV, IgM I/II Combination",2
,Anion Gap,255
,"Metanephrine, Ur",5
,Angiotensin-converting Enzyme,6
,Ejection Fraction,3
,M001-IgE Penicillium chrysogen,8
,COMPLEMENT C3,1
,Hematocrit (iSTAT),23
,W018-IgE Sheep Sorrel,8
,APOLIPOPROTEIN B,8
,"VMA, Random Urine",2
,F338-IgE Scallop,2
,Monocyte%,158
,#2 Salivary Cortisol,3
,W020-IgE Nettle,8
,"GALACTOSE APHPA 1,3 GALACTOSE IGE",1
,ANGIOTENSIN-1-CONVERTING$ENZYME,8
,THYROGLOBULIN ANTIBODIES,22
,"VITAMIN D3, 1,25 (OH)2",7
,"Carbamazepine(Tegretol), S",7
,"Alpha 2-Macroglobulins, Qn",3
,ABSOLUTE CD8+ CELLS,6
,G006-IgE Timothy Grass,8
,E005-IgE Dog Dander,9
,M002-IgE Cladosporium herbarum,8
,Actin (Smooth Muscle) Antibody,6
,DHEA-Sulfate,5
,INHIBIN A,12
,Fentanyl,2
,HDL-P (Total),7
,"Phenytoin (Dilantin), Serum",5
,Z SCORE (FEMALE),3
,"PLASMA RENIN ACTIVITY, LC/MS/MS",4
,Dehydroepiandrosterone (DHEA),10
,"Epinephrine, U, 24hr",4
,Aldos/Renin Ratio,5
,hCG MoM,4
,"W001-IgE Ragweed, Short",8
,THC,1
,AFP Value,4
,#3 Salivary Cortisol,3
,"GLUCOSE, 2 HOUR",2
,IA-2 Autoantibodies,4
,Lacosamide,2
,T18 (By Age),4
,HYALINE CAST,315
,FiO2,1
,"SED RATE BY MODIFIED WESTERGREN, MANUAL",3
,DOPAMINE,3
,ABSOLUTE BAND NEUTROPHILS,276
,LP-IR Score,7
,F207-IgE Clam,2
,T001-IgE Maple/Box Elder,8
,"Free Kappa Lt Chains, Ur",1
,BETA 2 GLYCOPROTEIN I IGA,1
,Lead,4
,TPMT Activity,3
,D002-IgE D farinae,9
,"Dopamine, Ur, 24hr",4
,"5-HIAA, Urine",2
,Nucleolar Pattern,115
,M010-IgE Stemphylium herbarum,7
,Macrophages,6
,"Folate, Hemolysate",2
,AMMONIA (P),11
,ABSOLUTE PROMYELOCYTES,271
,"Kappa/Lambda Ratio,U",1
,"Deamidated Gliadin Abs, IgG",2
,"VZV AB IGM, EIA",4
,Maternal Weight,12
,"Folate, RBC",2
,"NORMETANEPHRINE, FREE",4
,"FOLATE, RBC",3
,DIA Value,4
,ABSOLUTE BLAST COUNT,2
,von Willebrand Factor (vWF) Ag,1
,"CARBAMAZEPINE, TOTAL",6
,W006-IgE Mugwort,7
,LIPOPROTEIN (a),7
,Hep B Surf Ab Quant,2
,D201-IgE Blomia tropicalis,1
,"T006-IgE Cedar, Mountain",8
,"HSV 1 IgG, Type Spec",12
,"Metanephrine, U,24hr",5
,Noroxycodone,9
,F010-IgE Sesame Seed,2
,POC GLUCOSE METER RESULT,14
,Cortisol Baseline,1
,"Digoxin, Random, Serum",2
,"T3, Free, Dialysis, LC/MS-MS",1
,NORBUPRENORPHINE,2
,"VMA/Crt, Random U",2
,Promyelocytes,13
,Neutrophils Absolute,6
,"METANEPHRINES, TOTAL",3
,Lymphocytes (Absolute),72
,Norfentanyl,2
,PROMYELOCYTES,271
,"W014-IgE Pigweed, Rough",8
,Benzoylecgonine GC/MS Conf,3
,Methadone GC/MS Conf,2
,BETA 2 GLYCOPROTEIN I IGG,1
,"Thyrotropin Receptor, Ab",4
,DSR (By Age)    1 IN,4
,"ANTICARDIOLIPIN AB,IGG,QN",1
,"Growth Hormone, Serum",1
,Factor VIII Activity,1
,INSULIN AUTOANTIBODY,3
,T070-IgE White Mulberry,7
,Trypanosoma Cruzi Ab IgG,2
,"MONOCYTE/MACROPHAGE, %",5
,"ALDOSTERONE, LC/MS/MS",6
,Methylphenidate,1
,Insulin Antibodies,3
,PANCREATIC ELASTASE-1,2
,EDDP,6
,"Lactic Acid, Plasma",2
,CALCIUM:,144
,"MICROALBUMIN, URINE",1
,"T041-IgE Hickory, White",7
,DIA MoM,4
,Erythropoietin,2
,"Creatinine(Crt),U",1
,Fructosamine,4
,Epithelial Cells (renal),698
,PTT-LA,2
,Tandem-R Ostase,2
,"DHEA, LC/MS/MS",5
,"Parvovirus B19, IgG",2
,COMPLEMENT C4,1
,log10 HIV-1 RNA,19
,log10 HBV as IU/mL,3
,GESTATIONAL AGE,12
,"PROTEIN, TOTAL, 24 HR UR",1
,"PROLACTIN, UNDILUTED",2
,"SODIUM, RANDOM URINE",1
,"Osteocalcin, Serum",1
,"C REACTIVE PROTEIN, HIGH SENSITIVITY",2
,F026-IgE Pork,8
,"LDL, SMALL",4
,"CREATININE, 24 HOUR URINE",1
,ABNORMAL PROTEIN BAND 1,9
,NORDIAZEPAM,1
,B pertussis IgA Ab,1
,PROCOLLAGEN TYPE I INTACT N TERMINAL PROPEPTIDE,3
,"HSV 1 IGG, HERPESELECT$TYPE SPECIFIC AB",4
2162-6,"CREATININE, RANDOM URINE",7
,"TROPONIN T, HIGH SENSITIVITY (HS TNT)",1
,TOTAL NUCLEATED CELL CT,5
,uE3 MoM,4
,"VITAMIN B1 (THIAMINE), BLOOD",1
,Blasts/blast like cells,13
,Red Blood Cell (RBC) Count,200
,Liver-Kidney Microsomal Ab,2
,"PSA, Complexed",1
,Cortisol Stimulated,1
,SMOOTH MUSCLE AB TITER,1
,F003-IgE Codfish,2
,"GLUCOSE, 3 HOUR",2
,C TELOPEPTIDE (CTX),5
,BETA-GAMMA-TOCOPHEROL,1
,HDL-C,5
,BASO%,1
,"VITAMIN B2 (RIBOFLAVIN), PLASMA",1
,Nordiazepam GC/MS Conf,1
,eGFR (CKD-EPI 2021),1
,"CORTISOL, A.M.",1
,Forced Vital Capacity (FVC % Predicted),17
,ALPRAZOLAM,1
,Osmolality,257
,Methadone (GC/MS),1
,HDL,91
,"Estrone, Serum",2
,"Toxoplasma gondii Ab,IgG,Qn",1
,Chromogranin A,11
,Tramadol (GC/MS),1
,"Cytomegalovirus (CMV) Ab, IgG",2
,"Calprotectin, Fecal",2
,"LYMPHOCYTES, %",5
,"Zinc, Plasma or Serum",4
2162-6,"Creatinine, Urine",3
,Follicle Stimulating Hormone,1
,"T073-IgE Pine, Australian",1
,"ANTICARDIOLIPIN AB, IgM, QN",1
,LMP:,43
,PORK (SUS SPP) IGE,1
,OSMOLALITY (U),1
,Oxazepam GC/MS Conf,1
,B pertussis IgM Ab,1
,Lymphocytes (%),35
,Height:,3
,HBV as IU/mL,3
,"Calprotectin, Stool",2
,Centromere Pattern,115
2341-6,Glucose POC Bedside,1954153
2028-9,CO2 Lvl,986711
3094-0,BUN Lvl,992621
718-7,Hgb,1023033
88294-4,GFR Non Afr Amer by CKD-EPI,657791
2075-0,Chloride Lvl,986688
2160-0,Creatinine Lvl,1036645
1798-8,Amylase Total,5268
61152-5,Albumin Lvl,589362
1975-2,Bilirubin Total,588767
2885-2,Total Protein Lvl,588366
88293-6,GFR African Amer by CKD-EPI,268884
5811-5,UA Spec Grav,221392
2756-5,UA pH,222462
6598-7,Troponin-T,214179
16362-6,Ammonia Lvl,15399
2157-6,CK Total,40512
2744-1,ABG pH,81442
2703-7,ABG PO2,81442
1960-4,ABG HCO3 (Bicarb),81474
33762-6,N-Terminal Pro BNP,75608
2019-8,ABG PCO2,81444
2026-3,ABG Total CO2,46846
2708-6,ABG O2 Sat,82624
2027-1,VBG Total CO2,17548
5643-2,Ethanol Lvl,26567
2746-6,VBG pH,27505
2021-4,VBG PCO2,27494
2705-2,VBG PO2,27495
2519-7,Ven Lactate POC IStat,12631
14627-4,VBG HCO3 (Bicarb),27513
11054-4,LDL/HDL Ratio,65257
9830-1,Chol/HDL Ratio,65262
13458-5,VLDL,65275
43396-1,Non HDL Cholesterol,65265
2777-1,Phosphorus Lvl,139175
2498-4,Iron Lvl,24518
2888-6,Ur Protein Rdm,8890
2502-3,% Iron Sat,27550
2161-8,Ur Creatinine Rdm,12456
21198-7,Beta hCG Quant,11165
728-6,Hypochromasia,11138
3084-1,Uric Acid Lvl,20353
6298-4,Potassium POC IStat,62063
6299-2,BUN POC IStat,43978
2339-0,Glucose POC IStat,62788
2947-0,Sodium POC IStat,58216
20570-8,Hct POC IStat,59424
38483-4,Creatinine POC IStat,68191
2069-3,Chloride POC IStat,39014
1994-3,Ionized Ca POC IStat,57678
20509-6,Hgb POC IStat,63617
48643-1,GFR Afr Amer IStat POC by MDRD,20008
2027-1,Tot CO2 Ven POC,32843
10378-8,Polychromasia,18738
3255-7,Fibrinogen Lvl,19344
721-1,Hgb Free,4421
48642-3,GFR Non Afr Amer IStat POC by MDRD,51905
74099-3,Ur NGAL,620
52789-5,Heptem Clotting Time,370
52778-8,Intem Max Clot Firmness,672
46421-4,UA Mucous,95440
75241-0,Procalcitonin Lvl.,52651
60340-7,Amorphous,10989
52789-5,Intem Clotting Time,693
52782-0,Heptem Max Clot Firmness,367
1988-5,CRP Inflammatory,64964
779-9,Poikilocytosis,38645
2518-9,Art Lactate POC IStat,7778
1994-3,Ionized Ca POC,6624
6298-4,Potassium POC,7387
2600-5,Ionized Mg POC IStat,8717
13964-2,Methyl Malonic Acid Lvl,496
774-0,Ovalocytes,12004
32146-3,Large Plts,20573
20578-1,Vancomycin Random,16514
7796-6,Plt Clumps,5149
53962-7,AFP Tumor Marker,2897
20509-6,VBG Hgb (Calc),4500
20509-6,ABG Hgb (Calc),5235
2986-8,Testosterone Lvl,3935
4537-7,Sed Rate Westergren,31969
1825-9,Alpha 1 Antitrypsin,1895
5796-8,UA Hyaline Casts,23334
32764-3,Wet Prep Clue Cells,12272
1747-5,Fl Albumin,1872
1777-2,Alk Phos Bone,346
6768-6,Alk Phos Total,346
1779-8,Alk Phos Liver,346
30424-6,Macrocytes,8968
48067-3,D-Dimer Quant,40395
3298-7,Acetaminophen Lvl,14039
26052-1,UA Renal Epithelials,1230
46420-6,WBC Clumps,13636
25148-8,UA Calcium Ox Crystals,6236
1649-3,Vit D 1 25 Dihydroxy Lvl,469
13657-2,UA Amorph Urates,847
1986-9,C Peptide,850
44448-9,Beta 2 Glycoprot IgG,529
44447-1,Beta 2 Glycoprot IgA,529
44449-7,Beta 2 Glycoprot IgM,529
8099-4,Thyroid Perox Ab,2317
8098-6,Thyroglobulin Ab,1522
5803-2,Ur pH POC,3373
5811-5,Ur Specific Grav POC,3373
2885-2,PE Total Protein,3993
2283-0,RBC Folate,713
20568-2,Prolactin Lvl,1577
9800-4,Stone Number,1927
34714-6,INR POC IStat,10292
5964-2,PT POC IStat,9842
14959-1,Ur Microalb/Creat Ratio,7473
2161-8,Ur Creatinine (Microalb) mg/dL,7482
14957-5,Ur Microalb Random,7455
2998-3,Vit B1 Lvl for Deficiency,1323
1995-0,Calcium Ionized,21814
14196-0,Abs Reticulocytes,15128
17849-1,Reticulocyte Cnt,15122
777-3,Plt Cnt POC,10941
788-0,RDW POC,6569
785-6,MCH POC,6633
786-4,MCHC POC,6633
32623-1,MPV POC,6427
787-2,MCV POC,6633
20570-8,Hct POC,8629
20509-6,Hgb (Calc)  POC,9072
789-8,RBC POC,6633
6690-2,WBC POC,6634
13983-2,PE Gamma,3898
13981-6,PE Alpha 2,3898
13982-4,PE Beta,3898
13978-2,PE Alpha 1,3899
13980-8,PE Albumin,3960
4086-5,Valproic Acid Lvl,2038
2955-3,Ur Sodium Rdm,9958
27811-9,ATIII,1219
2145-1,Cortisol Lvl Free,563
19229-4,MVBG HCO3 (Bicarb),1240
19223-7,MVBG Total CO2,599
19213-8,MVBG pH,1240
19221-1,MVBG O2 Content,1552
20509-6,MVBG Hgb (Calc),1564
34969-6,MVBG Hgb O2,1552
19212-0,MVBG pCO2,1240
19211-2,MVBG pO2,1240
2695-5,Ur Osmolality,5753
3095-7,Ur Urea Nit Rdm,1310
1989-3,Vit D 25 Hydroxy Lvl,22962
27811-9,ATIII Stat,1766
13656-4,UA Amorph Phos,1260
3193-0,Factor 5,80
3209-4,Factor 8,906
3050-2,T3 Uptake.,196
59404-4,VBG O2 Capacity,2538
2716-9,VBG Hgb O2,2538
19220-3,VBG O2 Content,2538
2828-2,Ur Potassium Rdm,5054
2078-4,Ur Chloride Rdm,4798
2742-5,Angiotensin Convert Enz,697
2890-2,Ur Protein/Creat Ratio Rdm mg/mg Creat,6547
803-7,Toxic Granulation,3658
7798-2,Smudge Cells,4247
10381-2,Target Cells,5675
29247-4,Rapamycin Lvl,1218
7790-9,Burr Cells,9706
741-9,Microcytes,6445
38496-6,Retinyl Palmitate,361
2923-1,Retinol Lvl,361
11038-7,Gamma Tocopherol Lvl,338
1823-4,Alpha Tocopherol Lvl,338
3126-0,Arginine Vasopressin,61
45155-9,Heparin Ab,1756
2344-0,Fl Glucose,2044
2529-6,Fl LD,1845
2881-1,Fl Protein,2992
2748-2,Fl pH,1011
1795-4,Fl Amylase,1238
12841-3,% Free PSA,1662
35741-8,PSA Total,1662
18323-6,Smith Ab Index,739
30089-7,Transitional Epi Cells,4361
7793-3,Howell Jolly Bodies,1566
2900-9,Vit B6 Lvl,419
28009-9,Tot Vol Creatinine,1026
2162-6,Ur Creat mg/24 hr,1011
2161-8,Ur Creatinine mg/dL,1014
13362-9,Coll Hrs Creatinine,1027
46138-4,UA Uric Acid Crystals,603
4544-3,Hct RBC Folate,189
35741-8,PSA,6407
20565-8,BBG Total CO2,10041
1959-6,BBG HCO3 (Bicarb),10041
11556-8,BBG PO2,10041
20509-6,BBG Hgb (Calc),10037
11557-6,BBG PCO2,10041
11558-4,BBG pH,10041
5908-9,Giant Plts,2664
703-9,Baso Stippling,1617
33194-2,Viability (Trypan Blue),195
43416-7,Product Hct,7
33800-4,Double Strand DNA Index,1844
35741-8,PSA Scr OP,1986
24471-5,Epinephrine Rslt,376
15061-5,Erythropoietin Lvl.,770
7885-7,EBV VCA IgG Ab Index,1094
31374-2,EBV NAG Ab Index,774
7886-5,EBV VCA IgM Ab Index,903
24007-7,EBV EAG Ab Index,798
3184-9,ACT POC Hemochron,11334
6206-7,Allergy Peanut,470
6190-3,Allergy Oat,444
6174-7,Allergy Milk,460
7691-9,Allergy Scallop,433
6076-4,Allergy Clam,427
6106-9,Allergy Egg White,434
6087-1,Allergy Corn,444
6082-2,Allergy Codfish,436
6276-0,Allergy Wheat,460
6273-7,Allergy Walnut,428
6248-9,Allergy Soy,458
6246-3,Allergy Shrimp,393
6242-2,Allergy Sesame Seed,427
800-3,Schistocytes,4362
2466-1,IgG Subclass 1,599
2467-9,IgG Subclass 2,597
2469-5,IgG Subclass 4,625
2468-7,IgG Subclass 3,597
38445-3,Feces Calprotectin,1286
5209-2,Herpes 2 IgG Index,914
5206-8,Herpes 1 IgG Index,914
62238-1,GFR Non Afr Amer by CKD-EPI,132539
14622-5,Vit C Lvl,64
33613-1,SSB Ab Index,912
33610-7,SSA Ab Index,959
32998-7,Transglutaminase IgG,874
31017-7,Transglutaminase IgA,1183
58710-5,Gliadin IgG,812
58709-7,Gliadin IgA,827
3271-4,Heparin Assay LMW,267
42176-8,Fungitell Lvl,1747
5820-6,UA WBC Cast,137
25907-7,Feces Pancr Elastase,691
53939-5,Transpl Imm Cell,698
8122-4,Abs CD3 Cnt,1705
8123-2,CD4 Helper Cells,1704
24467-3,Abs CD4 Cnt,1704
14135-8,Abs CD8 Cnt,1704
8101-8,CD8 Suppressor Cells,1704
13338-9,Natural Killer Cells,292
21017-9,Abs NK Cell Cnt,292
8124-0,Tot CD3 Cells,1704
3520-4,Cyclosporin Lvl,1669
15069-8,Fructosamine Lvl,348
13965-9,Homocysteine Total,1038
50544-6,Everolimus Lvl,283
2333-3,Gastrin Lvl,117
20455-2,WBCs Ur Smear,2205
51639-3,Acanthocytes,1530
4552-6,Hgb A2,1270
51196-4,Hgb A1,1200
2947-0,Sodium POC,459
20565-8,Tot CO2  POC,453
2069-3,Chloride POC,453
4625-0,Sickle Cells,3150
30315-6,Tis Maltase,176
14168-9,Tis Palatinase,177
30372-7,Tis Sucrase,177
5902-2,PT POC,4504
3255-7,Fibrinogen POC,2130
1835-8,Alpha 2 Macroglobulin,244
13362-9,Coll Hrs Calcium,157
28009-9,Tot Vol Calcium,159
17862-4,Ur Calcium mg/dL,152
6874-2,Ur Calcium mg/24hr,153
33393-0,UA Coarse Gran Casts,270
10501-5,LH Lvl,1270
15067-2,FSH Lvl,1686
3052-8,T3 Reverse,289
6265-3,Allergy Timothy Grass,879
6244-8,Allergy Sheep Sorrel,755
6085-5,Allergy Ragweed,884
7604-2,Allergy Pigweed,880
6212-5,Allergy Pen.notatum,909
6109-3,Allergy Elm,750
6098-8,Allergy Dog Dander,888
6096-2,Allergy D.pternyssinus,763
6095-4,Allergy Dermat.farinae,891
6078-0,Allergy Cockroach,894
6189-5,Allergy Oak,885
6186-1,Allergy Nettle,749
7155-5,Allergy Maple(Boxelder),881
6075-6,Allergy Hormodendrum,913
6209-1,Allergy Hickory,751
6020-2,Allergy Alt.tenuis,915
6833-8,Allergy Cat,890
6041-8,Allergy Bermuda Grass,886
6034-3,Allergy Bahia Grass,759
6032-7,Allergy Australn Pine,569
6025-1,Allergy Asp.fumigatus,954
2888-6,Ur PE Total Protein,1225
5793-5,UA Gran Casts,1647
33571-1,Jo1 Ab Index,252
31588-7,RNP Ab Index,549
47322-3,SCL70 Ab Index,601
3663-2,Gentamicin Peak,76
2880-3,CSF Protein,1782
2342-4,CSF Glucose,1772
24472-3,Plt Func Anyl ADP,125
4477-6,C1 Esterase Inhib,47
5403-1,Varicella IgG Index,719
5244-9,Rubeola IgG Index,404
25418-5,Mumps IgG Index,356
13362-9,Coll Hrs TP,961
2888-6,Ur Protein mg/dL,950
2889-4,Ur Protein mg/24hr,939
28009-9,Tot Vol Protein,958
5126-8,CMV IgM Ab Index,918
5390-0,Toxoplasma IgM Index,121
5388-4,Toxoplasma IgG Index,413
5124-3,CMV IgG Ab Index,955
5334-8,Rubella IgG Quant,1657
7791-7,Dacrocytes,3747
30522-7,CRP Cardiac Risk,1323
10634-4,C1 Esterase Inhib Func,40
43201-3,Ur BK Virus Log IU/mL,89
41480-5,Ur BK Virus Quant IU/mL,89
4485-9,C3,2158
4498-2,C4,2211
3013-0,Thyroglobulin.,524
2714-4,ABG Hgb O2,1150
59404-4,O2 Capacity,1150
19218-7,ABG O2 Content,1150
7795-8,Pappenheimer Bodies,1699
5822-2,UA Yeast,492
5574-9,Aluminum Lvl,137
2641-9,Ur Myoglobin Quant,23
34571-0,Lupus Sensitive APTT,1238
15359-3,Lupus Anticoag DRVVT,1229
27822-6,Protein S Actv,1021
27818-4,Protein C Actv,1020
48344-6,Kaolin Clot Time,1164
13967-5,Sex Horm Bind Glob,1390
2915-7,Renin Lvl,408
27831-7,C1q Binding,21
2258-2,Estrone Lvl,628
34445-7,Fl WBCs,422
62253-0,HDL Particle Size,235
43728-5,Large VLDL Particle Number,235
62254-8,VLDL Particle Size,235
43729-3,Large HDL Particle Number,235
43727-7,Small LDL Particle Number,235
2571-8,NMR Triglycerides,235
2085-9,NMR HDL Cholesterol,235
17782-4,NMR LDL Cholesterol,233
54434-6,LDL Particle Number,235
17782-4,LDL Particle Size,235
43729-3,HDL Particle Number,235
2093-3,NMR Total Cholesterol,235
31208-2,GC/Chlamydia PCR Source,18813
2141-0,ACTH Lvl,1083
24108-3,Cancer Ag 19-9,1707
5370-2,ASO Titer,142
25421-9,Rubeola IgM,24
25489-6,Normetanephrines Lvl,250
25474-8,Metanephrines Lvl,250
2254-1,Estrogens Total,512
35384-7,Estradiol Lvl,516
27882-0,Proinsulin Lvl,118
2064-4,Ceruloplasmin Lvl.,1513
2693-0,Feces Osmolality,35
35668-3,Gentamicin Random,441
32660-3,RBC 6-TG Nucleotides,86
32654-6,RBC 6-MMP Nucleotides,86
1521-4,Glucose 2Hr Post Pran,41
15189-4,Kappa/Lambda Ratio.,1513
11051-0,Lambda Light Chains Qnt,1512
11050-2,Kappa Light Chains Qnt,1512
3432-2,Carbamazepine Lvl,482
53814-0,Plt Function Aspirin,198
33915-0,Ur Anabasine Lvl,73
33917-6,Ur Nornicotine Lvl,60
33916-8,Ur 3 OH Cotinine Lvl,73
10366-3,Ur Cotinine Lvl,73
3854-7,Ur Nicotine Lvl,73
2357-2,G6PD,276
2731-8,Intraop PTH,280
11572-5,RF Titer,336
35670-9,Tobramycin Random,1035
41479-7,BK Virus Quant IU/mL,1384
44805-0,BK Virus Log IU/mL,1384
2839-9,Progesterone Lvl,812
17459-9,Phospholipid IgA,813
3287-0,Phospholipid IgM,813
3286-2,Phospholipid IgG,813
2162-6,Ur Creat mg/day Cortisol,63
34909-2,Ur Cortisol Free ug/l,89
2161-8,Ur Creat mg/dl Cortisol,88
32009-3,Ur Cortisol ug/g Creat,88
2147-7,Ur Cortisol Free ug/day,63
2026-3,Tot CO2 Art POC,4843
53959-3,HCG Tumor Marker,186
1952-1,Beta 2 Microglob.,477
47321-5,Sacc. cerevisiae IgG,447
47320-7,Sacc. cerevisiae IgA,439
31019-3,Oxcarbazepine or Eslicarbazepine Metab,119
6153-1,Allergy June Grass,316
6152-3,Allergy Johnson Grass,194
15283-5,Allergy Birch,189
28009-9,Tot Vol Cortisol,95
13362-9,Coll Hrs Cortisol,96
62238-1,GFR African Amer by CKD-EPI,50492
6875-9,Cancer Ag 15-3.,414
765-8,Hypersegs,179
38476-8,Anti Mullerian Hormone Lvl,142
34319-4,Inhibin B Lvl,112
6059-0,Allergy Ca.albicans,34
59640-3,Clonazepam Lvl Conf,2
59604-9,Alpha OH Alprazolam Lvl Conf,2
59611-4,Alprazolam Lvl Conf,2
59703-9,Lorazepam Lvl Conf,2
59750-0,Temazapam Lvl Conf,2
69797-9,Alpha Hydroxymidazolam Lvl Conf,2
59622-1,Chlordiazepoxide Lvl Conf,2
59711-2,Midazolam Lvl Conf,2
59595-9,7 Amino Clonazepam Lvl Conf,2
59730-2,Oxazepam Lvl Conf,2
59721-1,Nordiazepam Lvl Conf,2
26784-9,Diazepam Lvl Conf,2
49038-3,Vit B2 Lvl,87
12228-3,Fl Triglycerides,482
12190-5,Fl Creatinine,353
12416-4,Sotalol Lvl,6
35704-6,Pleural Fl Adenosine Deaminase,32
3256-5,Fibrinogen Ag,28
18262-6,LDL Direct,405
13995-6,Ur PE Gamma,726
13994-9,Ur PE Beta,726
13993-1,Ur PE Alpha 2,726
13990-7,Ur PE Alpha 1,727
13992-3,Ur PE Albumin,745
13590-5,Actv Protein C Resis,289
9522-4,Ent.histolytica Ab,80
2484-4,IGF 1,258
2492-7,Ur Iodine per Vol,19
2161-8,Ur Creatinine per Vol Iodine,19
55928-6,Ur Iodine per gm Creat,19
83099-2,Galectin 3 Lvl,23
33358-3,M Protein Peak,2767
2191-5,DHEA Sulfate Lvl,515
35140-3,3 OH Cotinine Lvl,253
10365-5,Cotinine Lvl,253
3853-9,Nicotine Lvl,253
14836-1,Methotrexate Lvl,1150
32680-1,UA Fine Gran Casts,197
46137-6,UA Triple Phos Crystals,515
12515-3,Fl CEA,120
4484-2,C2,59
41863-2,Yeast w Pseudohyphae,428
28009-9,Tot Vol Protein Electro,229
13362-9,Coll Hrs Protein Electro,236
23905-3,Mycophenolic Acid Lvl,117
9802-0,Stone Size,1927
29537-8,CSF West Nile Virus IgG,72
30038-4,CSF Toxoplasma IgG,54
31178-7,CSF Toxoplasma IgM,59
14062-4,Dexamethasone Lvl,23
60461-1,HSV 1 PCR Quant,347
60462-9,HSV 2 PCR Quant,345
58793-1,Vit K Lvl,102
9811-1,Chromogranin A,187
29942-0,Ur Copper ug/g Creat,46
5633-3,Ur Copper ug/day,43
30920-3,Ur Copper ug/dl,67
2161-8,Ur Creat mg/dl Copper,67
2162-6,Ur Creat mg/day Copper,60
35570-1,Renin Direct,90
3198-9,Factor 7,100
13362-9,Coll Hrs Metaneph,184
4049-3,Theophylline Lvl,287
2193-1,DHEA Lvl,97
2161-8,Ur Creat mg/dl Metaneph,174
2608-8,Ur Metanephrine ug/L,175
13783-6,Ur Normetaneph ug/g Creat,174
2670-8,Ur Normetanephrine ug/L,174
13771-1,Ur Metaneph ug/g Creat,174
18244-4,Vit B3 Lvl,35
13926-1,Glutamic Acid Decarbox,213
10548-6,% Free Phenytoin,155
13362-9,Coll Hrs Porphyrins,33
28009-9,Tot Vol Porphyrins,31
29599-8,MDEA Lvl,3
29619-4,MDMA Lvl,3
29598-0,MDA Lvl,3
17260-1,Methamphetamine Lvl,3
29592-3,Amphetamine Lvl,3
12480-0,CSF ACE,104
29996-6,Histone IgG,167
35560-2,Ur M Protein Peak,548
2464-6,CSF IgG.,104
50377-1,VonWillebrand Fact Actv,124
27816-8,VonWillebrand Fact Ag,95
1756-6,Alb Index,277
2470-3,CSF IgG/Alb Ratio,277
14117-6,IgG Index,277
1746-7,CSF Albumin,277
1751-7,Serum Albumin,277
2464-6,CSF IgG,278
2465-3,Serum IgG,279
5818-0,Ur Urobilinogen POC,3373
30567-2,TSIG,504
2873-8,CSF Gamma,162
2870-4,CSF Beta,162
2867-0,CSF Alpha 2,162
2864-7,CSF Alpha 1,162
2861-3,CSF Albumin,162
2876-1,CSF Prealbumin,162
2880-3,CSF Protein.,162
2889-4,Ur Protein mg/24hr Electro,133
33194-2,Product CD34 Viability,90
20602-9,% CD34 Pos Cells,74
74838-4,Tot CD34 Pos Cells,74
9656-0,Echinococcus IgG,16
23883-2,Inhibin A Lvl,68
2991-8,Testo Free Female or Child,565
26776-5,Quetiapine Lvl,22
2638-5,Myelin Basic Protein,201
13362-9,Coll Hrs 5HIAA,100
28009-9,Tot Vol 5HIAA,99
2536-1,LD1,24
2542-9,LD3,24
2539-5,LD2,24
2545-2,LD4,24
2548-6,LD5,24
2532-0,LD Total,24
6167-1,Allergy Mango,7
1854-9,Androstenedione Lvl,17
2142-8,Saliva Cortisol Lvl,64
53774-6,CSF EBV PCR Quant Log,28
34593-4,CSF EBV PCR Quant,28
12646-6,Glucose 1Hr Challenge,714
15202-5,Feces Potassium,37
15207-4,Feces Sodium,40
1558-6,Glucose Fasting,152
15112-6,Leukocyte Alk Phos,20
20436-2,Glucose 2Hr,145
20438-8,Glucose 1Hr,145
20437-0,Glucose 3Hr,113
2666-6,Norepinephrine Lvl,101
32682-7,Hgb F,343
45315-9,Ur Coproporphyrin III,31
45313-4,Ur Coproporphyrin I,31
2162-6,Ur Creat mg/day Porphyr,10
2161-8,Ur Creat mg/dl Porphyrins,32
7425-2,Allergy Dust Stier,143
30088-9,Allergy Horse,7
6070-7,Allergy Chick Feather,2
6179-6,Allergy Mouse,1
6129-1,Allergy Goose Feathers,2
30087-1,Allergy Cow,5
5693-7,Methanol Lvl,52
5669-7,Isopropanol Lvl,29
5568-1,Acetone Lvl,29
1668-3,17 Hydroxyprogesterone Lvl MS,63
6090-5,Allergy Poplar,130
6110-1,Allergy Plantain,140
7395-7,Allergy Helminthosporium,130
6124-2,Allergy Giant Ragweed,127
6156-4,Allergy Lambs Quarters,132
6038-4,Allergy Beech Tree,130
802-9,Spherocytes,759
5176-3,Hel. pylori IgG Index,105
35468-8,FLAER,153
49031-8,CD59,153
46080-8,CD55,153
14869-2,Path Smear Review,2321
42338-4,HSV 2 Glycopro G IgG,7
2171-7,Vit B12 Bind Cap,121
5060-9,Lyme Ab,119
2161-8,Ur Creat mg/dl 5HIAA,101
1695-6,Ur 5HIAA mg/day,77
31203-3,Ur 5HIAA mg/l,101
11145-0,Ur 5HIAA mg/g Creat,101
2162-6,Ur Creat mg/day 5HIAA,77
5273-8,Parvovirus B19 IgG Index,160
5274-6,Parvovirus B19 IgM Index,160
21563-2,Thiopur Methyltransf,158
46436-2,Histamine Lvl,11
30194-5,C22:0 Behenic Acid Lvl,10
22671-2,Phytanic Acid Lvl,10
22761-1,Pristanic Acid Lvl,10
30198-6,C26:0/C22:0 Ratio,10
30196-0,C24:0/C22:0 Ratio,10
30550-8,Pristanic/Phytanic Ratio,10
30197-8,C26:0 Hexacosanoic Acid Lvl,10
30195-2,C24:0 Tetracosanoic Acid Lvl,10
5255-5,Mycopl. pneumoniae IgG Index,93
2837-3,Pregnenolone Lvl,108
49585-3,Seq Scr2 AFP MoM C/O,8
20450-3,Seq Scr2 AFP MoM,8
32123-2,Seq Scr2 PAPP-A MoM,8
20465-1,Seq Scr2 HCG MoM,8
35738-4,Seq Scr2 Inhibin MoM,8
20466-9,Seq Scr2 UE3 MoM,8
73958-1,Lysosomal Acid Lipase Actv,39
2589-0,Muramidase,11
3095-7,Ur Urea Nit mg/dL,19
3096-5,Ur Urea Nit mg/24hr,19
28009-9,Tot Vol Urea Nit,19
13362-9,Coll Hrs UUN,19
24447-5,Ur Magnesium mg/24hr,52
28009-9,Tot Vol Mag,53
19124-7,Ur Magnesium mg/dL,50
28009-9,Tot Vol Uric Acid,52
13362-9,Coll Hrs Phos,47
3086-6,Ur Uric Acid mg/dL,49
3087-4,Ur Uric Acid mg/24hr,49
13362-9,Coll Hrs Magnesium,52
13362-9,Coll Hrs Uric Acid,50
28009-9,Tot Vol Phos,47
2778-9,Ur Phosphorus mg/dL,45
2779-7,Ur Phosphorus mg/24hr,46
57416-0,TSH Receptor Ab,141
28009-9,Tot Vol Heavy Metals,43
13362-9,Coll Hrs Heavy Metals,47
33984-6,Factor 10 Chromogenic,178
2494-3,Iodine Lvl,50
13362-9,Coll Hrs K,29
28009-9,Tot Vol K,26
2829-0,Ur Potassium mmol/24hr,26
28009-9,Tot Vol Sodium,56
2956-1,Ur Sodium mmol/24hr,57
13362-9,Coll Hrs Na,56
2955-3,Ur Sodium mmol/L,55
13362-9,Coll Hrs Chloride,10
28009-9,Tot Vol Chloride,10
2078-4,Ur Chloride mmol/L,10
2079-2,Ur Chloride mmol/24hr,10
2828-2,Ur Potassium mmol/L,26
53622-7,ADAMTS13 Actv,221
46984-1,LDL 2 Fraction,11
51002-4,Midband A,11
51003-2,Midband B,11
51004-0,Midband C,11
2091-7,VLDL Cholesterol,11
43392-0,LDL 1 Fraction,11
2089-1,LDL Cholesterol Total,11
5335-5,Rubella IgM Index,125
2162-6,Ur Creat mg/day Heavy Met,27
2161-8,Ur Creat mg/dl Heavy Met,41
13824-8,Ur Arsenic ug/g Creat,10
29914-9,Ur Arsenic ug/day,7
21074-0,Ur Arsenic ug/l,42
21383-5,Ur Mercury ug/l,41
20625-0,Ur Lead ug/l,45
5622-6,Chromium Lvl,21
5683-8,Manganese Lvl,13
20438-8,Glucose 1Hr Pregnant Pt,93
20437-0,Glucose 3Hr Pregnant Pt,91
20436-2,Glucose 2Hr Pregnant Pt,91
1558-6,Glucose Fasting Pregnant Pt,94
42185-9,Draw/Send Number Tubes Collected,11
35559-4,M Protein Peak 2,70
3013-0,Thyroglobulin by LC/MS,52
49585-3,MSAFP Expected AFP,207
20450-3,MSAFP Relative AFP,205
1834-1,MSAFP Absolute AFP,212
29638-4,Tis Wt Copper,13
56126-6,Tis Copper,11
2939-7,Serotonin Lvl,68
14207-5,DNAse B Ab,54
15212-4,Fl Lipase,89
32017-6,Other Hgb,21
2597-3,RBC Magnesium,64
6125-9,Allergy Gluten,39
33210-6,Soluble Transferrin Recept,70
51729-2,GM1 IgG,38
51703-7,GM1 IgM,38
6367-7,Tetanus IgG,33
27395-3,Pneumococ IgG 18c,132
27390-4,Pneumococ IgG 19f,132
25296-5,Pneumococ IgG 7f,132
27096-7,Pneumococ IgG 3,132
27118-9,Pneumococ IgG 6b,132
27387-0,Pneumococ IgG 14,132
30153-1,Pneumococ IgG 9v,132
27392-0,Pneumococ IgG 9n,132
2053-7,Carotene Lvl,13
75510-8,APTT LA 1:1 Mix,170
15087-0,PTH Related Peptide,199
58449-0,RBC Clumps,81
5609-3,Cadmium Lvl,1
2671-6,Ur Normetaneph ug/day,114
2609-6,Ur Metaneph ug/day,114
2162-6,Ur Creat mg/day Metaneph,114
28009-9,Tot Vol Metaneph,183
6062-4,Allergy Casein,9
7445-0,Allergy Lactalbumin,6
41397-1,Allergy Lactoglobulin,5
9738-6,Gabapentin Lvl,20
41171-0,C-Telopeptide Lvl,141
2251-7,Estriol Lvl,13
6892-4,T4 Free Dialysis,48
14177-0,Growth Hormone Lvl,81
41150-4,CSF HSV 1 and 2 IgM,31
6033-5,Allergy Avocado,4
29658-2,Bord. pertussis IgM,15
29659-0,Bord. pertussis IgG,15
3187-2,Factor 9,56
9328-6,Carbidopa Lvl,4
9385-6,Levodopa Lvl,4
3226-8,Factor 11,14
2752-4,Semen pH,74
10580-9,Semen Liquefaction,49
32789-0,Semen Viscosity,49
3160-9,Semen Volume,74
32825-2,Semen Leukocytes,49
72517-6,Total Sperm Number,49
9780-8,Sperm Concentration,49
71387-5,Total Progressive Motility,49
33311-2,Tot Porphyrins,11
25419-3,Mumps IgM,24
17842-6,Cancer Ag 27.29,236
3893-5,Oxycodone Lvl,4
12788-6,6 Acetylmorphine Lvl,4
3827-3,Morphine Lvl,4
3506-3,Codeine Lvl,4
3683-0,Hydromorphone Lvl,4
60467-8,Oxymorphone Lvl,4
3680-6,Hydrocodone Lvl,4
15049-0,CK MM,79
1992-7,Calcitonin Lvl,42
2701-1,Ur Oxalate mg/day,67
2779-7,Ur Phosphorus per Day,28
2162-6,Ur Creatinine per Day,28
21458-5,Ur Phosphorus per Vol,28
24447-5,Ur Magnesium per Day,28
32024-2,Ur Magnesium per Vol,28
2829-0,Ur Potassium per Day,28
2756-5,Ur pH for Calculi Risk Assmnt,28
21476-7,Ur Potassium per Vol,28
2956-1,Ur Sodium per Day,28
21525-1,Ur Sodium per Vol,28
3167-4,Tot Vol Kidney Stone Pnl,32
27222-9,Ur Oxalate mg/l,74
21587-1,Ur Uric Acid per Vol,28
6687-8,Ur Citric Acid mg/day,67
21203-5,Ur Citric Acid mg/l,75
3087-4,Ur Uric Acid per Day,28
20624-3,Ur Creatinine per Vol,28
21194-6,Ur Chloride per Vol,28
6874-2,Ur Calcium per Day,28
18488-7,Ur Calcium per Vol,28
2079-2,Ur Chloride per Day,28
13362-9,Coll Hrs Kidney Stone Pnl,31
2161-8,Ur Creat mg/dl Catechol,92
13733-1,Ur Dopamine ug/g Creat,92
2217-8,Ur Dopamine ug/L,92
13734-9,Ur Epineph ug/g Creat,92
11046-0,Ur Epinephrine ug/L,92
13782-8,Ur Norepineph ug/g Creat,92
2667-4,Ur Norepinephrine ug/L,92
2161-8,Ur Creat mg/dl Osteocal,13
14115-0,Ur N Telopeptide,13
2990-0,"Testosterone,Bioavailable",141
33863-2,Cystatin C Lvl,88
35669-1,Amikacin Random,312
16822-9,Nasal Smr Epi,19
2755-7,Feces pH,59
1836-6,Retinol Binding Protein,1
10992-6,Norclozapine Lvl,12
6896-5,Clozapine Lvl,12
2148-5,Creatine Lvl (mg/dl),24
15045-8,Creatine Lvl,24
2986-8,Testosterone Total LC/MS,44
5959-2,PT 1:1 Mix,56
5902-2,PT HTU,99
32681-9,Hgb C,68
1799-6,Ur Amylase Rdm,6
2697-1,Osteocalcin Lvl,22
5583-0,Arsenic Lvl,47
5685-3,Mercury Lvl,48
77307-7,Lead Lvl,48
19124-7,Ur Magnesium Rdm,48
53922-1,FNA Thyroglobulin,14
20465-1,Seq Scr1 HCG MoM,8
32123-2,Seq Scr1 PAPP-A MoM,8
42332-7,AFP L3,36
1834-1,AFP Total,36
6073-1,Allergy Chocolate,33
6107-7,Allergy Egg Yolk,19
1964-6,Ur Bicarbonate,16
3125-2,Vasoact Intest Polypep,25
6886-6,IgA Subclass 1,74
2458-8,Serum IgA,76
6939-3,IgA Subclass 2,74
23992-1,Dengue Fever IgM,17
23991-3,Dengue Fever IgG,17
27353-2,Est Avg Glucose,65
4548-4,Hgb A1c Referred,71
29620-2,Zonisamide Lvl,30
3218-5,Factor 10,53
3333-2,Amitriptyline Lvl,6
3872-9,Nortriptyline Lvl,8
14251-3,Mitochondrial M2 IgG,35
28608-8,Ur Tryptophan,3
32248-7,Ur Homocitrulline,3
28599-9,Ur Cystathionine,3
28596-5,Ur Anserine,3
32229-7,Ur Argininosuccinic Acid,3
30064-0,Ur Valine,3
28598-1,Ur Alpha Aminoadipic Acid,3
28590-8,Ur Alpha Aminobutyric Acid,3
2161-8,Ur Creat mg/dl Am Acd,9
30055-8,Ur Phenylalanine,3
30053-3,Ur Leucine,3
30049-1,Ur Ornithine,3
30063-2,Ur Methionine,3
30048-3,Ur Lysine,3
28591-6,Ur Beta Aminoisobutyric Acid,3
56678-6,Ur Ethanolamine,3
30054-1,Ur Tyrosine,3
30067-3,Ur Proline,3
30057-4,Ur Threonine,3
28595-7,Ur Taurine,3
30058-2,Ur Serine,3
30059-0,Ur Glutamic Acid,3
28603-9,Ur Asparagine,3
30065-7,Ur Cystine,3
30161-4,Ur Citrulline,3
30061-6,Ur Aspartic Acid,3
30052-5,Ur Isoleucine,3
30056-6,Ur Glutamine,3
28601-3,Ur Hydroxyproline,3
30047-5,Ur Histidine,3
30066-5,Ur Glycine,3
30062-4,Ur Arginine,3
30068-1,Ur Alanine,3
2457-0,CSF IgA,33
17862-4,Ur Calcium Rdm,128
56718-0,Insulinoma Ag 2 Ab,32
3436-3,Ur 11 Nor 9 Carboxy THC Qnt,48
4505-4,C5,27
3021-3,Thyroxine Bind Glob,10
2756-5,Ur pH Peds Chemo,195
5810-7,Ur Specific Gravity Peds Chemo,234
2020-6,CBG PCO2,17
2745-8,CBG pH,17
2704-5,CBG PO2,17
16551-4,CBG Total CO2,14
1961-2,CBG HCO3 (Bicarb),17
3330-8,Amiodarone Lvl,29
6774-4,NDesethyl Amiodarone Lvl,29
58941-6,Transcutan Bilirubin,7
48344-6,Kaolin Clot Time 1:1 Mix,36
1871-3,Apolipoprotein B100,25
28009-9,Tot Vol Catechol,90
13362-9,Coll Hrs Catechol,97
2722-7,Vit B5 Lvl,15
20657-3,Taurine Lvl,8
20656-5,Serine Lvl,8
20655-7,Proline Lvl,8
14875-9,Phenylalanine Lvl,9
20652-4,Ornithine Lvl,8
26600-7,AA Alpha Amino Adipic Acid,8
20634-2,AA Alpha Amino Butyric Acid,8
20661-5,Valine Lvl,8
20660-7,Tyrosine Lvl,8
20645-8,Histidine Lvl,8
20644-1,Glycine Lvl,8
20642-5,Glutamic Acid Lvl,8
20636-7,Alanine Lvl,8
20651-6,Methionine Lvl,8
20650-8,Lysine Lvl,8
20649-0,Leucine Lvl,8
20648-2,Isoleucine Lvl,8
20647-4,Hydroxyproline Lvl,8
22672-0,Cystine Lvl,8
20640-9,Citrulline Lvl,8
20639-1,Aspartic Acid Lvl,8
20637-5,Arginine Lvl,8
26608-0,AA Ethanolamine,8
30060-8,Beta Amino Isobutyric  Acid,8
20638-3,AA Asparagine,8
20659-9,AA Tryptophan,8
28009-9,Tot Vol Aldost,23
13362-9,Coll Hrs Aldost,24
3714-3,Lidocaine Lvl,50
13362-9,Coll Hrs Oxalate,49
28009-9,Tot Vol Oxalate,48
20509-6,CBG Hgb (Calc),7
19219-5,CBG O2 Content,6
2715-1,CBG Hgb O2,6
2031-3,CBG Hgb CO,6
2616-1,CBG Methemoglobin,6
16233-9,Ur Midazolam,5
51776-3,Ur 7 Aminoclonazepam,5
16229-7,Ur Clonazepam,5
16348-5,Ur Alphahydroxyalprazolam,5
59615-5,Ur Alprazolam,5
59590-0,Ur Alpha Hydroxymidazolam,5
20522-9,Ur Chlordiazepoxide,5
17088-6,Ur Lorazepam,5
20559-1,Ur Temazepam,5
16201-6,Ur Oxazepam,5
16228-9,Ur Nordiazepam,5
16227-1,Ur Diazepam,5
2162-6,Ur Creat mg/day Catechol,69
2218-6,Ur Dopamine ug/day,69
2668-2,Ur Norepinephrine ug/day,69
2232-7,Ur Epinephrine ug/day,69
2161-8,Ur Creat mg/dl Aldost,22
1765-7,Ur Aldosterone,22
2162-6,Ur Creat mg/day Aldost,11
12610-2,Glucose Lvl 2 Hr Specimen,1
2778-9,Ur Phosphorus Rdm,12
14725-6,Fl Type Cell Count,6406
13362-9,Coll Hrs Citrate,48
28009-9,Tot Vol Citrate,47
2339-0,Glucose POC,144
15060-7,NSE,8
41759-2,Ur BJ Kappa/Lambda Ratio,9
38178-0,Ur BJ Lambda Lt Chains,7
38176-4,Ur BJ Kappa Lt Chains,7
20448-7,Insulin Lvl Total,53
6901-3,Insulin Lvl Free,53
26881-3,Interleukin 6 Lvl,1317
1848-1,Dihydrotestosterone Lvl,30
7172-0,Candida IGG,27
56151-4,Candida IGA,27
56150-6,Candida IGM,27
3289-6,Factor 2,66
7714-9,Allergy Squash,1
10835-7,Lipoprotein a,57
6266-1,Allergy Tomato,42
6039-2,Allergy Beef,34
6035-0,Allergy Banana,36
7090-4,Allergy Apple,38
6257-0,Allergy Strawberry,38
6718-1,Allergy Cashew,11
6019-4,Allergy Almond,21
6208-3,Allergy Pecan,26
6081-4,Allergy Coconut,17
6194-5,Allergy Orange,37
6836-1,Allergy Chicken,33
34275-8,Ur Creatine mmol/mol Creat,21
14683-7,Ur Creatinine umol/l Creatine,21
12183-0,Fl Cholesterol,34
6841-1,Allergy Grape,4
6166-3,Allergy Malt,4
57884-9,Allergy Melon,8
7151-4,Allergy Blackberry,2
6083-0,Allergy Coffee,3
7152-2,Allergy Blueberry,2
6061-6,Allergy Carrot,3
6052-5,Allergy Broccoli,2
7591-1,Allergy Chili Pepper,3
6856-9,Allergy Spinach,1
7586-1,Allergy Green Pepper,3
6287-7,Allergy Bake/Brew Yeast,14
6264-6,Allergy Tea,1
28644-3,ACBG PCO2,30
39466-8,ACBG Total CO2,13
28640-1,ACBG HCO3 (Bicarb),30
28642-7,ACBG O2 Sat,30
28646-8,ACBG pH,32
28648-4,ACBG PO2,30
5946-9,APTT 1:1 Mix,6
3243-3,Thrombin Time HTU,13
14979-9,APTT HTU,28
1690-7,5 Nucleotidase Lvl,15
12173-1,Acid Phos,5
51440-6,Ur M Protein Peak 3,15
35561-0,Ur M Protein Peak 2,42
3274-8,Heparin Assay Unfract,5088
3274-8,Heparin Assay Anti Xa Unfract,21012
2250-9,AFP4 Absolute UE3,38
20465-1,AFP4 Relative HCG,36
19080-1,AFP4 Absolute HCG,37
49585-3,AFP4 Expected AFP,37
35738-4,AFP4 Relative Inhibin,36
23883-2,AFP4 Absolute Inhibin,37
20466-9,AFP4 Relative UE3,36
20450-3,AFP4 Relative AFP,36
1834-1,AFP4 Absolute AFP,37
5627-5,Cobalt Lvl,8
13362-9,Coll Hrs Microalb,27
28009-9,Tot Vol Microalb,28
14957-5,Ur Microalbumin mg/L,27
14956-7,Ur Microalb 24 Hr,27
26801-1,Ur Protein mg/12 hr,7
33939-0,Interleukin 2 Lvl,417
14336-2,Ethanol Lvl,16
2161-8,Ur Creat mg/dL Org Acids,5
29859-6,Ur Adipic Acid,6
25099-3,Ur Ethylmalonic Acid,6
25088-6,Ur Phenylacetic Acid,6
25136-3,Ur Succinic Acid,6
25132-2,Ur Pyruvic Acid,6
25112-4,Ur Lactic Acid,6
29509-7,Ur 3-OH-Butyric Acid,6
25116-5,Ur Methylmalonic Acid,6
29507-1,Ur 2 Ketoglutaric Acid,6
3204-5,Factor 8 Inhib Human,49
21365-2,Leptin Lvl,10
3271-4,Heparin Assay Anti Xa LMW,982
35655-0,C4 Iso/Butyryl,8
30551-6,C3 Propionyl,8
30191-1,C2 Acetyl,8
30534-2,C18-2 Linoleyl,8
30542-5,C18-1 Oleyl,8
30560-7,C18 Stearoyl,8
30540-9,C8 Octanoyl,8
30349-5,C5 DC Glytacyl,8
30357-8,C16-1 Palmitoleyl,8
30356-0,C16 Palmitoyl,8
30331-3,C12 Dodecanoyl,8
30328-9,C10-1 Decenoyl,8
30541-7,C8-1 Octanoyl,8
94506-3,SARS CoV 2 IgM Ab Qnt COVID19,39
94505-5,SARS CoV 2 IgG Ab Qnt COVID19,39
12731-6,Interferon Alpha Lvl,362
27415-9,Interferon Gamma Lvl,403
26848-2,Interleukin 10 Lvl,409
13362-9,Coll Hrs VMA,28
28009-9,Tot Vol VMA,28
38901-5,Leflunomide Lvl,43
3074-2,Tumor Necrosis Factor Alpha,404
13629-1,Interleukin 1 Beta Lvl,406
33211-4,Interleukin 8 Lvl,401
3394-4,Ur Cocaine Metab Benzoylecognine Qnt,10
38420-6,Cytokeratin Ab,93
3064-3,Trypsin Like Immunoreac,21
51623-7,Post Vasec Sperm Conc,25
2520-5,CSF Lactic Acid,22
2161-8,Ur Creat mg/dl Porphobil,37
2811-8,Ur Porphobil Umol/L,37
7123-3,Allergy Bayberry,9
6151-5,Allergy Italian Cypress,4
38178-0,Ur Lambda Lt Chains Prot Electro,19
38176-4,Ur Kappa Lt Chains Prot Electro,19
61422-2,Ur Norhydrocodone,14
16251-1,Ur Morphine,14
61425-5,Ur Noroxycodone,14
19593-3,Ur 6 Acetylmorphine Lvl,14
16249-5,Ur Oxycodone,14
16252-9,Ur Hydrocodone,14
16250-3,Ur Codeine,14
16998-7,Ur Hydromorphone,14
17395-5,Ur Oxymorphone,14
2162-6,Ur Creat mg/day VMA,20
30571-4,Ur VMA mg/g Creat,28
2161-8,Ur Creat mg/dl VMA,28
26706-2,Ur VMA mg/L,28
3122-9,Ur VMA,20
33905-1,UA Trichomonas,253
55180-4,Human Epididymis Pro 4,16
13362-9,Coll Hrs Prot Electro,19
28009-9,Tot Vol Prot Electro,18
3086-6,Ur Uric Acid Rdm,64
1869-7,Apolipoprotein A1,26
28660-9,Plasminogen Actv,8
3232-6,Factor 12,13
38177-2,Ur Kappa Excret/Day Prot Electro,19
20602-9,CD34 Pos Cells,30
14136-6,Tot CD34 Pos Cells,47
33193-4,CD34 Viability,31
16150-5,11 Nor 9 Carboxy THC Lvl,15
5646-5,Ethylene Glycol Lvl,37
3392-8,Cocaine Metab Benzoylecognine Lvl,4
28009-9,Tot Vol ALA,10
27823-4,Protein S Ag Total,22
27821-8,Protein S Ag Free,22
27820-0,Protein C Ag,18
4086-5,Valproic Acid Total Lvl,69
4087-3,Valproic Acid Free Lvl,69
5625-9,WB Cobalt Lvl,4
1974-5,Fl Bilirubin Total,48
2162-6,Ur Creat mg/day Citrate,40
2161-8,Ur Creat mg/dl Citrate,47
13722-4,Ur Citrate/Creat Ratio,47
13362-9,Coll Hrs ALA,10
2162-6,Ur Creat mg/day ALA,4
2161-8,Ur Creat mg/dl ALA,10
14689-4,Ur ALA umol/day,4
25896-2,Ur ALA umol/l,10
2162-6,Ur Creat mg/day Oxalate,40
2161-8,Ur Creat mg/dl Oxalate,46
3093-2,Fl Urea Nitrogen,11
35475-3,A-Oligosac/Di-Oligosac,6
35469-6,Mono-Oligosac/Di-Oligosac,6
59563-7,Ur M Protein Peak 4,12
2161-8,Ur Creat mg/dl MMA,3
25116-5,Ur MMA mmol/mol,3
32287-5,Ur MMA umol/l,3
27812-7,Antithrombin Ag,18
29638-4,Tis Wt Iron,6
49061-5,Hepatic Iron Index,6
15357-7,Hepatic Iron Conc,6
55199-4,Bld Chrom Metaphases Ktyped,14
62360-3,Bld Chrom Metaphases Anyl,14
62361-1,Bld Chrom Metaphases Cntd,14
32580-3,Chromatin Ab IgG,19
6092-1,Allergy Crab,46
20508-8,RPR Titer,295
2961-1,Somatostatin Lvl,12
5634-1,Cyanide Lvl,3
13591-3,Factor Inhib,2
2338-2,Glucagon Lvl,15
2999-1,Vit B1 Lvl for Intake Monitoring,79
2991-8,Testosterone Free by Dialysis,20
9383-1,9 Hydroxyrisperidone,4
9393-0,Risperidone Lvl,4
9394-8,Risp and Hydroxyrisp,4
3669-9,Haloperidol Lvl,2
13249-8,CSF HSV 1 and 2 IgG,13
28638-5,ACBG Base Excess,13
32552-2,Pyruvate Kinase,6
10989-2,Itraconazole Lvl,1
18337-6,Hydroxyitraconazole Lvl,1
6050-9,Allergy Brazil Nut,6
10864-7,Immune Complex C3b,5
27923-2,Coenzyme Q10 Lvl,7
40869-0,Carnitine Esterified/Free,22
14282-8,Carnitine Esterified,22
14288-5,Carnitine Total,28
14286-9,Carnitine Free,22
31666-1,SGPG IgM Ab,4
50772-3,GQ1B Ab,4
50768-1,GD1B Ab,4
31344-5,GD1A Ab,4
50770-7,GM1 Ab,4
50769-9,Asialo GM1 Ab,4
52789-5,Citrated R Time,683
52780-4,Citrated Func Fibrinogen MA,678
66753-5,Citrated Heparin R Time,683
66748-5,Citrated Angle,675
52781-2,Citrated Max Amplitude,674
52768-9,Citrated K Time,674
52778-8,Citrated Rapid TEG MA,680
12638-3,LTT Fasting,20
26778-1,LTT 60 Minute,20
26779-9,LTT 90 Minute,20
26777-3,LTT 30 Minute,20
25303-9,Feces A1 Antitrypsin,15
5974-1,Plasminogen Actv Inhib,9
38995-7,UA Cellular Casts,70
32283-4,% Free Valproic Acid,34
2889-4,Ur Tot Prot mg/d Prot Electro,19
38169-9,Ur Lambda Excret/Day Prot Electro,19
31208-2,JC Virus PCR Src,122
28009-9,Tot Vol Porphobil,36
29536-0,West Nile Virus IgM,12
29535-2,West Nile Virus IgG,15
25149-6,UA CaPhos Crys,12
31208-2,Nephropath Source,633
7291-8,Allergy Egg Whole,20
6220-8,Allergy White Potato,32
6219-0,Allergy Pork,32
1805-1,Pancr Amylase,14
1798-8,Tot Amylase,14
1809-3,Salivary Amylase,14
49585-3,Int Scr2 AFP MoM C/O,6
6234-9,Allergy Thistle,6
3638-4,Flecainide Lvl,5
14378-4,Polys Ur Smear,2
5819-8,UA Waxy Cast,15
53597-1,Mannobioside Carbohydrate Ab IgG,23
53596-3,Laminaribioside Carbohydrate Ab IgG,23
53594-8,Chitobioside Carbohydrate Ab IgA,23
6288-5,Allergy Yellow Hornet,5
6280-2,Allergy White Hornet,4
6198-6,Allergy Paper Wasp,4
6740-5,Allergy Yellow Jacket,5
6844-5,Allergy Bee,4
31208-2,Misc Test Spec,1938
7674-5,Allergy Rye,34
6037-6,Allergy Barley,29
6230-7,Allergy Rice,33
6193-7,Allergy Onion,33
8245-3,WB Zinc Lvl,20
15158-9,Feces Chloride,7
73818-7,Heparin Ab IgG Result,59
64038-3,Adenovirus PCR Quant log copy/mL,20
28009-9,Tot Vol BJ Prot,7
38546-8,HLA B Locus 2,466
38546-8,HLA B Locus 1,473
42663-5,HLA Cw Locus 1,49
38548-4,HLA A Locus 2,466
38548-4,HLA A Locus 1,472
12285-3,DPA Locus 1,34
44728-4,DQA Locus 1,34
45030-4,Molecular DRB1 Locus 2,38
45029-6,Molecular DQB1 Locus 1,42
38177-2,Ur BJ Kappa Excret/Day,7
2889-4,Ur BJ Tot Prot,7
13362-9,Coll Hrs BJ Prot,11
38169-9,Ur BJ Lambda Excret/Day,7
42663-5,HLA Cw Locus 2,42
7369-2,Allergy Rye Grass,7
7627-3,Allergy Sweet Potato,3
28009-9,Tot Vol HVA,2
13362-9,Coll Hrs HVA,2
2089-1,LDL Direct,9
6158-0,Allergy Latex,14
44728-4,DQA Locus 2,28
45030-4,Molecular DRB1 Locus 1,42
12285-3,DPA Locus 2,17
45029-6,Molecular DQB1 Locus 2,33
58453-2,Feces Occult Blood Immunoassay,21
2685-6,Alpha 1 Acid Glycoprotein,3
7195-1,Allergy Red Cedar,9
7565-5,Allergy Parakeet,1
6161-4,Allergy Lettuce,5
7118-3,Allergy Basil,1
6831-2,Allergy Green Bean,6
6122-6,Allergy Garlic,5
53938-7,DQB1 Locus B SSP,13
21342-1,DR Locus 2,13
13304-1,DR Locus 1,14
5786-9,Epithelial Cell Casts,7
50542-0,Ur EDDP Quant,10
3774-7,Ur Methadone Quant,10
53595-5,Ur HVA mg/L,2
12715-9,Ur HVA mg/day,2
13760-4,Ur HVA mg/g Creat,2
2162-6,Ur Creat mg/day HVA,2
2161-8,Ur Creat mg/dl HVA,2
29657-4,Bord. pertussis IgA,3
3312-6,Alprazolam Lvl,6
66723-8,Adenovirus PCR Quant log copy/mL,138
49334-6,Adenovirus PCR Quant copy/mL,138
26541-3,Glucose 4Hr,8
26543-9,Glucose 5Hr,6
20557-5,Ur Phentermine Lvl,11
45143-5,Ur MDEA Lvl,12
18358-2,Ur MDMA Lvl,12
20545-0,Ur MDA Lvl,12
16235-4,Ur Methamphetamine Lvl,12
16234-7,Ur Amphetamine Lvl,12
5971-7,Tis Plasminogen Ag,3
12723-3,IGF Bind Prot 2,9
27810-1,Antiplasmin,1
31208-2,EBV PCR Source,93
29944-6,Alpha 2 Macroglobulin,1
6177-0,Allergy Mosquito,2
6117-6,Allergy Fire Ant,4
12722-5,IGF Bind Prot 1,17
15066-4,Free Fatty Acids,10
2756-5,Ur pH (Met Scr),9
13485-8,Ur B2M ug/g Creat,9
2161-8,Ur Creat mg/dl B2 Micro,10
1953-9,Ur Beta 2 Microglob,9
20420-6,Prostatic Acid Phos,4
20599-7,Product CD3,8
7891-5,Giardia lamblia IgG,38
9658-6,Giardia lamblia IgA,38
7892-3,Giardia lamblia IgM,38
52123-7,Hepzyme Treated APTT,57
31208-2,Trichomonas PCR Source,179
14725-6,Fl Type LD,1906
31208-2,HSV PCR Qual Src,2258
31208-2,Toxoplasma PCR Src,73
6207-5,Allergy Pear,6
6204-2,Allergy Pea,6
6205-9,Allergy Peach,4
31208-2,M TB Complex PCR Qual Source,250
3537-8,Nordiazepam Lvl,2
3457-9,Chlordiazepoxide Lvl,3
6765-2,17 Hydroxypregnenolone Lvl,4
2721-9,Pancreatic Polypep,6
17016-7,Influenza B IgM,6
17015-9,Influenza B IgG,6
31438-5,Influenza A IgM,6
31437-7,Influenza A IgG,6
2161-8,Ur Creat mg/dl Cad,3
30925-2,Ur Cadmium ug/l,3
6077-2,Allergy Cocklebur,5
6183-8,Allergy Mugwort,1
6260-4,Allergy Sweetgum,4
7557-2,Allergy Ovomucoid,3
7556-4,Allergy Ovalbumin,3
7484-9,Allergy Marsh Elder,7
7272-8,Allergy Bald Cypress,6
31208-2,Fl Type Influenza Ag,9288
16471-5,Blastomyces Ab,5
4040-2,Sulfonamides Lvl,6
5761-2,"Zinc, RBC",11
3982-6,Procainamide Lvl,20
3834-9,"NAPA Lvl",20
6906-2,Sertraline Lvl,4
6851-0,Allergy Penicillin G,7
7678-6,Allergy Sage,2
6228-1,Allergy Red Top Grass,2
6222-4,Allergy Queen Palm,6
6182-0,Allergy M. racemosus,4
6169-7,Allergy Meadow Fescue,3
6155-6,Allergy Lamb,3
6285-1,Allergy Willow,3
6281-0,Allergy Mulberry,4
14882-5,Ur Porphobil Umol/Day,2
2162-6,Ur Creat mg/day Porphobil,2
13362-9,Coll Hrs Porphobil,39
12389-3,Olanzapine Lvl,6
6263-8,Allergy Sycamore,2
4551-8,Hgb A2 Ref Lab,3
4576-5,Hgb F Ref Lab,3
49058-1,CRRT Blue Port APTT,3
6837-9,Allergy Cinnamon,2
3819-0,Mexiletine Lvl,3
9828-5,Allergy Dust Greer,4
42337-6,HSV 1 Glycopro G IgG,4
6159-8,Allergy Lemon,2
6178-8,Allergy Mountain Cedar,4
6029-3,Allergy Aur.pullulans,3
3002-3,Thiocyanate Lvl,4
6203-4,Allergy Parsley,3
6065-7,Allergy Celery,4
44728-4,DQA1 Locus 1,257
13304-1,DRB1 Locus 1,396
42663-5,HLA C Locus 1,422
53938-7,DQB1 Locus 1,396
12285-3,DPA1 Locus 1,255
53938-7,DQB1 Locus A SSP,14
2077-6,Sweat Chloride Rslt,3
33247-8,Sweat Wt (Mg),3
14725-6,Fl Type Bronch Lav/Wash Diff,3204
31208-2,Misc Genzyme Sample,233
28645-0,VCBG PCO2,7
39465-0,VCBG Total CO2,1
28647-6,VCBG pH,7
28643-5,VCBG O2 Sat,7
28641-9,VCBG HCO3 (Bicarb),7
28649-2,VCBG PO2,1
2898-5,RBC Porphyrin,2
14894-0,Propylene Glycol Lvl,8
6165-5,Allergy Lobster,18
6048-3,Allergy Mussel,2
6278-6,Allergy Ash,4
6111-9,Allergy Epicoccum,4
7613-3,Allergy Pistachio,2
6270-3,Allergy Tuna,16
4064-2,Trazadone Lvl,7
1951-3,CSF Beta2 Microglobulin,2
58378-1,Ur Ethyl Glucuronide Qnt,2
58425-0,Ur Ethyl Sulfate Qnt,2
6223-2,Allergy Rabbit,1
49759-4,Peritoneal Fl Adenosine Deaminase,5
6210-9,Allergy Penicillin V,5
6829-6,Allergy Amoxicillin,4
71694-4,Reticulocyte Hgb Content,4
14121-8,Pyruvic Acid Lvl,2
2161-8,Ur Creat mg/dl Acylgly,1
3167-4,Tot Vol Iodine,19
13362-9,Coll Hrs Iodine,19
2162-6,Ur Creatinine per 24h Iodine,1
26842-5,Ur Iodine per 24h,1
14725-6,Fl Type Crystals,451
25375-7,Feces Chymotrypsin,3
4659-9,Leukocyte Alk Phos,15
3807-5,Ritalin Lvl,1
32153-9,Ritalinic Acid Lvl,1
42663-5,HLA C Locus 2,420
18487-9,UA Broad Cast,5
14803-1,CSF LD,13
2161-8,Ur Creat mg/dl 17OHCort,2
41404-5,Ur 17 OHCorticoster mg/g Creat,2
16878-1,Fran. tularensis IgM,3
70121-9,Fran. tularensis IgG,3
6237-2,Allergy Salmon,7
55730-6,Whole Fetal Bld,2
48556-5,% Fetal Cells,172
14170-5,Alpha Subunit,5
3724-2,Lorazepam Lvl,2
53612-8,Fl Uric Acid,5
2179-0,Ur Cystine mg/day,6
2178-2,Ur Cystine mg/dl,8
30065-7,Ur Cystine mg/g Creat,8
28009-9,Tot Vol Cystine,9
13362-9,Coll Hrs Cystine,9
58777-4,Allergy Peanut ARA H3,1
58778-2,Allergy Peanut ARA H2,1
58779-0,Allergy Peanut ARA H1,1
90880-6,Allergy Peanut ARA H6,1
64965-7,Allergy Peanut ARA H9,1
63477-4,Allergy Peanut ARA H8,1
6121-8,Allergy F.moniliforme,2
3335-7,Amitrip & Nortrip Lvl,5
50796-2,M Protein Peak 3,6
3639-2,5 Fluorocytosine Lvl,19
6953-4,Ambien Lvl,1
5702-6,Nickel Lvl,1
3924-8,Pentobarbital Lvl,2
67151-1,Troponin T HS,19282
2823-3,Potassium POC,1961
1995-0,Ionized Ca POC,1704
2951-2,Sodium POC,182
2075-0,Chloride POC,179
2028-9,Tot CO2  POC,178
49919-4,CSF Interleukin 6,2
70084-9,CSF Interleukin 5,2
70089-8,CSF Interleukin 13,2
49909-5,CSF Interleukin 10,2
70083-1,CSF Interleukin 4,2
70077-3,CSF Interleukin 2,2
16237-0,Ur Butalbital,2
16238-8,Ur Secobarbital,2
16239-6,Ur Amobarbital,2
16240-4,Ur Pentobarbital,2
16241-2,Ur Phenobarbital,2
6171-3,Allergy Melaleuca Tree,1
25147-0,UA Ca Carb Crys,3
9699-0,Paroxetine Lvl,1
20465-1,1st Scr HCG MoM,4
32123-2,1st Scr PAPP-A MoM,4
34405-1,Escitalopram Lvl,3
6848-6,Allergy Mushroom,3
3255-7,Fibrinogen Lvl HTU,1
31208-2,CMV PCR Specimen Type,444
13362-9,Coll Hrs 17OHCort,3
28009-9,Tot Vol 17OHCort,3
60071-8,EDDP,1
48403-0,Methadone Lvl,1
21036-9,Ur 17 OHCorticoster mg/day,2
2162-6,Ur Creat mg/day 17OHCort,1
6136-6,Allergy Hazelnut,5
7271-0,Allergy Cu.spicifera,2
6066-5,Allergy Cephalosporium,3
7514-3,Allergy Red Mulberry Tree,1
6252-1,Allergy Stem.botryosum,1
6195-2,Allergy Orchard Grass,2
6216-6,Allergy Phoma betae,2
31208-2,Lyme PCR Src,93
6067-3,Allergy Cheddar Cheese,1
6268-7,Allergy Trout,1
6068-1,Allergy Cheese Mold,1
2161-8,Ur Creat mg/dl Lead,3
7558-0,Allergy Oyster,3
7316-3,Allergy Flounder,3
29267-2,Feces Protoporphyrins,2
29266-4,Feces Coproporphyrin,2
14122-6,CSF Pyruvic Acid Lvl,2
3868-7,Norfluoxetine Lvl,1
3644-2,Fluoxetine Lvl,1
32693-4,Lactic Acid POC,9
2345-7,Glucose POC,6
2874-6,Electro Gamma,2
2871-2,Electro Beta,2
2868-8,Electro Alpha 2,2
2472-9,Serum IgM,2
2865-4,Electro Alpha 1,2
1751-7,Electro Albumin,2
2885-2,Electro Total Pro,2
6045-9,Allergy Black Pepper,4
3185-6,Factor 9 Inhib,1
33946-5,Ziprasidone Lvl,4
13362-9,Coll Hrs Creatine,40
28009-9,Tot Vol Creatine,40
2150-1,Ur Creatine mg/day,1
26614-8,CSF Taurine,2
22644-9,CSF Serine,2
26598-3,CSF Sarcosine,2
22645-6,CSF Proline,2
22646-4,CSF Phenylalanine,2
9412-8,CSF Leucine,2
22659-7,CSF Isoleucine,2
26596-7,CSF Hydroxyproline,2
26595-9,CSF Hydroxylysine,2
22660-5,CSF Homocystine,2
22649-8,CSF Valine,2
22642-3,CSF Tyrosine,2
26602-3,CSF Tryptophan,2
22643-1,CSF Threonine,2
22647-2,CSF Ornithine,2
22648-0,CSF Methionine,2
22651-4,CSF Lysine,2
26594-2,CSF Gamma-Aminobutyric Acid,2
26593-4,CSF Ethanolamine,2
22653-0,CSF Cystine,2
26592-6,CSF Cystathionine,2
22654-8,CSF Citrulline,2
22656-3,CSF Arginine,2
26588-4,CSF Anserine,2
26587-6,CSF Alpha-Aminoadipic Acid,2
22658-9,CSF Alloisoleucine,2
22657-1,CSF Alanine,2
55875-9,CSF Homocitrulline,2
9453-2,CSF Histidine,2
22650-6,CSF Glycine,2
22641-5,CSF Glutamine,2
22652-2,CSF Glutamic Acid,2
27337-5,CSF Beta-Aminoisobutyric Acid,2
26589-2,CSF Beta-Alanine,2
22655-5,CSF Aspartate,2
26603-1,CSF Asparagine,2
40838-5,CSF Argininosuccinic Acid,2
26586-8,CSF Alpha-Aminobutyric Acid,2
2161-8,Ur Creat mg/dl Glucose,4
2350-7,Ur Glucose mg/dl,4
13362-9,Coll Hrs Glucose.,4
6683-7,Reptilase Time,1
9418-5,Hydroxybupropion Lvl,1
6706-6,Bupropion Lvl,3
2483-6,IGF Bind Prot 3,2
2161-8,Ur Creat mg/dl Ars,1
55927-8,ST2 Soluble Lvl,2
3471-0,Chlorpromazine Lvl,1
89575-5,Troponin T HS Interp,19279
2950-4,Fl Sodium,2
28009-9,Tot Vol Cadmium,3
13362-9,Coll Hrs Cadmium,3
2162-6,Ur Creat mg/day Cad,2
5612-7,Ur Cadmium ug/day,1
13828-9,Ur Cadmium ug/g Creat,1
3687-1,Ibuprofen Lvl,3
6218-2,Allergy Pineapple,2
6131-7,Allergy Grapefruit,2
15066-4,Free Fatty Acids Tot,1
,GAD65 Ab CSF,4
,Manganese Lvl,1
,CoQ10 Total,1
,CoQ10 % Reduced,1
,CoQ10 Reduced,1
,Acylcarnit (AC),6
,AC/FC Ratio,6
,Carnit Fr (FC),6
,Allergen Aspergillus flavus,1
31112-6,Retic Cnt Man,2
26919-1,ALPHA AMINO BUTYRIC ACID,9
22685-2,"TYROSINE, URINE",14
,PDF Image,543
15015-1,LIVER ISOENZYME,1
22692-8,"VALINE, URINE",9
22681-1,"METHIONINE, URINE",9
25092-8,"CYSTATHIONINE, URINE",9
6032-7,"T073-IgE Pine, Australian",11
26575-1,"3-METHYLHISTIDINE, URINE",9
25086-0,"BETA AMINO ISOBUTYRIC ACID, URINE",9
20655-7,"PROLINE, URINE",9
25098-5,"ETHANOLAMINE, URINE",9
22682-9,"ORNITHINE, URINE",9
5209-2,HSV 2 IGG INDEX,13
22679-5,"LYSINE, URINE",9
2502-3,Iron Saturation,2
22691-0,"ASPARTIC ACID, URINE",9
15013-6,BONE ISOENZYME,1
29657-4,B pertussis IgA Ab,1
3013-0,Thyroglobulin (TG-RIA),3
22706-6,"ISOLEUCINE, URINE",9
22693-6,"LEUCINE, URINE",9
18475-4,"PHENYLALANINE, URINE",13
25139-7,"TRYPTOPHAN, URINE",9
22694-4,"CITRULLINE, URINE",9
7909-5,HSV 1 IGG INDEX,13
22697-7,"ARGININE, URINE",9
3126-0,ARGININE VASOPRESSIN,1
26776-5,"QUETIAPINE, SERUM/PLASMA",1
2923-1,"Vitamin A, Serum",1
48346-1,HIV 1/O/2 Abs Index Value,2
13926-1,GLUTAMIC ACID$DECARBOXYLASE 65 AB,1
30166-3,Thyroid Stimulating Immunoglobulin,5
19124-7,URINE MAGNESIUM,4
6768-6,ALKALINE PHOSPHATASE$(ALP),1
60370-4,ALLERGEN CRAB IGG,1
60403-3,ALLERGEN SHRIMP IGG,1
60383-7,ALLERGEN LOBSTER IGG,1
47320-7,SACCHAROMYCES CEREVISIAE$AB (ASCA) (IGA),2
,Saccharomyces cerevisiae Ab,2
8058-0,"AChR Binding Abs, Serum",1
22688-6,"THREONINE, URINE",9
22698-5,"ALANINE, URINE",9
,SPERMATOZOA:,176
26574-4,"1-METHYLHISTIDINE, URINE",9
20643-3,"GLUTAMINE, URINE",9
25138-9,"TAURINE, URINE",9
22703-3,"HISTIDINE, URINE",9
22711-6,"GLUTAMIC ACID, URINE",9
22684-5,"SERINE, URINE",9
26577-7,"ASPARAGINE, URINE",9
43030-6,HSV 1/2 IGM INDEX,12
26601-5,ALPHA AMINO ADIPIC ACID,9
6171-3,MELALEUCA (T21) IGE,1
20644-1,"GLYCINE, URINE",9
17849-1,RETIC-AUTO COR,43
28641-9,BICARBONATE-CORD VENOUS,122
20564-1,O2 SAT ART,167
17849-1,RETIC-AUTO UNCOR,43
2532-0,LACTATE DEHYDROGENASE TOTAL,409
26498-6,MYELOCYTES PCT,132
28640-1,BICARBONATE-CORD ARTERIAL,108
28541-1,METAMYLOCYTES PCT,129
28541-1,META,85
19213-8,PH VEN,25
32771-8,PO2 ARTERIAL (POINT OF CARE),24
31112-6,RETIC COUNT- MANUAL UNCORRECTED,3
60017-1,"LD, BODY FLUID",7
3094-0,BUN BLD,4048
61151-7,ALBUMIN,2072
711-2,EOS,360
2340-8,GLUCOSE-WB POC,3774
30522-7,CRP,134
6768-6,ALKALINE PHOSPHATASE SERUM,2
26464-8,WBC PB THOU/UL,21
13926-1,GAD ANTIBODY,2
11579-0,"TSH, 3RD GENERATION",138
33959-8,PROCALCITONIN RESULT,87
32133-1,"LACTIC ACID, PLASMA",175
4625-0,HEMATOCRIT,60
33762-6,PRO BNP,97
1834-1,AFP RESULT,24
32717-1,SODIUM,50
32713-0,POTASSIUM BLD,50
34581-9,CALCIUM IONIZED,50
3084-1,"URIC ACID, SERUM",84
1834-1,HCG VALUE,11
23811-3,AFP MOM VALUE,18
53962-7,AFP VALUE (EIA),11
41399-7,HSV IGM TYPES I/11,5
1971-1,"BILIRUBIN, INDIRECT (MICRO)",1
1968-7,"BILIRUBIN, DIRECT (MICRO)",1
1975-2,"BILIRUBIN, TOTAL, NEONATAL",1
32100-0,MORPHINE UR QUANT,12
72737-0,COCAINE,1
60467-8,OXYMORPHONE UR QUANT,15
18208-9,COCAINE URINE QUANT,11
43230-2,BENZOYLECGONINE UR QNT,11
48955-9,LORAZEPAM UR QT,3
1695-6,"5-HIAA, URINE-MG/DAY",2
32101-8,OXYCODONE UR QUANT,14
48965-8,TEMAZEPAM UR QT,7
61031-1,7-AMINOCLONAZEPAM,2
48946-8,COCAETHYLENE UR QUANT,4
24467-3,CD3 CD4 CELLS/UL (CD4 COUNT),21
61051-9,NORDIAZEPAM UR QT,5
31203-3,5-HIAA,2
61055-0,OXAZEPAM UR QT,7
18338-4,NORTRAMADOL URINE,1
16233-9,MIDAZOLAM CONFIRM,2
3719-2,LITHIUM LVL,5
57863-3,HYDROMPORPHONE UR QUANT,6
29530-3,AMPHETAMINE QUANT UR,5
53525-2,PROTEIN CONFIRMATION UA,1
32551-4,"PROTEIN, TOTAL, RANDOM UR",7
20559-1,TEMAZEPAM GC/MS CONF,1
16228-9,NORDIAZEPAM GC/MS CONF,1
1694-9,5 HIAA UR,1
11145-0,"5-HIAA, URINE",1
57861-7,HYDROCODONE UR QUANT,4
40381-6,METHAMPHETAMINE QUANT UR,2
61037-8,HYDROXYALPRAZ UR,5
3493-4,CLOMIP & MET TOTAL,4
2162-6,CREATININE-U MG/DAY,12
17861-6,CALCIUM-PLASMA,1
1742-6,ALANINE AMINOTRANSFERASE - PLASMA,1
1920-8,ASPARTATE AMINOTRANSFERASE-PLASM,1
26453-1,RED BLOOD CELLS,2
1834-1,AFP MOM VALUE,7
17855-8,HEMOGLOBIN A1C,1916
5206-8,HSV 1 IGG,4
3050-2,% T3 UPTAKE,5
2160-0,CREATININE SERUM RESULTED JAX,5
777-3,PLATELET COUNT (SODIUM CITRATE),1
2823-3,"POTASSIUM, OP",5
732-8,LYMPHS ABS,200
69405-9,CALCULATED GFR,35
5193-8,HBV SURFACE ANTIGEN MUTATIONS,2
751-8,NEUTROPHIL ABS MAN,15
41399-7,HSV 1/2 IGM INDEX,1
23811-3,ADJUSTED MOM,1
6768-6,ALKALINE PHOSPHATASE (ALP),5
20436-2,GEST GLUCOSE TOL 2 HR,15
9830-1,TOTAL/HDL CHOLESTROL,2
1994-3,CALCIUM ION,1
42757-5,POC TROPONIN I,314
49136-5,CK MB INDEX,17
2157-6,CK WITH REFLEX CKMB,55
14775-1,HEMOGLOBIN (POINT OF CARE),25
6598-7,ED TROPONIN-T,130
6301-6,PROTHROMBIN TIME INR (POC),29
3050-2,T3-UPTAKE,251
2339-0,BEDSIDE GLUCOSE MONITOR,11357
2339-0,GLUCOSE (I-STAT),281
5126-8,CMV AB IGM,11
777-3,PLATELET COUNT(SODIUM CITRATE),7
2085-9,POC HDL CHOLESTEROL,4
13457-7,POC CHOLESTEROL,4
33762-6,PROBNP  N TERMINAL,26
29615-2,HEPATITIS B QUANTITATION,56
20416-4,HCV QUANTITATIVE,6
3255-7,FIBRINOGEN ACTIVITY   CLAUSS,2
45161-7,LOG10 HBV COPIES/ML,5
1558-6,GLUCOSE TOLERANCE TEST FASTING,4
58410-2,HGB,10
24323-8,Creatinine,13
34563-7,"WBC, CSF",4
34714-2,PT INR,363
34563-7,"Tube Number, CSF",3
34563-7,"Fluid Volume, CSF",3
24331-1,Cholesterol LDL,1
9804-6,"""""Stone Anaylsis, Weight""""""""""""""""""""",2
16268-5,"""""Stone Anaylsis, Calcium Phosphate""""""""""""""""""""",2
16264-4,"""""Stone Anaylsis, CA Oxalate Monohydrate""""""""""""""""""""",2
58410-2,Automated Count Percent Lymphocytes,1
58410-2,Automated Count Percent Monocytes,1
58410-2,Automated Count Percent Neutrophils,1
58410-2,Absolute Count Basophils,1
58410-2,Absolute Count Neutrophils,1
58410-2,Absolute Count Eosinophils,1
58410-2,Absolute Count Lymphocytes,1
58410-2,Absolute Count Monocytes,1
58410-2,Automated Count Percent Eosinophils,1
30238-0,C14 HYDROXY,1
30234-9,C16 Hydroxy,1
30235-6,C16:1 Hydroxy,1
55940-1,C3 Dicarboxylic,1
39000-5,C4 Hydroxy,1
51412-5,C5 Hydroxy,1
30349-5,C5 Dicarboxylic,1
58077-9,"""""Turbidity, UR""""""""""""""""""""",2
58077-9,"""""Leukocytes, UR""""""""""""""""""""",2
34539-7,"""""Urine Total Protein, Electrophoresis""""""""""""""""""""",1
5404-9,"Varicella Zoster AB, IgM",1
5403-1,"Varicella Zoster AB, IgG",1
10839-9,"Creatinine, Serum",359
,Non HDL Chol,56
20569-0,CPK,38
,DHEA SULFATE,2
,Protein C Antigen,24
,CO2:,141
2885-2,"Protein, Total, Serum",233
,"TSH, 3RD GENERATION",75
74457-3,Neutrophils,611
10839-9,%A1C,66
,CREATININE:,142
,Lymphs,466
6768-6,"Alkaline Phosphatase, S",234
,ALK.PHOS:,85
,LDL:,32
,PLT,156
,"Vitamin D, 25 Hydroxy",12
,TSH.,39
74402-9,Lymphocytes,122
2823-3,K+,173
,TOTAL BILI:,84
,Segs,10
74402-9,LYMPHOCYTES,313
,TP:,85
10839-9,CREATININE,269
10839-9,Creatinine,35
,BLOOD UREA,141
,ALT:,87
,Polys (Absolute),42
74457-3,NEUTROPHILS,313
,WHEAT (F4) IGE,3
20569-0,"Creatine Kinase, MB",2
,AST:,85
,Free T4,33
,Sed Rate,9
20569-0,"Creatine Kinase, Total, Serum",52
,"Triiodothyronine, Free, Serum",2
,24 HR URINE VOLUME,4
,eGFR If African American,60
,Monocyte #,86
2028-9,"Carbon Dioxide, Total",267
,Creatinine (i-STAT),4
,"VITAMIN D, 25 OH",5
,"Ferritin, Serum",8
,CHOLESTEROL:,32
,SCALLOP (F338) IGE,3
,BUN/CREA,141
,CPK:,5
,"Renin, Plasma",2
,TRIGLYCERIDE:,32
,Mono,10
,MILK (F2) IGE,3
,ALBUMIN:,85
,TOTAL PSA,2
,% A1C,13
,eGFR non African American,60
,Free Cortisol/Creatinine Rat.,1
,Cholesterol,58
,CODFISH (F3) IGE,3
,"Microalbumin,U,Random",11
,Magnesium,15
,HAZELNUT (F17) IGE,3
,FREE T4.,26
,"TESTOSTERONE,TOTAL,MALES",2
,VLDL:,32
,EGG WHITE (F1) IGE,3
,Amylase,4
,"Serotonin, Serum",1
,CYTOMEGALOVIRUS$ANTIBODY (IGM),1
,"5-HIAA, 24 HOUR URINE",2
,Vitamin A,1
,TBG,1
,B12.,10
,PEANUT (F13) IGE,3
,TUNA (F40) IGE,3
,Atypical Lymphs,5
,CASHEW NUT (F202) IGE,3
,WALNUT (F256) IGE,3
,PSA.,4
,Lymphs % (Manual),34
,GLIADIN ANTIBODY (IGA),1
,Elliptocytes,14
,"Free Cortisol, Urine",2
,Free Testosterone(Direct),5
,FREE PSA,2
,Homocysteine,1
,HEMOGLOBIN S,14
,DIGOXIN.,1
,QuantiFERON TB Ag Value,10
,Hemoglobin A1c,4
,"VASOACTIVE INTESTINAL POLYPEPTIDE (VIP), P",1
,Teardrop Cells,5
,"VIP, Plasma",1
,"Epinephrine,Pl",2
,Aniso,12
,"Intrinsic Factor Abs, Serum",1
,SALMON (F41) IGE,3
,"Uric Acid, Urine 24hr",1
,Epinephrine,2
,Dopamine,2
,Uric Acid,4
,GLIADIN (DEAMIDATED) AB (IGG),1
,PT-INR,3
,Androstenedione,1
,SOYBEAN (F14) IGE,3
,Microcytosis,4
,"Methymalonic Acid, Serum",2
,SESAME SEED (F10) IGE,3
,THYROGLOBULIN,1
,% CD8 (SUPPRESSOR T$CELLS),1
,PTH-RP,1
,LIVER ISOENZYMES,1
,Norepinephrine,4
,IA-2 Antibody,2
,"H. pylori IgG, Abs",2
,BONE ISOENZYMES,1
,Morphine GC/MS Conf,1
,Lipase,2
,GLUCOSE-6-PHOSPHATE DEHYDROGENASE,2
,REACTIVE LYMPHOCYTES,271
,"Uric Acid, Urine",1
,ACE,1
,URIC ACID:,4
,Morphine Confirm,2
,Cervix,270
,SHRIMP (F24) IGE,3
,"Dopamine,Pl",2
,% FREE PSA,2
,ALMOND (F20) IGE,3
,Tramadol GC/MS Conf,1
48642-3,GFR Non Afr Amer by MDRD,35519
1863-0,AGAP,34363
48643-1,GFR African Amer by MDRD,30932
10360-6,Single Strand DNA IgG,2
44805-0,BK Virus Log Copies/mL,28
41479-7,BK Virus DNA Quant,28
35383-9,Bronch Wash Aspergillus Ag Index,13
2161-8,Ur Creat mg/dl Cystine,2
62255-5,LP Insulin Resistance Score,25
44706-0,F Actin IgG,2
4501-3,C4a,2
6271-1,Allergy Turkey,2
49228-0,Porphobil Deaminase,1
718-7,Hgb Porphobil Deaminase,1
12589-8,Ur Creatinine mg/12 hr,1
6895-7,Butalbital Lvl,2
60468-6,Phenobarbital Lvl Drug Scr,2
3924-8,Pentobarbital Lvl Drug Scr,2
4028-7,Secobarbital Lvl,2
3338-1,Amobarbital Lvl,2
7280-1,Allergy Dill,1
2821-7,Fl Potassium,1
16254-5,Ur Phencyclidine,1
1657-6,11 Deoxycortisol Lvl,2
6853-6,Allergy Plum,1
7770-1,Allergy Watermelon,2
6154-9,Allergy Kiwi,3
48642-3,GFR Non Afr Amer POC by MDRD,123
33959-8,Procalcitonin Lvl.,246
6299-2,BUN POC,132
38483-4,Creatinine POC,264
7473-2,Allergy Black Locust,1
6229-9,Allergy Rhiz.nigricans,1
7552-3,Allergy Oregano,2
7720-6,Allergy Stem.solani,1
48643-1,GFR Afr Amer POC by MDRD,112
12285-3,DPB Locus 1,56
12285-3,DPB Locus 2,40
58023-3,Rabies Ab,1
41399-7,HSV IgM Index,18
27819-2,Protein C Actv,26
49111-8,UA Sperm,903
53774-6,EBV Log Copies/mL,5
32585-2,EBV UltraQuant,5
20570-8,Hct RBC Folate,1
10335-8,CSF Color Add'l Tube,565
6690-2,Neo WBC,1
789-8,Neo RBC,1
,Neo MCHC,1
718-7,Neo HGB,1
4544-3,Neo HCT,1
787-2,Neo MCV,1
,Neo MCH,1
21000-5,Neo RDW,1
777-3,Neo Platelet Count,1
32623-1,Neo MPV,1
2093-3,Chol Total LipMP,1
,LDL Trig LipMetab,1
,Trig LipMetab,1
,Apolipo LipMetab,1
2085-9,HDL Chol LipMetab,1
2089-1,LDL Chol LipMetab,1
2091-7,VLDL Chol LipMetab,1
3047-8,VLDL Trig LipMetab,1
,Lp(a) Chol LipMetab,1
,Max Prolif CA %CD45,1
,Viab of Lymphs Day 0,1
,Max Prolif TT % CD45,1
,Max Prolif CA % CD3,1
,Max Prolif TT % CD3,1
49340-3,Adenovirus DNA Qn PCR,4
,Plasminogen Act,1
32585-2,EBV Copies/mL,4
,Current Adalimumab frequency (weeks),5
,C4 Comp LupAn,2
,dsDNA Autoabs LupAn,2
,C3 Comp LupAn,2
56477-3,Thyroid Perox Autoabs LupAn,2
11572-5,RF LupAn,2
,ENA Scr Index,2
3053-6,"T3, TOTAL",1
6304-0,PARROT/PARAKEET DROPPINGS$(E77) IGE,1
1507-3,"GLUCOSE, 1 HOUR$IADPSG CUTOFF",1
2905-8,PYRUVIC ACID (PYRUVATE),1
2895-1,Zinc Protoporphyrin,1
16226-3,Benzoylecgonine (GC/MS),1
12470-1,Homocysteine-Norm,1
5625-9,COBALT,1
6075-6,C. HERBARUM (M2) IGE,1
1518-0,"GLUCOSE, 2 HOUR$IADPSG CUTOFF",1
48000-4,CHROMOSOME :,1
2161-8,"Creatinine(Crt), U",1
34416-8,CHROMATIN (NUCLEOSOMAL)$ANTIBODY,432
22687-8,"CYSTINE, URINE",1
25109-0,"HYDROXYLYSINE, URINE",1
53920-5,"Thyroglobulin, LN Aspirate",1
13458-5,"CHOLESTEROL, VERY LOW$DENSITY LIPOPROTEIN",1
1868-9,ANTITHROMBIN III ANTIGEN,2
6212-5,P. NOTATUM (M1) IGE,1
2700-3,"Oxalates, Urine",1
5176-3,"H. pylori IgG, Abs",2
6030-1,PARROT/PARAKEET FEATHERS$(E78) IGE,1
1558-6,"GLUCOSE, FASTIING$IADPSG CUTOFF",1
2892-8,Protoporphyrin (FEP),1
5133-4,DNASE B ANTIBODY,2
26975-3,SCL-70 ANTIBODY,666
6107-7,Egg Yolk,1
1795-4,"Amylase, Body Fluid",1
20420-6,PROSTATE ACID PHOS,1
2276-4,Ferritin,1
12470-1,"HOMOCYSTEINE, URINE",1
19113-0,"IGE,TOTAL,SERUM",1
8245-3,ZINC (B),1
26578-5,"BETA ALANINE, URINE",1
5696-0,MOLYBDENUM,1
5722-4,SELENIUM (B),1
32208-1,PLATELET ESTIMATE,304
6182-0,MUCOR RACEMOSUS (M4) IGE,1
6059-0,Candida Albicans,1
6025-1,A. FUMIGATUS (M3) IGE,1
6020-2,A. TENUIS (M6) IGE,1
30226-5,FDP-LATEX,1
43279-9,HBV AS IU/ML,1
16631-4,PT EQUAL MIX,1
30038-4,"TOXOPLASMA AB, IGG",1
3551-9,DIAZEPAM UR,3
16234-7,AMPHETAMINE GC/MS UR,1
48956-7,METHADONE,3
12375-2,CLOZAPINE + NORCOLZAPINE TOTAL,1
3436-3,CARBOXY THC,3
61038-6,ALPRAZOLAM UR,6
32057-2,BUTALBITAL UR QT,3
18355-8,MDA URINE,3
20447-9,HIV-1 RNA-PCR,2
25836-8,HIV-1 QUANT NUCL ACID,1
18348-3,"TOXOPLASMA AB, IGM",1
63432-9,"HSV 1/2 AB, IGM, CSF",1
2571-8,"TRIGLYCERIDES, SERUM",1
2093-3,"CHOLESTEROL, SERUM",1
41399-7,HSV 1/2 IGM INTERP,1
8123-2,CD4  PERCENTAGE,1
5671-3,LEAD BLOOD,25
2638-5,MYELIN BASIC PROTEIN CSF,1
24467-3,CD4  ABSOLUTE,1
53553-4,EAG(MMOL/L),1
4548-4,HB A1C DIABETIC ASSESSMENT,1
24321-2,Creatinine,2
55180-4,HE4,2
10839-9,ISTAT Troponin I,209
2839-9,Progesterone Level,2
2940-5,Serotonin Serum,1
24348-5,TSH,1
12515-3,"""""Carcinoembryonic Antigen, Fluid""""""""""""""""""""",1
2963-7,Human Growth Hormone Level,1
9804-6,"Stone Anaylsis, Weight",1
16263-6,"Stone Anaylsis, CA Oxalate Dihydrate",1
16264-4,"Stone Anaylsis, CA Oxalate Monohydrate",1
16268-5,"Stone Anaylsis, Calcium Phosphate",1
,Thyroxine Binding Globulin,1
,CALCIUM/CREATININE RATIO,2
,Alprazolam Confirm,3
,B2 GLYCOPROTEIN I (IGA)AB,3
,TOXOPLASMA IGG ANTIBODY,1
,LYMPHOCYTE,1
,Breastfeeding,1026
,M2 Antibody,1
,"Glucose, Plasma",1
,HEPATITIS B SURFACE ANTIBODY (QUANT),1
,Vitamin B1,1
,Oxcarbazepine,2
,Macrocytosis,10
,"G-6-PD, Quant",1
,Androstenedione LCMS,1
,"Free Testosterone, Serum",3
,B2 GLYCOPROTEIN I (IGM)AB,3
,F084-IgE Kiwi Fruit,1
,CARDIOLIPIN AB (IGA),2
,CARDIOLIPIN AB (IGM),2
,B2 GLYCOPROTEIN I (IGG)AB,3
,Polychromasia,6
,Rheumatoid Arthritis Factor,1
,F092-IgE Banana,1
,"NEUTROPHILS, %",1
,% Free Testosterone (Dialysis),3
,"CALCIUM, 24 HOUR URINE",1
,LDL Chol. (Direct),1
,TOXOPLASMA IGM ANTIBODY,1
,F299-IgE Sweet Chestnut,1
,Actin Antibody,1
,CARDIOLIPIN AB (IGG),2
,COPPER,1
,B TYPE NATRIURETIC PEPTIDE (BNP),1
,PTT LA SCREEN,1
,"CALCIUM, RANDOM URINE",2
,HSV 1 IGG TYPE SPECIFIC AB,1
,NEUTROPHIL,1
,Meta,1
,EPINEPHRINE,3
,SP. GRAVITY OF SPECIMEN,1
,K082-IgE Latex,1
,DRVVT Screen Seconds,1
,Alpha 1 Antitrypsin,1
,PREV. PAP:,44
,F096-IgE Avocado,1
,Thrombin Time,1
,Z SCORE (MALE),1
,Hexagonal Phospholipid Neutral,1
,"5-HIAA, Urine, 24hr",1
,"RETICULOCYTE COUNT, AUTOMATED",1
,Digoxin,1
,HSV 2 IGG TYPE SPECIFIC AB,1
1994-3,Calcium Ionized,5
11210-2,Fl CA 125,1
13362-9,Coll Hrs MMA,2
28009-9,Tot Vol MMA,2
2162-6,Ur Creat mg/day MMA,1
6719-9,Allergy Cherry,1
6185-3,Allergy Mustard,1
7099-5,Allergy Asparagus,1
7737-0,Allergy Thyme,1
7756-0,Allergy Vanilla,1
7335-3,Allergy Ginger,1
2964-5,Fl Specific Grav,4
630-4,URINE CULTURE,17840
50553-7,URINALYSIS WITH CULTURE IF INDICATED,37039
5767-9,URINALYSIS WITH CULTURE IF INDICATED,37441
77202-0,CELIAC DISEASE COMPREHENSIVE PANEL,25
21709-1,MTHFR MUTATION,3
38415-6,MTHFR MUTATION,2
21668-9,ACTIVATED PROTEIN C RESISTANCE WITH REFLEX TO FACTOR V (LEIDEN) MUTATION,1
19763-2,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,985
19764-0,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,985
8251-1,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,987
19767-3,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,1181
,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,1024
19774-9,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,988
10524-7,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,985
49034-2,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,60
19764-0,THINPREP PAP AND HPV MRNA E6/E7,98
10524-7,THINPREP PAP AND HPV MRNA E6/E7,98
19763-2,THINPREP PAP AND HPV MRNA E6/E7,98
19767-3,THINPREP PAP AND HPV MRNA E6/E7,111
,THINPREP PAP AND HPV MRNA E6/E7,101
69564-3,"SURESWAB(R), ADVANCED VAGINITIS PLUS",820
,REFERENCE ABORH,240
,ABORH RETYPE,4405
,ED INFORMATION EXCHANGE,11334
19764-0,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",278
10524-7,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",278
19763-2,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",278
19774-9,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",26
19767-3,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",319
600-7,BLOOD CULTURE,23765
47527-7,"IGP, APTIMA HPV, RFX 16/18,45",294
47528-5,"IGP, APTIMA HPV, RFX 16/18,45",294
19764-0,"IGP, APTIMA HPV, RFX 16/18,45",282
19767-3,"IGP, APTIMA HPV, RFX 16/18,45",282
8251-1,GESTATIONAL DIABETIC (3 HR) TOLERANCE,189
56888-1,HIV ANTIGEN/ANTIBODY,6385
,CHLAMYDIA/N.GONORRHOEAE RNA TMA URINE,583
586-8,"STREPTOCOCCUS, GROUP B CULTURE",365
5778-6,URINALYSIS WITH MICROSCOPIC LEGACY,363
8251-1,URINALYSIS WITH MICROSCOPIC LEGACY,5
5769-5,URINALYSIS WITH MICROSCOPIC LEGACY,293
5767-9,URINALYSIS WITH MICROSCOPIC LEGACY,360
,PATHOLOGY TISSUE REQUEST,29730
5778-6,URINALYSIS WITH CULTURE IF INDICATED,410
5769-5,URINALYSIS WITH CULTURE IF INDICATED,311
,"IGP, RFX APTIMA HPV ASCU",86
47527-7,"IGP, RFX APTIMA HPV ASCU",68
47528-5,"IGP, RFX APTIMA HPV ASCU",67
19764-0,"IGP, RFX APTIMA HPV ASCU",40
19767-3,"IGP, RFX APTIMA HPV ASCU",40
,LIGHT GREEN TOP,12533
,LIGHT BLUE TOP,17550
69565-0,NUSWAB VAGINITIS PLUS (VG+),297
69566-8,NUSWAB VAGINITIS PLUS (VG+),297
69567-6,NUSWAB VAGINITIS PLUS (VG+),297
58408-6,MANUAL DIFFERENTIAL,1156
626-2,THROAT CULTURE,463
19764-0,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",214
10524-7,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",214
19767-3,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",251
19763-2,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",214
49034-2,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",41
19774-9,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",215
,SST GOLD TOP,16712
,PURPLE TOP,14000
55305-7,KOH PREP,247
,HOUSE ACCOUNT TRACKING LEGACY,327
,SPECIMEN STATUS REPORT,1479
6463-4,AEROBIC CULT 997874,16
41852-5,AEROBIC CULTURE,19
19764-0,PAP SMEAR,384
50553-7,URINALYSIS WITH REFLEX MICROSCOPIC,7043
5767-9,URINALYSIS WITH REFLEX MICROSCOPIC,9737
664-3,BLOOD CULTURE,4595
883-9,ABORH,702
,"C TRACHOMATIS/N GONORRHOEAE RNA, TMA, UROGENITAL",84
,CLIENT EDUCATION TRACKING LEGACY,515
19763-2,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",274
19764-0,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",274
8251-1,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",281
,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",550
19767-3,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",324
10524-7,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",274
19774-9,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",275
18282-4,"DRUG PANEL, URINE",7648
19261-7,"DRUG PANEL, URINE",7648
19270-8,"DRUG PANEL, URINE",7648
19359-9,"DRUG PANEL, URINE",7648
19295-5,"DRUG PANEL, URINE",7648
59673-4,"DRUG PANEL, URINE",3278
19642-8,"DRUG PANEL, URINE",3676
19550-3,"DRUG PANEL, URINE",3747
10331-7,Q PLATELET ESTIMATION,7
883-9,Q PLATELET ESTIMATION,7
56888-1,Q PLATELET ESTIMATION,7
5196-1,Q PLATELET ESTIMATION,7
20507-0,Q PLATELET ESTIMATION,7
5778-6,URINALYSIS WITH REFLEX MICROSCOPIC,2722
,NON-GYNECOLOGIC CYTOLOGY,3079
24124-0,UR MICROSCOPIC 333328,389
5769-5,UR MICROSCOPIC 333328,434
12235-8,URINALYSIS WITH REFLEX MICROSCOPIC,487
,PATHOLOGY REQUEST,1369
12710-0,HEMOGLOBIN ELECTROPHORESIS,121
630-4,"Q CULTURE, URINE, ROUTINE",893
630-4,Q REFLEXIVE URINE CULTURE,896
5778-6,"UA/M W/RFLX CULTURE, COMP",731
5769-5,"UA/M W/RFLX CULTURE, COMP",633
5767-9,"UA/M W/RFLX CULTURE, COMP",710
,RED TOP,3551
45335-7,STAPH AUREUS SCREEN,434
19764-0,THINPREP PAP AND HPV DNA,15
19762-4,THINPREP PAP AND HPV DNA,3
,THINPREP PAP AND HPV DNA,15
19767-3,THINPREP PAP AND HPV DNA,16
19769-9,THINPREP PAP AND HPV DNA,4
19763-2,THINPREP PAP AND HPV DNA,15
10524-7,THINPREP PAP AND HPV DNA,15
19774-9,THINPREP PAP AND HPV DNA,3
31208-2,PATHOLOGY TISSUE REQUEST,495
,MAYO MISCELLANEOUS AMBIENT TEST,381
,STAPH AUREUS SCREEN,82
,MRSA CULTURE,222
45335-7,MRSA CULTURE,2042
49034-2,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",43
,POCT CREATININE & LACTIC ACID VENOUS UNSOLICITED RESULTS,32
8251-1,CBC WITH DIFFERENTIAL,469
16369-1,"COMPLIANCE DRUG ANALYSIS, UR",24
17376-5,"COMPLIANCE DRUG ANALYSIS, UR",24
19378-9,"COMPLIANCE DRUG ANALYSIS, UR",24
18334-3,"COMPLIANCE DRUG ANALYSIS, UR",24
16218-0,"COMPLIANCE DRUG ANALYSIS, UR",24
18390-5,"COMPLIANCE DRUG ANALYSIS, UR",48
16200-8,"COMPLIANCE DRUG ANALYSIS, UR",24
58388-0,"COMPLIANCE DRUG ANALYSIS, UR",24
16219-8,"COMPLIANCE DRUG ANALYSIS, UR",24
16207-3,"COMPLIANCE DRUG ANALYSIS, UR",24
58358-3,"COMPLIANCE DRUG ANALYSIS, UR",24
16190-1,"COMPLIANCE DRUG ANALYSIS, UR",24
16429-3,"COMPLIANCE DRUG ANALYSIS, UR",24
19289-8,"COMPLIANCE DRUG ANALYSIS, UR",24
18392-1,"COMPLIANCE DRUG ANALYSIS, UR",24
17033-2,"COMPLIANCE DRUG ANALYSIS, UR",24
72799-0,"COMPLIANCE DRUG ANALYSIS, UR",24
,"COMPLIANCE DRUG ANALYSIS, UR",504
78884-4,"COMPLIANCE DRUG ANALYSIS, UR",24
4025-3,"COMPLIANCE DRUG ANALYSIS, UR",24
3299-5,"COMPLIANCE DRUG ANALYSIS, UR",24
44036-2,"COMPLIANCE DRUG ANALYSIS, UR",24
14071-5,"COMPLIANCE DRUG ANALYSIS, UR",24
3408-2,"COMPLIANCE DRUG ANALYSIS, UR",24
11000-7,"COMPLIANCE DRUG ANALYSIS, UR",24
18335-0,"COMPLIANCE DRUG ANALYSIS, UR",24
3571-7,"COMPLIANCE DRUG ANALYSIS, UR",24
16209-9,"COMPLIANCE DRUG ANALYSIS, UR",24
12324-0,"COMPLIANCE DRUG ANALYSIS, UR",24
3586-5,"COMPLIANCE DRUG ANALYSIS, UR",24
4009-7,"COMPLIANCE DRUG ANALYSIS, UR",24
64129-0,"COMPLIANCE DRUG ANALYSIS, UR",24
52959-4,"COMPLIANCE DRUG ANALYSIS, UR",24
87766-2,"COMPLIANCE DRUG ANALYSIS, UR",24
12363-8,"COMPLIANCE DRUG ANALYSIS, UR",24
87768-8,"COMPLIANCE DRUG ANALYSIS, UR",24
68439-9,"COMPLIANCE DRUG ANALYSIS, UR",24
87767-0,"COMPLIANCE DRUG ANALYSIS, UR",24
87765-4,"COMPLIANCE DRUG ANALYSIS, UR",24
87764-7,"COMPLIANCE DRUG ANALYSIS, UR",24
12310-9,"COMPLIANCE DRUG ANALYSIS, UR",24
58367-4,"COMPLIANCE DRUG ANALYSIS, UR",24
53787-8,"COMPLIANCE DRUG ANALYSIS, UR",48
87774-6,"COMPLIANCE DRUG ANALYSIS, UR",24
32136-4,"COMPLIANCE DRUG ANALYSIS, UR",24
29288-8,"COMPLIANCE DRUG ANALYSIS, UR",24
3791-1,"COMPLIANCE DRUG ANALYSIS, UR",24
33041-5,"COMPLIANCE DRUG ANALYSIS, UR",24
59176-8,"COMPLIANCE DRUG ANALYSIS, UR",24
16195-0,"COMPLIANCE DRUG ANALYSIS, UR",24
3342-3,"COMPLIANCE DRUG ANALYSIS, UR",24
75232-9,"COMPLIANCE DRUG ANALYSIS, UR",24
16225-5,"COMPLIANCE DRUG ANALYSIS, UR",24
61415-6,"COMPLIANCE DRUG ANALYSIS, UR",24
59169-3,"COMPLIANCE DRUG ANALYSIS, UR",24
61412-3,"COMPLIANCE DRUG ANALYSIS, UR",24
75226-1,"COMPLIANCE DRUG ANALYSIS, UR",24
59170-1,"COMPLIANCE DRUG ANALYSIS, UR",24
60086-6,"COMPLIANCE DRUG ANALYSIS, UR",24
45144-3,"COMPLIANCE DRUG ANALYSIS, UR",24
64130-8,"COMPLIANCE DRUG ANALYSIS, UR",24
87770-4,"COMPLIANCE DRUG ANALYSIS, UR",24
58426-8,"COMPLIANCE DRUG ANALYSIS, UR",24
87769-6,"COMPLIANCE DRUG ANALYSIS, UR",24
61410-7,"COMPLIANCE DRUG ANALYSIS, UR",24
87772-0,"COMPLIANCE DRUG ANALYSIS, UR",24
61409-9,"COMPLIANCE DRUG ANALYSIS, UR",24
87771-2,"COMPLIANCE DRUG ANALYSIS, UR",24
87773-8,"COMPLIANCE DRUG ANALYSIS, UR",24
58373-2,"COMPLIANCE DRUG ANALYSIS, UR",24
64138-1,"COMPLIANCE DRUG ANALYSIS, UR",24
78823-2,"COMPLIANCE DRUG ANALYSIS, UR",24
78859-6,"COMPLIANCE DRUG ANALYSIS, UR",24
58014-2,"COMPLIANCE DRUG ANALYSIS, UR",24
4001-4,"COMPLIANCE DRUG ANALYSIS, UR",24
19629-5,"COMPLIANCE DRUG ANALYSIS, UR",24
27109-8,"COMPLIANCE DRUG ANALYSIS, UR",24
19471-2,"COMPLIANCE DRUG ANALYSIS, UR",24
61418-0,"COMPLIANCE DRUG ANALYSIS, UR",24
32074-7,"COMPLIANCE DRUG ANALYSIS, UR",24
61427-1,"COMPLIANCE DRUG ANALYSIS, UR",24
19396-1,"COMPLIANCE DRUG ANALYSIS, UR",24
19547-9,"COMPLIANCE DRUG ANALYSIS, UR",24
32129-9,"COMPLIANCE DRUG ANALYSIS, UR",24
59171-9,"COMPLIANCE DRUG ANALYSIS, UR",24
59174-3,"COMPLIANCE DRUG ANALYSIS, UR",24
32065-5,"COMPLIANCE DRUG ANALYSIS, UR",24
3729-1,"COMPLIANCE DRUG ANALYSIS, UR",24
40390-7,"COMPLIANCE DRUG ANALYSIS, UR",24
58369-0,"COMPLIANCE DRUG ANALYSIS, UR",24
19479-5,"COMPLIANCE DRUG ANALYSIS, UR",24
3510-5,"COMPLIANCE DRUG ANALYSIS, UR",24
14070-7,"COMPLIANCE DRUG ANALYSIS, UR",24
32105-9,"COMPLIANCE DRUG ANALYSIS, UR",24
19707-9,"COMPLIANCE DRUG ANALYSIS, UR",24
12320-8,"COMPLIANCE DRUG ANALYSIS, UR",24
12321-6,"COMPLIANCE DRUG ANALYSIS, UR",24
75233-7,"COMPLIANCE DRUG ANALYSIS, UR",24
4084-0,"COMPLIANCE DRUG ANALYSIS, UR",24
32112-5,"COMPLIANCE DRUG ANALYSIS, UR",24
75235-2,"COMPLIANCE DRUG ANALYSIS, UR",24
75231-1,"COMPLIANCE DRUG ANALYSIS, UR",24
75234-5,"COMPLIANCE DRUG ANALYSIS, UR",24
3737-4,"COMPLIANCE DRUG ANALYSIS, UR",24
75230-3,"COMPLIANCE DRUG ANALYSIS, UR",24
4065-9,"COMPLIANCE DRUG ANALYSIS, UR",24
32120-8,"COMPLIANCE DRUG ANALYSIS, UR",24
41270-0,"COMPLIANCE DRUG ANALYSIS, UR",26
13479-1,"COMPLIANCE DRUG ANALYSIS, UR",24
86607-9,"COMPLIANCE DRUG ANALYSIS, UR",24
3716-8,"COMPLIANCE DRUG ANALYSIS, UR",24
3423-1,"COMPLIANCE DRUG ANALYSIS, UR",24
27076-9,"COMPLIANCE DRUG ANALYSIS, UR",24
12301-8,"COMPLIANCE DRUG ANALYSIS, UR",24
3539-4,"COMPLIANCE DRUG ANALYSIS, UR",24
32090-3,"COMPLIANCE DRUG ANALYSIS, UR",24
43265-8,"COMPLIANCE DRUG ANALYSIS, UR",24
40464-0,"COMPLIANCE DRUG ANALYSIS, UR",24
52960-2,"COMPLIANCE DRUG ANALYSIS, UR",24
86231-8,"COMPLIANCE DRUG ANALYSIS, UR",24
86225-0,"COMPLIANCE DRUG ANALYSIS, UR",24
3816-6,"COMPLIANCE DRUG ANALYSIS, UR",24
87789-4,"COMPLIANCE DRUG ANALYSIS, UR",24
58417-7,"COMPLIANCE DRUG ANALYSIS, UR",24
3360-5,"COMPLIANCE DRUG ANALYSIS, UR",24
3993-3,"COMPLIANCE DRUG ANALYSIS, UR",24
4095-6,"COMPLIANCE DRUG ANALYSIS, UR",24
86605-3,"COMPLIANCE DRUG ANALYSIS, UR",24
19360-7,"COMPLIANCE DRUG ANALYSIS, UR",24
20528-6,"COMPLIANCE DRUG ANALYSIS, UR",24
27083-5,"COMPLIANCE DRUG ANALYSIS, UR",24
59590-0,"COMPLIANCE DRUG ANALYSIS, UR",24
10976-9,"COMPLIANCE DRUG ANALYSIS, UR",24
58384-9,"COMPLIANCE DRUG ANALYSIS, UR",24
86606-1,"COMPLIANCE DRUG ANALYSIS, UR",24
86608-7,"COMPLIANCE DRUG ANALYSIS, UR",24
58391-4,"COMPLIANCE DRUG ANALYSIS, UR",24
34180-0,"COMPLIANCE DRUG ANALYSIS, UR",24
19643-6,"COMPLIANCE DRUG ANALYSIS, UR",24
40839-3,"COMPLIANCE DRUG ANALYSIS, UR",24
61429-7,"COMPLIANCE DRUG ANALYSIS, UR",24
58401-1,"COMPLIANCE DRUG ANALYSIS, UR",24
86604-6,"COMPLIANCE DRUG ANALYSIS, UR",24
16208-1,"COMPLIANCE DRUG ANALYSIS, UR",24
86610-3,"COMPLIANCE DRUG ANALYSIS, UR",24
58390-6,"COMPLIANCE DRUG ANALYSIS, UR",24
16199-2,"COMPLIANCE DRUG ANALYSIS, UR",24
41466-4,"COMPLIANCE DRUG ANALYSIS, UR",24
61048-5,"COMPLIANCE DRUG ANALYSIS, UR",24
45272-2,"COMPLIANCE DRUG ANALYSIS, UR",24
19537-0,"COMPLIANCE DRUG ANALYSIS, UR",24
16191-9,"COMPLIANCE DRUG ANALYSIS, UR",24
59384-8,"COMPLIANCE DRUG ANALYSIS, UR",24
19354-0,"COMPLIANCE DRUG ANALYSIS, UR",24
16223-0,"COMPLIANCE DRUG ANALYSIS, UR",24
16192-7,"COMPLIANCE DRUG ANALYSIS, UR",24
16194-3,"COMPLIANCE DRUG ANALYSIS, UR",24
16193-5,"COMPLIANCE DRUG ANALYSIS, UR",24
44424-0,"COMPLIANCE DRUG ANALYSIS, UR",24
87762-1,"COMPLIANCE DRUG ANALYSIS, UR",24
19578-4,"COMPLIANCE DRUG ANALYSIS, UR",24
87761-3,"COMPLIANCE DRUG ANALYSIS, UR",24
16210-7,"COMPLIANCE DRUG ANALYSIS, UR",24
3596-4,"COMPLIANCE DRUG ANALYSIS, UR",24
3965-1,"COMPLIANCE DRUG ANALYSIS, UR",24
16220-6,"COMPLIANCE DRUG ANALYSIS, UR",24
16222-2,"COMPLIANCE DRUG ANALYSIS, UR",24
61058-4,"COMPLIANCE DRUG ANALYSIS, UR",24
,Q REFLEXIVE URINE CULTURE,25
,IMMUNOFIXATION ELECTROPHORESIS,167
,MAYO MISCELLANEOUS FROZEN TESTS,262
,PATHOLOGY SMEAR REPORT LEGACY,150
,DUPLICATE REPORT REQUEST LEGACY,32
19764-0,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",137
19762-4,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",24
,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",274
19767-3,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",159
19769-9,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",25
19774-9,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",24
19763-2,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",137
10524-7,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",137
49034-2,"THINPREP PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",30
5769-5,URINALYSIS WITH REFLEX MICROSCOPIC,1027
,"CULTURE, GROUP B STREP",108
19764-0,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",588
10524-7,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",588
19763-2,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",588
19774-9,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",588
19767-3,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",683
56888-1,"HIV 1/2 ANTIGEN/ANTIBODY, FOURTH GENERATION W/RFL",151
19151-0,"GLUCOSE TOLERANCE, 3 HOURS",464
8251-1,"GLUCOSE TOLERANCE, 3 HOURS",116
630-4,URINE CULT RT 997870,1250
8251-1,"AFP, MAT SERUM, OPEN SPINA BIFIDA",1053
49246-2,"AFP, MAT SERUM, OPEN SPINA BIFIDA",638
44877-9,"AFP, MAT SERUM, OPEN SPINA BIFIDA",667
53948-6,"AFP, MAT SERUM, OPEN SPINA BIFIDA",528
,HISTORICAL ABORH LAB ONLY,3754
19764-0,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,272
10524-7,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,272
19763-2,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,272
19774-9,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,272
19767-3,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,309
,MAYO MISCELLANEOUS REFRIGERATED TESTS,826
,POCT SARS COV 2,528
7793-3,MANUAL DIFFERENTIAL,43
801-1,MANUAL DIFFERENTIAL,223
,FACTOR II (PT G20210A) MUTATION,142
21669-7,FACTOR 5 LEIDEN,182
19764-0,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",131
19762-4,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",23
19769-9,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",25
19767-3,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",153
19763-2,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",131
10524-7,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",131
19774-9,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",23
25148-8,URINALYSIS WITH REFLEX MICROSCOPIC,50
25148-8,URINALYSIS WITH CULTURE IF INDICATED,12
741-9,MANUAL DIFFERENTIAL,1151
728-6,MANUAL DIFFERENTIAL,1014
,"IGP, CTNG, RFX APTIMA HPV ASCU",204
47527-7,"IGP, CTNG, RFX APTIMA HPV ASCU",100
47528-5,"IGP, CTNG, RFX APTIMA HPV ASCU",100
19764-0,"IGP, CTNG, RFX APTIMA HPV ASCU",99
19767-3,"IGP, CTNG, RFX APTIMA HPV ASCU",99
85380-4,HIV RNA QL  083950,163
12235-8,"UA/M W/RFLX CULTURE, ROUTINE",209
,"UA/M W/RFLX CULTURE, ROUTINE",103
5778-6,"UA/M W/RFLX CULTURE, ROUTINE",137
5767-9,"UA/M W/RFLX CULTURE, ROUTINE",137
8247-9,UR MICROSCOPIC 333328,43
19764-0,THINPREP TIS PAP,204
10524-7,THINPREP TIS PAP,204
,THINPREP TIS PAP,223
19767-3,THINPREP TIS PAP,244
19763-2,THINPREP TIS PAP,204
19774-9,THINPREP TIS PAP,204
19147-8,"HCV RT-PCR, QUANT (NON-GRAPH) 55036",4
62365-2,"HCV RT-PCR, QUANT (NON-GRAPH) 55036",4
,HCV FIBROSURE,6
77202-0,HCV FIBROSURE,2
8251-1,HCV FIBROSURE,2
48794-2,HCV FIBROSURE,2
48793-4,HCV FIBROSURE,2
,FUNGAL CULTURE,491
48557-3,STONE ANALYSIS,45
9795-6,STONE ANALYSIS,133
19764-0,THINPREP PAP RFX HR HPV,64
10524-7,THINPREP PAP RFX HR HPV,64
19763-2,THINPREP PAP RFX HR HPV,64
19767-3,THINPREP PAP RFX HR HPV,72
,THINPREP PAP RFX HR HPV,75
49034-2,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,20
883-9,ABO GROUP,9
,QNATAL(R) ADVANCED,524
8251-1,QNATAL(R) ADVANCED,56
75606-4,QNATAL(R) ADVANCED,56
76664-2,QNATAL(R) ADVANCED,56
77020-6,QNATAL(R) ADVANCED,56
75977-9,QNATAL(R) ADVANCED,56
49549-9,QNATAL(R) ADVANCED,56
,REFERENCE ABID ELUTION,190
14869-2,CBC WITH AUTO DIFFERENTIAL,3471
,"VON WILLEBRAND FACTOR MULTIMER ANALYSIS, PLASMA MAYO",7
625-4,"YERSINIA CULTURE, STOOL",110
625-4,"VIBRIO CULTURE, STOOL",105
,"IGP,CTNGTV,RFX APTIMA HPV ASCU",60
47527-7,"IGP,CTNGTV,RFX APTIMA HPV ASCU",30
47528-5,"IGP,CTNGTV,RFX APTIMA HPV ASCU",30
19764-0,"IGP,CTNGTV,RFX APTIMA HPV ASCU",29
19767-3,"IGP,CTNGTV,RFX APTIMA HPV ASCU",29
19763-2,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",151
19764-0,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",151
8251-1,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",152
,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",315
19767-3,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",174
19769-9,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",17
19774-9,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",151
19762-4,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",15
10524-7,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",151
,RBC MORPHOLOGY,94
19764-0,THINPREP TIS PAP RFX HPV,49
19762-4,THINPREP TIS PAP RFX HPV,9
19769-9,THINPREP TIS PAP RFX HPV,9
,THINPREP TIS PAP RFX HPV,61
19767-3,THINPREP TIS PAP RFX HPV,61
19763-2,THINPREP TIS PAP RFX HPV,49
10524-7,THINPREP TIS PAP RFX HPV,49
19774-9,THINPREP TIS PAP RFX HPV,49
12235-8,URINALYSIS WITH MICROSCOPIC LEGACY,178
,MISCELLANEOUS LAB TEST,139
,"FACTOR V (LEIDEN, G1691A) MUTATION",28
19762-4,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",53
19769-9,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",61
49034-2,"THINPREP TIS PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",45
49034-2,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",16
29990-9,"SPERMATOZOA, POST VASECTOMY SCREEN",2
19762-4,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",40
19769-9,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",43
,"CATECHOLAMINES, FRACTIONATED, URINE, 24 HOUR",5
,"CATECHOLAMINES, FRACTIONATED, PLASMA",3
,"VMA, URINE, 24 HOUR",2
,SLIDE FOR PATHOLOGIST REVIEW SOUTH LAKE LAB ONLY,173
13502-0,"LYME DISEASE, WESTERN BLOT",27
13503-8,"LYME DISEASE, WESTERN BLOT",27
12781-1,"LYME DISEASE, WESTERN BLOT",27
586-8,"CULTURE, GROUP B STREP",701
19764-0,THINPREP PAP REFLEX HPV MRNA E6/E7,52
10524-7,THINPREP PAP REFLEX HPV MRNA E6/E7,52
,THINPREP PAP REFLEX HPV MRNA E6/E7,53
19763-2,THINPREP PAP REFLEX HPV MRNA E6/E7,52
49034-2,THINPREP PAP REFLEX HPV MRNA E6/E7,9
19767-3,THINPREP PAP REFLEX HPV MRNA E6/E7,64
,CSF CULTURE,126
,"VDRL, CSF",18
,MENINGITIS/ENCEPHALITIS PCR PANEL,315
,CYSTIC FIBROSIS 97 MUTATION PANEL GENZYME LEGACY,2
,FRAG X - GENZYME,1
,MISCELLANEOUS INTEGRATED GENETICS(GENZYME),2
47527-7,"IGP,CTNG,APTIMAHPV,RFX16/18,45",104
47528-5,"IGP,CTNG,APTIMAHPV,RFX16/18,45",104
19764-0,"IGP,CTNG,APTIMAHPV,RFX16/18,45",100
19767-3,"IGP,CTNG,APTIMAHPV,RFX16/18,45",100
19769-9,"IGP,CTNGTV,RFX APTIMA HPV ASCU",5
,"URINE CULTURE,COMPREHENSIVE",116
59462-2,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
42178-4,LIPOPROTEIN METABOLISM PROFILE-MAYO,6
23658-8,URINE CULT RT 997870,296
19764-0,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
10524-7,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
19767-3,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",131
19763-2,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
19774-9,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",108
19769-9,THINPREP PAP RFX HR HPV,5
,MISCELLANEOUS NEOGENOMICS,974
,BLOOD BANK HOLD TUBE,3989
50941-4,AFB CULTURE,2921
676-7,AFB CULTURE,2925
6824-7,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",654
9335-1,"CELL COUNT WITH DIFFERENTIAL, BODY FLUID",654
57901-1,CLOSTRIDIUM DIFFICILE EIA,24
49586-1,SEQUENTIAL 2 LEGACY,4
44877-9,SEQUENTIAL 2 LEGACY,1
49090-4,SEQUENTIAL 2 LEGACY,1
43995-0,SEQUENTIAL 2 LEGACY,1
48803-1,SEQUENTIAL 2 LEGACY,1
34970-4,SEQUENTIAL 2 LEGACY,1
47223-3,SEQUENTIAL 2 LEGACY,1
43994-3,SEQUENTIAL 2 LEGACY,1
77202-0,SEQUENTIAL 2 LEGACY,1
33882-2,SEQUENTIAL 2 LEGACY,2
6864-3,HEMOGLOBINOPATHY EVALUATION,1
12710-0,HEMOGLOBINOPATHY EVALUATION,78
49586-1,LC SEQUENTIAL 1,3
47223-3,LC SEQUENTIAL 1,1
43994-3,LC SEQUENTIAL 1,1
49090-4,LC SEQUENTIAL 1,1
43995-0,LC SEQUENTIAL 1,1
77202-0,LC SEQUENTIAL 1,1
34970-4,LC SEQUENTIAL 1,1
738-5,MANUAL DIFF CELLAVISION,624
49296-7,"PROTEIN ELECTROPHORESIS, SERUM",1301
25700-6,IMMUNOFIXATION ELECTROPHORESIS,1253
,FINE NEEDLE ASPIRATION,21
741-9,MANUAL DIFF CELLAVISION,1354
10331-7,OBSTETRIC PANEL WITHOUT HIV,324
883-9,OBSTETRIC PANEL WITHOUT HIV,326
5196-1,OBSTETRIC PANEL WITHOUT HIV,326
31208-2,SARS-COV2-2 PCR MAYO,65
7791-7,MANUAL DIFFERENTIAL,292
10376-2,MANUAL DIFFERENTIAL,275
19764-0,THINPREP TIS PAP AND HR HPV DNA,111
10524-7,THINPREP TIS PAP AND HR HPV DNA,111
,THINPREP TIS PAP AND HR HPV DNA,113
19763-2,THINPREP TIS PAP AND HR HPV DNA,111
19774-9,THINPREP TIS PAP AND HR HPV DNA,111
19767-3,THINPREP TIS PAP AND HR HPV DNA,128
664-3,GRAM STAIN,620
,FLOW CYTOMETRY,26
,RAPID INFLUENZA A/B ANTIGENS,39
12710-0,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,18
49549-9,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,16
49246-2,"AFP, SERUM, OPEN SPINA BIFIDA",36
41274-2,"AFP, SERUM, OPEN SPINA BIFIDA",37
44877-9,"AFP, SERUM, OPEN SPINA BIFIDA",37
10381-2,MANUAL DIFFERENTIAL,274
7795-8,MANUAL DIFFERENTIAL,14
33882-2,"AFP, MAT SERUM, OPEN SPINA BIFIDA",29
77202-0,"AFP, MAT SERUM, OPEN SPINA BIFIDA",29
62364-5,"AFP, MAT SERUM, OPEN SPINA BIFIDA",29
49092-0,"AFP, MAT SERUM, OPEN SPINA BIFIDA",29
21112-8,"AFP, MAT SERUM, OPEN SPINA BIFIDA",29
,INTEGRATED SCREEN-GENZYME,26
5859-4,HERPES SIMPLEX VIRUS CULTURE,9
10354-9,"CULTURE, URINE, SPECIAL",52
12235-8,"URINALYSIS, ROUTINE W/RFX",17
5778-6,"URINALYSIS, ROUTINE W/RFX",16
5767-9,"URINALYSIS, ROUTINE W/RFX",16
738-5,MANUAL DIFFERENTIAL,605
702-1,MANUAL DIFFERENTIAL,688
,FLOW CYTOMETRY PATHOLOGY INTERPRETATION,851
33569-5,"SJOGREN'S ANTIBODIES (SS-A,SS-B)",22
45142-7,"SJOGREN'S ANTIBODIES (SS-A,SS-B)",21
,BLOOD CULTURE PCR ID,250
58408-6,MANUAL DIFF CELLAVISION,274
19762-4,THINPREP TIS PAP,17
19769-9,THINPREP TIS PAP,20
56888-1,OB PANEL W/HIV,151
20507-0,OB PANEL W/HIV,155
883-9,OB PANEL W/HIV,155
,TOXOPLASMA ABS IGG/IGM,19
,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",10
47527-7,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
47528-5,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
19764-0,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
19767-3,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",5
12710-0,Q HEMOGLOBINOPATHY EVALUATION,15
45335-7,CF UPPER RESPIRATORY CULTURE,13
45335-7,AEROBIC CULTURE,5187
664-3,AEROBIC CULTURE,11593
45335-7,ANAEROBIC CULTURE,4464
800-3,MANUAL DIFFERENTIAL,432
6462-6,WOUND CULTURE,2530
664-3,WOUND CULTURE,1421
19764-0,THINPREP-TIS (REFL) HPV RFX GENOTYPE LEGACY,3
10524-7,THINPREP-TIS (REFL) HPV RFX GENOTYPE LEGACY,3
,THINPREP-TIS (REFL) HPV RFX GENOTYPE LEGACY,3
19763-2,THINPREP-TIS (REFL) HPV RFX GENOTYPE LEGACY,3
19774-9,THINPREP-TIS (REFL) HPV RFX GENOTYPE LEGACY,3
19767-3,THINPREP-TIS (REFL) HPV RFX GENOTYPE LEGACY,4
728-6,MANUAL DIFF CELLAVISION,1213
56888-1,"HEPATITIS C ANTIBODY AND HIV-1/2, SCREEN AND DIAGNOSTIC PANEL WITH REFLEXES",124
,HEAVY METALS SCREEN,3
7791-7,MANUAL DIFF CELLAVISION,1042
,GREY TOP,182
77202-0,"PROTEIN ELECTROPHORESIS, SERUM",37
77202-0,"PROTEIN ELECTROPHORESIS, URINE",10
,MRSA PCR,152
,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",41
69668-2,RAPID HIV 1&2 SCREEN,8
8251-1,URINALYSIS WITH CULTURE IF INDICATED,11
702-1,MAN DIFF ONLY LEGACY,2
728-6,MAN DIFF ONLY LEGACY,1
19145-2,TEST AUTHORIZATION LEGACY,146
,TEST AUTHORIZATION LEGACY,438
69564-3,"SURESWAB(R), ADVANCED VAGINITIS",108
47528-5,"PAP IG, CT-NG",24
19764-0,"PAP IG, CT-NG",24
19767-3,"PAP IG, CT-NG",24
19769-9,"PAP IG, CT-NG",7
,"PAP IG, CT-NG",27
47527-7,"PAP IG, CT-NG",24
20507-0,PRENATAL PROFILE I,106
883-9,PRENATAL PROFILE I,106
,LAB CLIENT SPECIMEN HANDLING SERVICE,219
800-3,MANUAL DIFF CELLAVISION,877
,"OCCULT BLOOD X 1, STOOL",74
19769-9,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,86
19762-4,IMAGE-GUIDED PAP W/AGE BASED SCR PROTOCOLS,76
6825-4,BODY FLUID CRYSTAL,98
19764-0,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",15
10524-7,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",15
,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",15
19767-3,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",22
19763-2,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",15
49034-2,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",2
19774-9,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",15
664-3,LOWER RESPIRATORY CULTURE,6922
5196-1,"HEPATITIS PANEL, GENERAL",21
,UPPER RESPIRATORY CULTURE,9
803-7,MANUAL DIFFERENTIAL,209
702-1,MANUAL DIFF CELLAVISION,569
635-3,"CULTURE, AEROBIC AND ANAEROBIC W/GRAM STAIN",83
634-6,"CULTURE, AEROBIC AND ANAEROBIC W/GRAM STAIN",83
19769-9,"IGP, APTIMA HPV, RFX 16/18,45",30
,CARDIOVASCULAR REPORT,17
50553-7,URINALYSIS CHEM ONLY,220
5767-9,URINALYSIS CHEM ONLY,287
9592-7,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9597-6,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9596-8,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9587-7,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9588-5,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9590-1,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9591-9,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9594-3,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
9595-0,"LYME DISEASE ANTIBODIES (IGG,IGM), IMMUNOBLOT",9
36913-2,"XSENSE(R), FRAGILE X WITH REFLEX",37
69047-9,CYSTIC FIBROSIS CARRIER SCREEN,50
38404-0,CYSTIC FIBROSIS CARRIER SCREEN,50
21656-4,CYSTIC FIBROSIS CARRIER SCREEN,50
49549-9,CYSTIC FIBROSIS CARRIER SCREEN,50
19762-4,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",15
19769-9,"THINPREP PAP AND HPV MRNA E6/E7 REFLEX HPV 16,18/45",18
19764-0,THINPREP PAP TEST,44
10524-7,THINPREP PAP TEST,44
,THINPREP PAP TEST,45
19763-2,THINPREP PAP TEST,44
19774-9,THINPREP PAP TEST,3
19767-3,THINPREP PAP TEST,51
19764-0,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",29
10524-7,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",29
,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",58
19763-2,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",29
19767-3,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",37
49034-2,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG/TRICH",20
49034-2,"THINPREP PAP REFLEX HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",22
,"STREPTOCOCCUS, GROUP A CULTURE",17
19147-8,Q INTERPRETATION,90
19762-4,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",3
19769-9,"SUREPATH IMAGING PAP AND HPV DNA REFLEX HPV 16,18",3
8251-1,CBC (INCLUDES DIFF/PLT) WITH SMEAR REVIEW,5
,EXTRA SPECIMEN LEGACY,44
31208-2,EXTRA SPECIMEN LEGACY,44
12235-8,URINALYSIS WITH CULTURE IF INDICATED,92
630-4,"URINE CULTURE, ROUTINE",138
8251-1,URO RISK(R) DIAGNOSTIC PROFILE,5
,Q EXTRA LAVENDER-TOP TUBE,360
18314-5,CBC/DIFF AMBIGUOUS DEFAULT,32
,"AMINO ACIDS QN, PLASMA",2
,PAP IG (IMAGE GUIDED),119
47527-7,PAP IG (IMAGE GUIDED),88
47528-5,PAP IG (IMAGE GUIDED),88
19764-0,PAP IG (IMAGE GUIDED),86
19767-3,PAP IG (IMAGE GUIDED),86
19764-0,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",31
10524-7,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",31
19763-2,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",31
19774-9,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",31
19767-3,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",38
45335-7,FUNGAL CULTURE,2840
8251-1,MICROALBUMIN LEVEL URINE LEGACY,51
31208-2,"CYTOMEGALOVIRUS DNA, QN  RT PCR",10
6412-1,OVA AND PARASITES WITH GIARDIA ANTIGEN,24
43227-8,OVA AND PARASITES WITH GIARDIA ANTIGEN,27
21262-1,"SAL/SHIG/CAMPY, CULTURE AND SHIGA TOXIN, EIA W/RFL TO E.COLI, CULTURE",22
6331-3,"SAL/SHIG/CAMPY, CULTURE AND SHIGA TOXIN, EIA W/RFL TO E.COLI, CULTURE",22
43371-4,"SAL/SHIG/CAMPY, CULTURE AND SHIGA TOXIN, EIA W/RFL TO E.COLI, CULTURE",22
,"PAP IG, HPV, RFX 16/18 (SP)",65
47527-7,"PAP IG, HPV, RFX 16/18 (SP)",56
47528-5,"PAP IG, HPV, RFX 16/18 (SP)",56
19764-0,"PAP IG, HPV, RFX 16/18 (SP)",56
19767-3,"PAP IG, HPV, RFX 16/18 (SP)",56
19312-8,"DRUG PANEL, URINE",143
19659-2,"DRUG PANEL, URINE",143
19554-5,"DRUG PANEL, URINE",143
73971-4,"DRUG PANEL, URINE",143
,PATHOLOGY CONSULTATION REQUEST,245
,ADALIMUMAB QUANTITATIVE WITH REFLEX TO ANTIBODY- MAYO,1
10381-2,MANUAL DIFF CELLAVISION,190
,PROGNOSTIC MARKERS (VIRTUOSO),39
12235-8,"UA/M W/RFLX CULTURE, COMP",145
5782-8,UR MICROSCOPIC 333328,43
5783-6,UR MICROSCOPIC 333328,42
,GENITAL CULTURE,13
5778-6,URINALYSIS CHEM ONLY,69
18314-5,Q CBC MORPHOLOGY,122
,SPECIMEN INTEGRITY COMPROMISED,106
,Q INTERPRETATION,66
35265-8,PATHOLOGY TISSUE REQUEST,1111
45335-7,"CULTURE, GROUP B STREP",868
,"PAP IG, RFX HPV ASCU,16/18 (SP)",12
47527-7,"PAP IG, RFX HPV ASCU,16/18 (SP)",6
47528-5,"PAP IG, RFX HPV ASCU,16/18 (SP)",6
19764-0,"PAP IG, RFX HPV ASCU,16/18 (SP)",6
19767-3,"PAP IG, RFX HPV ASCU,16/18 (SP)",6
49092-0,QUAD SCREEN,123
8251-1,QUAD SCREEN,99
44877-9,QUAD SCREEN,69
30525-0,QUAD SCREEN,38
53948-6,QUAD SCREEN,38
43994-3,QUAD SCREEN,69
19764-0,SUREPATH FPGS PAP,1
10524-7,SUREPATH FPGS PAP,1
,SUREPATH FPGS PAP,3
19767-3,SUREPATH FPGS PAP,2
19763-2,SUREPATH FPGS PAP,1
19774-9,SUREPATH FPGS PAP,1
40793-2,"ALKALINE PHOSPHATASE, ISOENZYMES",28
18314-5,CBC WITH DIFFERENTIAL,134
,"CULTURE, AEROBIC AND ANAEROBIC W/GRAM STAIN",188
75693-2,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
75605-6,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",6
45335-7,GENITAL CULTURE,41
31208-2,"HERPES SIMPLEX VIRUS 1 AND 2, PCR",9
19764-0,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",7
10524-7,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",7
19767-3,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",8
,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",14
19763-2,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",7
49034-2,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",2
19774-9,"SUREPATH IMAGING PAP REFLEX HPV DNA AND C. TRACHOMATIS,N.GONORRHOEAE",7
29541-0,"RNA, PCR (GRAPH) RFX/GENO",1
,"RNA, PCR (GRAPH) RFX/GENO",1
49316-3,HEMOGLOBIN ELECTROPHORESIS,302
49586-1,"INTEGRATED SCREEN, PART 2",47
48803-1,"INTEGRATED SCREEN, PART 2",25
34970-4,"INTEGRATED SCREEN, PART 2",26
33882-2,"INTEGRATED SCREEN, PART 2",33
21112-8,"INTEGRATED SCREEN, PART 2",19
49090-4,"INTEGRATED SCREEN, PART 2",25
44877-9,"INTEGRATED SCREEN, PART 2",25
43995-0,"INTEGRATED SCREEN, PART 2",25
43994-3,"INTEGRATED SCREEN, PART 2",25
,"PROTEIN ELECTROPHORESIS, URINE",29
19764-0,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",33
10524-7,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",33
,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",68
19763-2,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",33
19774-9,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",33
19767-3,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",37
77202-0,INTEGRATED SCREEN-GENZYME,11
49586-1,INTEGRATED SCREEN-GENZYME,11
34970-4,INTEGRATED SCREEN-GENZYME,11
,"IGP, APTIMA HPV",18
47527-7,"IGP, APTIMA HPV",26
47528-5,"IGP, APTIMA HPV",26
19764-0,"IGP, APTIMA HPV",17
19767-3,"IGP, APTIMA HPV",17
19762-4,THINPREP PAP AND HPV MRNA E6/E7,13
19774-9,THINPREP PAP AND HPV MRNA E6/E7,17
33882-2,"INTEGRATED SCREEN, PART 1",15
8251-1,"INTEGRATED SCREEN, PART 1",15
44877-9,"INTEGRATED SCREEN, PART 1",15
30525-0,"INTEGRATED SCREEN, PART 1",15
53948-6,"INTEGRATED SCREEN, PART 1",15
34970-4,"INTEGRATED SCREEN, PART 1",15
21112-8,"INTEGRATED SCREEN, PART 1",15
,HCV AB NEG COMMENT 144067,30
19764-0,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
10524-7,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
19763-2,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
19774-9,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",8
19767-3,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",10
803-7,MANUAL DIFF CELLAVISION,164
,"NANOSPHERE GRAM NEGATIVE",404
,ELUTION ANTIBODY ID,55
77202-0,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
69048-7,S. ENCEPHALOPATHY AUTOIMMUNE EVAL- MAYO,17
,LEGIONELLA CULTURE,45
,IMMUNOFIXATION ELECTROPHORESIS URINE,122
49034-2,THINPREP TIS PAP,19
,PATHOLOGY SLIDE REVIEW PS CASE,2492
,EXTRA BLOOD CULTURE CONTAINER,25
15048-2,CREATINE KINASE ISOENZYME PANEL,4
5912-1,CREATINE KINASE ISOENZYME PANEL,4
7790-9,MANUAL DIFF CELLAVISION,110
13438-7,"PROTEIN ELECTROPHORESIS, URINE",139
49276-9,IMMUNOFIXATION ELECTROPHORESIS URINE,294
13438-7,IMMUNOFIXATION ELECTROPHORESIS URINE,294
,"POCT FERN TEST, VAGINAL FLUID",348
19764-0,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,3
10524-7,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,3
19767-3,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,4
19763-2,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,3
19774-9,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,3
,"NANOSPHERE GRAM POSITIVE",585
45335-7,"FUNGAL CULTURE, BLOOD",58
,"IGP,CTNGTV,APT HPV,RFX16/18,45",21
47527-7,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
47528-5,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
19764-0,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
19767-3,"IGP,CTNGTV,APT HPV,RFX16/18,45",20
77202-0,"ANA SCREEN, IFA, W/REFLEX TO TITER AND PATTERN/RHEUMATOID ARTHRITIS PANEL 2",3
,POCT WHOLE BLOOD OXIMETRY (HC) UNSOLICITED RESULTS,242
,"YERSINIA CULTURE, STOOL",8
,"VIBRIO CULTURE, STOOL",9
,CMV CULTURE,46
72486-4,MATERNIT GENOME (9W+),6
75693-2,MATERNIT GENOME (9W+),3
75605-6,MATERNIT GENOME (9W+),3
62364-5,MATERNIT GENOME (9W+),3
77202-0,MATERNIT GENOME (9W+),3
49549-9,MATERNIT GENOME (9W+),3
75608-0,MATERNIT GENOME (9W+),3
,MULTIPLE SCLER  PROFILE SERUM AND CSF- LEGACY,8
19764-0,THINPREP TIS AND HPV MRNA E6/E7,26
10524-7,THINPREP TIS AND HPV MRNA E6/E7,26
19763-2,THINPREP TIS AND HPV MRNA E6/E7,26
19774-9,THINPREP TIS AND HPV MRNA E6/E7,26
19767-3,THINPREP TIS AND HPV MRNA E6/E7,30
7789-1,MANUAL DIFF CELLAVISION,177
,HEPATITIS B SURFACE AG CONF. BY NEUTRAL LEGACY,9
,HEPATITIS BE ANTIGEN AND ANTIBODY-MAYO,6
43227-8,"OVA AND PARASITES, CONC/PERM SMEAR, 2 SPEC",4
57901-1,CLOSTRIDIUM DIFFICILE GLUTAMATE DEHYDROGENASE,12
19769-9,THINPREP PAP TEST,4
,AMIODARONE LEVEL,1
7795-8,MANUAL DIFF CELLAVISION,72
801-1,MANUAL DIFF CELLAVISION,169
7793-3,MANUAL DIFF CELLAVISION,64
10376-2,MANUAL DIFF CELLAVISION,170
19767-3,SUREPATH FPGS PAP AND HPV MRNA E6/E7,8
19769-9,THINPREP PAP REFLEX HPV MRNA E6/E7,9
19774-9,THINPREP PAP REFLEX HPV MRNA E6/E7,13
36913-2,"XSENSE(R), FRAGILE X WITH REFLEX AND CHROMOSOME ANALYSIS, BLOOD",6
29770-5,"XSENSE(R), FRAGILE X WITH REFLEX AND CHROMOSOME ANALYSIS, BLOOD",6
35462-1,SMA CARRIER SCREEN,41
54449-4,SMA CARRIER SCREEN,41
49857-6,SMA CARRIER SCREEN,41
21654-9,CYSTIC FIBROSIS GENE TEST,12
47528-5,"IGP,RFX APTIMA HPV ASCUS,LSIL",5
11546-9,"IGP,RFX APTIMA HPV ASCUS,LSIL",5
47527-7,"IGP,RFX APTIMA HPV ASCUS,LSIL",5
,LITHOLINK CKD PROGRAM,6
19764-0,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,11
10524-7,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,11
,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,22
19763-2,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,11
19767-3,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,14
40703-1,"FECAL LACTOFERRIN, QUALITATIVE",8
19764-0,SUREPATH IMAGING PAP AND HPV DNA,2
10524-7,SUREPATH IMAGING PAP AND HPV DNA,2
,SUREPATH IMAGING PAP AND HPV DNA,2
19767-3,SUREPATH IMAGING PAP AND HPV DNA,3
19763-2,SUREPATH IMAGING PAP AND HPV DNA,2
19774-9,SUREPATH IMAGING PAP AND HPV DNA,2
,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",45
47527-7,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
47528-5,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
19764-0,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
19767-3,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",40
88236-5,CSF CULTURE,320
664-3,CSF CULTURE,1034
10335-8,"CELL COUNT WITH DIFFERENTIAL, CSF",407
10333-3,"CELL COUNT WITH DIFFERENTIAL, CSF",407
,URINE CYTOLOGY,24
31208-2,TISSUE SPECIMEN A,66
8251-1,"DRUG PANEL, URINE",4
31208-2,CULTURE HERPES SIMPLEX VIRUS RAPID METHOD LEGACY,7
5859-4,CULTURE HERPES SIMPLEX VIRUS RAPID METHOD LEGACY,9
802-9,MANUAL DIFFERENTIAL,99
19764-0,SUREPATH FPGS PAP AND HPV MRNA E6/E7,6
10524-7,SUREPATH FPGS PAP AND HPV MRNA E6/E7,6
19763-2,SUREPATH FPGS PAP AND HPV MRNA E6/E7,6
19774-9,SUREPATH FPGS PAP AND HPV MRNA E6/E7,6
,VRE CULTURE,8
21694-5,HEMOCHROMATOSIS MUTATION,26
,RPR TITER,24
,TREPONEMA PALLIDUM (SYPHILIS) ANTIBODY,24
45335-7,UPPER RESPIRATORY CULTURE,32
,BODY FLUID CRYSTAL,13
10372-1,MANUAL DIFFERENTIAL,1
630-4,"URINE CULTURE, COMPREHENSIVE",61
49034-2,THINPREP TIS PAP AND HR HPV DNA,8
43304-5,"CHLAMYDIA/N. GONORRHOEAE RNA, TMA (VCM)",7
,"ROTAVIRUS ANTIGEN, STOOL",3
45335-7,ORGANISM ID CULTURE,119
49034-2,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",15
,"IGG SUBCLASSES  1, 2, 3, AND 4",10
69565-0,NUSWAB VAGINITIS (VG),86
69566-8,NUSWAB VAGINITIS (VG),86
69567-6,NUSWAB VAGINITIS (VG),86
13950-1,Q HEPATITIS A IGM,13
33569-5,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
45142-7,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
43182-5,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
14030-1,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
26975-3,ANACHOICE(R) PANEL 1 WITH REFLEXES,6
69048-7,"MYCOPLASMA PNEUMONIAE AB, IGG, IGM- MAYO",64
6463-4,AEROBIC CULT 080290,25
6463-4,ANAEROBIC CULT 080550,19
5769-5,URINALYSIS ONLY MICROSCOPIC,29
18314-5,T/B LYMPH PROFILE,4
14869-2,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",42
18314-5,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",7
34657-7,"SEMEN ANALYSIS, POST-VASECTOMY",3
42531-4,"SEMEN ANALYSIS, POST-VASECTOMY",3
12286-1,"DRUG SCREEN, PRESCRIPTION/OTC URINE-MAYO",23
14725-6,"CELL PROFILE, BAL",201
32802-1,"CELL PROFILE, BAL",201
32803-9,"CELL PROFILE, BAL",201
45335-7,HERPES SIMPLEX VIRUS CULTURE,123
,PATHOLOGY PNEUMO PREP REQUEST,128
45335-7,LEGIONELLA CULTURE,145
45335-7,CMV CULTURE,143
45335-7,"FUNGAL IDENTIFICATION, YEAST",2
5048-4,Q ANTINUCLEAR ANTIBODIES TITER AND PATTERN,132
13068-2,Q ANTINUCLEAR ANTIBODIES TITER AND PATTERN,132
43182-5,SM AND SM/RNP ANTIBODIES,20
14030-1,SM AND SM/RNP ANTIBODIES,19
19769-9,PAP IG (IMAGE GUIDED),14
,"CHLAMYDIA SEROLOGY, S MAYO",6
47223-3,QUAD SCREEN,31
14869-2,"AUTO DIFFERENTIAL, ADD ON",20
,"AUTO DIFFERENTIAL, ADD ON",12
29541-0,REALTIME ABBOTT,1
13951-9,HP5,1
5196-1,HP5,1
13952-7,HP5,1
22322-2,HP5,1
71773-6,LC QUANTIFERON-TB GOLD PLUS,3
21654-9,CYSTIC FIBROSIS MUTATION PANEL,19
77202-0,CYSTIC FIBROSIS MUTATION PANEL,18
,Q EXTRA GRAY-TOP TUBE,12
31147-2,Q RPR TITER,56
888-8,AB SCR+ANTIBODY ID 114041,23
47213-4,CARDIO IQ(R) ADVANCEDLIPID PANEL AND INFLAMMATION PANEL,5
18319-4,MANUAL DIFF CELLAVISION,55
10378-8,MANUAL DIFF CELLAVISION,241
802-9,MANUAL DIFF CELLAVISION,252
8251-1,CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW,25
26885-4,OVA AND PARASITE - BAYFRONT,15
12851-2,"PROTEIN ELECTROPHORESIS, SERUM",112
69048-7,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
77202-0,"PARANEOPLASTIC AUTOANTIBODY EVAL, CSF-MA",11
69048-7,"LYME CNS INFECTION IGG, AB INDEX",13
92814-3,"LYME CNS INFECTION IGG, AB INDEX",13
7790-9,MANUAL DIFFERENTIAL,44
664-3,UPPER RESPIRATORY CULTURE,20
10378-8,MANUAL DIFFERENTIAL,131
,OVA AND PARASITE - BAYFRONT,17
,"FECAL FAT, QUANTITATIVE",6
19762-4,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",14
19769-9,"THINPREP TIS PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/N.GONORRHOEAE",16
19762-4,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",2
19769-9,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",2
58436-7,UR MICROSCOPIC 333328,6
,FLOW CYTOMETRY AMERIPATH SLK,39
29770-5,"CHROMOSOME, BLOOD, ROUTINE",4
62365-2,"CHROMOSOME, BLOOD, ROUTINE",4
31208-2,"CHROMOSOME, BLOOD, ROUTINE",4
48672-0,"CHROMOSOME, BLOOD, ROUTINE",4
79184-8,HEAVY METALS SCREEN,19
79183-0,HEAVY METALS SCREEN,19
31208-2,HEAVY METALS SCREEN,19
13438-7,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE",11
77202-0,SMN1 COPY NUMBER ANALYSIS,12
72486-4,SMN1 COPY NUMBER ANALYSIS,12
62364-5,SMN1 COPY NUMBER ANALYSIS,24
31208-2,SMN1 COPY NUMBER ANALYSIS,11
41053-0,SMN1 COPY NUMBER ANALYSIS,12
49549-9,SMN1 COPY NUMBER ANALYSIS,12
21759-6,"FRAGILE X, PCR REFLEX SOUTHERN",9
77202-0,"FRAGILE X, PCR REFLEX SOUTHERN",9
41274-2,"AFP, MAT SERUM, OPEN SPINA BIFIDA",110
13955-0,HCV QN INTERP 144030,45
45335-7,VRE CULTURE,108
779-9,MANUAL DIFFERENTIAL,56
,BODY FLUID CULTURE BSP,33
49034-2,THINPREP TIS PAP RFX HPV,6
,REFERENCE ANTIBODY ID 2,155
48595-3,VON WILLEBRAND DISEASE PANEL,19
19762-4,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",1
19769-9,"SUREPATH FPGS PAP AND HPV MRNA E6/E7, C. TRACHOMATIS AND N. GONORRHOEAE",1
44877-9,PENTA SCREEN,10
53948-6,PENTA SCREEN,10
30525-0,PENTA SCREEN,10
21112-8,PENTA SCREEN,10
33882-2,PENTA SCREEN,10
,POCT IONIZED CALCIUM UNSOLICITED RESULTS,57
,"PAP IG, CT-NG, RFX HPV ALL",25
47528-5,"PAP IG, CT-NG, RFX HPV ALL",13
19764-0,"PAP IG, CT-NG, RFX HPV ALL",11
19767-3,"PAP IG, CT-NG, RFX HPV ALL",11
47527-7,"PAP IG, CT-NG, RFX HPV ALL",13
49034-2,THINPREP PAP AND HPV MRNA E6/E7,8
19764-0,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,15
10524-7,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,15
,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,30
19767-3,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,18
19763-2,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,15
19774-9,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,15
,"DRUG SCREEN,COMPREHENSIVE (URINE)",7
21026-0,"PATH REVIEW, PER PROTOCOL LEGACY",2
,PSA (REFLEX TO FREE) (SERIAL),4
19764-0,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
10524-7,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",2
19763-2,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
19774-9,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
19767-3,"SUREPATH IMAGING PAP AND HPV DNA, C. TRACHOMATIS, N. GONORRHOEAE",1
,QUANTITATIVE TISSUE CULTURE,6
698-1,GONOCOCCUS CULTURE,7
25148-8,URINALYSIS ONLY MICROSCOPIC,3
,VZV (NON-LESION) CULTURE,15
,ADENOVIRUS CULTURE,5
24124-0,URINALYSIS WITH MICROSCOPIC LEGACY,44
5787-7,URINALYSIS WITH MICROSCOPIC LEGACY,44
19764-0,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,16
10524-7,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,16
19767-3,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,19
,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,32
19763-2,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,16
49034-2,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,3
19774-9,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,4
,"DRUG MONITOR, PANEL 1, W/CONF, URINE",2
634-6,AEROBIC CULTURE,54
49034-2,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",2
19763-2,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",16
10524-7,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",16
19764-0,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",16
19767-3,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",22
,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",32
19774-9,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",16
5767-9,"Appearance, Urine",8376
5778-6,"Color, Urine",8382
59466-3,Smear Review,3869
,Mode,4175
74744-4,Nanosphere Gram Positive Report,194
74737-8,Nanosphere Gram Positive Report,194
74738-6,Nanosphere Gram Positive Report,194
,Final Report,19692
58445-8,Hematology Comment,873
,Drawn By:,4143
,Extra Blue Top.,12193
882-1,ABO Rh Interpretation,7643
,Comment PTT,506
,Technician ID,22213
,"Urinalysis, UTI Screen",7193
,Source,28248
,S. Pneumoniae Ag(Urine),1053
45390-2,"Squamous Epithelial, Urine",5603
890-4,ABS Interpretation,7457
,Arterial Site,4013
23826-1,B. pertussis,1754
41005-0,CoV-NL63 (Not COVID-19),1471
,Extra Lavender Top Tube,9827
,Preliminary Report,27481
,Organism,3322
,Risk Factor 2,2432
,RT Note:,715
,Extra SST Top.,11843
,Comment MPV,1607
,Extra Pink Top,1694
19295-5,Opiate Screen Qualitative,2445
3390-2,Benzodiazepine Screen Qualitative,2445
18282-4,Cannabinoid Level (THC),2446
,Clostridium Difficile Screen Comment,468
19261-7,Amphetamine Screen Qualitative,2445
19359-9,Cocaine Screen Qualitative,2445
,Extra CSF.,39
,A Spec Type,4019
,UA SG comment,85
3377-9,Barbiturate/Dilantin Screen,2445
,OBSERVATION,12611
,Comment C Diff PCR,35
66746-9,POCT Specimen Type,3794
,Rate total,2738
,ABORh Confirm,1813
,Allen's Test,4192
,Comment HCG,356
,Time Notified:,752
,Notification:,751
,Clinician Notified:,752
49521-8,FluA-H1-pan,1754
,Resp PCR Source,1754
,B. parapertussis,1754
34645-2,C. pneumoniae,1754
,Comment Enteric PCR,380
28545-2,"Mucus, Urine",4057
,Date Notified:,752
,Extra Lithium Heparin Gel.,6981
58430-0,Oxycodone Screen Qualitative,1550
,Strep PCR Comment,452
29257-3,M. pneumoniae,1754
,Complete Reg,340
,Comment Parasite PCR,190
59673-4,Fentanyl Screen Qualitative,1552
,Comment POCT-Hemoglobin,81
49524-2,FluA-H3,1754
49610-4,GrpA Strep,451
70068-2,GrpCG Strep,450
,Specimen Gram Stain,5923
,AFB Stain.,1858
74741-0,Nanosphere Gram Positive Report,194
74749-3,Nanosphere Gram Positive Report,194
74732-9,Nanosphere Gram Positive Report,194
74740-2,Nanosphere Gram Positive Report,194
,Fungitel Assay Qaul  (Mayo),161
,Thyroid Function Interpretation,1695
,Extra Green Top.,1092
,US Pl Chest Tube w/Imaging Perc,9
738-5,Macrocytosis,325
74736-0,Nanosphere Gram Positive Report,194
74742-8,Nanosphere Gram Positive Report,194
74731-1,Nanosphere Gram Positive Report,194
,Fungitel Assay Qnt (Mayo),160
,Notified By:,691
49111-8,"Sperm, Urine",49
,Legionella Ag(Urine),1059
,Extra Red Top.,445
7791-7,Tear Drop Red Bl Cells,563
74747-7,Nanosphere Gram Positive Report,194
74745-1,Nanosphere Gram Positive Report,194
74748-5,Nanosphere Gram Positive Report,194
74746-9,Nanosphere Gram Positive Report,194
74739-4,Nanosphere Gram Positive Report,194
74743-6,Nanosphere Gram Positive Report,194
,Results Available (Click camera to view),373
,Misc Reference Component Result,189
,Left Shift,506
,Extra Bl Culture Bottle.,323
,PHONE REPORT,385
42251-9,Methadone Screen Qualitative,1549
,Comment RubG,263
40485-5,Urine Uric Acid Crystal,35
,Vaginitis Panel Comment,121
10378-8,Polychromaphilia,88
,Comment BedGlu,1027
,Comment HBsAg,194
,Extra Urine Container.,958
56888-1,HIV Antigen/Antibody,845
,Amorph Crys,435
741-9,Microcytosis,518
,Comment POCT -Culture,123
31208-2,"* Source, DNA",665
,Varicella Zoster IgM,1
,Comment UA Bilirubin,157
18319-4,Neutrophil Vacuolation,40
49296-7,Protein Impression,111
,Misc Reference Component Name,188
,CEA Body Fluid Type,13
,Comment HBcM,115
,Comment HAVM,118
,Comment HCAb,147
,JAK2 RPT,10
6742-1,Normal Morphology,534
,Extra Culturette.,307
,Amyl BF Type,64
,Urine Calcium Oxalate Crystal,156
,Stone Analysis Herring,101
66746-9,* TEG Specimen Type,240
,Comment POCT-Arterial pH,176
,Trig BF Type,69
,Bili BF Type,7
,SARS CoV-2 Specimen Source,56
10333-3,"Appearance, CSF",118
,Comment POCT-Ionized Calcium,55
,Comment POCT-Hematocrit calc,42
,Comment POCT-Potassium,202
,Comment POCT-Arterial PCO2,55
,Comment GDNA,287
,Comment CDNA,284
10335-8,"Color, CSF",120
,Baby Rh Pos,141
,Nanosphere Gram Negative Report,195
11279-7,"Comment, Urine",34
,NM INJ -ID SENTINEL NODE,65
,Extra Translife.,18
7789-1,Acanthocytes,83
,"Interleukin 6, P",24
,Extra Gray Top.,503
14869-2,Smear for Pathologists Review,114
,Flow Profile - Whole Blood,20
,MRSA PCR.,353
5822-2,"Yeast, Urine",252
,QFT-Plus Interpretation,88
7018-5,--Gentamicin Synergy Screen,178
6933-6,--Streptomycin Synergy Screen,178
48378-4,Kappa/Lambda FLC Ratio,72
38445-3,Calprotectin Stl-Mayo,18
,UA Color Comment,22
33944-0,Lambda Free Light Chain S,72
,* Gestational Age Based on,140
1314-4,Rh Immunoglobulin Interp,139
36916-5,Kappa Free Light Chain S,72
,Performing Lab.,48
,Venous Site,209
,Influenza PCR Source,233
,"Vitamin D-1,25- Dihydroxy",22
,Comment POCT-Arterial  pO2,23
,Comment POCT-Sodium,10
,Extra Transport Media.,222
,Resp PCR Source Comment,114
,V Spec Type,210
2141-0,Adrenocorticotropic Hormone,56
31208-2,"* Source, Urine",105
,Comment Low WBC,65
,Antibody ID-,404
66746-9,S Source,141
1313-6,Vials of Rhogam,86
,Susceptibility Yeast-Mayo,7
,Small Bowel Disacch Interp,11
,Bile Acids Total,3
51338-2,Flow Profile Tissue,27
10496-8,Flow Profile Tissue,27
32511-8,Flow Profile Tissue,27
20595-5,Flow Profile Tissue,27
21169-8,Flow Profile Tissue,27
51296-2,Flow Profile Tissue,27
20602-9,Flow Profile Tissue,27
51378-8,Flow Profile Tissue,27
51214-5,Flow Profile Tissue,27
20596-3,Flow Profile Tissue,27
8251-1,Small Bowel Disacch Received Frozen,11
33511-7,Small Bowel Biopsy Quality,11
33020-9,Urine Triple Phosphate Crystal,32
85499-2,KPC,9
,Comment Carba R,9
,Aspergillus Antigen,56
48814-8,vanA PCR-,5
51291-3,Flow Profile Tissue,27
10499-2,Flow Profile Tissue,27
51278-0,Flow Profile Tissue,27
,Extra Body Fluid.,127
774-0,Elliptocytes,100
,Striate Mscl Ab-Mayo,8
,ACH Receptor Binding (AB),10
,MG Adult Interpretation,6
,ACHr Modul Ab-Mayo,6
31147-2,"RPR Quant, Bl",196
22587-0,Treponema Pallidum Antibodies,48
,Current Titer 1,12
,ABID Titer 1,14
,Creat BF Type,38
,Prev Titer 1,14
,Flow Profile - Bone Marrow,77
,"Varicella-Zoster Virus,PCR-Mayo",1
,Miscellaneous Test GO Frozn-Mayo,49
85500-7,NDM,9
85498-4,IMP,9
,"IFE Impression, Urine",76
,cANCA/titer,45
1763-2,"Aldosterone, Serum",22
,IFE Impression,114
,pANCA-Mayo,45
29585-7,"Protein Electrophoresis, Urine Interp",75
,Cryoglobulin Evaluation - Ref,10
,Cytomegalovirus DNA Qual PCR,4
,HSV PCR Rslt-Mayo,2
,Comment CMV Quant,21
801-1,Sickle Forms,48
1825-9,"Alpha 1 Antitrypsin, Serum",21
7790-9,Echinocytes,52
,Comment HBsAb,70
,Comments,717
,Aspergillus Fumigatus IgG Ab-REF,8
6824-7,"Color, Fluid",321
35671-7,"Aspergillus Ag, BAL",19
85503-1,OXA48,9
,Plt CTAD comment,18
,VZ Virus Source-Mayo,1
,Source Tox Gondii,11
49671-1,Neisseria meningitides,34
30326-3,Cytomegalovirus (CMV),34
61398-4,Escherichia coli K1,34
,Enterovirus,34
,Extra Microtainer Lavender.,25
,Myeloperoxidase,53
,Proteinase 3 Ab,53
,Liver Kidney Microsomal AB,6
,Angiotensin 1 Converting Enzyme,37
10333-3,Appear Add CSF,4
41236-1,"W. Nile Virus IGG, CSF",5
29569-1,"W. Nile Virus IGM, CSF",5
19157-7,Tube Num Add CSF,4
49672-9,Streptococcus pneumonia,34
,Streptococcus agalactiae,34
,Comment Meningitis/Encephalitis PCR,34
,Arbovirus Antibody Panel IgG and IgM CSF,1
61369-5,Listeria monocytogenes,34
10335-8,Color Add CSF,4
,Bone Marrow (Morphology),118
5290-2,"VDRL, CSF",96
,"Toxoplasma Gondii PCR, CSF",11
16952-4,Herpes simplex virus 1(HSV-1),34
61366-1,Haemophilus influenza,34
33942-4,Human herpesvirus 6 (HHV-6),34
51669-0,Human parechovirus,34
,Miscellaneous Test GO Rrefig-Mayo,71
,Extra Microtainer Green.,40
,Nanosphere Gram Positive Report 2,36
9335-1,Appearance,310
,Eluate Antibody Interp 1,42
3281-3,Lupus Interp,63
,TEG INT,1
,Comment POCT-Lactic Acid Venous,21
,Iron and IBC - Ref,8
,Iron Sat - Ref,8
,Crystal BF Type,17
,Prot BF Type,205
,Iron - Ref,8
,Extra Microtainer SST.,18
47938-6,* Fluid Type,130
,Gluc BF Type,159
47938-6,Body Fluid Type (BF),207
,LDH BF Type,175
33905-1,"Trichomonas, Urine",2
43180-9,"HSV Type 2 Ab, IgG, S",5
51916-5,"HSV Type 1 Ab, IgG, S",5
6825-4,Crystal Exam,18
,Lipoprotein A,30
,Protein S Free-Mayo,22
13514-5,Hemoglobin Impression,24
,Brucella Ab Scr IgM-Mayo,6
,Brucella Ab Interp-Mayo,6
,"Multiple Sclerosis, CSF - R",3
42209-7,CSF Smear for Pathology Review,39
,Bartonella Quintana IgG,25
,Bartonella Henselae IgM,25
,Bartonella Quintana IgM,25
48707-4,Hgb C Crystals,2
2044-6,HSV-2,32
,HSV/VZV PCR Comment,32
,Lesion Site,32
2044-6,HSV-1,32
2044-6,VZV,32
,CT Guide BX Lung-Mediastinum Perc,22
24475-6,Factor II Mutation (PTG20210A),38
21668-9,"Factor V Mutation (Leiden, G1691A)",40
,Lupus SCR,22
,Brucella Ab Scr IgG-Mayo,6
,Q Fever A,9
56888-1,HIV 1/2 DIFF,20
8072-1,"Insulin Antibodies, Serum",3
,Cog BM Chr Fish,1
,Chromo BM-Genzyme,1
,GAD-65 (AB),2
8251-1,HIV 1/2 Diff Accession Number,20
,Inhibitor (Mixing) Study Interpretation,10
82213-0,Sapovirus,13
82200-7,Vibrio,13
82199-1,Salmonella,13
79385-1,Yersinia enterocolitica,13
82205-6,Cryptosporidium,13
82209-8,Adenovirus F 40/41,13
80351-0,Enteropathogenic E. coli (EPEC),13
80349-4,Enteroaggregative E. coli (EAEC),13
82212-2,Rotavirus PCR,13
82203-1,Shiga-toxin,13
82210-6,Astrovirus,13
82200-7,Vibrio cholera,13
80350-2,Shigella/Enteroinvasive E. coli (EIEC),13
82211-4,Norovirus,13
70296-9,Plesiomonas shigelloides,13
82208-0,Giardia lamblia,13
,Lactate >2,53
82204-9,E. coli 0157,13
82206-4,Entamoeba histolytica,13
80351-0,Enterotoxigenic E. coli (ETEC),13
,Comment Stool PCR,13
82196-7,Campylobacter,13
82206-4,Cyclospora cayetanensis,13
,Blood Culture ID,32
,EDN Interpretation,2
,Comment HBcAb,29
,"Hepatitis B Viral DNA, Quant-R",11
,Comment (BF),91
,Barton PCR Rslt-Mayo,1
,Bartonella Henselae IgG,25
13971-7,U Hist Ag Value,51
44524-7,U Hist Ag Result,51
,UA Micro?,32
,Mycoplasma pneumoniae PCR,1
31208-2,Specimen Source MP,1
,BAL Fluid Type,98
,MTHFR Mutation Screen - Ref,6
,"HBe AG&AB, EIA - Ref",7
,Comment POCT-Lactic Acid Arterial,32
,US Loc Device Plc w/Ultrasound,9
,Miscellaneous Test GO RT-Mayo,47
41861-6,"Hyphae, Urine",40
,Mammo Loc Device Plc w/Mammo Ea Addl,3
,MA Breast Needle Loc 2 Lesions,10
85501-5,VIM,9
,EBV Interp,172
,Vitamin E Level,2
,"Heavy Metals Panel, Blood - Ref",1
30552-4,"Pyridoxal 5-Phosphate (PLP), P Mayo",4
,Thiamine Result,7
,Cyclic Citrulliant Peptide (AB),18
,Hct BF Type,6
47938-6,* Fluid Type BF,2
,Mammo Loc Device Place w/Mammo,37
,Prot C&S Interp,38
,"Myoglobin Quant, Serum",1
,"Metanephrines, Fractionated Free-Mayo",3
,Comment Mono,3
,PTH Related Protein,3
,Complement Total CH50,13
49311-4,ANA Interp,56
,IgG Subclasses Serum - Ref,12
5763-8,"Zinc, Serum",9
,Free Retinol(Vit A)-Mayo,2
,Progesterone 17-OH,1
,MA US Loc Device Place with US CA,7
,Comment RDW,45
,KOH.,10
,HE4-Mayo,1
,Normetane Free-Mayo,3
33923-4,Hemosiderin Stain Cytospin (BF),3
4633-4,Fetal Hemoglobin Stain,7
,Legionella Pneumophillia (AB),2
,Comment ANA,40
,Chol BF Type,13
882-1,ABO Rh Type Interp (post),17
14924-5,Interp for Trans React,18
,Path Sign,18
,Comment POCT-Cord pH,12
2963-7,Growth Hormone,6
2484-4,Somatomedin-C IgF-1,8
48069-9,Microspherocytes,5
,Levetiracetam Level,16
,Plt Comment,16
45388-6,Ca Phos Crystal,1
,Flow Profile - Body Fluid,5
,Voriconazole Lvl-Mayo,6
,Comment COV-19,4
,Specimen Type AMP,1
21785-4,Dengue Interpretation,1
,Streptococcal (AB) - Ref,2
,Comment POCT-Glucose,6
,US Nephrostomy Cath Insertion,2
,"Nicotine Quantitaive, Urine",3
,HLA Screen,2
10371-3,Bite Cell,8
,"Soluble Transferrin Receptor, S-Mayo",5
7797-4,Rouleaux,184
,BK Virus DNA QN by PCR,3
5218-3,Histo Immuno Ab-Mayo,5
20574-0,Histo Yeast Ab-Mayo,5
49836-0,Platelet Function Interp,7
20573-2,Histo Mycel Ab-Mayo,5
,Glomerular Basement (AB) IgG,8
,ADAMTS13 Activity-Mayo,12
,ADAMTS13 Interp,12
19659-2,Phencyclidine Screen Qualitative,38
,HLA B5701 Interp,3
,Aspiration Marker Interpretation,1
32798-1,Oil Cyto,7
29663-2,Dengue Fever IgM,1
29661-6,Dengue Fever IgG,1
,EBV DNA Qnt-Mayo,13
,Anti Dnase B,2
,Intrinsic Factor Antibody-Mayo,4
,Oligoclonal Bands CSF,4
,Oligoclonal Bands Interp,4
,"Parvovirus B19,PCR,P-Mayo",1
,Specimen Source Microsporidia (MAYO),1
,Parvovirus B19 IgM,9
,Parvovirus B19 IgG,9
2458-8,IgA - Mayo,8
,TTG IgA-Mayo,11
,Celiac Disease Interpretation-Mayo,8
,Pneumocystis Carinii Preparation,4
,Interleukin-2 Receptor-Mayo,3
,Epstein Barr Virus DNA by PCR,1
,Enterocytozoon Bieneusi (MAYO),1
,Parvovirus B19 Source-Mayo,1
,Parvovirus B19 AB Interp,9
,Allergen Result Ranges,6
,"Metanephrines, FX, 24 Hour Urine",5
,PS/PT IgM (MAYO),4
,PS/PT IgG (MAYO),4
,HIV1 RNA,1
,Glucose 6 Phosphate (G6PD),11
,Complement C1 Est Inhib,5
,Serotonin,1
,Talcum,1
40744-5,Factor Tested,1
,* Anticoagulant Drug,21
,Flow Profile PNH,2
,Inhibitor Titer,1
,MuSK Antibody-Mayo,2
48595-3,VWB Interp,8
,PAE Interpretive Comments,2
,"CRMP-5-IgG, CSF-Mayo",2
,"CRMP-5-IgG, S Mayo",2
,"Anti-Neuronal Nuclear Ab, Type 2 CSF-Mayo",2
,Neuronal (V-G) K+ Channel Ab-Mayo,2
,N-Type-Mayo,2
,P/Q-Type-Mayo,2
,PCA-1-Mayo,2
,"AGNA-1,-Mayo",2
,Amphiphysin Ab-Mayo,2
,"Anti-Glial Nuclear Ab, Type 1, CSF-Mayo",2
,ANNA-2-Mayo,2
,ANNA-3-Mayo,2
,ANNA-1-Mayo,2
,"Purkinje Cell Cytoplasmic Ab Type 2, CSF-Mayo",2
,PCA-Type Tr-Mayo,2
,"Paraneoplastic Interpretation, CSF",2
,PCA-2-Mayo,2
,HTLV 1/2 AB,4
,"Anti-Neuronal Nuclear Ab, Type 3 CSF-Mayo",2
,Amphiphysin Ab CSF-Mayo,2
,"Anti-Neuronal Nuclear Ab, Type 1, CSF-Mayo",2
,AChR Gng Nrl Ab-Mayo,2
,Purkinje Cell  Type 1 Cytoplasmic Antibody CSF-Mayo,2
,"Purkinje Cell Cytoplasmc Ab Type Tr , CSF-Mayo",2
,Comment GBS PCR,74
,"Viscosity, Serum",1
,5-Hydroxyindoleacetic Acid,2
,"Comment, CSF",35
,DBili BF Type,2
3021-3,Thyroxine Binding Globulin,1
,Comment ToxG,5
,Comment UMYO,2
,"Myoglobin Quant, Urine",2
,Comment POCT-Hemoglobin calc,2
,Color PEA,16
58710-5,"Gliadin (Deaminated) Ab, IgG, S",2
51724-3,--Cefuroxime,2
,ABID Titer 2,3
,Blastomyces (AB) - Ref,4
,Selenium Level,2
,Free Fatty Acid Total,1
,Pancreatic Enzyme Request (Component),4
,PEA Interp,4
,Received Frozen/Dry Ice PEA,4
,Plasminogen Activity,1
59464-8,Lyme CSF Comment-Mayo,1
4991-6,B. burgdorferi PCR-Mayo,1
82472-2,B. garinii/B. afzelii PCR-Mayo,1
,"Angiotensin Converting Enzyme, CSF",3
,* Specimen Source,1
82474-8,B. mayonii PCR-Mayo,1
56900-4,Flow Profile - CSF,17
,Prev Titer 2,3
,Current Titer 2,3
,Lamotrigine Lvl-Mayo,4
,Fecal Fat,3
,Susceptibility Aerobic-Mayo,4
,Oligoclonal Bands Serum,4
,Intrinsic Factor Antibody Comment,3
,Tryptase-Mayo,1
48176-2,Rifampin Resistance,2
,"Strongyloides Ab, IgG-Mayo",9
,"Protein S Ag, Total,Plasma-Mayo",3
,Celiac Gene Pairs Present,1
,DQ Beta 1,1
,DQ Alpha 1,1
,MRI Breast Biopsy w/MRI,1
,HLA Typing,2
,MA Loc Device Place with MA CA,4
,E. Histolytica (AB),1
,Coccidioides (AB),2
,Encephalitozoon Species (MAYO),1
,MTB PCR-,2
,Comment MTB PCR,2
33634-7,Rifampin Resistance,2
,Source MTB PCR,2
,Cord Type,4
10372-1,Blister Cells,3
,"Ceruloplasmin,S-Mayo",1
,US Gde Perc Tun Pleural Cath,3
1688-1,Pyridoxic Acid,4
32700-7,"Malaria, Thin Smear",1
58709-7,"Gliadin (Deaminated) AB, IgA, S",2
,Flecainide Lvl-Mayo,1
,"JC Virus, DNA,PCR,CSF-Mayo",1
,Hrs Cortisol-Mayo,1
,U24 Cortisol-Mayo,1
,TV Cortisol-Mayo,1
,Hemosiderin BF Type,1
,NIVL LE Pseudoaneurysm Eval,1
,Comment POCT-Hematocrit,1
,"Catecholamines FX, Plasma",1
,Testosterone Bioavailable-Mayo,2
,Testosterone Total-Mayo,2
2991-8,Testosterone Free,2
,HSV 2 PCR - Mayo,4
,HSV 1 PCR - Mayo,4
,Cancer Antigen 15-3,2
,Unstable Hgb-Mayo,1
2145-1,"Cortisol, Free, S",1
,Hb Vart by Mass Spec-Mayo,1
51638-5,RBC Agglut,1
,HLA-B27 Interp-Mayo,1
,TTR MET30 DNA-REF,1
,HLA B27 - Ref,1
,US Breast Needle Loc 2 Lesions,2
,"CSF, Encephalopathy Auto Eval - Mayo",1
,IBD Diagnostic -Prometheus,1
,"Amino Acids Quant Ion-Exc, Random, Urine",1
29566-7,West Nile IgG-Mayo,2
29567-5,West Nile IgM-Mayo,2
,"Catecholimines FX, Urine",1
,W Nile Interp-Mayo,2
,Received Frozen AMP,1
,POCT Specimen Site,2
,Lyme Disease (AB) Confirm Screen - Ref,2
,Immunofixation Cryoglobulin-Mayo,1
,C1Q Complement Component,1
6742-1,Minimal Red Bl Cell Variation,1
,US Loc DEVICE Plc Lymph Node,1
,Pathology Smear Report,2
06522,US Guide NDL Place Breast,2
,Manganese Lvl-Mayo,1
,Fungus ID-Mayo,2
,Aerobic Bacteria ID-Mayo,1
,Hepatitis E Virus Ab IgM-Mayo,1
2191-5,Dehydroepiandrosterone Sulfate,1
95228,US Lymph Node Biopsy Breast,2
72486-4,MATERNIT21 PLUS CORE+SCA,54
62364-5,MATERNIT21 PLUS CORE+SCA,27
49549-9,MATERNIT21 PLUS CORE+SCA,27
75693-2,MATERNIT21 PLUS CORE+SCA,27
77202-0,MATERNIT21 PLUS CORE+SCA,27
,MATERNIT21 PLUS CORE+SCA,162
75605-6,MATERNIT21 PLUS CORE+SCA,28
75608-0,MATERNIT21 PLUS CORE+SCA,27
23658-8,"URINE CULTURE, ROUTINE",20
18314-5,LC HEMATOLOGY COMMENTS,14
8264-4,TEST IN QUESTION- UNLABELED LEGACY,4
31208-2,TEST IN QUESTION- UNLABELED LEGACY,4
19764-0,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",12
10524-7,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",12
19763-2,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",12
19767-3,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",12
31208-2,"STREPTOCOCCUS GROUP B DNA, PCR WITH BROTH ENRICH W/RFX SUSCEPTIBILITY",199
,"Q SUSCEPTIBILITY,AEROBIC BACTERIA, MIC",52
19769-9,THINPREP PAP AND HPV MRNA E6/E7,16
69564-3,"Q SURESWAB(R) BACTERIAL VAGINOSIS, DNA, QN, RT PCR",31
31208-2,"MISC CHLAMYDIA TRACHOMATIS/N GONORRHOEAE, NAA-MAYO",64
8251-1,OBSTETRIC PANEL WITHOUT HIV,12
8251-1,URINALYSIS WITH REFLEX MICROSCOPIC,5
,FACTOR INHIBITOR ASSAY,7
783-1,CBC WITH DIFFERENTIAL,5
13046-8,CBC WITH DIFFERENTIAL,5
26523-1,CBC WITH DIFFERENTIAL,5
8246-1,URINALYSIS WITH REFLEX MICROSCOPIC,20
5822-2,URINALYSIS WITH REFLEX MICROSCOPIC,18
46138-4,URINALYSIS WITH REFLEX MICROSCOPIC,4
38459-4,URINALYSIS WITH REFLEX MICROSCOPIC,4
9842-6,URINALYSIS WITH REFLEX MICROSCOPIC,3
5793-5,URINALYSIS WITH REFLEX MICROSCOPIC,3
26052-1,URINALYSIS WITH REFLEX MICROSCOPIC,4
46137-6,URINALYSIS WITH REFLEX MICROSCOPIC,6
5882-6,VARICELLA ZOSTER DFA,2
19762-4,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,3
19769-9,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,3
,"ANTIBODY ID, TITER AND TYPING, RBC",30
,RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL 1,8
,"CULTURE REFER FOR ID, MYCOBACTERIUM-MAYO",3
19769-9,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",29
19762-4,"IMAGE-GUIDED PAP W/AGE BASED SCR,W/CT/NG",27
62356-1,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
62365-2,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
31208-2,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
48672-0,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
51967-8,"CHROMOSOME, LEUKEMIA/LYMPHOMA",6
19762-4,SUREPATH IMAGING PAP AND HPV DNA,1
19769-9,SUREPATH IMAGING PAP AND HPV DNA,1
,STREP GP B CULTURE,2
,"PAP IG, CT-NG TV HPV-HR",1
47527-7,"PAP IG, CT-NG TV HPV-HR",2
47528-5,"PAP IG, CT-NG TV HPV-HR",2
19764-0,"PAP IG, CT-NG TV HPV-HR",1
19767-3,"PAP IG, CT-NG TV HPV-HR",1
35265-8,STONE ANALYSIS,1
88448-6,FIBROTEST-ACTITEST,41
48794-2,FIBROTEST-ACTITEST,41
88447-8,FIBROTEST-ACTITEST,41
48793-4,FIBROTEST-ACTITEST,41
,PATHOLOGY REPORT,60
19774-9,THINPREP PAP RFX HR HPV,8
5822-2,UR MICROSCOPIC 333328,7
8251-1,URINE MICROALBUMIN,16
83321-0,PATHOLOGY TISSUE REQUEST,808
7918-6,HIV1/HIV2 DIFFERENTIATION,58
634-6,ANAEROBIC/AEROBIC/GRAM STAIN LEGACY,3
635-3,ANAEROBIC/AEROBIC/GRAM STAIN LEGACY,3
6463-4,ANAEROBIC/AEROBIC/GRAM STAIN LEGACY,8
664-3,ANAEROBIC/AEROBIC/GRAM STAIN LEGACY,3
,CELL-FREE DNA SCREEN,109
13068-2,ANA IFA TITER,355
45335-7,VZV (NON-LESION) CULTURE,70
,OIL CYTO REQUEST,34
800-3,CBC WITH AUTO DIFFERENTIAL,83
10378-8,CBC WITH AUTO DIFFERENTIAL,202
10381-2,CBC WITH AUTO DIFFERENTIAL,87
10376-2,CBC WITH AUTO DIFFERENTIAL,225
702-1,CBC WITH AUTO DIFFERENTIAL,265
801-1,CBC WITH AUTO DIFFERENTIAL,7
600-7,BLOOD CULT RT 997873,12
,RESEARCH ARCHIVE TECHNICAL REQUEST - LABONLY,4
77202-0,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",12
20401-6,ENA+DNA + 160024,2
,ENA+DNA + 160024,8
13169-8,"IFE, PE AND FLC, SERUM LEGACY",4
77202-0,"IFE, PE AND FLC, SERUM LEGACY",4
,RHEUMATOID FACTOR TITER,9
,MISCELLANEOUS POST-TRANSPLANT VIRACOR,489
,KARIUS,94
96625-9,HLA B27-MAYO,44
53938-7,CELIAC DISEASE COMPREHENSIVE CASCADE-MAY,73
94495-9,CELIAC DISEASE COMPREHENSIVE CASCADE-MAY,73
69048-7,CELIAC DISEASE COMPREHENSIVE CASCADE-MAY,73
13956-8,MTD,35
,MISCELLANEOUS STEM CELL,16
,"CHROMOSOME ANALYSIS, BONE MARROW",43
,MISCELLANEOUS PROMETHEUS,14
25148-8,"UA/M W/RFLX CULTURE, COMP",26
6742-1,MANUAL DIFFERENTIAL,100
31208-2,"GROUP B STREPTOCOCCUS COLONIZATION DETECTION, NAA",121
69047-9,SOLID TUMOR TARGETED CANCER PANEL (MAYO),20
50397-9,SOLID TUMOR TARGETED CANCER PANEL (MAYO),18
82939-0,SOLID TUMOR TARGETED CANCER PANEL (MAYO),25
31208-2,SOLID TUMOR TARGETED CANCER PANEL (MAYO),25
80398-1,SOLID TUMOR TARGETED CANCER PANEL (MAYO),25
19774-9,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",9
19769-9,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",3
19762-4,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",3
48595-3,"VON WILLEBRAND FACTOR MULTIMER ANALYSIS, PLASMA MAYO",5
69048-7,"WEST NILE ANTIBODIES, IGG AND IGM",5
23658-8,AEROBIC CULT 997874,4
77202-0,"KIDNEY STONE, URINE/SATURATION",3
,EXTRA URINE CONTAINER,49
49580-4,RAPID HIV 1&2 SCREEN,6
18396-2,RAPID HIV 1&2 SCREEN,6
83321-0,NON-GYNECOLOGIC CYTOLOGY,119
13438-7,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, URINE",5
5787-7,URINALYSIS WITH REFLEX MICROSCOPIC,28
58436-7,URINALYSIS WITH REFLEX MICROSCOPIC,1
24124-0,URINALYSIS WITH REFLEX MICROSCOPIC,28
,EBV ACUTE INFECTION ANTIBODIES,4
47213-4,"ADVANCED LIPID PANEL, CARDIO IQ(R)",7
,CELLULAR THERAPY DOCUMENTS,78
45335-7,BLOOD PRODUCT CULTURE,33
45335-7,CRE CULTURE,148
625-4,STOOL CULTURE PERFORMABLE,47
35462-1,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
21654-9,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
49857-6,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",15
54449-4,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",15
69047-9,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
21656-4,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
49549-9,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",22
38404-0,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",20
,URINE DRUG SCREEN SUPER PANEL 9,3
13945-1,"UA/M W/RFLX CULTURE, ROUTINE",36
5769-5,"UA/M W/RFLX CULTURE, ROUTINE",36
24124-0,"UA/M W/RFLX CULTURE, ROUTINE",36
5821-4,"UA/M W/RFLX CULTURE, ROUTINE",36
5787-7,"UA/M W/RFLX CULTURE, ROUTINE",36
12851-2,"PROTEIN ELEC + INTERP, SERUM",4
14895-7,IMMUNOFIXATION ELECTROPHORESIS,35
25700-6,"IMMUNOFIXATION IMMUNOGLOBULIN IGA, IGG, IGM QT. SERUM",16
7792-5,MANUAL DIFF CELLAVISION,66
82939-0,"LUNG CANCER TARGETED GENE PANEL REARRANGEMENT, TUMOR-MAYO",58
69047-9,"LUNG CANCER TARGETED GENE PANEL REARRANGEMENT, TUMOR-MAYO",58
80398-1,"LUNG CANCER TARGETED GENE PANEL REARRANGEMENT, TUMOR-MAYO",58
31208-2,"LUNG CANCER TARGETED GENE PANEL REARRANGEMENT, TUMOR-MAYO",58
35265-8,NON-GYNECOLOGIC CYTOLOGY,90
,ELECTRON MICROSCOPY REQUEST,49
,NON-GYN CYTOLOGY,224
58408-6,CBC WITH AUTO DIFFERENTIAL,48
,DIABETES PATIENT EDUCATION,8
728-6,CBC WITH AUTO DIFFERENTIAL,86
741-9,CBC WITH AUTO DIFFERENTIAL,105
,REFERENCE TITER 3,2
,REFERENCE TITER 2,4
29990-9,"SPERMATOZOA, POST VASECTOMY",13
586-8,STREP GP B CULTURE,31
14869-2,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,4
,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,8
,THALASSEMIA SUMMARY INTERPRETATION,4
,"HGB VARIANT BY MASS SPEC,B-MAYO",2
7793-3,CBC WITH AUTO DIFFERENTIAL,3
779-9,CBC WITH AUTO DIFFERENTIAL,125
10380-4,CBC WITH AUTO DIFFERENTIAL,31
7791-7,CBC WITH AUTO DIFFERENTIAL,42
,BLOOD CULTURE PCR PROBE,50
33358-3,"IFE AND PE, SERUM",5
77202-0,"IFE AND PE, SERUM",4
13169-8,"IFE AND PE, SERUM",5
77202-0,"PROTEIN ELEC + INTERP, SERUM",1
906-8,"ANTIBODY ID, TITER AND TYPING, RBC",13
15343-7,"ANTIBODY ID, TITER AND TYPING, RBC",23
664-3,"CULTURE, QUANTITATIVE SMALL INTESTINAL BRUSHING",15
630-4,"CULTURE, QUANTITATIVE SMALL INTESTINAL BRUSHING",12
738-5,CBC WITH AUTO DIFFERENTIAL,40
66746-9,THROMBOELASTOGRAPH CLOTTING PROFILE,731
,EXTRA URINE SPECIMEN LEGACY,116
19767-3,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",5
19774-9,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
10524-7,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
19763-2,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
19764-0,"THINPREP TIS PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",4
5393-4,FLUORESCENT TREPONEMAL ANTIBODY ABSORPTION,7
43371-4,"SALMONELLA/SHIGELLA CULT, CAMPY EIA AND SHIGA TOXIN W/RFL E.T",20
57768-4,"SALMONELLA/SHIGELLA CULT, CAMPY EIA AND SHIGA TOXIN W/RFL E.T",20
21262-1,"SALMONELLA/SHIGELLA CULT, CAMPY EIA AND SHIGA TOXIN W/RFL E.T",20
66485-4,"BRUCELLA ANTIBODY SCREEN IGM/IGG ELISA, S",11
44827-4,BARTONELLA ANITBODY PANEL,53
6954-2,BARTONELLA ANITBODY PANEL,53
6955-9,BARTONELLA ANITBODY PANEL,53
44825-8,BARTONELLA ANITBODY PANEL,53
9710-5,Q FEVER ANTIBODY,16
34716-1,Q FEVER ANTIBODY,16
34717-9,Q FEVER ANTIBODY,16
69048-7,Q FEVER ANTIBODY,16
9711-3,Q FEVER ANTIBODY,16
8251-1,INSULIN RESPONSE TO GLUCOSE 3 SPECIMENS,3
24476-4,PROTHROMBIN (FACTOR II) 20210G>A MUTATION ANALYSIS,15
50941-4,"AFB CULTURE, BLOOD",36
676-7,"AFB CULTURE, BLOOD",24
,ENA+ ABS 160014,3
31208-2,"NON-GYN, SPECIMEN A LEGACY",10
10380-4,MANUAL DIFFERENTIAL,56
47528-5,"PAP IG, CT-NG, HPV-HR",8
19764-0,"PAP IG, CT-NG, HPV-HR",8
47527-7,"PAP IG, CT-NG, HPV-HR",8
,"PAP IG, CT-NG, HPV-HR",9
19767-3,"PAP IG, CT-NG, HPV-HR",8
59462-2,TPMT ACTIVITY - MAYO,9
69048-7,CONNECTIVE TISSUE CASCADE,10
59466-3,RBC ENZYME EVALUATION MAYO,14
2902-5,RBC ENZYME EVALUATION MAYO,14
69048-7,"MYASTHENIA GRAVIS (MG) EVALUATION,SERUM",19
23658-8,URINE CULTURE,32
7790-9,CBC WITH AUTO DIFFERENTIAL,66
58737-8,"PARVOVIRUS B19 ANTIBODY, IGG AND IGM",34
19762-4,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,21
19769-9,THINPREP TIS PAP REFLEX HPV MRNA E6/E7,25
23658-8,AEROBIC CULT 080290,9
23658-8,"URINE CULTURE,COMPREHENSIVE",11
630-4,"URINE CULTURE,COMPREHENSIVE",46
77202-0,"IODINE/CREATININE RATIO, RANDOM, URINE",2
,T3FREE,8
48672-0,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
31208-2,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
48818-9,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
50619-6,"CHROMOSOME, HIGH RESOLUTION LEGACY",1
8251-1,Q NOTE,17
22587-0,TREPONEMA PALLIDUM (SYPHILIS) ANTIBODY,169
664-3,FUNGAL CULTURE,29
31208-2,"CYTOMEGALOVIRUS (CMV), MOLECULAR DETECTION, PCR",14
664-3,QUANTITATIVE BRONCHOALVEOLAR LAVAGE CULTURE,2
45335-7,QUANTITATIVE BRONCHOALVEOLAR LAVAGE CULTURE,1
19767-3,SUREPATH FPGS PAP RFX HPV MRNA E6/E7,1
19774-9,SUREPATH FPGS PAP RFX HPV MRNA E6/E7,1
,SUREPATH FPGS PAP RFX HPV MRNA E6/E7,12
10524-7,SUREPATH FPGS PAP RFX HPV MRNA E6/E7,1
19763-2,SUREPATH FPGS PAP RFX HPV MRNA E6/E7,1
19764-0,SUREPATH FPGS PAP RFX HPV MRNA E6/E7,1
630-4,COMPREHENSIVE URINE CULTURE 997600,6
23658-8,COMPREHENSIVE URINE CULTURE 997600,3
23658-8,"URINE CULTURE, COMPREHENSIVE",9
13359-5,SEMEN ANALYSIS,15
10569-2,SEMEN ANALYSIS,15
10580-9,SEMEN ANALYSIS,15
9631-3,SEMEN ANALYSIS,15
,BCR/ABL RT-PCR QUANT-GENZYME,1
16117-4,TICK-BORNE DISEASE ANTIBODIES PANEL- MAYO,9
47405-6,TICK-BORNE DISEASE ANTIBODIES PANEL- MAYO,9
23877-4,TICK-BORNE DISEASE ANTIBODIES PANEL- MAYO,9
31147-2,RPR QN+TP ABS 012021,26
47236-5,RPR QN+TP ABS 012021,25
,IMMUNOFLUORESCENCE PATHOLOGY REQUEST,25
43182-5,SMITH ANTIBODIES,6
,PERIPHERAL BLOOD CD34,24
7789-1,CBC WITH AUTO DIFFERENTIAL,20
18319-4,CBC WITH AUTO DIFFERENTIAL,10
51969-4,VECTRA(R),4
6371-9,"CRYPTOSPORIDIUM AG, EIA LEGACY",3
,EXTRA BODY FLUID CONTAINER,69
31208-2,"PARVOVIRUS B19 MOLECULAR DETECTION,PCR-M",6
,TEST IN QUESTION- MISC QUESTION LEGACY,148
703-9,MANUAL DIFF CELLAVISION,5
,AMERIPATH REFERRAL TEST,5
13440-3,IMMUNOFIXATION ELECTROPHORESIS URINE,56
8251-1,CELIAC DISEASE COMPREHENSIVE PANEL WITH GLIADIN ANTIBODY (IGG),13
69048-7,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
77202-0,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",20
40801-3,ORAL FLUID DRUG ANALYSIS,2
40799-9,ORAL FLUID DRUG ANALYSIS,2
40802-1,ORAL FLUID DRUG ANALYSIS,2
40808-8,ORAL FLUID DRUG ANALYSIS,2
40806-2,ORAL FLUID DRUG ANALYSIS,2
,AUTOPSY EXAM,115
,MISCELLANEOUS PRE-TRANSPLANT VIRACOR,30
6463-4,GENITAL CULT 997603,7
10352-3,GENITAL CULTURE,227
26885-4,OVA AND PARASITE - OH,4
69048-7,"ALZHEIMER'S EVALUATION, CSF",1
31208-2,"TISSUE, SPECIMEN E",1
31208-2,AT6,1
31208-2,"TISSUE, SPECIMEN B",15
31208-2,"TISSUE, SPECIMEN C",11
31208-2,"Q TISSUE, SPECIMEN D",5
,COMMENT LEGACY,6
8251-1,"GLUCOSE TOLERANCE, 2 HOURS",27
49291-8,"PORPHYRINS,QUANTITATIVE, RANDOM UR-MAYO",5
5787-7,URINALYSIS WITH CULTURE IF INDICATED,2
24124-0,URINALYSIS WITH CULTURE IF INDICATED,2
11011-4,"LC HCV RNA BY PCR, QN RFX GENO",1
38180-6,"LC HCV RNA BY PCR, QN RFX GENO",1
8061-4,ANA 308947,1
,AMBIG ABBREV CMP14 DEFAULT,1
,AMBIG ABBREV LP DEFAULT,1
53290-3,URINE FOR TRANSFUSION REACTION WK-UP,1
50553-7,URINE FOR TRANSFUSION REACTION WK-UP,1
9351-8,791042 10+CRT-BUND,1
18187-5,791042 10+CRT-BUND,1
14316-4,791042 10+CRT-BUND,1
19429-0,791042 10+CRT-BUND,1
19550-3,791042 10+CRT-BUND,1
19261-7,791042 10+CRT-BUND,1
19270-8,791042 10+CRT-BUND,1
19245-0,791042 10+CRT-BUND,1
3393-6,791042 10+CRT-BUND,1
3936-2,791042 10+CRT-BUND,1
14192-9,791042 10+CRT-BUND,1
3879-4,791042 10+CRT-BUND,1
16206-5,791042 10+CRT-BUND,1
18282-4,791042 10+CRT-BUND,1
19586-7,791042 10+CRT-BUND,1
3786-1,791042 10+CRT-BUND,1
3654-1,791042 10+CRT-BUND,1
3861-2,791042 10+CRT-BUND,1
12361-2,791042 10+CRT-BUND,1
16195-0,791042 10+CRT-BUND,1
69047-9,"HLA-B 5701 GENOTYPE, PGX",7
93308-5,"HLA-B 5701 GENOTYPE, PGX",7
62364-5,"HLA-B 5701 GENOTYPE, PGX",7
85069-3,"HLA-B 5701 GENOTYPE, PGX",7
31208-2,"TOXOPLASMA GONDII, MOLECULAR DETECTION, PCR",25
69048-7,"WEST NILE VIRUS, CSF",27
35265-8,BONE MARROW EXAM,64
,MISCELLANEOUS DCI REF FOR BMT,62
59462-2,FATTY ACID PROFILE ESSENTIAL- MAYO,7
13655-6,FECAL LEUKOCYTES,15
6331-3,"CULTURE, CAMPYLOBACTER",6
13636-6,LUPUS SCREEN/CONFIRM PANEL,21
33569-5,LUPUS SCREEN/CONFIRM PANEL,21
26975-3,LUPUS SCREEN/CONFIRM PANEL,21
43182-5,LUPUS SCREEN/CONFIRM PANEL,21
14030-1,LUPUS SCREEN/CONFIRM PANEL,21
45142-7,LUPUS SCREEN/CONFIRM PANEL,21
,"POCT POTASSIUM, GLUCOSE AND HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS",7
562-9,"CLOSTRIDIUM DIFFICILE CULT W/REFL TOXIN B, PCR",21
12851-2,Q PROTEIN ELECTROPHORESIS,1
69049-5,ADAMTS13 EVALUATION-MAYO,35
,EXTRA SWAB CONTAINER,17
58408-6,RBC MORPHOLOGY,43
57771-8,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
77202-0,"PARANEOPLASTIC AUTOANTIBODY EVAL,S-MAYO",27
6460-0,LOWER RESPIRATORY CULTURE,14
,"HIV 1 RNA, QN PCR W/REFLEX TO GENOTYPE",5
80689-3,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,1
93047-9,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,1
62364-5,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,1
703-9,MANUAL DIFFERENTIAL,16
,DRUG MONITORING TEMPLATE,15
8251-1,QFT-TB GOLD PLUS 182880,37
45335-7,ADENOVIRUS CULTURE,34
31208-2,"UREAPLASMA SPECIES, MOLECULAR DETECTION, PCR, VARIES",9
29770-5,"CHROMOSOME ANALYSIS, BLOOD",9
26975-3,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
45142-7,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
14030-1,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
33569-5,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
43182-5,"ANA SCR, IFA W/REFL TITER/PATTERN/LUPUS PNL 2",2
23658-8,"UA/M W/RFLX CULTURE, COMP",6
630-4,"UA/M W/RFLX CULTURE, COMP",25
5787-7,"UA/M W/RFLX CULTURE, COMP",22
24124-0,"UA/M W/RFLX CULTURE, COMP",22
8251-1,OB PANEL W/HIV,5
69047-9,CYSTIC FIBROSIS MUTATION PANEL (MAYO),6
38404-0,CYSTIC FIBROSIS MUTATION PANEL (MAYO),6
31208-2,CYSTIC FIBROSIS MUTATION PANEL (MAYO),6
85069-3,CYSTIC FIBROSIS MUTATION PANEL (MAYO),5
8251-1,"SPERMATOZOA, POST VASECTOMY",8
803-7,CBC WITH AUTO DIFFERENTIAL,4
10354-9,URINALYSIS WITH CULTURE IF INDICATED,66
53761-3,JAK2 V617F MUTATION DETECTION-MAYO,35
43399-5,JAK2 V617F MUTATION DETECTION-MAYO,35
47223-3,"INTEGRATED SCREEN, PART 2",7
77202-0,"INTEGRATED SCREEN, PART 2",7
38404-0,CYSTIC FIBROSIS MUTATION 97 LEGACY,2
53039-4,CYSTIC FIBROSIS MUTATION 97 LEGACY,2
51969-4,CYSTIC FIBROSIS MUTATION 97 LEGACY,2
,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",210
75605-6,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",36
75693-2,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",35
75608-0,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",35
77202-0,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",35
62364-5,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",35
49549-9,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",35
72486-4,"MATERNIT21 PLUS CORE (CHR21,18,13,SEX)",70
69048-7,CELIAC DISEASE SEROLOGY CASCADE-MAYO,27
3240-9,FACTOR XIII SCREEN,7
,H. PYLORI BREATH COLLECTION,4
6463-4,L - RESULT 080583,2
,FETAL DEMISE,34
664-3,URINE CULTURE,136
53835-5,A1C W/GLYCOMARK(R) REFLEX,2
8061-4,SCLERODERMA DIAGNOSTIC PROFILE LEGACY,3
18390-5,"OPIATE CONFIRMATION REFLEX, URINE",3
77202-0,STONE ANALYSIS,12
85793-8,STONE ANALYSIS,12
9796-4,STONE ANALYSIS,14
7792-5,MANUAL DIFFERENTIAL,47
,POCT HEMOGLOBIN CALC & HEMATOCRIT UNSOLICITED RESULTS,5
664-3,BODY FLUID CULTURE BSP,54
45335-7,BODY FLUID CULTURE BSP,29
10371-3,MANUAL DIFF CELLAVISION,32
31208-2,STONE ANALYSIS,89
,REFERENCE ANTIBODY ID 3,32
,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",362
16429-3,COMPL DRUG ANL W/ETG+NICOTINE,7
19537-0,COMPL DRUG ANL W/ETG+NICOTINE,7
18392-1,COMPL DRUG ANL W/ETG+NICOTINE,7
16194-3,COMPL DRUG ANL W/ETG+NICOTINE,7
19354-0,COMPL DRUG ANL W/ETG+NICOTINE,7
16192-7,COMPL DRUG ANL W/ETG+NICOTINE,7
16190-1,COMPL DRUG ANL W/ETG+NICOTINE,7
59384-8,COMPL DRUG ANL W/ETG+NICOTINE,7
16191-9,COMPL DRUG ANL W/ETG+NICOTINE,7
16193-5,COMPL DRUG ANL W/ETG+NICOTINE,7
16369-1,COMPL DRUG ANL W/ETG+NICOTINE,7
45272-2,COMPL DRUG ANL W/ETG+NICOTINE,7
19578-4,COMPL DRUG ANL W/ETG+NICOTINE,7
16223-0,COMPL DRUG ANL W/ETG+NICOTINE,7
16222-2,COMPL DRUG ANL W/ETG+NICOTINE,7
3596-4,COMPL DRUG ANL W/ETG+NICOTINE,7
16220-6,COMPL DRUG ANL W/ETG+NICOTINE,7
61048-5,COMPL DRUG ANL W/ETG+NICOTINE,7
16210-7,COMPL DRUG ANL W/ETG+NICOTINE,7
87761-3,COMPL DRUG ANL W/ETG+NICOTINE,7
61058-4,COMPL DRUG ANL W/ETG+NICOTINE,7
58423-5,COMPL DRUG ANL W/ETG+NICOTINE,7
64129-0,COMPL DRUG ANL W/ETG+NICOTINE,7
3816-6,COMPL DRUG ANL W/ETG+NICOTINE,7
,COMPL DRUG ANL W/ETG+NICOTINE,147
27076-9,COMPL DRUG ANL W/ETG+NICOTINE,7
52960-2,COMPL DRUG ANL W/ETG+NICOTINE,7
3539-4,COMPL DRUG ANL W/ETG+NICOTINE,7
3360-5,COMPL DRUG ANL W/ETG+NICOTINE,7
87789-4,COMPL DRUG ANL W/ETG+NICOTINE,7
58417-7,COMPL DRUG ANL W/ETG+NICOTINE,7
3993-3,COMPL DRUG ANL W/ETG+NICOTINE,7
86231-8,COMPL DRUG ANL W/ETG+NICOTINE,7
58363-3,COMPL DRUG ANL W/ETG+NICOTINE,7
3716-8,COMPL DRUG ANL W/ETG+NICOTINE,7
32090-3,COMPL DRUG ANL W/ETG+NICOTINE,7
4009-7,COMPL DRUG ANL W/ETG+NICOTINE,7
43265-8,COMPL DRUG ANL W/ETG+NICOTINE,7
3423-1,COMPL DRUG ANL W/ETG+NICOTINE,7
12301-8,COMPL DRUG ANL W/ETG+NICOTINE,7
40464-0,COMPL DRUG ANL W/ETG+NICOTINE,7
27083-5,COMPL DRUG ANL W/ETG+NICOTINE,7
86605-3,COMPL DRUG ANL W/ETG+NICOTINE,7
20528-6,COMPL DRUG ANL W/ETG+NICOTINE,7
58366-6,COMPL DRUG ANL W/ETG+NICOTINE,7
4095-6,COMPL DRUG ANL W/ETG+NICOTINE,7
86225-0,COMPL DRUG ANL W/ETG+NICOTINE,7
59590-0,COMPL DRUG ANL W/ETG+NICOTINE,7
86607-9,COMPL DRUG ANL W/ETG+NICOTINE,7
58392-2,COMPL DRUG ANL W/ETG+NICOTINE,7
19360-7,COMPL DRUG ANL W/ETG+NICOTINE,7
86606-1,COMPL DRUG ANL W/ETG+NICOTINE,7
86608-7,COMPL DRUG ANL W/ETG+NICOTINE,7
13479-1,COMPL DRUG ANL W/ETG+NICOTINE,7
58391-4,COMPL DRUG ANL W/ETG+NICOTINE,7
18390-5,COMPL DRUG ANL W/ETG+NICOTINE,14
49831-1,COMPL DRUG ANL W/ETG+NICOTINE,7
41270-0,COMPL DRUG ANL W/ETG+NICOTINE,7
58357-5,COMPL DRUG ANL W/ETG+NICOTINE,7
87770-4,COMPL DRUG ANL W/ETG+NICOTINE,7
87771-2,COMPL DRUG ANL W/ETG+NICOTINE,7
87768-8,COMPL DRUG ANL W/ETG+NICOTINE,7
87769-6,COMPL DRUG ANL W/ETG+NICOTINE,7
12310-9,COMPL DRUG ANL W/ETG+NICOTINE,7
87767-0,COMPL DRUG ANL W/ETG+NICOTINE,7
87773-8,COMPL DRUG ANL W/ETG+NICOTINE,7
58426-8,COMPL DRUG ANL W/ETG+NICOTINE,7
87772-0,COMPL DRUG ANL W/ETG+NICOTINE,7
58367-4,COMPL DRUG ANL W/ETG+NICOTINE,7
19396-1,COMPL DRUG ANL W/ETG+NICOTINE,7
32065-5,COMPL DRUG ANL W/ETG+NICOTINE,7
75235-2,COMPL DRUG ANL W/ETG+NICOTINE,7
32120-8,COMPL DRUG ANL W/ETG+NICOTINE,7
75234-5,COMPL DRUG ANL W/ETG+NICOTINE,7
19547-9,COMPL DRUG ANL W/ETG+NICOTINE,7
59171-9,COMPL DRUG ANL W/ETG+NICOTINE,7
3729-1,COMPL DRUG ANL W/ETG+NICOTINE,7
58358-3,COMPL DRUG ANL W/ETG+NICOTINE,7
52959-4,COMPL DRUG ANL W/ETG+NICOTINE,7
12363-8,COMPL DRUG ANL W/ETG+NICOTINE,7
3965-1,COMPL DRUG ANL W/ETG+NICOTINE,7
87762-1,COMPL DRUG ANL W/ETG+NICOTINE,7
87765-4,COMPL DRUG ANL W/ETG+NICOTINE,7
87766-2,COMPL DRUG ANL W/ETG+NICOTINE,7
68439-9,COMPL DRUG ANL W/ETG+NICOTINE,7
87764-7,COMPL DRUG ANL W/ETG+NICOTINE,7
86224-3,COMPL DRUG ANL W/ETG+NICOTINE,7
3408-2,COMPL DRUG ANL W/ETG+NICOTINE,7
16209-9,COMPL DRUG ANL W/ETG+NICOTINE,7
4025-3,COMPL DRUG ANL W/ETG+NICOTINE,7
18335-0,COMPL DRUG ANL W/ETG+NICOTINE,7
12324-0,COMPL DRUG ANL W/ETG+NICOTINE,7
11000-7,COMPL DRUG ANL W/ETG+NICOTINE,7
3571-7,COMPL DRUG ANL W/ETG+NICOTINE,7
3586-5,COMPL DRUG ANL W/ETG+NICOTINE,7
64138-1,COMPL DRUG ANL W/ETG+NICOTINE,7
3342-3,COMPL DRUG ANL W/ETG+NICOTINE,7
75226-1,COMPL DRUG ANL W/ETG+NICOTINE,7
32136-4,COMPL DRUG ANL W/ETG+NICOTINE,7
16225-5,COMPL DRUG ANL W/ETG+NICOTINE,7
59176-8,COMPL DRUG ANL W/ETG+NICOTINE,7
59170-1,COMPL DRUG ANL W/ETG+NICOTINE,7
75232-9,COMPL DRUG ANL W/ETG+NICOTINE,7
59169-3,COMPL DRUG ANL W/ETG+NICOTINE,7
60086-6,COMPL DRUG ANL W/ETG+NICOTINE,7
58369-0,COMPL DRUG ANL W/ETG+NICOTINE,7
78884-4,COMPL DRUG ANL W/ETG+NICOTINE,7
44036-2,COMPL DRUG ANL W/ETG+NICOTINE,7
32105-9,COMPL DRUG ANL W/ETG+NICOTINE,7
12321-6,COMPL DRUG ANL W/ETG+NICOTINE,7
14071-5,COMPL DRUG ANL W/ETG+NICOTINE,7
3299-5,COMPL DRUG ANL W/ETG+NICOTINE,7
44424-0,COMPL DRUG ANL W/ETG+NICOTINE,7
3791-1,COMPL DRUG ANL W/ETG+NICOTINE,7
61410-7,COMPL DRUG ANL W/ETG+NICOTINE,7
87774-6,COMPL DRUG ANL W/ETG+NICOTINE,7
58373-2,COMPL DRUG ANL W/ETG+NICOTINE,7
61409-9,COMPL DRUG ANL W/ETG+NICOTINE,7
53787-8,COMPL DRUG ANL W/ETG+NICOTINE,14
29288-8,COMPL DRUG ANL W/ETG+NICOTINE,7
33041-5,COMPL DRUG ANL W/ETG+NICOTINE,7
64130-8,COMPL DRUG ANL W/ETG+NICOTINE,7
75233-7,COMPL DRUG ANL W/ETG+NICOTINE,7
3737-4,COMPL DRUG ANL W/ETG+NICOTINE,7
4001-4,COMPL DRUG ANL W/ETG+NICOTINE,7
32112-5,COMPL DRUG ANL W/ETG+NICOTINE,7
61427-1,COMPL DRUG ANL W/ETG+NICOTINE,7
27109-8,COMPL DRUG ANL W/ETG+NICOTINE,7
75230-3,COMPL DRUG ANL W/ETG+NICOTINE,7
4084-0,COMPL DRUG ANL W/ETG+NICOTINE,7
75231-1,COMPL DRUG ANL W/ETG+NICOTINE,7
4065-9,COMPL DRUG ANL W/ETG+NICOTINE,7
16195-0,COMPL DRUG ANL W/ETG+NICOTINE,7
78823-2,COMPL DRUG ANL W/ETG+NICOTINE,7
19471-2,COMPL DRUG ANL W/ETG+NICOTINE,7
61415-6,COMPL DRUG ANL W/ETG+NICOTINE,7
58014-2,COMPL DRUG ANL W/ETG+NICOTINE,7
45144-3,COMPL DRUG ANL W/ETG+NICOTINE,7
61412-3,COMPL DRUG ANL W/ETG+NICOTINE,7
61418-0,COMPL DRUG ANL W/ETG+NICOTINE,7
78859-6,COMPL DRUG ANL W/ETG+NICOTINE,7
19629-5,COMPL DRUG ANL W/ETG+NICOTINE,7
32074-7,COMPL DRUG ANL W/ETG+NICOTINE,7
58368-2,COMPL DRUG ANL W/ETG+NICOTINE,7
19479-5,COMPL DRUG ANL W/ETG+NICOTINE,7
19707-9,COMPL DRUG ANL W/ETG+NICOTINE,7
32129-9,COMPL DRUG ANL W/ETG+NICOTINE,7
14070-7,COMPL DRUG ANL W/ETG+NICOTINE,7
40390-7,COMPL DRUG ANL W/ETG+NICOTINE,7
59174-3,COMPL DRUG ANL W/ETG+NICOTINE,7
12320-8,COMPL DRUG ANL W/ETG+NICOTINE,7
3510-5,COMPL DRUG ANL W/ETG+NICOTINE,7
10976-9,COMPL DRUG ANL W/ETG+NICOTINE,7
19643-6,COMPL DRUG ANL W/ETG+NICOTINE,7
58384-9,COMPL DRUG ANL W/ETG+NICOTINE,7
58376-5,COMPL DRUG ANL W/ETG+NICOTINE,7
58401-1,COMPL DRUG ANL W/ETG+NICOTINE,7
19378-9,COMPL DRUG ANL W/ETG+NICOTINE,7
58390-6,COMPL DRUG ANL W/ETG+NICOTINE,7
16219-8,COMPL DRUG ANL W/ETG+NICOTINE,7
58388-0,COMPL DRUG ANL W/ETG+NICOTINE,7
61429-7,COMPL DRUG ANL W/ETG+NICOTINE,7
16218-0,COMPL DRUG ANL W/ETG+NICOTINE,7
18334-3,COMPL DRUG ANL W/ETG+NICOTINE,7
16207-3,COMPL DRUG ANL W/ETG+NICOTINE,7
46983-3,COMPL DRUG ANL W/ETG+NICOTINE,7
17376-5,COMPL DRUG ANL W/ETG+NICOTINE,7
16200-8,COMPL DRUG ANL W/ETG+NICOTINE,7
72799-0,COMPL DRUG ANL W/ETG+NICOTINE,7
18338-4,COMPL DRUG ANL W/ETG+NICOTINE,7
17033-2,COMPL DRUG ANL W/ETG+NICOTINE,7
17718-8,COMPL DRUG ANL W/ETG+NICOTINE,7
19289-8,COMPL DRUG ANL W/ETG+NICOTINE,7
86454-6,COMPL DRUG ANL W/ETG+NICOTINE,7
74758-4,COMPL DRUG ANL W/ETG+NICOTINE,7
58360-9,COMPL DRUG ANL W/ETG+NICOTINE,7
86610-3,COMPL DRUG ANL W/ETG+NICOTINE,7
16208-1,COMPL DRUG ANL W/ETG+NICOTINE,7
41466-4,COMPL DRUG ANL W/ETG+NICOTINE,7
40839-3,COMPL DRUG ANL W/ETG+NICOTINE,7
16199-2,COMPL DRUG ANL W/ETG+NICOTINE,7
58361-7,COMPL DRUG ANL W/ETG+NICOTINE,7
58382-3,COMPL DRUG ANL W/ETG+NICOTINE,7
58380-7,COMPL DRUG ANL W/ETG+NICOTINE,7
86604-6,COMPL DRUG ANL W/ETG+NICOTINE,7
34180-0,COMPL DRUG ANL W/ETG+NICOTINE,7
50008-2,DIC PROFILE PERFORMABLE,7
,POCT VENOUS BLOOD GAS WITH LACTIC ACID UNSOLICITED RESULTS,3
,GASTRIC PARIETAL CELL ANTIBODY LEGACY,2
,HLA TYPE,9
47527-7,"IGP,APTIMA HPV,CTNG AGE GDLN",1
47528-5,"IGP,APTIMA HPV,CTNG AGE GDLN",1
11546-9,"IGP,APTIMA HPV,CTNG AGE GDLN",1
59420-0,"IGP,APTIMA HPV,CTNG AGE GDLN",1
31208-2,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
62365-2,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
48672-0,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
62356-1,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",1
6824-7,ASPIRATION MARKER PANEL,34
31208-2,BORDETELLA PERTUSSIS / PARAPERTUSSIS PCR,5
49090-4,PENTA SCREEN,8
49586-1,PENTA SCREEN,9
48803-1,PENTA SCREEN,8
43994-3,PENTA SCREEN,8
43995-0,PENTA SCREEN,8
69047-9,HEMOCHROMATOSIS MUTATION,19
85069-3,HEMOCHROMATOSIS MUTATION,18
31208-2,HEMOCHROMATOSIS MUTATION,19
8251-1,"UA/M W/RFLX CULTURE, COMP",11
5048-4,FE+ANA+TIBC+FER+A1A+AMA+ASM...,2
,URTICARIA TRANSFUSION REACTION WORKUP,3
94495-9,CELIAC ASSOCIATED HLA-DQ TYPING,6
53938-7,CELIAC ASSOCIATED HLA-DQ TYPING,6
69048-7,CELIAC ASSOCIATED HLA-DQ TYPING,6
19767-3,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",8
19774-9,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",8
,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",8
10524-7,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",8
19763-2,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",8
19764-0,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",8
,BCR/ABL BY PCR- BONE MARROW OR BLOOD-NEOGENOMICS,2
13655-6,WBC STOOL 080025,5
20507-0,RPR+HBSAG+HCVAB+HIV+HTLV I/II,1
5196-1,RPR+HBSAG+HCVAB+HIV+HTLV I/II,1
29901-6,RPR+HBSAG+HCVAB+HIV+HTLV I/II,1
31208-2,LEUKEMIA/LYMPHOMA EVALUATION,11
32760-1,LEUKEMIA/LYMPHOMA EVALUATION,11
38196-2,LEUKEMIA/LYMPHOMA EVALUATION,11
,LEUKEMIA/LYMPHOMA EVALUATION,11
49493-0,LEUKEMIA/LYMPHOMA EVALUATION,11
,REPEAT ANTIBODY SCREEN LAB ONLY,7
20507-0,RPR W/REFLEX TO TREPSURE,4
34147-9,RPR W/REFLEX TO TREPSURE,1
20401-6,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",2
26052-1,"UA/M W/RFLX CULTURE, ROUTINE",1
45142-7,SJOGREN'S ANTIBODY (SS-B),11
,CRYPTOCOCCAL ANTIGEN TITER,9
802-9,RBC MORPHOLOGY,8
800-3,RBC MORPHOLOGY,24
29579-0,"SUSCEPTIBILITY, AFB SLOW GROWER-MAYO",5
12598-9,"FECAL FAT, QUALITATIVE",1
42668-4,"FECAL FAT, QUALITATIVE",1
802-9,CBC WITH AUTO DIFFERENTIAL,4
,REPEAT ABORH LAB ONLY,9
673-4,OVA AND PARASITE EXAMINATION,9
6463-4,SALMONELLA CULT 997871,11
6463-4,CAMPY CULT 080172,10
10701-1,O AND P 080013,10
23658-8,"SUSCEPTIBILITY, AEROBIC BACTERIUM",5
45335-7,CATH TIP CULTURE,11
75514-0,LUPUS ANTICOAGULANT EVALUATION WITH REFLEX,39
50008-2,LUPUS ANTICOAGULANT EVALUATION WITH REFLEX,30
12851-2,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
25700-6,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS WITH IMMUNOFIXATION",5
35474-6,FACTOR V R2 DNA ANALYSIS,1
41103-3,FACTOR V R2 DNA ANALYSIS,1
49549-9,FACTOR V R2 DNA ANALYSIS,1
77202-0,FACTOR V R2 DNA ANALYSIS,1
21026-0,LUPUS ANTICOAG CONFIRM CONSULT,3
77202-0,LUPUS ANTICOAG CONFIRM CONSULT,3
43734-3,LUPUS ANTICOAG CONFIRM CONSULT,4
5946-9,LUPUS ANTICOAG CONFIRM CONSULT,4
51968-6,FACTOR V LEIDEN REFLEX TO R2,1
21667-1,FACTOR V LEIDEN REFLEX TO R2,1
49549-9,FACTOR V LEIDEN REFLEX TO R2,1
77202-0,FACTOR V LEIDEN REFLEX TO R2,1
69051-1,"SUPERSATURATION PROFILE, 24 HOUR, URINE",6
664-3,TISSUE CULTURE BSP,24
45335-7,TISSUE CULTURE BSP,12
14277-8,ANCA PANEL FOR VASCULITIS-MAYO,15
49503-6,ANCA PANEL FOR VASCULITIS-MAYO,15
14278-6,ANCA PANEL FOR VASCULITIS-MAYO,15
50410-0,LUPUS ANTICOAGULANT LEGACY,4
57838-5,LUPUS ANTICOAGULANT LEGACY,4
43734-3,LUPUS ANTICOAGULANT LEGACY,4
5946-9,LUPUS ANTICOAGULANT LEGACY,4
33771-7,MYOMARKER 3 PROFILE (RDL),2
33772-5,MYOMARKER 3 PROFILE (RDL),2
49963-2,MYOMARKER 3 PROFILE (RDL),2
18484-6,MYOMARKER 3 PROFILE (RDL),2
68549-5,MYOMARKER 3 PROFILE (RDL),2
18485-3,MYOMARKER 3 PROFILE (RDL),2
45152-6,MYOMARKER 3 PROFILE (RDL),2
33921-8,MYOMARKER 3 PROFILE (RDL),2
45149-2,MYOMARKER 3 PROFILE (RDL),2
57288-3,"CT/GC NAA, PHARYNGEAL LEGACY",1
57289-1,"CT/GC NAA, PHARYNGEAL LEGACY",1
7797-4,MANUAL DIFFERENTIAL,14
19769-9,THINPREP TIS PAP AND HR HPV DNA,13
49549-9,JAK2 V617F QT RFX CALR/MPL,1
43399-5,JAK2 V617F QT RFX CALR/MPL,2
77202-0,JAK2 V617F QT RFX CALR/MPL,1
72486-4,JAK2 V617F QT RFX CALR/MPL,4
,JAK2 V617F QT RFX CALR/MPL,1
75608-0,JAK2 V617F QT RFX CALR/MPL,1
75608-0,CALR + MPL,2
62948-5,CALR + MPL,1
49549-9,CALR + MPL,1
77174-1,CALR + MPL,1
,CALR + MPL,2
72486-4,CALR + MPL,2
8251-1,CALR + MPL,1
62947-7,CALR + MPL,1
15685-1,CHILDHOOD ALLERGY (FOOD AND ENVIRONMENTAL) PROFILE,1
20398-4,"ANTINUCLEAR ANTIBODIES (ANA), BY IFA, REFLEX TO 9-BIOMARKER PROFILE",2
19767-3,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",23
19774-9,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",36
10524-7,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
19763-2,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
19764-0,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",18
18314-5,"Q DIFFERENTIAL, MANUAL",10
90080-3,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,12
83325-1,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,8
61199-6,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,12
72525-9,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,12
72857-6,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,12
72526-7,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,12
96566-5,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,7
27038-9,Q ENDOMYSIAL ANTIBODY TITER,1
14725-6,"BLOOD UREA NITROGEN, BODY FLUID-MAYO",13
47527-7,"PAP, W/RFL TO HPV ALL",11
47528-5,"PAP, W/RFL TO HPV ALL",11
33271-8,MALARIA SMEAR,4
18314-5,T-HELPER CELLS (CD4) COUNT,9
13955-0,ACUTE HEPATITIS PANEL (REFL) LEGACY,9
13950-1,ACUTE HEPATITIS PANEL (REFL) LEGACY,9
24113-3,ACUTE HEPATITIS PANEL (REFL) LEGACY,9
5196-1,ACUTE HEPATITIS PANEL (REFL) LEGACY,9
6463-4,GENITAL CULTURE,9
85380-4,LC HIV-1/HIV-2 QUALITATIVE RNA,3
25835-0,LC HIV-1/HIV-2 QUALITATIVE RNA,3
69353-1,LC HIV-1/HIV-2 QUALITATIVE RNA,3
,POCT POTASSIUM UNSOLICITED RESULTS,16
35265-8,PATHOLOGY CONSULTATION REQUEST,15
,"PAP, W/RFL TO HPV ALL",37
19764-0,"PAP, W/RFL TO HPV ALL",9
19769-9,"PAP, W/RFL TO HPV ALL",3
19767-3,"PAP, W/RFL TO HPV ALL",9
43371-4,STOOL CULTURE,9
6331-3,STOOL CULTURE,9
49034-2,"THINPREP TIS PAP AND HPV MRNA E6/E7, CHLAMYDIA/N.GONORRHOEAE",5
,PATHOLOGY REVIEW - BSP,15
69050-3,"THC (MARIJUANA), URINE, CONFIRMATION",5
70173-0,STRATIFY JCV(TM) ANTIBODY INHIBITION ASSAY LEGACY,4
48813-0,BLOOD CULTURE PCR PROBE,2
47526-9,URINE CYTOLOGY,7
587-6,H PYLORI CULTURE WITH SUSCEPTIBILITES-MAYO,7
24429-3,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
23878-2,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
9585-1,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
23877-4,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
47405-6,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
48850-2,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
9584-4,LYMEAB(IGG/M)+BABESIA(IGG/M...,1
10380-4,MANUAL DIFF CELLAVISION,5
26052-1,UR MICROSCOPIC 333328,1
31208-2,LYME DISEASE PCR,17
59464-8,LYME DISEASE PCR,16
19145-2,PAP NOT PERFORMED LEGACY,17
635-3,"CULTURE, ANAEROBIC BACTERIA W/GRAM STAIN",7
31208-2,NON-GYNECOLOGIC CYTOLOGY,17
8251-1,"GLUCOSE TOLERANCE TEST, GEST, 3 SPEC (75G)",4
,PROSTATE HISTOLOGY,9
,TEST IN QUESTION- MISSING REQUIRED INFO LEGACY,36
10335-8,CSF ADDITIONAL CELL COUNT,36
10333-3,CSF ADDITIONAL CELL COUNT,36
9316-1,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
10897-7,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
9539-8,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
9540-6,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
9315-3,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
21509-5,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
21510-3,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
10899-3,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,13
46138-4,"UA/M W/RFLX CULTURE, COMP",8
47318-1,LIVER KIDNEY MICROSOME (LKM-1) AB (IGG),2
20570-8,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
718-7,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2019-8,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2744-1,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2703-7,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2026-3,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
1925-7,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
1960-4,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
2708-6,POCT ARTERIAL BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
,HEMEPATH CYTOGENETICS,20
,FISH,15
,BONE MARROW CORRELATION,16
19762-4,THINPREP TIS PAP AND HR HPV DNA,11
6463-4,L - RESULT 180813,4
648-6,GRAM STAIN W/SPUTUM CULT RFLX,8
14328-9,GRAM STAIN W/SPUTUM CULT RFLX,3
14327-1,GRAM STAIN W/SPUTUM CULT RFLX,3
6460-0,SPUTUM CULTURE,6
32355-0,LOWER RESPIRATORY CULTURE,4
40682-7,BODY FLUID CRYSTAL,19
630-4,"UA/M W/RFLX CULTURE, ROUTINE",27
50008-2,INHIBITOR (MIXING) STUDY,14
,EXTRA CSF CONTAINER,15
21687-9,ALPHA GLOBIN COMMON MUTATION ANALYSIS,33
53798-5,REFLEX TO GENOSURE(R) MG,4
93047-9,REFLEX TO GENOSURE(R) MG,4
5313-2,"SPOTTED FEVER GROUP ANTIBODY, IGG, IGM",6
5315-7,"SPOTTED FEVER GROUP ANTIBODY, IGG, IGM",6
,EXTRA STOOL CONTAINER,4
,GROSS ONLY WITH DIAGNOSIS,3
10372-1,MANUAL DIFF CELLAVISION,9
86611-1,"CHROMOSOMAL MICROARRAY, PRENTL, CLARISUREOLIGSNP",1
,CELL CULTURE FOR POSSIBLE ADDL PRENATAL STUDIES,2
43229-4,Q CRYPTOCOCCAL AG LATEX TITER,1
31208-2,"CRYPTOCOCCAL AG, LATEX SCREEN W/REFL TITER",6
,CBC/DIFF AMBIGUOUS DEFAULT,2
72756-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72738-8,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74651-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74656-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72764-4,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72763-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72752-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74677-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72759-4,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72733-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72744-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72735-4,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72750-3,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72386-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74657-8,"DRUG ANALYSIS,COMP,ORAL FLUID",2
77204-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72742-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87815-7,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72766-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72388-2,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72387-4,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72760-2,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72758-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72380-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74670-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87813-2,"DRUG ANALYSIS,COMP,ORAL FLUID",2
40801-3,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72755-2,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87809-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
78883-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87812-4,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87814-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72737-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72746-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87817-3,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72762-8,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72765-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87819-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74660-2,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87818-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72749-5,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94731-7,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72740-4,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72613-3,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74371-6,"DRUG ANALYSIS,COMP,ORAL FLUID",2
74370-8,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72610-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72377-5,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94727-5,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94730-9,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94733-3,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94728-3,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72761-0,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94732-5,"DRUG ANALYSIS,COMP,ORAL FLUID",2
96367-8,"DRUG ANALYSIS,COMP,ORAL FLUID",2
94729-1,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72748-7,"DRUG ANALYSIS,COMP,ORAL FLUID",2
87821-5,"DRUG ANALYSIS,COMP,ORAL FLUID",2
72456-7,"DRUG ANALYSIS,COMP,ORAL FLUID",2
21723-2,ALPHA-1-ANTITRYPSIN DEFICIENCY,1
72486-4,ALPHA-1-ANTITRYPSIN DEFICIENCY,1
6770-2,ALPHA-1-ANTITRYPSIN PHENOTYPE,1
7797-4,MANUAL DIFF CELLAVISION,8
6760-3,"GLUCOSE TOLERANCE, 2 HOURS",12
1542-0,"GLUCOSE TOLERANCE, 2 HOURS",12
1527-1,"GLUCOSE TOLERANCE, 2 HOURS",12
1539-6,"GLUCOSE TOLERANCE, 2 HOURS",12
1533-9,"GLUCOSE TOLERANCE, 2 HOURS",12
1496-9,"GLUCOSE TOLERANCE, 2 HOURS",12
,FISH-HER,7
53029-5,IBD EXPANDED PROFILE,1
77202-0,IBD EXPANDED PROFILE,1
4935-3,CELIAC ASSOCIATED HLA-DQ TYPING,2
41283-3,CELIAC ASSOCIATED HLA-DQ TYPING,2
,BV/VAGINITIS PANEL DNA PROBE,16
69564-3,SURESWAB(R) ADVANCED BACTERIAL VAGINOSIS,27
,MISCELLANEOUS REFERENCE LEGACY,21
,"TESTOSTERONE, TOTAL, MALES (ADULT),IA (REFL) LEGACY",3
,CRYOGLOBULIN,1
,"IMMUNOFIXATION REFLEX, SERUM LEGACY",2
,CAMPYLOBACTER JEJUNI ANTIBODY,1
7789-1,RBC MORPHOLOGY,6
11268-0,"STREPTOCOCCUS, GROUP A CULTURE",3
,EXTRA LEGACY,11
31208-2,EXTRA LEGACY,11
50670-9,MANUAL DIFF CELLAVISION,1
779-9,MANUAL DIFF CELLAVISION,5
19769-9,"IGP, CTNG, RFX APTIMA HPV ASCU",13
5794-3,"URINALYSIS, COMPLETE",4
2514-8,"URINALYSIS, COMPLETE",4
5778-6,"URINALYSIS, COMPLETE",4
5769-5,"URINALYSIS, COMPLETE",4
5782-8,"URINALYSIS, COMPLETE",1
13945-1,"URINALYSIS, COMPLETE",4
5770-3,"URINALYSIS, COMPLETE",4
5783-6,"URINALYSIS, COMPLETE",1
12235-8,"URINALYSIS, COMPLETE",6
24124-0,"URINALYSIS, COMPLETE",4
5802-4,"URINALYSIS, COMPLETE",4
5821-4,"URINALYSIS, COMPLETE",4
5787-7,"URINALYSIS, COMPLETE",4
2349-9,"URINALYSIS, COMPLETE",2
5799-2,"URINALYSIS, COMPLETE",4
20454-5,"URINALYSIS, COMPLETE",4
5767-9,"URINALYSIS, COMPLETE",4
,MULTIPLE SCLEROSIS PROFILE SERUM AND SPINAL FLUID,13
12851-2,PROTEIN ELECTROPHORESIS,7
29771-3,FECAL GLOBIN BY IMMUNOCHEM. (MEDICARE),4
,HIV VIRAL LOAD W/REFLEX TO GENOSURE PRIME,4
24476-4,FACTOR II (PT G20210A) MUTATION,6
21667-1,"FACTOR V (LEIDEN, G1691A) MUTATION",6
69002-4,"Q HPV MRNA E6/E7, SUREPATH VIAL",3
19769-9,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",2
19762-4,"SUREPATH FPGS PAP REFLEX HPV MRNA E6/E7, C.TRACHOMATIS,N.GONORRHOEAE",2
1007-4,"COOMBS', DIRECT",2
7791-7,RBC MORPHOLOGY,15
728-6,RBC MORPHOLOGY,10
45335-7,QUANTITATIVE TISSUE CULTURE,18
664-3,QUANTITATIVE TISSUE CULTURE,33
31208-2,"MYCOPLASMA HOMINIS, PCR-MAYO",9
19147-8,HEPATITIS B VIRAL DNA QUANT-MAYO,7
88447-8,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),3
33248-6,NON-ALCOHOLIC FATTY LIVER DISEASE CASCADE (NAFLD),3
19769-9,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",11
,ALCOHOL ETHYL URINE QUAL LEGACY,1
,REFERENCE ANTIGEN TYPE,11
,PROINSULIN,2
,JAK2 V617F MUTATION ANALYSIS,8
31208-2,JAK2 V617F MUTATION ANALYSIS,8
50398-7,JAK2 V617F MUTATION ANALYSIS,8
8266-9,JAK2 V617F MUTATION ANALYSIS,8
21821-4,"FISH, CML/ALL, BCR/ABL TRANSLOCATION 9,22",3
634-6,AEROBIC CULTURE + GRAMSTAIN,2
69567-6,"NUSWAB BV AND CANDIDA, NAA",7
69565-0,"NUSWAB BV AND CANDIDA, NAA",7
69566-8,"NUSWAB BV AND CANDIDA, NAA",7
19769-9,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",5
19762-4,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",5
11545-1,"CULTURE, MYCOBACTERIA W/FLUOROCHROME SMEAR",7
,ADD ON COMPREHENSIVE METABOLIC PANEL LEGACY,1
2110-5,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
20507-0,BMP8+LP+5AC+CBC/D/PLT+RPR+T...,1
19769-9,THINPREP TIS AND HPV MRNA E6/E7,4
19762-4,THINPREP TIS AND HPV MRNA E6/E7,4
5769-5,MICROSCOPIC EXAMINATION LEGACY,6
24124-0,MICROSCOPIC EXAMINATION LEGACY,6
83081-0,"LYME DISEASE ANTIBODY WITH REFLEX TO IMMUNOASSAY (IGG, IGM)",3
664-3,CF UPPER RESPIRATORY CULTURE,23
664-3,CF LOWER RESPIRATORY CULTURE,68
45335-7,CF LOWER RESPIRATORY CULTURE,38
21027-8,PLATELET AGGREGATION STUDY,4
19769-9,"PAP IG, HPV, RFX 16/18 (SP)",9
,STREP GP B SUSCEPTIBILITY,15
194-1,STREP GP B SUSCEPTIBILITY,15
41479-7,BK QUANT PCR (PLASMA/SERUM),1
49034-2,THINPREP PAP RFX HR HPV,8
21003-9,FUNGAL STAIN,1
19774-9,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,1
19769-9,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,1
19762-4,THINPREP PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,1
14367-7,TRICHOMONAS WET PREP,2
,L - RESULT 080031,4
21667-1,FACTOR 5 LEIDEN,14
,IBD SGI DIAGNOSTIC - PROMETHEUS,7
6958-3,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
10896-9,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
10904-1,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
10905-8,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
6957-5,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
10906-6,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
10907-4,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
10898-5,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,5
,LAB ADD ON ORDER LEGACY,9
20398-4,"ANTINUCLEAR ANTIBODIES, IFA",2
5782-8,URINALYSIS WITH REFLEX MICROSCOPIC,4
5783-6,URINALYSIS WITH REFLEX MICROSCOPIC,4
49308-0,"INFLAMMATORY BOWEL DISEASE PANEL, S (MAYO-DHI)",5
,RESEARCH LAB KIT,11
20574-0,"HISTOPLASMA AB, CF, SERUM",4
20573-2,"HISTOPLASMA AB, CF, SERUM",4
7789-1,MANUAL DIFFERENTIAL,66
,PLEASE NOTE:,237
69047-9,"SPINAL MUSCULAR ATROPHY CARRIER SCREENING, DELETION/DUPLICATION ANALYSIS, VARIES",2
50397-9,"SPINAL MUSCULAR ATROPHY CARRIER SCREENING, DELETION/DUPLICATION ANALYSIS, VARIES",2
49857-6,"SPINAL MUSCULAR ATROPHY CARRIER SCREENING, DELETION/DUPLICATION ANALYSIS, VARIES",2
31208-2,"SPINAL MUSCULAR ATROPHY CARRIER SCREENING, DELETION/DUPLICATION ANALYSIS, VARIES",2
21262-1,"SHIGA-LIKE TOXIN ANTIGEN, EIA",3
43371-4,"CULTURE, SHIGELLA AND SALMONELLA",3
57768-4,"CAMPYLOBACTER SPP. AG,EIA",2
48818-9,"CHROMOSOME ANALYSIS, HIGH RESOLUTION",2
62461-9,"NUSWAB VG+, CANDIDA 6SP",2
72389-0,"NUSWAB VG+, CANDIDA 6SP",2
69567-6,"NUSWAB VG+, CANDIDA 6SP",2
69565-0,"NUSWAB VG+, CANDIDA 6SP",2
69566-8,"NUSWAB VG+, CANDIDA 6SP",2
32705-6,"NUSWAB VG+, CANDIDA 6SP",2
45084-1,"NUSWAB VG+, CANDIDA 6SP",2
72390-8,"NUSWAB VG+, CANDIDA 6SP",2
69563-5,"NUSWAB VG+, CANDIDA 6SP",2
62460-1,"NUSWAB VG+, CANDIDA 6SP",2
69562-7,"NUSWAB VG+, CANDIDA 6SP",2
9595-0,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9594-3,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9589-3,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9588-5,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9596-8,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9591-9,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9592-7,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
9590-1,"LYME DISEASE ANTIBODY (IGG), IMMUNOBLOT",2
57779-1,SMALL BOWEL DISACCHARIDASE,28
,SMALL BOWEL DISACCHARIDASE,56
25835-0,HIV-1/HIV-2 QUALITATIVE RNA,3
69353-1,HIV-1/HIV-2 QUALITATIVE RNA,3
32769-2,ALPHA-1-ANTITRYPSIN PHENOTYPE,5
14367-7,"WET PREP, GENITAL BSP",15
32764-3,"WET PREP, GENITAL BSP",15
14370-1,"WET PREP, GENITAL BSP",15
31147-2,RPR QN 006464,5
738-5,RBC MORPHOLOGY,7
79184-8,"LEAD, BLOOD - MAYO",3
79183-0,"LEAD, BLOOD - MAYO",3
31208-2,"CYTOMEGALOVIRUS DNA, QL REAL TIME PCR",1
35265-8,FLOW CYTOMETRY PATHOLOGY INTERPRETATION,4
48707-4,MANUAL DIFFERENTIAL,4
19762-4,THINPREP PAP RFX HR HPV,3
18319-4,MANUAL DIFFERENTIAL,27
,BONE MARROW MORPHOLOGIC EVALUATION,21
43180-9,"HSV 1 AND 2-SPEC AB, IGG W/RFX",1
51969-4,VECTRA(R) WITH CV RISK,1
50670-9,MANUAL DIFFERENTIAL,3
19769-9,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,3
19762-4,THINPREP PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,3
8251-1,Q PLEASE NOTE:,2
57771-8,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
42233-7,"AUTOIMMUNE NEUROLOGY ANTIBODY COMPREHENSIVE PANEL W/REFL, SERUM LEGACY",1
19145-2,"ATHENA DIAGNOSTIC, INC MISCELLANEOUS ORDER",1
19146-0,"ATHENA DIAGNOSTIC, INC MISCELLANEOUS ORDER",1
10376-2,RBC MORPHOLOGY,10
626-2,"CULTURE, THROAT, SPECIAL W/GRP A STREP SUSCEPT.",4
8251-1,SPECIMEN ID NOTIFICATION MISSING SECOND ID LEGACY,10
36908-2,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
49549-9,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
31208-2,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
72486-4,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",10
77202-0,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
53039-4,"INHERITEST CARRIER SCREEN, SOCIETY-GUIDED PANEL (14 GENES)",5
8251-1,Q INTERPRETATION,4
19537-0,"COMPLIANCE DRUG ANALY, NO THC",8
45272-2,"COMPLIANCE DRUG ANALY, NO THC",8
59384-8,"COMPLIANCE DRUG ANALY, NO THC",8
87761-3,"COMPLIANCE DRUG ANALY, NO THC",8
16192-7,"COMPLIANCE DRUG ANALY, NO THC",8
3596-4,"COMPLIANCE DRUG ANALY, NO THC",8
16193-5,"COMPLIANCE DRUG ANALY, NO THC",8
16223-0,"COMPLIANCE DRUG ANALY, NO THC",8
16194-3,"COMPLIANCE DRUG ANALY, NO THC",8
61048-5,"COMPLIANCE DRUG ANALY, NO THC",8
44424-0,"COMPLIANCE DRUG ANALY, NO THC",8
19578-4,"COMPLIANCE DRUG ANALY, NO THC",8
87762-1,"COMPLIANCE DRUG ANALY, NO THC",8
16210-7,"COMPLIANCE DRUG ANALY, NO THC",8
52959-4,"COMPLIANCE DRUG ANALY, NO THC",8
16220-6,"COMPLIANCE DRUG ANALY, NO THC",8
12363-8,"COMPLIANCE DRUG ANALY, NO THC",8
61058-4,"COMPLIANCE DRUG ANALY, NO THC",8
3965-1,"COMPLIANCE DRUG ANALY, NO THC",8
16222-2,"COMPLIANCE DRUG ANALY, NO THC",8
,"COMPLIANCE DRUG ANALY, NO THC",168
58357-5,"COMPLIANCE DRUG ANALY, NO THC",8
86225-0,"COMPLIANCE DRUG ANALY, NO THC",8
87789-4,"COMPLIANCE DRUG ANALY, NO THC",8
4095-6,"COMPLIANCE DRUG ANALY, NO THC",8
3993-3,"COMPLIANCE DRUG ANALY, NO THC",8
3360-5,"COMPLIANCE DRUG ANALY, NO THC",8
58417-7,"COMPLIANCE DRUG ANALY, NO THC",8
27083-5,"COMPLIANCE DRUG ANALY, NO THC",8
86605-3,"COMPLIANCE DRUG ANALY, NO THC",8
3423-1,"COMPLIANCE DRUG ANALY, NO THC",8
52960-2,"COMPLIANCE DRUG ANALY, NO THC",8
40464-0,"COMPLIANCE DRUG ANALY, NO THC",8
43265-8,"COMPLIANCE DRUG ANALY, NO THC",8
32090-3,"COMPLIANCE DRUG ANALY, NO THC",8
12301-8,"COMPLIANCE DRUG ANALY, NO THC",8
3816-6,"COMPLIANCE DRUG ANALY, NO THC",8
3539-4,"COMPLIANCE DRUG ANALY, NO THC",8
27076-9,"COMPLIANCE DRUG ANALY, NO THC",8
13479-1,"COMPLIANCE DRUG ANALY, NO THC",8
86231-8,"COMPLIANCE DRUG ANALY, NO THC",8
86607-9,"COMPLIANCE DRUG ANALY, NO THC",8
58364-1,"COMPLIANCE DRUG ANALY, NO THC",8
20528-6,"COMPLIANCE DRUG ANALY, NO THC",8
59590-0,"COMPLIANCE DRUG ANALY, NO THC",8
19360-7,"COMPLIANCE DRUG ANALY, NO THC",8
10976-9,"COMPLIANCE DRUG ANALY, NO THC",8
86606-1,"COMPLIANCE DRUG ANALY, NO THC",8
18390-5,"COMPLIANCE DRUG ANALY, NO THC",16
58384-9,"COMPLIANCE DRUG ANALY, NO THC",8
58391-4,"COMPLIANCE DRUG ANALY, NO THC",8
86608-7,"COMPLIANCE DRUG ANALY, NO THC",8
41270-0,"COMPLIANCE DRUG ANALY, NO THC",8
16195-0,"COMPLIANCE DRUG ANALY, NO THC",8
58426-8,"COMPLIANCE DRUG ANALY, NO THC",8
58373-2,"COMPLIANCE DRUG ANALY, NO THC",8
87773-8,"COMPLIANCE DRUG ANALY, NO THC",8
87771-2,"COMPLIANCE DRUG ANALY, NO THC",8
87772-0,"COMPLIANCE DRUG ANALY, NO THC",8
87774-6,"COMPLIANCE DRUG ANALY, NO THC",8
61409-9,"COMPLIANCE DRUG ANALY, NO THC",8
61410-7,"COMPLIANCE DRUG ANALY, NO THC",8
19547-9,"COMPLIANCE DRUG ANALY, NO THC",8
40390-7,"COMPLIANCE DRUG ANALY, NO THC",8
3729-1,"COMPLIANCE DRUG ANALY, NO THC",8
32065-5,"COMPLIANCE DRUG ANALY, NO THC",8
59171-9,"COMPLIANCE DRUG ANALY, NO THC",8
14070-7,"COMPLIANCE DRUG ANALY, NO THC",8
19479-5,"COMPLIANCE DRUG ANALY, NO THC",8
59174-3,"COMPLIANCE DRUG ANALY, NO THC",8
32129-9,"COMPLIANCE DRUG ANALY, NO THC",8
64138-1,"COMPLIANCE DRUG ANALY, NO THC",8
87766-2,"COMPLIANCE DRUG ANALY, NO THC",8
12310-9,"COMPLIANCE DRUG ANALY, NO THC",8
87764-7,"COMPLIANCE DRUG ANALY, NO THC",8
87765-4,"COMPLIANCE DRUG ANALY, NO THC",8
68439-9,"COMPLIANCE DRUG ANALY, NO THC",8
87769-6,"COMPLIANCE DRUG ANALY, NO THC",8
87770-4,"COMPLIANCE DRUG ANALY, NO THC",8
87767-0,"COMPLIANCE DRUG ANALY, NO THC",8
87768-8,"COMPLIANCE DRUG ANALY, NO THC",8
11000-7,"COMPLIANCE DRUG ANALY, NO THC",8
4009-7,"COMPLIANCE DRUG ANALY, NO THC",8
3586-5,"COMPLIANCE DRUG ANALY, NO THC",8
12324-0,"COMPLIANCE DRUG ANALY, NO THC",8
16209-9,"COMPLIANCE DRUG ANALY, NO THC",8
3571-7,"COMPLIANCE DRUG ANALY, NO THC",8
3716-8,"COMPLIANCE DRUG ANALY, NO THC",8
75232-9,"COMPLIANCE DRUG ANALY, NO THC",8
45144-3,"COMPLIANCE DRUG ANALY, NO THC",8
60086-6,"COMPLIANCE DRUG ANALY, NO THC",8
59170-1,"COMPLIANCE DRUG ANALY, NO THC",8
75226-1,"COMPLIANCE DRUG ANALY, NO THC",8
59169-3,"COMPLIANCE DRUG ANALY, NO THC",8
58014-2,"COMPLIANCE DRUG ANALY, NO THC",8
78823-2,"COMPLIANCE DRUG ANALY, NO THC",8
61412-3,"COMPLIANCE DRUG ANALY, NO THC",8
61415-6,"COMPLIANCE DRUG ANALY, NO THC",8
64129-0,"COMPLIANCE DRUG ANALY, NO THC",8
14071-5,"COMPLIANCE DRUG ANALY, NO THC",8
44036-2,"COMPLIANCE DRUG ANALY, NO THC",8
3299-5,"COMPLIANCE DRUG ANALY, NO THC",8
18335-0,"COMPLIANCE DRUG ANALY, NO THC",8
3408-2,"COMPLIANCE DRUG ANALY, NO THC",8
4025-3,"COMPLIANCE DRUG ANALY, NO THC",8
64130-8,"COMPLIANCE DRUG ANALY, NO THC",8
53787-8,"COMPLIANCE DRUG ANALY, NO THC",16
59176-8,"COMPLIANCE DRUG ANALY, NO THC",8
33041-5,"COMPLIANCE DRUG ANALY, NO THC",8
3791-1,"COMPLIANCE DRUG ANALY, NO THC",8
29288-8,"COMPLIANCE DRUG ANALY, NO THC",8
16225-5,"COMPLIANCE DRUG ANALY, NO THC",8
3342-3,"COMPLIANCE DRUG ANALY, NO THC",8
32136-4,"COMPLIANCE DRUG ANALY, NO THC",8
4084-0,"COMPLIANCE DRUG ANALY, NO THC",8
32120-8,"COMPLIANCE DRUG ANALY, NO THC",8
4065-9,"COMPLIANCE DRUG ANALY, NO THC",8
75230-3,"COMPLIANCE DRUG ANALY, NO THC",8
3737-4,"COMPLIANCE DRUG ANALY, NO THC",8
75231-1,"COMPLIANCE DRUG ANALY, NO THC",8
19396-1,"COMPLIANCE DRUG ANALY, NO THC",8
75234-5,"COMPLIANCE DRUG ANALY, NO THC",8
75235-2,"COMPLIANCE DRUG ANALY, NO THC",8
78859-6,"COMPLIANCE DRUG ANALY, NO THC",8
61427-1,"COMPLIANCE DRUG ANALY, NO THC",8
32074-7,"COMPLIANCE DRUG ANALY, NO THC",8
61418-0,"COMPLIANCE DRUG ANALY, NO THC",8
19471-2,"COMPLIANCE DRUG ANALY, NO THC",8
19629-5,"COMPLIANCE DRUG ANALY, NO THC",8
32112-5,"COMPLIANCE DRUG ANALY, NO THC",8
75233-7,"COMPLIANCE DRUG ANALY, NO THC",8
27109-8,"COMPLIANCE DRUG ANALY, NO THC",8
4001-4,"COMPLIANCE DRUG ANALY, NO THC",8
3510-5,"COMPLIANCE DRUG ANALY, NO THC",8
12321-6,"COMPLIANCE DRUG ANALY, NO THC",8
12320-8,"COMPLIANCE DRUG ANALY, NO THC",8
19707-9,"COMPLIANCE DRUG ANALY, NO THC",8
78884-4,"COMPLIANCE DRUG ANALY, NO THC",8
32105-9,"COMPLIANCE DRUG ANALY, NO THC",8
86609-5,"COMPLIANCE DRUG ANALY, NO THC",8
58382-3,"COMPLIANCE DRUG ANALY, NO THC",8
58395-5,"COMPLIANCE DRUG ANALY, NO THC",8
58380-7,"COMPLIANCE DRUG ANALY, NO THC",8
19643-6,"COMPLIANCE DRUG ANALY, NO THC",8
58358-3,"COMPLIANCE DRUG ANALY, NO THC",8
18334-3,"COMPLIANCE DRUG ANALY, NO THC",8
16219-8,"COMPLIANCE DRUG ANALY, NO THC",8
19378-9,"COMPLIANCE DRUG ANALY, NO THC",8
17376-5,"COMPLIANCE DRUG ANALY, NO THC",8
16218-0,"COMPLIANCE DRUG ANALY, NO THC",8
58388-0,"COMPLIANCE DRUG ANALY, NO THC",8
16207-3,"COMPLIANCE DRUG ANALY, NO THC",8
16200-8,"COMPLIANCE DRUG ANALY, NO THC",8
46983-3,"COMPLIANCE DRUG ANALY, NO THC",8
16429-3,"COMPLIANCE DRUG ANALY, NO THC",8
16191-9,"COMPLIANCE DRUG ANALY, NO THC",8
17033-2,"COMPLIANCE DRUG ANALY, NO THC",8
19354-0,"COMPLIANCE DRUG ANALY, NO THC",8
18392-1,"COMPLIANCE DRUG ANALY, NO THC",8
72799-0,"COMPLIANCE DRUG ANALY, NO THC",8
16190-1,"COMPLIANCE DRUG ANALY, NO THC",8
16369-1,"COMPLIANCE DRUG ANALY, NO THC",8
86604-6,"COMPLIANCE DRUG ANALY, NO THC",8
41466-4,"COMPLIANCE DRUG ANALY, NO THC",8
86610-3,"COMPLIANCE DRUG ANALY, NO THC",8
61429-7,"COMPLIANCE DRUG ANALY, NO THC",8
58360-9,"COMPLIANCE DRUG ANALY, NO THC",8
58401-1,"COMPLIANCE DRUG ANALY, NO THC",8
16208-1,"COMPLIANCE DRUG ANALY, NO THC",8
16199-2,"COMPLIANCE DRUG ANALY, NO THC",8
58361-7,"COMPLIANCE DRUG ANALY, NO THC",8
58390-6,"COMPLIANCE DRUG ANALY, NO THC",8
34180-0,"COMPLIANCE DRUG ANALY, NO THC",8
45335-7,"FUNGAL CULTURE- SKIN, HAIR, NAIL",14
40839-3,"COMPLIANCE DRUG ANALY, NO THC",8
10353-1,"CULTURE, NP/NASAL",4
25397-1,ECHINOCOCCUS ANTIBODY LEGACY,1
3097-3,"BASIC METABOLIC PANEL, PLASMA",3
69052-9,LYMPHOCYTE PROLIFERATION TO AG - MAYO,1
33193-4,LYMPHOCYTE PROLIFERATION TO AG - MAYO,1
47528-5,GYN REPORT,1
19764-0,GYN REPORT,1
19767-3,GYN REPORT,1
8251-1,EARLY SJOGRENS SYNDROME PROFILE,1
75514-0,LUPUS ANTICOAGULANT PROFILE LEGACY,1
33771-7,MYOMARKER 3 PLUS PROFILE (RDL),2
33772-5,MYOMARKER 3 PLUS PROFILE (RDL),2
68549-5,MYOMARKER 3 PLUS PROFILE (RDL),2
18484-6,MYOMARKER 3 PLUS PROFILE (RDL),2
49963-2,MYOMARKER 3 PLUS PROFILE (RDL),2
18485-3,MYOMARKER 3 PLUS PROFILE (RDL),2
45152-6,MYOMARKER 3 PLUS PROFILE (RDL),2
33921-8,MYOMARKER 3 PLUS PROFILE (RDL),2
45149-2,MYOMARKER 3 PLUS PROFILE (RDL),2
31147-2,RPR,1
20401-6,LC ANA,1
5048-4,LC ANA,1
20398-4,LC ANA,1
54247-2,"DRUG MONITOR, PANEL 1, W/CONF, URINE",5
32764-3,WET PREP LEGACY,1
32766-8,WET PREP LEGACY,1
32765-0,WET PREP LEGACY,1
75514-0,PROLONGED APTT,1
,"ALLERGEN PROFILE WITH COMPONENT REFLEXES, RESPIRATORYAREA 3",1
33235-3,BODY FLUID CRYSTAL,7
50008-2,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,6
75514-0,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,7
194-1,"STREPTOCOCCUS GROUP B DNA, PCR WITH BROTH ENRICH W/RFX SUSCEPTIBILITY",1
7790-9,RBC MORPHOLOGY,7
3830-7,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
3507-1,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
14316-4,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
19261-7,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
19270-8,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
19550-3,MONITOR DRUG PROFILE 10 (MW) LEGACY,3
9834-3,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
12308-3,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
3936-2,MONITOR DRUG PROFILE 10 (MW) LEGACY,3
58430-0,MONITOR DRUG PROFILE 10 (MW) LEGACY,3
19429-0,MONITOR DRUG PROFILE 10 (MW) LEGACY,3
19295-5,MONITOR DRUG PROFILE 10 (MW) LEGACY,4
14314-9,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
18282-4,MONITOR DRUG PROFILE 10 (MW) LEGACY,2
69047-9,ALPHA-GLOBIN GENE ANALYSIS-MAYO,3
82939-0,ALPHA-GLOBIN GENE ANALYSIS-MAYO,3
85069-3,ALPHA-GLOBIN GENE ANALYSIS-MAYO,1
31208-2,ALPHA-GLOBIN GENE ANALYSIS-MAYO,3
8251-1,ANTIPHOSPHOLIPID ANTIBODY PANEL,1
,ANTIPHOSPHOTIDYL AB PANEL I,2
3349-8,"DRUG TOX MONITORING 1 SCREEN, URINE",1
,"DRUG TOX MONITORING 1 SCREEN, URINE",1
,THYROID PEROXIDASE (TPO) AB,5
49034-2,THINPREP PAP TEST,4
8251-1,"GLUCOSE TOLERANCE TEST, 2 SPECIMENS (75G)",2
26975-3,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
45142-7,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
34416-8,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
53982-5,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
35333-4,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
33569-5,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
14030-1,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
29374-6,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
43182-5,"ANALYZER ANA, IFA WITH REFLEX TITER/PATTERN, SYSTEMIC AUTOIMMUNE PANEL 1",3
32355-0,UPPER RESPIRATORY CULTURE,4
23658-8,GENITAL CULTURE,1
6463-4,"CULTURE, AEROBIC AND ANAEROBIC W/GRAM STAIN",9
23658-8,"CULTURE, AEROBIC AND ANAEROBIC W/GRAM STAIN",2
48069-9,MANUAL DIFF CELLAVISION,3
77202-0,INFLIXIMAB LEVEL AND ANTI-DRUG ANTIBODY FOR IBD,4
8251-1,INFLIXIMAB LEVEL AND ANTI-DRUG ANTIBODY FOR IBD,4
77202-0,"ANA, IFA RHEUMATOID ARTHRITIS DIAGNOSTIC PANEL WITH REFLEX TITER/PATTERN",6
,ANTIGEN OUTPATIENT,9
6463-4,AEROBIC CULTURE,7
,HEMOSIDERIN/OIL RED O REQUEST,4
23658-8,"UA/M W/RFLX CULTURE, ROUTINE",3
,ALLERGENS W/TOTAL IGE AREA 1,1
,TEST IN QUESTION -  NO TEST FOR CONTAINER LEGACY,20
580-1,"FUNGAL CULTURE- SKIN, HAIR, NAIL",1
64138-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
44424-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
34180-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
58364-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
19360-7,TOXASSURE SELECT (LABCORP MEDWATCH),5
86225-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
86606-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
59590-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
13479-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
86231-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
27083-5,TOXASSURE SELECT (LABCORP MEDWATCH),5
20528-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
86607-9,TOXASSURE SELECT (LABCORP MEDWATCH),5
58384-9,TOXASSURE SELECT (LABCORP MEDWATCH),5
86608-7,TOXASSURE SELECT (LABCORP MEDWATCH),5
10976-9,TOXASSURE SELECT (LABCORP MEDWATCH),5
64131-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
58391-4,TOXASSURE SELECT (LABCORP MEDWATCH),5
58394-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
18390-5,TOXASSURE SELECT (LABCORP MEDWATCH),10
49831-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
58392-2,TOXASSURE SELECT (LABCORP MEDWATCH),5
58393-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
64130-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
58363-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
16195-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
86605-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
58366-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
86224-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
64129-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
19643-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
40839-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
61420-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
86610-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
58382-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
58380-7,TOXASSURE SELECT (LABCORP MEDWATCH),5
58357-5,TOXASSURE SELECT (LABCORP MEDWATCH),5
16190-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
59384-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
19289-8,TOXASSURE SELECT (LABCORP MEDWATCH),5
16191-9,TOXASSURE SELECT (LABCORP MEDWATCH),5
16429-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
19055-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
19354-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
16369-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
16193-5,TOXASSURE SELECT (LABCORP MEDWATCH),5
19537-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
16194-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
16192-7,TOXASSURE SELECT (LABCORP MEDWATCH),5
16223-0,TOXASSURE SELECT (LABCORP MEDWATCH),5
58358-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
16208-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
58390-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
86604-6,TOXASSURE SELECT (LABCORP MEDWATCH),5
58361-7,TOXASSURE SELECT (LABCORP MEDWATCH),5
61429-7,TOXASSURE SELECT (LABCORP MEDWATCH),5
58360-9,TOXASSURE SELECT (LABCORP MEDWATCH),5
41466-4,TOXASSURE SELECT (LABCORP MEDWATCH),5
16199-2,TOXASSURE SELECT (LABCORP MEDWATCH),5
58401-1,TOXASSURE SELECT (LABCORP MEDWATCH),5
46983-3,TOXASSURE SELECT (LABCORP MEDWATCH),5
10371-3,MANUAL DIFFERENTIAL,8
,"ALPHA GLOBIN GENE SEQUENCING, B",2
,"BETA GLOBIN GENE SEQUENCING, B",2
59466-3,PLATELET ANTIBODY-MAYO,3
58436-7,"UA/M W/RFLX CULTURE, COMP",1
26052-1,"UA/M W/RFLX CULTURE, COMP",2
,SPINAL MUSCULAR ATROPHY (SMA)-INTEGRATED GENETICS,1
,PREECLAMPSIA MONITORING PROFILE,1
58413-6,PREECLAMPSIA MONITORING PROFILE,1
18314-5,PREECLAMPSIA MONITORING PROFILE,1
77202-0,LIPID PANEL,3
8251-1,"SARS-COV-2 RNA (COVID-19) AND RESPIRATORY VIRAL PANEL,Q NAAT",2
32653-8,FAMILIAL DYSAUTONOMIA MUTATION ANALYSIS,1
6824-7,PANCREATIC ENZYME FLUID COLLECTION 3,7
6824-7,PANCREATIC ENZYME FLUID COLLECTION 4,7
6824-7,PANCREATIC ENZYME FLUID COLLECTION 1,7
6824-7,PANCREATIC ENZYME FLUID COLLECTION 2,7
,REGIONAL PANEL 3,1
8251-1,"LIPID PANEL, STANDARD",7
19769-9,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",3
19762-4,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",3
6742-1,CBC+PLATELET+HEM REVIEW,3
9317-9,CBC+PLATELET+HEM REVIEW,3
,STONERISK(R) DIAGNOSTIC PROFILE,3
11011-4,HCV RNA QN (GRAPH) RFX NS3/4A,2
38180-6,HCV RNA QN (GRAPH) RFX NS3/4A,2
42595-9,"L - HBV RT PCR, QUANT (GRAPH) - 551620 LEGACY",1
45335-7,AMOEBA CULTURE,5
5822-2,"UA/M W/RFLX CULTURE, COMP",2
19762-4,THINPREP PAP TEST,1
46154-1,"SURESWAB(R), VAGINOSIS/VAGINITIS PLUS 17333",1
43304-5,"SURESWAB(R), VAGINOSIS/VAGINITIS PLUS 17333",1
74669-3,"SURESWAB(R), VAGINOSIS/VAGINITIS PLUS 17333",1
62460-1,"SURESWAB(R), VAGINOSIS/VAGINITIS PLUS 17333",1
24469-9,THALASSEMIA AND HEMOGLOBINOPATHY EVALUATION,1
5946-9,Q IMMEDIATE PTT LA MIX,2
15159-7,MIXING STUDY,2
15160-5,VON WILLEBRAND COMPREHENSIVE PANEL,4
32217-2,VON WILLEBRAND COMPREHENSIVE PANEL,4
6371-9,GIARDIA AND CRYPTOSPORIDIUM ANTIGEN PANEL QUEST,10
6412-1,GIARDIA AND CRYPTOSPORIDIUM ANTIGEN PANEL QUEST,10
703-9,CBC WITH AUTO DIFFERENTIAL,1
5880-0,"ROTAVIRUS ANTIGEN, STOOL",3
16195-0,"BENZODIAZEPINE CONFIRMATION REFLEX, U",2
,"AFB CULTURE, BLOOD",1
5372-8,MYASTHENIA GRAVIS PANEL 1,1
21688-7,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,1
12710-0,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,4
49549-9,MATERNIT21 PLUS CORE+ESS,6
75608-0,MATERNIT21 PLUS CORE+ESS,6
77202-0,MATERNIT21 PLUS CORE+ESS,6
62364-5,MATERNIT21 PLUS CORE+ESS,6
75605-6,MATERNIT21 PLUS CORE+ESS,6
75693-2,MATERNIT21 PLUS CORE+ESS,6
72486-4,MATERNIT21 PLUS CORE+ESS,12
77202-0,INTERPRETATION,2
8251-1,INTERPRETATION,12
47236-5,TREPONEMA PALLIDUM (SYPHILIS) ANTIBODY,7
31208-2,EPSTEIN BARR VIRUS CSF BY RAPID PCR-MAYO,8
,HEPATITIS B E ANTIGEN,1
92777-2,BLOOD CULTURE PCR PROBE,1
43227-8,"OVA AND PARASITES, CONC AND PERM SMEAR",8
48794-2,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
48793-4,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",2
6919-5,"CHLAMYDIA SEROLOGY, S MAYO",3
6913-8,"CHLAMYDIA SEROLOGY, S MAYO",3
6914-6,"CHLAMYDIA SEROLOGY, S MAYO",3
6916-1,"CHLAMYDIA SEROLOGY, S MAYO",3
6917-9,"CHLAMYDIA SEROLOGY, S MAYO",3
6920-3,"CHLAMYDIA SEROLOGY, S MAYO",3
69050-3,"BARBITURATES CONFIRMATION, U",1
8100-0,MTB-RIF NAA WITH AFB CULTURE,1
14556-5,MTB-RIF NAA WITH AFB CULTURE,1
33634-7,MTB-RIF NAA WITH AFB CULTURE,1
580-1,FUNGAL CULTURE,1
580-1,L - RESULT 080092,1
29579-0,"SUSCEPTIBILITY, AFB RAPID GROWER-MAYO",3
45324-1,"ETHYL GLUCURONIDE, URINE LEGACY",1
72525-9,HIV 1 GENO INTEGRASE,1
,HIV 1 GENO INTEGRASE,1
33882-2,HIV 1 GENO INTEGRASE,1
96566-5,HIV 1 GENO INTEGRASE,1
72857-6,HIV 1 GENO INTEGRASE,1
90080-3,HIV 1 GENO INTEGRASE,1
72526-7,HIV 1 GENO INTEGRASE,1
14658-9,COLD AGGLUTININ TITER,4
,Q GENOTYPE PHENOTYPE REVIEW,8
19146-0,Q ALPHA THALASSEMIA DNA MUTATION ANALYSIS,3
21687-9,Q ALPHA THALASSEMIA DNA MUTATION ANALYSIS,3
19769-9,"IGP,CTNG,APTIMAHPV,RFX16/18,45",11
25428-4,"URINALYSIS, COMPLETE",2
630-4,URINALYSIS WITH CULTURE IF INDICATED,2
31208-2,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",3
50014-0,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",3
,SOLID TUMOR TARGETED CANCER PANEL (MAYO),11
8246-1,"UA/M W/RFLX CULTURE, COMP",12
13516-0,"CELL COUNT WITH DIFFERENTIAL, CSF",1
,POCT CHLORIDE UNSOLICITED RESULTS,1
12782-9,"OLIGOCLONAL BANDS (IGG), CSF",3
49034-2,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,1
19769-9,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,1
19762-4,THINPREP TIS PAP RFX HR HPV DNA AND C. TRACHOMATIS AND N. GONORRHOEAE,1
48069-9,MANUAL DIFFERENTIAL,7
6457-6,DSDNA CRITHIDIA LUCILIAE IFA,2
29771-3,"AT HOME OCCULT BLOOD, FECAL,IA",4
19762-4,THINPREP PAP REFLEX HPV MRNA E6/E7,7
10656-7,CYCLOSPORA AND ISOSPORA EXAMINATION,4
77174-1,JAK2 V617F QT RFX CALR/MPL,1
48005-3,JAK2 V617F QT RFX CALR/MPL,1
62947-7,JAK2 V617F QT RFX CALR/MPL,1
48004-6,JAK2 V617F QT RFX CALR/MPL,1
,"CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION",3
11545-1,AFB STAIN,4
31208-2,"EBV DNA, QUANTITATIVE, REAL-TIME PCR",4
,"%TISSUE TRANSGLUTAMINASE AB, IGA",1
31147-2,"RPR, QUANT",76
80689-3,REFLEX TO GENOSURE PRIME(R),1
93047-9,REFLEX TO GENOSURE PRIME(R),1
62364-5,REFLEX TO GENOSURE PRIME(R),1
93194-9,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
41048-0,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
79713-4,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
62364-5,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
69047-9,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
85069-3,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
93195-6,"THIOPURINE METHYLTRANSFERASE GENOTYPING, (MAYO-TPNUQ)",1
36908-2,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
31208-2,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
62364-5,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
72486-4,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
50397-9,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
8262-8,"PRENATAL CARRIER SCREEN (CF, FRAGILE X, SMA)",2
35265-8,HISTORICAL PATHOLOGY CASE,10
,"HCV RT-PCR, QUANT (GRAPH) LEGACY",1
74665-1,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
49296-7,"MONOCLONAL PROTEIN STUDY, SERUM- MAYO",3
,Q SPECIMEN INTEGRITY COMPROMISED,1
58413-6,T/B LYMPH PROFILE,1
43227-8,"OVA AND PARASITES, CONC/PERM SMEAR, 3 SPEC",4
31208-2,"HERPES VIRUS 6 DNA,QL REAL TIME PCR",1
59462-2,"CARNITINE, SERUM",3
20401-6,ENA+DNA/DS+ANTICH+CENTRO+FA...,1
,ENA+DNA/DS+ANTICH+CENTRO+FA...,4
31208-2,NON-GYN CYTO  SPECIMEN A,1
13439-5,"PROTEIN ELECTROPHORESIS, CSF",1
29577-4,"SUSCEPTIBILTY, NOCARDIA SPECIES-MAYO",1
25158-7,URINALYSIS WITH REFLEX MICROSCOPIC,1
,URINE OIL RED O STAIN PATHOLOGY (LAB ONLY USE),2
5782-8,URINALYSIS WITH MICROSCOPIC LEGACY,1
5783-6,URINALYSIS WITH MICROSCOPIC LEGACY,1
31208-2,"BK VIRUS DNA, QN REAL TIME PCR, PLASMA",1
20464-4,TOXOPLASMA ABS IGG/IGM,1
,POCT HEMOGLOBIN & HEMATOCRIT CALC UNSOLICITED RESULTS,5
13465-0,"HEAVY METALS PROFILE, URINE, LEGACY",1
13463-5,"HEAVY METALS PROFILE, URINE, LEGACY",1
13466-8,"HEAVY METALS PROFILE, URINE, LEGACY",1
19295-5,"LC OPIATES CONFIRMATION, URINE",1
19289-8,"CANNABINOID (GC/MS), URINE",1
16206-5,"BENZODIAZEPINES CONFIRM, URINE",1
12361-2,"BENZODIAZEPINES CONFIRM, URINE",1
3390-2,"BENZODIAZEPINES CONFIRM, URINE",1
3861-2,"BENZODIAZEPINES CONFIRM, URINE",1
19586-7,"BENZODIAZEPINES CONFIRM, URINE",1
14192-9,"BENZODIAZEPINES CONFIRM, URINE",1
19245-0,"BENZODIAZEPINES CONFIRM, URINE",1
18187-5,"BENZODIAZEPINES CONFIRM, URINE",1
9351-8,"BENZODIAZEPINES CONFIRM, URINE",1
3654-1,"BENZODIAZEPINES CONFIRM, URINE",1
46138-4,URINALYSIS WITH CULTURE IF INDICATED,2
5292-8,VDRL,2
71773-6,QFT-TB PLUS (CLIENT INCUBATED),2
16220-6,"TOXASSURE SELECT 15, UR DLRFX",2
16190-1,"TOXASSURE SELECT 15, UR DLRFX",2
61058-4,"TOXASSURE SELECT 15, UR DLRFX",2
59384-8,"TOXASSURE SELECT 15, UR DLRFX",2
3965-1,"TOXASSURE SELECT 15, UR DLRFX",2
16191-9,"TOXASSURE SELECT 15, UR DLRFX",2
16222-2,"TOXASSURE SELECT 15, UR DLRFX",2
16429-3,"TOXASSURE SELECT 15, UR DLRFX",2
87762-1,"TOXASSURE SELECT 15, UR DLRFX",2
19354-0,"TOXASSURE SELECT 15, UR DLRFX",2
44424-0,"TOXASSURE SELECT 15, UR DLRFX",2
16193-5,"TOXASSURE SELECT 15, UR DLRFX",2
19537-0,"TOXASSURE SELECT 15, UR DLRFX",2
16194-3,"TOXASSURE SELECT 15, UR DLRFX",2
16192-7,"TOXASSURE SELECT 15, UR DLRFX",2
16223-0,"TOXASSURE SELECT 15, UR DLRFX",2
58357-5,"TOXASSURE SELECT 15, UR DLRFX",2
59590-0,"TOXASSURE SELECT 15, UR DLRFX",2
27083-5,"TOXASSURE SELECT 15, UR DLRFX",2
86231-8,"TOXASSURE SELECT 15, UR DLRFX",2
13479-1,"TOXASSURE SELECT 15, UR DLRFX",2
58369-0,"TOXASSURE SELECT 15, UR DLRFX",2
86607-9,"TOXASSURE SELECT 15, UR DLRFX",2
58368-2,"TOXASSURE SELECT 15, UR DLRFX",2
20528-6,"TOXASSURE SELECT 15, UR DLRFX",2
86605-3,"TOXASSURE SELECT 15, UR DLRFX",2
19360-7,"TOXASSURE SELECT 15, UR DLRFX",2
19289-8,"TOXASSURE SELECT 15, UR DLRFX",2
58391-4,"TOXASSURE SELECT 15, UR DLRFX",2
86606-1,"TOXASSURE SELECT 15, UR DLRFX",2
86608-7,"TOXASSURE SELECT 15, UR DLRFX",2
10976-9,"TOXASSURE SELECT 15, UR DLRFX",2
49831-1,"TOXASSURE SELECT 15, UR DLRFX",2
19055-3,"TOXASSURE SELECT 15, UR DLRFX",2
18390-5,"TOXASSURE SELECT 15, UR DLRFX",4
58384-9,"TOXASSURE SELECT 15, UR DLRFX",2
58392-2,"TOXASSURE SELECT 15, UR DLRFX",2
41270-0,"TOXASSURE SELECT 15, UR DLRFX",2
16195-0,"TOXASSURE SELECT 15, UR DLRFX",2
64129-0,"TOXASSURE SELECT 15, UR DLRFX",2
64138-1,"TOXASSURE SELECT 15, UR DLRFX",2
58366-6,"TOXASSURE SELECT 15, UR DLRFX",2
58363-3,"TOXASSURE SELECT 15, UR DLRFX",2
58367-4,"TOXASSURE SELECT 15, UR DLRFX",2
86224-3,"TOXASSURE SELECT 15, UR DLRFX",2
58364-1,"TOXASSURE SELECT 15, UR DLRFX",2
86225-0,"TOXASSURE SELECT 15, UR DLRFX",2
64130-8,"TOXASSURE SELECT 15, UR DLRFX",2
58394-8,"TOXASSURE SELECT 15, UR DLRFX",2
58396-3,"TOXASSURE SELECT 15, UR DLRFX",2
16199-2,"TOXASSURE SELECT 15, UR DLRFX",2
86609-5,"TOXASSURE SELECT 15, UR DLRFX",2
64131-6,"TOXASSURE SELECT 15, UR DLRFX",2
58395-5,"TOXASSURE SELECT 15, UR DLRFX",2
19643-6,"TOXASSURE SELECT 15, UR DLRFX",2
61423-0,"TOXASSURE SELECT 15, UR DLRFX",2
58358-3,"TOXASSURE SELECT 15, UR DLRFX",2
61429-7,"TOXASSURE SELECT 15, UR DLRFX",2
18334-3,"TOXASSURE SELECT 15, UR DLRFX",2
58401-1,"TOXASSURE SELECT 15, UR DLRFX",2
16207-3,"TOXASSURE SELECT 15, UR DLRFX",2
17718-8,"TOXASSURE SELECT 15, UR DLRFX",2
19378-9,"TOXASSURE SELECT 15, UR DLRFX",2
86454-6,"TOXASSURE SELECT 15, UR DLRFX",2
18338-4,"TOXASSURE SELECT 15, UR DLRFX",2
16218-0,"TOXASSURE SELECT 15, UR DLRFX",2
46983-3,"TOXASSURE SELECT 15, UR DLRFX",2
16219-8,"TOXASSURE SELECT 15, UR DLRFX",2
3596-4,"TOXASSURE SELECT 15, UR DLRFX",2
58388-0,"TOXASSURE SELECT 15, UR DLRFX",2
19578-4,"TOXASSURE SELECT 15, UR DLRFX",2
17376-5,"TOXASSURE SELECT 15, UR DLRFX",2
16210-7,"TOXASSURE SELECT 15, UR DLRFX",2
16200-8,"TOXASSURE SELECT 15, UR DLRFX",2
61048-5,"TOXASSURE SELECT 15, UR DLRFX",2
45272-2,"TOXASSURE SELECT 15, UR DLRFX",2
87761-3,"TOXASSURE SELECT 15, UR DLRFX",2
16369-1,"TOXASSURE SELECT 15, UR DLRFX",2
58390-6,"TOXASSURE SELECT 15, UR DLRFX",2
86604-6,"TOXASSURE SELECT 15, UR DLRFX",2
41466-4,"TOXASSURE SELECT 15, UR DLRFX",2
58361-7,"TOXASSURE SELECT 15, UR DLRFX",2
58380-7,"TOXASSURE SELECT 15, UR DLRFX",2
58360-9,"TOXASSURE SELECT 15, UR DLRFX",2
40839-3,"TOXASSURE SELECT 15, UR DLRFX",2
86610-3,"TOXASSURE SELECT 15, UR DLRFX",2
58382-3,"TOXASSURE SELECT 15, UR DLRFX",2
16208-1,"TOXASSURE SELECT 15, UR DLRFX",2
34180-0,"TOXASSURE SELECT 15, UR DLRFX",2
10380-4,RBC MORPHOLOGY,2
,POCT VENOUS BLOOD GAS UNSOLICITED RESULTS,2
18314-5,PRENATAL PROFILE I,3
,HIV1 RNA NAAT REFLEX LAB ONLY,3
77202-0,Q INTERPRETATION,8
14030-1,Q TIER 1,5
43182-5,Q TIER 1,5
34416-8,Q TIER 1,5
29374-6,Q TIER 1,5
26975-3,Q TIER 2,2
33569-5,Q TIER 2,2
45142-7,Q TIER 2,2
35333-4,Q TIER 2,2
53982-5,Q TIER 3,2
13636-6,Q TIER 3,2
,"WET PREP, GENITAL",161
24475-6,FACTOR II (PT G20210A) MUTATION,1
21668-9,"FACTOR V (LEIDEN, G1691A) MUTATION",1
,RESEARCH TISSUE REQUEST - LABONLY,6
23658-8,AEROBIC CULTURE,3
63557-3,"HBSAG QUANTITATIVE, MONITOR",1
5393-4,"T. PALLIDUM AB (FTA-ABS), SERUM LEGACY",1
3507-1,"OPIATES, URINE",1
19295-5,"OPIATES, URINE",4
12308-3,"OPIATES, URINE",1
9834-3,"OPIATES, URINE",1
3830-7,"OPIATES, URINE",1
43730-1,"EBV DNA, QUANTITATIVE, REAL-TIME PCR",1
25417-7,HUMAN HERPES VIRUS TYPE 6 IGM LEGACY,1
35456-3,INFERTILITY-MALE Y CHROM DNA LEGACY,1
51969-4,INFERTILITY-MALE Y CHROM DNA LEGACY,1
12201-0,"CRYOGLOBULIN, QL, SERUM 120956",2
77202-0,LUPUS ANTICOAGULANT LEGACY,3
10362-2,"ENDOMYSIAL (EMA) ANTIBODY, IGA TITER",1
49503-6,ANTINEUTROPHIL CYTOPLASMIC AB,3
14277-8,ANTINEUTROPHIL CYTOPLASMIC AB,3
14278-6,ANTINEUTROPHIL CYTOPLASMIC AB,3
20401-6,"ANTINUCLEAR ANTIBODIES, IFA",1
10331-7,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
883-9,CMP12+LP+TP+TSH+7AC+CBC/D/P...,1
13951-9,HAV ANTIBODY W/ RFX,1
36923-1,EBV PCR QUANT (WHOLE BLOOD),2
,SM AND SM/RNP ANTIBODIES,2
,HCV RNA QN (GRAPH) RFX NS3/4A,2
48506-0,PLATELET ANTIBODY PROFILE LEGACY,2
48501-1,PLATELET ANTIBODY PROFILE LEGACY,2
48505-2,PLATELET ANTIBODY PROFILE LEGACY,2
43302-9,PLATELET ANTIBODY PROFILE LEGACY,2
47084-9,PLATELET ANTIBODY PROFILE LEGACY,2
14316-4,"BENZODIAZEPINES, URINE",1
14314-9,"COCAINE, URINE",1
19643-6,"OXYCODONE/OXYMORPHONE, URINE",1
18325-1,"OXYCODONE/OXYMORPHONE, URINE",1
5247-2,ANTI-MITOCHONDRIAL AB BY IFA,1
26971-2,ANTI-SMOOTH MUSCLE AB BY IFA,1
,RPR (MONITOR) W/ REFL TITER (REFL) LEGACY,6
4029-5,MONITOR DRUG PROFILE 14(MW),1
3339-9,MONITOR DRUG PROFILE 14(MW),1
19344-1,MONITOR DRUG PROFILE 14(MW),1
58430-0,MONITOR DRUG PROFILE 14(MW),1
3830-7,MONITOR DRUG PROFILE 14(MW),1
19429-0,MONITOR DRUG PROFILE 14(MW),1
19550-3,MONITOR DRUG PROFILE 14(MW),1
9834-3,MONITOR DRUG PROFILE 14(MW),1
12308-3,MONITOR DRUG PROFILE 14(MW),1
3936-2,MONITOR DRUG PROFILE 14(MW),1
19261-7,MONITOR DRUG PROFILE 14(MW),1
19710-3,MONITOR DRUG PROFILE 14(MW),1
3746-5,MONITOR DRUG PROFILE 14(MW),1
3414-0,MONITOR DRUG PROFILE 14(MW),1
3637-6,MONITOR DRUG PROFILE 14(MW),1
3349-8,MONITOR DRUG PROFILE 14(MW),1
14314-9,MONITOR DRUG PROFILE 14(MW),1
3421-5,MONITOR DRUG PROFILE 14(MW),1
3507-1,MONITOR DRUG PROFILE 14(MW),1
3949-5,MONITOR DRUG PROFILE 14(MW),1
19295-5,MONITOR DRUG PROFILE 14(MW),2
3925-5,MONITOR DRUG PROFILE 14(MW),1
18282-4,MONITOR DRUG PROFILE 14(MW),1
14316-4,MONITOR DRUG PROFILE 14(MW),1
3377-9,MONITOR DRUG PROFILE 14(MW),1
19555-2,MONITOR DRUG PROFILE 14(MW),1
19270-8,MONITOR DRUG PROFILE 14(MW),1
5077-3,SCLERODERMA COMP PROFILE (RDL),1
42254-3,SCLERODERMA COMP PROFILE (RDL),1
20401-6,SCLERODERMA COMP PROFILE (RDL),1
81743-7,SCLERODERMA COMP PROFILE (RDL),1
,"AFB ID, SEQUENCING AND STAIN, PARAFFIN BLOCK LEGACY",2
,FUNGAL STAIN,1
,STOOL CULTURE PANEL SCH BSP,26
47236-5,T PALLIDUM SCREENING CASCADE,1
,MTD,10
,KOH PREP,9
19643-6,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
18325-1,MONITOR DRUG PROFILE 10 (MW) LEGACY,1
,"PAP IG, RFX APTIMA HPV ASCU 16/18,45",13
47527-7,"PAP IG, RFX APTIMA HPV ASCU 16/18,45",6
47528-5,"PAP IG, RFX APTIMA HPV ASCU 16/18,45",6
19764-0,"PAP IG, RFX APTIMA HPV ASCU 16/18,45",6
19767-3,"PAP IG, RFX APTIMA HPV ASCU 16/18,45",6
,SNP MICROARRAY PEDIATRIC-GENZYME,1
62461-9,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
45084-1,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
69565-0,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
68547-9,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
68546-1,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
69566-8,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
69567-6,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
69562-7,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
69563-5,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
32705-6,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
69935-5,"NUSWAB VG PLUS+MYCOPLASMAS,NAA",1
4991-6,LYME DISEASE PCR,1
19762-4,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
19769-9,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
19774-9,"THINPREP PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",4
,BARTONELLA ANITBODY PANEL,28
,ESTRADIOL SERUM-ESOTERIX,1
5822-2,URINALYSIS WITH CULTURE IF INDICATED,3
,"NEISSERIA GONORRHOEAE RNA, TMA, UROGENITAL",3
,JAK2 V617F MUTATION DETECTION-MAYO,3
31208-2,HERPES SIMPLEX VIRUS CULTURE,3
,AUTOPSY REPORT LEGACY,4
,"CSF, ENCEPHALOPATHY, AUTOIMMUNE EVAL - M",5
,"SUSCEPTIBILTY PANEL, YEAST-MAYO LEGACY",2
,"SUSCEPTIBILITY, AFB RAPID GROWER-MAYO",4
,INSULIN-LIKE GROWTH FACTOR I-MAYO,7
,MPL MUTATION ANALYSIS,1
,CALRETICULIN (CALR) MUTATION ANALYSIS,1
,HBV QUANT PCR RFX TO GENOTYPE LEGACY,2
,AMOEBA CULTURE,5
,"H. PYLORI ANTIGEN, EIA",2
49034-2,"THINPREP TIS PAP REFLEX HPV MRNA E6/E7, CT/NG, TRICH",5
5822-2,URINALYSIS WITH MICROSCOPIC LEGACY,3
,IGG INDEX CSF-MAYO,1
,GASTROCCULT,5
,EPSTEIN BARR VIRUS CSF BY RAPID PCR-MAYO,2
,MITOGENS BY FLOW CYTOMETRY-MAYO LEGACY,1
,ARBOVIRUS ANTIBODY PANEL IGG AND IGM CSF,4
49034-2,"THINPREP PAP AND HR HPV DNA, C. TRACHOMATIS AND N. GONORRHOEAE",6
19769-9,"PAP IG, CTNG RFX HPV ASCU,16/18 (SP)",1
8246-1,URINALYSIS WITH MICROSCOPIC LEGACY,3
,"OXALATE, URINE, 24 HOUR",1
,BK VIRUS DNA DETECT/QUANT,2
,ABO GROUP,45
46138-4,URINALYSIS WITH MICROSCOPIC LEGACY,3
,GRAM STAIN,143
801-1,MAN DIFF ONLY LEGACY,1
10378-8,MAN DIFF ONLY LEGACY,1
800-3,MAN DIFF ONLY LEGACY,1
,TSH RECEPTOR ANTIBODY-ESOTERIX LEGACY,1
82306-2,"CHLAMYDIA TRACHOMATIS RNA, TMA, THROAT",1
13951-9,HEPATITIS PANEL (REFL) LEGACY,2
5196-1,HEPATITIS PANEL (REFL) LEGACY,2
13952-7,HEPATITIS PANEL (REFL) LEGACY,2
13955-0,HEPATITIS PANEL (REFL) LEGACY,2
,REFLEX TIQ LEGACY,3
19764-0,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
10524-7,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
19763-2,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
19774-9,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
19767-3,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",2
,"COCAINE SCREEN, URINE",1
,"BARBITURATE SCREEN, URINE",1
,"OPIATE SCREEN, URINE",1
,"CANNABINOID SCREEN, URINE",1
,ARBOVIRUS ANTIBODY PANEL IGG AND IGM-MAY,1
19769-9,"IGP,CTNGTV,APT HPV,RFX16/18,45",3
,"HYDROXPROGESTERONE, 17A-ESOTERIX",1
,LUTEINIZING HORMONE(LH) ECL-ESOTERIX,2
49034-2,"THINPREP TIS PAP AND HPV MRNA E6/E7, CT/NG, TRICH",3
,TRANSFUSION REACTION WORKUP REVIEW,10
,"NICOTINE AND METABOLITES, SERUM LEGACY",1
59420-0,"IGP, RFX APTIMA HPV ASCU",1
,CHROMOGRANIN A-MAYO,2
38404-0,CFVANTAGE CYSTIC FIBROSIS EXPANDED SCREEN,5
8266-9,CFVANTAGE CYSTIC FIBROSIS EXPANDED SCREEN,5
21656-4,CFVANTAGE CYSTIC FIBROSIS EXPANDED SCREEN,5
24113-3,Q HEPATITIS B CORE ANTIBODY (IGM),2
,PLATELET ANTIBODY-MAYO,1
,EOSINOPHIL SMEAR NASAL,2
25148-8,URINALYSIS WITH MICROSCOPIC LEGACY,6
31208-2,"CREATINE KINASE ISOENZYME REFLEX, SERUM",14
72486-4,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",10
75608-0,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",5
,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",30
77202-0,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",5
62364-5,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",5
49549-9,"MATERNIT21 PLUS CORE (CHR21,18,13) NO GENDER",5
42664-3,"HLA A,B,C (HR)",2
49549-9,"HLA A,B,C (HR)",1
13298-5,"HLA A,B,C (HR)",2
57291-7,"HLA A,B,C (HR)",2
19773-1,"IGP,CTNG,APTIMAHPV,RFX16/18,45",1
41270-0,TOXASSURE SELECT (LABCORP MEDWATCH),7
,POCT VENOUS BLOOD GAS WITH HEMOGLOBIN & HEMATOCRIT UNSOLICITED RESULTS,2
,LYMPHOCYTE SUBSETS 5,8
,MISCELLANEOUS REFERENCE PATHOLOGY,3
13955-0,HEPATITIS C AB W/REFL TO HCV RNA QN PCR LEGACY,6
59462-2,HIV1 GENOTYPIC INTEGRASE INHIBITOR DRUG RESISTANCE - MAYO,5
15048-2,CREATINE KINASE$ISOENZYMES W/O TOTAL,2
5912-1,CREATINE KINASE$ISOENZYMES W/O TOTAL,2
19769-9,"PAP IG, RFX HPV ASCU,16/18 (SP)",1
39534-3,"GIARDIA / CRYPTOSPORIDIUM ANTIGENS, DFA",5
20454-5,UA+URINE CULTURE,1
2349-9,UA+URINE CULTURE,1
630-4,UA+URINE CULTURE,2
5769-5,UA+URINE CULTURE,1
12235-8,UA+URINE CULTURE,1
5802-4,UA+URINE CULTURE,1
5770-3,UA+URINE CULTURE,1
24124-0,UA+URINE CULTURE,1
13945-1,UA+URINE CULTURE,1
5787-7,UA+URINE CULTURE,1
5821-4,UA+URINE CULTURE,1
5778-6,UA+URINE CULTURE,1
5767-9,UA+URINE CULTURE,1
5799-2,UA+URINE CULTURE,1
2514-8,UA+URINE CULTURE,1
5794-3,UA+URINE CULTURE,1
,Q URO RISK(R) DIAGNOSTIC PROFILE,2
,REFERENCE ANTIBODY TITER,3
5794-3,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5778-6,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
5767-9,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
12235-8,CMP12+LP+TP+TSH+6AC+CBC/D/P... LEGACY,1
35462-1,SMA DIAGNOSTIC TEST LEGACY,1
54449-4,SMA DIAGNOSTIC TEST LEGACY,1
49857-6,SMA DIAGNOSTIC TEST LEGACY,1
33773-3,"CHROMOSOME ANALYSIS, AMNIOTIC FLUID",2
40704-9,MATERNAL CELL CONTAMINAT- ION STUDY STR ANALYSIS,1
30283-6,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30286-9,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
34700-5,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
51409-1,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
49630-7,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
52749-9,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
91897-9,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30291-9,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
45176-5,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
49618-2,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
68463-9,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
33630-5,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30289-3,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
45175-7,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
49621-6,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
42000-0,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30294-3,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
49619-0,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
49622-4,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30287-7,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30284-4,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
41402-9,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
41396-3,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
30282-8,"HIV-1 GENOTYPIC PROTEASE AND REVERSE TRANSCRIPTASE INHIBITOR DRUG RESISTANCE, PLASMA",4
19359-9,"COCAINE SCREEN, URINE",4
14869-2,"PATH REVIEW, PER PROTOCOL LEGACY",1
,HEMOGLOBPATHY FER W/A THAL RFX LEGACY,3
,CULTURE FLUID LEGACY,11
59462-2,"CARNITINE, PLASMA",2
8264-4,TEST IN QUESTION- MISLABELED NAME LEGACY,2
31208-2,TEST IN QUESTION- MISLABELED NAME LEGACY,2
,TISSUE2 SPECIMENS,8
702-1,RBC MORPHOLOGY,9
741-9,RBC MORPHOLOGY,11
,"INFLUENZA AB, SERUM LEGACY",4
,SMOOTH MUSCLE AB W/REFL TITER,4
,CULTURE CATH TIP LEGACY,3
8247-9,MICROSCOPIC EXAMINATION LEGACY,1
,STREP GROUP B AG LEGACY,1
7795-8,RBC MORPHOLOGY,2
,HEMOCHROMATOSIS MUTATION,2
,"IMMUNOFIXATION, URINE LEGACY",2
,"LYME DISEASE ANTIBODIES (IGG, IGM), IBL (CSF)",4
,PBP2A LEGACY,1
,"LEGIONELLA PNEUMOPHILA ANTIBODIES, TOTAL",1
47364-5,"DONOR, HEPATITIS B SURFACE AG W/REFL CONF",1
42675-9,HLA TYPING FOR CELIAC DISEASE,1
,HLA TYPING FOR CELIAC DISEASE,1
,"PYRIMIDINE 5' NUCLEOTIDASE, BLOOD- MAYO",1
17852-5,MYCOPLASMA / UREAPLASMA CULTURE,3
15388-2,MYCOPLASMA / UREAPLASMA CULTURE,3
43371-4,CDIFF A+B+GIARDIA+O+P+STOOL,1
6331-3,CDIFF A+B+GIARDIA+O+P+STOOL,1
673-4,CDIFF A+B+GIARDIA+O+P+STOOL,1
75514-0,LUPUS ANTICOAGULANT REFLEX LEGACY,3
43734-3,APTT MIXING STUDIES,2
5959-2,PT MIXING STUDY,1
33356-7,PT MIXING STUDY,1
33884-8,PT MIXING STUDY,1
8251-1,%INTERPRETATION,1
10701-1,O AND P 080206,1
10701-1,GIARDIA ANTIGEN W/REFL TO OVA AND PARASITES,1
6652-2,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
6932-8,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
31208-2,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
8251-1,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
42803-7,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
141-2,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
20396-8,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
29254-0,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
496-0,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
524-9,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",1
31208-2,FOLLOW UP CMA QPCR UNKNOWN VAR LEGACY,1
62357-9,FOLLOW UP CMA QPCR UNKNOWN VAR LEGACY,1
62365-2,FOLLOW UP CMA QPCR UNKNOWN VAR LEGACY,1
48672-0,FOLLOW UP CMA QPCR UNKNOWN VAR LEGACY,1
8246-1,URINALYSIS WITH CULTURE IF INDICATED,1
46137-6,URINALYSIS WITH CULTURE IF INDICATED,1
77202-0,%INTERPRETATION,1
,TISSUE SPECIMEN A,8
,"POLIOVIRUS (TYPE 1, 3) AB NEUTRA - MAYO",6
31208-2,STREPTOCOCCUS GROUP B DNA PCR BROTH ENRICHMENT LEGACY,25
8251-1,NOTE: LEGACY,1
25158-7,"FAT, URINE, QUALITATIVE",2
,MATERNIT21 TEST DECLINE,1
19145-2,TEST AUTHORIZATION 2 LEGACY,3
30896-5,TEST AUTHORIZATION 2 LEGACY,3
,TEST AUTHORIZATION 2 LEGACY,9
,Q FEVER ANTIBODY,5
19773-1,"IGP, APTIMA HPV, RFX 16/18,45",2
32286-7,HEPATITIS C GENOTYPE 550486,1
77202-0,HEPATITIS C GENOTYPE 550486,1
48707-4,MANUAL DIFF CELLAVISION,3
,TEST IN QUESTION - HISTOLOGY LEGACY,4
9795-6,STONE ANALYSIS W/O IMAGE,1
,"LYMPHOCYTE CLONALITY PANEL, PCR",1
,US OB LESS THAN 14 WEEKS EARLY,2
49549-9,CYSTIC FIBROSIS MUTATION PANEL (MAYO),1
49549-9,ALPHA-GLOBIN GENE ANALYSIS-MAYO,2
,HEMOSIDERIN STAIN REQUEST,6
28549-4,"YERSINIA CULTURE, STOOL",3
23877-4,EHRLICHIA ANTIBODY PANEL,1
47405-6,EHRLICHIA ANTIBODY PANEL,1
625-4,STOOL CULTURE PANEL SCH BSP,7
,ADDENDUM REPORT LEGACY,3
8251-1,THINPREP TIS PAP,1
47528-5,GYNECOLOGIC PAP TEST AGE-BASED GUIDELINE FOR CERVICAL CANCER (APTIMA),1
11546-9,GYNECOLOGIC PAP TEST AGE-BASED GUIDELINE FOR CERVICAL CANCER (APTIMA),1
47527-7,GYNECOLOGIC PAP TEST AGE-BASED GUIDELINE FOR CERVICAL CANCER (APTIMA),1
59420-0,GYNECOLOGIC PAP TEST AGE-BASED GUIDELINE FOR CERVICAL CANCER (APTIMA),1
8247-9,"UA/M W/RFLX CULTURE, COMP",1
,THYROID FNA EVALUATION REFLEX AFIRMA GENE SEQUENCING CLASSIFIER,5
48672-0,CHROMOSOME MICROARRAY,1
31208-2,CHROMOSOME MICROARRAY,1
,CHROMOSOME MICROARRAY,2
62357-9,CHROMOSOME MICROARRAY,1
62365-2,CHROMOSOME MICROARRAY,1
20507-0,Q RPR SCREEN WITH REFLEX TO TITER,1
19773-1,"PAP IG, HPV, RFX 16/18 (SP)",1
8266-9,"LEUKOVANTAGE(R), MYELOPROLIFERATIVE NEOPLASMS (MPN)",2
50398-7,"LEUKOVANTAGE(R), MYELOPROLIFERATIVE NEOPLASMS (MPN)",1
82939-0,"LEUKOVANTAGE(R), MYELOPROLIFERATIVE NEOPLASMS (MPN)",1
41103-3,"LEUKOVANTAGE(R), MYELOPROLIFERATIVE NEOPLASMS (MPN)",1
92732-7,"LEUKOVANTAGE(R), MYELOPROLIFERATIVE NEOPLASMS (MPN)",1
12710-0,HGB SOLUBILITY,3
13438-7,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",2
12851-2,"PROTEIN ELECTROPHORESIS AND KAPPA/LAMBDA LIGHT CHAINS, SERUM LEGACY",2
601-5,"CULTURE, FUNGUS, BLOOD LEGACY",1
533-0,"MYCOBACTERIUM, CULTURE, BLOOD",1
19145-2,TEST AUTHORIZATION 3,1
30896-5,TEST AUTHORIZATION 3,1
,TEST AUTHORIZATION 3,3
40431-9,"OSMOTIC FRAGILITY, RBC",1
59466-3,"OSMOTIC FRAGILITY, RBC",1
20401-6,"ANA PROFILE 11, POSITIVE",1
,"ANA PROFILE 11, POSITIVE",1
77202-0,"ANA PROFILE 11, POSITIVE",1
5077-3,"ANA PROFILE 11, POSITIVE",1
,"RNA, PCR (NONGRAPH) RFX/PS",2
49665-3,REFLEX TO PHENOSENSE(R),1
46137-6,"UA/M W/RFLX CULTURE, COMP",4
19769-9,"PAP IG, CT-NG, RFX HPV ALL",1
29541-0,RNA PCR(NONGRAPH)RFX/PSGT+IN,1
,RNA PCR(NONGRAPH)RFX/PSGT+IN,1
10381-2,RBC MORPHOLOGY,1
49034-2,THINPREP TIS PAP AND C. TRACHOMATIS AND N. GONORRHOEAE,2
,PAP LB (LIQUID-BASED),2
47528-5,PAP LB (LIQUID-BASED),2
19764-0,PAP LB (LIQUID-BASED),2
19767-3,PAP LB (LIQUID-BASED),2
6371-9,GIARDIA AND CRYPTOSPORIDIUM ANTIGEN PANEL,1
6412-1,GIARDIA AND CRYPTOSPORIDIUM ANTIGEN PANEL,1
93047-9,GENOSURE ARCHIVE(R),1
80693-5,GENOSURE ARCHIVE(R),1
80694-3,GENOSURE ARCHIVE(R),1
77202-0,INTERPRETATION LEGACY,1
43399-5,JAK2 V617F RFX CALR/E12-15/MPL,1
77202-0,JAK2 V617F RFX CALR/E12-15/MPL,1
72486-4,JAK2 V617F RFX CALR/E12-15/MPL,1
,JAK2 V617F RFX CALR/E12-15/MPL,2
77202-0,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",1
49549-9,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",1
52130-2,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",1
52131-0,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",1
52132-8,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",1
72486-4,"BCR-ABL1 GENE REARRANGEMENT, QUANTITATIVE PCR",1
90080-3,HIV 1 INTEGRASE GENOTYPE LEGACY,1
,HIV 1 INTEGRASE GENOTYPE LEGACY,1
33882-2,HIV 1 INTEGRASE GENOTYPE LEGACY,1
72525-9,HIV 1 INTEGRASE GENOTYPE LEGACY,1
72526-7,HIV 1 INTEGRASE GENOTYPE LEGACY,1
72857-6,HIV 1 INTEGRASE GENOTYPE LEGACY,1
8262-8,"DRUG SCREEN,COMPREHENSIVE (URINE)",1
12286-1,"DRUG SCREEN,COMPREHENSIVE (URINE)",1
13440-3,"IFE AND PE, RANDOM URINE",2
13992-3,"PE(RFX IFE), RANDOM UR LEGACY",1
8266-9,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
31208-2,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
50398-7,"JAK2 V617F CASCADING REFLEX TO CALR, JAK2 EXON 12, MPL, AND CSF3R",2
13438-7,PROTEIN ELECTROPHORESIS Q,1
1539-6,GLUCOSE TOLERANCE (4 SP BLOOD),1
1527-1,GLUCOSE TOLERANCE (4 SP BLOOD),1
1496-9,GLUCOSE TOLERANCE (4 SP BLOOD),1
1542-0,GLUCOSE TOLERANCE (4 SP BLOOD),1
6760-3,GLUCOSE TOLERANCE (4 SP BLOOD),1
36913-2,"XSENSE(R), FRAGILE X METHYLATION ANALYSIS",2
43182-5,"ENA, SCL 70, SS A, SS B",2
14030-1,"ENA, SCL 70, SS A, SS B",2
33569-5,"ENA, SCL 70, SS A, SS B",2
45142-7,"ENA, SCL 70, SS A, SS B",2
26975-3,"ENA, SCL 70, SS A, SS B",2
,IGE ALLERGENS(16) LEGACY,1
,PROTEIN C AND S ACTIVITY W/REFLEX TO ANTIGEN,1
31208-2,"TROPHERYMA WHIPPLEI DNA, QL, REAL TIME PCR",1
,"DRUG TOX MONITORING 8 SCREEN, URINE",1
14278-6,Q P ANCA TITER,1
14045-9,"D-LACTATE, P LEGACY",1
31147-2,"RAPID PLASMA REAGIN, QUANT",6
25158-7,URINALYSIS WITH CULTURE IF INDICATED,1
8100-0,ACID FAST SMEAR+CULTURE,3
8100-0,ACID FAST SMEAR AND CULTURE WITH REFLEX ID,1
3393-6,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
3879-4,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
19261-7,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
19429-0,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
19270-8,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
3390-2,"DRUG PROFILE, UR, 9 DRUGS LEGACY",2
18282-4,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
3936-2,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
19550-3,"DRUG PROFILE, UR, 9 DRUGS LEGACY",1
779-9,RBC MORPHOLOGY,1
49580-4,RAPID HIV 1&2 SCREEN BSP,4
18396-2,RAPID HIV 1&2 SCREEN BSP,4
77174-1,CALRETICULIN (CALR) MUTATION ANALYSIS,1
72486-4,CALRETICULIN (CALR) MUTATION ANALYSIS,1
62947-7,MPL MUTATION ANALYSIS,1
72486-4,MPL MUTATION ANALYSIS,1
31037-5,MYCOBACTERIUM AVIUM COMPLEX MIC PANEL,1
12-5,MYCOBACTERIUM AVIUM COMPLEX MIC PANEL,1
3097-3,COMPREHENSIVE METABOLIC PANEL W/O EGFR,1
8266-9,JAK2 EXON 12 MUTATION,1
31208-2,JAK2 EXON 12 MUTATION,1
50398-7,JAK2 EXON 12 MUTATION,1
88999-8,OMEGA 3 AND 6 FATTY ACIDS,3
7796-6,CBC WITH AUTO DIFFERENTIAL,4
42176-8,"FUNGITELL(R) (1-3)-B-D GLUCAN ASSAY,ENDPOINT",1
,TEST IN QUESTION - CYTOLOGY LEGACY,8
6919-5,"CHLAMYDIA TRACHOMATIS AB (IGG,IGA,IGM)",1
6918-7,"CHLAMYDIA TRACHOMATIS AB (IGG,IGA,IGM)",1
6920-3,"CHLAMYDIA TRACHOMATIS AB (IGG,IGA,IGM)",1
44079-2,"CHLAMYDIA TRACHOMATIS AB (IGG,IGA,IGM)",1
5260-5,Q ANTIMYOCARDIAL ANTIBODY TITER,1
19773-1,"PAP IG, CTNG, HPV, RFX 16/18 (SP)",2
5372-8,"STRIATION ABS, SERUM",1
21687-9,ALPHA-THALASSEMIA DNA ANALYSIS,2
49034-2,"THINPREP TIS PAP REFL HPV (IF ASCUS,+) REL GENOT",1
42595-9,HBV QUANT PCR RFX TO GENOTYPE LEGACY,1
,MYASTHENIA GRAVIS PROFILE,1
664-3,GENITAL CULTURE,2
19659-2,"PHENCYCLIDINE (PCP) SCREEN, URINE",2
,THROAT CULTURE,10
32769-2,ALPHA 1 ANTITRYPSIN (AAT)$PHENOTYPE,2
35265-8,PATHOLOGY SLIDE REVIEW PS CASE,1
29990-9,"POST-VAS SPERM EVALUATION,QUAL LEGACY",3
19769-9,"IGP, RFX APTIMA HPV ASCU",2
19764-0,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
10524-7,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",2
19763-2,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
19767-3,"THINPREP PAP, HPV MRNA E6/E7 RFX HPV 16,18/45, CHLAMYDIA/.E",1
94500-6,"Q SARS COV 2 RNA(COVID 19), QUALITATIVE NAAT",1
76070-2,Q RESPIRATORY VIRAL PANEL PCR,1
50595-8,ANTIPHOSPHOLIPID SYNDROME DIAGNOSTIC PANEL,2
21026-0,COAG STUDIES INTERP REPORT,3
21654-9,Q CFVANTAGE(R) CYSTIC FIBROSIS EXPANDED SCR,1
38404-0,Q CFVANTAGE(R) CYSTIC FIBROSIS EXPANDED SCR,1
8266-9,Q CFVANTAGE(R) CYSTIC FIBROSIS EXPANDED SCR,1
21656-4,Q CFVANTAGE(R) CYSTIC FIBROSIS EXPANDED SCR,1
,Q PANEL SUMMARY,2
19146-0,Q SMA CARRIER SCREEN,2
35462-1,Q SMA CARRIER SCREEN,2
54449-4,Q SMA CARRIER SCREEN,2
49857-6,Q SMA CARRIER SCREEN,2
,Q HSV 1 IGM TITER,1
8266-9,"BRCAVANTAGE(R), COMPREHENSIVE",2
69047-9,"BRCAVANTAGE(R), COMPREHENSIVE",1
77202-0,"BRCAVANTAGE(R), COMPREHENSIVE",1
15174-6,CRYOGLOBULIN,1
15175-3,CRYOGLOBULIN,1
48614-2,CRYOGLOBULIN,1
8251-1,URINALYSIS ONLY MICROSCOPIC,1
31208-2,CULTURE HERPES SIMPLEX VIRUS WITH TYPING LEGACY,2
5859-4,CULTURE HERPES SIMPLEX VIRUS WITH TYPING LEGACY,2
,CULTURE HERPES SIMPLEX VIRUS WITH TYPING LEGACY,2
13438-7,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
13440-3,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
2889-4,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",1
13801-6,"PROTEIN,TOTAL AND PROTEIN ELECTROPHORESIS,24 HOUR URINE AND N",2
5783-6,"UA/M W/RFLX CULTURE, COMP",1
5782-8,"UA/M W/RFLX CULTURE, COMP",1
20398-4,ENA+DNA + 160024,2
90739-4,PI-LINKED ANTIGEN-MAYO,1
8251-1,NOTE,1
5096-3,"COCCIDIOIDES ANTIBODY, CF",2
8251-1,Q URO RISK(R) DIAGNOSTIC PROFILE,1
8251-1,EBV ACUTE INFECTION ANTIBODIES,1
24475-6,Q PROTHROMBIN (FACTOR II) 20210G>A MUTATION,1
24476-4,Q PROTHROMBIN (FACTOR II) 20210G>A MUTATION,1
21668-9,Q FACTOR V (LEIDEN) MUTATION ANALYSIS,1
21667-1,Q FACTOR V (LEIDEN) MUTATION ANALYSIS,1
20398-4,ENA+DNA/DS+ANTICH+CENTRO+FA...,1
3879-4,071910 7 DRUG-SCR,1
3936-2,071910 7 DRUG-SCR,1
19261-7,071910 7 DRUG-SCR,1
19270-8,071910 7 DRUG-SCR,1
3390-2,071910 7 DRUG-SCR,1
18282-4,071910 7 DRUG-SCR,1
3393-6,071910 7 DRUG-SCR,1
19762-4,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",1
19769-9,"SUREPATH FPGS AND HPV MRNA E6/E7 REFLEX GENOTYPES 16,18/45",1
,VDRL,4
,CYSTIC FIBROSIS MUTATION PANEL (MAYO),1
,"METANEPHRINES, FRACTIONATED RANDOM URINE",1
,TEG FOR TRAUMA,30
66746-9,TEG FOR TRAUMA,10
,PLEASE NOTE,4
,CHROMOSOME ANALY PERIPHERAL BLD-GENZYME,1
23658-8,BLOOD CULT RT 997873,2
32635-5,FACTOR II INHIBITOR ASSAY,1
5959-2,FACTOR II INHIBITOR ASSAY,1
33356-7,FACTOR II INHIBITOR ASSAY,1
33884-8,FACTOR II INHIBITOR ASSAY,1
48018-6,LYNCH SYNDROME PANEL,5
82939-0,LYNCH SYNDROME PANEL,1
50398-7,LYNCH SYNDROME PANEL,2
69047-9,LYNCH SYNDROME PANEL,1
59462-2,INFLIXIMAB QUANT W/REFLEX TO AB - MAYO,1
,REQUEST PROBLEM,1
22322-2,HBV+MMR+VZ,1
49549-9,HEMOCHROMATOSIS MUTATION,1
,"LUNG CANCER TARGETED GENE PANEL REARRANGEMENT, TUMOR-MAYO",9
21668-9,FACTOR V(LEIDEN) MUTATION ANALYSIS W/RFL HR2 MUT,1
21667-1,FACTOR V(LEIDEN) MUTATION ANALYSIS W/RFL HR2 MUT,1
19773-1,PAP IG (IMAGE GUIDED),1
,AMNIOCENTESIS DIAGNOSTIC,1
,"5 HIAA, URINE, QUANTITATIVE, 24 HOUR",1
48672-0,FISH FOLLOW-UP KNOWN VARIANT LEGACY,1
31208-2,FISH FOLLOW-UP KNOWN VARIANT LEGACY,1
48674-6,FISH FOLLOW-UP KNOWN VARIANT LEGACY,1
62365-2,FISH FOLLOW-UP KNOWN VARIANT LEGACY,1
,"HIV RNA, QUANTITATIVE, PCR",1
,COCCIDIOIDES ANTIBODIES,1
,INSULIN ANTIBODY,1
50758-2,"HSV 1 AND 2 IGM ABS, INDIRECT",1
26927-4,"HSV 1 AND 2 IGM ABS, INDIRECT",1
,"CULTURE, QUANTITATIVE SMALL INTESTINAL BRUSHING",3
,"LEAD, BLOOD - MAYO",1
,LYMPH NODE CYTOGENETICS,1
9816-0,ACTINOMYCES CULTURE,1
,BLASTOMYCES ANTIBODIES,1
,"FUNGAL CULTURE, BLOOD",1
69047-9,"BRCAVANTAGE PLUS(R) (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)",2
8266-9,"BRCAVANTAGE PLUS(R) (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)",4
82939-0,"BRCAVANTAGE PLUS(R) (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)",2
36908-2,"BRCAVANTAGE PLUS(R) (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)",2
77202-0,"BRCAVANTAGE PLUS(R) (BRCA1, BRCA2, TP53, PTEN, CDH1, STK11, PALB2)",2
46137-6,URINALYSIS WITH MICROSCOPIC LEGACY,2
,HIV 1 GENOTYPING-LEGACY,1
,"OVA AND PARASITES, CONC/PERM SMEAR, 3 SPEC",1
21026-0,"PERIPHERAL BLOOD SMEAR, PATH REVIEW",1
,"CRYOGLOBULIN AND CRYOFIBRINOGEN PANEL, SERUM AND PLASMA",1
8251-1,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",1
77202-0,"NASH FIBRO TEST, SERUM AND PLASMA (MAYO)",1
69565-0,"BACTERIAL VAGINOSIS, NAA",1
69566-8,"BACTERIAL VAGINOSIS, NAA",1
69567-6,"BACTERIAL VAGINOSIS, NAA",1
,"ALLERGEN PROFILE, BASIC FOOD",1
,PNH WITH FLAER,1
,NEO-T CELL GENE REARRANGEMENT,1
,"NEURO-ONCOLOGY EXPANDED PANEL WITH REARRANGEMENT, TUMOR",3
34519-9,"HERED.HEMOCHROMATOSIS, DNA LEGACY",2
,ENA+DNA/DS+SJOGREN'S 016123,1
21003-9,"CULTURE, FUNGUS W/SMEAR NOT HAIR, SKIN, BLOOD",1
19764-0,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
10524-7,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
19763-2,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
19774-9,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
19767-3,"THINPREP TIS PAP AND HR HPV DNA REFLEX GENOTYPES 16,18",2
50659-2,"FISH,B CELL CHRONIC LYMPH LEUKEMIA PANEL",1
5245-6,"MEASLES (RUBEOLA) ANTIBODY, IGM - MAYO",1
,"BLADDER CANCER FISH, MD REVIEW LEGACY",1
56030-0,"BLADDER CANCER FISH, MD REVIEW LEGACY",1
31208-2,"BLADDER CANCER FISH, MD REVIEW LEGACY",1
33511-7,"BLADDER CANCER FISH, MD REVIEW LEGACY",1
19769-9,"PAP IG, CT-NG, HPV-HR",1
33248-6,%92133SB NAFLD FIBROSIS SCORE,2
88447-8,%92133SB NAFLD FIBROSIS SCORE,2
75514-0,LUPUS ANTICOAGULANT COMP LEGACY,1
,EXTRA BLUE-TOP TUBE LEGACY,2
18314-5,OB PANEL W/HIV,1
,AFIRMA GENE SEQUENCING CLASSIFIER,1
,MUSK ANTIBODY TEST LEGACY,1
19146-0,MUSK ANTIBODY TEST LEGACY,1
8251-1,MUSK ANTIBODY TEST LEGACY,1
49549-9,MUSK ANTIBODY TEST LEGACY,1
8265-1,MUSK ANTIBODY TEST LEGACY,1
,LYMPHOCYTE ACTIVITY PROFILE LEGACY,1
18314-5,LYMPHOCYTE ACTIVITY PROFILE LEGACY,1
,DNA SEQUENCING PR-RT,1
80692-7,DNA SEQUENCING PR-RT,1
80694-3,DNA SEQUENCING PR-RT,1
,TISSUE CULTURE BSP,4
43399-5,"JAK2 V617F, RFX CALR/MPL",1
77202-0,"JAK2 V617F, RFX CALR/MPL",1
72486-4,"JAK2 V617F, RFX CALR/MPL",1
,"JAK2 V617F, RFX CALR/MPL",1
72486-4,"JAK2 V617F, QUANTITATIVE",1
43399-5,"JAK2 V617F, QUANTITATIVE",1
77202-0,"JAK2 V617F, QUANTITATIVE",1
49549-9,"JAK2 V617F, QUANTITATIVE",1
75608-0,"JAK2 V617F, QUANTITATIVE",1
10753-2,"FECAL FAT, QUALITATIVE",1
2902-5,"PYRIMIDINE 5' NUCLEOTIDASE, BLOOD- MAYO",1
,HPA TEST,1
,"ALLERGENS, ZONE 4",1
35265-8,PATHOLOGY PNEUMO PREP REQUEST,2
47982-4,"EBV DNA, QUANTITATIVE, REAL-TIME PCR",1
,"SEASONAL ALLRGNS, FALL--WEED",1
40661-1,"PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS, RANDOM URINE (REL)",1
50996-8,Q BETA GLOBIN COMPLETE,1
33358-3,"L - PE AND FLC, SERUM",1
77202-0,"L - PE AND FLC, SERUM",1
69048-7,DENGUE ANTIBODIES IGG IGM,1
77202-0,ADALIMUMAB LEVEL FOR RHEUMATIC DISEASEDISEASES,1
8251-1,ADALIMUMAB LEVEL FOR RHEUMATIC DISEASEDISEASES,1
,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
47527-7,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
47528-5,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
19764-0,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
19767-3,"HPV, COBAS HIGH-RISK/16/18 LEGACY",1
82520-8,Q HEPATITIS C VIRAL RNA GENO 1 NS5A DRUG RESIST,2
82380-7,Q HEPATITIS C VIRAL RNA GENO 1 NS5A DRUG RESIST,2
82379-9,Q HEPATITIS C VIRAL RNA GENO 1 NS5A DRUG RESIST,2
82377-3,Q HEPATITIS C VIRAL RNA GENO 1 NS5A DRUG RESIST,2
82378-1,Q HEPATITIS C VIRAL RNA GENO 1 NS5A DRUG RESIST,2
82376-5,Q HEPATITIS C VIRAL RNA GENO 1 NS5A DRUG RESIST,2
51968-6,MPN PROFILE,2
51968-6,"CHROMOSOMAL MICROARRAY, POSTNATAL, OLIGO SNP",1
,"CMV DNA, QUANTITATIVE, PCR LEGACY",2
42216-2,"DRUG TOX MONITORING 9 W/CONF, URINE LEGACY",2
18482-0,"CULTURE, YEAST, W/IDENTIFICATION",1
8266-9,"SURESWAB(R), RECURRENT VAGINITIS",1
69564-3,"SURESWAB(R), RECURRENT VAGINITIS",1
87755-5,C DIFF TOX B GENE DETECTION BY PCR SCH BSP,4
59462-2,FATTY ACID PROFILE COMPREHESIVE C8-C26 - MAYO,2
87755-5,C DIFF TOX B GENE DETECTION BY PCR,1
2112-1,"PREGNANCY, URINE",1
,"HERPES SIMPLEX VIRUS, MOLECULAR DETECTION, PCR, SPINAL FLUID, MAYO",1
,OUTSIDE CONSULT REPORT LEGACY,4
93047-9,HIV GENOSURE (R) INTEGRASE LEGACY,1
,HIV GENOSURE (R) INTEGRASE LEGACY,1
93047-9,GENOSURE(R) MG,1
53798-5,GENOSURE(R) MG,1
16117-4,TICK BORNE DISEASE AB PANEL,1
16118-2,TICK BORNE DISEASE AB PANEL,1
23877-4,TICK BORNE DISEASE AB PANEL,1
8251-1,TICK BORNE DISEASE AB PANEL,2
48850-2,TICK BORNE DISEASE AB PANEL,1
51760-7,TICK BORNE DISEASE AB PANEL,1
47405-6,TICK BORNE DISEASE AB PANEL,1
23878-2,TICK BORNE DISEASE AB PANEL,1
55150-7,TICK BORNE DISEASE AB PANEL,1
41415-1,TICK BORNE DISEASE AB PANEL,1
88700-0,TICK BORNE DISEASE AB PANEL,1
,"NICOTINE METABOLITE, URINE LEGACY",2
7905-3,HEPATITIS B SURFACE ANTIGEN,2
41270-0,"COMPREHENSIVE DRUG ANALYSIS,UR",1
,ORPHAN SPECIMEN,5
,Q CBC MORPHOLOGY,1
32623-1,PLATELET CTAD,1
47528-5,"PAP IG, CT-NG TV",1
19764-0,"PAP IG, CT-NG TV",1
19767-3,"PAP IG, CT-NG TV",1
19769-9,"PAP IG, CT-NG TV",1
,"PAP IG, CT-NG TV",1
47527-7,"PAP IG, CT-NG TV",1
58430-0,"OXYCODONE/OXYMORPHONE SCR, UR",1
38373-7,"BUPRENORPHINE CONFIRM, URINE",2
93047-9,RFLX TO GENOSURE(R) MG,1
53798-5,RFLX TO GENOSURE(R) MG,1
5640-8,"ALCOHOL, ETHYL",4
31208-2,"ALCOHOL, ETHYL",2
8262-8,"DRUG SCREEN PANEL 1, SERUM",2
31208-2,"DRUG ABUSE PNL 8, W/CONF, SERUM AND VOLATILES, B",1
9334-4,"DRUG ABUSE PNL 8, W/CONF, SERUM AND VOLATILES, B",1
3528-7,"DRUG ABUSE PNL 8, W/CONF, SERUM AND VOLATILES, B",1
12286-1,"DRUG SCREEN PANEL 1, SERUM",1
,"DRUG SCREEN PANEL 1, SERUM",1
7792-5,CBC WITH AUTO DIFFERENTIAL,1
,FROZEN SECTION REQUEST,2
77202-0,ADALIMUMAB DRUG LEVEL AND ANTI-DRUG ANTIBODY FOR IBD (Q),1
8251-1,ADALIMUMAB DRUG LEVEL AND ANTI-DRUG ANTIBODY FOR IBD (Q),1
,FECAL LEUKOCYTES,1
634-6,"Q CULTURE, AEROBIC BACTERIA",1
635-3,"Q CULTURE, ANAEROBIC BACTERIA W/GRAM STAIN",1
31208-2,"SUSCEPT, ANTIMIC, AEROBIC BACTERIA, CUSTOM MIC 1",1
42803-7,"SUSCEPT, ANTIMIC, AEROBIC BACTERIA, CUSTOM MIC 1",1
23658-8,"SUSCEPT, ANTIMIC, AEROBIC BACTERIA, CUSTOM MIC 1",1
21070-8,"SUSCEPT, ANTIMIC, AEROBIC BACTERIA, CUSTOM MIC 1",1
,HEPATITIS C GENOTYPE,1
,"SPERMATOZOA, POST VASECTOMY SCREEN",1
,"SUSCEPTIBILITY, AEROBIC BACTERIUM",1
,"SUSCEPTIBILITY,AEROBIC BACTERIA, MIC LEGACY",10
30089-7,"UA/M W/RFLX CULTURE, COMP",1
38459-4,"UA/M W/RFLX CULTURE, COMP",1
9842-6,"UA/M W/RFLX CULTURE, COMP",1
5946-9,INHIBITOR (MIXING) STUDY,1
43734-3,INHIBITOR (MIXING) STUDY,1
30323-0,INHIBITOR (MIXING) STUDY,1
82939-0,"NEURO-ONCOLOGY EXPANDED PANEL WITH REARRANGEMENT, TUMOR",2
69047-9,"NEURO-ONCOLOGY EXPANDED PANEL WITH REARRANGEMENT, TUMOR",2
31208-2,"NEURO-ONCOLOGY EXPANDED PANEL WITH REARRANGEMENT, TUMOR",2
80398-1,"NEURO-ONCOLOGY EXPANDED PANEL WITH REARRANGEMENT, TUMOR",2
19773-1,"IGP,CTNGTV,APT HPV,RFX16/18,45",1
26927-4,Q HSV 2 IGM TITER,1
,"CHROMOSOME ANALYSIS, HIGH RESOLUTION",1
,"SYNOVIAL FLUID, CRYSTAL",4
58430-0,OXYCODONE/OXYMORPHONE CONFIRM,1
19643-6,OXYCODONE/OXYMORPHONE CONFIRM,1
18325-1,OXYCODONE/OXYMORPHONE CONFIRM,1
,ONE SPECIMEN IDENTIFIER LEGACY,2
,UNABLE TO VOID,1
,CYSTIC FIBROSIS GENE TEST,1
,HCV INTERPRETATION:,1
,QUANTITATIVE BRONCHOALVEOLAR LAVAGE CULTURE,2
57317-0,FISH PRENATAL SCREEN,1
50397-9,"NEURO-ONCOLOGY EXPANDED PANEL WITH REARRANGEMENT, TUMOR",1
22322-2,HBV SCREENING AND DIAGNOSIS,1
,HBV SCREENING AND DIAGNOSIS,1
95236-6,HBV SCREENING AND DIAGNOSIS,1
77202-0,L - LIPID PANEL 303756,1
,BCR/ABL BY FISH-BONE MARROW OR BLOOD- NEOGENOMICS,1
,"IFE AND PE, RANDOM URINE",1
18314-5,T-AND B-LYMPHOCYTE/NAT KILLER LEGACY,1
,Platelet Appears,4237
6742-1,RBC Morph,4237
,Sample Ven,810
,RR/IVM Ven,624
,Site Ven,624
,Site Cap,1812
,Sample Cap,1813
5813-1,UA Trichomonas,2127
31999-6,UA Broad Cast,2127
5815-6,UA Tyrosine Crys,2127
5798-4,UA Leucine Crys,2127
33862-4,UA Waxy Cast,2127
25157-9,UA Epi Cast,2127
25160-3,UA Gran Cast,2127
25162-9,UA Hyal Cast,2127
5767-9,UA Appear,2459
5778-6,UA Color,223333
67848-2,UA WBC Clumps,2130
,UA RBC Clumps,2128
5784-4,UA Cystine Crys,2127
5773-7,UA CA Carbonate Crys,2127
,UA CA Phospate,2045
2272-3,UA Fat,2127
25159-5,UA Fatty Cast,2127
33825-1,UA WBC Cast,2127
25158-7,UA Oval Fat Body,2127
41865-7,UA Hyphae Yeast,2127
,RPP Comment,380
,History Check,1010
882-1,ABO/Rh,810
,Reason for Irr Blood,608
,PRBC Special Requirements,230
,Reason*,964
,Red Blood Cells LR/Irr Product*,233
53799-3,Computer XM Interp,701
,Internal QC,4003
,T Helper/Suppressor Panel Interpretation,67
,Celiac Genetics,14
,ATG16L1 SNP (rs2241880),30
,IBD sgi Diagnostic,30
,NKX2-3 SNP (rs10883365),30
,ECM1 SNP (rs3737240),30
,STAT3 SNP (rs744166),30
,RBC Special Requirements,375
,Red Blood Cell Product*,375
,Requested Reference Lab,66
,Sample Art,1003
60489-2,Group A Strep DNA,451
,Anser IFX.,213
31208-2,Mycopls PCR Source,1
6920-3,C Trachomatis M,4
,C Pneumoniae G,4
6919-5,C Trachomatis G,4
6914-6,C Pneumoniae M,4
6917-9,C Psittaci IgM,4
6916-1,C Psittaci IgG,4
3232-6,Factor XII,4
3226-8,Factor XI,4
3187-2,Factor IX Activ,5
3218-5,Factor X Activ,3
,Von Willebr Pkg,7
3209-4,Factor VIII Act,4
882-1,ABO/Rh Tube,200
30083-0,EBV Nuclear Ag IgG,147
10335-8,Color CSF,175
10333-3,Appear CSF,175
,Anser VDZ,20
,Consent discussed,108
,POC Ur Dipstick Color,125
,POC Ur Dipstick Appearance,125
,Drug Comment,172
,Cut Off DAU,172
,U Cannab Scr Internal Ctl,172
,U Cocaine Internal Ctl,172
,U PCP Scr Internal Ctl,172
,U Oxy Scr Internal Ctl,172
,U Propoxyphene Internal Ctl,172
,U MTD Scr Internal Ctl,172
,U Benzodia Scr Internal Ctl,172
,U Amph Internal Ctl,172
,U Barb Scr Internal Ctl,172
,U Methamp Internal Ctl,172
,U Opiate Scr Internal Ctl,172
,U TCA Scr Internal Ctl,172
,Cassette Expiration Date,171
,Specimens Collected,3
42216-2,Reference Lab,3
,Bz U Chain of Cust,22
,MTB Complex PCR,7
14725-6,Protein Total Fluid Type,9
14725-6,Cell Cnt BF Type,32
6824-7,Color BF,32
9335-1,Appear BF,32
,Comment BF,4
14725-6,LDH BF Type,9
,Bacterial 16S RDNA CSF,20
,Fungal PCR,5
14869-2,Path Review,14
,Human 3PLX2 Luminex,13
,Human CEACAM-1 Luminex,13
,Human 3PLX200 Luminex,13
,Human MMP Luminex,13
,Human IL-7 Luminex,13
,Monitr Crohn's Disease,13
,Cortical Brain Malformations,1
14725-6,Glucose BF Type,9
,THC U Chain of Cust,54
40724-7,Hep A IgG,15
14725-6,Alb BF Type,2
,TR Culture,1
,C/T-13910,4
,Lactose Intolerance (Hypolactasia Varian,4
46268-9,TR Unit ABO/Rh,1
,Initial TR Interp,6
882-1,Post-TR ABO/Rh,1
,Product Number,1
,DOB Match,5
,Unit ABO/Rh Match,5
,Unit Number Match,5
,Patient Name Match,5
,Patient MRN Match,5
,BBID Number Match,5
,Crossmatch Compatible,5
882-1,Pre TR ABO/Rh,1
,HGB Interp,35
1251-8,Crossmatch IS,268
,Oxidative Burst,1
,TR Interp,5
,Karius Test,18
,Elution Testing,5
888-8,Antibody ID,10
,DAT C3 QC,22
1007-4,DAT IgG and C3,22
,Fresh Frozen Plasma Product*,59
,C H pyl Status (Focus),15
,C H pyl Gram Stain (Focus),15
,C H pyl Culture (Focus),15
40703-1,Lactoferrin Stl,1
,Reflex Added,10
,PAVAL Interp Comments,2
,Plt Pher Special Requirements,268
,Platelet Pheresis Product*,274
,Cryoprecipitate Product*,23
,Site ArtPump,26
,Sample Art Pump,26
,Site Ven Pump,14
,Sample Ven Pump,14
3180-7,Cardiolipin Ab (BC),3
44447-1,Beta 2 Glyco Ab,4
,Thrombosis Pk A,2
3198-9,Factor VII,3
14725-6,Creat BF Type,17
14725-6,Urea BF Type,39
,C H pyl MIC Panel-Org,5
,C H pyl MIC Panel-Clarith,5
,Candida Ag,1
20507-0,RPR Ql,65
,HTLV I/II Bands,1
,HTLV I/II Confirmation,1
,Cell Markers,47
,Lymphoid Tissue Panel,7
32769-2,A-1-AT Pheno,6
,Sweat Cl Interp,4
,Peak # 8 (Qualitative),6
,Peak # 9 (Qualitative),6
,Peak # 10 (Qualitative),6
,Peak # 2 (Qualitative),6
,Peak # 1 (Qualitative),6
,Peak # 7 (Qualitative),6
,Peak # 3 (Qualitative),6
,Peak # 4 (Qualitative),6
,Peak # 5 (Qualitative),6
,Peak # 6 (Qualitative),6
,Crossmatch Extend,230
49248-8,Interp Ur Amino acids,1
,Wilson Dis ATP7B Seq Anly,1
6173-9,Mesquite IgE,1
,A-Glob Result,2
,A-Glob Method,2
,A-Glob Additional Info,2
,A-Glob Interp,2
,A-Glob Source,2
,A-Glob Spec,2
,A-Glob Released By,2
,Jaundice Panel,1
,JAG1 Gene,1
,Encep Eval Interp,8
,Cunningham Pnl,1
43113-0,Hgb Electro,2
14611-8,ANA Pattern,104
,HLA-B27 Interp,9
,Current Adalimumab start date,5
,Prometheus Reason for Order,12
,Prior Adalimumab frequency (weeks),5
,Prior Adalimumab dose (mg),4
,Prior Adalimumab start date,5
,Current Adalimumab dose (mg),5
12841-3,PSA Free/PSA,1
45270-6,Acute Leukemia Scr,22
,Celiac Plus,15
,Celiac Disease Serology,13
,UGT1A1 Genotyping Gilbert,1
,Lupus Anticoag,9
,Current Inflisimab start date,12
,Prior Inflisimab start date,12
,Prior Inflisimab freq (wks),12
,Current Inflisimab freq (wks),12
,Current Inflisimab dose (mg/kg),12
,Prior Inflisimab dose (mg/kg),13
,Reflex Added CSF,4
,NMDA-R Ab CBA CSF,2
,Enceph Eval Interp CSF,4
17726-1,FTA-ABS,3
,Dengue Fev Interp,1
,S ustekinumab  (UST) conc,5
,Ab's to ustekinumab (ATU) conc,5
,QC Exp Date,10
,External Pos Ctl,10
,External Neg Ctl,10
,ALPS Pan Interp,4
,Dengue Virus 1 or 3 RNA,1
,Dengue Virus 2 or 4 RNA,1
47532-7,Mumps Virus Qual RT PCR,1
,Chimerism,16
,SARS-CoV-2 Patient Race,20
31208-2,SARS-CoV-2 Source,191
,SARS-CoV-2 Patient Ethnicity,20
,VWF Tech Interp,2
,SC5B-9 (Mac Complex),7
,HLA Ab SA Class I,1
,HLA Ab SA Class II,1
31208-2,K kingae Source,1
,"Amikacin Lvl, Peak",7
,"Amikacin Lvl, Trough",11
59462-2,Porphyrins Intrp,2
,Porph Reviewed By,2
,U Porphyrin Interp,3
,Bacteria Stl,8
,ST2 aGVHD,4
,Porphobil Ur Qt,1
,Porphobil Intrp,1
,Porphobil Rev By,1
4532-8,CH50,6
,PNH Flaer/CD59,1
6955-9,B henselae IgM,12
6954-2,B henselae IgG,12
9361-7,B quintana IgM,12
9360-9,B quintana IgG,12
,Plt Aggregation,2
,Biotinidase (Interp),3
888-8,Ref Antibody ID,7
,Soluble Interleukin,5
,Comp Drug Analy,9
,HIT Ab,1
3289-6,Factor II,1
31208-2,JC Source,1
2638-5,"Myelin Basic Protein, CSF",1
,Myelin Oligo Glyco,2
,Organic Acids Ur (Mayo),1
,NK Function,1
,Lyme Ab Conf Interp,2
,IgG Band(s),2
,IgM Band(s),2
,F5DNA Interp,2
,F5DNA Reviewed By,2
21668-9,Factor V Leiden (R506Q),2
32217-2,VWF Multimer,2
11006-4,Lyme Ab,1
,B. mayonii PCR,1
4991-6,B. burgdorferi PCR,1
,B. garinii/B. afzelii PCR,1
4991-6,Lyme PCR comment,1
31208-2,Lyme Source,1
,U Tot Porphyrins,3
,U Coproporphy,3
,U Pentacarboxyp,3
,U Uroporphyrin,3
,U Hexacarboxyp,3
,U Heptacarboxyp,3
,BM Failure Syndrome Pnl,1
,Porph RBC Eval Interp,1
,Neuromyelitis Optica AutoAb IgG CSF,1
,Mycoplasma DNA Source,1
,Myo Anti-U1-RNP Ab,1
,Myo Fibrillarin (U3 RNP),1
,Myo MDA-5 (P140/CADM-140),1
,Myo NXP-2 (P140),1
,Myo TIF1 GAMMA (P155/140),1
,"Myo Anti-SS-A 52 kD Ab, IgG",1
,"Myo Anti-SAE 1, IgG",1
,MYO Anti-PM/Scl-100 Ab,1
,Myo Anti-Jo-1 Ab,1
,Myo EJ,1
,Myo PL-7,1
,Myo PL-12,1
,Myo KU,1
,Myo OJ,1
,Myo SRP,1
,Myo MI-2,1
,Myo U2 SNRNP,1
,TPMT Enz (Prometheus),4
,PT/PTT Mixing,1
,M. Pneumoniae Ab CF CSF,1
,M Spike 2 SPE,4
,M Spike 1 SPE,4
,SPE Impression,4
23905-3,"Mycophenolic Acid, S",2
23906-1,MPA Glucuronide,2
,Hemochr Order Date,1
,Hemochr Specimen,1
31208-2,Hemochr Source,1
,Hemochr Specimen ID,1
,Hemochr Reviewed by,1
,Hemochr Results,1
,Hemochr Method,1
,Hemochr Ammend,1
,Hemochr Interp,1
,Hemochr Release Date,1
,Pan ANCA AutoAb,4
5290-2,VDRL Scr CSF,1
,TPMT Enzyme,2
,Parvo B19 Int,3
,Vitamin B3 Lvl,1
,Ph-Like ALL Panel FISH,2
,NGAMT Variants,2
,NGAMT Result,2
,Pathogenic Mutations Det,2
,NGAMT Interp,2
,NGAMT Clin Trials,2
,NGAMT Reviewed by,2
,NGAMT Addl Notes,2
,NGAMT Method Sum,2
,NGAMT Disclaimer,2
,AML 4 Gene Panel,2
,NGAMT Diag/Ind,2
,NGAMT Spec Type,2
41048-0,TPMT Genotype,1
79713-4,TPMT Phenotype,1
,NUDT15 Genotype,1
,NUDT15 Phenotype,1
,TPMT/NUDT15 Interp,1
,Flow Cytometry and FISH,1
,BoneMarrow Flow,2
,MRD-Bone Marrow Asp,9
,Endoscopic Healing Index Score,1
,CK Isos Electrophoresis,2
2157-6,CK Total Activity,1
,Total CK (Isos),2
,"HLA A, B, C, DR, DQ High Res",4
,Soluble CD163,3
,Asparaginase Assay,3
,Ur Meth Chain of Custody,1
,Ur Methadone Intrepretation,1
11280-5,Cabot Ring,1
,NGS HLH Panel,1
,U Thymine,1
,U Uric Acid Pur/Pyr,1
,U Hypoxanthine,1
,PUPYU Interpretation,1
,U Deoxythymidine,1
,U Adenine,1
,U Xanthine,1
,U Orotic Acid,1
,U Dihydroorotic,1
,U Uracil,1
,U Deoxyinosine,1
,U Deoxyuridine,1
,U Thymidine,1
,U Uridine,1
,U Deoxyadenosine,1
,U AICAR,1
,U Deoxyguanosine,1
,U Adenosine,1
,U Inosine,1
,U Guanosine,1
,U N-carbamoyl-beta-aminoisobutyric Acid,1
,U Succinyladenosine,1
,U Dihydrouracil,1
,U Dihydrothymine,1
,U N-carbamoyl-beta-alanine,1
,PUPYU Reviewed By,1
3948-7,Phenobarbital Level (Mayo),1
3978-4,Primidone Level,1
2755-7,pH Stool,3
13967-5,Sex Hormone Binding Glob,1
,Heparin Inhib,2
,HIT Comment,2
31208-2,Adenovirus Qn Source,4
,Ref Ranges BM,1
882-1,Ref ABO/Rh Typing,3
,Parvo B19 Source,3
,Mycobacterium Non-Tuberculosis DNA,2
,Mycobacterium by PCR,6
,HLA A Low Res,1
,HLA B Low Res,1
,HLA DR High Res,1
,BMT Screen,5
,Hep-PF4 Ab (HIT) (Group),2
,Co U Chain of Cust,1
31208-2,HHV-6 Source,1
44728-4,Celiac HLA DQ Alpha 1,1
43291-4,Celiac HLA DQ Beta 1,1
,Celiac Gene Pairs Present?,1
,Celiac Disease Interp,1
,"IgLON5 IFA, S",8
,Inflam Bowel Dis: Seq,1
14725-6,Amy BF Type (Mayo),1
,Lipid An Fluid Type,8
43837-4,Influenza A IgG,1
43838-2,Influenza A IgM,1
,Acylglyc Ur Interp,1
,Acylglyc Ur Rev By,1
,Famil Med Fever,1
31208-2,FACV Specimen,1
,ANA Titer (Specialty),2
,ANA Pattern (Specialty),2
21419-7,ANCA Pattern,359
,VDRL Scr,2
47938-6,pH BF Source,3
,Histone Auto Ab,1
,Fetal Fibronectin,1
,Ref Lab XM Interp,11
,Lymph Prolif Mito Interp,2
,Mitogen Comment,2
,Ref Direct Coombs,1
62364-5,NGSHM Disclaimer,3
,NGSHM OncoHeme Pnl Gene List,3
,NGSHM Reviewed by,3
,NGSHM Diagnosis/Indication,3
,NGSHM Spec type,3
,NGSHM Clinical Trials,3
,NGSHM Pathogenic Muts Det,3
,NGSHM Interp,3
,NGSHM Method Summary,3
,NGSHM Variant of Unknown Significance,3
,NGSHM Addtl Notes,3
,NGSHM Result,3
,Infliximab Activity and Neutralizing Ab,1
,Interleukin 1-Alpha,2
,B Cell Panel,2
14869-2,BF Path Review,1
67151-1,"Troponin T, 5th Gen",1
,PNH Interp,1
12183-0,Chol BF,2
14045-9,D-Lactate Lvl,1
6742-1,RBC MORPHOLOGY,36216
10381-2,TARGET CELLS,7802
7793-3,HOWELL-JOLLY BODIES,1224
,Prev Pregnancy Down Synd,2613
800-3,SCHISTOCYTES,2862
11274-8,ELLIPTOCYTES,7736
803-7,TOXIC GRANULATION,1245
7791-7,TEAR DROP CELLS,1956
7798-2,SMUDGE CELLS,678
7795-8,PAPPENHEIMER BODIES,284
802-9,SPHEROCYTES,288
7792-5,DOHLE BODIES,498
,Ultrasonographer's Name,963
10379-6,DUAL RBC POPULATION,216
703-9,BASOPHILIC STIPPLING,516
7789-1,ACANTHOCYTES,701
10380-4,STOMATOCYTES,381
,Ultrasound Date,963
50670-9,AGGLUTINATED RBC,74
7797-4,ROULEAUX,60
5784-4,CYSTINE CRYSTALS,4
29629-3,3-METHYLGLUTACONIC,1
18314-5,Hematology Comments,897
31208-2,SPECIMEN TYPE,142
13359-5,Appearance,85963
69566-8,BVAB 2,492
9796-4,CSF COLOR,1117
19764-0,Statement of Adequacy,2166
48803-1,Open NTD Risk Est,1430
888-8,Antibody Identification 1,72
634-6,Aerobic Bacterial Culture,894
11483-5,,269
12286-1,$URINE RESULTS,57
8251-1,SERVICE COMMENT,90
9754-3,COXSACKIE A4 AB,1
31208-2,Specimen Type:,88
,PANIC VALUE CALLED,48696
5778-6,COLOR,97534
14664-7,COLOR,36
8266-9,ASSAY DETAILS,20
31208-2,Specimen Type,1648
2270-7,"Fat Qual Total, Stl",6
93491-9,"AMPA-R Ab CBA, CSF",11
,Intact PTH,96
34187-5,DNA Ab (DS) Crithidia Titer,54
634-6,"CULTURE, AEROBIC BACTERIA",280
48558-1,HIV GenoSure(R),7
,PhenoSense Integrase(TM)Interp,1
193-3,CLINDAMYCIN,84
5781-0,"CRYSTALS, SYNOVIAL FLUID",19
7837-8,COXSACKIE B2 AB,20
82939-0,VARIANT INTERPRETATION (FAM HYPERCHOL PANEL),1
93489-3,"AMPA-R Ab CBA, S",7
21723-2,"AAT, DNA Analysis",5
,"AChR Ganglionic Neuronal Ab, S",5
31208-2,SPECIMEN TYPE RECEIVED:,56
14278-6,P-ANCA,64
9447-4,HEPTACARBOXYPORPHYRIN,2
,Ethnicity:,89
,Interpretation,1286
15847-7,CLASS,1
,Cells Counted,1
59466-3,"INTERPRETATION (PLATELET AB SCREEN, S)",1
,F PROCEDURE,20
69353-1,HIV-2 RNA,1
,Prescribed Drug 1,273
,H PROCEDURE,16
,I PROCEDURE,16
,G PROCEDURE,17
,J PROCEDURE,15
,K PROCEDURE,15
,L PROCEDURE,15
,# of Genotyping Targets,6
13299-3,HLA-B,12
9335-1,"Clarity, Fluid",7
,Additional Information:,8
,Donor Egg,2613
32356-8,Yeast,33
29630-1,3-METHYLGLUTARIC,1
19773-1,Recommendation:,14
14327-1,Epithelial Cells,6
19146-0,RESULTS RECEIVED,26
,Client Specimen ID:,31
10333-3,APPEARANCE,11
5048-4,ANA TITER,25
42803-7,ORGANISM,6
13068-2,ANA PATTERN,76
20625-0,"LEAD, URINE",20
,Prescribed Drug 2,92
21419-7,ANCA PATTERN,3
116-4,CEFOXITIN,12
12-5,Amikacin,17
49503-6,ATYPICAL P ANCA TITER,72
5285-2,POLIO 3 TITER,6
13362-9,DURATION (MIN),1
14869-2,RBC,15
883-9,ABO Grouping,4175
13363-7,COLLECTION DURATION,3
49546-5,SPECIMEN AGE,4
6825-4,"CRYSTALS, FLUID",1
3834-9,"NAPA",4
687-4,MYCO/UREAPLASMA RESULT,3
29880-2,2-HYDROXY-3-METHYLVALERIC,1
,Reflex Criteria,14
31208-2,"STREPTOCOCCUS PNEUMONIAE AG, SOURCE",14
48005-3,AMINO ACID,2
31208-2,SOURCE:,157
,Director Review:,19
48558-1,GeneSeq(TM) PDF,4
,PATHOLOGIST:,13
3675-6,HYDROCHLOROTHIAZIDE,1
9802-0,Size,11
10332-5,CORTISOL 1,2
9374-0,"Clarity, CSF",2
33477-1,Interpretation,8
10898-5,E.EQUINE ENCEPH.VIRUS IGM,2
32701-5,MICROSPORIDIA ID,2
52131-0,E14A2 (B3A2) TRANSCRIPT,6
31208-2,SARS-COV-2 (COVID-19) SOURCE:,84
10860-5,"CULT, VARICELLA-ZOSTER",1
6331-3,Campylobacter Culture,146
5106-0,COXSACKIE B2 AB,1
,M PROCEDURE,1
5077-3,ANTI-CENTROMERE AB (RDL),2
31208-2,SPECIMEN SOURCE,1
23658-8,ANTIMICROBIAL 2,1
14278-6,P ANCA TITER,2
3426-4,MARIJUANA METABOLITES,2
19762-4,General Categorization,764
42805-2,FUNGUS IDENTIFIED,2
13466-8,"LEAD, RANDOM URINE",23
56888-1,"HIV AG/AB, 4TH GEN",9153
31208-2,G SOURCE,20
5814-9,Triple Phosphate Crystals,211
29868-7,4-HYDROXYBUTYRIC,1
18311-1,PELGER-HUET,7
29869-5,4-HYDROXYCYCLOHEXYLACETIC,1
79712-6,HLA-A*31:01,5
,PREGNANCY RESULT OF IVF,151
53311-7,URIC ACID CRYSTAL,213
27270-8,4-HYDROXYPHENYLACETIC,1
57979-7,HLA-B*15:02,5
,Mother's Ethnic Origin,2602
49505-1,RBC CLUMPS,60
50233-6,WBC CLUMPS,898
84925-7,Purkinje Cell Cytoplasmic Ab Type 2,13
31208-2,F SOURCE,25
46138-4,Uric Acid Crystals,35
26685-8,3-HYDROXYISOVALERIC,1
5819-8,WAXY CASTS,35
79721-7,CYP4F2 GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
43994-3,T18 Risk,440
,Director Review,146
12454-5,Amorphous,105
84926-5,Purkinje Cell Cytoplasmic Ab Type Tr,13
29625-1,3-HYDROXYPROPIONIC,1
79719-1,DPYD GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
47223-3,T18 (By Age),442
,Insulin Depend Diabetic,1666
29626-9,3-HYDROXYSEBACIC,1
29627-7,3-HYDROXYVALERIC,1
,Hx Of Neural Tube Defects,2612
25153-8,"Cholesterol Crys, UA",2
24436-8,3-METHYLCROTONYLGLYCINE/CREATININE,1
,Prescribed Drug 5,14
31208-2,I SOURCE,18
53278-8,RBC CAST,17
30472-5,ETHYLMALONIC,1
69567-6,Megasphaera 1,490
49549-9,METHOD,120
43995-0,MSS# Down Syndrome Risk,961
38404-0,INTERPRETATION,104
14277-8,C-ANCA,64
9755-0,COXSACKIE A7 AB,1
11070-0,Micro Description A,715
29605-3,APPEARANCE,34
7838-6,COXSACKIE B3 AB,20
18868-0,Aztreonam,19
49549-9,METHODS AND LIMITATIONS,7
53037-8,CLASSIFICATION (BRCA PANEL),1
,"Amphiphysin Ab, S",13
9825-1,IDENTIFICATION:,1
29953-7,ANA TITER,566
49090-4,Age Risk Down Syndrome,200
580-1,Fungus (Mycology) Culture,17
13202-7,"LYME DISEASE AB (IGG), IBL",6
30896-5,REFERENCE LAB TEST IDENTIFIER,5
,Cells Analyzed,1
62365-2,Interpretation,6
,Array Type,6
,Please note:,46
26799-7,FUMARIC,1
19767-3,Performed by:,2168
14020-2,P19 I/II,4
23658-8,ANTIMICROBIAL 1,4
31208-2,Specimen:,1
12481-8,"Arsenic(Inorganic),U",7
185-9,CIPROFLOXACIN,19
888-8,Antibody Identification 2,15
13465-0,"MERCURY, RANDOM URINE",23
,Genotype Assay,2
49023-5,"MICROALBUMIN, TIMED$URINE",1
,MOST SIGNIFICANT DIAGNOSIS,1
,ETHNICITY,122
,Reflex to ID,3
26797-1,2-HYDROXYBUTYRIC,1
24365-9,Microscopic Examination,6242
,Methodology:,6
,PSGT-Net Assessment,5
32044-0,Volatile analysis serum,2
13169-8,Interpretation,1
24006-9,INTERPRETATION,2
21723-2,A-1 Antitrypsin Mutation,34
52132-8,E1A2 TRANSCRIPT,5
45182-3,PHENOSENSE(R),2
33773-3,Cytogenetic Diagnosis,7
5108-6,COXSACKIE B3 AB,1
141-2,CEFTRIAXONE,3
,Contact:,1
13169-8,IFE 1,64
30473-3,GLUTACONIC,1
30474-1,GLUTARIC,1
30475-8,GLYCERIC,1
29870-3,4-HYDROXYPHENYLLACTIC,1
630-4,"Urine Culture, Routine",14970
50956-2,HLA-B*57:01,5
31208-2,H SOURCE,19
29871-1,4-HYDROXYPHENYLPYRUVIC,1
46252-3,Interpretation,1
79711-8,HLA-B*58:01,5
29872-9,5-OXOPROLINE,1
27132-0,ACETOACETIC,1
49549-9,Methodology,1
26751-8,ADIPIC,1
12710-0,Hgb Interp.,521
,"LGI1-IgG CBA, CSF",11
25144-7,"Ammonium Biurate Crys, UA",36
29621-0,3-HYDROXYADIPIC,1
79714-2,CYP2C19 GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
48672-0,Director Review,3
79716-7,CYP2C9 GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
673-4,Ova + Parasite Exam,127
883-9,ABO,36075
69565-0,Atopobium vaginae,490
3281-3,LUPUS ANTICOAGULANT,687
21667-1,FACTOR 5 MUTATION,384
43399-5,JAK2 V617F mutation detection,11
21723-2,A1 AT PHENOTYPE,369
547-0,Strep B Culture,1627
13655-6,FECAL WRIGHT STAIN,429
10701-1,OVA AND PARASITES RESULT,420
17898-8,RESPIRATORY CULTURE,191
6371-9,CRYPTOSPORIDIUM ANTIGEN,93
562-9,CLOSTRIDIUM DIFFICILE$CULTURE,234
6825-4,CRYSTAL FLUID,212
57901-1,CLOSTRIDIUM DIFFICILE TOXIN/GDH,76
11043-7,Cryofibrinogen,1
34519-9,HEMOCHROMATOSIS DNA,152
9818-6,"Cryptococcal Titer, serum",10
21654-9,"CF, Screen",345
6460-0,Lower Respiratory Culture,14
3281-3,Lupus Anticoagulant,343
32140-6,KLEIHAUER-BETKE,190
9753-5,COXSACKIE A2 AB,1
5098-9,COLD AGGLUTININS,22
14895-7,"Immunofixation Result, Serum",97
,Genetic Counselor:,88
2270-7,FAT SCREEN,72
12598-9,"Fat Qual Neutral, Stl",6
,Source:,45
40704-9,MATERNAL CELL,10
33773-3,"CHROMOSOME, AMNIOTIC$FLUID",14
69048-7,"Encephalopathy, Interpretation, CSF",11
5372-8,ANTI STRIATED MUSCLE AB$TITER,49
10349-9,BRUCELLA AB,20
53039-4,Interpretation:,98
5292-8,"VDRL, SERUM",85
7836-0,COXSACKIE B1 AB,20
623-9,CF Lower Respiratory Culture,26
29770-5,"CHROMOSOME ANALYSIS, MOSAICISM",19
,"Encephalopathy, Interpretation, S",7
9817-8,"CRYPTOCOCCAL TITER, CSF",4
57771-8,Interpretive Comments,5
5859-4,HSV Culture/Type,24
12241-6,OSMOTIC FRAGILITY SC,2
13440-3,IFE Interpretation,33
10857-1,MICROSPORIDIA  SOURCE,16
12294-5,Nicotine screen,9
5043-5,"ADRENAL AB, TITER",9
33774-1,"CHROMOSOME, CVS",15
587-6,Helicobacter pylori Culture,19
24376-6,VWF MULTIMERIC ANAL,29
29901-6,"HTLV I/II ANTIBODY, WITH$REFL CONFIRMATORY ASSAY",19
21003-9,Fungus Stain,11
33773-3,AMNIOTIC CHROMOSOMES,27
21821-4,"BCR/ABL T(9,22)",35
13087-2,ALTERNATIVE PATHWAY,8
5858-6,HSV Culture/Type,4
8100-0,AFB Specimen Processing,5
33062-1,"Antigen Typing,(RBC)",2
51962-9,PHARMACOGENETIC DNA ANALYSIS PANEL,5
68990-1,PERFORMING LABORATORY MEDICAL DIRECTOR,5
,Fragile X DNA,3
18482-0,"Yeast Only, Culture",3
21747-1,Interpretation:,1
888-8,ANTIBODY IDENT.,13
30314-9,Antibody Titer,9
13663-0,"GANGLIOSIDE ASIALO GM 1$ANTIBODY (IGG), EIA",18
10359-8,"GANGLIOSIDE ASIALO GM 1$ANTIBODY (IGM), EIA",16
21283-7,"GANGLIOSIDE GD1A ANTIBODY$(IGG), EIA",6
21282-9,"GANGLIOSIDE GD1A ANTIBODY$(IGM), EIA",6
13662-2,"GANGLIOSIDE GD1B ANTIBODY$(IGG), EIA",4
13661-4,"GANGLIOSIDE GD1B ANTIBODY$(IGM), EIA",4
14254-7,"GANGLIOSIDE GQ1B AB$(IGG), EIA",5
21694-5,DNA MUTATION ANALYSIS,25
31208-2,J SOURCE,17
31208-2,K SOURCE,17
31208-2,L SOURCE,17
21688-7,Alpha-Thalassemia,11
24429-3,Malaria Prep,1
45284-7,Result:,2
41044-9,Result:,1
33664-4,Interpretation:,2
5774-5,Calcium Oxalate Crystals,261
,"mGluR1 Ab IFA, CSF",11
,"mGluR1 Ab IFA, S",7
29622-8,3-HYDROXYBUTYRIC,1
79715-9,CYP2C9 GENE PRODUCT METABOLIC ACTIVITY,5
36922-3,TPMT GENOTYPE,24
664-3,Gram Stain Result,279
14328-9,White Blood Cells,5
57317-0,"FISH, PRENATAL SCREEN",8
10335-8,COLOR,11
42192-5,NIDUS,184
33773-3,"CHROMOSOME ANALYSIS,$AMNIOTIC FLUID",5
10860-5,"Viral Culture,Rapid,Varicella",1
12201-0,"Cryoglobulin, Ql, Serum, Rflx",3
50996-8,BETA-GLOBIN DNA MUTATIONS,17
5128-4,ANCA TOTAL AUTOABS,3
29990-9,"SPERMATOZOA,$POST VASECTOMY",5
,AMIKACIN,1
91544-7,"MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) AB TITER, SERUM",1
49024-3,DIFFERENTIAL TYPE,431573
6584-7,Viral Culture:,11
39087-2,"MYELIN ASSOC GLYCOPROTEIN$(MAG) IGM, EIA",23
57802-1,"FISH,AML,AML1/ETO,$TRANSLOCATION 8,21",2
43360-7,RESULT/COMMENT,11
5281-1,POLIO 1 TITER,6
18255-0,SUFONYLUREA SCREEN,16
19153-6,TOTAL VOLUME,1
34718-7,"CYSTIC FIBROSIS, FETUS",1
,ANTI-SMOOTH MUSCLE AB BY IFA,3
45284-7,DPD GENE MUTATION,6
,DIAGNOSIS SYNOPSIS,1
6825-4,"Crystals, Joint Fluid",8
5294-4,"RESPIRATORY SYNCYTIAL$VIRUS ANTIBODY, SERUM",1
33602-4,ANTI-MYELIN ASSOC GLYCOP IGG,1
45327-4,FRAGILE X,1
35456-3,Y CHROMOSOME$MICRODELETION,3
33774-1,"CHROMOSOME ANALYSIS,$CHORIONIC VILLUS SAMPLE",6
,Report Status,3
5401-5,"VARICELLA ZOSTER VIRUS$ANTIBODY, SERUM",1
34187-5,DNA AB (DS) CRITHIDIA$TITER,62
29770-5,"CHROMOSOME ANALYSIS,$BLOOD",14
56022-7,ACE INSERTION/DELETION,4
45182-3,PhenoSense(TM) PDF,4
51968-6,PANEL SUMMARY,2
3464-5,CHLOROTHIAZIDE,1
9796-4,Color,6
2693-0,"OSMOLALITY, FECES",3
32206-5,MALARIA/BLOOD PARASITES,4
611-4,"Body Fluid Culture, Sterile",1
29770-5,"CHROMOSOME ANALYSIS,$MOSAICISM",2
6909-6,"MUCIN CLOT, SYNOVIAL FL",1
18485-3,MI-2 AUTOANTIBODIES,1
10896-9,E.EQUINE ENCEPH.VIRUS IGG,2
6598-7,Troponin T,1
44533-8,"DONOR, HIV 1/2 AB SCREEN",3
52130-2,E13A2 (B2A2) TRANSCRIPT,6
,SARS-COV-2 (COVID-19) PATIENT SYMPTOMATIC:,142
34509-0,UGT1A1 TA REPEAT,3
5104-5,COXSACKIE B1 AB,1
15085-4,OXALATE (OXALIC ACID),1
24312-1,"TREPONEMA PALLIDUM AB,$PARTICLE AGGLUTINATION",2
31208-2,M SOURCE,1
16133-1,"LEGIONELLA PNEUMOPHILA ANTIBODY (IGM), IFA",1
21362-9,"LEGIONELLA PNEUMOPHILA$ANTIBODY (IGG), IFA",1
21757-0,DMPK RE Result,2
81883-1,CNBP RE Result,2
21689-5,Routing,2
43190-8,"MAG SGPG AB (IGM),EIA",1
3063-5,"TRYPSIN, FECAL",1
2345-7,"GLUCOSE, RANDOM (P)",1
19146-0,TEST RESULTS,2
3185-6,FACTOR IX INHIBITOR,1
60553-5,CHAGAS DONOR SCREEN RESULT,1
635-3,ANAEROBIC CULTURE,6
11060-1,"REDUCING SUBSTANCES,$FECES",1
50398-7,Interpretation,1
,"NIF IFA, CSF",11
,"NIF IFA, S",7
29623-6,3-HYDROXYDODECANOIC,1
93502-3,"NMDA-R Ab CBA, CSF",11
93503-1,"NMDA-R Ab CBA, S",7
29624-4,3-HYDROXYGLUTARIC,1
79717-5,CYP3A5 GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
84924-0,Purkinje Cell Cytoplasmic Ab Type 1,13
27272-4,3-HYDROXYISOBUTYRIC,1
85269-9,x-ald,367
26975-3,SCL-70,64
,Carrier Detection Rate:,31
75693-2,FETAL SEX,347
82989-5,"DPPX Ab IFA, CSF",11
408-5,PIPERACILLIN,19
,Disclaimer:,124
49299-1,UPEP Interp,222
,Resulting Path Name,19
12851-2,SPEP Interpretation,486
,P/Q-Type Calcium Channel Ab,7
82976-2,"DPPX Ab IFA, S",7
,Signed out by:,67
29865-3,2-OXOISOCAPROIC,1
6909-6,MUCIN CLOT,4
500-9,TICARCILLIN,19
,REASON FOR REQUEST?,1
49549-9,Method/Limitations:,88
,LYSOSOMAL STORAGE DISEASE,238
93426-5,"GABA-B-R Ab CBA, CSF",11
93428-1,"GABA-B-R Ab CBA, S",7
516-5,TRIMETHOPRIM/$SULFAMETHOXAZOLE,1
6909-6,Mucin Clot,4
5781-0,CRYSTALS,4
29866-1,2-OXOISOVALERIC,1
32379-0,Voriconazole,2
508-2,Tobramycin,19
,Clinician provided ICD9:,1
79564-1,MUCOPOLYSACCHARIDOSIS TYPE I,3
10524-7,PAP SMEAR,1
14869-2,RESULTS REVIEWED,2
,IVIG IN LAST MONTH?,2
,References:,33
92004-1,SPINAL MUSCULAR ATROPHY,228
,"GAD65 Ab Assay, CSF",11
,"GAD65 Ab Assay, S",7
,Background:,3
,CPT DISCLAIMER,1
30576-3,3-HYDROXY-2-$ETHYLPROPIONIC,1
79720-9,CYP2B6 GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
63415-4,POMPE DISEASE,3
,"GFAP IFA, CSF",11
,CLINICIAN PROVIDED ICD,1
30577-1,3-HYDROXY-2-METHYLBUTYRIC,1
48000-4,Diagnosis,3
26515-7,PLATELET COUNT X10(9)/L?,1
,Electronically Signed by:,36
,"IgLON5 IFA, CSF",11
29867-9,3-HYDROXY-3-$METHYLGLUTARIC,1
64090-4,Interpretation,3
54247-2,MDMA + Metabolites,6
29874-5,ISOVALERYLGLYCINE,1
79713-4,TPMT GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
,Reflex,8
9334-4,"ALCOHOL, METHYL",43
21656-4,MUTATIONS/POLYMORPHISMS,104
9757-6,COXSACKIE A9 AB,1
5767-9,Appearance,6
7839-4,COXSACKIE B4 AB,20
6644-9,CEFEPIME,19
84927-3,"Anti-Glial Nuclear Ab, Type 1",13
51867-0,FISH Result,1
10882-9,PENTACARBOXYPORPHYRIN,2
43573-5,"LYME AB IGM, CSF",6
5912-1,INTERPRETATION,12
48674-6,FISH Result,1
29875-2,LACTIC,1
79718-3,UGT1A1 GENE PRODUCT METABOLIC ACTIVITY INTERPRETATION,5
,Specimen(s) Received:,31
14021-0,P24,4
21070-8,MIC,3
,Submitted Dx:,1
189-1,CLARITHROMYCIN,24
648-6,Gram Stain Evaluation,5
,PSGT-Net Assessment Interp.,5
62357-9,Diagnosis,3
29881-0,2-HYDROXYGLUTARIC,1
,Composition,11
,Assessment of Leukocytes,18
49665-3,PSGT-PhenoSense(TM) Results,2
50619-6,Cytogenetic Interpretation,7
5110-2,COXSACKIE B4 AB,1
69548-6,GENETIC VARIANT ASSESSMENT,1
90080-3,BICTEGRAVIR RESISTANCE,4
30478-2,MALONIC,1
29876-0,METHYLCITRIC,1
30479-0,METHYLSUCCINIC,1
26682-5,GLYCOLIC,1
79722-5,SLCO1B1 GENE PRODUCT FUNCTINOAL INTERPRETATION,5
30476-6,GLYOXYLIC,1
24438-4,HEXANOYLGLYCINE,1
2432-3,HOMOGENTISIC,1
29873-7,ISOBUTYRYLGLYCINE,1
33477-1,INTERPRETATION:,1
19769-9,Electronically signed by:,289
8251-1,REVIEWER,104
6688-6,COXSACKIE A16 AB,1
,Performed by:,46
9631-3,Viscosity,6
7841-0,COXSACKIE B6 AB,20
185-9,Ciprofloxacin,17
31539-0,"Anti-Neuronal Nuclear Ab, Type 2",13
17501-8,PROTOPORPHYRIN,2
,ADDITIONAL CLINICAL INFORM.,1
21130-0,"Cadmium, Ur",2
14027-7,GP21,4
,Cell Population,1
29770-5,Cytogenetic Result,11
279-0,IMIPENEM,13
,PSGT-GeneSeq(TM) Interp.,5
48672-0,Director Review:,4
29882-8,2-HYDROXYISOVALERIC,1
16612-4,CHLORTHALIDONE,1
279-0,Imipenem,19
,Director,2
,Analysis and Gating Strategy,19
249-3,FLUCONAZOLE,2
5114-4,COXSACKIE B6 AB,1
,Trofile(TM) Interpretation,1
26831-8,SUBERIC,1
30482-4,SUBERYLGLYCINE,1
25137-1,SUCCINYLACETONE/CREATININE,1
30484-0,TIGLYLGLYCINE/CREATININE,1
25140-5,URACIL,1
,PATIENT STATE,4
35668-3,GENTAMICIN,15
43102-3,"Anti-Neuronal Nuclear Ab, Type 3",13
67128-9,Immunophenotypic Profile,3
32760-1,MARKERS,20
41053-0,Results:,87
14020-2,P19,4
53831-4,Granulocytes:,1
12710-0,Interpretation,9
29254-0,LINEZOLID,50
29883-6,2-HYDROXYPHENYLACETIC,1
,PSGT-PhenoSense(TM) Interp.,5
3661-6,FUROSEMIDE,1
42192-5,Nidus,6
6932-8,PENICILLIN,2
,Trofile(TM) Methodology,1
32583-7,PHENYLLACTIC,1
9750-1,COXSACKIE A10 AB,1
7840-2,COXSACKIE B5 AB,20
33615-6,"Anti-Neuronal Nuclear Ab, Type 1",13
13203-5,"LYME DISEASE AB (IGM), IBL",6
9527-3,HEXACARBOXYPORPHYRIN,3
2772-2,PHENYLPYRUVIC,1
,Clinical Data:,31
13516-0,"NEUTROPHILS, %",11
14019-4,GP46,4
33194-2,Viability:,1
225-3,DOXYCYCLINE,14
43226-0,2-HYDROXYISOCAPROIC,1
16260-2,Triamterene,1
41273-4,Interpretation,1
49660-4,PSGT-GeneSeq(TM) Results,2
5112-8,COXSACKIE B5 AB,1
25684-2,TOTAL LAMBDA CHAINS,3
32584-5,PROPIONYLGLYCINE/CREATININE,1
30481-6,PYRUVIC,1
26835-9,SEBACIC,1
29877-8,METHYLMALONIC,1
,N-ACETYLASPARTIC,1
25119-9,N-ACETYLTYROSINE/CREATININE,1
30480-8,OROTIC,1
32582-9,PHENPROPIONYLGLYCINE,1
,Insulin Dep Diabetes,716
,"CRMP-5-IgG, S",12
,Cabotegravir Islt Genotyp,1
35462-1,Interpretation:,31
,GP46 I,4
60554-3,Monocytes:,1
335-0,Minocycline,1
29884-4,2-METHYLBUTYRYLGLYCINE,1
17277-5,METOLAZONE,1
496-0,TETRACYCLINE,2
,Trofile(TM) References,1
,"Neuronal (V-G) K+ Channel Ab, S",4
,GP46 II,4
,Antibodies Performed:,1
31037-5,MOXIFLOXACIN,23
29864-6,2-OXO-3-METHYLVALERIC,1
,TIME 5,1
,Surface Crystals,2
524-9,VANCOMYCIN,2
49497-1,PLATELET ESTIMATE,108579
20507-0,TREPONEMA PALLIDUM ANTIBODY,7057
50758-2,HSV 1 IGM AB,56
5010-4,HEPATITIS C RNA-PCR - QUANT,2245
22459-2,SYPHILIS VDRL QUANT CSF,316
47213-4,LDL PHENOTYPE,148
17857-4,RHEUMATOID FACTOR TITER,174
26927-4,HSV 2 IGM AB,58
22322-2,"HEP B SURFACE AB, QUAL",109
31147-2,"RPR, QUANT.",89
32286-7,HCV GENOSURE(R) NS3/4A,3
13955-0,INTERPRETATION,10
13955-0,HCV ANTIBODY VERIFICATION,7
883-9,BLOOD TYPE,100821
77397-8,ABORH RESOLUTION,383
1920-8,SGOT (AST),1
5289-4,SYPHILIS VDRL QUANT CSF,1
59052-1,"DONOR, HIV 1/HBV/HCV/NAT",3
21570-7,TOXOPLASMOSIS IGG (DYE TEST),1
54247-2,DRUG COMMENT,357
54247-2,"MEDMATCH OH,ET FLURAZEPAM",55
41270-0,SUMMARY,2044
54247-2,MEDMATCH METHADONE,356
54247-2,MEDMATCH PHENCYCLIDINE,355
54247-2,MEDMATCH AMPHETAMINES,320
54247-2,MEDMATCH AOH ALPRAZOLAM,55
54247-2,MEDMATCH COCAINE METAB,356
54247-2,MEDMATCH METHAMPHETAMINE,36
54247-2,MEDMATCH OXYCODONE,368
54247-2,MEDMATCH BENZODIAZEPINES,309
54247-2,MEDMATCH MARIJUANA METAB,355
54247-2,MEDMATCH OPIATES,187
54247-2,DRUG SCREEN COMMENT,635
54247-2,MEDMATCH CODEINE,177
12286-1,"DRUG TEST, GENERAL TOXICOLOGY, (U)",11
54247-2,MEDMATCH NORHYDROCODONE,177
54247-2,MEDMATCH BARBITURATES,343
54247-2,MEDMATCH EDDP,8
54247-2,MEDMATCH AOH TRIAZOLAM,55
54247-2,MEDMATCH AMOBARBITAL,12
73823-7,COCAINE AND METABOLITES-BLD,9
54247-2,MEDMATCH TEMAZEPAM,56
20785-2,SERUM RESULTS,61
54247-2,MEDMATCH HYDROCODONE,177
54247-2,MEDMATCH MORPHINE,177
54247-2,MEDMATCH NORDIAZEPAM,56
12286-1,URINE RESULTS,94
54247-2,MEDMATCH HYDROMORPHONE,177
54247-2,MEDMATCH AMINOCLONAZEPAM,55
54247-2,MEDMATCH AOH MIDAZOLAM,55
54247-2,MEDMATCH BENZOYLECGONINE,9
54247-2,MEDMATCH PHENOBARBITAL,12
49690-1,MIRTAZEPINE,5
44909-0,5-HIAA URINE INTERPRETATION,60
32107-5,PHENCYCLIDINE,9
59730-2,OXAZEPAM,1
51691-4,OPIATES,9
18470-5,DESMETHYLCLOMIPRAMINE,5
54247-2,MEDMATCH LORAZEPAM,55
54247-2,MEDMATCH OXAZEPAM,56
12386-9,DESMETHYLDOXEPIN,5
54247-2,DESMETHYLTRAMADOL,20
16246-1,METHADONE GC/MS CONF,3
54247-2,MEDMATCH NOROXYCODONE,70
29530-3,AMPHETAMINES,9
3875-2,"NORTRIPTYLINE, ANTIDEPR PANEL",5
20787-8,ADDITIONAL DRUGS DETECTED,7
54247-2,MEDMATCH AMPHETAMINE,36
74157-9,MARIJUANA METABOLITE,9
54247-2,MEDMATCH OXYMORPHONE,70
12443-8,TRIMIPRAMINE,5
32101-8,OXYCODONE,9
54247-2,MEDMATCH SECOBARBITAL,12
72879-0,2C19 INTERPRETATION,13
3999-0,PROTRIPTYLINE LVL,5
3341-5,AMOXAPINE LVL,5
54247-2,MEDMATCH PENTOBARBITAL,12
54247-2,MEDMATCH BUTALBITAL,12
19348-2,AMPHETAMINE GC/MS CONF,2
14056-6,CARBAMAZEPINE METABOLITE,1
34176-8,TRICYCLIC ANTIDEPRESSANTS,8
26776-5,QUETIAPINE,1
3493-4,CLOMIPRAMINE LVL,5
16114-1,"AMITRIPTYLINE, URINE",5
3735-8,MAPROTILINE LVL,5
3937-0,PCP SCRN UR,2
19359-9,"COCAINE (METAB.) SCREEN, URINE",1
10975-1,6 ACETYLMORPHINE,2
12444-6,DESMETHYLTRIMIPRAMINE,5
16250-3,CODEINE GC/MS CONF,1
42492-9,"CANNABINOID SCREEN, BLOOD",1
3778-8,METHAMPHETAMINE,1
16251-1,MORPHINE GC/MS CONF,1
3937-0,PHENCYCLIDINE GC/MS CONF,1
40585-2,CONFIRMATORY TESTING,3
19635-2,PROPOXYPHENE METABOLITE,1
59052-1,HIV 1/HCV/HBV NAT,13
26453-1,RBCS,1
31147-2,RAPID PLASMA REAGIN  QUANT,297
22322-2,HEP B SURFACE AB,1062
31156-3,HEMOGLOBIN BARTS,8
20507-0,RPR TITER,83
50758-2,HSV 1 IGM ANTIBODIES,79
31147-2,RPR  QUANT,5
31147-2,RPR  QUANT.,202
2345-7,GLUCOSE  5 HOUR,101
7905-3,CONFIRMATION,139
26927-4,HSV 2 IGM ANTIBODIES,79
21570-7,IGG (DYE TEST),8
2345-7,GLUCOSE  4 HOUR,101
5196-1,HEPATITIS B SURFACE ANTIGEN (REFL),50
26927-4,HSV 2 IGM TITER,8
50758-2,HSV 1 IGM TITER,10
13955-0,HEPATITIS C ANTIBODY (REFL),2
2638-5,METHOD,8
,UNIT ISBT PRODUCT CODE,12797
933-2,BLOOD COMPONENT TYPE,12619
,SPECIAL REQUESTS,22949
664-3,GRAM STAIN RESULT,11913
,ABO GROUP AND RH TYPE,11684
5782-8,CRYSTALS,708
,URINE CULTURE REFLEX:,7732
,MODE  VENOUS,221
,SARS-COV-2  NAA 2 DAY TAT,1907
,ABO GROUP/RH TYPE (TUBE METHOD),1503
936-5,UNIT NUMBER,16531
,UNIT BLOOD GROUP,10649
,CRIT VALUE READBACK  ARTERIAL,2295
,PLATELET UNIT,591
11279-7,URINE SEDIMENT,9229
,POC CARDIO PULMONARY BYPASS APPLIED,1030
11125-2,PLT MORPHOLOGY,4289
90101-7,POCT INTERNAL QC,2892
5774-5,CALCIUM OXALATE CRYSTALS,243
,MYCOLOGY DIRECT EXAM,499
,PATHOGEN REDUCED PLATELET PHERESIS,1592
,GRAM POS PANEL INTERPRETATION,285
,BLOOD TYPE CONFIRMATION,4380
,STATUS OF UNIT,11182
32167-9,CLARITY,10399
,LABCORP REQUEST PROBLEM,307
,PACKED RED BLOOD CELL UNIT,11846
,CRIT VALUE NOTIFIED WHO  ARTERIAL,2995
5817-2,URIC ACID CRYSTALS,58
31208-2,POC SOURCE,1041
580-1,FUNGUS ID #1,926
,CRIT VALUE NOTIFIED BY  ARTERIAL,2848
29815-8,CALIFORNIA ENCEPHALITIS IGG ANTIBODY,22
51760-7,INTERPRETATION,32
673-4,OVA + PARASITE EXAM,282
21033-6,YEAST,787
,BODY FLUID CULTURE  STERILE,185
62364-5,DISCLAIMER:,270
,AMORPHOUS CRYSTAL,181
25700-6,MD IFE REVIEW,50
28062-8,BORRELIA BURGDORFERI 23KD AB.IGM,14
54210-0,HBV PRECORE MUTATION,5
,INTERNAL QUALITY CONTROL,1595
,REPORTABLE COMMENTS,13
30896-5,TEST CODE:,21
12235-8,MICROSCOPIC EXAMINATION,107
,SPECIMEN DESCRIPTION,749
,LABCORP NOTE BELOW,22
580-1,FUNGUS (MYCOLOGY) CULTURE,913
45284-7,RESULT:,107
72486-4,DIRECTOR REVIEW:,14
62365-2,INTERPRETATION,101
,LOCAL RAM  LOCAL REPORT ALWAYS MESSAGE,121
,CRIT VALUE NOTIFIED WHO  VENOUS,113
,LVDS  PLATELET PHERESIS,1544
50014-0,INTERPRETATION,1
49503-6,ATYPICAL PANCA,102
,DEVICE  MIXED VENOUS,710
33718-8,UMH CYTOLOGY FNA,243
53798-5,HIV GENOSURE,15
,FRESH FROZEN PLASMA UNIT,1203
9594-3,45 KD (IGG) BAND,2
50595-8,INTERPRETATION,1
5778-6,COLOR  POC,65
6584-7,VIRAL CULTURE,86
21402-3,MUMPS AB IGM  IFA (CSF),53
,LABCORP WRITTEN AUTHORIZATION,35
UNLOINC,COMMENT:,2
14725-6,FLUID TYPE,121
,SPONTANEOUS RESPONSE,2
,DEVICE  VENOUS,463
,COMMENT  MIXED VENOUS,120
,MDC_IDC_SESS_CLINIC_NAME,46
,PERIPHERAL SMEAR SCAN,278
,PLATELET PHERESIS,1472
26723-7,VZV TOTAL AB (ACIF),33
8251-1,COMMENT(S):,16
,CRYOPRECIPITATE UNIT,79
9595-0,IGG P58 AB.,11
50398-7,SUMMARY INTERPRETATION,52
,SARS-COV-2 NEUT AB COMMENT,47
,CRIT VALUE NOTIFIED BY  VENOUS,110
,SITE  VENOUS,457
,SPECIMEN TYPE RECEIVED,22
5024-5,M GORDONAE,37
8100-0,AFB SPECIMEN PROCESSING,589
,CRIT VALUE READBACK  MIXED VENOUS,55
655-1,AFB SMEAR,315
49296-7,SPE INTERPRETATION,170
20401-6,SPECKLED PATTERN,42
,SITE  MIXED VENOUS,691
10701-1,O&P ID 1,282
5096-3,COCCIDIOIDES ANTIBODY  CF,29
630-4,URINE CULTURE  ROUTINE,35
63569-8,TISSUE IFA OBSERVATION  CSF,10
28037-0,BORRELIA BURGDORFERI 39KD AB.IGM,14
,TEST INFORMATION:,125
,CRIT VALUE READBACK  VENOUS,96
72215-7,PML BCR2-RARA TRANSCRIPT,4
630-4,REFLEXIVE URINE CULTURE,253
10898-5,EASTERN EQUINE ENCEPHALITIS IGM ANTIBODY,28
8251-1,QUANTIFERON CRITERIA,320
8251-1,COMMENT,117
9599-2,39 KD (IGM) BAND,2
,PATHOLOGIST REVIEW,40
25700-6,IMMUNOFIX ELECTR INT,50
49248-8,INTERPRETATION,16
46131-9,C DIFF TOXIN B,44
66488-8,SRA  INTERPRETATION,64
,LITTLE S ANTIGEN,3
32167-9,CLARITY  POC,66
,MODE  MIXED VENOUS,305
5767-9,APPEARANCE,492
17898-8,UPPER RESPIRATORY CULTURE,99
13174-8,INTERPRETATION,3
45030-4,DRB1-2 NMDP,11
9796-4,COLOR,122
80694-3,HIV GENOSURE ARCHIVE INTERP,5
49549-9,METHODOLOGY,21
,CLIENT CONTACT:,21
,GRANULCYTES UNIT,15
21401-5,MUMPS AB IGG  IFA (CSF),55
19147-8,TEST INFORMATION:,47
634-6,CULTURE,111
,REPORT ALWAYS MESSAGE SIGNATURE,20
,REFERENCES:,7
,COMMENT UA,23
29816-6,CALIFORNIA ENCEPHALITIS IGM ANTIBODY,28
21667-1,FACTOR V LEIDEN,27
32760-1,MARKERS:,4
,GRAM NEGATIVE MARKER INTERPRETATION,229
49082-1,WESTERN EQUINE INTERPRETATION,22
,TESTED DATE  POST TX LUMINEX SAB CLASS II,2
14277-8,CYTOPLASMIC (C-ANCA),102
8265-1,REFERENCES,14
10907-4,ENCEPHALITIS ST.LOUIS IGM,6
,NOTE,164
10359-8,GANGLIOSIDE ASIALO GM 1 ANTIBODY (IGM)  EIA,10
,B* 2 NMDP,10
12710-0,HEMOGLOBIN INTERPRETATION,15
39087-2,MAG AB (IGM) EIA,1
,DQB1 ALLELE 1,1
593-4,LEGIONELLA CULTURE,45
,LABCORP TEST(S) REQUESTED,22
,TRANSFUSION REACTION-PATHOLOGIST REVIEW,23
,MDC_IDC_PG_MFG,46
43854-9,OTHER:,37
49067-2,INTERPRETATION,53
,PLT CLUMPS FLAG,88
5218-3,HISTOPLASMA ANTIBODY  ID,7
15363-5,BUSULFAN LEVEL,29
33634-7,MTB RIFAMPIN RESISTANCE,16
9825-1,ORGANISM ID,187
,URINALYSIS REFLEX,40
,SPECIMEN SOURCE,243
17819-4,ALBUMIN  URINE,3
8251-1,COMMENTS,84
49287-6,ORGANIC ACID INTERPRETATION,1
9315-3,WESTERN EQUINE ENCEPHALITIS IGG AB,22
53717-5,PURKINJE CELL CYTOPLASMIC AB TYPE 1,3
9588-5,IGG P18 AB.,11
,FLUID COMMENT,275
,HISTOPLASMA AG  QN  EIA  URINE (MIRAVISTA),19
59462-2,INTERPRETATION,52
,REFERENCE PLATELET AB SCREEN,9
,RESULT 1,51
16123-2,CRYPTOCOCCUS AB IFA (CSF),29
,LCM IGM,54
34519-9,HEREDITARY  HEMOCHROMATOSIS,11
19145-2,TEST(S) ORDERED ON REQUISITION,20
5838-8,CYTOMEGALOVIRUS (CMV) CULTURE,24
82939-0,INTERPRETIVE RESULTS TABLE,51
6463-4,RESULT 1,138
46252-3,INTERPRETATION,2
,MDC_IDC_PG_MODEL,46
29901-6,HTLV-I/II ANTIBODY,1
,SUSCEPTIBILITY TESTING,16
13440-3,IFE INTERPRETATION:U,26
8251-1,STATUS:,16
13655-6,RESULT 1,84
,CRIT VALUE NOTIFIED BY  MIXED VENOUS,54
22459-2,VDRL  CSF,71
,PRODUCT DIFF TYPE CELL COUNT,7
,A*-1  HLA NGS BM,11
,TEST INFORMATION,112
42803-7,ORGANISM ID,11
,VIRAL PROFILE RESULT,8
,CLIENT INSTRUCTIONS:,3
,APS PANEL INTERPRETATION,42
21500-4,MEASLES (RUBEOLA) IGG IFA,33
,REFERENCE PLATELET CROSSMATCH,34
,EXAM,38
,MDC_IDC_PG_TYPE,46
,MYELOID MOLECULAR PROFILE,70
9335-1,APPEARANCE FLUID,119
21596-2,VZV IGM (IFA),32
75608-0,REFERENCES:,3
,SPECIMEN STATUS,6
13655-6,WHITE BLOOD CELLS (WBC)  STOOL,88
14278-6,PERINUCLEAR (P-ANCA),102
,C* 2 NMDP,11
630-4,RESULT,4
,COMMENT  VENOUS,80
,DIRECTOR REVIEW:,6
48500-3,P18 AB.,14
2270-7,FAT QUALITATIVE TOTAL STOOL,15
8251-1,INTERPRETATION:,9
21654-9,RESULTS,2
,TECHNICAL RESULTS,17
28055-2,P45 AB.,14
,HEMOLYSIS CHECK,43
,SAMPLE SOURCE,19
,BLOOD CULTURE PCR COMMENT,50
516-5,TRIMETHOPRIM/SULFA,12
28054-5,P93 AB.,14
21282-9,GANGLIOSIDE GD1A ANTIBODY (IGM)  EIA,10
,TEST CODE CHANGE,4
,C* 1 NMDP,11
,ICTERIC CHECK,43
,CRIT VALUE NOTIFIED WHO  MIXED VENOUS,53
,NOTE:,70
,ME PANEL COMMENT,56
13663-0,GANGLIOSIDE ASIALO GM 1 ANTIBODY (IGG)  EIA,11
43240-1,GANGLIOSIDE GM 1 AB (IGG)  EIA,10
11268-0,CULTURE,12
,MDT_EVALUATION_DEPENDENCY,38
12-5,AMIKACIN,22
,RESOLUTION:,19
,C DIFFICILE INTERPRETATION,114
26980-3,COCCIDIOIDES ANTIBODY CF,1
,RED BLOOD CELL CLUMP,2
,FLT3 MUTATION ANALYSIS ITD/TKD,5
,HIV AG/AB  4TH GEN,91
31208-2,SPECIMEN TYPE:,65
40699-1,MYCOBACTERIUM SP IDENTIFIED,9
6463-4,RESULT 2,15
,FLOW DIFFERENTIAL (%),1
428-3,RIFAMPIN,56
,MPN TARGETED PROFILE,3
,COMMENTS,140
93047-9,HIV GENOSURE,16
,VIRAL PROFILE RESULT 2,8
,EXTRA TUBE RECEIVED,22
,CRYPTOCOCCUS NEOFORMANS/GATTII BY PCR,12
19145-2,TEST NAME,86
,RAD ONC ARIA COURSE START DATE,2
45030-4,DRB5 1,1
24110-9,T PALLIDUM ANTIBODIES,4
78014-8,DQA1 1 NMDP,11
,B*-1  HLA NGS BM,11
,SAMPLE TYPE,19
28053-7,P30 AB.,14
16100-0,RIFABUTIN,1
33232-0,SPERM,18
21502-0,MEASLES (RUBEOLA) IGM IFA,32
,POOLED PLATELETS  LVDS,32
,FISH  MDS/MYELOID PANEL  -5/5Q- -7/7Q- +8 20Q-,1
,NEGATIVE,18
48668-8,OLIGOCLONAL BANDS,43
28039-6,P66 AB.,14
9589-3,IGG P23 AB.,11
48638-1,IFE RESULT  CRYOPRECIPITANT,2
28048-7,P58 AB.,14
62364-5,TROFILE(R) DNA INTERPRETATION,5
,MYELOMA MRD PROFILE,3
5026-0,M KANSASII,37
,TEST METHOD  POST TX LUMINEX SAB CLASS II,2
49549-9,METHODOLOGY:,12
,INPATIENT,9
78015-5,B* 1 NMDP,11
,RAD ONC ARIA REFERENCE POINT ID,7
12598-9,FAT QUALITATIVE NEUTRAL STOOL,16
,TEST METHOD  BM SSOP,11
,CLASS DESCRIPTION,21
13950-1,HEPATITIS A IGM,19
,TOTAL CD21- B CELLS,1
,PRODUCT TYPE,17
,HUMAN HERPESVIRUS 6 BY PCR,2
8251-1,.,12
,DQA1-2  HLA NGS BM,12
,M. TUBERCULOSIS COMMENT,30
,REFERENCE LAB HLA TYPING,5
71773-6,T-SPOT.TB,1
,ANTIGEN STIMULATION PHYTOHEMAGGLUTININ,2
33356-7,1 HR INCUB PT 1:1NP,1
50790-5,TROPOTYPE:,5
,PHOTO,2
,FLUORESCENT TREPONEMAL ABS-CSF,1
9596-8,IGG P66 AB.,11
,REFERRAL TEST RESULTS,9
77202-0,PLEASE NOTE:,26
,URINE HEMOLYSIS,23
20398-4,HOMOGENEOUS PATTERN,37
543-9,CULTURE,15
24110-9,TREPONEMA PALLIDUM ANTIBODIES,32
,LEUKOCYTES,1
18314-5,CBC MORPHOLOGY,8
,ANTI-IGE,4
30201-8,B TITER,1
21283-7,GANGLIOSIDE GD1A ANTIBODY (IGG)  EIA,10
,DIN/PRODUCT ID,18
28036-2,P39 AB.,14
,TRIPHOSPHATE CRYSTAL,18
,CLERICAL CHECK,43
78015-5,DQB1-1 NMDP,11
11545-1,CULTURE  MYCOBACTERIA W/FLUOROCHROME SMEAR,1
,TESTED DATE  BM SSOP,11
,C*-2  HLA NGS BM,11
77202-0,BACKGROUND:,8
,CAUCASIAN DETECTION RATE,2
10896-9,EASTERN EQUINE ENCEPHALITIS IGG ANTIBODY,22
9593-5,IGG P41 AB.,11
34661-9,ANTI-SMOOTH MUSCLE AB BY IFA,22
,TESTED DATE,16
28057-8,P23 AB.,14
92934-9,RS10757278,1
49549-9,TEST METHOD,16
62361-1,CELLS COUNTED,2
,BLAST/ABN LYMPH FLAG,5
82191-8,HSV2 DNA CSF QL NAA+NON-PROBE,2
78015-5,B* 2 NMDP,3
5077-3,CENTROMERE PATTERN,3
43409-2,ISOLATE 1,8
43291-4,HLA-DQB1,1
82977-0,GABA-B-R AB CBA  S,3
49625-7,INTERPRETATION,1
,LCM IGG,55
,NEISSERIA MENINGITIDIS BY PCR,2
51867-0,FISH RESULT,2
,DRB4-2  HLA NGS BM,7
10524-7,INTERPRETATION/RESULT:,9
5393-4,T PALLIDUM AB (FTA-AB),39
,REVIEWED BY:,4
14895-7,IMMUNOFIXATION RESULT  SERUM,4
5048-4,ANTINUCLEAR ANTIBODIES,13
19147-8,INTERPRETATION,33
16982-1,HTLV I/II AB  WESTERN BLOT,5
,DRB4-1  HLA NGS BM,6
38347-1,ORGANISM ID BY SEQUENCING,24
33927-5,AMPHIPHYSIN AB  S,3
,REFERRAL LAB,9
24475-6,PROTHROMBIN G20210A MUTATION,24
,DIRECT EXAM,22
,ESCHERICHIA COLI K1 BY PCR,4
45030-4,DRB1-1 NMDP,11
,SPECIMEN INFORMATION,15
49549-9,BACKGROUND:,4
,MDS FISH PROFILE (EXTENDED),2
9508-3,CHLOROTHIAZIDE,1
,ANTI-RI ANTIBODIES*,3
,LYMPHOID MOLECULAR PROFILE,23
,TRACKING HOUSE ACCOUNT,5
,DRB1-2 NMDP,7
,DRB5-2  HLA NGS BM,5
9595-0,58 KD (IGG) BAND,2
,REFERENCE HLA ANTIBODY ID,16
69563-5,CANDIDA GLABRATA  NAA,1
890-4,ANTIBODY SCREEN  RBC W/REFL ID  TITER AND AG,1
,A* 1 NMDP  BM SSOP,11
,DRB1-1 NMDP,4
9587-7,IGM P41 AB.,11
9316-1,WESTERN EQUINE ENCEPHALITIS IGM  AB,28
35559-4,ABNORMAL PROTEIN BAND 2,1
,NMDA-R AB CBA  S,3
18314-5,HEMATOLOGY COMMENTS:,47
,CONVALESCENT PLASMA,8
86468-8,COMMENT:,10
8264-4,MESSAGE:,4
10704-5,O+P EXAM  FORMALIN ONLY,2
,POOLED CRYOPRECIPITATE 5 UNITS,7
,MUTATION:,5
,TYPHUS FEVER GROUP IGM,2
,DQB1-1 NMDP,10
9597-6,IGG P93 AB.,12
,REFLEX TIQ,4
,INTERPRETATIONS:,1
,VARICELLA ZOSTER VIRUS AB (IMMUNITY SCR) ACIF (S),1
9599-2,IGM P39 AB.,11
,METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR),3
,B*-1 NMDP  HLA NGS BM,3
29770-5,SPECIMEN TYPE/SOURCE/VOL,1
33925-9,PURKINJE CELL CYTOPLASMIC AB TYPE 2,3
,PCR AMPLIFICATION + DETECTION,3
,ASSAY DETAILS,1
,CD27+ B220+ B CELLS,1
9587-7,41 KD (IGM) BAND,2
,ASPERGILLUS SERIAL MONITORING,1
33926-7,PURKINJE CELL CYTOPLASMIC AB TYPE TR,3
,ECHOVIRUS 11,2
5724-0,SELENIUM,1
,ECHOVIRUS 30,2
,SPECIMEN STATUS  POST TX CHIMERISM,16
,TYPHUS FEVER GROUP IGG,2
,TISSUE IFA OBSERVATION(S),14
,DEXAMETHASONE REFLEX,3
49549-9,METHODS,18
50407-6,OTHER  CELLS CSF,1
77202-0,TPMT COMMENT,5
,AFRICAN AMERICAN DETECT. RATE,2
38404-0,COMMENTS,5
28040-4,P41 AB.,14
32769-2,A-1 ANTITRYPSIN MUTATION,2
13169-8,IMMUNOFIXATION RESULT  SERUM,1
9590-1,IGG P28 AB.,11
78016-3,DRB5 2,1
5687-9,MERCURY,2
,SERUM DATE,3
,HISPANIC DETECTION RATE,2
5218-3,HISTOPLASMA SPP AB  PRECIPITIN,6
,CHYLOMICRON SCREEN  BF,2
,B* 2  HLA NGS BM,11
19764-0,STATEMENT OF ADEQUACY:,9
72214-0,PML BCR3-RARA TRANSCRIPT,4
,DRB5-1 NMDP,3
9317-9,PLATELET ESTIMATION,3
6770-2,PHENOTYPE (PI),35
53294-5,EPITHELIAL CELLS,3
69562-7,CANDIDA ALBICANS  NAA,1
45030-4,DRB4 1 NMDP,4
3298-7,ACETAMINOPHEN,5
,CIDOFOVIR (UL54 GENE TARGET),2
5645-7,ETHANOL U  QUAN,2
,SPECIMEN RECEIVED,14
35333-4,JO 1 ANTIBODY,3
10860-5,VIRAL CULTURE  RAPID VARICELLA,12
,GUARDANT 360,3
78015-5,DQB1-2 NMDP,11
19767-3,CYTOTECHNOLOGIST:,9
,DQA1-1  HLA NGS BM,11
53039-4,INTERPRETATION,2
43190-8,MAG SGPG AB (IGM) EIA,8
5946-9,APTT 1:1 NP,1
62365-2,TPMT INTERPRETATION,4
49031-8,RED BLOOD CELLS:,4
,DRB3-1  HLA NGS BM,6
,E14A2 (B3A2) TRANSCRIPT,1
,GANCICLOVIR (UL97 GENE TARGET),2
,DQB1-1 EQUIVALENT,1
11034-6,ACH RECEPTOR (MUSCLE) BINDING AB,3
580-1,FUNGUS ID STATUS,3
78014-8,DQA1* 1 EQUIVALENT,3
38196-2,SAMPLE DESCRIPTION:,4
43188-2,ANTI-NEURONAL NUCLEAR AB  TYPE 2,3
,CD5- B220- B CELLS,1
,APPEARANCE,379
78014-8,DQA1-2 NMDP,10
,RESIDUAL RISK TABLE,1
,CONTACT:,4
44011-5,INTERPRETATION,32
,HBV GENOTYPE,5
8251-1,COMMENT(S),13
72486-4,DIRECTOR REVIEW,5
,ASIAN DETECTION RATE,2
,AMPA-R AB CBA  S,3
28056-0,P28 AB.,14
,ADENO QPCR,2
13956-8,M TUBERCULOSIS  NAA,16
56255-3,WHOLE EGG,1
27811-9,ANTITHROMBIN III ACTIVITY,1
,ST. LOUIS IGG,22
,ST. LOUIS IGM,22
,ENTEROVIRUS BY PCR,2
,REPRESENTATIVE HISTOGRAMS:,4
10904-1,CA ENCEPH. VIRUS IGG,1
,CELL POPULATION,4
33664-4,INTERPRETATION:,6
,HAEMOPHILUS INFLUENZAE BY PCR,2
,FLUID UNIDENTIFIED CELLS,3
,UNCLEAR ORDER,3
,TESTED DATE  LUMINEX SCREEN CLASS II,2
,CK ISOENZYMES:,8
,A* 1 NMDP  HLA NGS BM,3
,C*-1  HLA NGS BM,11
9594-3,IGG P45 AB.,11
42233-7,ACHR GANGLIONIC NEURONAL AB  S,3
,QUANTIFERON INCUBATION,10
80693-5,HIV GENOSURE ARCHIVE,5
,HISTOPLASMA AG  QNT (MIRAVISTA),30
12853-8,TECHNICAL RESULTS,1
,QUESTION:,3
,A*-2 NMDP  HLA NGS BM,3
,REFERRAL TEST CODE OR MNEMONIC,9
53831-4,GRANULOCYTES:,4
,DRB5-1  HLA NGS BM,4
38196-2,SAMPLE DESCRIPTION,3
5768-7,ASCORBIC ACID  POC,1
5858-6,HSV CULTURE/TYPE,12
8262-8,PLEASE NOTE:,11
48672-0,DIRECTOR REVIEW:,3
31208-2,A SOURCE,2
335-0,MINOCYCLINE,11
13440-3,INTERPRETATION,2
5775-2,CALCIUM PHOSPHATE CRYSTALS,1
9591-9,IGG P30 AB.,11
,E13A2 (B2A2) TRANSCRIPT,1
,CD3+,1
,ANTI NR1 INTERPRETATION,13
,SUPERSATURATION INDEX WITH RESPECT TO:,1
,ANTI-YO ANTIBODIES*,3
,COPPER  PLASMA,1
,CD10+ B CELLS,1
,DRB4-1 NMDP,3
9598-4,IGM P23 AB.,11
,B-ALL MRD PROFILE,2
30323-0,APTT 1:1 NP MIX  60 MIN INCUB.,1
72879-0,INTERPRETATION:,1
,VALUE OF LAST VIRAL LOAD,1
,AMBIGUOUS TEST ORDER,12
45030-4,DRB4 2 NMDP,5
,DQA1-2 NMDP,3
54449-4,SMN2,1
,BACKGROUND:,4
623-9,CF LOWER RESPIRATORY CULTURE,2
,BLOCK NUMBER:,3
,CD8:MEMORY TEM:,1
35386-2,CRMP-5-IGG  S,3
,TEST METHOD  LUMINEX SCREEN CLASS II,2
,INTERNAL CONTROL,1
508-2,TOBRAMCYIN,11
5859-4,HSV CULTURE/TYPE,3
21031-0,INTERPRETATION,1
,DQB1-2 NMDP,8
8266-9,ADDITIONAL INFORMATION,1
,CD4:NAIVE CD31+,1
30046-7,LEGIONELLA PNEUMOPHILIA ANTIBODY,1
13997-2,ANTI-NEURONAL NUCLEAR AB  TYPE 1,3
,COMMENT:,50
89372-7,RIFAMPIN RESISTANCE,9
75608-0,REFERENCES,1
23658-8,SUSCEPTIBILITY RESULT,11
,CYTOMEGALOVIRUS BY PCR,16
,RAD ONC ARIA PLAN ID,2
,RAD ONC ARIA FIRST TREATMENT DATE,2
56231-4,CORN,1
17947-3,RESULT 2,2
69048-7,IMMUNOLOGIST REVIEW OF RESULTS,5
,ANTI NUCLEAR ANTIBODY TITER,1
34439-0,LU 30,1
21709-1,METHYLENETETRAHYDROFOLATE$REDUCTASE (MTHFR)  DNA,1
,CLIENT EDUCATION TRACKING,2
,ALL FUSION PROFILE,1
12201-0,CRYOGLOBULIN  QL  SERUM  RFLX,6
9592-7,IGG P39 AB.,11
60554-3,MONOCYTES,1
,JEWISH NON-ASHKENAZI DET. RATE,2
44081-8,CHLAMYDIA PSITTACI INTERPRETATION,1
,HUMAN PARECHOVIRUS BY PCR,2
,DRB3-2 NMDP,4
,JC VIRUS ANTIBODY INHIBITION ASSAY,1
,HYPHAE YEAST,5
9592-7,39 KD (IGG) BAND,2
,DIURETIC SCREEN  URINE,1
,INFLUENZA A (NO SUBTYPE DETECTED),1
6917-9,CHLAMYDIA PSITTACI IGM ANTIBODY,1
69426-5,INTERPRETATION,1
30107-7,ECGONINE METHYL ESTER,2
,CD4:NAIVE CD31-,1
78014-8,DQA1-1,2
19767-3,REVIEW CYTOTECHNOLOGIST:,2
,SEE BELOW:,1
,SPECIMEN SUBMITTED,3
,KIF6 GENOTYPE,1
41617-2,NEUTROPHIL AB,3
43241-9,GM 1 ANTIBODY IGM,10
UNLOINC,COMPOSITION,2
,SPOTTED FEVER GROUP IGG,2
,CD4:TEMRA:,1
,BCR-ABL1 TRANSCRIPT,5
41871-5,NEURONAL (V-G) K+ CHANNEL AB  S,3
,DRB5 2 NMDP,3
21074-0,ARSENIC URINE,1
,MODERATE RISK  CLASS I,2
77202-0,SEE BELOW:,2
78015-5,DQA1-2,2
,PLATELET REFRACTION PATH INTER,1
9802-0,SIZE,2
21770-3,FISH  CLL  CEP 12  TRISOMY 12,2
,LGI1-IGG CBA  S,3
,FOSCARNET (UL54 GENE TARGET),2
,DRB1-1 EQUIVALENT,1
19769-9,PATHOLOGIST:,1
460-6,STREPTOMYCIN,10
,A*-2 HLA NGS BM,11
6192-9,CAST TYPE,2
,COAG CONSULT LEVEL LIMITED,1
38404-0,CYSTIC FIBROSIS MUTATION 97,2
13466-8,LEAD  RANDOM URINE,1
,IMMATURE CELLS,6
95272-1,AQUAPORIN 4 AB  TITER  SERUM,1
35863-0,MOLD SUSCEPTIBILITY  VORICONAZ,1
18974-6,RIFAMPIN,1
6331-3,CULTURE  CAMPYLOBACTER,1
,DONOR 4,1
57838-5,DRVVT CONFIRM SECONDS,1
,FISH CML/ALL BCR/ABL TRANS 9 22,1
9591-9,30 KD (IGG) BAND,2
,REFERRAL TEST NAME,10
,MTHFR MUTATION,3
,SUBMITTED DX:,4
,STREPTOCOCCUS PNEUMONIAE BY PCR,2
,AML MOLECULAR PROFILE PCR,2
,SPOTTED FEVER GROUP IGM,2
,CRYSTAL TYPE,8
21759-6,FRAGILE X CGG REPEATS,1
9520-8,ECHOVIRUS AB TYPE 9,1
30347-9,GAD65 AB ASSAY  S,3
,STREPTOCOCCUS AGALACTIAE BY PCR,2
,CD21+ CD23- B CELLS,1
9589-3,23 KD (IGG) BAND,2
,ADV  SPECIMEN DESC  PCR QUANT,2
,VARICELLA ZOSTER VIRUS BY PCR,2
28043-8,BORRELIA BURGDORFERI 41KD AB.IGM,14
48004-6,NUCLEOTIDE CHANGE:,1
23658-8,ANTIMICROBIAL SUSCEPTIBILITY,1
10906-6,ST.LOUIS ENCEPH.VIRUS IGG,1
12285-3,C* 1 NMDP,3
,CD38+CD138+BCELLS INTERMEDIATE,1
45030-4,DRB3 1 NMDP,5
31302-3,CHLAMYDIA PNEUMONIAE IGG ANTIBODY,1
,MLL-PTD MUTATION ANALYSIS,7
,CD21+ CD23+ B CELLS,1
60554-3,MONOCYTES:,4
,RAD ONC ARIA PLAN PRIMARY REFERENCE POINT,2
,ANTI GAD65 INTERPRETATION,1
,COCCIDIOIDES QN ANTIGEN  EIA  SERUM,8
9825-1,ORGANISM ID  MYCOBACTERIA,1
,CD5- B220+ B CELLS,1
48794-2,FIBROSIS STAGE,1
25700-6,INTERPRETATION,6
77202-0,LIMITATIONS,3
,RAD ONC ARIA COURSE LAST TREATMENT DATE,2
6331-3,CAMPYLOBACTER CULTURE,1
,SPECIFICITY  CLASS I,1
,HISTOPLASMA ANTIGEN  SERUM,1
53709-2,ANTI-GLIAL NUCLEAR AB  TYPE 1,3
,ADDITIONAL INFORMATION:,4
8246-1,AMORPHOUS SEDIMENT,10
,NK FUNCTION,1
,DRB5-2 NMDP,2
33980-4,P/Q-TYPE CALCIUM CHANNEL AB,3
,PEMPHIGUS ANTIBODY PANEL,2
8116-6,CD19+B CELLS TOTAL,1
,2009 INFLUENZA H1 GENE,1
,HLA METHODOLOGY,2
45030-4,DRB3 2 NMDP,2
648-6,GRAM STAIN EVALUATION,4
50790-5,TROFILE(R) DNA,5
31208-2,SPECIMEN:,4
,HEMOSIDERIN  URINE,1
59021-6,DRB4,1
33924-2,ANTI-NEURONAL NUCLEAR AB  TYPE 3,3
77202-0,GENERAL GUIDANCE,3
,DRB3-1 NMDP,4
2484-4,RAD ONC ARIA PLAN NAME,2
12458-6,ACTH #3,1
,DQA1*-2 EQUIVALENT,3
,HISTOCOMPATILITY LABORATORY INFO,1
9597-6,93 KD (IGG) BAND,2
5630-9,COPPER  RBC,1
18494-5,CONCENTRATE (2),1
49247-0,INTERPRETATION,2
,CD8:MEMORY,1
21383-5,MERCURY  UR,1
,CALR MUTATION DETECTION RESULT,1
,BACTERIA BLD CULT,1
,STATUS REPORT,3
49117-5,NOROVIRUS  EIA (STOOL),3
,CD4:MEMORY,1
2693-0,OSMOLALITY  FECES,1
,CD8:NAIVE,1
580-1,FUNGUS ID RESULT,3
9596-8,66 KD (IGG) BAND,2
,DRUG SCREEN COMMENT:,4
69426-5,REVIEWER,5
5130-0,DNA DOUBLE STRAND AB (UNITS/VOLUME) IN SERUM,1
,PATHOLOGIST NAME,2
6412-1,G LAMBLIA AG STL QL EIA,1
,CANDIDA ALBICANS AG RESPONSE,2
45030-4,DRB1 1,1
,CD5+ B220+ B CELLS,1
,BLOCK ID,2
,RAM1,1
20-8,AMOXICILLIN/CLAVULANATE,1
,"NAME ON REQUISITION:",1
,ANTIBODY ID  PATHOLOGIST REVIEW,3
21667-1,FACTOR V (LEIDEN) MUTATION,1
41091-0,FAMILIAL MEDITERRANEAN FEVER MUTATION ANALYSIS,1
,FACTOR V INHIBITOR,1
31304-9,CHLAMYDIA PNEUMONIAE IGM ANTIBODY,1
34569-4,DRVVT 1:1 MIX,2
,ECHOVIRUS 6,2
,DRB3-2  HLA NGS BM,5
8251-1,CLINICAL INDICATION,1
5640-8,ALCOHOL  ETHYL (B) 1,2
9516-6,ECHOVIRUS AB TYPE 11,1
,ANTIGEN STIMULATION  TETANUS,2
,GATING STRATEGY:,4
78015-5,B* 1,1
,TREPONEMA PALLIDUM ANTIBODY  IFA  CSF,1
43290-6,HLA-DRB1,1
12285-3,C* 2 NMDP,3
,ABL1 KINASE DOMAIN MUTATION (GENOPTIX),1
9588-5,18 KD (IGG) BAND,2
6912-0,CHLAMYDIA PNEUMONIAE IGA ANTIBODY,1
35462-1,SMN1,1
10905-8,CA ENCEPH. VIRUS IGM,1
78015-5,B* 2,1
18906-8,CIPROFLOXACIN,1
10996-7,NORMEPERIDINE,1
,DERMPATH SURGICAL REPORT,2
72486-4,DIRECTOR,2
,CLOSTRIDIUM DIFFICILE TOXIN/GDH W/REFL TO PCR,23
62947-7,MPL MUTATION ANALYSIS RESULT,1
,ISOLATE 2:,1
21709-1,METHYLENETETRAHYDROFOLATE REDUCTASE,1
,ABNORMAL CELLS DETECTED,1
,SUMMARY,1
21656-4,MUTATIONS ANALYZED,2
,CD5+ B220- B CELLS,1
,CD27+ B220- B CELLS,1
42482-0,ABNORMAL PROTEIN BAND 1,1
,DONOR 2,1
43227-8,OVA AND PARASITES  STOOL,4
,ASHKENAZI JEWISH DETECT. RATE,2
,DQA1-1 NMDP,3
,HMGCR ANTIBODY  IGG,3
62360-3,CELLS ANALYZED,2
,THE PATIENT HAS:,1
14328-9,WHITE BLOOD CELLS,3
,YERSINIA CULTURE,2
,DRB4-2 NMDP,3
,CD4:NAIVE,1
,ANTIBODIES PERFORMED:,4
,CRYPTOSPORIDIUM AG  DFA,1
69548-6,VARIANTS TESTED TABLE,1
,CD4:MEMORY TCM:,1
,SIGNATURE MESSAGE,1
34416-8,NUCLEOSOME AB (UNITS/VOLUME) IN SERUM BY IMMUNOASSAY,1
,PJI SYNOVASURE,2
,RESULTS REVIEWED BY:,13
,CD38-CD138- B CELLS,1
,CASPR2-IGG CBA  S,3
20399-2,NUCLEOLAR PATTERN,4
,CONTACT,1
,SPECIAL COAGULATION MD INTERPRETATION,2
,OTHER OR MIXED ETHNICITY RATE,2
,MODERATE RISK  POST TX LUMINEX SAB CLASS II,1
,COLD AGGLUTININS TITER,3
,SPECIMEN STATUS  NGSCBM,1
9590-1,28 KD (IGG) BAND,2
,C*-2,1
8251-1,COMMENT:,1
49262-9,INTERP  FATTY ACIDS PROFILE SP,2
12851-2,P E INTERPRETATION  S,1
13465-0,MERCURY  RANDOM URINE,1
,CD4+ (OF CD3),1
,.,3
77202-0,GUIDANCE STATEMENTS,3
,REFLEX TEST INFORMATION,4
,DQB1 ALLELE 2,1
,CD38+CD138+B CELLS DIM,1
,JAK2 V617F MUTATION QUANT RSLT,1
5404-9,VZV AB IGM  EIA,1
6957-5,W.EQUINE ENCEPH.VIRUS IGG,1
,CLL PROGNOSTIC PROFILE,1
,RECENT THYMIC EMIGRANTS ASSAY,1
,RISK,1
,CD27- B220+ B CELLS,1
49549-9,CYP2C19 INFORMATION:,1
,CD8+ (OF CD3),1
6915-3,C PSITTACI IGA,1
,CYP2C19: MED. DIR. REVIEW,1
,LYMPHOCYTE PROLIF TO ANTI-CD3,1
45030-4,DRB1-2,1
3745-7,MEPERIDINE,1
,CYTOLOGY GYN (STUDENT CENTER),1
,CD38+CD138+ B CELLS BRIGHT,1
78014-8,A*-2,1
43371-4,CULTURE  SALMONELLA AND SHIGELLA,3
,OVERALL INTERPRETATION,1
,FISH ALL EXTENDED PANEL,2
43291-4,HLA-DQB2,1
,LEGIONELLA PNEUMOPHILA ANTIBODY,1
30314-9,A TITER,1
15359-3,DRVVT RATIO,1
6958-3,W.EQUINE ENCEPH.VIRUS IGM,1
,DRB1-2 EQUIVALENT,1
,LOG10 HHV-6 QN PCR,1
,CD4:MEMORY TEM:,1
13298-5,HLA-A,1
24376-6,VON WILLEBRAND FACTOR MULTIMERS,1
50796-2,ABNORMAL PROTEIN BAND 3,1
78014-8,A*-1,1
8251-1,LIMITATIONS:,1
,CD8:TEMRA:,1
42664-3,HLA-CW,1
59022-4,DRB3,1
,HERPES SIMPLEX VIRUS 1 BY PCR,2
50595-8,PATHOLOGIST INTERPRETATION,1
,CD19+B CELLS ABSOLUTE,1
48005-3,PREDICTED AMNIO ACID CHANGE:,1
,ANTIMICROBIAL SUSCEPTIBILITY,1
,RESOURCES,1
57298-2,DRB1,1
43290-6,HLA-DRB2,1
9519-0,ECHOVIRUS AB TYPE 4,1
19145-2,TEST NAME:,1
,DATE RECEIVED:,1
11545-1,SMEAR RESULT:,1
,CLIENT ACCESSION #:,1
24016-8,INTERPRETATION,1
33662-8,RBCS,1
,AML MOLECULAR PROFILE NGS,1
43371-4,SALMONELLA/SHIGELLA SCREEN,1
,ECHOVIRUS 7,2
19146-0,14-3-3 PROTEIN TAU/THETA  CSF,1
,ECHOVIRUS 9,2
3204-5,FACTOR VIII INHIBITOR ASSAY HUMAN,2
69568-4,BV CATEGORY:,2
,LISTERIA MONOCYTOGENES BY PCR,2
43734-3,APTT 1:1 MIX SALINE,1
19762-4,GENERAL CATEGORIZATION:,1
,RAD ONC ARIA COURSE ID,2
92933-1,RS1333049,1
,MUTATION DETECTION RATES,2
46137-6,TRIPLE PHOSPHATE CRYSTALS,1
49549-9,METHOD/LIMITATIONS,2
,PRIOR RESULT,1
31208-2,VOLATILE ANALYSIS PERFORMED ON:,1
6916-1,CHLAMYDIA PSITTACI IGG ANTIBODY,1
,GANCICLOVIR (UL54 GENE TARGET),2
59020-8,DRB5,1
,SUMMARY REPORT,1
UNLOINC,NECROINFLAMM ACTIVITY SCORING:,1
69567-6,MEGASPHAERA 1,2
,SPECIAL COAGULATION INTERPRETATION,2
,DQB1-2,1
45001-5,CHLAMYDIA TRACHOMATIS AB  IGM,1
48793-4,NECROINFLAMMAT ACTIVITY GRADE,1
23993-9,ECHOVIRUS AB TYPE 7,1
,SPECIMEN STATUS  LUMINEX SCREEN CLASS I AND II,2
9598-4,23 KD (IGM) BAND,2
,POPULATION(S) GATED,1
92930-7,LPA INTRON 25 GENOTYPE,1
,DONOR 3,1
,% ABNORMAL,1
21262-1,SHIGA TOXIN  EIA,2
9518-2,ECHOVIRUS AB TYPE 30,1
587-6,HELICOBACTER PYLORI CULTURE,1
29374-6,RIBONUCLEOPROTEIN EXTRACTABLE NUCLEAR AB(UNITS/VOL) SERUM,1
10907-4,ST.LOUIS ENCEPH.VIRUS IGM,1
,EPILEPSY  AUTOIMMUNE EVALUATION  SERUM,1
,METHOD AND MARKERS TESTED,1
5095-5,COCCIDIOIDES AB (ID),1
69048-7,EPILEPSY  AUTOIMMUNE EVALUATION  SPINAL FLUID,1
,POOLED PLATELETS,1
,DONOR 1,1
,LAC INTERPRETATION,1
,SUSPECTED PROBLEM IS:,1
,CD8:MEMORY TCM:,1
,FIBROSIS SCORING:,1
,SPECIMEN STATUS  PRE TX CHIMERISM,2
10701-1,RESULT 3,1
18496-0,TRICHROME (2),1
10701-1,CONCENTRATE (1),1
43734-3,APTT 1:1 SALINE,1
,ABO GROUPING,1
,C*-1,1
,COCCIDIOIDAL COMPLEMENT FIXATION (CF),1
57132-3,2C19 GENOTYPE:,1
53831-4,GRANULOCYTES,1
,DQB1-2 EQUIVALENT,1
,GIARDIA AG  EIA  STOOL,1
32667-8,LYME DISEASE (BORRELIA SPP) DNA  QL  BLOOD,1
508-2,TOBRAMYCIN,1
,MITOGEN STIMULATION,2
,FACTOR V HR2 ALLELE,1
,PRIOR THERAPY,1
,CLIENT/PHONE #,1
18998-5,TRIMETHOPRIM/SULFA,1
5723-2,SELENIUM  RBC,1
79714-2,2C19 METABOLIC ACTIVITY:,1
62364-5,DISCLAIMER,1
883-9,BLOOD GROUPING,1
,COMPLEMENT SC5B-9 AB,1
31208-2,ISTAT Sample Source,6385
8251-1,"RESP.Data, DELIVERY SYSTEM",2984
8251-1,"RESP.Data, MODE",1017
8251-1,"RESP.Data, SITE",2871
2160-0,Est. GFR Interpretive Comment,87700
49024-3,Differential Method,30359
5778-6,"Color, UR",25373
58445-8,PLT Estimate,693
58445-8,Polychromasia,217
30400-6,Hypochromasia,182
58410-2,Differential Method,9348
38892-6,Anisocytosis,638
58445-8,Tear Drop Cells,51
72375-9,Urine Microscopic Method,18951
52789-5,TEG Procedure,123
11125-2,Manual PLT Morphology,3838
5909-7,Peripheral Blood Smear Interp.,1418
58445-8,Ovalocytes,121
58445-8,Target Cells,100
31208-2,Wet Prep - Source,232
32766-8,Wet Prep - Trichomonas,232
32765-0,Wet Prep - Yeast,232
6742-1,Manual RBC Morphology,3763
33768-3,"WBC Clumps, UR",1648
23201-7,Leptospira IGM ABS,6
8251-1,Quantiferon Criteria,26
58077-9,"Macroscopic Comment, UR",30
58445-8,Poikilocytosis,294
58445-8,Acanthocytes,107
62364-5,MMAL DISCLAIMER:,26
14278-6,Perinuclear (pANCA) Ab.,79
14277-8,Cytoplasmic (cANCA) Ab.,79
14611-8,Review ANA Screen,154
43227-8,"O and P Trichrome, Feces",24
10703-7,"O and P Modified Acid Fast, Feces",48
33511-7,"Appearance, Feces",71
33512-5,"Color, Feces",71
10701-1,"O and P Concentrate, Feces",59
31208-2,"O and P Specimen  Source, Feces",70
33234-6,"Calcium Oxalate Crystals, UR",296
47523-6,Body Fluid Smear Interp.,522
5817-2,"Uric Acid Crystals, UR",36
47938-6,Fluid Triglyceride Source,62
47938-6,Fluid PH Source,260
47938-6,Fluid Total Protein Source,452
47938-6,Fluid LDH Source,424
47938-6,Fluid Glucose Source,420
47938-6,Fluid Carcinoembryonic Antigen Source,53
,"Fluid Turbidity, BF",547
47938-6,Body Fluid Source,611
14725-6,"Cell Count Method, BF",408
33512-5,"Fluid Color, BF",553
4621-9,Sickle Cells,35
30434-5,Microcytes,53
47938-6,Fluid Albumin Source,133
47938-6,Fluid Amylase Source,64
8251-1,Venous Gas Comment,248
58445-8,Rouleaux,8
,"PE, Please note:",4
,Please Note,20
33358-3,M Spike,20
50564-4,"Macroscopic Comment, UR",134
50564-4,"Color, UR",103
34556-1,"Fluid Color, BF",25
34556-1,"Fluid Turbidity, BF",32
12598-9,"Fecal Fat, Qual. - Neutral Fat",6
2270-7,"Fecal Fat, Qual. - Total Fat",6
58445-8,Platelet Clumps,31
8251-1,COVID-19 ANTIBODY COMMENT,115
58445-8,Schistocytes,47
58445-8,Toxic Granulation,21
24356-8,"Color, UR",52
24356-8,"Macroscopic Comment, UR",63
13969-1,CKMB Abnormal Review,140
58445-8,Toxic Vacuolation,23
6770-2,Alpha-1-Antitrypsin Phenotype,20
58077-9,"Color, UR",14
50554-5,"Macroscopic Comment, UR",7186
47938-6,"Crystals Source, BF",43
53307-5,"Crystals Interp., BF",30
11156-7,Manual WBC Morphology,559
66488-8,SRA Interpretation,40
47938-6,Fluid Specific Gravity Source,197
12515-3,Fluid Carcinoembryonic Antigen Source,5
19075-1,"Cell Count Method, CSF",141
33512-5,"Fluid Color, CSF",142
11156-7,"Fluid Turbidity, CSF",114
13532-7,"Xanthochromia, CSF",142
42209-7,CSF Smear Interpretation,41
,"""""Macroscopic Comment, UR""""""""""""""""""""",2480
5778-6,"""""Color, UR""""""""""""""""""""",3347
12190-5,Fluid Creatinine Source,2
50564-4,"""""Macroscopic Comment, UR""""""""""""""""""""",62
33768-3,"""""WBC Clumps, UR""""""""""""""""""""",148
5814-9,"Triple Phosphate Crystals, UR",43
24476-4,Prothrombin Gene Mutation,10
673-4,"O and P Trichrome, Feces",44
33511-7,"""""Appearance, Feces""""""""""""""""""""",6
33512-5,"""""Color, Feces""""""""""""""""""""",6
10701-1,"""""O and P Concentrate, Feces""""""""""""""""""""",4
10703-7,"""""O and P Modified Acid Fast, Feces""""""""""""""""""""",4
31208-2,"""""O and P Specimen  Source, Feces""""""""""""""""""""",6
673-4,"""""O and P Trichrome, Feces""""""""""""""""""""",3
,Ova and Parasites Interp.,1
33234-6,"""""Calcium Oxalate Crystals, UR""""""""""""""""""""",29
5814-9,"""""Triple Phosphate Crystals, UR""""""""""""""""""""",5
53813-2,Platelet Mapping Procedure,57
66756-8,TEG Procedure,78
5393-4,FTA Absorption,17
8251-1,"ISTAT HCT, Comment",219
34556-1,Body Fluid Source,17
57803-9,Microsporidium Sp.- Stool,3
14330-5,Fecal Polymorphs,17
14326-3,Fecal Eosinophils,17
20399-2,"ANA Titer Pattern, Indirect IFA",39
,Review ANA Titer,48
24351-9,Path Interp. FPDS,76
25700-6,Interpretation Serum IFE,58
25700-6,Immunofixation Serum,63
9594-3,"Lyme IgG AB, Western Blot, P45",2
9590-1,"Lyme IgG AB, Western Blot, P28",2
9589-3,"Lyme IgG AB, Western Blot, P23",2
9591-9,"Lyme IgG AB, Western Blot, P30",2
9592-7,"Lyme IgG AB, Western Blot, P39",2
9593-5,"Lyme IgG AB, Western Blot, P41",2
9595-0,"Lyme IgG AB, Western Blot, P58",2
9596-8,"Lyme IgG AB, Western Blot, P66",2
9597-6,"Lyme IgG AB, Western Blot, P93",2
9598-4,"Lyme IgM AB, Western Blot, P23",2
9599-2,"Lyme IgM AB, Western Blot, P39",2
9587-7,"Lyme IgM AB, Western Blot, P41",2
31579-6,"Purkinje Cells, YO Antibody, CSF",1
9588-5,"Lyme IgG AB, Western Blot, P18",2
,Microsporidium Sp.- Stool,7
3281-3,LAC Interpretation,10
43734-3,aPTT 1:1 Mix Saline,10
21667-1,Factor V Leiden,16
,"""""Fluid Turbidity, BF""""""""""""""""""""",30
14725-6,"""""Cell Count Method, BF""""""""""""""""""""",28
33512-5,"""""Fluid Color, BF""""""""""""""""""""",32
10788-8,Hansel Stain Result,17
31208-2,Hansel Stain Specimen Source,17
34539-7,Path Interp. FPDU,31
77202-0,JAK2 Exon 12 background:,1
,Diff - Comment,5
,"Fluid Turbidity, CSF",28
2106-3,OR Urine Pregnancy Test,39
24339-4,Venous Gas Comment,1
12710-0,Hemoglobinopathy Interpretation,11
34556-1,"""""Cell Count Method, BF""""""""""""""""""""",6
673-4,"O and P Concentrate, Feces",4
673-4,"O and P Modified Acid Fast, Feces",23
53307-5,"""""Crystals Interp., BF""""""""""""""""""""",3
47938-6,"""""Crystals Source, BF""""""""""""""""""""",8
6825-4,"""""Crystals, BF""""""""""""""""""""",8
20399-2,ANA Titer Pattern,5
8251-1,"""""ISTAT HCT, Comment""""""""""""""""""""",14
2270-7,"""""Fecal Fat, Qual. - Total Fat""""""""""""""""""""",1
12598-9,"""""Fecal Fat, Qual. - Neutral Fat""""""""""""""""""""",1
,"""""Fluid Turbidity, CSF""""""""""""""""""""",16
19075-1,"""""Cell Count Method, CSF""""""""""""""""""""",16
33512-5,"""""Fluid Color, CSF""""""""""""""""""""",16
13532-7,"""""Xanthochromia, CSF""""""""""""""""""""",16
21026-0,Path Interp. FPDS,16
50595-8,Path Interp. FPDU,4
,Test Information,31
58445-8,Basophilic Stipling,14
13440-3,Immunofixation Urine,16
13440-3,"Interpretation Urine IFE, UR",14
3281-3,Lupus Anticoag. - INTERP:,9
673-4,"""""O and P Concentrate, Feces""""""""""""""""""""",2
673-4,"""""O and P Modified Acid Fast, Feces""""""""""""""""""""",1
12228-3,Fluid Triglyceride Source,1
14803-1,Fluid LDH Source,1
2748-2,Fluid PH Source,1
2881-1,Fluid Total Protein Source,2
1747-5,Fluid Albumin Source,1
1795-4,Fluid Amylase Source,1
2344-0,Fluid Glucose Source,2
8251-1,ISTAT Comments,50
34556-1,"""""Fluid Turbidity, BF""""""""""""""""""""",4
637-9,"Interpretation, Thick",9
33271-8,"Interpretation, Thin",9
637-9,"Malaria & Blood Parasites Smear, Thick",9
33271-8,"Malaria & Blood Parasites Smear, Thin",9
,See below:,274
5671-3,"Lead, Blood (Adult)",1
58445-8,Large Platelet,30
20399-2,"ANA Titer 2 Pattern, Indirect IFA",3
62364-5,HBVQD3 Test Information:,5
58445-8,Howell-Jolly Bodies,3
58445-8,Burr,22
58445-8,Spherocytosis,14
6825-4,"Crystals Source, BF",1
24336-0,"HCO3, ISTAT POC",4
24336-0,"Total CO2 (Calc), ISTAT POC",4
34519-9,Hereditary Hemochromatosis,1
20399-2,"""""ANA Titer Pattern, Indirect IFA""""""""""""""""""""",4
,ADAMTS13 Ab Comment:,4
13440-3,"""""Interpretation Urine IFE, UR""""""""""""""""""""",2
43227-8,"""""O and P Trichrome, Feces""""""""""""""""""""",2
51990-0,"Anion Gap, ISTAT POC",1
51990-0,"BUN, ISTAT POC",1
51990-0,"Chloride, ISTAT POC",1
51990-0,"Glucose, ISTAT POC",1
51990-0,"Hematocrit, ISTAT POC",1
51990-0,"Hemoglobin (Calc), ISTAT POC",1
51990-0,ISTAT Comments,1
51990-0,ISTAT Sample Source,2
51990-0,"Ionized Calcium, ISTAT POC",1
51990-0,"Potassium, ISTAT POC",1
51990-0,"Sodium, ISTAT POC",1
51990-0,"Total CO2 (Measured), ISTAT POC",1
2077-6,"""""Sweat Chloride, Site 2""""""""""""""""""""",1
58445-8,Dohle Bodies,10
52132-8,e1a2 transcript,2
,BCR Background:,2
49549-9,BCR Methodology,2
8061-4,Review ANA Screen,1
62364-5,Toxoplasma Comment,8
50237-7,"Trichomonas, UR",3
,EBV Interpretation,4
24336-0,Gas Comment,3
637-9,"""""Interpretation, Thick""""""""""""""""""""",1
33271-8,"""""Interpretation, Thin""""""""""""""""""""",1
637-9,"""""Malaria & Blood Parasites Smear, Thick""""""""""""""""""""",1
33271-8,"""""Malaria & Blood Parasites Smear, Thin""""""""""""""""""""",1
11040-3,"17-Hydroxycorticosteroids, UR",1
2147-7,"17-Hydroxycorticosteroids, UR, 24Hr",1
58077-9,"""""Macroscopic Comment, UR""""""""""""""""""""",803
24356-8,"""""Macroscopic Comment, UR""""""""""""""""""""",2
58077-9,"""""Color, UR""""""""""""""""""""",1
58077-9,"""""Urobilinogen , UR""""""""""""""""""""",2
,Blood Lead Purpose,2
,Blood Lead Source,2
5817-2,"""""Uric Acid Crystals, UR""""""""""""""""""""",1
6013-7,von Willebrand Factor Multimers,1
,Fluid Miscellaneous Source,1
,"Misc. Fluid, Test Name",1
34556-1,"""""Fluid Color, BF""""""""""""""""""""",2
32167-9,Clarity,4108
,Clue Cells,406
,OVA AND PARASITES WITH GIARDIA ANTIGEN,21
,Result1,2524
,GFR INTERPRETIVE COMMENT,1332
,Note:,118
,Bacteria,698
,Hematology Comments:,4246
,Microscopic Examination,1488
,Megasphaera 1,92
5778-6,Color,4257
,medMATCH Oxycodone,25
,Immature Cells,4141
,"CULTURE, URINE, ROUTINE",1247
,Antimicrobial Susceptibility,1065
,Comment:,4860
,Atopobium vaginae,95
,Contraception,965
,Color,309
,"Urine Culture, Routine",2593
,Color - UCC,3429
,Gram Stain Result,165
,"Fats, Total",2
,EKG 12 Lead Report,268
,Character,3424
,Foot Exam,298
,Anticoag Dosing Comments,499
,Leakage of Fluid,1102
,CONFIRMATION TESTING PERFORMED AT:,1
,Comment,705
,Trichomonas,1091
,Result 1,968
,Pre-Term Labor Symptoms,1084
,Fetal Movement,1099
,Zika,726
,Mucus Threads,698
,Clarity,290
,Duplex Scan - Carotid,86
,COMMENT(S),329
,DIFFERENTIAL METHOD,895
,Result 2,314
,Yeast,701
,TRANSITIONAL EPITHELIAL$CELLS,125
,CRYSTALS,132
,BVAB 2,92
,SJOGREN'S ANTIBODY (SS-B),130
,Crystal Type,698
,Anticoag Dosing Change,689
,Echo 2D & M Mode,809
,MACROSCOPIC COMMENT,421
,Fungal Hyphae,386
,Cast Type,698
,Pregnancy-Induced HTN Symptoms,1084
,Colonoscopy Result (Historical),93
,RAM-Message,209
,Pathologist,19
,BACTERIA,316
,"EIA, SHIGA TOXIN",27
,Contractions,1103
,Echo with Definity,21
94500-6,SOURCE:,10
,HIV 4th Generation,549
,Urinalysis Reflex,321
,DEXA result,4
,TRIPLE PHOSPHATE CRYSTALS,127
,Anaerobic Culture,170
,Urine-Color,930
,SURGICAL PATHOLOGY,177
,medMATCH Cocaine Metab,22
,Aerobic Bacterial Culture,98
,EDD Determined by,12
,Summary,85
,Fetal Position,583
,HSV Culture/Type,40
,QuantiFERON Incubation,68
,RH TYPE,40
,medMATCH Barbiturates,21
,URINE COLOR,421
,Appearance,930
,UTI Symptoms,1086
,REFLEXIVE URINE CULTURE,103
,medMATCH Phencyclidine,23
,Centriole Pattern,115
,"Body Fluid Culture, Sterile",6
,"medMATCH OH,Et flurazepam",12
,PA/Lateral Chest X-Ray Reading,83
,GRANULAR CAST,126
,medMATCH Opiates,18
,Stress Echocardiography,15
,CONFIRMATION,85
,RNP ANTIBODY,4
,medMATCH Marijuana Metab,25
,Perinuclear (P-ANCA),24
,Ova + Parasite Exam,64
,"HIV AG/AB, 4TH GEN",292
,medMATCH Amobarbital,6
,Spermatozoa,311
,medMATCH 6 Acetylmorphine,4
,Spindle Apparatus Pattern,115
,"CULTURE, CAMPYLOBACTER",38
,IgG P58 Ab.,10
,COLOR,22
,Nuclear Medicine (Cardiolite - GXT or Lexiscan,256
,PCNA Pattern,115
,"Cryoglobulin, Ql, Serum, Rflx",2
,Budding Yeast,380
,medMATCH Phenobarbital,6
,medMATCH Benzodiazepines,15
,"Hep B Surface Ab, Qual",42
,PREV. BX:,44
,YEAST,126
,MANUAL WBC MORPHOLOGY,6
,Eye Exam,31
,"Color, Fluid",7
,RBC Comment,6
,QuantiFERON Criteria,66
,medMATCH Tramadol,3
,Nuclear Dot Pattern,115
,IgG P93 Ab.,10
,Interpretation(See Below),12
,"DONOR, HEPATITIS C ANTIBODY (ANTI-HCV)",102
,"STREPTOCOCCUS, GROUP A$CULTURE",39
,TISSUE PATHOLOGY,7
,SJOGREN'S ANTIBODY (SS-A),130
,Please Note:,42
,Upper Respiratory Culture,149
,Aerobic Culture,173
,IgG P41 Ab.,10
,Nuclear Membrane Pattern,115
,IgG P23 Ab.,10
,REDUCING SUBSTANCES,76
,Result,61
,Limitations:,3
,Midbody Pattern,115
,medMATCH Pentobarbital,6
,RENAL EPITHELIAL CELLS,125
,PLTs,19
,HSV 2 IgM Antibodies,6
,Campylobacter Culture,68
,"OVA AND PARASITES, STOOL$CONC AND PERM SMEAR",27
,ABO Grouping,59
,Result 3,38
,IgG P30 Ab.,10
,CLINICAL INFORMATION:,44
,Salmonella/Shigella Screen,68
,ETHNICITY:,9
,CYTOTECHNOLOGIST:,44
,"CULTURE, BLOOD",3
,REVIEWER,9
,METHAMPHETAMINE,7
,MANUAL RBC MORPHOLOGY,32
,Ethyl Sulfate (ETS),4
,CASTS,125
,medMATCH Amphetamines,20
,SM ANTIBODY,126
,IgG P28 Ab.,10
,AMORPHOUS SEDIMENT,129
,HSV 1 IgM Antibodies,7
,Microscopic,60
,"Blood Culture, Routine",9
,medMATCH Secobarbital,6
,CYTOLOGY THINPREP,37
,STATEMENT OF ADEQUACY:,44
,Hereditary  Hemochromatosis,2
,medMATCH Butalbital,6
,Mammogram Result (Historical),49
,CALCIUM OXALATE CRYSTALS,130
,URIC ACID CRYSTALS,126
,Ethyl Glucuronide (ETG),4
,"ANTIBODY SCREEN, RBC$W/REFL ID, TITER AND AG",37
,Echo 2 D Only,8
,medMATCH EDDP,5
,HEPATITIS B CORE ANTIBODY (IGM),52
,MANUAL PLT MORPHOLOGY,32
,"Immunofixation Result, Serum",10
,medMATCH Lorazepam,12
,OTHER HEMOGLOBIN 2,13
,Cytoplasmic (C-ANCA),24
,Megakaryocytes,13
,Cigarette smoker,9
,"QUANTIFERON(R)-TB GOLD PLUS, 4T, INCUBATED",2
,IgM P23 Ab.,10
,"CULTURE, SALMONELLA AND$SHIGELLA",41
,"PROLACTIN, DILUTED",2
,IgM P39 Ab.,10
,medMATCH Nordiazepam,12
,93 KD (IGG) BAND,2
,"HELICOBACTER PYLORI AG, EIA, STOOL",14
,Steatosis Grading,3
,medMATCH Hydrocodone,9
,HEMOGLOBIN E,13
,medMATCH Desmethyltram,3
,Anisocytosis,3
,"Cyclospora Smear, Stool",3
,INFECTION:,6
,Rhythm Strip Report,3
,BV CATEGORY:,40
,Comments:,6
,PDF,6
,medMATCH Codeine,9
,Pap Result (Historical),36
,23 KD (IGG) BAND,2
,CONCENTRATE (1),15
,"CULTURE, GROUP B STREP$WITH SUSCEPTIBILITY",36
,Benzodiazepines Comments,2
,"Ultrasound, Doppler Venous",3
,Serial Monitoring,8
,medMATCH Morphine,9
,medMATCH Oxazepam,12
,medMATCH Noroxycodone,9
,DEXA result (Historical),9
,"Clarity, Fluid",7
,"Other, Lineage Uncertain",13
,medMATCH aOH midazolam,12
,medMATCH Oxymorphone,9
,"Crystal,Synovial/Joint Fl",9
,medMATCH ETG,4
,Gestat. Age Based On,4
,"Echo, Bubble Study",4
,Arterial Duplex Lower Extremity,13
,medMATCH Methadone,25
,SCL-70,1
,58 KD (IGG) BAND,2
,Class Description,15
,Comments/Recommendations,19
,medMATCH Methamphetamine,7
,"Microalbumin,mg/day",2
,medMATCH Aminoclonazepam,12
,Interpretations:,3
,"Immunofixation Result, Urine",3
,AGE RISK DOWN SYNDROME,12
,INTERPRETATION/RESULT:,44
,medMATCH Hydromorphone,8
,39 KD (IGM) BAND,2
,ABNORMAL PROTEIN BAND 2,7
,"White Blood Cells (WBC), Stool",18
,Spirometry Results,18
,medMATCH Benzoylecgonine,5
,Platelet Comment,6
,medMATCH 6 Acetylmorph,4
,66 KD (IGG) BAND,2
,medMATCH Amphetamine,7
,"CULTURE, GENITAL",11
,HSV CULTURE:,16
,medMATCH Temazepam,12
,RIBOSOMAL P ANTIBODY,1
,REVIEW CYTOTECHNOLOGIST:,12
,HIV 1 GENOTYPE,1
,FECAL LEUKOCYTE STAIN,11
,Repeat Specimen,12
,"RPR, Quant.",19
,"Arsenic,Urine 24 Hr",1
,METHOD,9
,"Arsenic(Inorganic),U",1
,QUAD RISK DOWN SYNDROME,12
,SUREPATH FPGS PAP AND HR HPV,10
,SITE,5
,Abnormal Specimen Validity Test:,5
,IgG P66 Ab.,10
,ABNORMAL PROTEIN BAND 3,7
,Differential Comment,6
,$COMMENTS:,12
,medMATCH Norhydrocodone,9
,medMATCH aOH alprazolam,12
,TITER,2
,OTHER HEMOGLOBIN 1,13
,CBC MORPHOLOGY,14
,Hepatitis C Quantitation,1
,Result 4,7
,MUTATIONS/POLYMORPHISMS,9
,Duplex Scan-Renal Artery (DSRA/Schedule E2 Only),10
,"NASH Scoring",3
,IgG P18 Ab.,10
,RPR (MONITOR)$W/REFL TITER,19
94500-6,COMMENT,3
,Coombs Titer #1,3
,Dilated Eye Exam Findings,8
,Results,4
,PLT Estimate,4
,CHROMATIN (NUCLEOSOMAL) ANTIBODY,5
,Est'd Date of Delivery,12
,Factor V Leiden Result,2
,medMATCH Alcohol Metab,4
,IgM P41 Ab.,10
,"Ultrasound, Doppler Arterial",2
,"Viral Culture, Rapid,Varicella",5
,Prescribed Drug 3,14
,IgG P45 Ab.,10
,T18 Risk,4
,IgG P39 Ab.,10
,"NASH Grade",3
,"TRICHOMONAS, WET PREP",6
,"Pap IG, rfx HPV ASCU",1
,IMAGE,12
,REPORT TYPE,2
,"FECAL FAT, QUALITATIVE",1
,30 KD (IGG) BAND,2
94500-6,PATIENT SYMPTOMATIC?,10
,Race,3
,"Fats, Neutral",2
,"Ultrasound, AAA Screen",4
,Colonoscopy Summary,11
,medMATCH aOH triazolam,12
,medMATCH ETS,4
,Multiple Gestation,4
,"P E Interpretation, S",2
,US Thyroid Parathyroid,3
,LDL PHENOTYPE,4
,Cologuard Result (Historical),1
,Antibody Id. #2,3
,"CLUE CELLS, WET PREP",5
,Fibrosis Stage,3
,$URINE RESULTS,2
,Historical Echocardiogram,1
,Ovalocytes,1
,medMATCH Norfentanyl,1
,3+ View Wrist X-Ray Reading,1
,MSAFP RISK OPEN NTD,12
,"Viral Culture, General",5
,MSS3 TRISOMY 18 RISK,12
,Clue Cell Exam,1
,18 KD (IGG) BAND,2
,"Prolactin, Serum (ICMA)",1
,"Stool Culture, Yersinia Only",2
,IFE Interpretation:U,4
,Steatosis Grade,3
,CLINICAL INFORMATION,3
,GIARDIA AND CRYPTOSPORIDIUM ANTIGEN PANEL,3
,41 KD (IGM) BAND,2
,"STREPTOCOCCUS, GROUP B$CULTURE",6
,Benzoylecgonine,5
,Urine Culture,7
,"CULTURE, STOOL, SAL/SHIG/CAMPY AND SHIGA TOXINS EIA W/RFL E.COLI O157 CULT",9
,LKM-1 ANTIBODY (IGG),3
,39 KD (IGG) BAND,2
,45 KD (IGG) BAND,2
,Toxic Vacuolation,2
,SJOGREN'S ANTIBODIES(SSA),1
,AAA Ultrasound Screen,1
,medMATCH Fentanyl,1
,"Urine Culture,Comprehensive",4
,"BV, Sialidase Activity",1
,Fibrosis Scoring:,3
,28 KD (IGG) BAND,2
,ANTIGEN TYPE:,2
,"Ultrasound, Abdominal Aorta",4
,DNA MUTATION ANALYSIS,1
,SJOGREN'S ANTIBODIES(SSB),1
,Amphetamines Holding,1
,MUCIN CLOT,5
,Percent Macroprolactin,1
,Methodology,3
,"CF, Screen",3
,Factor V Leiden,1
,"Stool Culture, Vibrio Only",2
,JO-1 ANTIBODY,6
,Test Results:,4
,Inorg. As/Crt Ratio,1
,Dilute Prothrombin Time(dPT),1
,ECHO with Strain,1
,Prescribed Drug 4,1
,Test Information:,4
,medMATCH NORBUPRENORPHINE,1
,PROCALCITONIN LEVEL,1
,HEPATITIS B CORE AB TOTAL (REFL),1
,medMATCH BUPRENORPHINE,1
,Wound Cult With Gram,2
,"VIBRIO, CULTURE",1
,Documentation,1
,Coombs Titer #2,3
,"Pancreatic Elastase, Fecal",1
,3+ View Hand X-Ray Reading,1
,"TISSUE, 2 SPECIMENS",1
,"ANDROSTERONE, SERUM",1
,HCV log10,1
,dPT Confirm Ratio,1
,Monomeric Prolactin (ICMA),1
5767-9,Ur Clarity,220840
6742-1,RBC Morphology,13132
14725-6,Fl Type Diff,6207
31208-2,Onc Chrom Specimen Type,644
6824-7,Fl Color,6168
14725-6,Fl Type Albumin,1922
33515-8,Fl Clarity,6170
10358-0,Teichoic Acid Ab,45
9795-6,Stone Composition,2095
14618-3,Stone Description,2076
32167-9,Ur Clarity POC,3373
5778-6,Ur Color POC,3373
69564-3,Bacterial Vaginosis Category,232
687-4,Ureaplasma/Mycoplasma Cult,80
31208-2,Ureaplasma Cult Src,83
21026-0,T Cell Interp,1702
593-4,Legionella Cult,1664
31208-2,Legionella Cult Src,1784
58445-8,Diff Comment,1288
14725-6,Fl Type pH,1054
14725-6,Fl Type Amylase,1271
14725-6,Fl Type Protein,3096
14725-6,Fl Type Glucose,2125
5096-3,Coccidioides Ab,142
5113-6,Coxsackie B6,92
5111-0,Coxsackie B5,92
5109-4,Coxsackie B4,92
5107-8,Coxsackie B3,92
5105-2,Coxsackie B2,92
5103-7,Coxsackie B1,92
10701-1,Feces O&P Organism #4,6
10701-1,Feces O&P Organism #3,6
10701-1,Feces O&P Organism #2,9
31208-2,BRBPCS Source,484
21667-1,Factor 5 Leiden,1016
882-1,Recip ABO and Rh.,72
14577-1,Donor ABO and Rh.,126
49296-7,Prot Elec Interp,3903
49836-0,Plt Func Interp,360
31208-2,Flow Cytometry Source,2807
4694-6,Recipient HLA,1140
51938-9,Donor HLA,1123
49275-1,IFX Interp,3174
31208-2,Specimen Description.,1955
24475-6,Factor 2 Gene Mut,940
38404-0,CF Interp,89
31208-2,CF Spec Type,96
21654-9,CF Results,88
31208-2,Group B Strep PCR Intrapartum Source,552
10335-8,CSF Color,1909
49736-2,CSF Clarity,1910
20458-6,Rubella Imm Status,1654
31208-2,Misc Adenovirus PCR Source,108
13514-5,Hb Electro Interp,1274
31279-3,Camp. jejuni Ab,12
23213-2,Skin Ab,4
31208-2,Group B Strep PCR Antepartum Source,671
31208-2,CMV PCR Qual Source..,1176
31208-2,JAK2 Spec Type,218
29967-7,ANCA Titer,357
31208-2,Pn jirovecii PCR Source,1286
31208-2,Aptima Media Type,215
31208-2,Aptima Source,220
31208-2,Varicella PCR Src,195
49282-7,Metanephrines Interp,250
6313-1,Blastomyces Ag,83
31208-2,Blastomyces Ag Source,91
31208-2,Chimerism Sample Source,176
12285-3,DPB1 Locus 1,397
53938-7,DQB1 Locus 2,395
21342-1,DRB1 Locus 2,394
12285-3,DPB1 Locus 2,397
31208-2,Legionella PCR Source,303
31208-2,MTHFR Specimen,70
21709-1,MTHFR Interpretation,157
10753-2,Feces Fat Qual,409
9838-4,Liver Kidney Microsome Ab,799
31208-2,Misc Onc/Gen Sample,196
49736-2,CSF Clarity Add'l Tube,564
9757-6,Coxsackie A9,90
20574-0,Histoplasma Yeast Ab,68
20573-2,Histoplasma Mycelia Ab,68
31208-2,Enterovirus PCR Src,220
31208-2,Parvovirus B19 PCR Src,234
12285-3,DPA1 Locus 2,255
44728-4,DQA1 Locus 2,256
5358-7,Smooth Muscle Ab Titer,399
14725-6,Fl Type Triglycerides,504
14725-6,Fl Type Creatinine,365
49276-9,UR IFX Interp,625
49299-1,Ur Prot Elect Interp,723
23820-4,Asp flavus,85
6809-8,Asp fumigatus 6,112
6808-0,Asp fumigatus 1,112
6733-0,Pigeon Stool,112
14725-6,Fl Type CEA,125
49659-6,HIV Genotype Results,101
593-4,Legionella Cult Results,1617
31208-2,Source.,504
6955-9,Bart. henselae IgM,59
6954-2,Bart. henselae IgG,59
9783-2,Ehr. chaffeensis IgG,17
9784-0,Ehr. chaffeensis IgM,17
5247-2,Mitochondrial Ab Titer,24
31208-2,Source..,41
49283-5,Ur Metaneph Interp,180
49293-4,MS Interp,253
9360-9,Bart. quintana IgG,43
9361-7,Bart. quintana IgM,43
44534-6,Post Transpl Ab Monitoring,1382
66488-8,SRA Unfract Heparin Interp,194
32769-2,Alpha 1 Antitrypsin Phenotype,151
31208-2,CSF EBV PCR Quant Source,28
31208-2,Hemochrom DNA Source,193
34519-9,Hemochrom Mutation,218
32366-7,HBV Genotype.,12
49257-9,Catecholamines Interp,101
31208-2,Misc Onc/Gen Sample 2,22
31208-2,Mycopl. pneumoniae PCR Src,92
17784-0,Blood Parasites Smear,31
41852-5,AFB Susc Organism 1,160
31208-2,AFB Susc Source 1,160
41852-5,AFB ID Organism 1,104
31208-2,AFB ID Source 1,104
31208-2,Micro Ref Specimen 2,59
41852-5,Micro Ref Organism 2,56
31208-2,Micro Ref Specimen 1,157
41852-5,Micro Ref Organism 1,152
6913-8,Chl pneumoniae IgG,46
6916-1,Chl psittaci IgG,46
6919-5,Chl trachomatis IgG,40
6917-9,Chl psittaci IgM,36
6920-3,Chl trachomatis IgM,30
6914-6,Chl pneumoniae IgM,36
21026-0,PNH Interp,155
44909-0,Interp (5HIAA),101
61177-2,Purkinje Cell Ab/Neuronal Nuc Ab IgG Scr,103
49263-7,Very Long Chain Fatty Acids Interp,10
49582-0,Seq Scr2 Tri18 Rsk C/O,8
49090-4,Seq Scr2 Down Age Risk,8
47223-3,Seq Scr2 Tri18 Age Rsk,8
43994-3,Seq Scr2 Tri18 Scr Rsk,8
49583-8,Seq Scr2 Down Risk C/O,8
48803-1,Seq Scr2 ONTD Scr Risk,8
49586-1,Seq Scr2 Interp,8
49584-6,Seq Scr2 ONTD Risk C/O,8
49091-2,Seq Scr2 ONTD Age Risk,8
43995-0,Seq Scr2 Down Scr Risk,8
49032-6,Seq Scr2 Result,8
31208-2,HSV PCR Src,157
23901-2,CSF Amoeba,8
23901-2,CSF Amoeba Add'l Tube,4
26474-7,Abs Lymph Cnt,5
73836-9,Fluoroquinolone Resistant Org Cult,74
73836-9,Fluoroquin Res Org Cult Source,74
35505-7,LDL Phenotype,11
5211-8,Herpesvirus 6 IgG,38
31208-2,Draw/Send Tube Type,11
43309-4,IgG Desmoglein 1 & 3 Ab,5
41274-2,MSAFP Interpretation,217
41274-2,MSAFP Result A,227
14725-6,Fl Type Lipase,97
42771-6,Pneumococ IgG Interp,132
21362-9,Leg. pneumophilia IgG 1-6,9
49914-5,Leg. pneumophilia 1-6 IgM,8
33009-2,Fl Chylomicrons,11
14725-6,Fl Type Chylomicrons,11
56027-6,High Ristocetin,27
3241-7,Factor 13,20
31208-2,Fl CMV PCR Quant Source,64
5308-2,Rocky Mt Spot Fvr IgM,12
13359-5,Semen Appearance,49
10569-2,Semen Color,49
33217-1,Sperm Agglutination,49
9704-8,Sperm Morphology,49
13942-8,Sperm Motility Comment,10
13942-8,Motility,49
21027-8,Ristocetin Interp,12
31208-2,Chl trachomatis Cult Src,6
49256-1,Ur Catechol Interp,93
50670-9,RBC Agglutination,26
19053-8,Brucella Ab,31
50391-2,Inhibitor Scr,82
31208-2,FNA Source/Site Thyroglobulin,15
49583-8,Seq Scr1 Down Risk C/O,8
49090-4,Seq Scr1 Down Age Risk,8
43995-0,Seq Scr1 Down Scr Risk,8
50679-0,Seq Scr1 Result,8
49588-7,Seq Scr1 Interp,8
49582-0,Seq Scr1 Tri18 Rsk C/O,8
47223-3,Seq Scr1 Tri18 Age Rsk,8
43994-3,Seq Scr1 Tri18 Scr Rsk,8
31208-2,Misc Onc/Gen Sample 3,4
51699-7,Endomysial IgG,27
31208-2,Candidiasis PCR Source,34
31208-2,Bact Vaginosis PCR Source,43
5325-6,Typhus Fever IgM,4
5324-9,Typhus Fever IgG,4
5307-4,Rocky Mt Spot Fvr IgG,10
49250-4,Ur Amino Acids Interp,3
16118-2,B. microti IgM,8
16117-4,B. microti IgG,8
20671-4,Amino Acids Interp,8
31208-2,GC PCR Source,54
31208-2,Chl trachomatis PCR Source,37
34142-0,Neuronal Nuc Ab IgG Immunoblot,9
49024-3,Buffy Coat Diff,47
59063-8,Lymphocyte Mitogens,1
31208-2,Cortisol Specimen Site,15
13440-3,Ur BJ Prot Interp,7
5075-7,Candida Ag.,1
41492-0,Echovirus Ab 7,20
5144-1,Echovirus Ab 6,20
5146-6,Echovirus Ab 9,20
6393-3,Echovirus Ab 30,20
41489-6,Echovirus Ab 11,20
28005-7,MTHFR C665C>T PCR,26
31208-2,Bordetella PCR Source,10
14725-6,Fl Type Cholesterol,36
13290-2,Tryp. cruzi IgM,7
31208-2,Misc ARUP Test 1 Sample,1365
49092-0,AFP4 Interpretation,40
49092-0,AFP4 Result A,44
31208-2,Neogen Test Specimen Type,2471
31208-2,RF Test2 Specimen Type,4
49287-6,Ur Organic Acids Interp,6
31208-2,CYP2C19 Source,2
72879-0,CYP2C19 Interp,1
14725-6,Fl Type RSV,145
33472-2,Acylcarnitine Interp,8
5098-9,Cold Agglutinin,37
73825-2,NIPT Trisomy 18,28
73821-1,NIPT Monosomy X,28
73824-5,NIPT Trisomy 13,28
73966-4,NIPT Trisomy 21,28
56021-9,Thrombin Lvl,15
56012-8,Arachadonic Acid,15
5285-2,Poliovirus 3 Ab,3
5281-1,Poliovirus 1 Ab,3
13440-3,Ur Prot Interp Prot Electro,19
31208-2,West Nile Virus PCR Src,17
31208-2,Chl pneumoniae PCR Source,14
5058-3,Blastomyces Ab,33
13927-9,Islet Cell IgG,42
50948-9,Ur VMA Interp,28
21027-8,Plt Aggr Interp,15
31989-7,CSF 14-3-3 Protein Tau/Theta (CJD),16
31208-2,CD34 Spec Type,30
25155-3,UA Cystine Crys,3
31208-2,Specimen Type Flu & RSV PCR,497
14725-6,Fl Type O and P,34
14725-6,Fl Type Bilirubin Total,50
14725-6,Fl Type Urea Nitrogen,12
58442-5,Other Micro Elements,9
59462-2,CDT Congen Disorders Interp,6
62359-5,Bld Chrom Band Tech,14
62356-1,Bld Chrom Karyotype,14
62357-9,Bld Chrom Interp,14
50619-6,Bld Chrom Karyotype Desc,14
31208-2,Bld Chrom Spec Type,16
31208-2,Misc ARUP Test 2 Sample,53
49092-0,AFP4 Result B,11
9704-8,Sperm Morphology Comment,1
22410-5,Lympho Choriomen IgG,6
9767-5,Lympho Choriomen IgM,6
31146-4,CSF VDRL Titer,3
48595-3,VonWillebrand Interp,6
82979-6,CASPR2 Ab IgG Scrn,5
5788-5,UA Oval Fat Bodies,2
49586-1,Int Scr2 Interp,7
49582-0,Int Scr2 Tri18 Rsk C/O,6
49584-6,Int Scr2 ONTD Risk C/O,6
49091-2,Int Scr2 ONTD Age Risk,7
48803-1,Int Scr2 ONTD Scr Risk,6
49032-6,Int Scr2 Result,7
47223-3,Int Scr2 Tri18 Age Rsk,6
43995-0,Int Scr2 Down Scr Risk,6
43994-3,Int Scr2 Tri18 Scr Rsk,6
49583-8,Int Scr2 Down Risk C/O,6
49090-4,Int Scr2 Down Age Risk,6
82978-8,LGI1 IgG Scrn,4
31208-2,RF Test3 Specimen Type,1
32217-2,VonWillebrand Multimers,13
50797-0,M Protein Peak 4,4
31208-2,HV6 Quant Specimen,36
31208-2,Adenovirus PCR Quant Source,26
49340-3,Adenovirus PCR Quant copy/mL,20
18343-4,Heroin Lvl,2
6915-3,Chl psittasi IgA,3
50612-1,Chl pneumoniae Interp,6
28556-9,Chl trachomatis DK IgG,6
44081-8,Chl psittaci Interp,6
6912-0,Chl pneumoniae IgA,6
28557-7,Chl trachomatis DK IgA,6
44005-7,Chl trachomatis DK Interp,6
28558-5,Chl trachomatis DK IgM,6
43113-0,Hb Electro Isoelec Focus Rslt,6
20510-4,Lipoprotein Electro Interp,9
11158-3,Serum Appearance,9
25742-8,Prothrom Frag 1.2 Rslt,3
49269-4,Ur HVA Interp,2
43175-9,Chl trachomatis L2 IgM,1
43173-4,Chl trachomatis L2 IgG,1
51734-2,Chl trachomatis L2 Interp,1
43174-2,Chl trachomatis L2 IgA,1
12189-7,CK MB % of Total,185
62357-9,Prod Concep Chrom Interp,15
62356-1,Prod Concep Chrom Karyotype,15
62359-5,Prod Concep Chrom Band Tech,15
31208-2,Prod Concep Chrom Spec Type,15
62357-9,Tis Chrom Interp,1
62356-1,Tis Chrom Karyotype,1
62359-5,Tis Chrom Band Tech,1
31208-2,Tis Chrom Spec Type,1
48819-7,Prod Concep Chrom Karyotype Desc,10
31208-2,Min Resid Dis Specimen,10
31208-2,2019 nCoV Specimen,3
6527-6,Rabies Ab,4
31208-2,Misc ARUP Test 3 Sample,4
4631-8,Feces Fetal Hgb,1
5041-9,Adenovirus Ab,11
9820-2,Bld Crypto Ag Titer,4
21561-6,Thermoact sacchari,5
31208-2,Atyp Pneum Pnl Source,2
21026-0,Hb A2 & F Interp,3
31208-2,Misc Genzyme Sample 2,53
6915-3,Chl psittaci IgA,3
3732-5,Ur LSD Scr,2
33536-4,Salad Panel Interp,3
45025-4,Molec HLA A2 Locus,12
57297-4,Molec HLA Cw1 Loc,12
45025-4,Molec HLA A1 Locus,12
38357-0,Flow XM B Cell Result Addl,7
35459-7,Flow XM T Cell Result Addl,7
57297-4,Molec HLA Cw2 Loc,9
45028-8,Molec HLA B2 Locus,10
9540-6,CSF West Equ Enceph IgM,6
10899-3,CSF East Equ Enceph IgM,6
21510-3,CSF St Louis Enceph IgM,6
9540-6,CSF California Enceph IgM,6
31208-2,Misc Genzyme Sample 3,16
6958-3,West Equ Enceph IgM,4
10898-5,East Equ Enceph IgM,4
10907-4,St Louis Enceph IgM,4
10905-8,California Enceph IgM,4
10904-1,California Enceph IgG,7
6957-5,West Equ Enceph IgG,7
10896-9,East Equ Enceph IgG,7
10906-6,St Louis Enceph IgG,7
31208-2,T922 Spec Type,1
31208-2,Interleukin 28B Source,2
60279-7,IL28B rs12979860,1
31208-2,Frag X Scr Specimen Type?,16
36913-2,Frag X Scr Interpretation,15
41107-4,Frag X Scr Result,15
31208-2,BHPGx Specimen Type,27
56030-0,UroVysion FISH Result,10
31208-2,UroVysion Source,11
40734-6,Class 1 DSA Titer 4,4
40734-6,Class 1 DSA Titer 1,4
46995-7,Class II DSA Titer 1,2
31208-2,Specimen Type CSF LD,13
10897-7,CSF East Equ Enceph IgG,3
9315-3,CSF West Equ Enceph IgG,3
21509-5,CSF St Louis Enceph IgG,3
9539-8,CSF California Enceph IgG,3
53119-4,UA Tyrosine Crys,3
14725-6,Fl Type Uric Acid,5
48406-3,Parietal Cell Ab Titer,4
31208-2,GC/Chlamydia RNA PCR Source,534
43305-2,GC RNA PCR,534
43304-5,Chl trachomatis RNA PCR,534
83327-7,HIV1 Phenosense Interp,11
83327-7,HIV1 Phenosense,8
80689-3,HIV1 Drug Resis by NGS,11
552-0,Brucella Cult Result,1
31208-2,Org NGS Specimen Type,229
13362-9,Coll Hrs Lead,5
28009-9,Tot Vol Lead,5
552-0,Brucella Cult.,1
17784-0,Malarial Parasites,17
2162-6,Ur Creat mg/day Lead,1
31208-2,H pylori Culture Source,4
678-3,CSF Trichrome Stain,2
23901-2,CSF Wet Prep,2
31208-2,SARS CoV Ag Specimen,467
49583-8,1st Scr Down Risk C/O,4
49090-4,1st Scr Down Age Risk,4
43995-0,1st Scr Down Scr Risk,4
49588-7,1st Scr Interpretation,4
43994-3,1st Scr Tri18 Scr Risk,4
49582-0,1st Scr Tri18 Risk C/O,4
47223-3,1st Scr Tri18 Age Risk,4
31208-2,1st Scr Spec Type,4
31208-2,B & T Cell Specimen type,1
14725-6,Fl Type RBCs,1
31208-2,Specimen Type RSV PCR,31
31208-2,Bordetella PCR Specimen,7
50409-2,HDL Subclasses Rslt,2
24078-8,WBC Arylsulfatase A Rslt,1
28009-9,Tot Vol Glucose.,4
31208-2,WGS Specimen Type,1
25700-6,Immunofixation,2
31208-2,Alpha 1 Antitryp Geno Source,21
1830-9,Alpha 1 Antitryp Geno Interp,21
9409-4,Ur Steroids Screen,2
75605-6,MT21 Fetal Fraction,4
77020-6,MT21 Fetal Sex,4
49244-7,Alpha 1 Antitryp Pheno,1
49303-1,CSF Amino Acids Interp,2
82991-1,Phospholip A2 Recept IgG Scr,2
3559-2,Digitoxin Lvl,1
28009-9,Tot Vol Arsenic,1
13362-9,Coll Hrs Arsenic,1
2162-6,Ur Creat mg/day Glucose,2
2351-5,Ur Glucose mg/day,2
31208-2,Brucella Cult Source,1
14725-6,Fl Type Sodium,2
50758-2,HSV 1 IgM Titer,1
31208-2,Misc ARUP Test 4 Sample,2
25163-7,UA Leucine Crys,1
6905-4,Propafenone Lvl,1
81201-6,Phospholip A2 Recept IgG Titer,1
31208-2,Resp Infec Pnl Source,4
13514-5,Hgb Capillary Electrophoresis,1
,Trichinella Ab,1
,Hemolytic Anemia Pnl,1
,Encep Eval NMDA-R Ab CBA,2
,Encep Eval AChR Ganglionic Neuronal Ab,2
,Encep Eval Amphiphysin Ab,2
,N-Type Calc Channel Ab,2
,Xome DX Plus,1
,EBV Lower 95% Conf Lvl,4
,EBV Upper 95% Conf Lvl,4
,CMV qPCR (Tissue),2
53622-7,ADAMTS13 Activity,1
,Vitamin B1 Comment,1
2999-1,Vit B1 Level,1
1649-3,"Vitamin D3, 1,25 (OH) 2",1
62290-2,"Vitamin D,1,25 (OH) 2,Total",1
62291-0,"Vitamin D2, 1,25 (OH)2",1
,CoQ10 Interp,1
49038-3,Vitamin B2 Lvl,1
2900-9,Vitamin B6,1
30552-4,Pyridoxal 5-Phosphate,1
,Vitamin B5 Lvl,1
,Fungitell,1
,Carnitine Intrp,6
31208-2,HSV-1/2 Source,1
,IBD SGI,8
,Comp NF1,1
2147-7,URINE CORTISOL,1
,DATE VIRAL LOAD COLLECTED,1
29990-9,"Post-Vas Sperm, Qual",1
46769-6,Cystic Fibrosis Interp.,13
21759-6,FRAGILE X SOUTHERN BLOT,1
6362-8,C diff Toxin B,2
13952-7,HEPATITIS B CORE AB TOTAL$(REFL),3
14789-2,"Parasite ID, Worm",1
21070-8,Min Inhibitory Conc (1 Drug),1
25684-2,URINE 24 HR LAMBDA,1
44008-1,HSV 1/2 IGM$INTERPRETATION,12
79190-5,ZIKA VIRUS RNA,2
48398-2,HBV QUANTASURE,7
42595-9,HEPATITIS B DNA QUANT,7
44909-0,"INTERPRETATION, 5HIAA, URINE",2
41270-0,REPORT SUMMARY,17
53796-9,INTERFERON BETA USED FOR TREATMENT,1
12477-6,D METHAMPHETAMINE,1
15404-7,L METHAMPHETAMINE,1
10900-9,HEPATITIS B SURFACE AB QL (REFL),1
5196-1,HEP B SURFACE AG  CONFIRMATION,2
6921-1,CYTOMEGALOVIRUS IGG  ELISA (CSF),2
,Est. GFR Interpretive Comment,740
24323-8,Est. GFR Interpretive Comment,22
8251-1,"Bedside Glucose, Comments",144
34563-7,"Fluid Turbidity, CSF",2
24321-2,Est. GFR Interpretive Comment,4
34563-7,"Cell Count Method, CSF",3
9802-0,"""""Stone Anaylsis, Size""""""""""""""""""""",2
,"""""Stone Anaylsis, Comment (3)""""""""""""""""""""",2
9796-4,"""""Stone Anaylsis, Color""""""""""""""""""""",2
42192-5,"""""Stone Anaylsis, NIDUS""""""""""""""""""""",2
,"""""Stone Anaylsis, Composition""""""""""""""""""""",2
,"""""Stone Anaylsis, Please Note:""""""""""""""""""""",2
,"Testosterone, Comment:",1
49549-9,Acyl Quant Methodology,1
46252-3,Acyl Quant Interpretation,1
72486-4,Acyl Quant Director Review,1
673-4,"O and P Specimen  Source, Feces",1
,KU AUTOABS,4
,A GROSS DESCRIPTION,1
,HEPATITIS B CORE$ANTIBODY (IGM),6
,PATHOLOGIST,2
,Epithelial,41
,"24 hr Creatinine, Urine",1
,HIV GenoSure(R),8
,Plt Est,26
,CICD10,5
,"MTHFR, DNA Analysis",2
,"pH, Stool",1
,A SOURCE,1
,PL 7 AUTOABS,4
,TPMT GENOTYPE,1
,OJ AUTOABS,4
,MI 2 AUTOABS,4
,SRP AUTOABS,4
,Poik,1
,"Ultrasound, Abdomen",1
,Nicotine,2
,"Genital Culture, Routine",9
,HIV GenoSure(R) MG PDF,1
,DIAGNOSIS:,4
,Schistocytes,4
,LOG COPIES/ML,2
,"C difficile, Cytotoxin B",2
,Target Cells,2
,"URINE CULTURE, ROUTINE",9
,A MICRO DESCRIPTION,1
,Cotinine,2
,PL 12 AUTOABS,4
,Hypochromasia,2
,Gross description:,4
,COPIES/ML,2
,ANA COMMENT,1
,EJ AUTOABS,4
,HIV Screen 4th Generation wRfx,1
,HLA-B,1
,HLA Methodology,1
,"SHIGA TOXINS, EIA W/RFL$TO E.COLI O157 CULTURE",1
,A DIAGNOSIS,1
59681-7,GHBT,2
31208-2,Misc Genzyme Sample 4,2
31208-2,Group B Streptococcus PCR Source,5
22566-4,Strep. pyogenes Ab Scr,1
31208-2,Influenza PCR Source,23
5673-9,Hair Lead,1
31208-2,Hair Lead Source,1
19253-4,Trichinella Ab,1
31208-2,Zika Test Specimen(s) Submitted,6
31208-2,Zika Test Specimen(s) Received,6
14725-6,Fl Type Potassium,1
31208-2,Metapneumovirus Source,1
33536-4,Allergy Interp,1
53939-5,Cylex Result,2
31208-2,EBV PCR Quant Source,5
,PT Gene 20210A,1
,Factor VIII Inh,3
,Celiac Serology,5
,Neo Ref Ranges,1
,Lipo Metab Interp,1
21668-9,Factor V Leiden,1
,Lymph Prolif Ag Comment,1
,Lymph Prolif Ag Interp,1
,Marfan/TAAD Pnl,1
,Crohn's Prog,2
,Adenovirus PCR CSF,10
,Adenovirus DNA Log 10,1
,Engraf 1st Port,1
,Thiopurine Met,1
,Encep Eval AChR (Muscle) Binding Ab,1
,nRNP/Sm IgG Autoabs LupAn,2
,SS-A/Ro IgG Autoabs LupAn,2
,Sm IgG Autoabs LupAn,2
,SS-B/La IgG Autoabs LupAn,2
,Ribosom P Prot Autoabs LupAn,2
47322-3,Scl-70 IgG Autoabs LupAn,2
,Syphilis IgM,1
,Syphilis IgG,1
21709-1,INTERPRETATION,2
5619-2,CHROMIUM (B),1
8251-1,ANA COMMENT,1
13927-9,ISLET CELL ANTIBODY TITER,1
28005-7,RESULT,2
5609-3,CADMIUM,1
45323-3,"QUANTIFERON(R)-TB GOLD,$(INCUBATED)",1
57802-1,CHROMOSOME SPECIFIC PROBE,1
32366-7,HBV GENOTYPE:,1
12731-6,"INTERFERON ALPHA, EIA",1
55201-8,c-KIT Mutation Analysis Result,1
5753-9,VANADIUM (B),1
16140-6,TELLURIUM (B),1
4097-2,"Volatiles Screen, Ur",2
5685-3,MERCURY,1
,Reference:,1
10552-8,Tricyclics,1
5578-0,ANTIMONY (B),1
5700-0,NICKEL (B),1
5583-0,ARSENIC,1
15160-5,INTERPRETATION,1
8161-2,BISMUTH (B),1
3289-6,PROTHROMBIN MUTATION,2
54247-2,MEDMATCH ETG,2
54247-2,MEDMATCH ETS,2
54247-2,MEDMATCH BUPRENORPHINE,1
54247-2,MEDMATCH NORBUPRENORPHINE,1
22459-2,"VDRL, CSF SENDOUT",1
34563-7,"Xanthochromia, CSF",2
9597-6,"""""Lyme IgG AB, Western Blot, P93""""""""""""""""""""",1
9593-5,"""""Lyme IgG AB, Western Blot, P41""""""""""""""""""""",1
9594-3,"""""Lyme IgG AB, Western Blot, P45""""""""""""""""""""",1
9595-0,"""""Lyme IgG AB, Western Blot, P58""""""""""""""""""""",1
9596-8,"""""Lyme IgG AB, Western Blot, P66""""""""""""""""""""",1
9587-7,"""""Lyme IgM AB, Western Blot, P41""""""""""""""""""""",1
9598-4,"""""Lyme IgM AB, Western Blot, P23""""""""""""""""""""",1
9599-2,"""""Lyme IgM AB, Western Blot, P39""""""""""""""""""""",1
9588-5,"""""Lyme IgG AB, Western Blot, P18""""""""""""""""""""",1
9592-7,"""""Lyme IgG AB, Western Blot, P39""""""""""""""""""""",1
9589-3,"""""Lyme IgG AB, Western Blot, P23""""""""""""""""""""",1
9590-1,"""""Lyme IgG AB, Western Blot, P28""""""""""""""""""""",1
9591-9,"""""Lyme IgG AB, Western Blot, P30""""""""""""""""""""",1
34563-7,"Fluid Color, CSF",1
42192-5,"Stone Anaylsis, NIDUS",1
,"Stone Anaylsis, Please Note:",1
,"Stone Anaylsis, Surface Crystals",1
9802-0,"Stone Anaylsis, Size",1
9796-4,"Stone Anaylsis, Color",1
,"Stone Anaylsis, Composition",1
,"Stone Anaylsis, Comment (3)",1
,Flow LLS Tracking,1
,Jo-1 (WB)*,1
,Methamphetamine GC/MS Conf,1
,P66 AB.,1
,Mi-2 antibodies*,1
,"Beta-2 Glycoprotein I, IgG",1
,P23 AB.,2
,B-2 NMDP,1
,P30 AB.,1
,Signal Recognition Particle*,1
,B-1 NMDP,1
,Organism Identification,2
,RPR (DX) W/REFL TITER AND CONFIRMATORY TESTING,1
,Indications for Study,1
,CANDIDA:,1
,B1 EQUIVALENT,1
,Resulting ICD9:,1
,TEST METHOD,1
,DRVVT MIX INTERPRETATION:,1
,OJ*,1
,Final Interpretation,2
,DRVVT Ratio,1
,Clindamycin,2
,P18 AB.,1
,P41 AB.,1
,Immunophenotypic Profile,1
,P39 AB.,1
,B2 EQUIVALENT,1
,APTT 1:1 NP,1
,RPR (MONITOR) W/REFL TITER,1
,Clinical Information,1
,Fungus (Mycology) Culture,1
,P45 AB.,1
,P41,1
,B-1,1
,Cellularity Assessment,1
,PA Chest X-Ray Reading,1
,APTT 1:1 Saline,1
,"SPECIMEN SOURCE, WET PREP",4
,P93 AB.,1
,P39 Ab,1
,Flow Interpretation,1
,Viability,1
,LAC Interpretation,1
,GENERAL CATEGORIZATION:,1
,P28 AB.,1
,LUPUS ANTICOAGULANT,1
,Specimen Type,1
,B-2,1
,PL-12*,1
,"Beta-2 Glycoprotein I, IgA",1
,"MICROALBUMIN, 24 HOUR UR",1
2161-8,"CREATININE, 24 HOUR URINE",1
,P58 AB.,1
,Flow Comment,1
,"Rheumatoid Arthritis, Qn/Fluid",1
,"CULTURE, FUNGUS, W/SMEAR HAIR, SKIN, NAIL",1
,PICD10,1
,Ku*,1
,Aessessment of Leukocytes,1
,"Beta-2 Glycoprotein I, IgM",1
,GARDNERELLA:,1
,Clinician Provided ICD9,1
,Phenotype Chart,1
,HISTOCOMPATIBILITY LABORATORY INFORMATION,1
,EJ*,1
,PL-7*,1
,DRVVT Confirm Seconds,1
,Dianon Case Number,1
,PNH Flow Assay,1
14725-6,Fl Type CA125,1
14725-6,Fl Type Specific Grav,4
9542-2,Leg. pneumophilia 1 IgM,1
